Clustering O 0 4.2464154148547095e-07
of O 0 1.1743280481368856e-07
missense O 0 6.879023999317724e-07
mutations O 0 6.816778697071868e-09
in O 0 3.81291265227901e-09
the O 0 5.889493877475616e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 1.1846731467812788e-05
in O 0 5.037376293870466e-09
a O 0 5.9757030435036995e-09
sporadic B-Disease 1 0.7964593768119812
T I-Disease 1 0.9999966621398926
- I-Disease 0 0.17280332744121552
cell I-Disease 1 0.9883078932762146
leukaemia I-Disease 1 0.9999775886535645
. O 0 3.5121934160997625e-07

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999938011169434
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 5.254390256226316e-10
is O 0 2.3676017743556876e-11
a O 0 8.409598017955489e-11
recessive B-Disease 0 4.14246486002412e-08
multi I-Disease 0 0.001736010075546801
- I-Disease 0 0.00012130834511481225
system I-Disease 0 0.006482562981545925
disorder I-Disease 0 0.000984773738309741
caused O 0 3.0419142760251816e-09
by O 0 7.539662470745778e-12
mutations O 0 1.4343477794387383e-11
in O 0 2.3774667998188725e-11
the O 0 8.686867891682937e-10
ATM O 0 5.67450058497343e-07
gene O 0 1.9710588716748134e-09
at O 0 7.881747698945674e-09
11q22 O 0 2.4038303791940052e-08
- O 0 9.453407834314476e-09
q23 O 0 3.0408717321961376e-08
( O 0 9.120595945155685e-11
ref O 0 9.565132685906974e-09
. O 0 7.718831823710914e-11
3 O 0 9.694733016374357e-09
) O 0 3.18823772937904e-10
. O 0 3.6859857388549244e-09

The O 0 2.987572997881216e-07
risk O 0 1.7632049775784253e-07
of O 0 8.507993243256351e-08
cancer B-Disease 0 0.4271968901157379
, O 0 5.666483726685101e-09
especially O 0 4.305985346064745e-09
lymphoid B-Disease 0 0.0005491694901138544
neoplasias I-Disease 0 0.37065377831459045
, O 0 1.7035366450812717e-09
is O 0 6.065020707879398e-11
substantially O 0 2.7512545019980905e-10
elevated O 0 2.3265556592377834e-07
in O 0 3.5609279080972556e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.767857942842511e-08
and O 0 8.67257654579845e-11
has O 0 2.284260454399334e-11
long O 0 1.6191745860760776e-11
been O 0 8.011522001361016e-12
associated O 0 4.0364163400585795e-11
with O 0 4.174919021604495e-10
chromosomal O 1 1.0
instability O 1 1.0
. O 0 1.7383815702487482e-06

By O 0 1.1101887409381561e-08
analysing O 0 1.0846956683963072e-06
tumour B-Disease 1 1.0
DNA O 0 1.3207241522650293e-07
from O 0 1.788439396577246e-10
patients O 0 5.1918549320850715e-11
with O 0 2.8861220705000967e-11
sporadic B-Disease 0 0.005781548097729683
T I-Disease 1 0.9995667338371277
- I-Disease 0 2.1791043764096685e-05
cell I-Disease 0 0.09738250076770782
prolymphocytic I-Disease 1 0.9928440451622009
leukaemia I-Disease 1 0.9999985694885254
( O 0 9.848624138442119e-09
T B-Disease 0 8.588967466494069e-05
- I-Disease 0 1.4816964721831027e-07
PLL I-Disease 0 4.198062470095465e-06
) O 0 1.4054438168820127e-11
, O 0 5.909230570144697e-12
a O 0 3.9944460933361015e-11
rare O 0 1.5069198111561377e-09
clonal B-Disease 0 6.105513250531658e-08
malignancy I-Disease 0 5.0173376564544014e-08
with O 0 3.452975969389649e-12
similarities O 0 6.482365338955631e-11
to O 0 2.1373677133729174e-11
a O 0 1.1253425746815537e-08
mature B-Disease 0 2.399653169504745e-07
T I-Disease 0 0.0008826101548038423
- I-Disease 0 4.814123144569749e-07
cell I-Disease 0 1.538537435408216e-05
leukaemia I-Disease 0 0.10295169800519943
seen O 0 2.0428094771318683e-09
in O 0 1.3078819138812037e-09
A B-Disease 1 1.0
- I-Disease 1 0.5226616859436035
T I-Disease 1 0.9999997615814209
, O 0 2.1695081842132424e-10
we O 0 1.6651933304467903e-11
demonstrate O 0 2.4317447361310585e-11
a O 0 6.211096307412456e-12
high O 0 3.539261245188996e-11
frequency O 0 6.873119434702701e-11
of O 0 8.697876308083607e-10
ATM O 0 5.504547857526632e-07
mutations O 0 3.677628868103966e-09
in O 0 1.6951490877659126e-08
T B-Disease 0 0.01197371631860733
- I-Disease 0 2.3576438252348453e-05
PLL I-Disease 0 0.0007780519081279635
. O 0 3.374610457740346e-07

In O 0 1.0551147511250747e-08
marked O 0 2.041735314151083e-08
contrast O 0 8.730703937587236e-10
to O 0 5.857200141567986e-11
the O 0 1.742581412500499e-09
ATM O 0 2.361968654440716e-06
mutation O 0 4.085636273742921e-09
pattern O 0 1.2256670345323073e-08
in O 0 1.046157382944557e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999837875366211
T I-Disease 1 1.0
, O 0 3.236271250983691e-10
the O 0 1.6060112961735484e-10
most O 0 5.7169555547909034e-12
frequent O 0 1.2637786650504523e-11
nucleotide O 0 1.943625815847838e-10
changes O 0 5.377863085409551e-11
in O 0 3.7056632068432904e-11
this O 0 1.0619905649322803e-10
leukaemia B-Disease 0 8.130988135235384e-06
were O 0 6.701194266156563e-09
missense O 0 4.396622443891829e-07
mutations O 0 7.311818706057238e-08
. O 0 1.0565128150119563e-07

These O 0 1.100574742451954e-08
clustered O 0 5.707837047452813e-08
in O 0 9.736497164070101e-10
the O 0 5.78990633215426e-09
region O 0 4.6853489976683704e-09
corresponding O 0 1.0819500850800523e-09
to O 0 2.0056176164295891e-10
the O 0 3.84809872855385e-09
kinase O 0 1.2208909438982118e-08
domain O 0 2.296244971944361e-09
, O 0 2.916368882499576e-11
which O 0 2.197785790164497e-12
is O 0 3.770987428569628e-12
highly O 0 4.0540387019616375e-11
conserved O 0 1.6240375710907529e-10
in O 0 6.772066241111929e-10
ATM O 0 6.559238499903586e-06
- O 0 1.110120972924733e-08
related O 0 5.476785136515616e-10
proteins O 0 4.70256125706392e-11
in O 0 2.6456536961205757e-10
mouse O 0 7.206946595061936e-09
, O 0 5.963138316467109e-11
yeast O 0 1.0176827380803388e-08
and O 0 1.9039081422533854e-09
Drosophila O 0 3.6958508076168073e-07
. O 0 2.3830047268802446e-08

The O 0 5.912280016673321e-07
resulting O 0 4.227025272030005e-07
amino O 0 2.2880080052800622e-07
- O 0 2.970600689877756e-07
acid O 0 3.7666243457579185e-08
substitutions O 0 5.1064496631170186e-08
are O 0 1.8298244863768076e-10
predicted O 0 7.521662404030849e-09
to O 0 9.199689621208762e-11
interfere O 0 1.24469479167999e-09
with O 0 4.770090433758867e-10
ATP O 0 0.0001878688926808536
binding O 0 1.0246125725643651e-08
or O 0 2.120909559089057e-10
substrate O 0 6.9731114216153856e-09
recognition O 0 1.0489586088624492e-08
. O 0 2.2533923171863535e-08

Two O 0 9.404005574253915e-09
of O 0 6.032230004393568e-08
seventeen O 0 4.034937433061714e-07
mutated O 0 6.073058216315985e-07
T B-Disease 0 8.723836799617857e-06
- I-Disease 0 1.43778535743877e-07
PLL I-Disease 0 2.798424247885123e-06
samples O 0 9.28120802434762e-10
had O 0 2.435473489548201e-10
a O 0 8.07516137291131e-11
previously O 0 1.119587089704055e-09
reported O 0 2.3165082296827677e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999912977218628
T I-Disease 1 1.0
allele O 0 2.460158611938823e-06
. O 0 2.0034408976243867e-07

In O 0 8.895199243852403e-09
contrast O 0 3.737167908468564e-09
, O 0 5.117774537488629e-10
no O 0 4.3918155223643396e-10
mutations O 0 2.3770646562226716e-10
were O 0 2.13680212413081e-10
detected O 0 3.5657429786617456e-10
in O 0 4.4593068820875104e-11
the O 0 3.876754195442089e-10
p53 O 0 5.433273275734507e-10
gene O 0 2.7724572637666256e-10
, O 0 9.248347747348173e-12
suggesting O 0 2.928928280465648e-11
that O 0 1.976013536825194e-12
this O 0 8.626679232071055e-11
tumour B-Disease 1 1.0
suppressor O 0 3.1913489237922477e-06
is O 0 4.442514758840055e-11
not O 0 2.5127714579215032e-12
frequently O 0 2.3950659164273524e-12
altered O 0 1.4523333924376658e-10
in O 0 5.645592326963822e-11
this O 0 5.739785313707557e-10
leukaemia B-Disease 0 0.031655579805374146
. O 0 2.0469435924042045e-07

Occasional O 0 1.2261449455763795e-06
missense O 0 7.360680456258706e-07
mutations O 0 6.105977057302425e-09
in O 0 1.868551091632753e-09
ATM O 0 4.840510882786475e-06
were O 0 4.387848751008505e-09
also O 0 1.4756490473999406e-10
found O 0 9.367905756674233e-11
in O 0 3.9812136920502894e-10
tumour B-Disease 1 1.0
DNA O 0 1.207648381296167e-07
from O 0 9.70660149479663e-11
patients O 0 8.09165495024855e-12
with O 0 6.389279730290021e-12
B B-Disease 0 0.0038612980861216784
- I-Disease 0 3.4749385235954833e-07
cell I-Disease 0 0.08806619048118591
non I-Disease 1 0.9983161687850952
- I-Disease 1 0.9983291029930115
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 0 0.0033123278990387917
( O 0 3.789572267098862e-10
B B-Disease 0 1.1387688658714978e-07
- I-Disease 0 6.515017414443491e-10
NHL I-Disease 0 1.0440444064840904e-08
) O 0 3.67762287636908e-12
and O 0 1.1827328179336849e-11
a O 0 5.773218569871119e-10
B B-Disease 0 2.8979428634556825e-07
- I-Disease 0 4.287752020104563e-08
NHL I-Disease 0 7.034966529317899e-07
cell O 0 6.529728011628322e-07
line O 0 5.6339079179679175e-08
. O 0 1.781271485867819e-08

The O 0 1.212582745324653e-08
evidence O 0 2.732064352528596e-09
of O 0 1.903047719409301e-09
a O 0 3.3525693332592255e-10
significant O 0 1.0614600864933266e-10
proportion O 0 1.2893346112985427e-10
of O 0 2.702223556028116e-09
loss O 0 5.0117428429530264e-08
- O 0 4.525614549777401e-09
of O 0 9.368079645355465e-08
- O 0 5.355911270044089e-09
function O 0 6.259485374471296e-09
mutations O 0 8.976419607620301e-11
and O 0 1.6578757464080773e-11
a O 0 1.9335795464758831e-10
complete O 0 2.1994214449705396e-08
absence O 0 2.2096349638900392e-08
of O 0 3.884365273876256e-09
the O 0 2.6116162010758615e-10
normal O 0 1.1820207312940312e-10
copy O 0 1.265989257870359e-10
of O 0 1.764194762499116e-10
ATM O 0 9.214239149457626e-09
in O 0 1.2400561480441219e-11
the O 0 1.4039681917044078e-10
majority O 0 7.729557965907574e-11
of O 0 3.3984948188958697e-09
mutated O 0 2.2647596154001803e-07
tumours B-Disease 1 0.9999996423721313
establishes O 0 2.0865131844516327e-08
somatic O 0 3.032704398719943e-08
inactivation O 0 5.966036837889988e-07
of O 0 2.0647854537259036e-09
this O 0 1.601687879548841e-11
gene O 0 7.949149671837574e-11
in O 0 1.4290910468894857e-11
the O 0 4.795742691854343e-10
pathogenesis O 0 1.863990405581717e-06
of O 0 1.3169064949636322e-08
sporadic B-Disease 0 0.41856512427330017
T I-Disease 1 0.9990298748016357
- I-Disease 0 1.8036920664599165e-05
PLL I-Disease 0 0.00023836734180804342
and O 0 1.4669250258947386e-09
suggests O 0 3.419488303624263e-10
that O 0 2.087517311788467e-11
ATM O 0 3.92252388792258e-07
acts O 0 1.980031605341992e-08
as O 0 2.9524944711312173e-09
a O 0 3.7693698828888955e-08
tumour B-Disease 1 1.0
suppressor O 0 0.00010892380669247359
. O 0 1.494740899943281e-07

As O 0 4.295815259069968e-08
constitutional O 0 7.590640507260105e-07
DNA O 0 4.064877145992796e-08
was O 0 6.23912699282414e-09
not O 0 1.3837890035228728e-11
available O 0 2.0568002162546506e-11
, O 0 6.022576187758588e-11
a O 0 1.3038866653047876e-09
putative O 0 2.441397271013557e-07
hereditary O 1 0.9391695261001587
predisposition O 0 7.041725621093065e-05
to O 0 1.3133751508576097e-07
T B-Disease 1 0.9999624490737915
- I-Disease 0 4.9708229198586196e-05
PLL I-Disease 0 0.0006312206387519836
will O 0 2.7871810415192044e-10
require O 0 4.2043236947453266e-11
further O 0 7.722558703626703e-11
investigation O 0 3.667491033088055e-10
. O 0 4.144389276206084e-10
. O 0 1.7279631947531016e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 2.4593078705947846e-05
kinase O 0 6.895628530401154e-07
is O 0 2.9487054464816254e-10
involved O 0 9.206653668603071e-12
in O 0 5.226856707868377e-12
the O 0 5.7721143836841904e-11
modulation O 0 5.832454519349994e-10
of O 0 9.147744228776844e-10
the O 0 1.2809373561850634e-09
Ca2 O 0 4.095748185051207e-09
+ O 0 1.840333574421038e-08
homeostasis O 0 1.029951818054542e-06
in O 0 6.35946495464168e-09
skeletal O 0 0.0001114871192839928
muscle O 0 1.1033744158339687e-05
cells O 0 1.5343480299634393e-06
. O 0 9.048647342524418e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9988200068473816
DM B-Disease 1 1.0
) O 0 1.7272175911742238e-09
, O 0 4.005761000680508e-11
the O 0 1.2334447352380096e-10
most O 0 2.8040414434826744e-10
prevalent O 1 0.9329115152359009
muscular B-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
in O 0 4.548564636053243e-09
adults O 0 2.9275654817029206e-11
, O 0 3.433064813332387e-12
is O 0 3.844307251005263e-12
caused O 0 1.8265153278740343e-10
by O 0 6.53308240838868e-11
( O 0 3.560399544633164e-11
CTG O 0 7.280548430799172e-08
) O 0 1.2980608341678357e-12
n O 0 3.59108992542545e-11
- O 0 4.356654967341278e-11
repeat O 0 1.7905622817782074e-10
expansion O 0 1.9360631153819696e-10
in O 0 1.6632443686215304e-11
a O 0 4.883132787014688e-11
gene O 0 8.613788848865767e-11
encoding O 0 2.512798025211538e-10
a O 0 1.148982908816265e-09
protein O 0 2.9280151636612572e-09
kinase O 0 6.317613099326991e-08
( O 0 8.790427052929317e-09
DM B-Disease 1 0.9999979734420776
protein O 0 4.0546403567987e-08
kinase O 0 1.2671090843241473e-08
; O 0 1.5991032109585746e-10
DMPK O 0 2.2072902083891677e-06
) O 0 1.7768203575130315e-11
and O 0 1.1542357347682497e-11
involves O 0 2.0949761023181246e-11
changes O 0 2.9097514328557672e-11
in O 0 8.094931669422323e-11
cytoarchitecture O 0 9.435847658778584e-08
and O 0 2.2854480530298815e-09
ion O 0 1.968683363884338e-06
homeostasis O 0 0.0002631223760545254
. O 0 5.393906690187578e-07

To O 0 6.795190632402637e-09
obtain O 0 1.1206943817398951e-08
clues O 0 7.3126944499790625e-09
to O 0 4.3444321057295454e-11
the O 0 4.795779884325668e-10
normal O 0 1.2886418598867522e-09
biological O 0 3.169909001954352e-09
role O 0 6.667965068984927e-10
of O 0 2.988579606011399e-09
DMPK O 0 9.714312000141945e-06
in O 0 4.607776826759391e-09
cellular O 0 1.0480230372422739e-07
ion O 0 1.0897051083702536e-07
homeostasis O 0 1.7735643496052944e-06
, O 0 6.469373925455102e-10
we O 0 6.599686075414724e-11
have O 0 4.619217768703221e-12
compared O 0 2.634775037035908e-11
the O 0 3.3098090934657876e-10
resting O 0 4.945912568388167e-09
[ O 0 1.0002371847450675e-10
Ca2 O 0 1.7810683483610035e-11
+ O 0 7.329890860940935e-11
] O 0 4.3861539400502636e-11
i O 0 9.668938392992654e-12
, O 0 2.5153657368798266e-12
the O 0 6.237736889513901e-12
amplitude O 0 1.3771465912082448e-10
and O 0 1.0219449418646942e-11
shape O 0 1.6246572143163718e-10
of O 0 5.624357091171817e-10
depolarization O 0 1.2885638334125815e-08
- O 0 3.53875173608742e-09
induced O 0 2.2669848220857602e-08
Ca2 O 0 5.954140513964035e-10
+ O 0 4.553440402510489e-10
transients O 0 1.0532603678115038e-09
, O 0 2.952428015609576e-12
and O 0 9.058382299462209e-13
the O 0 9.816633617099058e-12
content O 0 1.0487289855976023e-11
of O 0 6.757098769405445e-10
ATP O 0 1.2429752587195253e-06
- O 0 1.6331429542049136e-09
driven O 0 2.069887816702476e-09
ion O 0 6.00496408154072e-09
pumps O 0 3.1433036173922346e-09
in O 0 3.3137270705196897e-09
cultured O 0 1.2173802588222316e-07
skeletal O 0 0.000251662393566221
muscle O 0 1.0945544914875427e-07
cells O 0 4.991582258639937e-09
of O 0 1.0110542625341168e-08
wild O 0 7.175799510150682e-08
- O 0 3.8392919399221626e-10
type O 0 3.397540304650448e-10
and O 0 5.5854626479501235e-11
DMPK O 0 8.277847314275277e-07
[ O 0 1.6751883213927954e-09
- O 0 3.184149388602009e-09
/ O 0 3.376277035727071e-08
- O 0 4.756303795261374e-08
] O 0 3.7379184192332104e-08
knockout O 0 0.0005194833502173424
mice O 0 1.5955758954078192e-06
. O 0 3.6928980762240826e-08

In O 0 6.458579804302644e-08
vitro O 0 5.128156885803037e-07
- O 0 1.9757862901315093e-07
differentiated O 0 1.5345163717483956e-07
DMPK O 0 3.241221929783933e-05
[ O 0 3.431840767120775e-08
- O 0 3.057330033584549e-08
/ O 0 1.4002235104726424e-07
- O 0 2.9971438664233574e-08
] O 0 3.802403725217118e-09
myotubes O 0 7.782261945976643e-08
exhibit O 0 4.457236357779948e-09
a O 0 9.584998350575802e-10
higher O 0 8.741434243120239e-10
resting O 0 1.3258207864907945e-08
[ O 0 3.8169561955569975e-10
Ca2 O 0 1.492471146669061e-10
+ O 0 5.403962832772891e-10
] O 0 4.1332109956826457e-10
i O 0 4.9538664836923374e-11
than O 0 3.5534032313822017e-12
do O 0 5.995833603916756e-12
wild O 0 3.1844165082617337e-09
- O 0 2.3938628856967625e-10
type O 0 3.389707958767474e-10
myotubes O 0 1.458497589368335e-08
because O 0 2.7854206788302527e-11
of O 0 1.8693414871595593e-10
an O 0 8.770049790551848e-12
altered O 0 1.7032367183311692e-10
open O 0 3.9650191463458384e-10
probability O 0 1.7292869913809739e-10
of O 0 3.96617655384901e-10
voltage O 0 3.0921416538376434e-08
- O 0 5.206049813466507e-09
dependent O 0 5.145542325557528e-10
l O 0 3.763188094474401e-10
- O 0 1.577148550646612e-10
type O 0 1.2582737629607266e-10
Ca2 O 0 1.4308863816037132e-10
+ O 0 3.7739558700344844e-10
and O 0 1.0855835674838943e-10
Na O 0 4.3651127157318115e-08
+ O 0 1.0446773446304292e-09
channels O 0 1.3734015036348524e-09
. O 0 4.518128093877749e-09

The O 0 4.6135698994476115e-07
mutant O 0 5.559987243941578e-07
myotubes O 0 1.0796891274367226e-06
exhibit O 0 2.518933328587991e-08
smaller O 0 4.36028990691284e-10
and O 0 2.856125058681158e-10
slower O 0 3.3199776261483294e-09
Ca2 O 0 1.3715192315189029e-09
+ O 0 6.304679001090108e-10
responses O 0 2.187014978838331e-11
upon O 0 7.630927834068046e-11
triggering O 0 9.571716752532211e-10
by O 0 1.6778599343236777e-11
acetylcholine O 0 1.6441264349964513e-08
or O 0 1.7321787060264882e-10
high O 0 2.736634385769321e-08
external O 0 1.1852960568603521e-07
K O 0 3.2521720072509197e-07
+ O 0 3.7857756041148605e-08
. O 0 1.1714171854748656e-08

In O 0 7.75949349218763e-09
addition O 0 7.576951288612577e-10
, O 0 1.6629882193530676e-10
we O 0 1.8870731366416038e-11
observed O 0 1.513794645191524e-11
that O 0 4.127572307381644e-13
these O 0 1.891684942370575e-12
Ca2 O 0 2.5946009230004563e-10
+ O 0 1.0521601367941003e-09
transients O 0 5.2395012772876726e-09
partially O 0 6.108012429173471e-10
result O 0 1.8451108696471152e-11
from O 0 1.810851707299832e-12
an O 0 1.2095497129924193e-12
influx O 0 9.204687359543051e-12
of O 0 8.477495094805221e-11
extracellular O 0 2.4283117183721004e-10
Ca2 O 0 1.0194244060013347e-10
+ O 0 5.5041984858839044e-11
through O 0 6.3892185812874924e-12
the O 0 6.201629487723181e-11
l O 0 6.23307863656386e-11
- O 0 5.446000941877749e-11
type O 0 1.5746777493053088e-10
Ca2 O 0 4.5155587602430103e-10
+ O 0 1.2063651189109237e-09
channel O 0 1.176996100582528e-08
. O 0 4.738951453475693e-09

Neither O 0 1.439305350459108e-07
the O 0 8.574849275078122e-09
content O 0 4.3677733652103257e-10
nor O 0 8.654469363378325e-10
the O 0 6.502078736536632e-11
activity O 0 1.061842697103188e-10
of O 0 6.059335255770293e-10
Na O 0 1.2966955864612828e-07
+ O 0 3.3233353846640057e-09
/ O 0 1.3356180161849807e-08
K O 0 4.036712741850579e-09
+ O 0 4.054241942164083e-10
ATPase O 0 6.511141070753013e-10
and O 0 1.7219538295254466e-10
sarcoplasmic O 0 2.2363979113038113e-08
reticulum O 0 5.930670177178854e-09
Ca2 O 0 2.3371349300305155e-09
+ O 0 4.070577652726115e-09
- O 0 2.001961041386835e-09
ATPase O 0 2.5234905276505515e-09
are O 0 8.331267967176537e-12
affected O 0 1.870503231471421e-11
by O 0 1.9894329239544817e-10
DMPK O 0 0.00014316699525807053
absence O 0 3.8426846913353074e-06
. O 0 1.7583285227829037e-07

In O 0 3.415183513766351e-08
conclusion O 0 7.399603418889455e-08
, O 0 1.0327230182127778e-09
our O 0 1.6120139945119405e-10
data O 0 1.7021455078758407e-10
suggest O 0 6.773663574488609e-11
that O 0 2.1591702384360367e-11
DMPK O 0 7.1278905124927405e-06
is O 0 1.2783739344879308e-10
involved O 0 1.6282704351500144e-11
in O 0 1.1223912424473959e-11
modulating O 0 1.9962911324000743e-09
the O 0 2.9676971990966194e-10
initial O 0 2.462241521783426e-10
events O 0 5.0992200045785196e-11
of O 0 2.1931787497209143e-09
excitation O 0 2.7663913897413295e-06
- O 0 1.3025770613239729e-06
contraction O 0 3.9031573351167026e-07
coupling O 0 1.5773629513660126e-07
in O 0 2.717565728005411e-08
skeletal O 0 0.00810589361935854
muscle O 0 4.00567842007149e-06
. O 0 6.046202827292291e-08
. O 0 5.214957710109047e-08

Constitutional O 0 0.00030727018020115793
RB1 O 0 0.002980315824970603
- O 0 1.388125951962138e-06
gene O 0 4.469011827268332e-08
mutations O 0 4.528826647032247e-09
in O 0 4.520177565581207e-10
patients O 0 3.7040115419273434e-10
with O 0 3.6283878679377324e-10
isolated O 0 8.00295947556151e-06
unilateral B-Disease 0 0.003493894124403596
retinoblastoma I-Disease 1 0.9988980293273926
. O 0 3.043383685508161e-06

In O 0 9.319870031276878e-08
most O 0 1.0421621787770619e-08
patients O 0 6.276746344902051e-10
with O 0 1.8642426491410902e-10
isolated O 0 8.914751106203767e-07
unilateral B-Disease 0 0.0019712517969310284
retinoblastoma I-Disease 1 0.9984242916107178
, O 0 1.6268295155441592e-08
tumor B-Disease 0 1.635362082197389e-06
development O 0 4.162898026294215e-09
is O 0 2.6090903743059002e-11
initiated O 0 2.973136459250014e-10
by O 0 3.8197583984711514e-11
somatic O 0 4.767854999698784e-09
inactivation O 0 1.7411429098501685e-07
of O 0 8.148114960526698e-10
both O 0 1.5197688593704406e-11
alleles O 0 2.8669573659545478e-11
of O 0 9.443453796720291e-10
the O 0 3.28369829105668e-08
RB1 O 0 5.907532249693759e-05
gene O 0 3.42109075290864e-07
. O 0 1.3636287121698842e-07

However O 0 4.261953989725953e-08
, O 0 1.2431857765449195e-09
some O 0 3.445129251322676e-11
of O 0 2.4659276842697864e-09
these O 0 2.2350822581618246e-10
patients O 0 1.6648735168267592e-10
can O 0 2.8519372627378026e-11
transmit O 0 1.1309262859526825e-08
retinoblastoma B-Disease 0 1.8877743059420027e-05
predisposition O 0 6.637998239966691e-08
to O 0 1.758641149374185e-10
their O 0 1.2514530522977907e-09
offspring O 0 1.2573130092619067e-08
. O 0 1.9317530686180362e-08

To O 0 6.65708710378965e-10
determine O 0 3.8849556904807514e-10
the O 0 2.161528317445871e-10
frequency O 0 1.7344408131947375e-09
and O 0 3.209799440129224e-11
nature O 0 6.15520190372365e-10
of O 0 4.4703138968316125e-09
constitutional O 0 4.042276941618184e-06
RB1 O 0 6.169058906380087e-05
- O 0 2.6048082801821693e-08
gene O 0 3.33405902885886e-09
mutations O 0 3.921771241088834e-10
in O 0 1.3835338430467914e-10
patients O 0 4.569533640363943e-11
with O 0 6.049666323448832e-11
isolated O 0 3.81267540205954e-07
unilateral B-Disease 0 1.0052635843749158e-05
retinoblastoma I-Disease 0 0.00012322349357418716
, O 0 1.5760487359628428e-09
we O 0 1.51665374703569e-10
analyzed O 0 6.672825070275223e-10
DNA O 0 3.745845855718244e-09
from O 0 3.3195390880536024e-10
peripheral O 0 1.0103941576744546e-06
blood O 0 5.481177289823336e-09
and O 0 2.2853303693892713e-09
from O 0 7.959109815658394e-09
tumor B-Disease 0 0.003024898236617446
tissue O 0 2.8561758881551214e-05
. O 0 6.089633188821608e-07

The O 0 3.296348793924153e-08
analysis O 0 6.23151574785652e-09
of O 0 9.663887112765224e-08
tumors B-Disease 1 0.9999972581863403
from O 0 1.417187145413834e-09
54 O 0 8.416345842476858e-09
( O 0 3.847588567196247e-11
71 O 0 7.486138819956523e-09
% O 0 1.0952524998053548e-10
) O 0 6.00642148865238e-12
of O 0 4.4792561326723046e-10
76 O 0 2.7256950474452424e-08
informative O 0 3.2992470977433186e-09
patients O 0 1.4647406898493642e-10
showed O 0 1.3303798063191152e-09
loss O 0 8.440781407159648e-09
of O 0 3.98408879220824e-08
constitutional O 0 5.30431270817644e-06
heterozygosity O 0 1.8808877939591184e-05
( O 0 2.157625544896291e-08
LOH O 1 0.9997366070747375
) O 0 4.311351720076573e-09
at O 0 2.980867748192395e-07
intragenic O 0 1.7230306184501387e-05
loci O 0 2.044827851932496e-06
. O 0 5.296142262523063e-07

Three O 0 3.8490401976787325e-08
of O 0 2.4850851332303137e-07
13 O 0 3.248866050853394e-06
uninformative O 0 0.0013918796321377158
patients O 0 1.4044978513538808e-07
had O 0 3.243560797727696e-08
constitutional O 0 3.044654931727564e-06
deletions O 0 8.687420631758869e-07
. O 0 2.3372123791887134e-07

For O 0 9.404494250020434e-08
39 O 0 2.8391607997946267e-07
randomly O 0 1.0760174085078233e-08
selected O 0 9.952563573278894e-08
tumors B-Disease 1 0.9999998807907104
, O 0 5.708968942030879e-08
SSCP O 0 0.16596652567386627
, O 0 4.698076594422673e-08
hetero O 0 2.2376978847660212e-07
- O 0 6.300859389796187e-09
duplex O 0 1.1582954151378999e-08
analysis O 0 1.2587227093963094e-10
, O 0 1.1033496165324674e-11
sequencing O 0 9.757574609414732e-11
, O 0 1.5537925113218165e-11
and O 0 2.8356433520726476e-11
Southern O 0 1.2221483824959023e-09
blot O 0 7.302769944317333e-09
analysis O 0 1.389452164435312e-10
were O 0 4.8406150615631915e-11
used O 0 1.6648408346364718e-11
to O 0 4.706733613968339e-11
identify O 0 2.0582189286244557e-09
mutations O 0 2.730929971050955e-08
. O 0 5.3641031172446674e-08

Mutations O 0 1.5869087377495816e-08
were O 0 8.278749907830729e-10
detected O 0 5.351793452845754e-10
in O 0 9.252675015058998e-11
21 O 0 6.849243394668747e-09
( O 0 4.262687425260481e-11
91 O 0 5.059581198452179e-09
% O 0 9.468628658915179e-11
) O 0 1.3279193716853044e-11
of O 0 2.9530686784795535e-09
23 O 0 2.1714911326853326e-06
tumors B-Disease 1 1.0
with O 0 3.786484228385234e-07
LOH O 1 1.0
. O 0 1.4580936067432049e-06

In O 0 8.662516925994623e-09
6 O 0 5.549345161171004e-08
( O 0 1.6873377695070246e-10
38 O 0 1.1566038127241995e-09
% O 0 1.0271082595547654e-10
) O 0 1.1852665550426966e-11
of O 0 1.4449870189281455e-09
16 O 0 1.278237050428288e-06
tumors B-Disease 1 1.0
without O 0 2.5523032576302285e-08
LOH O 1 0.9999064207077026
, O 0 6.067219643357546e-11
one O 0 6.2687116782200736e-12
mutation O 0 1.4497255826362299e-11
was O 0 2.5252711033374453e-10
detected O 0 9.960848812440304e-11
, O 0 2.0765279686724147e-12
and O 0 1.8192921127924144e-12
in O 0 3.517671223751684e-11
9 O 0 5.381378009872151e-09
( O 0 6.235382002395262e-12
56 O 0 3.1211910833661705e-10
% O 0 2.30463200606712e-11
) O 0 5.982981471364113e-12
of O 0 9.592295846516663e-10
the O 0 9.498632635995818e-08
tumors B-Disease 1 1.0
without O 0 8.266055573358244e-08
LOH O 1 0.999992847442627
, O 0 1.903355112409244e-10
both O 0 7.060040052575545e-11
mutations O 0 5.920099965806003e-10
were O 0 2.131357090817687e-09
found O 0 7.74788411206373e-09
. O 0 3.733763875857221e-08

Thus O 0 3.458691111291046e-08
, O 0 3.147093419197944e-10
a O 0 2.1478757661341774e-10
total O 0 2.7397445423460454e-10
of O 0 7.492977349699004e-10
45 O 0 1.1069806182817388e-09
mutations O 0 2.0436619063701755e-10
were O 0 2.4490989791736695e-10
identified O 0 7.73853037205896e-10
in O 0 2.1266546301745848e-09
tumors B-Disease 1 1.0
of O 0 2.907869657065021e-06
36 O 0 8.177349627658259e-06
patients O 0 2.80632974636319e-07
. O 0 2.5835524297690426e-07

Thirty O 0 6.198250730449217e-07
- O 0 1.9993825262076825e-08
nine O 0 5.123832469422496e-09
of O 0 6.415898923251007e-09
the O 0 2.4496793482597923e-09
mutations O 0 4.684524990139494e-10
- O 0 1.7156830400821832e-09
including O 0 9.211809093301326e-10
34 O 0 7.918559141728565e-09
small O 0 4.508312612117038e-10
mutations O 0 3.3021224643547953e-10
, O 0 1.126412990659631e-10
2 O 0 7.417829017697386e-09
large O 0 5.811766068397617e-10
structural O 0 1.2716373021248728e-06
alterations O 0 2.1919048265317542e-07
, O 0 1.188425802212123e-09
and O 0 7.782715027992992e-10
hypermethylation O 0 0.00035536743234843016
in O 0 3.184946706369374e-08
3 O 0 5.5660053476458415e-05
tumors O 1 1.0
- O 0 6.4593166371196276e-09
were O 0 2.419043021451017e-10
not O 0 4.025934533663511e-12
detected O 0 8.71379635114522e-11
in O 0 1.7618668676777638e-11
the O 0 4.752118698547747e-10
corresponding O 0 7.35126404194375e-09
peripheral O 0 2.0461486201384105e-05
blood O 0 7.595826900796965e-08
DNA O 0 3.715425407335715e-07
. O 0 1.7741239588531243e-08

In O 0 1.17866072457673e-08
6 O 0 6.548260955696605e-08
( O 0 1.0942043798811696e-10
17 O 0 7.227509146723321e-10
% O 0 2.7260129917272558e-11
) O 0 1.6381476253615745e-12
of O 0 2.0840332237703763e-10
the O 0 2.0128847477707268e-09
36 O 0 5.528825397504988e-09
patients O 0 9.646139442764934e-11
, O 0 1.828347889754056e-11
a O 0 7.436946197758587e-11
mutation O 0 1.3619072536386057e-10
was O 0 4.626699856569161e-10
detected O 0 8.787903738038949e-11
in O 0 1.7423172279928956e-11
constitutional O 0 4.945761133967608e-09
DNA O 0 1.4895398248171432e-09
, O 0 1.6414106185358435e-11
and O 0 1.4178291353472705e-11
1 O 0 1.6367822652796349e-09
of O 0 4.867642955375118e-10
these O 0 1.1183460407737655e-11
mutations O 0 3.4820514527300617e-11
is O 0 6.171748008487743e-12
known O 0 8.395554217111023e-12
to O 0 2.0417235610525886e-12
be O 0 7.300865641213239e-12
associated O 0 7.576311106261002e-11
with O 0 1.1302114799605079e-10
reduced O 0 5.6860983477236e-07
expressivity O 0 1.6373458493035287e-05
. O 0 2.412116657524166e-07

The O 0 2.2755491713155607e-08
presence O 0 5.868877606118872e-10
of O 0 4.886211879551183e-09
a O 0 3.812359761212747e-09
constitutional O 0 2.393285853941052e-07
mutation O 0 3.3440514801696963e-09
was O 0 1.2145056071943827e-09
not O 0 1.343412902622687e-12
associated O 0 3.88282591842759e-12
with O 0 6.970823657886926e-13
an O 0 3.685333288538928e-12
early O 0 7.161522042054003e-09
age O 0 7.222028308717654e-09
at O 0 1.913442275736088e-07
treatment O 0 6.561801768611986e-08
. O 0 4.510707896088206e-08

In O 0 1.3351052530197194e-07
1 O 0 3.6188582726026652e-06
patient O 0 1.6735707220050244e-07
, O 0 2.9476217022761375e-09
somatic O 0 3.5941457099397667e-07
mosaicism O 0 5.0820062824641354e-06
was O 0 1.0417091189651728e-08
demonstrated O 0 1.431743612556602e-10
by O 0 2.9836484845280342e-12
molecular O 0 8.463923312218569e-11
analysis O 0 9.425126477891066e-12
of O 0 1.0011609596904947e-10
DNA O 0 7.158718617894522e-10
and O 0 7.954518294051027e-11
RNA O 0 1.3408812726822816e-08
from O 0 1.6549519532560453e-09
peripheral O 0 2.5230374376405962e-05
blood O 0 6.491746944448096e-07
. O 0 3.872871161547664e-07

In O 0 8.593060130124286e-08
2 O 0 1.0641996368576656e-06
patients O 0 1.1152095913402604e-09
without O 0 9.582251658812879e-11
a O 0 2.548093125387396e-10
detectable O 0 1.1177958469943405e-07
mutation O 0 5.45183398426019e-10
in O 0 1.0107949199866795e-10
peripheral O 0 2.0396419131429866e-07
blood O 0 6.184928680319501e-10
, O 0 1.950853506516026e-10
mosaicism O 0 1.9704712030943483e-06
was O 0 7.935024193272966e-09
suggested O 0 1.3673889798226924e-10
because O 0 7.150864102245524e-12
1 O 0 2.871672455384555e-09
of O 0 1.0744234391069085e-09
the O 0 6.7753767041267565e-09
patients O 0 4.749773907519739e-09
showed O 0 7.568189062112651e-07
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 2.7619713183213435e-09
the O 0 3.786301050467955e-09
other O 0 9.587388521969942e-11
later O 0 6.026420695803836e-09
developed O 0 7.300667181908693e-09
bilateral B-Disease 0 1.936926423695695e-07
retinoblastoma I-Disease 0 2.36210416915128e-05
. O 0 1.7600733315248362e-07

In O 0 9.97846694161808e-09
conclusion O 0 2.8313781541555727e-08
, O 0 6.406724595287017e-10
our O 0 4.688279209297264e-10
results O 0 1.6996799800939044e-10
emphasize O 0 1.8183744787680922e-10
that O 0 2.4130081613393806e-12
the O 0 1.3816243982223142e-10
manifestation O 0 5.019366966507732e-08
and O 0 1.679227867867894e-10
transmissibility O 0 8.465340783914144e-08
of O 0 1.7999522983203065e-09
retinoblastoma B-Disease 0 2.087607775536071e-08
depend O 0 3.4496072665035626e-11
on O 0 5.7102562261990286e-11
the O 0 1.8102862958668808e-11
nature O 0 3.5228684552857104e-11
of O 0 2.2343661643109414e-10
the O 0 3.651436930596219e-10
first O 0 3.6272462811126616e-10
mutation O 0 2.2545205979884742e-10
, O 0 1.8319467470773176e-11
its O 0 3.497640718719275e-11
time O 0 9.748923890384731e-11
in O 0 5.974307160094838e-11
development O 0 1.581354380775224e-09
, O 0 2.406501387053339e-11
and O 0 3.001281168035774e-11
the O 0 2.572926871557968e-10
number O 0 2.86132117999216e-10
and O 0 6.511188116453681e-11
types O 0 5.40567424156535e-10
of O 0 1.7085282077999864e-09
cells O 0 1.8993044637038992e-10
that O 0 6.00712014853233e-12
are O 0 9.154088077834022e-12
affected O 0 1.6196202712315255e-10
. O 0 3.902177747594493e-10
. O 0 1.6007740910595203e-08

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
of I-Disease 1 0.5906195044517517
the I-Disease 0 1.7766078599379398e-05
fifth I-Disease 0 1.1189887118234765e-05
component I-Disease 0 2.70528374812784e-07
of I-Disease 0 6.728065926608906e-08
complement I-Disease 0 4.549920618046599e-08
in O 0 3.592383635009355e-08
man O 0 7.823098258086247e-07
. O 0 2.699165975172946e-07

I O 0 0.00040145308594219387
. O 0 8.004394658200908e-06

Clinical O 0 0.0001965076371561736
, O 0 1.5157681332311768e-07
immunochemical O 0 4.24917416239623e-05
, O 0 2.993738945633595e-08
and O 0 4.203317693907138e-09
family O 0 1.5932343222502254e-09
studies O 0 2.2952390210662088e-08
. O 0 5.810552750062925e-08

The O 0 4.0797669242920165e-08
first O 0 7.48596740152152e-09
recognized O 0 2.8158890330587383e-08
human O 0 2.4239135143488966e-08
kindred O 0 1.0873937981159543e-06
with O 0 1.763577550661921e-08
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999908208847046
the I-Disease 0 0.00032524444395676255
fifth I-Disease 0 7.782411557855085e-06
component I-Disease 0 8.853547228682146e-08
of I-Disease 0 1.0916896542312315e-07
complement I-Disease 0 1.3618391392355989e-07
( O 0 7.860983863849924e-09
C5 O 0 0.421589195728302
) O 0 6.182463985204834e-10
is O 0 6.760631499069802e-10
described O 0 1.735748966780193e-08
. O 0 3.428929318260998e-08

The O 0 3.417953564621712e-07
proband O 0 7.232290499814553e-06
, O 0 5.405501379840416e-09
a O 0 1.4049091889845045e-09
20 O 0 1.2002119298415437e-09
- O 0 8.81268336083707e-10
year O 0 6.137312325016353e-10
- O 0 1.1565227886478624e-08
old O 0 3.688195704398822e-08
black O 0 2.522792641457272e-09
female O 0 1.5505959016781645e-10
with O 0 8.577516474872482e-09
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9750428795814514
age O 0 5.923991466261214e-07
11 O 0 1.4639272194472142e-07
, O 0 1.1353650242185154e-09
lacked O 0 2.7907594812859315e-07
serum O 0 7.211115615746166e-08
hemolytic O 0 0.0033637769520282745
complement O 0 3.4479399335651806e-09
activity O 0 2.186032688200612e-09
, O 0 3.5354760785644146e-11
even O 0 3.0113210536253376e-11
during O 0 4.951160370580965e-09
remission O 0 1.7386370245731086e-06
. O 0 6.907430361025035e-08

C5 O 0 0.014998389407992363
was O 0 3.5104965263599297e-06
undetectable O 0 6.237907655304298e-06
in O 0 3.817380633819312e-09
her O 0 2.045939667683072e-10
serum O 0 1.5189240976098972e-09
by O 0 2.792161502007673e-10
both O 0 1.9345247626034734e-09
immunodiffusion O 0 1.2109011549910065e-05
and O 0 4.8566672461447524e-08
hemolytic O 1 0.9998302459716797
assays O 0 4.024275767733343e-06
. O 0 3.143767344226944e-07

Other O 0 7.895254450218658e-10
complement O 0 1.0111541604018726e-09
components O 0 8.144140473120842e-09
were O 0 3.934275683015187e-10
normal O 0 9.201607253928046e-10
during O 0 1.8042901617221219e-09
remission O 0 2.1422323470687843e-07
of O 0 1.3648919150455185e-07
lupus O 1 0.8845033049583435
, O 0 8.713040955399265e-09
but O 0 7.587121153562748e-09
C1 O 0 1.2263249118404929e-05
, O 0 9.033331416219426e-09
C4 O 1 0.9917438626289368
, O 0 1.8279077806937494e-08
C2 O 0 6.929492997187481e-07
, O 0 1.027810392351114e-09
and O 0 3.392271130664426e-09
C3 O 0 0.0058407108299434185
levels O 0 2.303037490491988e-06
fell O 0 7.5739390013040975e-06
during O 0 5.068098403171462e-07
exacerbations O 0 0.066367007791996
. O 0 3.6393674918144825e-07

A O 0 3.622761141741648e-05
younger O 0 4.912163831249927e-08
half O 0 1.3399046316919794e-08
- O 0 6.706375188514357e-08
sister O 0 1.746452227280315e-08
, O 0 1.3423545608404197e-09
who O 0 4.1363026892504706e-10
had O 0 1.876740984840808e-09
no O 0 1.0140825956739263e-08
underlying O 1 0.9977312684059143
disease O 1 0.9999961853027344
, O 0 4.453885871225083e-10
was O 0 1.6390105272989786e-08
also O 0 1.66794383860136e-10
found O 0 7.165257970287442e-11
to O 0 9.735600520199839e-11
lack O 0 1.1841858622574364e-06
immunochemically O 0 0.013829691335558891
detectable O 1 0.9975510239601135
C5 O 1 0.8398600816726685
. O 0 4.416858132572088e-07

By O 0 1.7819009201502922e-07
hemolytic O 1 0.9986340403556824
assay O 0 1.354589699076314e-06
, O 0 3.892597355559246e-09
she O 0 8.194321610144328e-11
exhibited O 0 1.4856866847878791e-09
1 O 0 1.4550298743642998e-08
- O 0 3.54168722127568e-10
2 O 0 5.051633000796585e-10
% O 0 5.265953038208204e-12
of O 0 9.17485878937363e-11
the O 0 7.767633203314972e-10
normal O 0 3.244798207902022e-08
serum O 0 3.0790587857154605e-08
C5 O 0 2.3789280021446757e-05
level O 0 4.806058839790239e-08
and O 0 2.336392711244084e-11
normal O 0 2.2107456143505289e-10
concentrations O 0 2.2008250777361127e-10
of O 0 1.1824108359093088e-10
other O 0 2.3515753580505283e-11
complement O 0 2.0592674232489117e-09
components O 0 3.028661410553468e-07
. O 0 7.867361517810423e-08

C5 O 0 0.0025470617692917585
levels O 0 2.9383562605289626e-07
of O 0 7.684514002903597e-08
other O 0 2.9998803441344535e-10
family O 0 1.7811338515194564e-10
members O 0 5.854229601087724e-11
were O 0 6.03113226027574e-10
either O 0 3.1453170623585436e-10
normal O 0 1.4602232312199703e-08
or O 0 8.060020012523594e-11
approximately O 0 6.162541310583691e-11
half O 0 2.1899380919787603e-10
- O 0 8.170867316081853e-10
normal O 0 2.511031382823603e-09
, O 0 3.36598422745471e-11
consistent O 0 9.165173620040434e-10
with O 0 9.70443655989861e-11
autosomal O 0 2.6843284217648034e-07
codominant O 0 5.232343482930446e-07
inheritance O 0 5.665410918176406e-10
of O 0 3.7173172873217197e-10
the O 0 1.8355231778954817e-09
gene O 0 1.0295065067111864e-07
determining O 0 3.989316610386595e-06
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 7.473831374227302e-06

Normal O 0 1.490565136919031e-05
hemolytic O 0 0.07190926373004913
titers O 0 1.19920548513619e-06
were O 0 1.3136220999854231e-09
restored O 0 1.4345990173580958e-08
to O 0 1.7007785804712405e-11
both O 0 2.3310969821110916e-10
homozygous O 0 2.488811696821358e-05
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 3.706870543851437e-08
C5D B-Disease 1 1.0
) O 0 6.984645500862641e-11
sera O 0 1.7269211616266489e-09
by O 0 7.47177666959864e-12
addition O 0 6.347534303730029e-11
of O 0 2.6827446930610677e-09
highly O 0 4.30490310066034e-08
purified O 0 7.714031369232544e-08
human O 0 1.0010114692704519e-07
C5 O 0 0.0003070309467148036
. O 0 1.8443049043526116e-07

In O 0 7.02761795423612e-08
specific O 0 5.4750465494635137e-08
C5 O 0 6.177548493724316e-05
titrations O 0 1.378550678055035e-07
, O 0 1.6046455830753814e-10
however O 0 3.005910104159071e-11
, O 0 4.196710253617786e-12
it O 0 5.746546359423899e-13
was O 0 9.458196031930655e-11
noted O 0 6.801573193548904e-12
that O 0 2.7405868915399145e-13
when O 0 1.9911620095791616e-12
limited O 0 1.2716710497129302e-11
amounts O 0 5.082641772735652e-12
of O 0 7.67754804176235e-10
C5 O 0 6.85829206759081e-07
were O 0 4.090172367465783e-10
assayed O 0 2.031665280455286e-09
in O 0 1.4576026149959453e-11
the O 0 3.782673480001719e-11
presence O 0 2.5205346490531078e-11
of O 0 6.031155019847745e-10
low O 0 2.8539007601580124e-08
dilutions O 0 2.682322133296111e-07
of O 0 1.0024559315979786e-07
either O 0 4.1447185594734037e-07
C5D B-Disease 1 1.0
serum O 0 9.941423968484742e-07
, O 0 5.71153657702439e-09
curving O 0 2.8366214266384304e-08
rather O 0 1.4717221885618414e-10
than O 0 1.1360245209812714e-11
linear O 0 1.078566902457112e-09
dose O 0 8.609822188532235e-09
- O 0 1.4791381452994301e-09
response O 0 8.944393142806817e-11
plots O 0 2.1455294485495102e-10
were O 0 8.561570896681303e-11
consistently O 0 9.067017275876665e-11
obtained O 0 4.0039811743941556e-11
, O 0 1.6606068950486552e-11
suggesting O 0 6.913457306634285e-11
some O 0 1.6606513039696402e-11
inhibitory O 0 1.4178475282733416e-08
effect O 0 1.3622782546462986e-07
. O 0 2.39249580147316e-08

Further O 0 4.467552106035555e-09
studies O 0 6.268933705477764e-10
suggested O 0 1.643776920134954e-10
that O 0 2.7031177643466187e-11
low O 0 4.568416400729802e-08
dilutions O 0 4.037745839013951e-06
of O 0 9.429908823221922e-05
C5D B-Disease 1 1.0
serum O 0 6.525507387777907e-07
contain O 0 2.4884603266883687e-09
a O 0 4.975924117189834e-10
factor O 0 1.3818933497500296e-10
( O 0 4.4607676927266304e-12
or O 0 4.319287982834652e-12
factors O 0 5.1187283578446596e-11
) O 0 4.441716092151715e-12
interfering O 0 5.080919365796355e-11
at O 0 6.356138948504508e-10
some O 0 7.258433437629108e-12
step O 0 4.514206786154773e-10
in O 0 1.1996757753873766e-10
the O 0 6.5713807728684515e-09
hemolytic O 0 0.3626492917537689
assay O 0 2.78565948974574e-07
of O 0 2.205624696216546e-07
C5 O 0 0.0569479763507843
, O 0 6.487513859454452e-10
rather O 0 8.45984046704551e-11
than O 0 9.199597680864535e-12
a O 0 1.7525445539234852e-09
true O 0 1.0855271170839842e-07
C5 O 0 0.0025466729421168566
inhibitor O 0 4.942699547427765e-07
or O 0 8.476161994508402e-09
inactivator O 0 7.586930223624222e-06
. O 0 3.518811411140632e-07

Of O 0 4.824445341000683e-07
clinical O 0 2.1841995476279408e-05
interest O 0 7.676541180501317e-09
are O 0 5.280479178915165e-11
( O 0 2.1096922819818786e-11
a O 0 1.637037450041845e-10
) O 0 5.491455380701726e-12
the O 0 1.1138102246066595e-10
documentation O 0 6.175513878048378e-09
of O 0 3.754745847572849e-08
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 0 1.8987196881425916e-06
vasculitis B-Disease 1 1.0
, O 0 7.099385612718834e-08
and O 0 3.0243891160353087e-06
arthritis B-Disease 1 1.0
in O 0 4.774928541451118e-08
an O 0 5.418039905613625e-10
individual O 0 9.179642601608862e-10
lacking O 0 0.07251862436532974
C5 O 1 0.9954223036766052
( O 0 8.049358402040241e-11
and O 0 4.352851065703156e-11
its O 0 1.4184466101685445e-10
biologic O 0 4.147556609268577e-08
functions O 0 4.630663630322829e-10
) O 0 8.601843738166581e-13
, O 0 1.1429549797922767e-12
and O 0 1.948958355812991e-12
( O 0 2.9969204201618638e-12
b O 0 3.567178497032586e-10
) O 0 2.08521611436141e-12
a O 0 2.261358635069488e-11
remarkable O 0 5.413763326522769e-10
propensity O 0 1.885380518373836e-09
to O 0 5.366735181255855e-11
bacterial B-Disease 1 1.0
infections I-Disease 1 0.999996542930603
in O 0 6.867223456552551e-11
the O 0 9.760738745034914e-11
proband O 0 2.961689382630084e-08
, O 0 1.705908504734399e-11
even O 0 1.6106846759122995e-12
during O 0 6.459224127786101e-11
periods O 0 3.989019947692185e-10
of O 0 1.1655105769392549e-09
low O 0 1.0003831540927877e-08
- O 0 3.4239588941886723e-10
dose O 0 1.6731063201547158e-09
or O 0 4.3494648854780493e-11
alternate O 0 3.140403048718099e-09
- O 0 2.6786810991552557e-08
day O 0 4.6723311442065096e-08
corticosteroid O 0 0.07548729330301285
therapy O 0 1.9239052562625147e-05
. O 0 1.0713364417824778e-07

Other O 0 1.7729558932089162e-09
observations O 0 1.5188083013484288e-09
indicate O 0 9.422153057769833e-10
that O 0 7.436889298828575e-11
the O 0 7.851154393279103e-09
C5D B-Disease 1 1.0
state O 0 1.137714922272437e-09
is O 0 1.2683377785538408e-11
compatible O 0 1.825362500040839e-10
with O 0 1.9438055765680362e-12
normal O 0 3.0030861131180586e-10
coagulation O 0 3.794403402590518e-10
function O 0 2.4492483041704816e-10
and O 0 4.052691775918715e-12
the O 0 3.15383379134726e-11
capacity O 0 7.932095258400551e-11
to O 0 2.3761112868947443e-11
mount O 0 2.555238722834474e-07
a O 0 5.1527468514223074e-08
neutrophilic O 0 0.0009292565518990159
leukocytosis O 0 5.8340483519714326e-05
during O 0 1.4886721828588634e-06
pyogenic B-Disease 0 0.001980588538572192
infection I-Disease 0 2.073581526929047e-06
. O 0 5.257259960700367e-09
. O 0 3.1659290300467546e-08

Susceptibility O 0 0.0005326017853803933
to O 0 1.035594232234871e-05
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.009948255494236946
twins O 0 1.654475227041985e-06
: O 0 5.7270209408155637e-11
the O 0 1.7885960768015963e-10
role O 0 1.543201955112039e-10
of O 0 8.761414926894417e-10
genes O 0 2.40221925684736e-10
, O 0 4.693943012057389e-10
HLA O 0 4.35370509421773e-07
, O 0 3.7550212939052585e-10
and O 0 2.0337928563485264e-10
the O 0 2.3149180350401366e-08
environment O 0 4.200619230232405e-07
. O 0 5.967288529973303e-08

OBJECTIVE O 0 7.4497579589660745e-06
To O 0 8.108518856353442e-10
determine O 0 3.740232290549983e-10
the O 0 2.4855512092969434e-10
relative O 0 1.3301920676056511e-09
effects O 0 2.21851177428789e-08
of O 0 1.8002028756569644e-09
genetic O 0 4.7480983589309744e-09
and O 0 5.4621043799052416e-11
environmental O 0 6.333053637064268e-09
factors O 0 2.4957363953248546e-10
in O 0 2.3383286973377437e-10
susceptibility O 0 7.914537491160445e-06
to O 0 6.355368782351434e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 0.00013253180077299476
AS B-Disease 1 1.0
) O 0 1.901737878284848e-09
. O 0 1.1793938270443505e-08

METHODS O 0 2.7360870262782555e-06
Twins O 0 1.4632266243097547e-07
with O 0 2.5701607508921143e-10
AS B-Disease 1 0.9995459914207458
were O 0 5.543056014190029e-10
identified O 0 4.0432816816871053e-11
from O 0 8.312269275667639e-12
the O 0 5.785034673522205e-10
Royal O 0 1.291170065087499e-06
National O 0 0.4975540041923523
Hospital O 0 0.28209275007247925
for O 0 3.7106946138010244e-07
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 3.5287087030155817e-06
. O 0 1.4502289502615895e-07

Clinical O 0 4.5639940253749955e-06
and O 0 3.7997791579869045e-09
radiographic O 0 1.0206695151282474e-06
examinations O 0 1.1510523734159506e-07
were O 0 1.5284448151575702e-09
performed O 0 2.0346009321769998e-09
to O 0 2.3088557107864283e-11
establish O 0 1.7542165497985707e-09
diagnoses O 0 2.4486157101932804e-08
, O 0 2.4147833732612867e-10
and O 0 3.986441454717493e-10
disease O 0 0.0014416786143556237
severity O 0 2.880291958717862e-06
was O 0 1.739669919231801e-08
assessed O 0 4.867633518479408e-10
using O 0 4.277271679203887e-12
a O 0 3.111566213021e-11
combination O 0 3.366589507169948e-10
of O 0 2.69849476097761e-09
validated O 0 7.815015834466976e-08
scoring O 0 5.537683023248974e-08
systems O 0 1.0831150802914635e-06
. O 0 7.560515769000631e-08

HLA O 0 2.5787061531445943e-05
typing O 0 2.42458895627351e-07
for O 0 6.930390483717019e-09
HLA O 0 9.13679912173393e-07
- O 0 2.674515364731178e-08
B27 O 0 1.2182420050521614e-07
, O 0 8.188341671377941e-10
HLA O 0 3.730447062366693e-08
- O 0 2.1570196739872927e-09
B60 O 0 1.6566296778819378e-08
, O 0 1.536098331866853e-10
and O 0 1.255322928939151e-10
HLA O 0 8.111991434134325e-08
- O 0 4.334911452019696e-08
DR1 O 0 9.327461884822696e-05
was O 0 6.211958503143933e-09
performed O 0 9.252679733506852e-10
by O 0 9.102574249908457e-11
polymerase O 0 3.157050842972353e-09
chain O 0 1.1464681648476471e-08
reaction O 0 5.655766480150426e-11
with O 0 1.4119406165080672e-11
sequence O 0 7.91103738073673e-10
- O 0 1.177240194216722e-09
specific O 0 9.205113060684056e-11
primers O 0 1.8416004277099773e-09
, O 0 3.1972730019091955e-11
and O 0 7.54108997469416e-11
zygosity O 0 1.30447233459563e-07
was O 0 2.1219232593239212e-08
assessed O 0 5.134730862721426e-09
using O 0 8.458973521641155e-10
microsatellite O 0 3.9627104797546053e-07
markers O 0 1.5673462883114553e-07
. O 0 1.0414016315962726e-07

Genetic O 0 1.0720851832957123e-06
and O 0 1.5997050351046482e-09
environmental O 0 1.0117449100732756e-08
variance O 0 3.4135844151350625e-10
components O 0 1.2380154679192401e-09
were O 0 1.7110678152132408e-10
assessed O 0 3.237135837164118e-10
with O 0 1.2494650279692987e-11
the O 0 1.3725242054007936e-09
program O 0 2.280053479353228e-09
Mx O 0 2.3924593861579524e-08
, O 0 6.082371585558466e-12
using O 0 6.490139914210047e-13
data O 0 3.641953492256045e-12
from O 0 4.855266037308292e-13
this O 0 4.683820605672073e-13
and O 0 2.197165409681401e-12
previous O 0 1.3267098530889143e-10
studies O 0 5.357285101648124e-11
of O 0 5.038411909907836e-10
twins O 0 9.373652076760663e-09
with O 0 1.1203027394657283e-09
AS B-Disease 1 0.9999983310699463
. O 0 2.473404947522795e-07

RESULTS O 0 2.225700512781259e-07
Six O 0 3.977185247805437e-09
of O 0 2.0589659754932654e-08
8 O 0 2.6446732590557076e-06
monozygotic O 0 7.027147148619406e-06
( O 0 1.688540329780608e-08
MZ O 1 0.6136528849601746
) O 0 3.3965441570416033e-09
twin O 0 3.2167025665330584e-07
pairs O 0 9.630058972476263e-10
were O 0 3.8538203739335586e-09
disease O 0 0.0014678806765004992
concordant O 0 3.1521852861260413e-07
, O 0 3.764571640529901e-11
compared O 0 9.58133312273235e-12
with O 0 5.267067598041519e-12
4 O 0 7.869264351256788e-09
of O 0 2.9612585716876083e-09
15 O 0 4.203822623338738e-09
B27 O 0 1.486557632546237e-08
- O 0 1.4848651197496565e-09
positive O 0 1.377750830089397e-10
dizygotic O 0 1.0732773603194801e-07
( O 0 2.543553145883948e-10
DZ O 0 5.218965725362068e-06
) O 0 1.3133857890146317e-10
twin O 0 8.132515105785387e-09
pairs O 0 2.4015628027895808e-11
( O 0 1.1169327615578872e-11
27 O 0 1.8673538271229972e-09
% O 0 6.869253776908835e-11
) O 0 2.397927342800976e-12
and O 0 1.606344224303058e-11
4 O 0 3.744645482584019e-09
of O 0 9.862477945432602e-09
32 O 0 1.6825292448174878e-07
DZ O 0 0.31458228826522827
twin O 0 2.7348141884431243e-07
pairs O 0 1.5270278097556655e-10
overall O 0 8.39886649117716e-09
( O 0 1.3794547448764405e-10
12 O 0 1.7648048578067232e-09
. O 0 4.816861839951336e-11
5 O 0 2.2314541325840764e-09
% O 0 2.1146968898211327e-10
) O 0 1.6365346577895679e-10
. O 0 8.064703571619702e-09

Nonsignificant O 0 9.501650310994592e-06
increases O 0 4.60911264710262e-09
in O 0 1.9352323910037939e-10
similarity O 0 3.8770350818673194e-10
with O 0 2.5004569595421522e-11
regard O 0 1.5253548424354335e-09
to O 0 3.512133986416366e-11
age O 0 9.984712612265412e-09
at O 0 2.1548778477153974e-06
disease O 0 0.08520173281431198
onset O 0 0.0007953981985338032
and O 0 3.8189860995796465e-11
all O 0 1.177939776969561e-11
of O 0 7.760421194547007e-10
the O 0 4.632282557537337e-09
disease O 0 5.835548108734656e-06
severity O 0 2.2368250540694135e-07
scores O 0 2.719441338783213e-09
assessed O 0 2.339760607483754e-10
were O 0 1.4557854921548596e-11
noted O 0 1.3708360835362754e-10
in O 0 1.4029276629301535e-09
disease O 1 0.9991543292999268
- O 0 2.04496845981339e-05
concordant O 0 0.20650655031204224
MZ O 1 0.9999985694885254
twins O 0 7.210524017864373e-07
compared O 0 8.265988782341083e-09
with O 0 1.2437603835735445e-08
concordant O 0 0.01736443303525448
DZ O 1 0.9999845027923584
twins O 0 5.815855911350809e-05
. O 0 8.239192652581551e-07

HLA O 0 0.00017673350521363318
- O 0 8.339216037711594e-07
B27 O 0 5.850554316566559e-07
and O 0 1.2279993688579793e-09
B60 O 0 4.5533671055864033e-08
were O 0 2.1297547059262456e-10
associated O 0 1.388207188091073e-10
with O 0 1.7739554616924558e-11
the O 0 5.4490509882043625e-09
disease O 0 0.00011283340427326038
in O 0 2.1350909928941064e-10
probands O 0 5.82542213578563e-07
, O 0 7.08604980248495e-11
and O 0 4.823497070510774e-12
the O 0 6.092964327519823e-11
rate O 0 2.524640219103702e-10
of O 0 5.872013431051926e-10
disease O 0 3.251198279485834e-07
concordance O 0 5.599471442074844e-10
was O 0 5.427224225584837e-10
significantly O 0 1.331917041935693e-11
increased O 0 1.4097482903263625e-10
among O 0 4.97806906807341e-10
DZ O 1 0.993669331073761
twin O 0 5.667636742145987e-07
pairs O 0 1.3268161569435222e-10
in O 0 1.8553460157111346e-10
which O 0 8.868560052999186e-11
the O 0 1.7098200189025192e-08
co O 0 4.2881777062575566e-07
- O 0 3.448217711365942e-08
twin O 0 5.658667134866846e-08
was O 0 1.4515649127133656e-08
positive O 0 9.638617681773098e-11
for O 0 1.4706390272234415e-10
both O 0 1.7458984258311716e-09
B27 O 0 7.112314506230177e-07
and O 0 5.340368502970705e-08
DR1 O 1 0.840806782245636
. O 0 4.754095357384358e-07

Additive O 0 1.8681048459257e-06
genetic O 0 1.4378072421550314e-07
effects O 0 1.0992450683033894e-07
were O 0 4.27780616485407e-10
estimated O 0 4.79122401475518e-11
to O 0 3.381051948830871e-12
contribute O 0 1.1320793261160311e-11
97 O 0 2.5559456773294187e-09
% O 0 3.291079561651422e-11
of O 0 8.445475568885641e-11
the O 0 1.1279889522430864e-10
population O 0 1.4949661300556194e-11
variance O 0 1.374520497421372e-09
. O 0 1.264233873143894e-08

CONCLUSION O 0 4.865150913246907e-06
Susceptibility O 0 7.014828042883892e-07
to O 0 1.6870522756562423e-09
AS B-Disease 1 0.9999874830245972
is O 0 3.6539521408585074e-10
largely O 0 1.5975371026044627e-09
genetically O 0 4.078580528865672e-10
determined O 0 3.3012703681833955e-11
, O 0 5.956019531738743e-12
and O 0 8.751785754435026e-12
the O 0 1.4985790386390363e-09
environmental O 0 2.9542431434492755e-07
trigger O 0 8.343334911842248e-09
for O 0 2.9301311377238903e-10
the O 0 5.786673895613603e-08
disease O 0 0.3429056406021118
is O 0 1.4148184845907963e-09
probably O 0 2.659751086042661e-09
ubiquitous O 0 2.397077878413256e-07
. O 0 4.3905217239625927e-08

HLA O 0 0.0001517652126494795
- O 0 6.53153392704553e-07
B27 O 0 2.7814226655209495e-07
accounts O 0 1.6498201416137448e-10
for O 0 1.1134385774491662e-10
a O 0 2.570366697263182e-10
minority O 0 5.2331840250108286e-11
of O 0 4.94999652378425e-10
the O 0 1.5523603513756257e-09
overall O 0 1.4600958309074485e-07
genetic O 0 8.477101687276445e-07
susceptibility O 0 7.491883025068091e-07
to O 0 1.7495620507901322e-09
AS B-Disease 1 0.9999996423721313
. O 0 5.317692171047383e-07

Cell O 0 5.314364898367785e-05
cycle O 0 1.0476374882273376e-05
- O 0 5.885210043743427e-07
dependent O 0 3.705817164245673e-08
colocalization O 0 2.1676796677638777e-06
of O 0 3.699835815496044e-07
BARD1 O 0 0.10346615314483643
and O 0 7.827828163442518e-09
BRCA1 O 0 8.0823046033629e-09
proteins O 0 5.035113645468492e-11
in O 0 5.794374355327925e-11
discrete O 0 2.050653336027608e-08
nuclear O 0 1.1230224572500447e-06
domains O 0 6.213181791281386e-08
. O 0 5.112257639439122e-08

Germ O 0 0.0002828693832270801
- O 0 6.80768550864741e-07
line O 0 4.64535325761517e-08
mutations O 0 9.30680588151489e-10
of O 0 6.860226164917549e-09
the O 0 4.7719879603391746e-08
BRCA1 O 0 1.6663307178532705e-07
gene O 0 9.387500554680628e-09
predispose O 0 1.3126402187424446e-09
women O 0 2.0328482820686222e-12
to O 0 2.2165151658537496e-12
early O 0 3.867869509122102e-06
- O 1 0.9995487332344055
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 1.5260881980339036e-07
compromising O 0 1.6563366500577104e-07
the O 0 6.883491110443174e-09
genes O 0 7.437404025978367e-10
presumptive O 0 2.964284249173943e-07
function O 0 5.667326608005396e-09
as O 0 3.431163408951221e-10
a O 0 3.525479908006446e-09
tumor B-Disease 0 1.3919171806264785e-06
suppressor O 0 7.595813713123789e-06
. O 0 9.231517594798788e-08

Although O 0 4.255707253264518e-08
the O 0 8.548688867904275e-09
biochemical O 0 3.6876325992807324e-08
properties O 0 3.1210753093091625e-08
of O 0 7.953605063448776e-08
BRCA1 O 0 6.653664996747466e-08
polypeptides O 0 1.8606273188837008e-09
are O 0 8.502996050319123e-12
not O 0 1.3757623512633543e-11
understood O 0 2.156035489031538e-10
, O 0 1.2120443537710912e-11
their O 0 1.1014382982066362e-11
expression O 0 2.383220565338462e-10
pattern O 0 9.900242847749041e-10
and O 0 7.979682886682937e-11
subcellular O 0 2.6015172238658124e-07
localization O 0 3.7937385855002503e-07
suggest O 0 2.2386618947489723e-10
a O 0 8.027219167150434e-11
role O 0 2.7769611610217737e-10
in O 0 5.178259487870207e-10
cell O 0 1.7679026598216296e-07
- O 0 9.104601161880055e-08
cycle O 0 9.532796525490994e-07
regulation O 0 6.4982023104676045e-06
. O 0 1.5008616571776656e-07

When O 0 7.930531751298986e-07
resting O 0 1.1620900295383763e-05
cells O 0 1.9112148308408905e-08
are O 0 5.789933463229424e-11
induced O 0 7.41935712866848e-09
to O 0 1.9590818550740963e-11
proliferate O 0 3.896889477772447e-10
, O 0 1.1882749124947356e-11
the O 0 2.2102639163357196e-11
steady O 0 3.3243735542143327e-10
- O 0 1.758610097823965e-11
state O 0 8.161716094634563e-12
levels O 0 7.991182715549883e-11
of O 0 2.9059522149710304e-11
BRCA1 O 0 5.609184991484106e-11
increase O 0 9.995438721502325e-13
in O 0 1.494823535785894e-11
late O 0 1.0147249263070535e-08
G1 O 0 1.1176418901470697e-08
and O 0 1.3578862860519347e-11
reach O 0 1.4445371288029918e-10
a O 0 6.65389757181778e-11
maximum O 0 3.4932241543828013e-09
during O 0 2.6481300707814626e-08
S O 0 7.222395197459264e-07
phase O 0 8.849441996972018e-07
. O 0 5.958304427622352e-08

Moreover O 0 2.408958152955165e-07
, O 0 8.222698966164899e-09
in O 0 4.121719410221658e-09
S O 0 4.7033844907673483e-07
phase O 0 4.349305697814998e-07
cells O 0 4.804809439207247e-09
, O 0 8.822504948824417e-10
BRCA1 O 0 1.6469105190708433e-08
polypeptides O 0 3.554750938050688e-09
are O 0 2.760514733468611e-11
hyperphosphorylated O 0 2.4512184282343696e-08
and O 0 1.3216837346785582e-10
accumulate O 0 1.2052052411615222e-10
into O 0 3.47761784647016e-11
discrete O 0 9.747762597100973e-09
subnuclear O 0 1.626248263164598e-06
foci O 0 2.8547308374982094e-06
termed O 0 3.2534532579120423e-07
" O 0 2.4115598762364243e-07
BRCA1 O 0 2.3216041711293656e-07
nuclear O 0 1.120352294492477e-06
dots O 0 7.133822066407447e-08
. O 0 8.566664178033534e-08

" O 0 9.63707861956209e-06
BRCA1 O 0 4.45477553512319e-06
associates O 0 1.8649900823675125e-07
in O 0 1.4190940644809302e-09
vivo O 0 3.385272506761794e-08
with O 0 5.950632209206219e-10
a O 0 4.517087859312596e-08
structurally O 0 2.46991930907825e-06
related O 0 7.155981052164861e-08
protein O 0 2.8464748993428657e-06
termed O 0 8.373420860152692e-05
BARD1 O 1 0.9983510971069336
. O 0 9.110869427786383e-07

Here O 0 2.4675378185179397e-08
we O 0 3.321964647806652e-10
show O 0 4.509894957482885e-10
that O 0 8.792124146783653e-12
the O 0 1.7520221384792478e-10
steady O 0 5.150828208400071e-09
- O 0 2.0460527716537058e-10
state O 0 3.454986990947262e-11
levels O 0 5.637535438474117e-10
of O 0 6.975210409265742e-10
BARD1 O 0 7.316684786928818e-06
, O 0 1.3486517458360936e-10
unlike O 0 1.0472023942442732e-10
those O 0 1.0784608449332378e-11
of O 0 2.1032899866213484e-09
BRCA1 O 0 2.1706528130494007e-08
, O 0 1.4002508874622066e-10
remain O 0 3.899275902163879e-10
relatively O 0 3.737634507450238e-11
constant O 0 3.906802104047813e-10
during O 0 7.411931068901367e-09
cell O 0 5.040315045334864e-07
cycle O 0 3.21098667654951e-07
progression O 0 2.5367132820974803e-06
. O 0 2.7726134277372694e-08

However O 0 1.5843446021790442e-07
, O 0 1.3520270236710985e-08
immunostaining O 0 8.792902121967927e-07
revealed O 0 4.727145608285355e-08
that O 0 9.24534115931408e-10
BARD1 O 0 3.8921974919503555e-05
resides O 0 2.2794631959754952e-08
within O 0 4.366625727669771e-09
BRCA1 O 0 5.802808455968034e-09
nuclear O 0 2.798856080232781e-08
dots O 0 3.280358207291556e-10
during O 0 8.226134440292299e-09
S O 0 6.079704206740644e-08
phase O 0 3.917894986216197e-08
of O 0 1.0140536410574441e-08
the O 0 3.82798948095342e-09
cell O 0 1.170785068893565e-08
cycle O 0 5.368972821884199e-09
, O 0 3.156752984012634e-11
but O 0 5.275795425530028e-12
not O 0 3.537221297117421e-12
during O 0 8.245828464481519e-10
the O 0 5.065451613717187e-09
G1 O 0 8.291002586702234e-07
phase O 0 5.466781658469699e-07
. O 0 3.449967778124119e-08

Nevertheless O 0 1.6538378986297175e-06
, O 0 3.145086324707336e-08
BARD1 O 0 3.8502559618791565e-05
polypeptides O 0 1.704356478171576e-08
are O 0 3.045138793900115e-11
found O 0 8.332333087390786e-12
exclusively O 0 1.703681119791245e-11
in O 0 1.0930941048148402e-11
the O 0 9.434844572275836e-11
nuclear O 0 1.864108423177413e-09
fractions O 0 2.3194578202545557e-11
of O 0 1.5335485659129233e-10
both O 0 2.1644988579261337e-10
G1 O 0 8.706798126922877e-08
- O 0 2.533550924610495e-09
and O 0 5.040795558741706e-10
S O 0 3.642447268248361e-07
- O 0 2.982169533538581e-08
phase O 0 5.829807037116552e-07
cells O 0 4.4683297062420024e-08
. O 0 2.4476770832393413e-08

Therefore O 0 2.2548842792957657e-08
, O 0 1.74691772159008e-09
progression O 0 2.3125481973806927e-08
to O 0 2.1705097441593324e-10
S O 0 6.486628478796774e-08
phase O 0 2.4157303712968314e-08
is O 0 1.0578456513532508e-11
accompanied O 0 1.3068332874177635e-11
by O 0 2.101041346111443e-12
the O 0 3.1189818089361054e-11
aggregation O 0 2.871205495580398e-10
of O 0 1.0656576732159806e-09
nuclear O 0 4.33571386793119e-07
BARD1 O 0 2.855730372175458e-06
polypeptides O 0 1.4467665288009357e-08
into O 0 3.7062679592025916e-09
BRCA1 O 0 1.7772474336652522e-07
nuclear O 0 1.5621635611751117e-06
dots O 0 1.292635971594791e-07
. O 0 2.085308352661741e-07

This O 0 2.6562746668901127e-08
cell O 0 3.807925850196625e-07
cycle O 0 2.0834953318171756e-07
- O 0 3.001039416972162e-08
dependent O 0 5.477885256510717e-09
colocalization O 0 3.596950364226359e-07
of O 0 7.426906734053773e-08
BARD1 O 0 0.0035905917175114155
and O 0 1.5527098495837777e-09
BRCA1 O 0 8.694745368131862e-09
indicates O 0 1.6135737190836608e-10
a O 0 6.905220839570347e-11
role O 0 2.4907051421330095e-10
for O 0 2.923739028659611e-10
BARD1 O 0 4.779937808052637e-05
in O 0 7.61566898432875e-09
BRCA1 O 0 9.303341244049079e-07
- O 0 8.021887083486945e-07
mediated O 0 0.00010170079622184858
tumor B-Disease 0 0.0019702475983649492
suppression O 1 0.9266214966773987
. O 0 5.764717911915795e-07

Ethnic O 0 8.246119165278287e-08
differences O 0 1.5273380782332424e-08
in O 0 1.3162711809400207e-08
the O 0 7.212188535277164e-08
HFE O 0 0.00021658203331753612
codon O 0 5.898448307561921e-07
282 O 0 7.579140515190375e-08
( O 0 1.5927641427992967e-08
Cys O 0 0.00118452706374228
/ O 0 2.4317023417097516e-05
Tyr O 0 7.444694347213954e-06
) O 0 2.6101183436821884e-09
polymorphism O 0 1.3942990051418747e-07
. O 0 5.086550913802057e-08

Recent O 0 1.551925876697169e-08
studies O 0 9.566368808222592e-10
have O 0 3.6818360860113586e-11
shown O 0 1.400224935999006e-09
that O 0 2.988598168940371e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 1.4042449265616597e-06
HH B-Disease 1 0.9982835054397583
) O 0 1.3577886037730025e-10
is O 0 1.4149169683119744e-11
likely O 0 7.0797512817522e-12
to O 0 1.15576179269411e-12
be O 0 8.532873192745871e-12
caused O 0 4.126578523333535e-10
by O 0 3.510405854889598e-11
homozygosity O 0 7.773672905386775e-08
for O 0 3.07010084021897e-10
a O 0 1.0253941029603197e-09
Cys282Tyr O 0 4.155173627395925e-08
mutation O 0 6.627820514637506e-10
in O 0 3.086764455151325e-10
the O 0 8.173818066836702e-09
HFE O 0 3.745280992006883e-05
gene O 0 2.28488712394892e-08
located O 0 2.0973541126068085e-08
4 O 0 4.3709280816983664e-07
. O 0 6.574429534111914e-08

5 O 0 1.7091120753320865e-05
Mb O 0 0.00010944875975837931
telomeric O 0 1.904031705635134e-05
to O 0 5.626541010883557e-08
HLA O 0 0.000538174354005605
- O 0 1.0712904440879356e-05
A O 0 6.245473741728347e-06
. O 0 2.2183048997703736e-07

Population O 0 9.250739063659807e-10
studies O 0 3.514916968594406e-10
of O 0 6.762075344113327e-10
this O 0 5.741370573408844e-11
polymorphism O 0 1.3797976095020204e-09
are O 0 6.0423176878598994e-12
facilitated O 0 8.872282075689242e-11
by O 0 1.3312618368788165e-11
the O 0 1.7673942864782077e-10
fact O 0 4.4614846539392516e-11
that O 0 7.551766503799406e-12
the O 0 1.0168634823060074e-09
Cys282Tyr O 0 2.53920370596461e-06
mutation O 0 1.981293351605018e-08
creates O 0 5.457704954636711e-09
a O 0 6.291012155656972e-09
Rsal O 0 2.686861307665822e-06
restriction O 0 2.1939543159987807e-07
site O 0 8.938777540379306e-08
. O 0 2.4872848669588166e-08

We O 0 7.654550771007962e-09
have O 0 1.452255676825942e-10
studied O 0 5.155300186743261e-09
the O 0 7.2740218293176895e-09
codon O 0 5.673905789649325e-08
282 O 0 3.9907966709051834e-08
( O 0 9.81082681761336e-09
Cys O 0 0.0006822723662480712
/ O 0 5.98660017203656e-06
Tyr O 0 9.733114438859047e-07
) O 0 6.161635784929231e-11
polymorphism O 0 6.336989266664261e-10
in O 0 3.3044206260157694e-11
different O 0 5.3564448883325344e-12
ethnic O 0 1.741833899338019e-09
groups O 0 1.4147564231237197e-09
. O 0 2.5368741773945658e-08

In O 0 8.292044384461406e-09
agreement O 0 8.105538462643835e-09
with O 0 1.1623665224780311e-10
previous O 0 4.208981607689566e-09
observations O 0 4.035211720321286e-09
the O 0 1.4493405586790686e-08
Tyr O 0 1.1624229045992251e-06
allele O 0 1.1969595092864438e-08
appeared O 0 1.1407679245678537e-09
to O 0 1.2344326949520479e-11
be O 0 3.4674974697113115e-11
rare O 0 2.347132488367265e-09
or O 0 2.9169544557561267e-10
absent O 0 3.3061276383250515e-08
in O 0 3.6096678424080153e-10
Asiatic O 0 8.807588756098994e-07
( O 0 6.960056142535365e-11
Indian O 0 3.9617459313134873e-10
, O 0 6.663181117971817e-11
Chinese O 0 1.8555797176578182e-10
) O 0 3.936930989545395e-11
populations O 0 6.471237434801935e-10
. O 0 1.183962528017446e-08

The O 0 3.751753752112563e-08
highest O 0 2.1417783102606336e-08
allele O 0 2.0152655932914598e-10
frequency O 0 5.965599125801191e-10
( O 0 7.872750194815037e-12
7 O 0 3.6271077807903396e-10
. O 0 2.603129300657314e-12
5 O 0 9.519911942090786e-11
% O 0 6.177413181679414e-12
) O 0 1.4240455602915203e-12
was O 0 3.3462191351141257e-10
found O 0 8.890203850864253e-11
in O 0 5.766912503091248e-10
Swedes O 0 8.215606612793636e-07
. O 0 1.9098598613709328e-07

Saamis O 0 9.615228918846697e-06
( O 0 7.597591000774173e-09
2 O 0 3.450145413808059e-08
% O 0 2.0968560221490407e-10
) O 0 1.967484855591728e-11
and O 0 1.6084474030453322e-11
Mordvinians O 0 1.8161198767074893e-08
( O 0 2.3349938302330564e-11
1 O 0 6.26452334451244e-10
. O 0 3.3762573899837056e-12
8 O 0 9.824617508424893e-11
% O 0 2.741043069603988e-12
) O 0 7.538278811933252e-13
had O 0 1.845779779019452e-11
significantly O 0 1.6752186443591555e-11
lower O 0 1.237311503254901e-10
frequencies O 0 3.362623790525987e-10
of O 0 3.858314556737241e-09
the O 0 2.9816973778906686e-08
Tyr O 0 3.3424767025280744e-06
allele O 0 9.630232966628682e-08
. O 0 2.5188228391925804e-08

Comparisons O 0 1.3189099590249498e-08
with O 0 1.1624330664705695e-10
allele O 0 6.250129302998175e-10
frequencies O 0 1.5383354312614728e-10
based O 0 3.974966883424358e-11
on O 0 4.281364984759506e-10
prevalence O 0 5.627149857190261e-09
estimates O 0 5.894250365567899e-11
of O 0 3.2392480364684673e-10
HH B-Disease 0 0.00011565347813302651
showed O 0 1.6640177236126874e-08
some O 0 1.7028201765301176e-11
disagreements O 0 3.8880267894114695e-09
with O 0 1.215988421066072e-10
the O 0 6.306847044612596e-09
RFLP O 0 2.251541246778288e-07
data O 0 1.6050810680567906e-09
, O 0 2.5526220026605984e-10
particularly O 0 6.478140801569054e-10
in O 0 1.7616635927808488e-09
Finns O 0 2.485891627657111e-06
. O 0 3.169760134369426e-07

The O 0 8.464038501188043e-07
newly O 0 1.5545053884125082e-06
described O 0 7.463557381015562e-07
HFE O 0 0.0030038715340197086
marker O 0 1.7288321032538079e-06
provides O 0 1.0653670168281337e-09
a O 0 3.9990757927377274e-10
new O 0 2.545164357048435e-10
approach O 0 4.4814951749572174e-10
to O 0 5.659767359639245e-12
the O 0 1.524592119217516e-10
screening O 0 2.2823682943595713e-09
of O 0 1.1757322893046762e-09
HH B-Disease 0 1.9830227756756358e-05
as O 0 6.285072462475227e-10
well O 0 2.5013059332112952e-11
as O 0 1.0532011027186705e-11
studies O 0 1.2160759378654351e-11
of O 0 9.884803392479213e-11
the O 0 1.5496705307871395e-10
relationship O 0 1.6553165088639687e-11
between O 0 4.2833092628313807e-10
the O 0 4.461210778572422e-08
HFE O 0 0.005216635297983885
Tyr O 0 2.1461289634316927e-06
allele O 0 7.147248126671002e-09
and O 0 1.7661541673597014e-10
different O 0 7.855868178197056e-10
disorders O 1 0.9999977350234985
including O 0 1.1985207493125927e-05
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9994625449180603
associated O 0 2.537729582030579e-09
with O 0 1.3208420468480142e-10
a O 0 1.8160012382750779e-09
missense O 0 2.2172850222546003e-08
mutation O 0 6.159970311614416e-10
encoding O 0 5.42523748148227e-10
Gly23 O 0 7.162739734667412e-07
- O 0 3.8738130569981877e-07
- O 0 3.781821646953176e-07
> O 0 7.246211453093565e-07
Val O 0 3.648503650310886e-07
in O 0 2.5547873150344458e-08
neurophysin O 0 6.761010445188731e-05
II O 1 0.9986592531204224
. O 0 1.2117732239858015e-06

Autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 3.142598004046704e-08
ADNDI B-Disease 1 0.9981305003166199
) O 0 3.102216816763814e-10
is O 0 5.712260525703172e-11
an O 0 4.966508315717988e-10
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 1.2606684549609781e-06
by O 0 2.340403426615012e-10
progressive O 1 0.6601721048355103
degeneration O 1 0.9999995231628418
of O 0 3.549011751147191e-07
the O 0 3.938687243021377e-08
magnocellular O 0 8.624714951110946e-07
neurons O 0 6.848208666809796e-10
of O 0 2.0642616505028855e-09
the O 0 6.928460472011011e-09
hypothalamus O 0 7.420856817930144e-09
leading O 0 5.3619317874620265e-09
to O 0 2.7056194090713248e-11
decreased O 0 1.753370226786899e-09
ability O 0 2.6981110054502544e-11
to O 0 8.141643609294036e-12
produce O 0 3.841892359801591e-10
the O 0 8.261023864974959e-09
hormone O 0 4.478918924633035e-08
arginine O 0 6.204749780636121e-08
vasopressin O 0 1.1687295398132846e-07
( O 0 1.734017485155448e-09
AVP O 0 4.2700198719103355e-06
) O 0 9.922966892617069e-10
. O 0 8.093040904100235e-09

Affected O 0 7.488383602094473e-08
individuals O 0 1.7128115592512927e-10
are O 0 3.462831063560934e-11
not O 0 2.5308245082955594e-11
symptomatic O 0 1.0228595215266978e-07
at O 0 1.4332526632188092e-07
birth O 0 5.7529881303253205e-08
, O 0 1.6737311536729749e-10
but O 0 3.281107677222117e-11
usually O 0 9.555172209019247e-10
develop O 0 2.4461328962388507e-07
diabetes B-Disease 1 1.0
insipidus I-Disease 1 0.9999202489852905
at O 0 1.539576260256581e-06
1 O 0 4.977361186320195e-06
- O 0 7.207788144114602e-08
6 O 0 1.934793942837132e-07
yr O 0 9.866354275800404e-07
of O 0 1.259634174743951e-08
age O 0 6.49702940336283e-08
. O 0 6.316130907180195e-08

The O 0 5.9312728950544624e-08
genetic O 0 3.629111233749427e-08
locus O 0 3.229960299222512e-08
of O 0 1.3150415867357879e-08
the O 0 1.390241379795043e-07
disease O 1 0.6657616496086121
is O 0 9.562300951060365e-10
the O 0 5.202796771186513e-08
AVP O 1 0.5915868282318115
- O 0 6.901648248458514e-07
neurophysin O 0 0.000544551236089319
II O 1 0.9999994039535522
( O 0 3.095444789380508e-09
NPII O 0 1.1023017577826977e-05
) O 0 6.499598775855375e-11
gene O 0 2.643646135336297e-10
, O 0 1.0733081957925439e-11
and O 0 4.686164650768987e-12
mutations O 0 2.5348487198151304e-11
that O 0 5.266193731090496e-12
cause O 0 2.2614655037500597e-08
ADNDI B-Disease 1 0.6254189610481262
have O 0 4.430802946764345e-11
been O 0 2.299608767297734e-11
found O 0 1.8252773424654034e-12
in O 0 2.676959565475756e-12
both O 0 2.9161616697803705e-12
the O 0 1.0165449038090912e-10
signal O 0 4.719539425934727e-09
peptide O 0 1.1779679454093639e-09
of O 0 2.3922572811585496e-09
the O 0 3.471830822832089e-08
prepro O 0 0.000598768936470151
- O 0 0.0008177419076673687
AVP O 0 0.2980584502220154
- O 0 1.3493344113157946e-06
NPII O 0 9.421001595910639e-05
precursor O 0 4.969607516613905e-07
and O 0 2.086723016603287e-09
within O 0 1.1887709483460185e-08
NPII O 0 9.818737453315407e-05
itself O 0 1.8502456100577547e-07
. O 0 1.2479002009513351e-07

An O 0 2.626930850624376e-08
affected O 0 4.5617902344474714e-08
girl O 0 2.2447355974009042e-08
who O 0 3.6256692093061815e-10
presented O 0 5.237822620074439e-09
at O 0 3.40025358980256e-08
9 O 0 8.305609533465486e-09
months O 0 7.995039352781674e-11
of O 0 3.3974559277005767e-10
age O 0 1.4085796973262177e-09
and O 0 1.64109531519685e-10
her O 0 2.6409949227534923e-10
similarly O 0 3.0927536087688168e-09
affected O 0 9.862981542596572e-10
younger O 0 3.7907721406327255e-10
brother O 0 4.750643878281835e-09
and O 0 4.691642629950366e-10
father O 0 1.928762483061064e-09
were O 0 4.320346580488632e-10
all O 0 2.1685472861854294e-11
found O 0 1.4629335937099697e-11
to O 0 1.566776005809678e-12
have O 0 3.0750207068164226e-12
a O 0 5.7549874588058714e-11
novel O 0 3.246912183563211e-10
missense O 0 1.6607005770552519e-09
mutation O 0 1.3866668924222836e-10
( O 0 9.667832506776719e-12
G1758 O 0 1.1337231597963182e-08
- O 0 1.7816587316588084e-08
- O 0 4.55858959469424e-08
> O 0 5.929791058179035e-08
T O 0 1.4155696170803367e-08
) O 0 2.4446534206690185e-12
encoding O 0 3.5935431713651766e-11
the O 0 2.8704497112563843e-10
amino O 0 1.4647497659225905e-09
acid O 0 4.475626813604805e-10
substitution O 0 6.3709744146933645e-09
Gly23 O 0 2.783017180263414e-06
- O 0 5.42358691291156e-07
- O 0 3.120671010492515e-07
> O 0 8.129166531034571e-07
Val O 0 7.949749942781636e-07
within O 0 1.125744475416468e-07
NPII O 0 0.0002867266593966633
. O 0 3.929023648652219e-07

The O 0 1.5553906962395558e-07
mutation O 0 1.7566549104230944e-08
was O 0 2.8538570617797632e-08
confirmed O 0 3.223521005679686e-09
by O 0 3.7198280566919095e-10
restriction O 0 3.505727264041525e-08
endonuclease O 0 2.0709163095489203e-07
analysis O 0 1.2875566390846416e-08
. O 0 2.271507781870241e-08

A O 0 2.243605922558345e-05
T1 O 0 4.671033093472943e-05
- O 0 3.270696424806374e-08
weighted O 0 4.9262167678421065e-09
magnetic O 0 1.2125890291869723e-09
resonance O 0 1.1395219212673169e-09
imaging O 0 3.9551586894504e-08
of O 0 5.688252358027057e-08
the O 0 7.610298098370549e-07
fathers O 0 7.488997084692528e-07
pituitary O 0 0.00012179143959656358
gland O 0 6.945994755369611e-06
demonstrates O 0 5.277355441535292e-08
an O 0 1.8244933341904357e-09
attenuated O 0 1.0117410056409426e-05
posterior O 0 4.364339929452399e-06
pituitary O 1 0.9975186586380005
bright O 0 6.022393063176423e-05
spot O 0 5.6272368965437636e-05
. O 0 2.3139341465139296e-07

This O 0 1.0592505539364083e-08
mutation O 0 1.543862993003131e-08
may O 0 5.596278440656022e-10
be O 0 5.4352810446856026e-11
valuable O 0 1.1444765968260384e-10
for O 0 2.332705729968243e-11
developing O 0 1.2529212389811306e-10
models O 0 1.4079262755650745e-10
of O 0 3.2089269019763833e-09
dominantly B-Disease 0 8.083818102022633e-05
inherited I-Disease 0 0.028803134337067604
neurodegeneration I-Disease 1 1.0
, O 0 7.56594620288098e-10
as O 0 3.086639624449994e-11
the O 0 1.136276558955096e-10
early O 0 2.3671886673071185e-09
age O 0 6.140872810256326e-10
of O 0 6.0111293720410686e-09
onset O 1 0.9999880790710449
of O 0 1.1071837434428744e-05
symptoms O 0 0.0008037113584578037
suggests O 0 1.5333671832262752e-10
that O 0 1.95448648585006e-12
this O 0 9.966297752350695e-12
mutation O 0 5.714628215081063e-10
may O 0 1.6054292617528887e-10
be O 0 3.423918093492517e-11
particularly O 0 6.766200794094956e-11
deleterious O 0 2.7236666255703312e-09
to O 0 5.725710530701811e-11
the O 0 1.7013682906963368e-08
magnocellular O 0 7.343758170463843e-06
neuron O 0 1.2485858746913436e-07
. O 0 2.8078748215421e-09
. O 0 2.2626132079039962e-08

Frequent O 0 4.752486404413503e-07
inactivation O 0 7.082084630383179e-05
of O 0 7.2296215876122005e-06
PTEN O 1 0.9999634027481079
/ O 0 0.24970680475234985
MMAC1 O 1 0.9891812205314636
in O 0 3.015481695456401e-07
primary O 1 0.9999977350234985
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.864506677724421e-05

Sporadic B-Disease 1 0.9999998807907104
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 3.058563152080751e-06
the O 0 3.0734733513781975e-07
most O 0 3.1680655876442643e-09
common O 0 1.1321040460643417e-07
male B-Disease 0 9.984953974750965e-10
cancer I-Disease 0 2.470250315411704e-08
in O 0 9.968451758490815e-11
the O 0 2.0251926802217213e-09
Western O 0 2.2106085850737145e-08
world O 0 3.8024330351049684e-09
, O 0 1.749937347805819e-11
yet O 0 1.049827759447286e-11
many O 0 4.0403018929623113e-13
of O 0 4.287361091148689e-11
the O 0 1.178587644146134e-10
major O 0 1.6254236845369974e-09
genetic O 0 9.188260707837514e-10
events O 0 3.1825007906771674e-11
involved O 0 4.187259913801533e-12
in O 0 1.2339853965037673e-11
the O 0 1.9392895622694084e-10
progression O 0 3.239449597458588e-07
of O 0 8.43177083709179e-09
this O 0 2.613810057283672e-09
often O 0 1.4161015471358951e-08
fatal O 1 0.9999911785125732
cancer B-Disease 0 0.12565073370933533
remain O 0 4.561755773124787e-08
to O 0 2.0325557903433378e-10
be O 0 2.720385472443354e-09
elucidated O 0 3.4411893921060255e-06
. O 0 9.060426009455114e-08

Numerous O 0 3.2262542504213343e-07
cytogenetic O 0 2.658205085026566e-05
and O 0 1.2821137929108772e-08
allelotype O 0 3.598090188461356e-06
studies O 0 1.8400133638962757e-09
have O 0 4.951986390389074e-11
reported O 0 1.165314372775228e-10
frequent O 0 4.1327066768737097e-10
loss O 0 3.638933065985839e-08
of O 0 3.716495768912864e-07
heterozygosity O 0 0.03859079256653786
on O 0 2.3014583348412998e-05
chromosomal O 1 0.9998986721038818
arm O 0 7.618426479893969e-06
10q O 0 3.958988600061275e-06
in O 0 1.0631107727476774e-07
sporadic B-Disease 1 0.9999998807907104
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.870827327365987e-05

Deletion O 0 2.355013322130617e-07
mapping O 0 3.9244390848125477e-08
studies O 0 4.057601366014296e-09
have O 0 2.1600610189409508e-10
unambiguously O 0 1.257303416934974e-08
identified O 0 1.202335897509954e-09
a O 0 7.970195614603881e-10
region O 0 3.916570623374582e-09
of O 0 1.0461772781411582e-08
chromosome O 0 2.1120069959579268e-07
10q23 O 0 7.520804246041735e-08
to O 0 7.355730607949695e-11
be O 0 5.779881434575529e-11
the O 0 2.241460350660418e-10
minimal O 0 6.00005520823288e-08
area O 0 2.720702108049977e-09
of O 0 2.5480118015508424e-09
loss O 0 6.824938054705854e-07
. O 0 1.6877055486475e-07

A O 0 1.1959516541537596e-06
new O 0 5.302590366795812e-08
tumor B-Disease 0 4.981366146239452e-07
suppressor O 0 4.6059511760176974e-07
gene O 0 1.3550192079492263e-08
, O 0 1.505845226290603e-09
PTEN O 0 3.661020309664309e-05
/ O 0 1.4545672684107558e-06
MMAC1 O 0 0.00023451830202247947
, O 0 1.4934714576142483e-09
was O 0 1.1666677401933612e-08
isolated O 0 6.577650424333115e-09
recently O 0 7.354205022735982e-10
at O 0 1.877374700143264e-09
this O 0 1.4224284076991278e-11
region O 0 3.5494576722250315e-10
of O 0 8.295220066401043e-10
chromosome O 0 2.3739769261510446e-08
10q23 O 0 3.827786798638044e-08
and O 0 8.032181864070509e-11
found O 0 8.431902745464903e-12
to O 0 7.730611940523491e-13
be O 0 2.2783719355601306e-12
inactivated O 0 4.906767880896723e-09
by O 0 1.831321379264228e-11
mutation O 0 6.18346651659607e-10
in O 0 5.301563632542639e-10
three O 0 1.583900512969194e-07
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9981833100318909
lines O 0 2.676700319170777e-07
. O 0 2.7914506262050054e-08

We O 0 1.8455894235103187e-07
screened O 0 2.6177135623584036e-06
80 O 0 1.8857393797588884e-06
prostate B-Disease 1 0.9998964071273804
tumors I-Disease 1 0.9999977350234985
by O 0 6.429174415067962e-10
microsatellite O 0 5.804261249409137e-08
analysis O 0 3.219678690324912e-10
and O 0 9.523581229187172e-11
found O 0 2.709116819765711e-10
chromosome O 0 4.454287161337334e-09
10q23 O 0 5.98245497585026e-09
to O 0 5.1197050071616346e-11
be O 0 4.743558323916375e-11
deleted O 0 2.472053117763551e-10
in O 0 8.794576872306337e-11
23 O 0 8.72884253766415e-09
cases O 0 2.0306154535632004e-09
. O 0 2.2676680089261936e-08

We O 0 1.6656500179124123e-08
then O 0 6.280279074566408e-10
proceeded O 0 4.5010781213328244e-10
with O 0 2.204259127655539e-12
sequence O 0 1.8255705974690173e-11
analysis O 0 7.836898664737024e-12
of O 0 2.960133249629848e-10
the O 0 1.5328123215141432e-09
entire O 0 2.0808338163647022e-08
PTEN O 0 1.5297136997105554e-05
/ O 0 3.7266426033966127e-07
MMAC1 O 0 4.075578090123599e-06
coding O 0 7.402101687148388e-08
region O 0 1.7484110825805033e-09
and O 0 4.9434366322653744e-11
tested O 0 9.269350564888867e-11
for O 0 2.2771565882928613e-11
homozygous O 0 1.984779895991551e-09
deletion O 0 1.0104118652876082e-09
with O 0 1.715311746808279e-11
new O 0 2.7811061786842117e-10
intragenic O 0 1.0516153281514562e-07
markers O 0 1.5434618028109526e-09
in O 0 6.32803601186005e-11
these O 0 9.550971125094065e-12
23 O 0 1.3625550687734744e-09
cases O 0 1.919658702831395e-11
with O 0 4.612405943293929e-11
10q23 O 0 3.288637913101411e-07
loss O 0 2.43471475869228e-07
of O 0 2.836167709574511e-07
heterozygosity O 0 0.0002566679904703051
. O 0 7.11938639597065e-07

The O 0 8.545542051763277e-09
identification O 0 2.889826600238621e-09
of O 0 3.0732663081067813e-09
the O 0 2.435205148643149e-09
second O 0 1.1104174468812289e-08
mutational O 0 4.087505942607095e-07
event O 0 1.930441761999191e-08
in O 0 3.271485582434508e-10
10 O 0 4.700438371862958e-10
( O 0 1.671427059257713e-11
43 O 0 1.5189212110300332e-09
% O 0 1.7295845866627246e-09
) O 0 4.114508733721323e-09
tumors B-Disease 1 0.9999991655349731
establishes O 0 1.0221939419352566e-06
PTEN O 0 0.2633516192436218
/ O 0 1.4291512115960359e-06
MMAC1 O 0 6.397855031536892e-06
as O 0 4.211717918867208e-10
a O 0 2.417170352764231e-10
main O 0 4.4393511089424464e-09
inactivation O 0 1.4137380333067995e-07
target O 0 2.0805985823102446e-09
of O 0 8.371960347197671e-10
10q O 0 1.7524392603718297e-07
loss O 0 7.13465269086555e-08
in O 0 1.2301590857077827e-08
sporadic B-Disease 1 0.9999997615814209
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.4177426521655434e-07
. O 0 8.229935843928615e-08

Risk O 0 8.593253824074054e-07
reversals O 0 4.171070600023086e-08
in O 0 1.1638844332750864e-09
predictive O 0 5.053295737411645e-08
testing O 0 1.4900923872573912e-07
for O 0 3.646211439445324e-07
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 4.763466847634845e-07

The O 0 7.002674440315104e-09
first O 0 2.1128676586101847e-09
predictive O 0 3.312420560064311e-08
testing O 0 7.083587405531944e-08
for O 0 1.1901303764716431e-07
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 2.9032486484337205e-11
HD B-Disease 0 3.301924067500295e-08
) O 0 1.6231998384297341e-12
was O 0 5.499214278392728e-11
based O 0 4.076732874891409e-12
on O 0 1.7963980303292715e-10
analysis O 0 3.9800347045870765e-11
of O 0 9.57978918414426e-10
linked O 0 2.3114324676498654e-08
polymorphic O 0 1.269177118956577e-08
DNA O 0 2.294773704392128e-09
markers O 0 2.1960365470530263e-10
to O 0 5.1639131339042965e-12
estimate O 0 1.479521227754077e-10
the O 0 4.479544513102951e-11
likelihood O 0 5.150186943581048e-10
of O 0 3.1947040568525154e-09
inheriting O 0 9.58306500820072e-09
the O 0 2.8110365146716276e-09
mutation O 0 3.180713692430004e-09
for O 0 1.8164411086374344e-09
HD B-Disease 0 8.794417954050004e-05
. O 0 2.4457082758999604e-07

Limits O 0 6.738031288477941e-08
to O 0 2.456096992453638e-10
accuracy O 0 7.522982237162523e-09
included O 0 9.223325436735763e-10
recombination O 0 4.493872218791495e-10
between O 0 2.1832483043660034e-10
the O 0 2.240794660934853e-09
DNA O 0 2.611143967712337e-09
markers O 0 5.8111115919246e-10
and O 0 5.642147513085227e-11
the O 0 1.7845419586492994e-09
mutation O 0 2.7504791777488435e-09
, O 0 2.7473634478525355e-10
pedigree O 0 3.0369982084721414e-09
structure O 0 2.505644358663517e-09
, O 0 4.470155842706269e-11
and O 0 3.098903772480455e-11
whether O 0 8.058114592257581e-11
DNA O 0 8.611772961408803e-10
samples O 0 6.324633178289574e-11
were O 0 5.042138928601503e-11
available O 0 6.905945260093915e-11
from O 0 2.0837073733126488e-10
family O 0 7.782225419639133e-10
members O 0 8.270353846207001e-10
. O 0 6.792420492729434e-08

With O 0 3.566600070836756e-10
direct O 0 1.2125890291869723e-09
tests O 0 2.1088042423400566e-10
for O 0 4.433584402385726e-11
the O 0 6.12433270763546e-10
HD B-Disease 0 8.126964985422092e-07
mutation O 0 4.2676029377020086e-10
, O 0 8.309400043038373e-12
we O 0 3.5963113997200535e-12
have O 0 4.920112711345737e-13
assessed O 0 1.1212508352342887e-11
the O 0 6.192335706700636e-12
accuracy O 0 1.1465129540200181e-10
of O 0 1.1100415725495694e-10
results O 0 4.741695230903176e-11
obtained O 0 7.293544240782879e-12
by O 0 1.793360598911775e-11
linkage O 0 2.4018860234065187e-09
approaches O 0 1.2998738752045824e-09
when O 0 6.716593947686533e-11
requested O 0 7.22352247461977e-11
to O 0 7.0524185449838406e-12
do O 0 6.029492877202003e-12
so O 0 1.2486376949755185e-12
by O 0 8.950599809931514e-12
the O 0 5.227170918331581e-10
test O 0 2.178041969003175e-09
individuals O 0 8.876868684559724e-11
. O 0 2.0277097334542304e-08

For O 0 9.630064745635991e-09
six O 0 1.2017008499398685e-09
such O 0 8.601229450899694e-11
individuals O 0 2.408672003170742e-12
, O 0 1.9147806604169482e-11
there O 0 6.039566763371695e-11
was O 0 6.361418058986601e-09
significant O 0 2.09334838352504e-09
disparity O 0 4.508710294004459e-09
between O 0 4.195562230968619e-10
the O 0 7.603795815214198e-09
tests O 0 2.6007027642549474e-08
. O 0 1.6593082463600695e-08

Three O 0 5.616363374372213e-09
went O 0 9.174500270603403e-09
from O 0 2.7878457875551987e-10
a O 0 2.72334466089319e-09
decreased O 0 1.4105108192552507e-08
risk O 0 8.542425100621642e-10
to O 0 4.8304025709877685e-12
an O 0 7.786716584023967e-12
increased O 0 4.546497900381752e-10
risk O 0 1.4387276925376113e-09
, O 0 7.571222294944224e-12
while O 0 6.408501767446451e-12
in O 0 1.1530167445816808e-11
another O 0 3.226728606531282e-11
three O 0 2.029529148905862e-11
the O 0 9.05932939776477e-10
risk O 0 1.274227123815308e-08
was O 0 1.9642518722662317e-08
decreased O 0 1.800903248749819e-07
. O 0 3.6337450382006864e-08

Knowledge O 0 1.191782956766474e-07
of O 0 7.25210966834311e-08
the O 0 9.748208462667662e-09
potential O 0 1.8858588024528444e-09
reasons O 0 3.555800098808959e-10
for O 0 7.918124489414424e-12
these O 0 7.347884778928504e-13
changes O 0 6.684703138248871e-12
in O 0 8.38670365793659e-12
results O 0 2.5648606502559623e-11
and O 0 4.720928075546693e-12
impact O 0 1.3795863063048586e-10
of O 0 1.154566650618527e-10
these O 0 3.035412633051182e-12
risk O 0 1.6514320466676224e-10
reversals O 0 2.2814834743645207e-10
on O 0 1.571902830121985e-09
both O 0 1.091001317066187e-10
patients O 0 4.0566685427512184e-11
and O 0 4.7864195246161145e-11
the O 0 1.3205007753924747e-08
counseling O 0 5.267387415130997e-09
team O 0 2.3047386221719535e-10
can O 0 2.702322523737144e-12
assist O 0 1.7125002804707634e-11
in O 0 1.473659562434282e-11
the O 0 2.5824256622009045e-10
development O 0 5.498367872114329e-10
of O 0 1.5456587398876565e-10
strategies O 0 1.7013211672800566e-10
for O 0 5.759928992099539e-11
the O 0 3.547826477046101e-10
prevention O 0 2.3701673512732668e-08
and O 0 1.4530807113111166e-11
, O 0 7.562620668588593e-12
where O 0 2.950841654358882e-11
necessary O 0 9.49690326379482e-10
, O 0 1.8230522647044722e-10
management O 0 2.3556943062885694e-09
of O 0 1.853217801439655e-09
a O 0 4.699696187770996e-09
risk O 0 3.766414291561659e-09
reversal O 0 1.7216787995266714e-09
in O 0 4.267470751773139e-11
any O 0 1.2763128054427142e-10
predictive O 0 5.843681538664214e-09
testing O 0 1.667360116641703e-08
program O 0 3.2984794895440928e-09
. O 0 6.402460783760944e-10
. O 0 1.1939040867048334e-08

A O 0 6.514787287414947e-07
novel O 0 3.470115927939332e-08
common O 0 2.2975866542651602e-08
missense O 0 5.327102314822696e-08
mutation O 0 1.83466919434494e-09
G301C O 0 6.254162965291243e-09
in O 0 2.905587714874258e-10
the O 0 9.848224458153254e-10
N O 0 1.7492483550540783e-07
- O 0 2.6353520254929208e-08
acetylgalactosamine O 0 2.2859694581711665e-06
- O 0 2.9435170745273354e-07
6 O 0 1.5460030908798217e-06
- O 0 5.181445885682479e-07
sulfate O 0 1.7035739574566833e-07
sulfatase O 0 5.073370266472921e-05
gene O 0 1.0293062047139756e-07
in O 0 1.1479824202353939e-08
mucopolysaccharidosis B-Disease 0 0.00019791396334767342
IVA I-Disease 1 1.0
. O 0 4.0871464079828e-06

Mucopolysaccharidosis B-Disease 1 0.9833115339279175
IVA I-Disease 1 1.0
( O 0 0.0105526652187109
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 2.2657959064531497e-08
is O 0 6.835875754340748e-10
an O 0 1.398148596898352e-09
autosomal B-Disease 1 0.9999995231628418
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 1.1891607982761343e-06
by O 0 5.14796705264331e-10
a O 0 5.149907451595936e-07
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 9.320986649186125e-09
N O 0 1.228878431902558e-06
- O 0 2.898107531734695e-08
acetylgalactosamine O 0 2.6101802177436184e-06
- O 0 1.3977340529436333e-07
6 O 0 1.1700448112605955e-06
- O 0 1.500576871649173e-07
sulfate O 0 1.0421487672829244e-07
sulfatase O 0 0.0001797664153855294
( O 0 1.2812361838143715e-08
GALNS O 0 0.00019257422536611557
) O 0 4.961227428879056e-09
. O 0 1.4788398949860948e-08

In O 0 1.5066589753587323e-08
previous O 0 1.96795326701249e-08
studies O 0 2.3116253355937033e-09
, O 0 3.7620109805125423e-10
we O 0 1.5038525980060058e-10
have O 0 1.791401749162702e-11
found O 0 1.5689028201593125e-11
two O 0 5.300072013214585e-12
common O 0 7.793436729297554e-11
mutations O 0 5.747517045628925e-11
in O 0 1.0451391141419464e-10
Caucasians O 0 6.411482900148258e-09
and O 0 1.914047670359409e-10
Japanese O 0 6.599355373282378e-08
, O 0 2.114762587268615e-09
respectively O 0 5.101357913872562e-08
. O 0 1.084562697428737e-07

To O 0 2.1767100122360716e-08
characterize O 0 1.042956085939295e-07
the O 0 1.943094041223503e-08
mutational O 0 1.10377652617899e-06
spectrum O 0 1.9839481169015016e-08
in O 0 6.691097675926017e-11
various O 0 2.973395835104142e-11
ethnic O 0 1.8973672633038063e-10
groups O 0 1.3360950366914093e-11
, O 0 9.023054872714376e-12
mutations O 0 1.1985589604135427e-11
in O 0 3.108766369330773e-11
the O 0 1.762406331984323e-09
GALNS O 0 5.369570862967521e-05
gene O 0 1.1558237034137164e-08
in O 0 5.98697202924825e-10
Colombian O 0 7.483994522772264e-06
MPS B-Disease 1 0.9999998807907104
IVA I-Disease 1 1.0
patients O 0 1.781166929504252e-07
were O 0 1.2079837130585247e-09
investigated O 0 5.7138684894653125e-09
, O 0 9.905129494391929e-11
and O 0 9.808028694768822e-11
genetic O 0 1.4543140913758634e-08
backgrounds O 0 4.717475854398856e-10
were O 0 1.9527818251319218e-10
extensively O 0 7.825565889740815e-11
analyzed O 0 7.688094605384777e-11
to O 0 1.48002287508886e-11
identify O 0 5.886116594133739e-11
racial O 0 2.651361907801686e-10
origin O 0 1.921277720251524e-11
, O 0 5.3206328232136e-12
based O 0 7.408951924192664e-12
on O 0 9.004684775604233e-10
mitochondrial O 0 1.6836834149103197e-09
DNA O 0 6.776872951697044e-10
( O 0 2.978731497571552e-11
mtDNA O 0 6.31540209017345e-10
) O 0 2.8763688653121733e-10
lineages O 0 2.0208950957112393e-08
. O 0 5.4898535495340184e-08

Three O 0 2.637383467174459e-08
novel O 0 2.77669904846789e-08
missense O 0 3.3202837812496e-07
mutations O 0 5.405109693157328e-09
never O 0 1.5220562588069697e-09
identified O 0 1.720017184236866e-10
previously O 0 2.6597293811825296e-10
in O 0 1.8439218901766807e-11
other O 0 2.841565090866416e-12
populations O 0 1.1298423134575852e-11
and O 0 3.891908496866936e-12
found O 0 1.4220269926867868e-11
in O 0 1.5816787116151865e-11
16 O 0 8.013760766090172e-10
out O 0 2.6182032236699015e-11
of O 0 1.9544483809141866e-09
19 O 0 1.5105730710729404e-07
Colombian O 0 2.021265754592605e-05
MPS B-Disease 1 0.9998916387557983
IVA I-Disease 1 1.0
unrelated O 0 2.1667030125627207e-07
alleles O 0 1.0741529887781098e-09
account O 0 8.103443610574246e-11
for O 0 4.891207439072787e-10
84 O 0 6.065515663067345e-07
. O 0 3.462044730895286e-07

2 O 0 1.8264567813730537e-07
% O 0 1.2970901019926373e-09
of O 0 2.090140949206898e-09
the O 0 1.961401929762019e-09
alleles O 0 2.284492456317011e-10
in O 0 7.037197907733272e-11
this O 0 1.5204247583167074e-10
study O 0 2.4310700119656303e-09
. O 0 2.0851604887184294e-08

The O 0 5.746632041336852e-07
G301C O 0 3.687285470732604e-06
and O 0 1.3968246115325655e-08
S162F O 0 5.405636898103694e-07
mutations O 0 5.3944497757640875e-09
account O 0 3.881993060339539e-10
for O 0 2.633973705812309e-09
68 O 0 1.1230351901758695e-06
. O 0 3.988263870269293e-07

4 O 0 2.274164216942154e-06
% O 0 2.891123607184909e-08
and O 0 9.383508192684076e-09
10 O 0 2.2680406175368262e-07
. O 0 2.9122330147401954e-07

5 O 0 9.577751569622706e-08
% O 0 9.340006545954793e-10
of O 0 2.466651993771052e-09
mutations O 0 3.661941028187954e-10
, O 0 1.1533538707420021e-10
respectively O 0 5.287304483125865e-10
, O 0 7.669172241708822e-11
whereas O 0 9.639095771563078e-11
the O 0 1.164577323464755e-09
remaining O 0 2.663702325378381e-08
F69V O 0 6.81161109241657e-05
is O 0 1.6304280148204953e-10
limited O 0 5.853559303936606e-11
to O 0 1.1360678890681708e-11
a O 0 1.1016411116671065e-09
single O 0 1.2984374464508619e-08
allele O 0 6.96452744364251e-08
. O 0 3.952322913391981e-08

The O 0 2.3574941110382497e-07
skewed O 0 3.197747844296828e-08
prevalence O 0 6.418618880843496e-08
of O 0 4.433529543490522e-09
G301C O 0 3.914966484330762e-08
in O 0 9.849802085071246e-10
only O 0 3.8261696588826055e-10
Colombian O 0 6.676293651253218e-08
patients O 0 2.1289019158654554e-10
and O 0 2.8872286506054223e-11
haplotype O 0 9.527800770570138e-10
analysis O 0 2.797672163379339e-11
by O 0 8.751434472931141e-12
restriction O 0 1.1661059617917857e-10
fragment O 0 9.199391248770894e-11
length O 0 1.9625001276835086e-11
polymorphisms O 0 7.502787835456104e-10
in O 0 1.4469747622314344e-10
the O 0 3.7247287476560587e-09
GALNS O 0 3.625505632953718e-05
gene O 0 2.3624255884868717e-09
suggest O 0 5.834620980804672e-11
that O 0 3.841478350696814e-12
G301C O 0 4.941338893615921e-09
originated O 0 3.060541542421191e-10
from O 0 3.1875550809967734e-11
a O 0 4.1722522658993455e-10
common O 0 2.029198364894569e-09
ancestor O 0 3.552949578988773e-08
. O 0 7.23172135508321e-08

Investigation O 0 8.094094283705999e-08
of O 0 1.1093954555008168e-07
the O 0 3.4685545102774995e-08
genetic O 0 3.941272197494072e-08
background O 0 1.8088591735576642e-09
by O 0 1.9129635375758625e-10
means O 0 2.06552197568044e-09
of O 0 9.166769565638333e-09
mtDNA O 0 2.402554821756553e-09
lineages O 0 2.7870375451932716e-10
indicate O 0 9.764724445693318e-11
that O 0 1.7185306996903016e-11
all O 0 5.592927787567703e-10
our O 0 5.063307551012031e-09
patients O 0 1.0168726277681728e-10
are O 0 1.5399837438243025e-12
probably O 0 1.9057916703091315e-11
of O 0 3.135182669034009e-10
native O 0 2.7769306853997477e-09
American O 0 1.0439173081522313e-07
descent O 0 2.994786655108328e-06

Low O 0 4.380784801583104e-08
frequency O 0 2.020039602257384e-08
of O 0 2.8026008180859208e-08
BRCA1 O 0 5.890213472525829e-08
germline O 0 7.612869268314171e-08
mutations O 0 1.1744631656096516e-10
in O 0 4.495481764621445e-11
45 O 0 2.710658586480008e-09
German O 1 0.9999884366989136
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.326438502426754e-07
. O 0 5.456691951621906e-07

In O 0 5.145319281751881e-09
this O 0 8.801524786772319e-11
study O 0 7.465043166954288e-11
we O 0 2.946488886212961e-11
investigated O 0 8.20486567576495e-10
45 O 0 5.41345634985646e-09
German O 1 0.999613344669342
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.363938295639855e-09
for O 0 1.6811001479766219e-09
germline O 0 3.333749418743537e-07
mutations O 0 6.832890919739043e-10
in O 0 1.0239595837902016e-09
the O 0 4.419828059099018e-08
BRCA1 O 0 1.3758111663264572e-06
gene O 0 3.929120850898471e-07
. O 0 1.1945263622692437e-07

We O 0 1.714728803392518e-08
identified O 0 9.22456155905138e-09
four O 0 1.930897441937418e-09
germline O 0 3.0209682222448464e-07
mutations O 0 1.7657036943674598e-09
in O 0 1.150302852970242e-09
three O 0 9.13023079363029e-09
breast B-Disease 1 0.95865797996521
cancer I-Disease 1 0.9747962355613708
families O 0 4.1183677995659806e-11
and O 0 5.474372621883106e-10
in O 0 2.7933955948356015e-07
one O 1 0.9998295307159424
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.1060715223720763e-05
. O 0 5.331986518974929e-10
among O 0 1.5094727551234755e-11
these O 0 7.278618679995574e-12
were O 0 1.6567355820562568e-10
one O 0 6.6376848462113e-11
frameshift O 0 3.306436369143739e-08
mutation O 0 7.498767717883936e-10
, O 0 1.5352488724751367e-10
one O 0 8.818378666175519e-11
nonsense O 0 2.7188981732706452e-08
mutation O 0 1.7991628187274955e-09
, O 0 1.1348427059187927e-10
one O 0 5.1188456251516357e-11
novel O 0 3.3626620932203366e-10
splice O 0 1.3676459964528931e-08
site O 0 1.5167412881211817e-09
mutation O 0 2.879717297954443e-10
, O 0 5.834409344540603e-11
and O 0 2.0985885251789682e-10
one O 0 3.073184151602959e-09
missense O 0 3.2433372325613163e-06
mutation O 0 1.0849822729142033e-06
. O 0 3.7461123270077223e-07

The O 0 2.740709703630273e-07
missense O 0 1.111544747800508e-06
mutation O 0 3.107437152038983e-08
was O 0 8.250556504663109e-08
also O 0 5.588342566476001e-10
found O 0 1.3259104925111842e-10
in O 0 9.790838140233404e-10
2 O 0 1.0045706630990026e-06
. O 0 1.399879039354346e-07

8 O 0 9.422095672562136e-07
% O 0 2.9890871999782576e-09
of O 0 4.494868921511852e-09
the O 0 1.675993566152556e-09
general O 0 4.58130200442497e-09
population O 0 5.4969070961696787e-11
, O 0 2.7920802822545276e-11
suggesting O 0 6.246193146042245e-11
that O 0 7.643539447210745e-12
it O 0 1.8037101326418004e-11
is O 0 5.64354674104095e-11
not O 0 2.115503883182157e-10
disease O 0 2.8055535494786454e-06
associated O 0 2.3307434204866695e-08
. O 0 3.0565018960260204e-08

The O 0 5.336875474881708e-08
average O 0 3.30233818068848e-09
age O 0 1.4097980560734413e-08
of O 0 2.6561181698525616e-07
disease O 1 0.9999922513961792
onset O 1 0.999991774559021
in O 0 5.291201699009207e-09
those O 0 1.4234632916831913e-10
families O 0 2.4767760758992452e-11
harbouring O 0 4.615228874627064e-07
causative O 0 1.400138103235804e-07
mutations O 0 1.00530472835203e-08
was O 0 6.014595754777474e-08
between O 0 1.940360760954718e-08
32 O 0 1.0249057140754303e-06
. O 0 3.789338052229141e-07

3 O 0 1.020739546220284e-05
and O 0 1.2034084306833392e-07
37 O 0 2.3838197193981614e-06
. O 0 1.0169869710807689e-06

4 O 0 9.258077966478595e-07
years O 0 1.0187761745328316e-08
, O 0 1.2603810217726164e-09
whereas O 0 7.331781848307628e-10
the O 0 1.7686023756624536e-09
family O 0 1.4197945596983175e-10
harbouring O 0 1.0131782346434193e-07
the O 0 3.573159101932788e-09
missense O 0 4.649182372418181e-08
mutation O 0 9.425746849700545e-10
had O 0 2.684591438040229e-10
an O 0 4.186013948664913e-12
average O 0 3.0344185497632736e-11
age O 0 1.1041296765768038e-09
of O 0 2.4738621817732565e-08
onset O 1 0.9999548196792603
of O 0 2.1788966478197835e-05
51 O 0 3.190436018485343e-06
. O 0 2.7928254553444276e-07

2 O 0 1.6028163372538984e-05
years O 0 1.0548229738560622e-06
. O 0 7.206859322650416e-07

These O 0 5.110214473802444e-10
findings O 0 6.159558973983792e-10
show O 0 9.545881862749184e-10
that O 0 6.844626254665087e-11
BRCA1 O 0 1.6528076685062842e-08
is O 0 1.0027185332051047e-10
implicated O 0 2.905260754193506e-10
in O 0 4.003461798185448e-11
a O 0 7.114489553039505e-11
small O 0 1.1078687446597346e-11
fraction O 0 1.0657608129349683e-10
of O 0 1.6650579709676094e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.4521395197419906e-10
suggesting O 0 5.132731462076379e-10
the O 0 4.903145112145069e-10
involvement O 0 3.640416634809185e-09
of O 0 8.50309067601529e-09
another O 0 2.7401900748458274e-09
susceptibility O 0 5.503119950844848e-07
gene O 0 1.5537065678472572e-07
( O 0 5.731441987677499e-09
s O 0 2.357962330279406e-06
) O 0 1.429265523711365e-07

Paternal O 0 1.9481618437566794e-05
transmission O 1 0.9822573065757751
of O 1 0.999995231628418
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.999893307685852

We O 0 4.610389581216623e-08
report O 0 2.2224322382413675e-09
a O 0 1.020084239300445e-09
rare O 0 6.904806504337557e-09
case O 0 1.6779063694016827e-09
of O 0 7.620409547826057e-08
paternally O 1 0.6223960518836975
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999793767929077
DM B-Disease 1 1.0
) O 0 5.392425705963433e-08
. O 0 6.181431899676681e-08

The O 0 2.9025895287304593e-07
proband O 0 7.478708084818209e-06
is O 0 2.051403269476282e-09
a O 0 1.3566113787888412e-09
23 O 0 1.0163171637600499e-08
year O 0 1.8806074475463674e-09
old O 0 1.1569308071557316e-06
, O 0 7.812257649675303e-07
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 1.103050408346462e-06
who O 0 2.1593140786535514e-07
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9967784285545349

He O 0 3.3720489511779306e-08
presented O 0 1.804349949452444e-07
with O 0 4.750555504529075e-08
respiratory O 1 1.0
and O 0 1.1989546067070478e-07
feeding O 0 7.053091053421667e-07
difficulties O 0 3.3751584851415828e-06
at O 0 1.6115740436362103e-05
birth O 0 5.575020168180345e-06
. O 0 4.986094950254483e-07

His O 0 1.1981148873019265e-06
two O 0 4.318394530855585e-07
sibs O 1 0.9983665347099304
suffer O 0 1.4029027624928858e-05
from O 0 1.0776692249692132e-07
childhood O 1 0.9999455213546753
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.0004195704823359847

Their O 0 2.553924893788917e-08
late O 0 3.947780555790814e-07
father O 0 1.441893271447725e-08
had O 0 2.0564687730484366e-09
the O 0 1.9427965902707456e-09
adult O 0 1.6725224538660655e-09
type O 0 1.0888694390587261e-08
of O 0 3.980344445153605e-06
DM B-Disease 1 1.0
, O 0 8.27556512206229e-09
with O 0 5.008861103661388e-10
onset O 1 0.9983454942703247
around O 0 6.669977903328572e-09
30 O 0 2.5874179243601247e-08
years O 0 1.5884287662970564e-08
. O 0 4.451868917954016e-08

Only O 0 1.2532117565910994e-08
six O 0 2.9782118993182394e-09
other O 0 2.5980363693722808e-11
cases O 0 3.620297811535167e-11
of O 0 1.2200987997701418e-09
paternal O 0 3.5409208010150905e-08
transmission O 0 7.688421464990824e-05
of O 1 0.9741986393928528
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 4.5642096324627346e-08
been O 0 1.5920434970340125e-09
reported O 0 1.1214829065409049e-09
recently O 0 2.2473532368394444e-08
. O 0 5.049017914871001e-08

We O 0 1.1587285797531877e-08
review O 0 2.0427199931560835e-09
the O 0 1.2513551306270188e-09
sex O 0 3.0631755465471144e-10
related O 0 3.4341160470852117e-10
effects O 0 1.698210461142935e-08
on O 0 1.0520001758607123e-08
transmission O 0 4.011102646472864e-06
of O 0 6.183217192301527e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.061840202659368515

Decreased O 0 6.187631242937641e-07
fertility O 0 9.250852883724292e-08
of O 0 1.4501390088739186e-09
males O 0 8.604753194696446e-12
with O 0 1.4626517011451234e-11
adult O 0 6.594624579747688e-08
onset O 1 1.0
DM B-Disease 1 1.0
and O 0 1.4982818319353441e-09
contraction O 0 1.1970096025493149e-08
of O 0 1.5197276326262e-08
the O 0 9.917711096818493e-09
repeat O 0 2.7003805413983173e-08
upon O 0 1.0050013043994e-09
male O 0 7.96905111344337e-11
transmission O 0 1.9441818988052972e-10
contribute O 0 2.3791259760874706e-12
to O 0 1.3023959081343017e-12
the O 0 8.433209686131704e-11
almost O 0 1.3287713984677652e-10
absent O 0 4.1622449931111305e-10
occurrence O 0 6.137230723624043e-10
of O 0 1.417668427095009e-09
paternal O 0 7.02413105457822e-09
transmission O 0 1.5333431292674504e-05
of O 0 0.0002163479948649183
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.0018727508140727878

Also O 0 3.9344300262200704e-08
the O 0 8.51224246645188e-09
fathers O 0 1.5060980240733102e-09
of O 0 6.922512563178884e-10
the O 0 1.2691376838347423e-09
reported O 0 4.088161809079338e-09
congenitally O 0 1.2365103430056479e-06
affected O 0 5.094011878981064e-10
children O 0 1.1275280188682846e-11
showed O 0 3.771818413156325e-10
, O 0 2.4050284333498873e-11
on O 0 1.0764253932649126e-09
average O 0 3.087524125255925e-10
, O 0 5.868810992737394e-10
shorter O 0 1.6064539920535026e-08
CTG O 0 9.29644829739118e-06
repeat O 0 6.874519442590099e-08
lengths O 0 1.8237601651094337e-08
and O 0 8.161331332967592e-11
hence O 0 7.909422561347412e-10
less O 0 2.074554694697639e-10
severe O 0 0.0025528166443109512
clinical O 1 0.9955991506576538
symptoms O 0 7.885968807386234e-05
than O 0 2.7239030475634252e-11
the O 0 5.548514425690598e-10
mothers O 0 2.418621899979989e-11
of O 0 9.735934974886007e-11
children O 0 2.3113948255382155e-10
with O 0 7.814181657295194e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.8557471036911011

We O 0 1.1300486768561768e-08
conclude O 0 1.0952641460448831e-08
that O 0 4.0558254671418936e-11
paternal O 0 2.710999646993173e-09
transmission O 0 1.11467625174555e-06
of O 1 0.9367655515670776
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 9.325022801931482e-06
rare O 0 5.7194103675328734e-08
and O 0 7.967212306558835e-11
preferentially O 0 6.620943376889343e-11
occurs O 0 1.1882160186327262e-11
with O 0 6.123520527451243e-12
onset O 1 0.9992786049842834
of O 0 0.23184514045715332
DM B-Disease 1 1.0
past O 0 3.798962566747832e-08
30 O 0 1.1129401844556241e-09
years O 0 7.626010239958347e-11
in O 0 1.1553332596170307e-10
the O 0 1.8608828922239695e-09
father O 0 5.84594461727761e-09
. O 0 3.055579345101478e-09
. O 0 4.4264169218877214e-08

The O 0 2.45717137659085e-06
RB1 O 0 0.00026218657149001956
gene O 0 7.960145609331448e-08
mutation O 0 1.2656864001314716e-08
in O 0 8.920459926287094e-10
a O 0 1.333795296432072e-08
child O 0 2.2303574098714307e-08
with O 0 3.4257325864928134e-08
ectopic B-Disease 1 0.9999991655349731
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 2.4556587959523313e-05

The O 0 7.25494487596734e-07
RB1 O 0 3.670553633128293e-05
gene O 0 3.925734404219838e-08
mutation O 0 2.968785883794567e-09
was O 0 7.680788449704323e-09
investigated O 0 1.119972203866837e-08
in O 0 1.9530808081924533e-09
a O 0 3.983739205182246e-08
child O 0 3.5294583256018086e-08
with O 0 8.165963905071294e-09
ectopic B-Disease 1 0.9998663663864136
intracranial I-Disease 1 0.9999967813491821
retinoblastoma I-Disease 0 0.14021246135234833
using O 0 9.39910593800164e-10
DNA O 0 2.5968832639833295e-10
obtained O 0 8.50721403045096e-12
from O 0 5.754293309206959e-12
both O 0 5.2735444483476e-11
the O 0 4.917946050397859e-09
pineal B-Disease 1 0.8308941125869751
and I-Disease 0 1.4952165727777356e-08
retinal I-Disease 1 0.9999984502792358
tumours I-Disease 1 1.0
of O 0 1.0241895324725192e-05
the O 0 1.189384306599095e-06
patient O 0 2.3432703528669663e-06
. O 0 3.229480114441685e-07

A O 0 1.1236812724746414e-06
nonsense O 0 3.3952639455492317e-07
mutation O 0 9.241361453860009e-09
in O 0 1.3206109539254385e-09
exon O 0 1.205765727263497e-07
17 O 0 2.0688348811859214e-08
( O 0 1.2690111461655107e-10
codon O 0 1.6847819805931863e-09
556 O 0 4.127082564586715e-10
) O 0 9.14377514676934e-12
of O 0 9.53465417730115e-10
the O 0 2.3476710353520502e-08
RB1 O 0 1.287567829422187e-05
gene O 0 7.671125956676406e-09
was O 0 8.92008955588608e-09
found O 0 2.4090042460844785e-11
to O 0 3.907678000625303e-12
be O 0 1.5289389546091492e-11
present O 0 4.329055169893792e-11
homozygously O 0 4.0873608497804526e-08
in O 0 3.3248934161456134e-10
both O 0 1.8988806360642485e-10
the O 0 3.4955900396482775e-09
retinal B-Disease 0 3.8129476251924643e-06
and I-Disease 0 5.192820839994283e-09
the I-Disease 0 1.0429038184156525e-06
pineal I-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 2.5194483441737248e-06

The O 0 2.8667050955277773e-08
same O 0 9.511731402511714e-10
mutation O 0 1.8170475124534846e-09
was O 0 3.596605235856032e-09
present O 0 2.3416760197569886e-10
heterozygously O 0 6.376459538159907e-08
in O 0 6.213140557598251e-10
the O 0 1.1531609001025345e-09
DNA O 0 1.15222653640501e-09
from O 0 1.5632753772032437e-11
the O 0 3.30247523772087e-10
constitutional O 0 1.972244412229429e-08
cells O 0 9.567331649140698e-11
of O 0 5.277299708339456e-10
the O 0 1.8446483229794808e-09
patient O 0 1.6540684377730486e-09
, O 0 1.1745303341026414e-10
proving O 0 4.733178737836852e-09
it O 0 6.141896886913134e-12
to O 0 4.126991717118278e-12
be O 0 2.1118945134346312e-11
of O 0 6.172742872401216e-10
germline O 0 1.6116305801006092e-07
origin O 0 1.6470415031832886e-09
. O 0 1.0620361479141138e-08

The O 0 5.571914840629688e-08
initial O 0 2.11170831931895e-08
mutation O 0 4.658127217282981e-09
was O 0 3.6323088981049523e-09
shown O 0 1.154676770864782e-10
to O 0 1.3124386126495136e-11
have O 0 1.1347036157904888e-11
occurred O 0 2.368525597873372e-09
in O 0 1.6586991502531845e-10
the O 0 4.898211614090542e-09
paternally O 0 3.432397477354243e-08
derived O 0 5.42104050538228e-09
RB1 O 0 7.640224794158712e-06
allele O 0 8.741325530081667e-08
. O 0 3.9128913442709745e-08

The O 0 1.0140887951592958e-07
mutation O 0 1.0261341998329954e-08
is O 0 4.6504612660758227e-11
in O 0 1.0286879854881636e-11
an O 0 3.3541262215580625e-12
area O 0 2.000486859499162e-10
of O 0 3.5430522404844567e-10
the O 0 2.298549794943483e-09
gene O 0 2.730098924708102e-10
that O 0 1.1221386667092936e-11
encodes O 0 8.443671456470625e-11
the O 0 5.537064695637639e-10
protein O 0 1.0876234357581893e-09
- O 0 1.0727934096621539e-09
binding O 0 8.524456696079596e-10
region O 0 9.93084281475376e-10
known O 0 1.3350386074417742e-10
as O 0 3.541678755825117e-11
the O 0 1.844506630765963e-10
pocket O 0 6.6425802636160824e-09
region O 0 2.9597663209202096e-10
and O 0 2.7410445441189424e-11
has O 0 1.9550579904992205e-11
been O 0 3.002448983879802e-11
detected O 0 1.7107577854336142e-10
in O 0 1.866735932498642e-11
other O 0 8.858106956277645e-12
cases O 0 2.8468829724181965e-11
of O 0 2.966928924763579e-09
retinoblastoma B-Disease 0 3.186416279277182e-06
. O 0 6.203504820945227e-09
. O 0 4.8515016004557765e-08

Low O 0 7.859762831685657e-07
levels O 0 3.295185990737082e-08
of O 0 9.751054186324382e-09
beta O 0 5.717735120924772e-07
hexosaminidase O 0 6.8965432546974625e-06
A O 0 4.5842941887030975e-08
in O 0 1.3747845917233548e-10
healthy O 0 3.714794027942503e-10
individuals O 0 6.493297110936325e-13
with O 0 4.2330011024160896e-11
apparent O 1 0.9468117356300354
deficiency O 1 0.9999951124191284
of O 1 0.574981153011322
this O 0 3.112170929853164e-07
enzyme O 0 2.300893982010166e-07
. O 0 1.3880237759167358e-07

Appreciable O 0 9.145376679953188e-06
beta O 0 4.9088480409409385e-06
hexosaminidase O 0 3.476956771919504e-05
A O 0 8.074385959844221e-07
( O 0 7.583948469225277e-10
hex O 0 9.57283887714766e-08
A O 0 1.7938798890781982e-08
) O 0 4.3753399341095456e-12
activity O 0 7.255778616821473e-11
has O 0 1.2006182506518748e-11
been O 0 2.2400616084272684e-11
detected O 0 1.2859606712822824e-09
in O 0 7.797276713183976e-10
cultured O 0 5.519586920854636e-07
skin O 0 1.4728724636370316e-05
fibroblasts O 0 0.00015536011778749526
and O 0 2.7096675125903857e-08
melanoma B-Disease 1 0.9999558925628662
tissue O 0 1.7598013357655873e-07
from O 0 3.928276870457381e-10
healthy O 0 2.777739704917792e-10
individuals O 0 4.3782509627325605e-13
previously O 0 1.9009607776787618e-10
reported O 0 1.0478677647807189e-10
as O 0 3.0850458299092054e-10
having O 0 6.145681652469648e-08
deficiency B-Disease 1 0.5361374020576477
of I-Disease 0 0.26994630694389343
hex I-Disease 1 0.5278606414794922
A I-Disease 0 1.523361845556792e-07
activity O 0 2.830889134219916e-10
indistinguishable O 0 4.6162785399817e-11
from O 0 2.739118339697283e-13
that O 0 1.5142466273931898e-13
of O 0 1.10255908569723e-10
patients O 0 5.132398395168991e-10
with O 0 1.675240923759702e-07
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.1822518217741163e-06
TSD B-Disease 1 0.999992847442627
) O 0 1.8663008916064427e-08
. O 0 1.4319751073799125e-07

Identification O 0 2.568904449162801e-07
and O 0 1.310284591937716e-08
quantitation O 0 3.319962343084626e-05
of O 0 1.2088023595424602e-06
hex O 0 3.5988297895528376e-05
A O 0 6.55450946851488e-07
, O 0 8.664908790478876e-10
amounting O 0 1.7882354486076224e-09
to O 0 4.807154119212953e-10
3 O 0 8.453575901512522e-07
. O 0 1.7443123567773e-07

5 O 0 8.946483944782813e-07
% O 0 5.781378575875351e-08
- O 0 3.468568365860847e-07
6 O 0 2.40498502535047e-06
. O 0 3.853304804124491e-07

9 O 0 4.4150684175292554e-07
% O 0 2.1508121950120085e-09
of O 0 2.5129047731553555e-09
total O 0 4.4015786571094395e-09
beta O 0 6.041464928330242e-08
hexosaminidase O 0 7.537520474443227e-08
activity O 0 1.8323329520342213e-09
, O 0 3.016466243455085e-11
has O 0 5.295009656430816e-12
been O 0 6.555022150078749e-12
obtained O 0 2.9285206204487935e-11
by O 0 1.4431766892641917e-10
cellulose O 0 6.20348191660014e-06
acetate O 0 1.1354781008776627e-06
gel O 0 6.399048402272456e-08
electrophoresis O 0 8.618859403952683e-09
, O 0 1.866897969549086e-09
DEAE O 0 7.064729743433418e-06
- O 0 4.082460236531915e-08
cellulose O 0 7.751668817945756e-07
ion O 0 8.983009536223108e-08
- O 0 1.767126356355675e-08
exchange O 0 3.53300566580117e-09
chromatography O 0 8.058952616352144e-09
, O 0 3.9731723466829294e-10
radial O 0 1.4379136992204167e-08
immunodiffusion O 0 2.6506424433137e-07
, O 0 1.6063306240710062e-09
and O 0 1.5334440384151549e-09
radioimmunoassay O 0 2.809012357829488e-06
. O 0 2.0285111190787575e-07

Previous O 0 6.4933160501823295e-06
family O 0 9.329791161860612e-09
studies O 0 3.3697262757925728e-09
suggested O 0 1.296907137238179e-09
that O 0 1.1339680063005009e-11
these O 0 1.720783932013248e-11
individuals O 0 5.115729454635565e-12
may O 0 3.3775426899751437e-10
be O 0 1.785109560170639e-10
compound O 0 6.623022130725076e-09
heterozygotes O 0 1.3696214162806086e-09
for O 0 4.4190883591310737e-11
the O 0 3.6877909059818137e-10
common O 0 4.928967789474825e-10
mutant O 0 5.497460620063066e-08
TSD B-Disease 0 4.565086328511825e-06
gene O 0 5.611627273971465e-10
and O 0 3.7400593039249586e-11
a O 0 2.383879760259333e-10
rare O 0 2.2220594253496984e-09
( O 0 6.866542057171188e-11
allelic O 0 5.042887352146863e-08
) O 0 5.474278252926013e-10
mutant O 0 1.6319144435783528e-07
gene O 0 2.466385637944768e-07
. O 0 6.299623578343017e-08

Thus O 0 4.545340814843257e-08
, O 0 1.138502958575316e-09
the O 0 9.26788812360968e-10
postulated O 0 1.1157462509459037e-08
rate O 0 1.301332486214335e-09
mutant O 0 6.192274248917329e-09
gene O 0 2.385271424820701e-10
appears O 0 1.2223616216444633e-11
to O 0 3.8145850952790716e-13
code O 0 4.228512505422e-12
for O 0 1.6865350262185164e-12
the O 0 2.3648534519526976e-11
expression O 0 7.939572610471402e-11
of O 0 1.3140448451576248e-10
low O 0 1.1786646103573162e-09
amounts O 0 7.54176651684979e-11
of O 0 2.3533008874920824e-09
hex O 0 2.3904240151750855e-06
A O 0 1.0918016641880968e-06
. O 0 8.455287314745874e-08

Heterozygotes O 0 3.960491994803306e-06
for O 0 1.2994210152328378e-08
the O 0 2.880786098558019e-08
rare O 0 5.673354053215007e-08
mutant O 0 2.0935337374794472e-07
may O 0 7.248230904366437e-10
be O 0 3.1828650826071225e-11
indistinguishable O 0 3.595485020824185e-10
from O 0 6.872867292645468e-12
heterozygotes O 0 6.138143882061797e-10
for O 0 9.704787667930148e-11
the O 0 7.832203330337961e-09
common O 0 5.951591930397626e-08
TSD B-Disease 0 0.00017564304289408028
mutant O 0 1.4777255046283244e-06
. O 0 9.968237435487026e-08

However O 0 1.0191260280123515e-08
, O 0 2.7638566435506107e-10
direct O 0 5.135629699282163e-10
visualization O 0 2.201881166286057e-08
and O 0 1.2884354694264744e-09
quantitation O 0 1.7676509742159396e-05
of O 0 3.778959012379346e-07
hex O 0 1.815886321310245e-06
A O 0 1.2499866031134843e-08
by O 0 1.852692825543567e-11
the O 0 1.1871745253522192e-10
methods O 0 3.792739178276605e-10
described O 0 3.343532950506045e-10
may O 0 9.330244910010776e-11
prevent O 0 2.666170062504136e-10
false O 0 3.1962624214010305e-10
- O 0 1.0466478794768364e-09
positive O 0 7.921240052777279e-11
prenatal O 0 2.3443917029908334e-07
diagnosis O 0 3.00057621416272e-07
of O 0 4.212075666032433e-08
TSD B-Disease 0 0.39607104659080505
in O 0 3.768196421560788e-09
fetuses O 0 4.5651131763690955e-09
having O 0 2.0109459930583995e-10
the O 0 3.3538243293662617e-09
incomplete O 0 1.606935882136895e-07
hex B-Disease 0 0.2494715452194214
A I-Disease 1 0.9222516417503357
deficiency I-Disease 0 0.0054312581196427345
of O 0 6.22414518147707e-06
the O 0 1.836077956340887e-07
type O 0 1.1818646328265459e-07
described O 0 7.072311625222483e-09
in O 0 7.874305096855494e-10
the O 0 1.4836485817681933e-08
four O 0 2.088615325135379e-08
healthy O 0 4.4297496515355306e-07
individuals O 0 4.610187431808299e-08

The O 0 1.3531152944779024e-06
tumor B-Disease 0 1.1188414646312594e-05
suppressor O 0 7.536221801274223e-06
gene O 0 1.1765229857019222e-07
Smad4 O 0 1.047347814164823e-05
/ O 0 4.584942416840931e-06
Dpc4 O 0 5.241301096248208e-06
is O 0 2.9661129108404793e-10
required O 0 5.3787044262954e-11
for O 0 1.1061040972037972e-10
gastrulation O 0 6.939228001101583e-07
and O 0 1.8298523807303013e-10
later O 0 2.67660649200252e-09
for O 0 4.556333643712662e-10
anterior O 0 4.724889812735e-09
development O 0 3.923262159588603e-09
of O 0 1.090708945383767e-08
the O 0 5.918423440220977e-08
mouse O 0 2.922148212292086e-07
embryo O 0 1.1161340296439448e-07
. O 0 3.9679282082261125e-08

Mutations O 0 1.648900820327981e-07
in O 0 2.4511482621392133e-08
the O 0 1.7498506110769085e-07
SMAD4 O 1 0.5295148491859436
/ O 0 0.00024648700491525233
DPC4 O 0 0.0009851191425696015
tumor B-Disease 0 1.7448094240535283e-06
suppressor O 0 2.897478736940684e-07
gene O 0 9.36369537463122e-10
, O 0 6.674323593802711e-11
a O 0 2.357828376986504e-10
key O 0 1.6389073209666094e-08
signal O 0 1.0928584259772833e-07
transducer O 0 4.303836220742596e-08
in O 0 8.680988150544522e-10
most O 0 3.612285193188569e-10
TGFbeta O 0 1.9680657715070993e-05
- O 0 6.56659722153563e-08
related O 0 1.2489285161620955e-08
pathways O 0 1.0687093876526887e-08
, O 0 1.4324093994266818e-11
are O 0 2.436538384248399e-13
involved O 0 1.1682219861613996e-12
in O 0 1.4831766023681858e-11
50 O 0 3.6292671645732355e-10
% O 0 6.499675797577709e-10
of O 0 2.6740468683783547e-07
pancreatic B-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
. O 0 5.466387392516481e-06

Homozygous O 0 6.834976375102997e-06
Smad4 O 0 0.0001118689906434156
mutant O 0 4.0326296584680676e-05
mice O 0 3.8728967410861515e-06
die O 0 1.307309389630973e-07
before O 0 5.196952201913518e-09
day O 0 2.020655998080656e-08
7 O 0 1.088513272406999e-06
. O 0 9.839276771117511e-08

5 O 0 2.6440759484103182e-06
of O 0 7.195960733952234e-07
embryogenesis O 0 8.767932013142854e-05
. O 0 2.9510092645068653e-06

Mutant O 0 7.365961209870875e-07
embryos O 0 2.546866362251876e-08
have O 0 2.1357468571459037e-10
reduced O 0 1.2085575873399534e-09
size O 0 5.756702892156795e-10
, O 0 7.349577613169345e-10
fail O 0 2.299568357955195e-08
to O 0 2.440644353285393e-10
gastrulate O 0 1.2790845858035027e-06
or O 0 9.003173762067718e-10
express O 0 3.6612635145871764e-10
a O 0 6.025406285026236e-10
mesodermal O 0 3.7353384385596655e-08
marker O 0 1.4615050503152816e-08
, O 0 4.830920732890043e-11
and O 0 3.314981622537516e-11
show O 0 5.45056844103442e-09
abnormal O 0 1.7101372407068993e-07
visceral O 0 4.139865268371068e-06
endoderm O 0 2.2956362954573706e-05
development O 0 6.2298070702127e-08
. O 0 2.8455954037553965e-08

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 3.832648872048594e-06
the O 0 3.927240186385461e-07
Smad4 O 0 0.10273479670286179
- O 0 2.8663607736234553e-06
deficient O 0 6.994973773544189e-07
embryos O 0 1.9201915613109577e-09
results O 0 4.881319237703963e-10
from O 0 1.8885217001329835e-10
reduced O 0 5.771705602342081e-08
cell O 0 3.6589813134924043e-07
proliferation O 0 8.43120972149336e-07
rather O 0 3.878623464070863e-11
than O 0 4.713154345969972e-12
increased O 0 1.004518357383688e-09
apoptosis O 0 2.0328523078205762e-06
. O 0 3.0030548714421457e-08

Aggregation O 0 2.851877241027978e-07
of O 0 1.6824587589781004e-07
mutant O 0 2.5837864541244926e-06
Smad4 O 0 7.904549420345575e-05
ES O 0 0.0001922036608448252
cells O 0 8.49621206722162e-10
with O 0 6.088503312629001e-11
wild O 0 3.141010438412195e-07
- O 0 7.3872215011761e-08
type O 0 2.0390585575569276e-07
tetraploid O 0 6.7424030021356884e-06
morulae O 0 5.3032275900477543e-05
rescues O 0 1.68034659964178e-06
the O 0 1.5702862299349363e-07
gastrulation B-Disease 0 0.2782483994960785
defect I-Disease 0 0.0003269072622060776
. O 0 9.282726409765019e-07

These O 0 2.5414206294982478e-09
results O 0 2.4218693717159567e-09
indicate O 0 7.341494079327049e-10
that O 0 4.584339505231405e-11
Smad4 O 0 2.606806788207905e-07
is O 0 9.89381979121795e-11
initially O 0 3.650495183915581e-11
required O 0 5.733871277086022e-12
for O 0 5.215255744622782e-12
the O 0 3.978213244937301e-11
differentiation O 0 4.868859204698595e-10
of O 0 1.3786130570458965e-10
the O 0 2.710734692268346e-10
visceral O 0 5.866329200188147e-09
endoderm O 0 1.7914523198214738e-08
and O 0 3.3818278039055016e-11
that O 0 4.759461488118566e-12
the O 0 7.854070727120188e-10
gastrulation B-Disease 0 7.19010567991063e-05
defect I-Disease 0 2.292660354896725e-07
in O 0 6.269914032408508e-10
the O 0 1.5470112302296002e-08
epiblast O 0 4.4096912461100146e-05
is O 0 4.6556022925692275e-10
secondary O 0 6.3069189870645914e-09
and O 0 4.363767958093234e-10
non O 0 3.3402542953808734e-07
- O 0 2.3604097521001677e-07
cell O 0 4.1649564082035795e-06
autonomous O 0 3.678080133795447e-07
. O 0 1.1532191024343774e-07

Rescued O 0 8.760453965805937e-06
embryos O 0 2.1439674924295105e-07
show O 0 7.006657938291028e-07
severe O 1 0.9543222188949585
anterior O 0 1.3124742508807685e-05
truncations O 1 0.5042369365692139
, O 0 1.0059876487389374e-08
indicating O 0 1.3399327869478839e-08
a O 0 1.782698100250002e-09
second O 0 3.7046774536975136e-09
important O 0 1.1977192571066553e-09
role O 0 1.3592661440853249e-09
for O 0 9.554698143787732e-10
Smad4 O 0 2.5086974346777424e-06
in O 0 8.73820393820779e-09
anterior O 0 1.720964633022959e-07
patterning O 0 1.6191421536859707e-06
during O 0 5.842073733219877e-06
embryogenesis O 0 0.00035322149051353335
. O 0 9.024136033985997e-07

Prevalence O 0 7.822942279744893e-06
of O 0 9.153127678018791e-08
p16 O 0 1.306251249388879e-07
and O 0 7.934676027332443e-09
CDK4 O 0 0.00027491088258102536
germline O 0 2.9739842375420267e-06
mutations O 0 4.402796349722848e-09
in O 0 1.3543596244502965e-09
48 O 0 2.0067120658495696e-06
melanoma B-Disease 1 1.0
- O 1 0.9390602111816406
prone O 0 4.025657744932687e-06
families O 0 2.7251968043318087e-11
in O 0 2.587056346925465e-09
France O 0 4.090077709406614e-05
. O 0 3.325259967823513e-06

The O 0 2.194602075178409e-06
French O 0 0.00016077315376605839
Familial B-Disease 1 0.9999518394470215
Melanoma I-Disease 1 0.9999998807907104
Study O 0 4.1373036765435245e-06
Group O 0 1.6018957467167638e-06
. O 0 9.075643561118341e-07

Germline O 0 1.4327349163067993e-05
mutations O 0 2.2855408232658192e-08
in O 0 1.9712920185099847e-09
the O 0 7.508904609210276e-09
p16 O 0 1.972846419562302e-08
and O 0 1.7964265630610043e-09
CDK4 O 0 2.1130288587301038e-05
genes O 0 3.0812294382620564e-10
have O 0 3.2584048306749658e-12
been O 0 6.950368666019946e-12
reported O 0 1.3650247598917531e-11
in O 0 1.9497103584398268e-11
a O 0 3.8018144188356473e-10
subset O 0 1.7489398373982112e-07
of O 0 3.085908701905282e-07
melanoma B-Disease 1 0.9992730021476746
pedigrees O 0 5.722814933051268e-08
, O 0 4.026514677235582e-10
but O 0 3.6408993875358675e-11
their O 0 1.6468898467181248e-10
prevalence O 0 2.0380787191243144e-07
is O 0 3.133411585753976e-11
not O 0 1.0933087768449923e-11
well O 0 1.3937360987537062e-10
known O 0 1.1199294824848494e-08
. O 0 4.722342694662984e-08

We O 0 1.8535086354631858e-08
searched O 0 8.38580493933705e-09
for O 0 1.3509429686031638e-10
such O 0 3.8565611815144507e-10
germline O 0 2.6025765009762836e-07
mutations O 0 9.516069043868924e-10
in O 0 6.249258888146869e-10
48 O 0 5.003566982964003e-08
French O 0 0.025205913931131363
melanoma B-Disease 1 1.0
- O 0 0.018629489466547966
prone O 0 1.4014648286320153e-06
families O 0 1.893711056022429e-11
selected O 0 5.9881453962074e-11
according O 0 7.951465874622698e-12
to O 0 3.2783721484047623e-12
two O 0 4.221598331327625e-12
major O 0 7.641743238195886e-09
criteria O 0 2.2970345625594746e-08
families O 0 9.932987592164988e-13
with O 0 4.237086809882884e-12
at O 0 6.6011529575860095e-09
least O 0 6.820361636572514e-11
three O 0 4.374707540666378e-11
affected O 0 1.2307468932881704e-10
members O 0 1.0228594880812292e-11
( O 0 1.5514175014108567e-11
n O 0 4.006330378558687e-09
= O 0 1.1594419868643513e-09
20 O 0 3.0958918761925247e-10
) O 0 1.8686692818126183e-12
or O 0 1.3513127249120682e-12
families O 0 4.455533571213685e-14
with O 0 7.630047310115684e-13
two O 0 1.5497613609083416e-11
affected O 0 6.372146560407188e-11
members O 0 2.2734026466908475e-11
, O 0 3.7042497541550645e-11
one O 0 1.5313701695607307e-11
of O 0 1.0928887794747766e-09
them O 0 1.851534203733962e-11
affected O 0 1.3477406690665106e-11
before O 0 5.0567203202511735e-11
the O 0 7.094705378740684e-11
age O 0 7.485288777697718e-11
of O 0 1.578421560122223e-10
50 O 0 1.186594988933365e-10
( O 0 2.6623659873936667e-12
n O 0 3.8941994073837805e-10
= O 0 7.431036896932142e-10
28 O 0 1.5642910300428525e-09
) O 0 8.642205007181047e-12
, O 0 6.565482532638889e-12
and O 0 1.1508855500552695e-11
one O 0 2.643110209865629e-11
additional O 0 3.651513535984918e-10
minor O 0 3.682600606680353e-07
criterion O 0 0.19852720201015472
. O 0 5.760244903285638e-07

Sixteen O 0 5.969052949694742e-07
different O 0 1.0190029930967626e-09
p16 O 0 1.0193363664257049e-07
germline O 0 1.4942962422992423e-07
mutations O 0 7.847871241750681e-10
were O 0 3.448727414756547e-10
found O 0 4.948596740717015e-11
in O 0 6.787476830583117e-11
21 O 0 5.8431464111663445e-09
families O 0 7.740457580451832e-12
, O 0 4.285668694925526e-11
while O 0 1.2516887526459186e-10
one O 0 4.2099509989235173e-10
germline O 0 1.971259706579076e-07
mutation O 0 3.763663602995848e-09
, O 0 2.0139476197833517e-10
Arg24His O 0 1.5708313583218114e-07
, O 0 3.089974942582785e-10
was O 0 4.565052336147346e-09
detected O 0 3.886944099917855e-09
in O 0 2.0154655722137704e-10
the O 0 1.6165264682399538e-08
CDK4 O 0 0.0013762512244284153
gene O 0 9.491213290857559e-07
. O 0 1.6459439677873888e-07

The O 0 8.8674854126225e-09
frequency O 0 4.872735548389073e-09
of O 0 1.1772206320870282e-08
p16 O 0 6.390422857549538e-09
gene O 0 5.935794078482104e-10
mutation O 0 1.2047479680532547e-10
in O 0 1.0148821019684284e-11
our O 0 1.2023002385341819e-11
sample O 0 4.872793574889345e-12
( O 0 1.4740384477254787e-12
44 O 0 3.457373623505511e-11
% O 0 4.0565602960063174e-11
) O 0 4.96206287864398e-12
is O 0 4.496328656622417e-12
among O 0 2.0005954358415234e-12
the O 0 2.263737391983156e-10
highest O 0 2.0173558823444182e-08
rates O 0 4.476216064475125e-10
yet O 0 1.905348274988672e-11
reported O 0 1.5139708930966833e-11
and O 0 7.715796751517345e-12
the O 0 1.1192157201023178e-09
CDK4 O 0 3.176199970766902e-05
mutation O 0 1.3114339614261894e-09
is O 0 1.4184538960071436e-11
the O 0 8.934247786029914e-11
second O 0 1.603104649028353e-09
mutation O 0 2.188459830021472e-10
detected O 0 5.043565010076634e-10
in O 0 1.55212492164436e-11
this O 0 3.768494544198475e-11
gene O 0 9.864810301962734e-09
worldwide O 0 8.235101489617591e-08
. O 0 5.222711862984397e-08

In O 0 3.680542803863318e-08
summary O 0 7.449463055309025e-07
, O 0 1.7300333388092781e-09
our O 0 5.981801165511058e-10
results O 0 1.6993623175309835e-10
show O 0 3.0985089494173224e-10
frequent O 0 1.3466365522685209e-10
involvement O 0 1.4403449544175828e-09
of O 0 2.8048612321640576e-09
the O 0 4.792453545121589e-09
p16 O 0 1.671091531818547e-08
gene O 0 3.3342686389659093e-09
in O 0 5.228477095720052e-10
familial B-Disease 0 1.6704357221897226e-06
melanoma I-Disease 0 0.10136563330888748
and O 0 5.070524000672094e-10
confirm O 0 2.2861019743913857e-09
the O 0 2.0630375185959338e-09
role O 0 2.155818634719253e-09
of O 0 1.7732714852058962e-08
the O 0 1.4543034865255322e-07
CDK4 O 1 0.9840937256813049
gene O 0 9.23081344694765e-08
as O 0 3.835970652232845e-09
a O 0 2.3456971476321087e-08
melanoma B-Disease 0 0.025428006425499916
- O 0 5.021929041504336e-07
predisposing O 0 1.3105865264151362e-06
gene O 0 1.3540687859858735e-07
. O 0 1.1644890385298368e-08
. O 0 9.033058745444578e-08

Progression O 0 2.6642352167982608e-05
of O 0 1.8296486814506352e-06
somatic O 0 2.7871425118064508e-05
CTG O 0 8.647194044897333e-05
repeat O 0 1.0133173589110811e-07
length O 0 7.228060372455047e-10
heterogeneity O 0 2.3504668433815823e-08
in O 0 4.107904294503584e-10
the O 0 2.2191326554121815e-09
blood O 0 8.180945698654796e-09
cells O 0 1.6901746846542665e-07
of O 0 0.009316965006291866
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9671121835708618
. O 0 3.2918822512328916e-07

The O 0 2.843804658425597e-08
genetic O 0 5.98545852881216e-08
basis O 0 7.052755535141841e-08
of O 1 0.9955450296401978
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9996427297592163
DM B-Disease 1 1.0
) O 0 3.866224007609276e-10
is O 0 9.580766735517443e-12
the O 0 2.1320055096363255e-11
expansion O 0 6.366379645683651e-10
of O 0 8.916904437050732e-10
an O 0 3.563703498965509e-10
unstable O 0 9.931173394761572e-08
CTG O 0 5.53669724467909e-06
repeat O 0 2.5479938159378435e-08
in O 0 2.702469636961524e-10
the O 0 1.544707695089187e-09
34 O 0 1.5054526514290956e-08
UTR O 0 1.36706739795045e-05
of O 0 6.083555348368463e-08
the O 0 2.187448444601614e-07
DM B-Disease 1 0.9999675750732422
protein O 0 1.1000609845268627e-07
kinase O 0 1.0166626651653132e-07
gene O 0 9.685677149207095e-09
on O 0 1.3567906798073182e-08
chromosome O 0 1.1282981660087898e-07
19 O 0 3.7859462054257165e-07
. O 0 7.763107845448758e-08

One O 0 6.109273975596352e-09
of O 0 1.1811678746198595e-08
the O 0 7.627559917011695e-09
principal O 0 1.821269961510552e-07
features O 0 5.253010026962102e-09
of O 0 3.135323467517992e-08
the O 0 9.38024004426552e-06
DM B-Disease 1 1.0
mutation O 0 5.408003858065058e-07
is O 0 3.2009722650272465e-10
an O 0 2.8248467801028632e-11
extraordinarily O 0 6.538374286435555e-09
high O 0 4.761786343010499e-08
level O 0 1.0036992534878664e-06
of O 0 1.6838873762026196e-07
somatic O 0 0.0003183046937920153
mosaicism O 0 0.006859193090349436
, O 0 1.68882852147334e-10
due O 0 2.637558171869614e-09
to O 0 9.58056550759423e-12
an O 0 2.1246089956794556e-11
extremely O 0 3.1391919619316866e-10
high O 0 7.243172173154733e-10
degree O 0 3.2406358485559394e-08
of O 0 1.4905467082826362e-08
somatic O 0 3.5605719972409133e-07
instability O 0 5.868906072237223e-08
both O 0 1.8391168796205726e-11
within O 0 1.5641023198842419e-10
and O 0 1.607052164953604e-11
between O 0 2.357544992559468e-10
different O 0 3.6594063890227346e-10
tissues O 0 1.0077854994960944e-07
. O 0 6.616104997192451e-08

This O 0 6.8052554702546786e-09
instability O 0 4.5836208073524176e-07
appears O 0 1.3631294981664155e-09
to O 0 2.5034634087983676e-11
be O 0 2.1867896382588015e-11
biased O 0 4.552535085022846e-11
towards O 0 3.0820550105115085e-12
further O 0 9.87292279180929e-13
expansion O 0 2.2144498040832516e-11
and O 0 1.1872639373369798e-12
continuous O 0 2.499195961291889e-09
throughout O 0 2.159327855411064e-10
the O 0 1.2984681385663777e-10
life O 0 1.1401620099438237e-11
of O 0 7.509126653815201e-11
an O 0 4.0460187283875015e-12
individual O 0 9.452793365768986e-13
, O 0 1.1032254103315875e-11
features O 0 3.147873628428499e-10
that O 0 6.994947589905598e-12
could O 0 1.2960155518215721e-11
be O 0 2.2800238259901295e-12
associated O 0 9.072790262132369e-12
with O 0 2.797531954354393e-12
the O 0 1.1469815097697733e-09
progressive O 0 1.4523924392051413e-06
nature O 0 3.2856888321219913e-09
of O 0 6.139317942910338e-09
the O 0 1.273063929829732e-07
disease O 0 0.009255635552108288
. O 0 7.861916628826293e-08

Although O 0 1.1029452018362917e-08
increasing O 0 1.1728876758709816e-09
measured O 0 5.850704365428783e-10
allele O 0 7.320435924107471e-10
size O 0 7.34424951409629e-11
between O 0 2.3329826959184174e-10
patients O 0 1.6612509978752854e-10
clearly O 0 2.8904465626533593e-11
correlates O 0 1.5223391991447954e-11
with O 0 3.055421855194945e-13
an O 0 7.656740367602277e-13
increased O 0 2.345053838614941e-11
severity O 0 5.0472078072516524e-08
of O 0 2.2172045532897755e-08
symptoms O 0 5.74108298678766e-07
and O 0 2.461479631232777e-11
an O 0 2.7144311104398966e-12
earlier O 0 2.2665933019361262e-10
age O 0 3.0304350695509186e-10
of O 0 3.6144922610503727e-09
onset O 0 0.11658142507076263
, O 0 2.677941375595072e-11
this O 0 7.661722818685934e-13
correlation O 0 4.9222199233200925e-11
is O 0 4.306421972494201e-12
not O 0 9.437354326832792e-13
precise O 0 6.675825864332907e-11
and O 0 7.925406858566575e-12
measured O 0 7.884580488504156e-11
allele O 0 4.8430159188539434e-11
length O 0 1.3836834455993596e-11
cannot O 0 5.8927190384194805e-12
be O 0 3.402275206357275e-13
used O 0 3.627033027218951e-13
as O 0 1.2962819836634387e-12
an O 0 9.007385223976094e-13
accurate O 0 2.850079339200562e-10
predictor O 0 4.7731347763146914e-08
of O 0 1.4399521575114704e-09
age O 0 3.9055301215285e-09
of O 0 1.5781191464725453e-08
onset O 0 0.3948639929294586
. O 0 2.009479942444159e-07

In O 0 1.50118015795897e-08
order O 0 4.687029431238443e-09
to O 0 5.6997993130858404e-11
further O 0 9.35717336947306e-11
characterize O 0 8.946325347203299e-10
the O 0 1.2571397256522232e-09
dynamics O 0 1.2970809315504539e-08
of O 0 7.635815677531355e-07
DM B-Disease 1 1.0
CTG O 1 0.9959208965301514
repeat O 0 1.5737882677058224e-06
somatic O 0 2.3516020064562326e-07
instability O 0 2.9257277489591615e-08
, O 0 2.1947959075174772e-11
we O 0 4.032966668954252e-12
have O 0 3.735521007103282e-13
studied O 0 2.541568344671674e-11
repeat O 0 1.7909652927361464e-10
length O 0 7.095568056725288e-12
changes O 0 9.488800370438533e-12
over O 0 1.0984130272007064e-11
time O 0 2.7030610388889542e-11
in O 0 7.85488007970514e-10
111 O 0 0.3217977285385132
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.6962811599796623e-08
with O 0 1.2278763943107673e-11
varying O 0 4.020474786425865e-10
clinical O 0 3.4492578038225474e-07
severity O 0 3.7710276501456974e-06
and O 0 4.3094359192252796e-09
CTG O 0 5.322935066942591e-06
repeat O 0 4.938154329892086e-09
size O 0 4.640785325471519e-11
over O 0 2.162219882306804e-11
time O 0 9.174626336427849e-12
intervals O 0 1.286632189678727e-10
of O 0 9.025197811318719e-10
1 O 0 4.320639490629219e-08
- O 0 2.5002877546143054e-09
7 O 0 1.4504246692581546e-08
years O 0 4.198253744647218e-09
. O 0 1.7159031528990454e-08

We O 0 1.1675582278769525e-08
have O 0 1.5937502706453444e-10
found O 0 6.454580619985606e-11
a O 0 3.0344358969980334e-11
direct O 0 6.908553590312394e-11
progression O 0 5.819489334868422e-09
of O 0 1.2580367858561203e-09
the O 0 2.092800516217963e-10
size O 0 2.4271109427820292e-11
heterogeneity O 0 7.246447331077377e-10
over O 0 1.7251094996950656e-10
time O 0 1.4476124465812035e-10
related O 0 1.6573707684042205e-10
to O 0 2.1759179527625072e-11
initial O 0 5.145005310680517e-09
CTG O 0 2.230782229162287e-06
repeat O 0 7.118107436809851e-09
size O 0 1.407571836864463e-10
and O 0 1.726672450852451e-11
the O 0 7.266484636225812e-11
time O 0 6.689911125068448e-11
interval O 0 4.569294276279834e-09
and O 0 3.1730107430405496e-10
always O 0 1.9068507883801544e-10
biased O 0 1.9858843736120235e-10
towards O 0 7.134683122078656e-11
further O 0 1.3184256464349176e-10
expansion O 0 1.8690650804842335e-08
. O 0 4.8045095013549144e-08

Attempts O 0 8.085653746547905e-08
to O 0 1.402087668189722e-09
mathematically O 0 1.2534580484668822e-08
model O 0 5.844636996599206e-10
the O 0 1.089728973724391e-09
dynamics O 0 7.991236117277367e-09
have O 0 1.6417965598147788e-10
proved O 0 1.2587623388071734e-08
only O 0 2.943833232738058e-10
partially O 0 4.62241764864757e-08
successful O 0 1.7045896916201286e-09
suggesting O 0 1.8714427230115405e-10
that O 0 6.23635735066963e-12
individual O 0 2.1204908488836605e-12
specific O 0 1.1449978985778042e-11
genetic O 0 1.8976578086693507e-09
and O 0 1.48445658543217e-10
/ O 0 1.0507992698194357e-07
or O 0 1.0830273483586339e-10
environmental O 0 3.0705258780017175e-08
factors O 0 4.2086745200009545e-10
also O 0 4.1632912395339616e-11
play O 0 6.346145275948345e-10
a O 0 4.973579881273338e-10
role O 0 1.2902602319897483e-09
in O 0 1.8734329643166348e-09
somatic O 0 7.769008902869246e-07
mosaicism O 0 1.8245717001263984e-05
. O 0 8.593645794974236e-09
. O 0 5.365576782878634e-08

Aspartylglucosaminuria B-Disease 1 0.9999927282333374
among O 0 2.0553314072913054e-07
Palestinian O 0 6.403535621757328e-07
Arabs O 0 4.4198117166160955e-07
. O 0 4.826686677006364e-07

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.9947555065155029
AGU B-Disease 1 1.0
) O 0 1.179839426157514e-08
is O 0 7.451517736178914e-10
a O 0 4.578978529679034e-09
rare O 0 0.00020803498046007007
disorder B-Disease 1 0.9999959468841553
of I-Disease 0 0.01698702946305275
glycoprotein I-Disease 0 0.0034743817523121834
metabolism I-Disease 0 0.4515867829322815
caused O 0 1.9905590420421504e-07
by O 0 4.924382568383123e-10
the O 0 4.509908251293382e-07
deficiency B-Disease 1 0.9975531697273254
of I-Disease 1 0.5634514093399048
the I-Disease 0 0.04088144749403
lysosomal I-Disease 1 0.999985933303833
enzyme I-Disease 0 7.497573051296058e-08
aspartylglucosaminidase I-Disease 0 1.14704080260708e-05
( O 0 2.0660497757063467e-09
AGA O 0 1.10239525383804e-05
) O 0 3.931157621650527e-09
. O 0 3.182104890697701e-08

AGU B-Disease 1 1.0
is O 0 1.901401986970086e-07
inherited O 0 1.7408403891749913e-06
as O 0 7.226451437247761e-09
an O 0 2.391189912742675e-09
autosomal O 0 0.43938636779785156
recessive O 0 0.00955747626721859
trait O 0 1.1925749276997522e-08
and O 0 3.9258034323363944e-11
occurs O 0 1.4220975091960852e-11
with O 0 7.023674176986905e-13
a O 0 5.4956598299904513e-11
high O 0 3.5968639178207695e-10
frequency O 0 1.1473404448736346e-09
in O 0 1.0336152767020934e-10
Finland O 0 7.0870029844627425e-09
because O 0 8.374495541474403e-11
of O 0 5.195535113244887e-09
a O 0 9.238330989091992e-09
founder O 0 3.6430620298233407e-07
effect O 0 3.8089646636763064e-07
. O 0 6.973193933390576e-08

While O 0 3.439973639274285e-08
very O 0 1.975624552841282e-09
few O 0 3.302873752275559e-09
patients O 0 8.291707875862642e-10
with O 0 5.006113301675441e-09
AGU B-Disease 1 1.0
have O 0 1.034889604567546e-10
been O 0 1.9678751683738227e-11
reported O 0 6.622266103539776e-12
from O 0 6.879582407220974e-12
non O 0 4.090946692514308e-09
- O 0 9.611433871015151e-10
Finnish O 0 5.135752445539765e-08
origin O 0 3.941929560546953e-10
, O 0 9.369513498391768e-11
we O 0 1.9003877638201772e-10
diagnosed O 0 6.916909001120075e-07
the O 0 7.033702953407328e-09
disorder O 0 3.264474798925221e-05
in O 0 1.0431779884356729e-09
8 O 0 4.6362760031115613e-07
patients O 0 1.4855329466545442e-10
originating O 0 1.7625668979892595e-10
from O 0 8.297051240502284e-11
3 O 0 5.92103219787532e-08
unrelated O 0 1.741996658033429e-09
families O 0 8.571136964237447e-13
, O 0 3.009315886759456e-12
all O 0 6.9692454932046566e-12
Palestinian O 0 4.99205621284915e-10
Arabs O 0 5.859814716790979e-11
from O 0 8.965738741706364e-12
the O 0 1.1721894288552193e-10
region O 0 6.744454994489502e-10
of O 0 2.2441222213842593e-09
Jerusalem O 0 7.252288583003974e-07
. O 0 1.389647650285042e-07

The O 0 1.151133588450648e-07
clinical O 0 0.000997436116449535
diagnosis O 1 0.9997512698173523
of O 1 0.9999939203262329
AGU B-Disease 1 1.0
is O 0 3.0690330277138855e-07
often O 0 1.373573615959245e-10
difficult O 0 1.094519544442285e-10
, O 0 9.6651584305385e-12
in O 0 6.78055051342441e-12
particular O 0 1.7120497727840522e-11
early O 0 8.591133915381022e-10
in O 0 2.926147518733657e-11
the O 0 3.156742089949205e-10
course O 0 2.9170170723347155e-09
of O 0 6.918420836221628e-10
the O 0 3.527316216889176e-09
disease O 0 3.50434856954962e-06
, O 0 7.441029563348689e-12
and O 0 2.769420760426189e-12
most O 0 3.915966943074389e-12
of O 0 1.0807393868716986e-09
the O 0 3.4568049755989705e-08
patients O 0 9.675866774472297e-10
are O 0 1.365868616126642e-11
diagnosed O 0 2.2143433753285535e-08
after O 0 1.385097592176976e-09
the O 0 5.600304109343313e-10
age O 0 6.971884736195477e-10
of O 0 3.807585802206859e-09
5 O 0 5.018256388211739e-08
years O 0 7.865768480996849e-09
. O 0 3.102693213463681e-08

However O 0 3.88326313327525e-08
, O 0 9.161258418544094e-10
since O 0 2.1831161323149217e-09
these O 0 1.0671642736159725e-10
patients O 0 1.5869856817563033e-10
excrete O 0 1.5852470447441647e-09
early O 0 9.77699143867028e-10
large O 0 3.3099776391987135e-11
amounts O 0 1.3962258432753671e-11
of O 0 6.319704204393872e-10
aspartylglucosamine O 0 9.71533964388982e-08
in O 0 3.1923752530360616e-10
urine O 0 5.449349305131079e-10
, O 0 2.787674258097894e-11
biochemical O 0 2.205705174063155e-09
screening O 0 4.072923331932543e-09
is O 0 7.489572850793991e-11
easy O 0 3.5540573262160535e-10
by O 0 1.5940360142963073e-10
urine O 0 1.3491205930193928e-09
chromatography O 0 2.854334546498194e-09
. O 0 2.344398675191428e-09
. O 0 3.703647877273397e-08

Detection O 0 1.439831521565793e-06
of O 0 5.768183442000918e-08
heterozygous O 0 6.6477516824647864e-09
carriers O 0 3.3135297283770626e-10
of O 0 6.749142578144074e-09
the O 0 5.035466529079713e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.2158818069328845e-07
ATM O 0 9.599379700375721e-05
) O 0 2.084446643069171e-10
gene O 0 6.125594476102947e-10
by O 0 2.452815450748602e-10
G2 O 0 4.568774784274865e-06
phase O 0 3.4168260754086077e-07
chromosomal O 0 5.1652123147505336e-06
radiosensitivity O 0 5.0257754082849715e-06
of O 0 4.795052745976136e-07
peripheral O 0 0.06651024520397186
blood O 0 3.836990458694345e-07
lymphocytes O 0 1.0709529760788428e-06
. O 0 4.267998221507696e-08

In O 0 3.431705408729613e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999953508377075
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 8.334360424022691e-10
patients O 0 6.137591129773412e-11
, O 0 4.4317470700161454e-12
mutations O 0 4.406864630157603e-12
in O 0 5.980996514026726e-12
a O 0 4.085312990675938e-11
single O 0 8.330414830171051e-11
gene O 0 9.126582128926586e-11
, O 0 1.215605133914055e-11
ATM O 0 9.083973573353887e-09
, O 0 2.934216238037468e-12
result O 0 1.9014928520633134e-11
in O 0 3.468992454402908e-11
an O 0 9.752412211128103e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 1.6227936772139628e-09
embraces O 0 1.995149156996945e-09
a O 0 1.9555987038066824e-11
variety O 0 3.853794366959207e-11
of O 0 1.5521463281320536e-10
clinical O 0 2.357848849499078e-08
features O 0 5.517108991881514e-10
and O 0 3.6160262284479217e-11
manifests O 0 3.186413910505337e-10
extreme O 0 3.4973299989360385e-07
radiosensitivity O 0 1.2269987564650364e-05
and O 0 1.213204425809522e-09
a O 0 2.975299118190833e-09
strong O 0 5.414127368652544e-09
pre O 1 0.7231731414794922
- O 0 8.84877681528451e-06
disposition O 0 2.4935630790423602e-05
to O 0 3.7929311247353326e-08
malignancy B-Disease 1 0.987672746181488
. O 0 4.083629505657882e-07

Heterozygotes O 0 5.623970764645492e-07
for O 0 3.742932186412418e-09
the O 0 1.0133382133403757e-08
ATM O 0 7.193091846602329e-07
gene O 0 2.410661226193156e-09
have O 0 5.084736451332894e-12
no O 0 1.0546585306470124e-11
clinical O 0 2.6809390263338173e-09
expression O 0 1.200493593422891e-09
of O 0 5.002870580028684e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 2.6380864159847306e-09
may O 0 2.3808954807691407e-09
be O 0 1.3737525561552388e-09
cancer B-Disease 0 0.0001295227266382426
prone O 0 4.404938636071165e-09
with O 0 1.2705993375494717e-11
a O 0 5.14633724524316e-10
moderate O 0 3.283358473993303e-09
increase O 0 8.244959576186872e-11
in O 0 3.350057176110255e-10
in O 0 1.8909880328266127e-09
vitro O 0 9.167775942842127e-07
radiosensitivity O 0 2.631178176670801e-05
. O 0 1.918988488114337e-07

We O 0 1.354021961219587e-08
performed O 0 4.0010174728877246e-08
a O 0 1.0679126916102177e-08
blind O 0 5.6550849336645115e-08
chromosomal O 0 5.521683377196496e-08
analysis O 0 3.1854172077849796e-10
on O 0 4.499912886757329e-09
G2 O 0 2.8823586717408034e-07
- O 0 5.946547698698623e-10
phase O 0 6.649298889271904e-09
lymphocytes O 0 2.8077234981438437e-10
from O 0 6.378041324250905e-12
7 O 0 2.2189263759742062e-08
unrelated O 0 5.724861011913163e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 7.052967543330624e-09
, O 0 9.021785402074656e-11
13 O 0 1.3266499010455846e-09
obligate O 0 3.9950847963154956e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999990463256836
T I-Disease 1 1.0
heterozygotes O 0 1.1712299397004244e-07
( O 0 3.986528555183222e-12
parents O 0 3.1307438195724013e-13
of O 0 1.3000684730146705e-11
the O 0 5.301237573918094e-11
patients O 0 1.7395303947287388e-12
) O 0 2.8120068122985953e-13
, O 0 1.908806663078466e-12
and O 0 1.1194878357656535e-11
14 O 0 5.547329262611811e-10
normal O 0 5.660064639201323e-10
controls O 0 1.9527492955973003e-09
following O 0 3.069035303671086e-10
X O 0 3.2519171355716026e-08
- O 0 3.4717079211432633e-10
irradiation O 0 5.449556916836684e-10
with O 0 3.935362105633722e-11
1 O 0 1.580143305091042e-08
Gy O 0 5.039348849322778e-08
in O 0 2.8181628905499245e-11
order O 0 4.0740532475380675e-11
to O 0 7.302509291706727e-12
evaluate O 0 9.849309562381947e-11
this O 0 1.3709608101541981e-11
cytogenetic O 0 1.945905303557538e-08
method O 0 8.384968830377204e-10
as O 0 1.0658034177435383e-10
a O 0 2.230572254680041e-10
tool O 0 4.212772353184846e-09
for O 0 2.2845840497165426e-10
detection O 0 1.1320511816848011e-07
of O 0 3.781813617820262e-08
ATM O 0 9.393184154760092e-05
carriers O 0 2.621020769311144e-07
. O 0 7.541446933601037e-08

Both O 0 2.306679562025238e-06
A B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
T I-Disease 1 1.0
homozygotes O 0 4.467381586437114e-06
and O 0 3.3760419460016067e-10
heterozygotes O 0 1.8633521392530383e-08
showed O 0 2.912007024402641e-10
significantly O 0 3.810333125409127e-12
increased O 0 7.469126879489085e-12
levels O 0 1.0420379836784122e-10
of O 0 3.0343333401461337e-10
radiation O 0 0.001859117764979601
- O 0 7.315047696465626e-07
induced O 0 5.616728594759479e-05
chromatid O 0 1.0383980225014966e-05
damage O 0 1.4127353153980948e-07
relative O 0 9.813592161123097e-10
to O 0 7.768070041380692e-12
that O 0 6.74857869240042e-12
of O 0 2.0246981868865532e-09
normal O 0 1.110879708221546e-07
controls O 0 9.316126465819252e-07
. O 0 6.560362919572071e-08

These O 0 7.191371942383284e-10
results O 0 7.060474427333929e-10
show O 0 1.0728916643998332e-09
that O 0 4.648652296435074e-11
the O 0 5.163763194815374e-09
G2 O 0 2.259792381664738e-05
- O 0 1.708535535271949e-08
phase O 0 1.2684007799634855e-07
chromosomal O 0 2.2643976080871653e-06
radiosensitivity O 0 4.082784244019422e-07
assay O 0 4.2595056370942075e-09
can O 0 2.0503833006446648e-12
be O 0 3.8067574266442694e-13
used O 0 1.577266420769996e-13
for O 0 1.2060778807956862e-12
the O 0 3.786210581169236e-11
detection O 0 2.9183377492358886e-08
of O 0 1.3304240553679847e-07
A B-Disease 1 1.0
- I-Disease 1 0.9999971389770508
T I-Disease 1 1.0
heterozygotes O 0 1.5835465092095546e-05
. O 0 2.1711770159527077e-07

In O 0 3.61533523118851e-08
combination O 0 2.037467794480108e-08
with O 0 4.332774417026286e-10
molecular O 0 2.5815080562097137e-07
genetic O 0 2.3396784953888528e-08
analyses O 0 3.1715344239735543e-10
, O 0 1.68624628149594e-11
this O 0 7.938251618544445e-12
test O 0 5.60625657008984e-10
may O 0 1.9022871819429632e-11
be O 0 1.2449635506533996e-12
of O 0 6.891178166296141e-12
value O 0 6.064555108098446e-12
in O 0 2.347478331513053e-12
studies O 0 4.655402365688621e-12
of O 0 2.1759595861259307e-11
familial B-Disease 0 5.515480516748994e-09
and I-Disease 0 2.447665126137366e-10
sporadic I-Disease 0 1.1694720342347864e-05
cancers I-Disease 0 3.914767148671672e-05
aimed O 0 8.569748466413785e-09
at O 0 2.4722663916065812e-09
determination O 0 9.067004924645516e-10
of O 0 3.168869389114093e-09
the O 0 1.429182439061094e-09
potential O 0 1.1114933418099326e-09
involvement O 0 3.608313425829124e-09
of O 0 5.11143838366479e-08
ATM O 0 0.48809370398521423
mutations O 0 2.3191031317537636e-08
in O 0 7.744455743363687e-09
tumor B-Disease 1 0.8853707313537598
risk O 0 2.9413283186841e-07
or O 0 3.722546437767704e-10
development O 0 2.5458852803694754e-08
. O 0 4.14908152279736e-09
. O 0 1.1644628727935924e-07

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 3.757454862807208e-07
identification O 0 7.114472566627228e-08
and O 0 1.8677519253440522e-10
detection O 0 2.361107043213906e-08
of O 0 8.63009486096189e-09
founder O 0 1.2663450661420939e-06
- O 0 8.838544118816571e-09
effect O 0 7.411662394929408e-09
mutations O 0 2.0199682204680158e-10
in O 0 1.297074669892595e-10
the O 0 3.3503717578042824e-09
ATM O 0 4.340697159932461e-06
gene O 0 6.371387861747735e-09
in O 0 2.8209609648222056e-10
ethnic O 0 6.120937534603854e-09
populations O 0 7.201793827960046e-09
. O 0 1.9160363962100746e-08

To O 0 2.8839512999923045e-09
facilitate O 0 9.739770767680511e-09
the O 0 3.4163218920468807e-09
evaluation O 0 7.802070101092795e-09
of O 0 8.147516439294122e-08
ATM O 0 0.025435758754611015
heterozygotes O 0 4.6934999886616424e-07
for O 0 6.108210048871854e-10
susceptibility O 0 2.0204826256531305e-08
to O 0 2.5773756393010494e-11
other O 0 9.315538618270836e-11
diseases O 1 0.7346677184104919
, O 0 4.7887298293414204e-11
such O 0 3.750190158413602e-10
as O 0 5.3015490664165554e-08
breast B-Disease 1 0.9216240048408508
cancer I-Disease 1 0.734991192817688
, O 0 3.0177813581389046e-09
we O 0 2.9313049210166753e-10
have O 0 1.1829652708794658e-11
attempted O 0 4.755682514456794e-10
to O 0 3.5725879719838982e-12
define O 0 1.5154073829126702e-10
the O 0 1.5537696129719336e-10
most O 0 7.815075843409236e-12
common O 0 1.5477792658646905e-11
mutations O 0 1.321304394022449e-12
and O 0 6.561272792443562e-13
their O 0 2.613601826281786e-12
frequencies O 0 1.937832810883222e-10
in O 0 1.706991703542826e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.995118260383606
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.1934977712543287e-10
homozygotes O 0 1.107473224237765e-08
from O 0 6.926841739085532e-11
10 O 0 7.912002719656641e-10
ethnic O 0 1.7486710968128705e-09
populations O 0 1.9581274379731894e-09
. O 0 8.68672334064513e-09

Both O 0 8.900494563590655e-09
genomic O 0 7.970643878252304e-08
mutations O 0 1.5549266318970467e-09
and O 0 1.791252285388012e-10
their O 0 1.7710827249217687e-10
effects O 0 3.926700387069104e-08
on O 0 2.4186116220903386e-08
cDNA O 0 8.132766282642478e-08
were O 0 2.0512469500744146e-09
characterized O 0 6.481681680270412e-08
. O 0 8.978710042129023e-08

Protein O 0 9.590675631443446e-08
- O 0 1.5936910457980957e-08
truncation O 0 1.818761887761866e-07
testing O 0 1.1114642539666875e-08
of O 0 2.66378208380047e-09
the O 0 1.3439608315124474e-09
entire O 0 2.4461541681120025e-09
ATM O 0 3.6943493597618726e-08
cDNA O 0 3.353178401610535e-09
detected O 0 2.734085458033775e-10
92 O 0 1.2353100764528335e-09
( O 0 2.335608442760595e-11
66 O 0 1.942526139941947e-09
% O 0 9.355138885780434e-11
) O 0 1.0062893227025249e-11
truncating O 0 5.931292346161854e-09
mutations O 0 9.897462016628111e-11
in O 0 8.145530777659005e-11
140 O 0 1.3827166078783648e-09
mutant O 0 4.410438592117316e-08
alleles O 0 2.237109386626912e-09
screened O 0 1.164120888574871e-07
. O 0 3.108818447117301e-08

The O 0 7.310911769309314e-07
haplotyping O 0 0.00014416882186196744
of O 0 8.050019459915347e-06
patients O 0 1.7396333262809094e-08
with O 0 6.107092054286056e-10
identical O 0 5.878473530174233e-08
mutations O 0 1.5455769997174684e-09
indicates O 0 4.8856130252517e-10
that O 0 6.5275983403279e-12
almost O 0 5.707740877158862e-11
all O 0 1.313633229971245e-11
of O 0 3.250437974333664e-10
these O 0 1.944257905714397e-12
represent O 0 1.9794168040765392e-11
common O 0 6.483675402124689e-11
ancestry O 0 5.284879738692849e-12
and O 0 7.302954248278315e-12
that O 0 7.590077004404616e-12
very O 0 7.117149924962263e-11
few O 0 2.243115554412256e-10
spontaneously O 0 2.2667112631324926e-09
recurring O 0 4.3529901461170084e-08
ATM O 0 3.4660817618714646e-05
mutations O 0 1.3575362167728144e-08
exist O 0 1.2746038891009448e-08
. O 0 2.871613702382092e-08

Assays O 0 2.384887807238556e-07
requiring O 0 8.05852273799701e-09
minimal O 0 4.760288163652149e-08
amounts O 0 2.3061369480714689e-10
of O 0 1.5813000908693198e-09
genomic O 0 1.3642642571198849e-08
DNA O 0 3.651940527760189e-09
were O 0 1.5653855989228305e-10
designed O 0 2.260290288269573e-10
to O 0 1.2210288335978703e-11
allow O 0 5.8069542230310134e-11
rapid O 0 9.619252061554562e-09
screening O 0 1.5265044783774329e-09
for O 0 5.964993082807624e-11
common O 0 8.49086634335805e-10
ethnic O 0 2.5174238249547898e-09
mutations O 0 5.100139421898575e-09
. O 0 2.352866523835928e-08

These O 0 7.721151717987595e-09
rapid O 0 1.407073284553917e-07
assays O 0 9.558731584036195e-09
detected O 0 4.922797725015471e-09
mutations O 0 6.276239944424944e-11
in O 0 3.1978465014903534e-11
76 O 0 1.6608621145053348e-09
% O 0 6.39958849801836e-11
of O 0 1.6063429475465796e-09
Costa O 0 3.251667658332735e-05
Rican O 0 4.710302164312452e-06
patients O 0 8.899569275966357e-11
( O 0 2.0992309453238267e-12
3 O 0 4.0526726419187753e-10
) O 0 8.840279311535248e-13
, O 0 1.2073483489014047e-12
50 O 0 7.145874170166877e-12
% O 0 1.9340865714534416e-12
of O 0 9.934210398743204e-11
Norwegian O 0 1.2303942753533192e-07
patients O 0 1.2463452492283977e-10
( O 0 4.152875526103328e-12
1 O 0 9.670313438903122e-10
) O 0 9.791795195848718e-13
, O 0 8.517779038520745e-13
25 O 0 5.182977311224413e-12
% O 0 3.4329468521360207e-12
of O 0 2.0727471128356711e-10
Polish O 0 1.6396708701904572e-07
patients O 0 4.930068020492229e-10
( O 0 8.357402443703865e-12
4 O 0 2.0150474622226966e-09
) O 0 1.4818750610282039e-12
, O 0 1.2682549238238194e-12
and O 0 2.087986034071676e-12
14 O 0 1.5829046406956593e-10
% O 0 1.4210129600789045e-11
of O 0 7.292521586599321e-10
Italian O 0 9.090907155950845e-07
patients O 0 1.458201198678566e-10
( O 0 4.740327488178542e-12
1 O 0 2.983197910921831e-09
) O 0 1.4947801026468643e-12
, O 0 1.3852223404789421e-12
as O 0 3.6153484719858575e-12
well O 0 5.145419246926908e-12
as O 0 1.6554395007584155e-11
in O 0 1.0900132185742706e-10
patients O 0 4.121856675420865e-11
of O 0 2.087925388138956e-09
Amish O 0 1.7063413793039217e-07
/ O 0 1.3895999018131988e-07
Mennonite O 0 1.0753900880899891e-07
and O 0 1.1806492450361361e-09
Irish O 0 1.5192472346825525e-07
English O 0 6.026284893323464e-08
backgrounds O 0 2.3426254713854178e-08
. O 0 5.4608833011116076e-08

Additional O 0 8.813679563957066e-09
mutations O 0 3.2756208856454805e-09
were O 0 4.510118944978103e-10
observed O 0 6.209598391038185e-10
in O 0 1.9228843517460348e-10
Japanese O 0 1.2689156392298173e-08
, O 0 3.7933831076308877e-10
Utah O 0 1.5719516355261476e-08
Mormon O 0 1.271798444335559e-09
, O 0 1.1756712270383218e-10
and O 0 1.3265580300902968e-10
African O 0 7.3687975721270504e-09
American O 0 2.4683616928200536e-08
patients O 0 8.804555307051487e-09
. O 0 3.9001498919333244e-08

These O 0 7.030078186254229e-10
assays O 0 2.7936011282037043e-09
should O 0 4.279395587891699e-11
facilitate O 0 4.963153499293327e-11
screening O 0 4.7471653275010794e-09
for O 0 1.674556671105165e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999982118606567
T I-Disease 1 1.0
heterozygotes O 0 8.722788891191158e-08
in O 0 8.65614940837034e-11
the O 0 9.614436330407372e-11
populations O 0 3.02707720001294e-11
studied O 0 6.007619401948716e-10
. O 0 5.675263592408442e-10
. O 0 1.2735418941645094e-08

The O 0 1.2442687875591218e-05
von B-Disease 1 0.9990864992141724
Hippel I-Disease 1 0.9999681711196899
- I-Disease 1 0.720146894454956
Lindau I-Disease 0 0.04466090351343155
tumor I-Disease 0 6.207676779013127e-05
suppressor O 0 2.0095194486202672e-06
gene O 0 1.917483283264687e-09
is O 0 1.687906758807145e-11
required O 0 2.0752422350001076e-11
for O 0 3.9501991955237514e-11
cell O 0 6.527247631282762e-09
cycle O 0 7.477490626683903e-09
exit O 0 9.353542829160233e-09
upon O 0 2.579009505954133e-10
serum O 0 5.878336484244073e-09
withdrawal O 0 5.1319631211299566e-08
. O 0 9.500440434351276e-09

The O 0 2.5200728259733296e-07
inactivation O 0 3.14299832098186e-05
of O 0 5.439649726213247e-07
the O 0 6.080446723899513e-07
von B-Disease 1 0.9999545812606812
Hippel I-Disease 1 0.9999997615814209
- I-Disease 1 0.9999674558639526
Lindau I-Disease 1 0.9999845027923584
( I-Disease 0 1.4510108030663105e-06
VHL I-Disease 1 0.9644638895988464
) I-Disease 0 6.323928047891059e-09
tumor I-Disease 0 5.278702701616567e-06
suppressor O 0 9.94050205918029e-05
gene O 0 1.9194023082036438e-07
predisposes O 0 4.3282173400882584e-09
affected O 0 1.7797992246659788e-10
individuals O 0 3.979916710864645e-13
to O 0 4.5969634349107835e-12
the O 0 2.115183050932501e-08
human O 1 0.9999974966049194
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 7.360098641662205e-10
is O 0 4.935023570351582e-11
associated O 0 2.3329294052132354e-10
with O 0 4.266447195533374e-10
sporadic B-Disease 1 1.0
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 1.413166472730154e-07
RCC B-Disease 1 0.9996272325515747
) O 0 1.925652748369089e-09
and O 0 8.07584754625168e-09
brain B-Disease 1 0.588585615158081
hemangioblastomas I-Disease 0 0.30819517374038696
. O 0 6.88337479459733e-07

VHL O 0 0.020957106724381447
- O 0 1.5118167766559054e-06
negative O 0 8.804257589645204e-08
786 O 0 5.924877768848091e-06
- O 0 1.2025028809148353e-05
0 O 0 1.42442995638703e-05
RCC B-Disease 0 0.048158448189496994
cells O 0 1.4290877814460146e-08
are O 0 3.1872265243704234e-11
tumorigenic O 0 7.657387612880484e-08
in O 0 8.266946571744427e-10
nude O 0 1.3679329669002982e-08
mice O 0 1.2367056267947873e-09
which O 0 2.6307864307156814e-12
is O 0 5.9292245592479365e-12
suppressed O 0 2.212622862707292e-10
by O 0 2.4214881835793456e-11
the O 0 1.234193747201573e-09
reintroduction O 0 3.036713565052196e-07
of O 0 5.3784560805070214e-08
VHL B-Disease 0 0.0003983474744018167
. O 0 3.5743408943744726e-07

Remarkably O 0 6.233566637092736e-06
, O 0 4.649924889577051e-09
this O 0 1.0048704923715235e-10
occurs O 0 2.4931290365515224e-10
without O 0 2.1820743822953403e-10
affecting O 0 4.995425254006314e-11
the O 0 6.625592435804961e-11
growth O 0 4.931949293407456e-10
rate O 0 4.690005606100556e-10
and O 0 8.689100827741214e-11
cell O 0 1.0410759188062002e-07
cycle O 0 1.916859027062401e-08
profile O 0 3.7782268980102174e-10
of O 0 9.500580322452379e-10
these O 0 2.1822897655621176e-11
cells O 0 1.0012850965024356e-10
in O 0 1.0278922157880288e-10
culture O 0 1.771479851697677e-08
. O 0 1.3546108235118481e-08

The O 0 5.158528892934555e-07
786 O 0 1.7595239114598371e-06
- O 0 4.4965176471123414e-07
0 O 0 2.393085196672473e-07
cell O 0 1.1154764933962724e-07
line O 0 3.064977160960325e-09
, O 0 5.0146706231934957e-11
like O 0 2.460625453393206e-11
many O 0 1.2970345283913609e-11
cancer B-Disease 0 1.5398633479435375e-08
cells O 0 1.4471100706625606e-10
, O 0 3.890492789038191e-11
fails O 0 2.0362071750934518e-10
to O 0 6.029009756713943e-12
exit O 0 6.195298496436408e-09
the O 0 3.3374419894371954e-10
cell O 0 2.9642310828137397e-09
cycle O 0 4.014382992689747e-10
upon O 0 1.7937891449992804e-10
serum O 0 2.509168872677492e-09
withdrawal O 0 1.7684211428559138e-08
. O 0 8.134531270798107e-09

Here O 0 4.872515191323146e-08
, O 0 5.797019531073033e-10
it O 0 5.007346967622617e-12
is O 0 1.1046777641937622e-12
shown O 0 2.2297489375711077e-12
that O 0 6.058933194573457e-13
reintroduction O 0 1.0114241666414614e-09
of O 0 1.1749336226163365e-10
the O 0 7.715054151091749e-10
wild O 0 5.447089534982297e-08
- O 0 9.159201397324068e-09
type O 0 2.9638311360713487e-08
VHL B-Disease 0 1.0973029930028133e-05
gene O 0 3.2373721481349094e-09
restores O 0 1.9360649972099964e-08
the O 0 6.334112678807458e-10
ability O 0 1.6805895564075968e-10
of O 0 3.510585244725917e-08
VHL O 1 0.998616099357605
- O 0 2.033500095421914e-06
negative O 0 1.3229541195869388e-07
RCC B-Disease 1 0.9999959468841553
cancer I-Disease 0 9.669864812167361e-05
cells O 0 9.43938482933504e-10
to O 0 6.071028402221401e-11
exit O 0 1.1520198484049615e-07
the O 0 1.1737985028403841e-09
cell O 0 1.2333942756015404e-08
cycle O 0 2.400860177331765e-09
and O 0 4.5544283622245274e-11
enter O 0 4.044049539686512e-09
G0 O 0 4.3680379349098075e-06
/ O 0 2.6509400896657098e-08
quiescence O 0 1.1799748023122447e-07
in O 0 8.738650358885991e-10
low O 0 9.693258107290603e-08
serum O 0 1.7675485253221268e-07
. O 0 1.1263136201478119e-07

Both O 0 9.260189131055085e-07
VHL O 0 0.008699702098965645
- O 0 9.391288813276333e-07
positive O 0 3.002980619726259e-08
and O 0 3.3690078282688773e-08
VHL O 1 0.9085959792137146
- O 0 1.3036631116847275e-06
negative O 0 5.558858617860096e-08
RCC B-Disease 0 0.013897798024117947
cells O 0 5.391223112383159e-08
exit O 0 1.1130498478451045e-06
the O 0 5.115727397253522e-09
cell O 0 1.8450187155849562e-08
cycle O 0 2.937227794319597e-09
by O 0 8.537077988979291e-11
contact O 0 4.35395142162065e-09
inhibition O 0 1.3467358428442822e-07
. O 0 2.3031677898188718e-08

The O 0 9.262997195946809e-07
cyclin O 0 1.5940397588565247e-06
- O 0 1.9031617171094695e-07
dependent O 0 1.6059516383393202e-08
kinase O 0 4.274262721537525e-08
inhibitor O 0 2.8521863981723072e-08
, O 0 3.357509270607295e-10
p27 O 0 1.3786144670291378e-08
, O 0 3.398601539084112e-11
accumulates O 0 2.953657457505088e-11
upon O 0 1.2421582859523106e-11
serum O 0 5.095584024172872e-11
withdrawal O 0 1.8214846297937015e-10
, O 0 4.7117791439343915e-12
only O 0 7.351936442447082e-13
in O 0 2.62759193743467e-12
the O 0 2.048578320867911e-11
presence O 0 1.0817349793690312e-10
of O 0 9.825714464284374e-09
VHL B-Disease 0 0.00019855833670590073
, O 0 3.4368810575280406e-10
as O 0 6.464523361060515e-11
a O 0 7.478781482994634e-11
result O 0 2.199868204266764e-10
of O 0 7.1667788370533e-10
the O 0 1.2953297323647917e-09
stabilization O 0 1.9731820088964014e-07
of O 0 4.764211780639016e-08
the O 0 3.4388000358376303e-07
protein O 0 1.6122161241582944e-06
. O 0 3.997867850102921e-07

We O 0 1.2525545045605213e-08
propose O 0 4.965601707596079e-09
that O 0 1.951693667789911e-11
the O 0 5.608545849966617e-10
loss O 0 9.75955760651459e-09
of O 0 7.20996027325782e-08
wild O 0 7.680141607124824e-06
- O 0 1.0221262414233934e-07
type O 0 2.0785675758361322e-07
VHL B-Disease 0 0.0006363927968777716
gene O 0 3.455866925961004e-09
results O 0 3.286752814357641e-10
in O 0 5.2580467757579186e-11
a O 0 2.4946511523182835e-10
specific O 0 6.255746476391266e-10
cellular O 0 0.004091608803719282
defect O 0 7.238272701215465e-06
in O 0 1.1571466007609388e-09
serum O 0 4.926519636683224e-08
- O 0 1.2561773132802045e-07
dependent O 0 4.701445011079386e-09
growth O 0 4.124597552390696e-09
control O 0 7.783669708771868e-09
, O 0 2.1556518722820606e-11
which O 0 9.919664048507748e-12
may O 0 1.3919534969097924e-10
initiate O 0 3.1970261993308213e-09
tumor B-Disease 0 4.1781973436627595e-07
formation O 0 1.0374306214089302e-07
. O 0 5.370193889575603e-08

This O 0 5.825019577798685e-09
is O 0 4.234699535476949e-10
corrected O 0 8.580456900553202e-10
by O 0 2.1024454746609855e-11
the O 0 3.2524100079811546e-10
reintroduction O 0 3.2977578001691654e-08
of O 0 9.808300838187733e-09
wild O 0 3.298240926596918e-06
- O 0 5.564352250075899e-07
type O 0 2.605778036013362e-06
VHL B-Disease 1 0.9998979568481445
, O 0 5.051204610140303e-08
implicating O 0 1.786246002666303e-06
VHL B-Disease 0 0.00028205799753777683
as O 0 1.79989745330289e-09
the O 0 1.5135942499355792e-09
first O 0 2.1373087744080976e-09
tumor B-Disease 0 6.20434761344768e-08
suppressor O 0 5.4805319393835816e-08
involved O 0 5.233064329090986e-11
in O 0 2.286941469531456e-11
the O 0 7.109528521453967e-10
regulation O 0 3.826939831697018e-08
of O 0 1.5688932819557522e-08
cell O 0 4.7086129484341654e-07
cycle O 0 4.973936285068703e-08
exit O 0 5.246504031219956e-08
, O 0 1.1716142812867592e-11
which O 0 5.582517412748567e-13
is O 0 8.036494646840309e-13
consistent O 0 2.6954466436635016e-11
with O 0 2.636965515737111e-12
its O 0 1.6604305430600874e-10
gatekeeper O 0 5.1861320571333636e-08
function O 0 1.313464115249019e-09
in O 0 1.7462638279841514e-10
the O 0 9.914722376436202e-09
kidney O 0 4.579075175570324e-05
. O 0 4.406333076190094e-09
. O 0 2.4410381271877668e-08

Piebaldism B-Disease 1 1.0
with O 0 0.0010699506383389235
deafness B-Disease 1 1.0
: O 0 3.124583614066978e-08
molecular O 0 2.68062851915829e-08
evidence O 0 3.9314101973886295e-10
for O 0 3.6411908210798316e-11
an O 0 2.5402563386123234e-10
expanded O 0 1.543273356219288e-06
syndrome O 1 0.9999778270721436
. O 0 1.0347030183766037e-06

In O 0 2.507376173355169e-08
a O 0 2.6486302928674377e-08
South O 0 1.5519650276019092e-07
African O 0 3.76097482046589e-08
girl O 0 6.7867973463364706e-09
of O 0 8.32087909685697e-09
Xhosa O 0 2.3684515326749533e-06
stock O 0 7.633061294143317e-09
with O 0 4.0758899033654927e-10
severe O 1 0.9007828831672668
piebaldism B-Disease 1 0.9969362020492554
and O 0 5.798528945888393e-07
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 1.4459118347076583e-07
identified O 0 1.8568364901216938e-10
a O 0 4.0536674711377785e-11
novel O 0 9.751006946334684e-11
missense O 0 2.1076793643715064e-09
substitution O 0 2.819111832863541e-09
at O 0 1.1991874160344196e-08
a O 0 1.0503274916473515e-09
highly O 0 1.34355337966241e-09
conserved O 0 1.6072929653887513e-09
residue O 0 2.231161744248311e-08
in O 0 7.226557685591217e-10
the O 0 3.297001116564502e-09
intracellular O 0 8.243898896864721e-09
kinase O 0 1.5935937014432966e-08
domain O 0 4.364752115293413e-09
of O 0 1.39423468326072e-08
the O 0 6.601772639669434e-08
KIT O 0 2.4940602088463493e-05
proto O 0 8.02251452114433e-06
- O 0 1.0980209026456578e-06
oncogene O 0 1.0954271601804066e-05
, O 0 2.1247339887509042e-08
R796G O 0 1.418205329173361e-06
. O 0 2.3331770648837846e-07

Though O 0 1.919167829100843e-07
auditory B-Disease 0 1.1469161108834669e-05
anomalies I-Disease 0 1.1751251349778613e-06
have O 0 1.184286418931535e-10
been O 0 3.302901702140204e-11
observed O 0 2.231912848982276e-10
in O 0 1.1816984890611337e-10
mice O 0 1.5750361015420822e-09
with O 0 9.948734891462863e-11
dominant O 0 1.1647392966551706e-05
white O 0 2.0068519290816766e-08
spotting O 0 2.6537634312262526e-07
( O 0 1.054701881386677e-09
W O 0 1.5041465303511359e-05
) O 0 1.0932155181109238e-10
due O 0 3.336783294116685e-08
to O 0 3.2674571381896556e-10
KIT O 0 0.00033742503728717566
mutations O 0 2.6475342806975277e-08
, O 0 5.771033428914052e-08
deafness B-Disease 1 1.0
is O 0 2.505520013684759e-09
not O 0 1.915412446706899e-11
typical O 0 5.462492125296592e-10
in O 0 2.0020135549358997e-10
human O 0 8.67564597939463e-09
piebaldism B-Disease 0 2.7891255740541965e-06
. O 0 6.380401629257904e-08

Thus O 0 8.577074162019471e-09
, O 0 7.519818795431732e-11
the O 0 6.409556219111323e-11
occurrence O 0 2.353728412174405e-08
of O 0 5.983141363685718e-06
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 1.000928136818402e-06
this O 0 1.2112344460746272e-09
patient O 0 6.63772947717689e-09
extends O 0 5.370260347525857e-10
considerably O 0 5.390782611969236e-11
the O 0 7.066452284432145e-11
phenotypic O 0 7.676453250837767e-09
range O 0 3.8723274586871526e-10
of O 0 5.24660925815823e-10
piebaldism B-Disease 0 2.0921766008541454e-07
due O 0 2.9842411208846897e-07
to O 0 1.1646594799685772e-09
KIT O 0 1.662885733821895e-05
gene O 0 5.629920085681306e-09
mutation O 0 3.448201169042875e-10
in O 0 3.6245749457375354e-11
humans O 0 5.925180485144566e-11
and O 0 3.573802712097951e-11
tightens O 0 1.6533774349625219e-09
the O 0 4.052927715658683e-10
clinical O 0 2.537895227305853e-08
similarity O 0 1.4124699188045042e-09
between O 0 3.032932793800569e-10
piebaldism B-Disease 0 3.153490126805991e-07
and O 0 6.814353942230511e-11
the O 0 7.960923587013724e-11
various O 0 3.96562990778726e-11
forms O 0 1.0420504459318636e-09
of O 0 7.462987809958577e-07
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 0.9999983310699463
. O 0 4.642288686795837e-08
. O 0 2.58605695080405e-07

Cycloheximide O 0 3.315859066788107e-05
facilitates O 0 5.186607054952219e-08
the O 0 4.740343673148573e-09
identification O 0 1.3316626024106881e-08
of O 0 1.2142212568733157e-08
aberrant O 0 3.468944598239432e-08
transcripts O 0 9.519377286437702e-09
resulting O 0 8.19595058487721e-10
from O 0 6.724310691597069e-11
a O 0 4.6103321160728683e-10
novel O 0 9.422332913899822e-10
splice O 0 6.425196374948428e-08
- O 0 1.3277035471048748e-08
site O 0 6.659782947338044e-09
mutation O 0 1.3305980761657565e-09
in O 0 4.968422340212442e-10
COL17A1 O 0 0.0003528351371642202
in O 0 6.893397408447299e-09
a O 0 1.989977604921478e-08
patient O 0 5.807051906003835e-08
with O 0 1.62717714857763e-08
generalized O 1 0.9999963045120239
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999990463256836
. O 0 1.2995262295589782e-05

Patients O 0 4.480593815969769e-07
with O 0 3.011986748902018e-08
generalized O 1 0.9998273849487305
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999995231628418
often O 0 1.1288289192279422e-09
show O 0 4.3292555651497366e-10
decreased O 0 1.0595591071194121e-09
expression O 0 1.0757419399709534e-09
of O 0 3.4857896569207014e-09
type O 0 3.453780834661302e-07
XVII O 0 0.0013973709428682923
collagen O 0 2.098255890814471e-06
, O 0 2.167714230338902e-09
a O 0 2.076059768540972e-09
transmembrane O 0 2.148328626105922e-08
hemidesmosomal O 0 1.1881786576850573e-07
protein O 0 3.079086541291076e-09
encoded O 0 3.305808959908063e-10
by O 0 4.663734398668851e-10
COL17A1 O 0 1.2383994544507004e-05
. O 0 1.2263058124517556e-07

This O 0 4.274170795071086e-09
report O 0 1.1620212569951605e-09
documents O 0 4.1518663507211784e-10
a O 0 8.280929275628068e-10
novel O 0 1.6177408301842888e-09
splice O 0 4.7385199763994024e-08
- O 0 1.2051651232525273e-08
site O 0 4.698791133961322e-09
mutation O 0 1.0538512285052093e-09
in O 0 3.632258660513088e-10
COL17A1 O 0 0.0005905888392589986
in O 0 3.491338995686988e-09
a O 0 9.180889826154726e-09
patient O 0 1.8144094227068308e-08
with O 0 2.2911177399720373e-09
generalized O 1 0.9999974966049194
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999995231628418
, O 0 2.9671498591454792e-09
and O 0 1.498138141320382e-10
applies O 0 2.7955454617867304e-10
a O 0 1.1580159747781593e-10
new O 0 4.848792548028946e-11
methodology O 0 1.4764119093957362e-10
to O 0 5.351461461466922e-12
define O 0 2.6228630378710704e-10
and O 0 3.859031497133181e-11
characterize O 0 4.275579335022428e-10
the O 0 1.33326816253998e-09
resulting O 0 3.358805011899335e-09
mRNA O 0 1.519052439391544e-08
splice O 0 1.9117040039873245e-07
variants O 0 1.0087201474107133e-07
. O 0 1.1233743180127931e-07

Mutational O 0 1.4120355444902088e-05
analysis O 0 2.672261700809031e-08
of O 0 1.247502865453498e-07
COL17A1 O 0 0.16534356772899628
identified O 0 9.24464416129922e-08
a O 0 2.5584101948084026e-08
maternally O 0 2.4463467696023145e-08
inherited O 0 1.2747722166750464e-07
G O 0 1.2001461982436012e-05
- O 0 4.330928504714393e-07
to O 0 2.0194462990730244e-08
- O 0 3.060050221392885e-05
T O 0 1.7708565792418085e-05
transversion O 0 1.7268403098569252e-06
at O 0 1.9434089892911288e-08
the O 0 1.1379862607796554e-09
- O 0 7.184009498395483e-10
1 O 0 3.3393092735423124e-09
position O 0 9.90560744540403e-10
of O 0 3.136045423346445e-09
exon O 0 6.27189308488596e-07
32 O 0 1.102781510553541e-07
. O 0 6.205684854876381e-08

This O 0 4.355598193228616e-08
acceptor O 0 1.8414432645386114e-08
splice O 0 2.225551867240938e-07
- O 0 4.8281648901138396e-08
site O 0 9.85777592887871e-09
mutation O 0 8.534298268081386e-10
led O 0 6.666909802000021e-10
to O 0 1.7911727656638732e-11
the O 0 8.136079587828249e-10
formation O 0 3.1676123946056123e-09
of O 0 2.1761744406489925e-08
aberrant O 0 5.372888622900973e-08
transcripts O 0 4.060684943851811e-08
present O 0 3.5475371529258837e-09
at O 0 2.811862032103818e-07
extremely O 0 5.881412334929337e-08
low O 0 9.673270824350766e-07
levels O 0 1.3468351198753226e-06
. O 0 9.704208991934138e-08

Based O 0 1.70807616939328e-08
on O 0 4.5902087464355645e-08
our O 0 1.8033233795122783e-09
recent O 0 4.4097947515808755e-10
finding O 0 5.104437983405319e-10
that O 0 4.916309026548049e-11
cycloheximide O 0 1.5454280344329163e-07
stabilized O 0 2.463104351591028e-07
mutant O 0 8.767290182731813e-08
COL17A1 O 0 8.112298814921814e-07
transcripts O 0 1.756861878199345e-09
in O 0 4.504854822506843e-11
keratinocytes O 0 2.1612038825225e-09
homozygous O 0 5.921680923393069e-10
for O 0 9.709972409455148e-11
a O 0 7.016762171296875e-10
frameshift O 0 1.3485758287856697e-08
mutation O 0 1.8513303390310654e-10
, O 0 2.2050047551736007e-11
the O 0 2.3880983301971526e-10
effects O 0 5.37131050748485e-08
of O 0 1.2656766301688549e-08
the O 0 7.476407049011868e-09
splice O 0 4.216737892193123e-08
- O 0 3.377589541386783e-09
site O 0 9.170734172059269e-10
mutation O 0 9.597323630261556e-11
on O 0 4.738397452186405e-10
splicing O 0 3.0836591058402973e-09
of O 0 4.229632200036804e-09
COL17A1 O 0 1.1538345461303834e-06
transcripts O 0 7.818367286915873e-09
were O 0 1.9231924386353683e-10
determined O 0 1.4538908965633368e-10
using O 0 5.851003015422407e-11
reverse O 0 6.184649237184203e-09
transcriptase O 0 4.34373248481279e-09
polymerase O 0 1.923813552906495e-09
chain O 0 3.270607562555483e-09
reaction O 0 3.892927299964377e-11
of O 0 1.5912663409167749e-09
total O 0 3.2779019498718753e-09
RNA O 0 1.2413430283686466e-08
from O 0 1.751764983071169e-10
keratinocytes O 0 1.3372596363581124e-08
incubated O 0 2.75511014002916e-09
for O 0 6.480155301247237e-10
2 O 0 1.79958988155704e-07
. O 0 2.7345055997329837e-08

5 O 0 5.671049052580202e-07
h O 0 4.124560604168437e-08
in O 0 5.769464905824861e-10
the O 0 6.08475714258816e-10
presence O 0 2.070352778105189e-10
or O 0 1.5126179475632995e-10
absence O 0 2.004525967436166e-08
of O 0 5.392508484192149e-08
10 O 0 1.1339722760794757e-07
microg O 0 7.031517725408776e-06
cycloheximide O 0 4.571686531562591e-06
per O 0 1.5927884788879965e-08
ml O 0 4.685726935349521e-07
. O 0 1.3375866103615408e-07

Using O 0 4.051321944587016e-09
this O 0 1.513114217255307e-10
approach O 0 1.1096759067186213e-09
, O 0 1.6060082430602307e-10
an O 0 3.7885222736733226e-11
abnormally O 0 5.043471418275658e-09
spliced O 0 6.004265529213626e-09
transcript O 0 1.9136551898668586e-08
was O 0 3.556466676712944e-09
identified O 0 1.332252450719773e-11
that O 0 8.421146267291457e-13
contains O 0 9.377554288647616e-12
an O 0 2.110641088987064e-12
extra O 0 2.2724185380629258e-11
264 O 0 5.2444753401159616e-11
bases O 0 7.891155784367498e-11
upstream O 0 2.595143891448437e-11
from O 0 2.0214161941534137e-11
exon O 0 3.6804497227649335e-09
32 O 0 2.964885559286756e-10
, O 0 1.954062606168705e-11
resulting O 0 2.424137557355266e-10
in O 0 3.4153424532945564e-10
a O 0 1.735523902368641e-08
premature O 0 9.739403594721807e-08
termination O 0 7.147714597977028e-08
codon O 0 1.1351451689733949e-07
27 O 0 1.6376174016841105e-07
bp O 0 3.471254572673388e-08
downstream O 0 2.4118478325618753e-09
from O 0 6.219104120575025e-10
the O 0 2.366476792303729e-08
cryptic O 0 1.8882990104884811e-07
splice O 0 1.870019332272932e-06
site O 0 7.585256867059798e-07
. O 0 1.711324983943996e-07

Three O 0 3.448691288099326e-08
other O 0 8.92876661495734e-10
splice O 0 8.579368682148925e-08
variants O 0 1.1313923131694992e-08
, O 0 2.9884697494431123e-10
including O 0 1.6859062756946486e-10
one O 0 1.2632870444173605e-11
derived O 0 8.154123209980213e-12
from O 0 2.3189446890503618e-11
the O 0 6.064561630658716e-10
skipping O 0 4.069832026942777e-09
of O 0 2.573487867252311e-09
exon O 0 9.407435896946481e-08
32 O 0 3.095291356558505e-09
, O 0 2.1577467590461197e-10
were O 0 8.670645867958626e-10
also O 0 5.574141703768021e-10
identified O 0 1.434139385025901e-08
. O 0 5.359644461577773e-08

These O 0 4.032219003136106e-09
results O 0 2.816188393595098e-09
indicate O 0 8.445238397492005e-10
the O 0 8.912211524325642e-10
usefulness O 0 2.5398566805279188e-08
of O 0 5.72927749686869e-09
cycloheximide O 0 1.1083808431067155e-06
treatment O 0 1.482355127535584e-09
in O 0 5.874328801169781e-11
evaluating O 0 4.3773473734631807e-10
the O 0 4.5198586540173835e-10
abnormal O 0 1.955940076570073e-09
processing O 0 2.5552731042211008e-09
of O 0 2.531575171715872e-09
mRNA O 0 2.383376163095363e-09
due O 0 8.814772023413298e-09
to O 0 6.506668814854066e-11
splice O 0 1.1385773213135053e-08
- O 0 1.8825885295115086e-09
site O 0 1.0282907858538692e-09
mutations O 0 6.005141522935631e-11
, O 0 1.7827133866332723e-11
because O 0 2.0400545835963513e-11
( O 0 1.8111012689558947e-11
i O 0 5.23797005769211e-10
) O 0 4.4422687750511614e-11
aberrant O 0 2.707377433353031e-09
splicing O 0 6.697923105036807e-09
often O 0 3.580667012892391e-11
generates O 0 3.533575168579439e-11
a O 0 7.238821764232739e-10
premature O 0 5.466842090129376e-09
termination O 0 2.3401145465840045e-09
codon O 0 1.2226147871885473e-09
, O 0 1.7859705034317663e-11
( O 0 1.6888977195927968e-12
ii O 0 5.229257915573271e-09
) O 0 8.719844291071865e-12
transcripts O 0 9.180797788665984e-10
with O 0 2.1736749900025387e-10
premature O 0 3.9278987173929636e-08
termination O 0 8.862345524107695e-09
codons O 0 3.612775856254302e-09
can O 0 7.527133430440536e-12
occur O 0 2.2348253456150324e-11
at O 0 3.778826584976969e-09
low O 0 1.5385776208631796e-08
or O 0 6.241227673564609e-11
undetectable O 0 2.792239683913067e-07
levels O 0 1.8285415404051264e-09
due O 0 2.018120781599464e-09
to O 0 9.47601285633537e-12
nonsense O 0 1.4335725939673694e-09
- O 0 7.036862759157714e-11
mediated O 0 2.990117597967412e-10
mRNA O 0 9.73968752870924e-11
decay O 0 1.5232702876843973e-09
, O 0 3.1549754128668006e-12
and O 0 7.3040786743514e-13
( O 0 1.8812718310251553e-12
iii O 0 3.0617168800262107e-09
) O 0 4.177447884140539e-12
the O 0 3.8496438675705846e-11
levels O 0 2.7087654341784173e-10
of O 0 1.463417026448255e-10
these O 0 5.6577815349401206e-12
transcripts O 0 4.761736005498562e-10
can O 0 2.4031562330384393e-12
be O 0 3.694468342363422e-12
increased O 0 4.885759505302012e-11
by O 0 2.2462023907543482e-10
cycloheximide O 0 1.1433190820753225e-06
. O 0 8.748347823939184e-08

A O 0 1.8670468762138626e-06
deletion O 0 1.8065539109102247e-07
mutation O 0 2.8238115845624634e-08
in O 0 2.0188060112502626e-09
COL17A1 O 0 2.372817471041344e-05
in O 0 2.9780073962371034e-09
five O 0 2.062529924629075e-09
Austrian O 0 2.5222752242370916e-07
families O 0 2.342712412950476e-10
with O 0 9.926946376026535e-09
generalized O 1 0.9999995231628418
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999972581863403
represents O 0 3.046793395355962e-08
propagation O 0 8.783841849435703e-07
of O 0 2.1606895828085726e-08
an O 0 4.4988637815102095e-10
ancestral O 0 5.0705970977560355e-08
allele O 0 1.497416235451965e-07
. O 0 6.748346947915707e-08

Patients O 0 1.2253021850483492e-06
with O 0 3.669782699944335e-08
generalized O 1 0.9999359846115112
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 3.828115424653333e-08
a O 0 2.5918371893141057e-09
usually O 0 2.6583904522148316e-10
nonlethal O 0 9.388686095235244e-08
form O 0 3.650993285475579e-09
of O 0 5.02565171700553e-07
junctional B-Disease 1 0.9999996423721313
epidermolysis I-Disease 1 0.9999997615814209
bullosa I-Disease 1 0.9780318140983582
, O 0 1.3693497447064829e-09
have O 0 5.416765994081807e-11
generalized O 0 4.534758701879582e-08
blistering B-Disease 0 4.213126885588281e-06
, O 0 2.1560833829425974e-07
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 8.010871169972233e-06
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 3.040268481413477e-08
and O 0 1.2762512824338046e-07
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 1.5472816812689416e-05

Skin B-Disease 1 0.9981250166893005
fragility I-Disease 1 0.959896445274353
in O 0 8.10609819268393e-08
most O 0 6.264630481034317e-10
cases O 0 9.807055861843494e-11
is O 0 2.2040964539615793e-11
due O 0 2.4341881843525925e-09
to O 0 1.8098581661130098e-11
mutations O 0 3.917649885054608e-11
in O 0 2.733390770670585e-11
the O 0 4.641619866241342e-10
gene O 0 1.0724456878108413e-09
encoding O 0 1.0450280640839082e-09
type O 0 1.1316604542344066e-07
XVII O 0 0.0004290660726837814
collagen O 0 8.188509127649013e-06
( O 0 2.1233402591747108e-08
COL17A1 O 0 0.00024561877944506705
) O 0 4.547731524695564e-09
. O 0 1.948040662114181e-08

Recently O 0 1.6743305764066463e-07
, O 0 1.657434856028317e-09
we O 0 1.76705039489633e-10
reported O 0 3.468954290486437e-10
five O 0 4.0104722320855046e-10
Austrian O 0 7.932379020303415e-08
families O 0 2.3329915777026144e-10
with O 0 5.104615841133864e-09
generalized O 1 0.999984860420227
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999996423721313
who O 0 2.9718465910377745e-08
share O 0 9.098152231601375e-10
the O 0 1.3051389302631833e-08
same O 0 4.550536658598503e-08
COL17A1 O 0 0.48460638523101807
mutation O 0 1.3264780136523768e-06
. O 0 1.3938044673977856e-07

Affected O 0 2.926167042005545e-07
individuals O 0 3.150480709646075e-10
in O 0 6.352297576839305e-10
three O 0 4.304430700763362e-10
families O 0 1.395677410448437e-11
are O 0 1.1777510390553747e-11
homozygous O 0 1.1726684068236182e-09
for O 0 1.800068011315048e-10
4003delTC O 0 4.744651604937644e-08
, O 0 1.7957814402169703e-10
whereas O 0 6.261605123292213e-11
those O 0 6.8559385599242795e-12
in O 0 3.988789507025636e-11
two O 0 7.14792253164731e-11
others O 0 9.596248240484329e-10
are O 0 2.349420102909505e-10
compound O 0 1.9598235212470172e-07
heterozygotes O 0 1.9817960037471494e-06
. O 0 1.5407309206239006e-07

To O 0 2.4319466440658744e-09
determine O 0 1.4016812155404068e-09
if O 0 6.871651858642025e-11
the O 0 2.5421464933117477e-10
occurrence O 0 7.908959709368446e-09
of O 0 5.1012580826181875e-09
4003delTC O 0 3.747284083033264e-08
in O 0 2.6537905206680534e-10
these O 0 2.587354636096606e-11
unrelated O 0 3.3308727998004883e-10
families O 0 9.099457298766822e-13
signifies O 0 6.237253075136451e-11
propagation O 0 2.5281989834979868e-08
of O 0 8.571432452697536e-09
an O 0 1.2034617746792264e-10
ancestral O 0 9.097463227192293e-09
allele O 0 2.123266229503429e-09
or O 0 3.059923148196475e-10
a O 0 4.987185775462422e-09
mutational O 0 7.978872599778697e-05
hot O 1 0.555672824382782
spot O 0 4.2897340790659655e-06
, O 0 3.523770442104279e-10
haplotypes O 0 2.6095110516877185e-09
were O 0 2.525396280983472e-10
determined O 0 4.144088960877923e-10
for O 0 1.3347482841208347e-10
polymorphisms O 0 1.2262399096130139e-08
both O 0 5.831864990923918e-10
within O 0 1.9658600081129407e-08
and O 0 2.5517678636788332e-08
flanking O 0 5.125726238475181e-05
COL17A1 O 1 0.9953902959823608
. O 0 3.5565813050197903e-06

Five O 0 7.544178970420035e-07
intragenic O 0 9.776113984116819e-06
polymorphisms O 0 1.0699187669160892e-06
were O 0 1.5903326655575256e-08
chosen O 0 1.5706350664501656e-09
based O 0 6.515564199283119e-10
on O 0 3.131916415100022e-08
their O 0 8.781210425468089e-09
informativeness O 0 1.1473252925497945e-05
. O 0 4.701102227500087e-07

One O 0 5.680302450628005e-09
of O 0 3.7733745017476394e-09
these O 0 1.883836663052474e-11
, O 0 2.9014329133714156e-11
not O 0 1.6647637044939212e-12
previously O 0 3.111453455995061e-11
reported O 0 1.9089677755212975e-11
, O 0 6.109046601920909e-11
was O 0 4.138918896501309e-08
2988 O 0 5.023911398893688e-06
A O 0 1.0563642263150541e-06
or O 0 5.706002337291238e-10
C O 0 1.897863768363095e-07
that O 0 1.1966956592335265e-10
introduces O 0 1.436772478768944e-09
a O 0 1.5687331988978315e-10
new O 0 3.418573410463033e-11
restriction O 0 5.586999751727717e-10
site O 0 2.930851950022628e-10
for O 0 1.6837853333839803e-10
Eco0109 O 0 1.743251374364263e-07
I O 0 7.964388260006672e-07
. O 0 9.353402674605604e-08

All O 0 1.0432480657129872e-08
the O 0 5.68313085480554e-09
4003delTC O 0 4.072583337233482e-08
alleles O 0 7.359761688974231e-10
showed O 0 1.034777596942149e-09
the O 0 2.3287416439643494e-10
same O 0 9.677283974163231e-11
haplotype O 0 9.120274313545451e-09
for O 0 4.344525295074675e-10
these O 0 1.8648045607694286e-10
five O 0 2.3156849771055477e-09
polymorphic O 0 2.002829688763086e-07
markers O 0 2.900591482557502e-07
. O 0 9.328922345730462e-08

Fourteen O 0 5.43727992408094e-07
microsatellite O 0 7.095743512763875e-07
polymorphisms O 0 1.2790647474503203e-07
were O 0 2.2399699872721612e-09
selected O 0 2.4524504649292567e-10
based O 0 6.887791725862513e-11
on O 0 3.3561535772719253e-09
their O 0 1.7159310083947332e-10
high O 0 1.0675644368518533e-08
heterozygosity O 0 7.42279979704108e-08
and O 0 1.769769053527881e-10
their O 0 2.376575047868812e-10
location O 0 7.420291048276795e-09
within O 0 4.848464296713928e-09
10q23 O 0 3.2703042052162345e-07
- O 0 3.6762773447662767e-07
q25 O 0 1.7687132185528753e-06
near O 0 7.556257060059579e-06
COL17A1 O 0 0.00027958385180681944
. O 0 4.4030170442965755e-07

Three O 0 2.1230567526231425e-08
families O 0 1.3267656417959017e-10
shared O 0 1.97287564063231e-09
microsatellite O 0 3.804024117926019e-07
polymorphisms O 0 6.996368142608844e-07
covering O 0 5.197936729928188e-07
at O 0 1.9358767531230114e-06
most O 0 1.7567076682212246e-09
19 O 0 9.820565338714005e-08
cM O 0 2.589600178737328e-08
, O 0 2.3542065519244204e-10
whereas O 0 2.701861512299786e-10
the O 0 2.0010182399943233e-09
others O 0 9.273665169118317e-11
shared O 0 3.462665917886021e-11
smaller O 0 1.2020755918440429e-11
regions O 0 1.0622336343857341e-10
consistent O 0 9.268082412638989e-10
with O 0 1.1673181518623288e-11
cross O 0 3.9421327313604593e-10
- O 0 1.4488527044775878e-10
over O 0 7.954397557297099e-11
events O 0 1.0051273008349071e-10
during O 0 6.132655494539563e-10
passage O 0 3.889478461527318e-10
of O 0 9.849947246731716e-11
this O 0 8.053316694067725e-12
mutation O 0 8.060481448968204e-11
through O 0 3.03494521181058e-11
several O 0 3.355537792071317e-10
generations O 0 1.3055672098971627e-08
. O 0 4.641500694901879e-08

These O 0 7.078492458845176e-09
results O 0 5.6674562820546726e-09
indicate O 0 8.682328744846757e-10
that O 0 8.2572983173268e-11
4003delTC O 0 2.2788023912312383e-08
occurs O 0 5.493555610414091e-10
on O 0 2.284214817294128e-09
a O 0 3.961972416810511e-10
single O 0 1.0476124412406307e-09
ancestral O 0 2.97139735039309e-09
allele O 0 7.472244156758734e-09
. O 0 1.0927094784562996e-09
. O 0 8.789538874509617e-09

The O 0 5.830752343172207e-07
haptoglobin O 0 2.1421640212793136e-06
- O 0 2.1105411462940538e-07
gene O 0 2.6853520296299394e-08
deletion O 0 2.3968578233279914e-08
responsible O 0 1.2888146549983048e-08
for O 0 6.7516912061194034e-09
anhaptoglobinemia B-Disease 0 3.5898148780688643e-05
. O 0 1.3712094641959993e-06

We O 0 2.978565660782806e-08
have O 0 3.3288274914333726e-10
found O 0 4.7687596926859754e-11
an O 0 1.2765117088364697e-11
allelic O 0 4.233427475242024e-08
deletion O 0 8.970951981268627e-09
of O 0 4.634609140907742e-08
the O 0 2.45785223285111e-08
haptoglobin O 0 4.1282248730567517e-07
( O 0 5.170837091839076e-10
Hp O 0 8.842016896437599e-09
) O 0 5.657201443409754e-11
gene O 0 6.203678681870883e-10
from O 0 4.1793787181054753e-11
an O 0 2.278112247455777e-11
individual O 0 2.788205950843281e-11
with O 0 4.276063059194257e-09
anhaptoglobinemia B-Disease 1 0.8785135746002197
. O 0 3.2843170174601255e-06

The O 0 9.057175134330464e-07
Hp O 0 4.948604441779025e-07
gene O 0 5.978931483241468e-08
cluster O 0 4.614999937757602e-08
consists O 0 7.186503614420303e-10
of O 0 1.197691834597947e-09
coding O 0 3.43299291216681e-08
regions O 0 1.3488478112222424e-09
of O 0 6.124733165080443e-09
the O 0 7.88652876337892e-09
alpha O 0 1.5769607841775724e-08
chain O 0 1.6619616793889236e-09
and O 0 4.4275416666295087e-11
beta O 0 4.381618179394309e-09
chain O 0 6.262889318264797e-09
of O 0 3.5694192046520357e-09
the O 0 4.716786072833656e-09
haptoglobin O 0 4.646194895485678e-08
gene O 0 3.484298960465537e-10
( O 0 6.36766073897066e-12
Hp O 0 2.2092071227941545e-10
) O 0 1.6601469548030434e-12
and O 0 5.989523980953759e-12
of O 0 7.014313574416065e-10
the O 0 4.37800062869087e-09
alpha O 0 1.3884786653761694e-08
chain O 0 1.6837540250946859e-09
and O 0 4.244611259696107e-11
beta O 0 8.890179259424258e-09
chain O 0 5.037184447331811e-09
of O 0 2.279636035495969e-09
the O 0 5.828009186359395e-09
haptoglobin O 0 1.58720595777595e-07
- O 0 4.4869801207880755e-09
related O 0 6.267056318343123e-10
gene O 0 7.193388107396004e-10
( O 0 3.4408871585345224e-11
Hpr O 0 3.641458690140098e-09
) O 0 2.6573703307275487e-11
, O 0 1.8841959242843487e-11
in O 0 5.1876478807111326e-11
tandem O 0 3.922513869270006e-09
from O 0 5.484395160237909e-10
the O 0 3.284468519382244e-08
5 O 0 8.682765724188357e-07
side O 0 4.865902951678436e-07
. O 0 6.305393895900124e-08

Southern O 0 7.888576192272012e-07
blot O 0 1.3587688272309606e-06
and O 0 5.8599103347489745e-09
PCR O 0 4.746823734080863e-08
analyses O 0 1.8997945439025443e-09
have O 0 4.214174842420704e-11
indicated O 0 6.902284993559604e-11
that O 0 2.2485234160707357e-12
the O 0 5.682994699829358e-11
individual O 0 1.4091660780965465e-12
with O 0 4.676565558414669e-12
anhaptoglobinemia B-Disease 0 1.909101854380424e-08
was O 0 3.798279468725241e-09
homozygous O 0 3.461333997201166e-10
for O 0 3.048893429391519e-11
the O 0 1.1485550011069989e-10
gene O 0 3.453221389393413e-11
deletion O 0 2.999117967861231e-11
and O 0 1.4472989863859032e-12
that O 0 4.0431311185314123e-13
the O 0 2.74301605734939e-11
gene O 0 4.298086886400654e-11
deletion O 0 8.843289989179937e-11
was O 0 7.664730516943052e-10
included O 0 6.849119188467867e-11
at O 0 1.3024151757079494e-09
least O 0 1.6865035409874274e-11
from O 0 1.9876112908323584e-11
the O 0 1.0102134684331077e-09
promoter O 0 3.800027798206429e-06
region O 0 3.838497519836892e-08
of O 0 2.972861423700124e-08
Hp O 0 4.3453006526306126e-08
to O 0 1.0250655879673332e-09
Hpr O 0 3.563891084468196e-07
alpha O 0 2.896919681916188e-08
but O 0 9.206658352356456e-11
not O 0 2.1628551380437067e-11
to O 0 7.305688692893497e-11
Hpr O 0 8.447936750144436e-08
beta O 0 5.419905946268955e-08
( O 0 4.280614196439103e-10
Hpdel O 0 5.688306146112154e-07
) O 0 2.2487154360817385e-09
. O 0 2.844444857430517e-08

In O 0 1.2364303358936013e-08
addition O 0 2.360700523951209e-09
, O 0 6.689722664710018e-10
we O 0 2.0035950676344783e-10
found O 0 5.331007510434027e-11
seven O 0 2.2313328268408483e-11
individuals O 0 6.177857162469047e-13
with O 0 2.4319627908719887e-11
hypohaptoglobinemia B-Disease 0 2.291535565746017e-06
in O 0 2.055253300881077e-09
three O 0 1.3691113520675202e-10
families O 0 2.465740502402558e-12
, O 0 1.3564935633092468e-11
and O 0 1.5014213830544243e-11
the O 0 9.093468755771994e-10
genotypes O 0 4.430283695455728e-09
of O 0 7.822126057988044e-09
six O 0 9.115696530948014e-10
of O 0 5.285825110945552e-09
the O 0 5.3332405158812435e-09
seven O 0 3.513991597703381e-10
individuals O 0 6.566146498049319e-12
were O 0 6.777131078550269e-10
found O 0 2.13491599398985e-10
to O 0 8.439388771153133e-11
be O 0 6.227238280587244e-09
Hp2 O 0 0.0008672245312482119
/ O 0 0.0006732200854457915
Hpdel O 0 0.0008321653585880995
. O 0 1.2678096936724614e-06

The O 0 1.1234814678573457e-07
phenotypes O 0 2.6173534450890656e-08
and O 0 4.987468771311399e-10
genotypes O 0 8.362309067422302e-09
in O 0 1.2162876261712086e-10
one O 0 1.005713654717022e-11
of O 0 4.873941805705329e-10
these O 0 2.0727223756789037e-11
three O 0 5.111274944957778e-11
families O 0 1.1918062023386078e-12
showed O 0 1.0327270150156664e-09
the O 0 2.226947293237913e-09
father O 0 9.096035591404927e-10
to O 0 3.5637697654022915e-11
be O 0 2.730031478659356e-10
hypohaptoglobinemic B-Disease 0 1.2747283051339764e-07
( O 0 1.6376150435704062e-10
Hp2 O 0 1.5614158144217072e-07
) O 0 9.082317536934781e-11
and O 0 2.0762805363894188e-10
Hp2 O 0 2.740453282967792e-06
/ O 0 1.75006709923764e-06
Hpdel O 0 8.335809980053455e-06
, O 0 3.126650494067462e-09
the O 0 4.073839487972464e-09
mother O 0 2.9491889486088496e-10
to O 0 4.101279038604133e-11
be O 0 1.1501092439525351e-10
Hp2 O 0 2.1657589854839898e-07
- O 0 1.0030293928764422e-08
1 O 0 3.8059901896758674e-08
and O 0 2.823630773640673e-10
Hp1 O 0 9.494572168478044e-07
/ O 0 1.2244045421994088e-07
Hp2 O 0 6.293775527410617e-07
, O 0 2.541889476681547e-10
one O 0 1.264313913978965e-11
of O 0 5.57078327911853e-10
the O 0 1.256765691515227e-09
two O 0 3.57351682966911e-11
children O 0 4.457535902890886e-12
to O 0 8.759718644890668e-12
be O 0 1.446489178436039e-10
hypohaptoglobinemic B-Disease 0 6.272748578339815e-07
( O 0 6.490174508932967e-10
Hp2 O 0 1.2777946949427132e-06
) O 0 2.456654601967756e-10
and O 0 3.2518021608751724e-10
Hp2 O 0 4.077226549270563e-06
/ O 0 1.3518512105292757e-06
Hpdel O 0 1.1124100637971424e-05
, O 0 8.620992253405291e-10
and O 0 6.686300818570245e-11
the O 0 1.3203893534097233e-09
other O 0 6.948649294846732e-11
child O 0 3.622765976096787e-10
to O 0 3.0656404498285994e-11
be O 0 2.873605242648125e-10
Hp1 O 0 9.069050861398864e-07
and O 0 1.968755602987926e-09
Hp1 O 0 1.5209305274765939e-05
/ O 0 1.4211175312084379e-06
Hpdel O 0 1.7591867162991548e-06
, O 0 3.857385522110235e-10
showing O 0 1.1578309422333177e-09
an O 0 8.24525864251413e-11
anomalous O 0 2.6504293870743822e-08
inheritance O 0 5.7542797193832484e-09
of O 0 8.254821892705877e-08
Hp O 0 1.1116173226355386e-07
phenotypes O 0 8.427911701858193e-09
in O 0 1.2832702678267083e-09
the O 0 2.401662690942885e-08
child O 0 1.6075942355087136e-08
with O 0 4.5882808663577634e-09
Hp1 O 0 0.21625705063343048
. O 0 5.769597464677645e-06

The O 0 9.538342737869243e-07
Hp2 O 0 8.60137733980082e-05
/ O 0 2.756159483396914e-05
Hpdel O 0 7.480226940970169e-06
individuals O 0 1.6578324824045865e-10
had O 0 3.4908993473692362e-09
an O 0 2.2737811633533056e-10
extremely O 0 1.4321214214518818e-09
low O 0 1.1852050896266064e-08
level O 0 2.389885480624798e-07
of O 0 2.0500353414831807e-08
Hp O 0 1.0010531070747675e-08
( O 0 3.36658791122435e-11
mean O 0 1.5104527351095243e-10
+ O 0 6.755008358227954e-11
/ O 0 4.975819756225519e-10
- O 0 2.746252669716398e-10
SD O 0 7.944413127347616e-09
= O 0 2.1363376345728824e-10
0 O 0 2.038235413781564e-10
. O 0 4.181114655887885e-12
049 O 0 3.6591271679320414e-10
+ O 0 9.751281379588583e-12
/ O 0 1.7130434570855613e-10
- O 0 6.60147422837376e-11
0 O 0 2.5233162781468366e-10
. O 0 1.5094208868915437e-11
043 O 0 2.2501185359402598e-09
mg O 0 5.353202880975516e-10
/ O 0 5.405302871963613e-10
ml O 0 9.669035710979657e-11
; O 0 5.113356569760863e-13
n O 0 3.8604598684433e-11
= O 0 3.450218930001192e-11
6 O 0 6.279377712248291e-11
) O 0 1.3597949806085086e-13
, O 0 1.0816218390776247e-13
compared O 0 1.9939506588819572e-13
with O 0 1.442423247901073e-13
the O 0 1.546347945524662e-11
level O 0 3.935363979135076e-10
( O 0 3.7998366931267513e-13
1 O 0 2.801570433974554e-11
. O 0 6.528143368760009e-13
64 O 0 1.0690992362227814e-11
+ O 0 3.842914268054054e-12
/ O 0 3.6349111220967956e-11
- O 0 1.213756265633359e-11
1 O 0 5.247997522661585e-11
. O 0 3.038383997525096e-12
07 O 0 3.5500061223991963e-10
mg O 0 6.727149393093157e-10
/ O 0 3.908874335323276e-10
ml O 0 6.283906728299371e-11
) O 0 1.8249003653700302e-13
obtained O 0 2.9841890677312355e-12
from O 0 1.0067154575243986e-11
52 O 0 7.744776486795502e-10
healthy O 0 1.2151218919953521e-09
volunteers O 0 1.38368413948875e-10
having O 0 3.417995053656142e-10
phenotype O 0 2.7253297396612197e-09
Hp2 O 0 1.1147575662562303e-07
, O 0 2.0444923531925951e-10
whereas O 0 9.105317888558062e-11
the O 0 3.4232275347712005e-10
serum O 0 1.0562801744384842e-09
Hp O 0 2.4579869251084574e-09
level O 0 1.8232420018193807e-08
of O 0 1.8624309872095068e-09
an O 0 2.5544665341326045e-11
individual O 0 4.4100513171829725e-12
with O 0 1.9393450734206397e-10
Hp1 O 0 9.05083870748058e-05
/ O 0 1.5947429346852005e-05
Hpdel O 0 3.153707802994177e-05
was O 0 1.1258147196713253e-06
0 O 0 2.107430645992281e-06
. O 0 1.124079531678035e-07

50 O 0 1.375450011664725e-07
mg O 0 2.021917424599451e-07
/ O 0 1.0167906339120236e-07
ml O 0 7.186918615786908e-09
, O 0 2.9778110532951985e-11
which O 0 2.0303218741662965e-12
was O 0 1.5859691337993809e-10
approximately O 0 4.009481548855609e-12
half O 0 4.593326153462529e-12
the O 0 2.0331245367821715e-11
level O 0 8.992464550772183e-10
of O 0 3.5091624051020176e-10
Hp O 0 6.446230216283766e-10
in O 0 4.032383801866324e-11
control O 0 3.5821527966106714e-09
sera O 0 7.451094852228834e-09
from O 0 3.180225180421381e-11
the O 0 1.7090227844018813e-10
Hp1 O 0 3.569189743757306e-08
phenotype O 0 2.448939939725392e-10
( O 0 1.5314131256508046e-12
1 O 0 1.8229617815279653e-10
. O 0 4.211304482221179e-12
26 O 0 9.118265170693363e-11
+ O 0 3.6180131807173055e-11
/ O 0 2.46635434297815e-10
- O 0 9.853668575532382e-11
0 O 0 2.1736087929546954e-10
. O 0 8.71651795880668e-12
33 O 0 1.6048415374392277e-10
mg O 0 1.0358518487407764e-09
/ O 0 9.785928734018512e-10
ml O 0 1.4024452432703782e-10
; O 0 9.249384027784635e-13
n O 0 4.868773093025247e-11
= O 0 4.158291419531501e-11
9 O 0 2.5858759578056834e-10
) O 0 6.016760982670288e-13
, O 0 8.215940948408385e-13
showing O 0 3.8845312383406494e-11
a O 0 1.563374429913722e-10
gene O 0 2.2188448856041987e-09
- O 0 5.844405848165479e-09
dosage O 0 1.3743250804054696e-07
effect O 0 3.9575439814143465e-07
. O 0 4.082982130171331e-08

The O 0 1.3804741172407375e-07
other O 0 5.889825849259012e-10
allele O 0 3.2588449716541845e-09
( O 0 2.7210639297337025e-10
Hp2 O 0 1.5345396775501285e-07
) O 0 2.971967116849328e-11
of O 0 7.380552835556387e-10
individuals O 0 4.4734801800394575e-12
with O 0 3.939441828304524e-10
Hp2 O 1 0.6482746601104736
/ O 0 0.011796733364462852
Hpdel O 0 0.002350152935832739
was O 0 1.83933764219546e-07
found O 0 5.293356378222036e-11
to O 0 2.4181824077873504e-12
have O 0 2.8444822452317053e-12
, O 0 4.232675841764344e-12
in O 0 1.2161664036947073e-11
all O 0 7.200962048869997e-11
exons O 0 4.1502470793375323e-08
, O 0 4.50057803524917e-11
no O 0 5.441774808545574e-11
mutation O 0 1.0571563763273062e-10
, O 0 1.3237518720066177e-11
by O 0 1.529339294092935e-10
DNA O 0 1.2351999423287907e-08
sequencing O 0 2.430060774827325e-08
. O 0 2.6573998113121888e-08

On O 0 9.413017920678612e-08
the O 0 3.4813376625919545e-09
basis O 0 1.7488712700242104e-09
of O 0 3.132835324493044e-09
the O 0 1.1010633516050916e-09
present O 0 1.5241297113277597e-10
study O 0 7.427292808559471e-11
, O 0 3.7909942546265896e-11
the O 0 2.3513793689922124e-10
mechanism O 0 3.0777889126198943e-09
of O 0 5.4565179041787815e-09
anhaptoglobinemia B-Disease 0 2.4726177798584104e-06
and O 0 9.740379613987216e-10
the O 0 3.8141854119544405e-09
mechanism O 0 1.5391734109471145e-08
of O 0 6.1111387061885125e-09
anomalous O 0 7.811171798266514e-08
inheritance O 0 1.7796617512999546e-08
of O 0 3.98771540233156e-08
Hp O 0 1.2223989642734523e-07
phenotypes O 0 4.993603752723175e-08
were O 0 5.808367120607727e-09
well O 0 5.623223220396767e-09
explained O 0 2.0782404419605882e-07
. O 0 1.973693883883243e-07

However O 0 4.182797752605438e-08
, O 0 2.9593896222479543e-09
the O 0 3.937978831913824e-09
mechanism O 0 3.063967213279284e-08
of O 0 1.3525253450552555e-07
hypohaptoglobinemia B-Disease 0 0.0006596922175958753
remains O 0 5.6920336646726355e-05
unknown O 0 3.380237103556283e-05

ATM O 0 2.611126001283992e-05
mutations O 0 2.2957731715678165e-08
and O 0 5.164489391695781e-10
phenotypes O 0 6.852408773738716e-08
in O 0 3.8343821984199167e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 9.60522106296935e-10
in O 0 4.563839861582153e-10
the O 0 2.4014188415577564e-09
British O 0 6.017576659189672e-09
Isles O 0 1.970499852177454e-08
: O 0 3.447804888812023e-11
expression O 0 6.558977666548671e-11
of O 0 1.6538656555376008e-10
mutant O 0 4.678009091207969e-09
ATM O 0 4.326345859340108e-08
and O 0 1.0085527898939795e-11
the O 0 8.204079082752003e-11
risk O 0 1.1545980838079117e-09
of O 0 1.3572720725107956e-08
leukemia B-Disease 1 1.0
, O 1 0.841701865196228
lymphoma B-Disease 1 1.0
, O 0 0.00040707510197535157
and O 0 3.325086072436534e-05
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.03813067823648453

We O 0 7.437152227396382e-09
report O 0 1.442477665092312e-10
the O 0 2.7098867594332887e-10
spectrum O 0 3.3330924686936214e-09
of O 0 5.8557874105247265e-09
59 O 0 1.7150853182101855e-08
ATM O 0 2.0993257976442692e-07
mutations O 0 2.554672584587081e-10
observed O 0 1.0065629441058377e-09
in O 0 2.0167824743566598e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.999982476234436
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 9.575387149851622e-10
patients O 0 1.0399849037501241e-10
in O 0 7.772164162256345e-11
the O 0 2.873387305868391e-09
British O 0 4.6723933166958886e-08
Isles O 0 8.545266041437571e-07
. O 0 6.442917310778284e-08

Of O 0 4.880104370386107e-06
51 O 0 3.0515677735820645e-06
ATM O 0 4.9752572522265837e-05
mutations O 0 2.909578356025122e-08
identified O 0 1.665998783373368e-09
in O 0 5.92195237292259e-10
families O 0 8.635927042921487e-12
native O 0 1.2313010333553365e-10
to O 0 1.8987710709295058e-11
the O 0 1.4436372097748063e-09
British O 0 1.2220184864020212e-08
Isles O 0 7.255678724504833e-08
, O 0 4.0778339038816114e-10
11 O 0 4.826265609381153e-09
were O 0 1.3068495174906047e-09
founder O 0 8.214629332314871e-08
mutations O 0 2.7261184976090647e-10
, O 0 5.953785381374033e-11
and O 0 2.7850699177434102e-11
2 O 0 3.5893819028132157e-09
of O 0 1.3441889823440079e-09
these O 0 2.7982272748916515e-11
11 O 0 3.900348932717179e-09
conferred O 0 2.0332711514470247e-08
a O 0 1.274425676101032e-09
milder O 0 1.0549941364956794e-08
clinical O 0 7.234522314547576e-08
phenotype O 0 4.059635405617712e-10
with O 0 4.977579980136593e-12
respect O 0 1.839615959564611e-10
to O 0 4.411601292608758e-11
both O 0 2.1241817194095347e-09
cerebellar B-Disease 1 0.9999996423721313
degeneration I-Disease 1 1.0
and O 0 4.6515509666278376e-08
cellular O 0 9.567219422024209e-06
features O 0 2.8020133413519943e-07
. O 0 6.045429756795784e-08

We O 0 6.9835608407231575e-09
report O 0 2.0207542583694504e-10
, O 0 4.1731812450152006e-11
in O 0 1.6457657459056918e-10
two O 0 2.414195066080538e-09
A B-Disease 1 1.0
- I-Disease 1 0.9997568726539612
T I-Disease 1 1.0
families O 0 3.8233371330020915e-11
, O 0 4.1049025290007535e-11
an O 0 2.4078603694244194e-11
ATM O 0 1.5538978459517239e-07
mutation O 0 8.513683646960146e-10
( O 0 1.8999374989947526e-11
7271T O 0 1.3193099945851827e-08
- O 0 1.8595637030216494e-08
- O 0 3.667522463501882e-08
> O 0 4.871836623010495e-08
G O 0 4.477313453321585e-08
) O 0 1.034239317451724e-12
that O 0 1.3044137981126774e-13
may O 0 2.680739202669258e-13
be O 0 5.326323759759395e-14
associated O 0 1.1509897039369693e-13
with O 0 2.4662646667191097e-14
an O 0 1.9180280465009442e-13
increased O 0 1.6500238675387635e-11
risk O 0 4.208401682692653e-10
of O 0 3.3512153052583926e-09
breast B-Disease 0 0.0020305155776441097
cancer I-Disease 0 1.0656120139174163e-05
in O 0 1.232410729024025e-09
both O 0 3.3853209124856676e-10
homozygotes O 0 5.4374464042439286e-08
and O 0 7.038446214746585e-11
heterozygotes O 0 4.230987560305266e-09
( O 0 7.721435470176008e-12
relative O 0 8.645263949169646e-10
risk O 0 2.7745258868172584e-10
12 O 0 1.0074612671884253e-10
. O 0 4.383057718854166e-12
7 O 0 9.637812770080245e-10
; O 0 8.441638880973823e-12
P O 0 2.0066298844767516e-08
= O 0 1.7505992488953126e-10
. O 0 1.295004901924468e-11
0025 O 0 4.70371430694172e-09
) O 0 6.776073842654218e-13
, O 0 3.105533137506139e-13
although O 0 6.866823190794513e-13
there O 0 1.6410183758738817e-12
is O 0 2.5050337238569087e-12
a O 0 6.44048772646677e-11
less O 0 5.999466479167381e-10
severe O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 1.5910418538211957e-09
in O 0 6.919390407866821e-12
terms O 0 1.2007235483668666e-11
of O 0 1.4594386463229192e-11
the O 0 3.505989595864456e-11
degree O 0 1.3059283432426128e-08
of O 0 5.749291176471161e-08
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 0 3.3716330563038355e-06

This O 0 4.1008920703689e-09
mutation O 0 1.9010668594887647e-09
( O 0 1.5775186712474465e-10
7271T O 0 3.129492398556977e-08
- O 0 5.024664062602824e-08
- O 0 8.010666618929463e-08
> O 0 1.3082797067909269e-07
G O 0 1.351163945173539e-07
) O 0 1.5931598054685914e-11
also O 0 3.457865938027993e-12
allows O 0 5.648343663448852e-13
expression O 0 7.573417587503073e-12
of O 0 5.395236687966154e-11
full O 0 1.6463497232166446e-10
- O 0 9.880864182409965e-11
length O 0 6.756128989593435e-11
ATM O 0 1.0675607597931958e-07
protein O 0 7.80138231792904e-10
at O 0 1.8036949711586203e-09
a O 0 5.324178944943192e-11
level O 0 8.099290682572757e-10
comparable O 0 1.4922177382636903e-10
with O 0 2.067564435631608e-12
that O 0 7.822099738763466e-12
in O 0 3.7708183797668937e-10
unaffected O 0 8.606690471424372e-08
individuals O 0 1.1528436538732478e-10
. O 0 1.91888194223111e-08

In O 0 1.5960781585278028e-09
addition O 0 3.007081250672172e-10
, O 0 4.022658942059998e-11
we O 0 6.973340741650569e-12
have O 0 9.986138435266745e-13
studied O 0 7.152836656310058e-10
18 O 0 3.2076135880743095e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.5076040416062142e-09
, O 0 9.094464764602961e-12
in O 0 1.2513252586887624e-11
15 O 0 9.661976080321821e-11
families O 0 4.163414133850213e-13
, O 0 8.533622593287493e-12
who O 0 7.215535807736373e-11
developed O 0 1.298069264521473e-06
leukemia B-Disease 1 1.0
, O 0 0.14356957376003265
lymphoma B-Disease 1 1.0
, O 0 5.0684382586041465e-05
preleukemic O 1 0.9999996423721313
T O 1 0.9999847412109375
- O 0 1.199211169478076e-06
cell O 0 2.4574760573159438e-06
proliferation O 0 0.001872220542281866
, O 0 5.15109011001158e-10
or O 0 2.9574273696653108e-08
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 4.816897103410156e-07
mostly O 0 3.1829092139723514e-10
in O 0 6.184244782936332e-10
childhood O 0 2.5373690277774585e-06
. O 0 1.9363574210728984e-07

A O 0 2.1219532300165156e-06
wide O 0 4.901205130636299e-08
variety O 0 1.6139599878783883e-08
of O 0 9.796357858249394e-08
ATM O 0 5.987268013996072e-05
mutation O 0 6.579131461847965e-09
types O 0 5.781924383718717e-10
, O 0 3.5486568544795816e-11
including O 0 7.653653405492733e-11
missense O 0 8.897269587748724e-09
mutations O 0 1.6824915072266577e-10
and O 0 1.2867647225522916e-10
in O 0 9.66922542033899e-10
- O 0 6.478836578338587e-09
frame O 0 9.733976291670388e-09
deletions O 0 1.3507273077806303e-09
, O 0 1.9319759680946902e-10
were O 0 2.117659658740223e-10
seen O 0 1.1011327405441307e-09
in O 0 2.0690381352661547e-10
these O 0 8.09039779614551e-10
patients O 0 1.103972202542991e-08
. O 0 6.355659820656001e-08

We O 0 4.139477649545142e-09
also O 0 6.013141373717446e-11
show O 0 3.452832811334794e-11
that O 0 7.152961491348198e-13
25 O 0 2.7265434701662095e-11
% O 0 5.431992963073062e-12
of O 0 3.0772120962474503e-10
all O 0 1.2142212568733157e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.622051049032791e-09
carried O 0 2.010167449162381e-10
in O 0 2.177758529064988e-10
- O 0 2.1912260894652036e-09
frame O 0 4.0368441922566944e-09
deletions O 0 8.999499478967721e-10
or O 0 1.956580730766433e-10
missense O 0 2.986313418773534e-08
mutations O 0 4.3601489085887124e-10
, O 0 2.3012189376281356e-11
many O 0 2.3887792785504125e-12
of O 0 4.4713180380462347e-10
which O 0 2.3169065624384366e-11
were O 0 5.755942250607049e-11
also O 0 5.834852132707846e-12
associated O 0 8.664933354163296e-12
with O 0 5.949025994045343e-12
expression O 0 1.5034632427912697e-09
of O 0 6.411543740370007e-09
mutant O 0 3.4020541761492495e-07
ATM O 0 1.2284155673114583e-05
protein O 0 7.022364911790646e-07
. O 0 5.1684263979723255e-08

The O 0 2.8701251153506746e-07
DMPK O 0 0.0001790055976016447
gene O 0 2.8921283501404105e-07
of O 0 1.0181922789342934e-06
severely O 1 0.9999980926513672
affected O 1 0.9999995231628418
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999994039535522
is O 0 9.688470470337052e-08
hypermethylated O 0 3.981536337960279e-06
proximal O 0 2.8145789698896806e-08
to O 0 6.543994512941964e-11
the O 0 1.6450981688009847e-09
largely O 0 3.6947911397078315e-09
expanded O 0 4.2752388296207755e-09
CTG O 0 4.5141482587496284e-06
repeat O 0 1.0855784466912155e-06
. O 0 1.3371861484756664e-07

Using O 0 1.8138143431656317e-08
methylation O 0 5.026361122872913e-07
- O 0 1.7066244595298485e-07
sensitive O 0 2.5467207009910453e-08
restriction O 0 9.707092907262904e-09
enzymes O 0 9.99126115175386e-10
, O 0 1.0873408423650588e-10
we O 0 2.283079801601584e-11
characterized O 0 9.418339025346611e-11
the O 0 5.056460111729777e-11
methylation O 0 1.742498367818257e-09
pattern O 0 1.1968765978309648e-09
on O 0 7.041942029495374e-10
the O 0 1.240892111287195e-10
5 O 0 6.264200269612274e-10
side O 0 2.094549533815382e-10
of O 0 5.240637923620284e-10
the O 0 2.219119998869701e-09
CTG O 0 9.445495834370377e-07
repeat O 0 4.886062665576674e-09
in O 0 1.3347101202043632e-10
the O 0 2.271211885229718e-09
DMPK O 0 8.622284440207295e-06
gene O 0 1.0468275135622207e-09
of O 0 4.492484162454957e-10
normal O 0 3.0481445145724706e-10
individuals O 0 4.4147536104252594e-13
and O 0 9.484240649781928e-12
of O 0 1.1725438398002552e-08
patients O 0 1.756413681164304e-08
affected O 0 8.220099800837488e-08
with O 0 0.0261414535343647
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.7140952479621774e-07
showing O 0 9.484725005393102e-09
expansions O 0 1.4995148234220324e-08
of O 0 1.4341804188688911e-08
the O 0 3.262024250716422e-08
repetitive O 0 2.0912239051540382e-06
sequence O 0 1.6291947702029574e-07
. O 0 9.455809646397029e-08

The O 0 3.7557279597422166e-07
gene O 0 1.771652158311099e-08
segment O 0 3.321269703704388e-09
analyzed O 0 3.837820339303022e-10
corresponds O 0 1.60012531003062e-10
to O 0 8.0071255181835e-11
the O 0 2.098433427022428e-09
genomic O 0 1.2371762636576022e-07
SacI O 0 3.6078931771044154e-06
- O 0 1.4701217132540023e-08
HindIII O 0 8.686743768748784e-08
fragment O 0 4.629827188296076e-09
carrying O 0 2.5938995396046494e-09
exons O 0 1.7278304653700616e-07
11 O 0 6.487395864951395e-08
- O 0 1.3360465800360544e-07
15 O 0 2.315298388566589e-07
. O 0 1.7809597352425044e-07

There O 0 2.9276760571406157e-08
is O 0 1.119300985230609e-09
constitutive O 0 4.9050392192384606e-08
methylation O 0 4.2050437798479834e-08
in O 0 1.3887454519689868e-09
intron O 0 2.1287341667175497e-07
12 O 0 1.1816950973297935e-08
at O 0 5.1586050986429655e-09
restriction O 0 4.737900627382885e-10
sites O 0 6.826582354957367e-11
of O 0 2.1096933922049033e-10
SacII O 0 3.218945465732759e-08
and O 0 2.7568644589415214e-10
HhaI O 0 1.3961086153813085e-07
, O 0 2.0782259246843182e-10
localized O 0 8.91377993639253e-09
1 O 0 2.6919570572658813e-08
, O 0 6.530740531696111e-11
159 O 0 2.1648538517382576e-10
- O 0 6.06917849310662e-10
1 O 0 6.5648411151641994e-09
, O 0 1.8413184865728738e-10
232 O 0 2.9093477627029074e-10
bp O 0 2.995494963187184e-10
upstream O 0 9.773350878594655e-11
of O 0 4.350620141924111e-10
the O 0 5.471191499850647e-09
CTG O 0 1.0746149200713262e-05
repeat O 0 1.0779570658314697e-07
, O 0 2.653466613100619e-10
whereas O 0 1.3920198327355138e-10
most O 0 1.2642077489022352e-11
, O 0 7.688486132473304e-12
if O 0 1.0954332059498473e-12
not O 0 2.242728138618366e-12
all O 0 4.4473027691060985e-12
, O 0 6.994947589905598e-12
of O 0 4.319454516288346e-11
the O 0 7.221814812830019e-11
other O 0 2.2862599400458317e-12
sites O 0 1.653479957119952e-11
of O 0 4.2587888771095095e-10
SacII O 0 2.58158706856193e-07
, O 0 1.7309114141994542e-09
HhaI O 0 7.516078994740383e-07
, O 0 1.3810481647169581e-09
and O 0 4.355660276900153e-10
HpaII O 0 6.657371613982832e-07
in O 0 1.336239119353877e-09
this O 0 1.173437597090654e-10
region O 0 3.939143233822051e-09
are O 0 4.779158319090371e-11
unmethylated O 0 8.380084182135761e-08
, O 0 1.2720427489121278e-10
in O 0 4.577096687774507e-11
normal O 0 8.447283983414877e-10
individuals O 0 4.916126099957507e-13
and O 0 3.851646866032121e-12
most O 0 3.676587159717748e-11
of O 0 1.0544389361655249e-08
the O 0 1.2279829775252438e-07
patients O 0 1.244842628977949e-08
. O 0 2.8565036558347856e-08

In O 0 3.760513678230382e-09
a O 0 6.12959183410311e-10
number O 0 3.0858343658124454e-10
of O 0 1.6044543471593897e-08
young O 0 3.4890621503080865e-09
and O 0 1.1639117225570317e-08
severely O 0 0.008809826336801052
affected O 0 7.446506522512664e-09
patients O 0 9.965680503043473e-10
, O 0 1.5387785490261763e-10
however O 0 3.7129946339753417e-10
, O 0 4.5945639653988124e-11
complete O 0 4.8047730238920394e-09
methylation O 0 6.568260602080045e-09
of O 0 3.2557925799814313e-10
these O 0 6.168661501743111e-13
restriction O 0 9.982716042689077e-12
sites O 0 5.124206180900925e-12
was O 0 1.1106154190754225e-10
found O 0 1.0273840805874457e-11
in O 0 1.6616048814643847e-11
the O 0 1.1599263771699952e-09
mutated O 0 1.8775118348912656e-08
allele O 0 6.440680522246112e-08
. O 0 3.276803184348864e-08

In O 0 1.092334933616712e-08
most O 0 2.910574559145118e-10
of O 0 3.9459338019298684e-09
these O 0 2.1589201260052704e-10
patients O 0 2.0592035021582689e-10
, O 0 3.2919271475417844e-11
the O 0 3.1180374948647227e-10
onset O 1 0.541410505771637
of O 0 2.250281170290691e-07
the O 0 2.3171016891865293e-06
disease O 1 1.0
was O 0 0.3799821436405182
congenital O 1 1.0
. O 0 6.047986971680075e-05

Preliminary O 0 2.5982294005189033e-07
in O 0 3.5239288820321235e-08
vivo O 0 8.968121960606368e-07
footprinting O 0 2.523815510357963e-06
data O 0 3.6688010407459615e-09
gave O 0 1.2203454913262135e-09
evidence O 0 3.506646917283973e-10
for O 0 1.9571930187645137e-10
protein O 0 7.894848108591646e-10
- O 0 1.2164204088449537e-09
DNA O 0 5.851731321726561e-10
contact O 0 4.645797982427702e-11
in O 0 3.439371357161214e-11
normal O 0 8.44738057281802e-10
genes O 0 2.7787770348619567e-11
at O 0 9.751588425643831e-10
an O 0 3.766166198349019e-11
Sp1 O 0 2.299349830536812e-07
consensus O 0 1.9709349707852653e-09
binding O 0 3.3946512267846174e-10
site O 0 3.418157978885006e-10
upstream O 0 2.478765630253843e-11
of O 0 1.0642210723776913e-10
the O 0 2.12031592283779e-09
CTG O 0 1.349890453639091e-06
repeat O 0 9.140284085162875e-09
and O 0 4.040467960209071e-11
for O 0 9.005848150556162e-11
a O 0 1.8721460492976405e-10
significant O 0 4.840238765346783e-10
reduction O 0 1.678496275303587e-08
of O 0 3.605987952681744e-09
this O 0 4.6908258527489366e-11
interaction O 0 1.3948291133214497e-10
in O 0 1.0725227650443259e-10
cells O 0 1.2935269522174053e-10
with O 0 1.864295003095595e-11
a O 0 8.711976917652464e-09
hypermethylated O 0 9.080094059754629e-06
DMPK O 0 0.003754007862880826
gene O 0 6.807049857115999e-08
. O 0 2.107639174298015e-09
. O 0 1.7432638443892756e-08

The O 0 2.4621071133879013e-05
hemochromatosis B-Disease 1 1.0
gene O 0 1.9424757624619815e-07
product O 0 7.448395678011366e-09
complexes O 0 4.5109704860379907e-10
with O 0 7.284121916750763e-11
the O 0 5.7795679353489504e-09
transferrin O 0 9.416052648703044e-08
receptor O 0 1.972431773467065e-09
and O 0 1.0732308097782806e-10
lowers O 0 3.768346967802927e-09
its O 0 1.0381972365136605e-10
affinity O 0 1.6961014537297814e-10
for O 0 2.558680767261734e-10
ligand O 0 9.687487256826444e-09
binding O 0 3.33971854615811e-08
. O 0 1.9921763794172875e-08

We O 0 1.236241775615099e-08
recently O 0 2.6434558986210277e-09
reported O 0 3.190500641458982e-10
the O 0 7.073832075654707e-10
positional O 0 1.7996345036408457e-07
cloning O 0 1.9484419411242015e-08
of O 0 2.8687874298327642e-09
a O 0 1.3148803157392308e-09
candidate O 0 5.934211788627408e-09
gene O 0 5.097749422589004e-08
for O 0 3.1984009751795384e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999924898147583
HFE O 1 0.9995542168617249
. O 0 6.228268034647044e-07

The O 0 9.567125403009413e-08
gene O 0 8.346040303308655e-09
product O 0 3.235261170075887e-09
, O 0 1.313137931724384e-10
a O 0 1.8474148599789686e-10
member O 0 2.7695346016543e-10
of O 0 3.5727569791532687e-09
the O 0 1.850202480113694e-08
major O 0 3.809494501183508e-06
histocompatibility O 1 0.8571437001228333
complex O 0 1.1129958693345543e-05
class O 0 4.396259800643065e-09
I O 0 4.831656497117365e-08
- O 0 1.808224459054486e-09
like O 0 8.849668220456408e-11
family O 0 1.7679227873323988e-11
, O 0 2.4691160574463744e-11
was O 0 5.399696800800768e-10
found O 0 5.179794961007733e-12
to O 0 1.3442126101451124e-12
have O 0 5.497847836710701e-12
a O 0 1.2747508604249447e-10
mutation O 0 2.138457466660526e-10
, O 0 1.7074784641746277e-10
Cys O 0 1.0878128477997961e-06
- O 0 2.874616988890466e-08
282 O 0 1.2373528868181438e-08
- O 0 3.5569507872423856e-07
- O 0 2.845427786724031e-07
> O 0 2.730477604018233e-07
Tyr O 0 2.85044706060944e-07
( O 0 4.0968693715282e-11
C282Y O 0 8.365288461931186e-10
) O 0 1.3735094875691467e-12
, O 0 1.394000583368471e-12
in O 0 4.235050678202956e-12
85 O 0 5.362614241555264e-10
% O 0 1.652679937347301e-10
of O 0 4.6295269839902176e-09
patient O 0 8.255420880232123e-08
chromosomes O 0 5.5212513672131536e-08
. O 0 1.0701620567488135e-07

This O 0 1.2830335904823187e-08
mutation O 0 2.402409648993853e-08
eliminates O 0 1.0234020209054506e-07
the O 0 5.419603432699205e-09
ability O 0 6.291596688079437e-10
of O 0 4.2798266264298945e-08
HFE O 0 0.00014974699297454208
to O 0 7.201487739472157e-10
associate O 0 1.754458445191176e-08
with O 0 3.6533182035114464e-10
beta2 O 0 3.246939377277158e-05
- O 0 2.070623168037855e-06
microglobulin O 0 4.642779822461307e-05
( O 0 1.9200048217982157e-09
beta2m O 0 1.0366289870944456e-06
) O 0 1.8894223685617106e-10
and O 0 1.4708241569127978e-10
prevents O 0 1.3711949353734099e-09
cell O 0 2.6258445018356724e-07
- O 0 1.008088901244264e-08
surface O 0 9.895074981614016e-09
expression O 0 3.650577440339475e-08
. O 0 2.9092340980696463e-08

A O 0 1.0554408618190791e-06
second O 0 4.3925151516077676e-08
mutation O 0 1.3038021773326136e-09
that O 0 1.1580374680020267e-11
has O 0 1.3682440597184709e-11
no O 0 2.2314605024886802e-11
effect O 0 1.3388642416956031e-09
on O 0 1.0005071438001778e-08
beta2m O 0 1.9116323528578505e-06
association O 0 5.88311488414206e-09
, O 0 8.903558446071713e-11
H63D O 0 3.577450513603253e-07
, O 0 1.4087241095861458e-10
was O 0 1.4859303787417844e-09
found O 0 1.7701293555938413e-11
in O 0 2.018353366384229e-11
eight O 0 1.5392923047308216e-10
out O 0 4.5734398906871476e-11
of O 0 4.346549786760079e-09
nine O 0 3.730205122565167e-08
patients O 0 4.3005901617654274e-10
heterozygous O 0 5.207636544213301e-10
for O 0 3.224785993793944e-10
the O 0 8.357031511252444e-09
C282Y O 0 8.849949040268257e-07
mutant O 0 1.487016334067448e-06
. O 0 1.2247981828750198e-07

In O 0 7.920251121618094e-09
this O 0 3.019023364636553e-10
report O 0 2.609619187410317e-10
, O 0 6.20446888310866e-11
we O 0 6.263325275090992e-11
demonstrate O 0 4.75122163834385e-10
in O 0 1.0928866700510298e-09
cultured O 0 1.4350943544627626e-08
293 O 0 8.119510397364138e-09
cells O 0 3.762816724872664e-09
overexpressing O 0 1.04983428173e-06
wild O 0 3.910251109573437e-07
- O 0 6.705132449269513e-09
type O 0 8.082550628785157e-09
or O 0 6.975023336686093e-10
mutant O 0 1.5736188174741983e-07
HFE O 0 2.517430857551517e-06
proteins O 0 9.458460924205436e-12
that O 0 1.0889794925181273e-12
both O 0 4.2823735009467345e-12
the O 0 3.8041284011747223e-10
wild O 0 6.11572374964453e-08
- O 0 5.5009925503668455e-09
type O 0 1.1951367007156932e-08
and O 0 1.708568220237794e-08
H63D O 0 0.17312556505203247
HFE O 0 0.0004935631295666099
proteins O 0 3.116913671608046e-10
form O 0 4.150631227606283e-10
stable O 0 3.5019966926341795e-09
complexes O 0 1.2906976876170262e-10
with O 0 2.0421803137438133e-11
the O 0 3.6433343009178998e-09
transferrin O 0 1.4692714955799602e-07
receptor O 0 8.570549603348354e-09
( O 0 2.4874530213381263e-10
TfR O 0 1.330567442892061e-07
) O 0 5.396495472709262e-10
. O 0 9.923842192449683e-09

The O 0 3.581342014058464e-07
C282Y O 0 2.4924765966716222e-06
mutation O 0 5.305676253897218e-08
nearly O 0 4.325163782681329e-09
completely O 0 9.563108527288477e-09
prevents O 0 2.0540176504102448e-10
the O 0 1.3426311173958538e-09
association O 0 1.3625653938476034e-09
of O 0 1.2147673977835893e-09
the O 0 4.654441720930436e-09
mutant O 0 1.165750660447884e-07
HFE O 0 3.9611300053365994e-06
protein O 0 1.4806766923669556e-09
with O 0 1.2789592995776644e-10
the O 0 3.5816285048895224e-08
TfR O 0 1.865406011347659e-05
. O 0 2.2406597111057636e-07

Studies O 0 1.356666512464244e-08
on O 0 1.9004877671591203e-08
cell O 0 2.161538681377806e-08
- O 0 1.0459851873534376e-09
associated O 0 3.8002556657090736e-10
transferrin O 0 9.164391912008796e-09
at O 0 8.446450650012594e-09
37 O 0 5.715805606598678e-10
degrees O 0 2.4055630820640772e-09
C O 0 6.658678053383937e-09
suggest O 0 2.836324924926359e-11
that O 0 3.5054396451544845e-12
the O 0 4.414811016761888e-10
overexpressed O 0 3.01491240861651e-07
wild O 0 7.559246029131828e-08
- O 0 6.368957805591435e-09
type O 0 1.335842192418113e-08
HFE O 0 6.069854862289503e-06
protein O 0 1.2415436456691964e-09
decreases O 0 6.981155931118366e-11
the O 0 4.2906005137677283e-11
affinity O 0 6.065507124342062e-11
of O 0 1.0230615243855823e-09
the O 0 3.2524118953602965e-09
TfR O 0 4.69899987365352e-07
for O 0 5.868948438347843e-09
transferrin O 0 3.613371291066869e-06
. O 0 1.7798119245071575e-07

The O 0 8.574535058869515e-06
overexpressed O 0 0.0007233248907141387
H63D O 0 0.008415134623646736
protein O 0 4.448490642516845e-08
does O 0 5.6645976104219287e-11
not O 0 4.436686695113989e-12
have O 0 6.076872403719402e-13
this O 0 3.5337398697314615e-13
effect O 0 9.593553035314173e-11
, O 0 3.6543181675119385e-12
providing O 0 4.22548107614773e-12
the O 0 6.011097435781876e-12
first O 0 4.6170862272321145e-12
direct O 0 1.0058325700113002e-11
evidence O 0 2.076089300473427e-11
for O 0 1.607269872749839e-11
a O 0 2.0763638031162657e-10
functional O 0 8.301570986191109e-09
consequence O 0 7.912882793448262e-09
of O 0 4.644969742173544e-09
the O 0 3.856499120047374e-08
H63D O 0 0.0008375826291739941
mutation O 0 1.181658944915398e-06
. O 0 1.1896015905676904e-07

Addition O 0 3.200090503696629e-08
of O 0 3.4312134289393725e-07
soluble O 0 1.4359316082845908e-06
wild O 0 3.0150817110552453e-05
- O 0 6.742801019754552e-07
type O 0 3.217421863155323e-06
HFE O 1 0.9999884366989136
/ O 0 0.0001627277088118717
beta2m O 0 8.681294275447726e-06
heterodimers O 0 1.5382936169316963e-07
to O 0 1.2604813026673156e-10
cultured O 0 1.0667700056643525e-09
cells O 0 4.421845181679096e-11
also O 0 3.1369379750040283e-12
decreased O 0 2.891769983193182e-11
the O 0 1.6856063420056522e-11
apparent O 0 1.243607300471794e-10
affinity O 0 1.4916422264033002e-11
of O 0 5.621718646153795e-10
the O 0 1.2662216830605644e-09
TfR O 0 1.5202118675006204e-08
for O 0 2.716784262835059e-11
its O 0 7.065023566177331e-11
ligand O 0 1.6501788824285768e-10
under O 0 1.6242366340790682e-09
steady O 0 5.421736304356273e-08
- O 0 1.1368581631643337e-09
state O 0 1.5811242592977948e-10
conditions O 0 1.066371879687722e-08
, O 0 3.1581799675439726e-11
both O 0 1.791224113478762e-11
in O 0 9.064613643028352e-11
293 O 0 1.0101594005718084e-09
cells O 0 1.6589173090775233e-10
and O 0 1.8997681205945582e-10
in O 0 3.1842952719074447e-09
HeLa O 0 3.9337614907708485e-06
cells O 0 6.286768439167645e-08
. O 0 3.643593515789689e-08

Furthermore O 0 3.596263908889341e-08
, O 0 1.3303645962636779e-09
at O 0 2.35013852822874e-09
4 O 0 4.085543015008852e-09
degrees O 0 1.508202984723539e-08
C O 0 1.3863885328646575e-07
, O 0 4.043985701862596e-10
the O 0 1.9508505921805863e-09
added O 0 1.3528059561451755e-08
soluble O 0 6.751485592815243e-09
complex O 0 2.4601035875093658e-08
of O 0 4.95286300861153e-08
HFE O 0 0.07204870879650116
/ O 0 1.37200879635202e-06
beta2m O 0 4.796022494701901e-07
inhibited O 0 2.071345095444599e-09
binding O 0 6.874644187249146e-10
of O 0 1.7882799685509099e-09
transferrin O 0 5.770263555859856e-08
to O 0 1.1715126646549834e-09
HeLa O 0 1.3551375559472945e-06
cell O 0 1.3325180248102697e-07
TfR O 0 1.1817992628948559e-07
in O 0 3.383777980037195e-10
a O 0 2.4236022078127917e-09
concentration O 0 8.75732666827389e-07
- O 0 3.348812072090368e-07
dependent O 0 2.091713113827609e-08
manner O 0 8.243367943805424e-08
. O 0 5.490921495265866e-08

Scatchard O 0 5.55187170903082e-06
plots O 0 7.076632613234324e-08
of O 0 1.4258423775004303e-08
these O 0 7.530655266041464e-11
data O 0 4.4688114320123873e-10
indicate O 0 1.1020041129627955e-10
that O 0 2.153325955045471e-11
the O 0 2.8759095105357346e-09
added O 0 9.404740985985427e-09
heterodimer O 0 5.749485776362917e-09
substantially O 0 2.273520954831909e-10
reduced O 0 6.358661930327969e-10
the O 0 1.2195397469660918e-10
affinity O 0 4.0114131460988744e-10
of O 0 6.363481741544774e-09
TfR O 0 4.049980475429038e-07
for O 0 2.6915039086361503e-09
transferrin O 0 2.4870132619980723e-06
. O 0 1.8269915358359867e-07

These O 0 5.473446140769056e-09
results O 0 5.393606006265372e-09
establish O 0 4.541854448092408e-09
a O 0 1.095267654349641e-09
molecular O 0 5.802177405200837e-09
link O 0 3.754500710329012e-09
between O 0 2.312754432409747e-09
HFE O 0 0.0002703737118281424
and O 0 1.009094474646588e-09
a O 0 2.475593063877568e-09
key O 0 4.961419719506921e-08
protein O 0 1.949006067647474e-09
involved O 0 1.4564889572188378e-10
in O 0 3.409140192367488e-10
iron O 0 6.108181764830078e-07
transport O 0 2.7441087624424654e-08
, O 0 1.7361147242045405e-10
the O 0 8.821343655540659e-10
TfR O 0 1.3232457263256947e-07
, O 0 1.1993325776948893e-10
and O 0 4.017736143779871e-11
raise O 0 5.83600112680216e-11
the O 0 8.940878593044488e-11
possibility O 0 2.1295516738906173e-10
that O 0 1.982793920371484e-12
alterations O 0 6.463121149380413e-10
in O 0 5.802104977026268e-11
this O 0 2.3846924435133587e-11
regulatory O 0 1.4109169832465795e-08
mechanism O 0 1.9286973795829e-08
may O 0 3.604060661022146e-10
play O 0 6.655462292393111e-10
a O 0 1.857463488574851e-10
role O 0 9.197917427705704e-11
in O 0 5.4287952605536205e-11
the O 0 1.9964891961876674e-09
pathogenesis O 0 0.0018414064543321729
of O 0 3.7944431824143976e-05
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.4152615221973974e-05
. O 0 5.985322104606894e-07

Genomic O 0 2.46409172177664e-06
organization O 0 2.206956679629002e-07
of O 0 1.7864473988993268e-07
the O 0 5.840876156071317e-07
UBE3A O 1 0.994596540927887
/ O 0 0.00010420339094707742
E6 O 0 0.00034365951432846487
- O 0 3.38967993229744e-07
AP O 0 4.996786060473823e-07
gene O 0 3.9264063111943415e-09
and O 0 2.3377089153342467e-10
related O 0 6.459599966035512e-09
pseudogenes O 0 1.1571271443244768e-06
. O 0 1.8246723243464658e-07

The O 0 2.557462494223728e-06
UBE3A O 0 0.00022491803974844515
gene O 0 1.0448595588741227e-07
encodes O 0 1.0565547547969345e-08
the O 0 2.3564011186749667e-08
E6 O 0 4.31324660894461e-05
- O 0 1.2861436289313133e-06
AP O 0 9.333919479104225e-06
ubiquitin O 0 1.6712770900539908e-07
- O 0 2.0174905301928447e-08
protein O 0 1.7333825486076648e-09
ligase O 0 4.109597107060381e-10
and O 0 2.4032125248152347e-11
has O 0 1.3674769649973939e-11
recently O 0 2.757473069325833e-11
been O 0 2.982288678163303e-12
shown O 0 3.483644145721443e-12
to O 0 1.9547885445753144e-12
be O 0 3.3801898779994843e-11
mutated O 0 7.883055097579472e-09
in O 0 1.1121475296249628e-07
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 1.8018188541191194e-07
who O 0 7.389215350706024e-10
lack O 0 5.323120717548591e-07
15q11 O 0 1.8112166344508296e-06
- O 0 8.306642484967597e-08
q13 O 0 2.404381405085587e-07
deletions O 0 1.3625141015438658e-08
or O 0 1.9007189155928472e-09
chromosome O 0 7.160383574955631e-07
15 O 0 1.7509902363599394e-06
paternal O 0 4.218426056468161e-06
uniparental B-Disease 1 0.9083291888237
disomy I-Disease 0 0.009860195219516754
. O 0 4.233219897287199e-06

Previous O 0 1.095397806238907e-06
UBE3A O 0 3.5065899282926694e-05
cDNA O 0 6.96460773497165e-08
analysis O 0 5.42112077450696e-10
has O 0 5.707740877158862e-11
shown O 0 9.139716761197292e-11
a O 0 1.8461257522695007e-10
coding O 0 6.010923314647698e-09
region O 0 1.319543363464959e-09
of O 0 1.3258731890175568e-09
approximately O 0 5.110555867382516e-10
2 O 0 2.1063706867607834e-07
. O 0 4.276635934274964e-08

6 O 0 9.904102626023814e-06
kb O 0 4.760800948133692e-06
and O 0 2.850308877810903e-09
a O 0 9.98368321347698e-09
3 O 0 1.9960414476827282e-07
- O 0 5.3556586721015265e-08
untranslated O 0 3.0270812203525566e-06
region O 0 1.2419919315220795e-08
( O 0 9.871614636836057e-11
UTR O 0 5.847842885486898e-07
) O 0 9.05306732357225e-12
of O 0 3.9329178802560705e-10
< O 0 1.1391550813755202e-08
50 O 0 5.586850426730905e-10
bp O 0 2.782671315593177e-10
, O 0 1.865732221495442e-11
whereas O 0 2.4483410090980762e-11
Northern O 0 1.652723929934652e-10
analysis O 0 1.4771800102564292e-11
has O 0 8.259498987528424e-12
indicated O 0 2.2237232888411285e-11
mRNA O 0 7.727155026948651e-11
sizes O 0 2.8679255151264904e-11
of O 0 3.802206050007584e-10
5 O 0 8.522675898348098e-08
- O 0 1.3911645169173426e-07
8 O 0 5.89034243603237e-07
kb O 0 6.777060207241448e-06
. O 0 1.3292014955368359e-07

We O 0 1.9171734422229747e-08
have O 0 1.4673132153752988e-10
analyzed O 0 1.4266761383385784e-10
additional O 0 5.533471944541013e-11
cDNA O 0 1.1018265411166794e-08
clones O 0 4.194068203844381e-09
and O 0 1.833051245514472e-11
provide O 0 8.574460585997201e-12
evidence O 0 3.0348123319923204e-11
for O 0 1.5268522557398967e-11
an O 0 5.2547983325768044e-11
additional O 0 1.2209787625394597e-09
0 O 0 6.194964612404874e-07
. O 0 4.936735464866615e-08

5 O 0 5.99017539570923e-07
kb O 0 1.5184402855084045e-06
of O 0 1.1149106882157866e-07
5 O 0 7.845459322197712e-07
- O 0 6.17383250300918e-07
UTR O 0 4.8691548727219924e-05
and O 0 2.4047692726014702e-09
> O 0 4.5180790664289816e-08
2 O 0 5.071709452408868e-08
kb O 0 1.8315378724764741e-07
of O 0 3.666900028065356e-08
3 O 0 8.719910510990303e-06
- O 0 9.468220923736226e-06
UTR O 0 0.0017898277146741748
. O 0 5.984956601423619e-07

We O 0 9.469468764677913e-09
have O 0 9.628254443727613e-11
established O 0 3.133401316190998e-10
the O 0 1.702613050547086e-10
genomic O 0 4.023890998183788e-09
organization O 0 8.866753997693877e-10
of O 0 9.1813801006424e-09
UBE3A O 0 7.709330930083524e-06
and O 0 2.2011358014051297e-10
the O 0 3.122399838684231e-10
sequence O 0 6.285204023903646e-10
of O 0 1.4646807322549193e-08
intron O 0 1.50381520143128e-05
- O 0 5.425493327493314e-06
exon O 0 7.758253559586592e-06
borders O 0 6.923588813378956e-08
. O 0 9.61243245001242e-08

We O 0 3.5470790749059233e-08
have O 0 3.0773297798880606e-10
also O 0 2.4048094071638104e-10
mapped O 0 1.4148211491260554e-09
two O 0 2.816100963531909e-10
highly O 0 2.6940412123366286e-09
homologous O 0 2.4140982546327905e-09
processed O 0 5.667499802797238e-09
pseudogenes O 0 5.0720480260224576e-08
, O 0 7.250138822634256e-10
UBE3AP1 O 0 1.0419124919280875e-05
and O 0 2.3670261306563134e-09
UBE3AP2 O 0 9.412757935933769e-05
, O 0 5.130694757937704e-10
to O 0 2.1656126544811194e-11
chromosomes O 0 1.2698271600886102e-10
2 O 0 1.2495187107219863e-09
and O 0 1.8500586479452963e-11
21 O 0 1.1579458503163664e-09
, O 0 2.184821941420001e-11
respectively O 0 6.843999672545564e-11
, O 0 1.3984540088440855e-11
and O 0 1.241691558601099e-11
determined O 0 2.5262922309643443e-10
their O 0 1.1278641215417551e-10
genomic O 0 5.789787493881704e-08
organization O 0 5.772332656306389e-08
. O 0 7.509667199201431e-08

These O 0 9.279584212151804e-09
results O 0 6.373916061619411e-09
will O 0 4.684522214581932e-11
form O 0 2.025005163552862e-11
the O 0 2.8437353166710366e-11
basis O 0 2.604893731272817e-11
for O 0 7.38141839318196e-12
studies O 0 1.4628805111716048e-11
of O 0 1.0619075757611895e-10
mutation O 0 3.6437214356865866e-10
and O 0 3.1564711955311964e-10
imprinting O 0 9.641789802117273e-07
of O 0 7.705530151724815e-07
UBE3A O 1 0.993740439414978
. O 0 1.1201141205674503e-06

Mutation O 0 3.011803073604824e-07
spectrum O 0 2.291290002176538e-07
and O 0 3.305003604126e-09
genotype O 0 4.496942551668326e-07
- O 0 1.2700094487172464e-07
phenotype O 0 1.6754064802171342e-08
analyses O 0 1.1586571702082438e-09
in O 0 1.2784867609028083e-09
Cowden B-Disease 1 0.9215218424797058
disease I-Disease 1 0.7454851865768433
and O 0 1.5183282187081204e-08
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.0347583234704416e-08
two O 0 1.1785664000285578e-08
hamartoma B-Disease 1 0.9999979734420776
syndromes I-Disease 1 0.7197723388671875
with O 0 2.5554214744261117e-07
germline O 1 0.9999556541442871
PTEN O 1 0.9999394416809082
mutation O 0 4.5203560148365796e-06
. O 0 2.0001192524432554e-07

The O 0 1.2280687769816723e-05
tumour B-Disease 1 1.0
suppressor O 0 0.00033131492091342807
gene O 0 8.876964443516044e-07
PTEN O 0 1.6719366612960584e-05
, O 0 6.455642687086538e-10
which O 0 2.93831764475172e-11
maps O 0 9.862849426056641e-10
to O 0 3.392450487194054e-10
10q23 O 0 1.2269028957234696e-06
. O 0 1.2014383798941708e-07

3 O 0 1.6546221104363212e-07
and O 0 1.6100236699401194e-09
encodes O 0 4.8817683229174236e-09
a O 0 4.715355661488729e-09
403 O 0 2.810854216050984e-09
amino O 0 6.918662087684879e-09
acid O 0 4.938220499184354e-09
dual O 0 8.99732768289141e-08
specificity O 0 3.899837608400958e-08
phosphatase O 0 1.8680619177757762e-05
( O 0 2.8408542185331953e-09
protein O 0 9.350296537036229e-09
tyrosine O 0 1.3033304213649899e-08
phosphatase O 0 3.081996524656461e-08
; O 0 2.351064135042158e-11
PTPase O 0 9.930942290736766e-09
) O 0 2.2004659379348812e-12
, O 0 1.5221758315614453e-12
was O 0 4.319973892497053e-11
shown O 0 1.429999001156812e-11
recently O 0 4.584934515383665e-11
to O 0 4.4608357806230625e-12
play O 0 5.29076449318211e-10
a O 0 6.763107296414717e-10
broad O 0 1.8235957188750263e-09
role O 0 5.744144604413748e-10
in O 0 6.465377677677964e-10
human O 0 7.021763082093457e-08
malignancy B-Disease 0 0.00014127699250821024
. O 0 1.6532118252143846e-07

Somatic O 0 6.236240733414888e-05
PTEN O 0 6.245215627131984e-05
deletions O 0 2.7156898951830044e-08
and O 0 1.1502282459829871e-09
mutations O 0 4.4076087224453886e-10
were O 0 7.658763900852961e-11
observed O 0 1.9826221220320406e-10
in O 0 1.608715244350023e-10
sporadic B-Disease 0 0.0015082182362675667
breast I-Disease 1 0.999927282333374
, I-Disease 0 2.622305999011587e-07
brain I-Disease 1 1.0
, I-Disease 0 6.819720965722809e-06
prostate I-Disease 1 1.0
and I-Disease 1 0.9999585151672363
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9922903180122375
lines O 0 2.248749630950897e-09
and O 0 1.0916939227612055e-11
in O 0 2.886479770480843e-11
several O 0 2.2547874678480184e-10
primary O 0 3.608631232054904e-05
tumours B-Disease 1 1.0
such O 0 2.8965423393145784e-09
as O 0 1.7880495306599187e-07
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.999736487865448
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9999829530715942
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.00042144869803451

In O 0 2.5690997773608615e-08
addition O 0 1.2187458153789521e-08
, O 0 6.515269657114686e-09
PTEN O 0 1.58326711243717e-05
was O 0 4.3601364296819156e-08
identified O 0 4.232220407462961e-10
as O 0 8.23882906342277e-11
the O 0 1.9058618572209696e-10
susceptibility O 0 9.609000706234383e-09
gene O 0 9.030380887509182e-10
for O 0 4.4622869288524214e-10
two O 0 7.055443340675538e-09
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 0.999998927116394
( O 0 1.6958856541293699e-09
CD B-Disease 0 0.014080053195357323
; O 0 4.0306273874080034e-09
MIM O 0 2.0653693354688585e-05
158350 O 0 6.809068509028293e-07
) O 0 2.3662033443727637e-10
and O 0 9.695559910483098e-10
Bannayan B-Disease 0 1.6063877410488203e-05
- I-Disease 0 1.4318443390948232e-05
Zonana I-Disease 0 0.030316604301333427
( I-Disease 0 4.46771375450794e-09
BZS I-Disease 0 5.484418124979129e-06
) I-Disease 0 1.6840678851437474e-10
or I-Disease 0 1.9932311356996024e-10
Ruvalcaba I-Disease 0 1.1936806458834326e-06
- I-Disease 0 1.4606239346903749e-06
Riley I-Disease 0 2.9090735552017577e-05
- I-Disease 1 0.9930470585823059
Smith I-Disease 0 0.0008458098745904863
syndrome I-Disease 1 0.9999996423721313
( O 0 6.274908770365073e-08
MIM O 1 0.8798877000808716
153480 O 0 0.00011739703768398613
) O 0 2.3974932261694448e-08
. O 0 1.0576459175126729e-07

Constitutive O 0 1.2528395927802194e-05
DNA O 0 1.0796669869250763e-07
from O 0 1.7253343198575521e-09
37 O 0 2.6608891090518227e-08
CD B-Disease 0 7.705170901317615e-06
families O 0 1.309136687943635e-10
and O 0 3.939081283377277e-10
seven O 0 1.1550127076986882e-08
BZS B-Disease 0 2.9615668609039858e-05
families O 0 1.4131806835848693e-10
was O 0 6.4251817200045025e-09
screened O 0 5.3028433200097425e-08
for O 0 2.0863739180754237e-08
germline O 0 8.204222103813663e-05
PTEN O 0 0.0018881361465901136
mutations O 0 1.5201355836325092e-06
. O 0 2.980577846756205e-07

PTEN O 0 0.0001408046664437279
mutations O 0 1.0315699405794021e-08
were O 0 4.4212827843281843e-10
identified O 0 6.142767544625727e-11
in O 0 4.921713037120412e-11
30 O 0 3.346244670243692e-10
of O 0 2.7632041099678872e-09
37 O 0 3.311913632231267e-09
( O 0 3.690118002830367e-11
81 O 0 2.9589946048957927e-09
% O 0 1.0044335502223944e-10
) O 0 1.126305038817721e-11
CD B-Disease 0 1.601788710559049e-07
families O 0 3.2879094412352483e-12
, O 0 3.691622528501082e-12
including O 0 2.7235080510279452e-11
missense O 0 4.258295049908156e-09
and O 0 2.0021777291656662e-10
nonsense O 0 4.590086177813646e-08
point O 0 1.583048359066197e-08
mutations O 0 1.2111622815780265e-10
, O 0 3.001464007890142e-11
deletions O 0 3.367360279504794e-10
, O 0 1.5044233914185412e-10
insertions O 0 3.3037934610291586e-09
, O 0 9.769255404634691e-10
a O 0 4.419177024317378e-09
deletion O 0 3.5986651880648424e-08
/ O 0 7.734952589544264e-08
insertion O 0 1.0625144319931223e-08
and O 0 4.501457873118397e-09
splice O 0 1.8405289665679447e-06
site O 0 3.318194501389371e-07
mutations O 0 8.934907924640356e-08
. O 0 8.44255652054926e-08

These O 0 3.0657372196429833e-09
mutations O 0 1.8039322258189827e-09
were O 0 6.667735807930342e-10
scattered O 0 1.3332909221119849e-09
over O 0 1.233198321237694e-09
the O 0 3.248865176885829e-09
entire O 0 4.006674547696321e-09
length O 0 4.198900671603667e-10
of O 0 1.2249915748441254e-08
PTEN O 0 1.2799320757039823e-05
, O 0 4.519287374882275e-11
with O 0 2.988962809896689e-12
the O 0 1.5724417601337137e-10
exception O 0 8.972603215973152e-11
of O 0 1.9922581639963965e-10
the O 0 1.9300644416020418e-10
first O 0 3.767554879186008e-10
, O 0 1.2029155449511109e-10
fourth O 0 6.516276407353416e-09
and O 0 1.0868934641194983e-09
last O 0 9.92006121691702e-08
exons O 0 1.5098015865078196e-05
. O 0 3.077086887515179e-07

A O 0 1.1218685358471703e-05
hot O 0 6.86707562636002e-06
spot O 0 3.14210694796202e-07
for O 0 2.6965909505349828e-09
PTEN O 0 3.4902036532002967e-06
mutation O 0 5.603199570991535e-10
in O 0 5.094903665625594e-11
CD B-Disease 0 9.412781878381793e-07
was O 0 3.468724640853793e-09
identified O 0 9.342372014886635e-11
in O 0 4.387835927932571e-11
exon O 0 7.693926384888528e-09
5 O 0 4.789399432603147e-10
that O 0 3.2052826105105625e-12
contains O 0 4.7469979336245416e-11
the O 0 4.541904352617365e-10
PTPase O 0 2.14101504525388e-07
core O 0 1.3912030283336208e-07
motif O 0 5.5019580003090596e-09
, O 0 9.465571555733465e-12
with O 0 2.9828234066747727e-12
13 O 0 3.3925345865881695e-10
of O 0 6.036517952168197e-10
30 O 0 7.358527120970848e-10
( O 0 6.3865987151578985e-12
43 O 0 2.0327689531640658e-10
% O 0 5.1799953215692085e-11
) O 0 1.9529707712129252e-11
CD B-Disease 0 1.7101730520607816e-07
mutations O 0 6.102969796195623e-10
identified O 0 1.0988725207550232e-10
in O 0 8.581303723165234e-11
this O 0 4.290717225963192e-10
exon O 0 1.6806350231490796e-06
. O 0 6.49963212140392e-08

Seven O 0 1.52729739966162e-08
of O 0 1.8559317638278117e-08
30 O 0 7.725733830454828e-09
( O 0 1.3201216508829106e-10
23 O 0 4.253416729937953e-09
% O 0 1.6860059182111087e-10
) O 0 1.1663411556006587e-11
were O 0 1.0472823303020462e-10
within O 0 1.3395150266770628e-10
the O 0 8.383625460517408e-10
core O 0 8.871735701632133e-08
motif O 0 7.847860139520435e-09
, O 0 4.991044036395387e-11
the O 0 1.755029038763567e-10
majority O 0 3.85053239293498e-11
( O 0 3.024715027055702e-12
five O 0 1.6445223655070507e-11
of O 0 7.525217116111094e-10
seven O 0 2.5868035491427577e-10
) O 0 5.860739844820717e-12
of O 0 3.221994893110036e-10
which O 0 8.076163349191035e-11
were O 0 9.347312923679851e-10
missense O 0 1.1942599087433337e-07
mutations O 0 3.217967670110511e-09
, O 0 8.888377811544501e-10
possibly O 0 1.3902905493523576e-09
pointing O 0 1.3166797652175433e-09
to O 0 1.6113615650126256e-11
the O 0 6.052612855356188e-10
functional O 0 7.286435899089838e-09
significance O 0 4.683231580315805e-09
of O 0 2.056111947368322e-09
this O 0 3.6797739855209954e-10
region O 0 4.797577801696207e-08
. O 0 4.620293481139015e-08

Germline O 0 0.00042861970723606646
PTEN O 0 0.00018338370136916637
mutations O 0 1.5583983881128916e-08
were O 0 8.665090867054914e-10
identified O 0 8.369018672516049e-11
in O 0 4.1628544361627107e-11
four O 0 7.417156472344644e-11
of O 0 3.7366119087778316e-09
seven O 0 4.6750030513464935e-09
( O 0 8.280470753518898e-10
57 O 0 3.877852350342437e-08
% O 0 6.8495440430638155e-09
) O 0 4.3988594988775276e-09
BZS B-Disease 0 4.654474469134584e-05
families O 0 8.973103926557258e-10
studied O 0 3.2119237403094303e-07
. O 0 5.035410026721365e-07

Interestingly O 0 3.0100255798970466e-07
, O 0 3.749891508419978e-09
none O 0 5.578311146337001e-10
of O 0 9.741810691465957e-10
these O 0 2.2018987327898643e-11
mutations O 0 1.5715963253004617e-10
was O 0 2.5761006661184638e-09
observed O 0 8.618460944909145e-10
in O 0 3.676729198875961e-10
the O 0 9.004122780709167e-09
PTPase O 0 2.053179923677817e-05
core O 0 3.436044426052831e-05
motif O 0 8.457102921965998e-06
. O 0 3.569568320926919e-07

It O 0 5.495508048625197e-09
is O 0 4.684059806692176e-10
also O 0 1.466638893665717e-10
worthy O 0 7.286696246389113e-10
of O 0 1.5206924608435202e-09
note O 0 3.425258687794752e-10
that O 0 1.4576610751770858e-11
a O 0 4.411999376952025e-10
single O 0 1.440394470364481e-09
nonsense O 0 2.8748470271011684e-08
point O 0 9.422158164795746e-09
mutation O 0 2.0415504009552166e-10
, O 0 1.0591701127271591e-11
R233X O 0 1.5036409894975122e-09
, O 0 2.4790681660280534e-11
was O 0 1.8025005099620017e-10
observed O 0 5.6958215921554256e-11
in O 0 3.123536151949935e-11
the O 0 6.968016164066171e-10
germline O 0 3.7518681494930206e-08
DNA O 0 7.805757706869088e-10
from O 0 3.52894137523041e-11
two O 0 4.519106616696078e-11
unrelated O 0 2.4869086789891526e-09
CD B-Disease 0 0.00012367480667307973
families O 0 6.698951116046459e-11
and O 0 7.948667835044887e-10
one O 0 2.4056603820099554e-08
BZS B-Disease 0 0.12427061796188354
family O 0 6.903518823264676e-08
. O 0 4.0191605421568966e-07

Genotype O 0 1.8184970031143166e-05
- O 0 8.472188142150117e-07
phenotype O 0 1.2246999858689378e-07
studies O 0 2.709211077700502e-09
were O 0 5.104535683031486e-10
not O 0 1.964679981203421e-11
performed O 0 3.43782691203387e-09
on O 0 4.8321608936419125e-09
this O 0 6.811248093319122e-11
small O 0 4.083764715279159e-10
group O 0 2.4267894360718856e-09
of O 0 2.0662173483287916e-07
BZS B-Disease 0 0.25419721007347107
families O 0 3.6243226197996137e-09
. O 0 6.15361130940073e-08

However O 0 6.681987940737599e-08
, O 0 6.9205361441504465e-09
genotype O 0 6.429425525311672e-08
- O 0 4.6507874884582634e-08
phenotype O 0 1.5611083981070806e-08
analysis O 0 1.0939440464596828e-09
inthe O 0 2.7429322813077306e-07
group O 0 1.777005098624329e-09
of O 0 1.590153786423798e-08
CD B-Disease 1 0.9866192936897278
families O 0 2.1729567797890148e-11
revealed O 0 4.483256543785785e-10
two O 0 1.9293788788843358e-11
possible O 0 1.2688907702340657e-09
associations O 0 3.3766858753558893e-10
worthy O 0 4.069149461827237e-09
of O 0 7.1502204157525284e-09
follow O 0 9.907572540157616e-10
- O 0 7.601544393942561e-10
up O 0 9.779280857324935e-11
in O 0 1.0495219276984713e-10
independent O 0 3.060379949459957e-09
analyses O 0 3.620835187234661e-08
. O 0 9.035023396108954e-08

The O 0 5.0300819509629946e-08
first O 0 1.5919288998134107e-08
was O 0 5.5893288219976967e-08
an O 0 2.696003420510351e-10
association O 0 2.7450863804290293e-09
noted O 0 3.964693850999623e-10
in O 0 6.700791310709775e-11
the O 0 1.019712647654103e-09
group O 0 6.306362654306952e-10
of O 0 6.8645191753091694e-09
CD B-Disease 1 0.9999357461929321
families O 0 2.96624863560524e-10
with O 0 5.870224306647742e-09
breast B-Disease 1 0.9999995231628418
disease I-Disease 1 1.0
. O 0 7.396790351776872e-06

A O 0 4.648659057693294e-08
correlation O 0 2.1144519468663248e-09
was O 0 4.077913562383628e-09
observed O 0 1.674775457205513e-10
between O 0 1.2428147053156202e-11
the O 0 7.854501771209499e-11
presence O 0 5.028434266196591e-11
/ O 0 7.3528063637695595e-09
absence O 0 6.841814226277165e-09
of O 0 1.088375256586005e-08
a O 0 1.0208049516791107e-08
PTEN O 0 9.46511408983497e-06
mutation O 0 7.065809048967253e-10
and O 0 1.9508747048369024e-11
the O 0 3.685111937823393e-10
type O 0 2.2491798645773997e-08
of O 0 1.8492818298909697e-06
breast O 1 0.9991901516914368
involvement O 0 0.0002532432845328003
( O 0 1.7902846138895256e-07
unaffected O 1 0.9875860214233398
versus O 1 0.9852988719940186
benign O 1 0.9999985694885254
versus O 0 0.003307973500341177
malignant O 1 0.7610617876052856
) O 0 1.0645996972868943e-08
. O 0 6.713862887863797e-08

Specifically O 0 8.121183725506853e-09
and O 0 6.946770936266944e-10
more O 0 2.6580025073302815e-12
directly O 0 5.710721825979981e-12
, O 0 2.031721318962454e-11
an O 0 3.2649261766382054e-11
association O 0 4.17135481711739e-09
was O 0 6.338781499692914e-09
also O 0 1.1028972006499327e-11
observed O 0 8.412610018326827e-12
between O 0 4.454170105666622e-12
the O 0 5.2971946273849824e-11
presence O 0 5.448182530121137e-11
of O 0 1.0411007611565992e-09
a O 0 1.9842925524926613e-08
PTEN O 1 0.9885998964309692
mutation O 0 2.331487394258147e-06
and O 0 1.3963243361558852e-07
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.804085695766844e-05

Secondly O 0 4.237095083681197e-07
, O 0 4.899014971471161e-09
there O 0 8.033564369291923e-10
appeared O 0 4.116832652556468e-09
to O 0 2.572508699116849e-11
be O 0 9.276460155582811e-11
an O 0 8.614479268809205e-11
interdependent O 0 5.991867055854527e-07
association O 0 1.2998249587781174e-08
between O 0 1.8991568317971996e-09
mutations O 0 1.1179526193672018e-09
upstream O 0 2.693587575208767e-10
and O 0 2.280703577384191e-11
within O 0 3.912797863492301e-10
the O 0 2.3039619101439257e-09
PTPase O 0 1.7869052726382506e-06
core O 0 9.71581812336808e-07
motif O 0 5.6225076150440145e-08
, O 0 3.3317559822165776e-10
the O 0 8.158051456597093e-10
core O 0 3.569625306454327e-08
motif O 0 3.794738745455106e-09
containing O 0 4.0025458641901324e-11
the O 0 8.911169718794909e-11
majority O 0 1.4952313692750963e-11
of O 0 6.368760518959959e-10
missense O 0 1.5717507295676114e-08
mutations O 0 2.9676971990966194e-10
, O 0 7.847687777395862e-11
and O 0 2.6183829410220127e-11
the O 0 9.97454230322603e-10
involvement O 0 3.13635672988255e-09
of O 0 5.214576770384838e-09
all O 0 8.359897218923606e-10
major O 0 6.799335210416757e-07
organ O 1 0.9999998807907104
systems O 1 0.9994754195213318
( O 0 4.352981974875547e-08
central O 1 0.9955254197120667
nervous O 1 0.9830469489097595
system O 1 0.9999104738235474
, O 0 9.49142577155726e-06
thyroid O 1 1.0
, O 0 0.0013717073015868664
breast O 1 1.0
, O 0 0.00021170078252907842
skin O 1 1.0
and O 1 0.806833803653717
gastrointestinal O 1 1.0
tract O 1 0.9999536275863647
) O 0 2.0344621987078426e-08
. O 0 1.5179031720435887e-07

However O 0 8.759016623116622e-08
, O 0 1.1533521915296774e-09
these O 0 1.0351022990129355e-11
observations O 0 1.8762534581551193e-10
would O 0 4.753793192424638e-11
need O 0 5.4418372585907093e-11
to O 0 6.64917426673739e-12
be O 0 9.801852905721997e-12
confirmed O 0 4.0616468521825766e-11
by O 0 3.5416971005258757e-12
studying O 0 4.2390285726057186e-11
a O 0 1.2491386397472937e-11
larger O 0 5.884250118409762e-12
number O 0 4.9851740790973764e-11
of O 0 7.777614108306352e-09
CD B-Disease 0 0.0005157160921953619
families O 0 3.04979774767844e-09
. O 0 2.6893552274032118e-08

Molecular O 0 0.06269897520542145
defects O 1 0.9958640336990356
leading O 0 1.6802394497972273e-07
to O 0 3.616925092764234e-10
human O 0 6.189453927163413e-08
complement B-Disease 0 2.6464470010978403e-06
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.428633649742551e-08
an O 0 2.2641649666255148e-10
African O 0 7.018881031939372e-09
- O 0 3.6996359309426907e-09
American O 0 8.367989856594704e-09
family O 0 3.6362322042293727e-09
. O 0 5.108407208354038e-08

Complement B-Disease 0 2.6515437639318407e-05
component I-Disease 1 0.999993085861206
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 1.4931936220818898e-07
C6D B-Disease 1 0.9497577548027039
) O 0 7.319863049026765e-10
was O 0 2.182014036122837e-08
diagnosed O 0 4.7702499728075054e-08
in O 0 1.2947611038871543e-10
a O 0 4.360813932180463e-10
16 O 0 2.4807311760355333e-09
- O 0 7.874185192768834e-10
year O 0 3.34318239758602e-10
- O 0 1.9770569625876533e-09
old O 0 1.1317916381869964e-08
African O 0 9.330752170910728e-09
- O 0 1.7344738978408714e-09
American O 0 1.3838300505497614e-09
male O 0 1.024555440487518e-09
with O 0 9.067631090431405e-09
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 2.1554103568632854e-06

The O 0 8.820298376122082e-07
patients O 0 2.8108880556487748e-08
father O 0 7.0939010221593435e-09
and O 0 1.5380133833176046e-09
two O 0 1.6216179510308848e-09
brothers O 0 2.9569886805802525e-07
also O 0 7.283490255360903e-09
had O 0 1.9315983479373244e-08
C6D B-Disease 1 0.6998429298400879
, O 0 9.322403959899361e-10
but O 0 2.4580828691944667e-11
gave O 0 2.432896661908046e-10
no O 0 1.312807362818802e-10
history O 0 7.821853720280103e-10
of O 0 4.078000870322285e-08
meningitis B-Disease 1 1.0
or O 0 1.011995376387631e-09
other O 0 1.085337708595091e-09
neisserial B-Disease 0 0.001998336287215352
infection I-Disease 0 0.11064459383487701
. O 0 5.208307811699342e-07

By O 0 9.319706784083337e-09
using O 0 7.64715224477186e-09
exon O 0 1.7158581044895982e-07
- O 0 4.146004428662309e-09
specific O 0 1.0262706240382613e-09
polymerase O 0 7.229939313901923e-09
chain O 0 3.2974053709722284e-08
reaction O 0 3.8227560006376393e-10
( O 0 4.004179626759807e-11
PCR O 0 9.098117814687612e-10
) O 0 5.690964626631212e-12
/ O 0 4.4352863048935376e-10
single O 0 1.887405370881723e-10
- O 0 5.474236619562589e-10
strand O 0 1.4891221589152792e-09
conformation O 0 4.749318716079642e-10
polymorphism O 0 4.172594492146686e-10
as O 0 4.5235561824119586e-11
a O 0 4.05694713934146e-11
screening O 0 2.0107926435031231e-10
step O 0 9.058512967508037e-11
and O 0 3.828910712794231e-12
nucleotide O 0 9.093914510316381e-11
sequencing O 0 9.561840208505146e-11
of O 0 8.66471061566898e-10
target O 0 8.197096335038623e-09
exons O 0 4.2824474633107457e-08
, O 0 1.5170471823200415e-10
we O 0 3.368045772833561e-11
determined O 0 1.4775528023314166e-10
that O 0 4.419035450065056e-12
the O 0 4.749092230582619e-10
proband O 0 1.948487096115059e-07
was O 0 6.20708107135215e-08
a O 0 3.851733154647263e-09
compound O 0 1.7234702553992065e-08
heterozygote O 0 2.7464860608006347e-08
for O 0 8.630880454774115e-10
two O 0 8.664251538448298e-09
C6 O 0 0.0009844895685091615
gene O 0 5.390687078943301e-07
mutations O 0 1.5821584042896575e-07
. O 0 1.4441864948366856e-07

The O 0 8.069168444535535e-08
first O 0 7.224990383747354e-09
, O 0 5.756680687696303e-10
1195delC O 0 1.1166276792096141e-08
located O 0 1.6431193072818928e-09
in O 0 1.8617089814210175e-10
exon O 0 4.007165443908889e-08
7 O 0 4.6576587919844314e-08
, O 0 7.531904960833558e-11
is O 0 6.760959847529335e-12
a O 0 9.65312899059434e-12
novel O 0 1.0609291223317996e-11
mutation O 0 9.405552725549882e-12
, O 0 2.614170165060603e-12
while O 0 2.7561152145250123e-12
the O 0 5.336164843328106e-11
second O 0 3.5488079141998696e-10
, O 0 3.4905030255050207e-11
1936delG O 0 2.901463513893532e-09
in O 0 2.8768681881174984e-10
exon O 0 2.5552793658789597e-08
12 O 0 1.37127609267651e-09
, O 0 3.6742317521820667e-11
has O 0 1.2160156562246449e-11
been O 0 2.4338886808750182e-11
described O 0 2.2883563099984627e-10
before O 0 4.4946868449358135e-10
to O 0 9.541090140174902e-11
cause O 0 4.25412487459198e-08
C6D B-Disease 0 0.020031865686178207
in O 0 1.3010743593611096e-09
an O 0 9.326010103061222e-11
unrelated O 0 1.0515868176241838e-08
African O 0 1.687754647150541e-08
- O 0 1.3125181830275778e-08
American O 0 1.4922363789082738e-08
individual O 0 4.7267465497213834e-09
. O 0 3.251381315294566e-07

Both O 0 2.380124719536525e-08
mutations O 0 3.917723034874143e-08
result O 0 4.197599423605425e-08
in O 0 2.1618603796014213e-08
premature O 0 1.2388167078825063e-06
termination O 0 5.277406103232352e-07
codons O 0 4.1847613374557113e-07
and O 0 4.135155151629988e-08
C6 O 0 0.0012665094109252095
null O 0 3.185738478350686e-06
alleles O 0 2.4930459474603595e-08
. O 0 4.0551661584231624e-08

Allele O 0 1.9428982511726645e-07
- O 0 1.0348451873198883e-08
specific O 0 4.744239445741982e-10
PCR O 0 8.393565842368389e-09
indicated O 0 3.687347926994988e-10
that O 0 6.316178916693227e-12
the O 0 3.7058839330583737e-10
probands O 0 1.5216194526601612e-07
two O 0 4.669279962676853e-10
brothers O 0 1.3169893620101902e-08
also O 0 4.2793241172844887e-10
inherited O 0 3.6402849623584643e-09
the O 0 1.7237061777919394e-09
1195delC O 0 1.3495587758427519e-08
mutation O 0 2.8812832675306765e-10
from O 0 1.857795514648153e-11
their O 0 3.380782806483573e-11
heterozygous O 0 2.6610538772509074e-10
mother O 0 4.0859909206103495e-11
and O 0 2.344284662225693e-11
the O 0 6.645707317787242e-10
1936delG O 0 1.3921699348884431e-08
mutation O 0 9.301623915547452e-10
from O 0 5.381526474446119e-11
their O 0 2.197653864444149e-10
homozygous O 0 1.804229121660228e-08
father O 0 5.597434515891564e-09
. O 0 4.040880519085022e-09
. O 0 6.260980711658704e-08

PAX6 O 0 0.01140513177961111
mutations O 0 5.172877990844427e-06
reviewed O 0 1.8342539078730624e-06
. O 0 6.492855391115882e-07

Mutations O 0 2.4940217713265156e-07
in O 0 2.160030376785471e-08
PAX6 O 0 0.014065597206354141
are O 0 2.715800917485467e-10
responsible O 0 1.3671549448091014e-09
for O 0 1.5909074058129136e-10
human O 0 6.183825718153457e-08
aniridia B-Disease 1 1.0
and O 0 2.872505122653024e-09
have O 0 6.070877828223686e-11
also O 0 2.529608293666552e-11
been O 0 3.930103811833341e-11
found O 0 1.493298887322858e-11
in O 0 2.86930982446032e-11
patients O 0 3.3203668980963386e-11
with O 0 1.546460876022948e-10
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.7216699177424744e-08
with O 0 1.667589276621584e-05
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 1.3464999710777192e-06
with O 0 9.052393323827346e-08
autosomal B-Disease 1 0.9999988079071045
dominant I-Disease 1 0.9999969005584717
keratitis I-Disease 1 1.0
, O 0 4.781880225124269e-09
and O 0 5.538416947281632e-10
with O 0 1.926270876140279e-08
isolated B-Disease 1 0.9999704360961914
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.0005271785776130855

No O 0 1.0272429307178754e-07
locus O 0 1.521117383163073e-07
other O 0 3.217609789718523e-10
than O 0 1.295858143013362e-10
chromosome O 0 2.5819309357189013e-08
11p13 O 0 1.9058097677771002e-07
has O 0 7.092057496826953e-10
been O 0 2.9882818441961945e-10
implicated O 0 1.9966908126889393e-09
in O 0 3.06198555399817e-09
aniridia B-Disease 1 1.0
, O 0 1.7833112764265024e-08
and O 0 2.899422257840456e-09
PAX6 O 1 0.9564626812934875
is O 0 1.714184905132754e-09
clearly O 0 1.572420943452002e-10
the O 0 2.730484449653403e-10
major O 0 5.530196744985005e-09
, O 0 3.664293868332891e-11
if O 0 1.8149803491726568e-12
not O 0 2.5983373438953627e-12
only O 0 5.485582474373807e-12
, O 0 4.976272519052749e-11
gene O 0 1.608366329008959e-09
responsible O 0 1.1199102978309838e-08
. O 0 1.185976294948432e-08

Twenty O 0 4.603123215929372e-07
- O 0 3.7287396281726615e-08
eight O 0 4.784014517866808e-09
percent O 0 1.2881454791724423e-09
of O 0 3.4909128920901367e-09
identified O 0 9.44403666380822e-09
PAX6 O 0 0.00023569112818222493
mutations O 0 5.71215785782897e-09
are O 0 2.0253346222354196e-10
C O 0 1.2559593415062409e-05
- O 0 8.648611583339516e-06
T O 0 3.203133928764146e-06
changes O 0 2.845393032302468e-09
at O 0 5.158656790626992e-08
CpG O 0 3.5606467463367153e-07
dinucleotides O 0 3.905606504872594e-08
, O 0 5.7090037558493734e-11
20 O 0 4.428335823036811e-11
% O 0 4.350475275166632e-12
are O 0 1.184064023045106e-12
splicing O 0 1.0680160089648894e-09
errors O 0 1.8869464213366882e-08
, O 0 1.0352509127731224e-10
and O 0 1.1077736818132511e-11
more O 0 4.682123829272133e-13
than O 0 2.270827406322673e-12
30 O 0 1.9320016420021346e-10
% O 0 6.848766692657549e-11
are O 0 8.257703548730788e-12
deletion O 0 4.908216610921556e-10
or O 0 1.3114734298547148e-10
insertion O 0 4.699902245164367e-09
events O 0 2.4797435216328267e-08
. O 0 1.9804855355687323e-07

There O 0 4.5659600544922796e-08
is O 0 2.412998023615387e-09
a O 0 4.283540189220503e-09
noticeably O 0 3.432292317029351e-08
elevated O 0 1.0607976008714104e-07
level O 0 1.9814596186051858e-08
of O 0 2.4769863937734726e-09
mutation O 0 4.901200001405925e-10
in O 0 6.339984093273188e-11
the O 0 4.1003345163659333e-10
paired O 0 1.733011512072835e-10
domain O 0 1.8549743685536413e-10
compared O 0 9.778623223655192e-12
with O 0 5.529302276457981e-12
the O 0 8.217928004761177e-10
rest O 0 4.119249663592228e-10
of O 0 2.3269755011767757e-09
the O 0 1.228597401592424e-08
gene O 0 5.658796808916122e-08
. O 0 2.8623121650639405e-08

Increased O 0 1.509731362148159e-08
mutation O 0 9.71201963295698e-09
in O 0 4.090999483619129e-10
the O 0 3.245192781164974e-09
homeodomain O 0 1.7664261520167202e-07
is O 0 6.173376393414642e-11
accounted O 0 8.882238000662568e-11
for O 0 1.5372376982458746e-11
by O 0 1.2446324526571573e-10
the O 0 1.0503921288318452e-08
hypermutable O 0 1.4030445527168922e-05
CpG O 0 3.119875691481866e-05
dinucleotide O 0 5.2240147851989605e-06
in O 0 3.438550422174558e-08
codon O 0 5.935968943049375e-07
240 O 0 5.7986508039675755e-08
. O 0 7.57458806788236e-08

Very O 0 2.885273353570028e-08
nearly O 0 7.101454535529683e-09
all O 0 2.5280130766525133e-10
mutations O 0 3.6538336245506287e-10
appear O 0 2.0259642574682601e-10
to O 0 1.275713475828999e-11
cause O 0 7.625392761667626e-09
loss O 0 1.4723385177717319e-08
of O 0 6.536803542900316e-09
function O 0 6.191613000083862e-09
of O 0 6.117467643562691e-10
the O 0 1.8857249095560746e-10
mutant O 0 4.1178824239374023e-10
allele O 0 1.8481504521217218e-11
, O 0 9.719023546031491e-13
and O 0 3.552615287453348e-13
more O 0 6.01054105033201e-14
than O 0 6.02555765699675e-13
80 O 0 6.642611460883074e-11
% O 0 3.8043949934785104e-11
of O 0 1.3523564490469653e-09
exonic O 0 3.480058978766465e-07
substitutions O 0 1.6342125874757585e-08
result O 0 1.7246048145125314e-08
in O 0 9.62938528914492e-09
nonsense O 0 6.280787943069299e-07
codons O 0 7.125927368178964e-07
. O 0 1.1148276968242499e-07

In O 0 4.853981749874947e-08
a O 0 1.4281994253906305e-08
gene O 0 2.954494204843172e-09
with O 0 6.630181820233005e-11
such O 0 2.171339108514303e-09
extraordinarily O 0 3.9607222390714014e-08
high O 0 1.9075294233061868e-08
sequence O 0 1.1748938488764793e-09
conservation O 0 1.2878457189557935e-09
throughout O 0 2.1995986629330666e-11
evolution O 0 9.887970997546347e-11
, O 0 4.894916937059346e-12
there O 0 7.666697138253298e-12
are O 0 1.0052726012732549e-11
presumed O 0 1.5207396231176062e-08
undiscovered O 0 1.942286417033756e-06
missense O 0 6.386160578131239e-08
mutations O 0 1.4315586494006993e-09
, O 0 5.935111430099838e-11
these O 0 8.508950488650413e-12
are O 0 2.6050962602386374e-12
hypothesized O 0 7.094624193682009e-11
to O 0 2.5526486306659546e-12
exist O 0 7.404477031514034e-11
in O 0 9.424377250821792e-11
as O 0 5.22723087037491e-10
- O 0 3.4583991226355693e-09
yet O 0 1.26877464090569e-09
unidentified O 0 5.623952414879341e-09
phenotypes O 0 3.482799160181571e-09
. O 0 6.38038344380476e-10
. O 0 1.510344738164804e-08

Genetic O 0 6.10060169492499e-07
heterogeneity O 0 3.883152714934113e-07
and O 0 2.388372832839991e-09
penetrance O 0 5.879863920199568e-07
analysis O 0 5.670361957754722e-10
of O 0 1.202994948101832e-08
the O 0 7.574862337378363e-08
BRCA1 O 0 2.5743344167494797e-07
and O 0 3.738194642721737e-09
BRCA2 O 0 1.4982374807459564e-07
genes O 0 4.565626987584892e-09
in O 0 2.2378786823651353e-08
breast B-Disease 1 0.9999973773956299
cancer I-Disease 1 0.9999892711639404
families O 0 2.9729012140933264e-08
. O 0 1.6141267451530439e-06

The O 0 0.0014557626564055681
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.995715320110321
Consortium O 0 5.604184480034746e-06
. O 0 7.088452207426599e-07

The O 0 2.1347593914811114e-08
contribution O 0 8.221161529320398e-09
of O 0 7.389772349597479e-08
BRCA1 O 0 6.137588002275152e-07
and O 0 1.3509932728084095e-08
BRCA2 O 0 2.8160934562038165e-06
to O 0 2.6293070831684417e-08
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 0.1952594518661499
assessed O 0 3.995867636774619e-09
by O 0 3.5141171222941026e-11
linkage O 0 1.01645287742258e-08
and O 0 5.7527267671719784e-11
mutation O 0 1.034642857500323e-10
analysis O 0 8.460239453444984e-12
in O 0 1.6556827089897475e-11
237 O 0 8.896276076919563e-11
families O 0 5.258854332904073e-13
, O 0 2.5502737942273423e-12
each O 0 2.784329028188842e-13
with O 0 1.3531136280886535e-11
at O 0 2.2766215579395066e-08
least O 0 7.429134391001568e-11
four O 0 4.8334277552575244e-11
cases O 0 3.1894768076634605e-11
of O 0 2.3503689305925946e-07
breast B-Disease 1 0.9965031147003174
cancer I-Disease 0 0.013858160004019737
, O 0 2.7272106795095397e-10
collected O 0 2.581739856621912e-11
by O 0 1.8903775766965225e-10
the O 0 1.1190026270924136e-05
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.922931432723999
Consortium O 0 6.324074774965993e-07
. O 0 1.2159669893208047e-07

Families O 0 2.970660606393949e-09
were O 0 2.102535923143023e-09
included O 0 9.68981117566159e-10
without O 0 1.0392794402847016e-09
regard O 0 7.292187964580421e-10
to O 0 1.3357534696389894e-11
the O 0 3.652523561381571e-10
occurrence O 0 7.659176048946392e-07
of O 0 3.082435068790801e-05
ovarian B-Disease 1 1.0
or I-Disease 0 5.024472784498357e-07
other I-Disease 0 1.939188507549261e-07
cancers I-Disease 1 0.9999992847442627
. O 0 7.4047379712283146e-06

Overall O 0 3.6658134376921225e-06
, O 0 1.5846318035528384e-07
disease O 0 0.3695213794708252
was O 0 1.7715784395022638e-07
linked O 0 8.525761430178136e-09
to O 0 1.3968498580041455e-10
BRCA1 O 0 2.4728230574311283e-09
in O 0 2.496591995637676e-11
an O 0 4.296118148727768e-12
estimated O 0 4.1501618114336836e-11
52 O 0 2.0907418851745518e-10
% O 0 2.0833326383473683e-11
of O 0 6.403254593223551e-10
families O 0 1.0925187837740324e-11
, O 0 1.7832643348092425e-11
to O 0 1.617045213009316e-11
BRCA2 O 0 4.2611611461573773e-10
in O 0 1.801908448839651e-11
32 O 0 1.626018070188806e-10
% O 0 1.68204148526252e-11
of O 0 3.3019398326672444e-10
families O 0 1.6121169069821528e-12
, O 0 3.990126805353267e-12
and O 0 3.625112363070393e-12
to O 0 3.5905267474489744e-12
neither O 0 1.3123691022798312e-10
gene O 0 7.361541237704827e-11
in O 0 1.1139711549035258e-11
16 O 0 1.2531840842822106e-10
% O 0 4.5205176407714376e-12
( O 0 1.409620358806818e-12
95 O 0 5.457306273548568e-10
% O 0 7.716271371860373e-11
confidence O 0 3.1750464479785023e-09
interval O 0 1.721952358479939e-08
[ O 0 1.1210535610928218e-08
CI O 0 2.108693252012017e-06
] O 0 4.781148255084133e-10
6 O 0 1.0213692114291462e-09
% O 0 2.3242940558332315e-11
- O 0 8.102778864538251e-11
28 O 0 6.321066448045087e-10
% O 0 6.148510867109991e-11
) O 0 8.82751250569358e-12
, O 0 2.5913750312245298e-11
suggesting O 0 4.031148193028855e-10
other O 0 1.4408112203323498e-10
predisposition O 0 7.175155758432084e-08
genes O 0 1.0616230561311113e-08
. O 0 3.6373787537513635e-08

The O 0 3.216515054305091e-08
majority O 0 1.139330629840174e-09
( O 0 5.904399885681144e-11
81 O 0 2.9750779617643275e-09
% O 0 6.300035493289613e-11
) O 0 2.6854592768271734e-12
of O 0 6.263256580041343e-10
the O 0 4.421789708430879e-05
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.861028081113659e-09
were O 0 8.444513421856925e-10
due O 0 2.3865435849756977e-08
to O 0 5.1546652363176904e-11
BRCA1 O 0 4.600004821497805e-09
, O 0 1.393217138878633e-11
with O 0 3.257721349625431e-12
most O 0 6.049539341690391e-11
others O 0 2.3654488090496528e-11
( O 0 1.9225378667525606e-12
14 O 0 4.56578108654071e-10
% O 0 5.2398755473470615e-11
) O 0 1.1877559699668971e-11
due O 0 1.0989030130303945e-08
to O 0 3.688193972450904e-09
BRCA2 O 0 4.417721868321678e-07
. O 0 3.40004575605235e-08

Conversely O 0 1.1055404058879503e-07
, O 0 1.2734150400817157e-09
the O 0 4.434339007097776e-10
majority O 0 1.1583516784652303e-10
of O 0 8.481559343742617e-10
families O 0 9.475199271025136e-12
with O 0 7.96674115566276e-11
male B-Disease 0 3.0170907994175877e-09
and I-Disease 0 1.0462650301690246e-08
female I-Disease 0 1.5994258717455523e-07
breast I-Disease 1 0.9999880790710449
cancer I-Disease 1 0.9999986886978149
were O 0 4.0183519445236016e-07
due O 0 0.00239940476603806
to O 0 1.1969588653570895e-09
BRCA2 O 0 7.853491190701334e-09
( O 0 3.867771034005152e-11
76 O 0 1.2284779415949743e-08
% O 0 7.499482701511795e-10
) O 0 5.267384306506528e-10
. O 0 1.3202187787442199e-08

The O 0 1.0554010287933124e-07
largest O 0 4.0235782705622114e-08
proportion O 0 2.882131200365734e-09
( O 0 2.055593195660066e-10
67 O 0 1.5999894742435572e-08
% O 0 3.4157987549576774e-10
) O 0 1.6718222292655405e-11
of O 0 1.179858988287208e-09
families O 0 5.51040419891069e-12
due O 0 2.054210801460954e-09
to O 0 1.1760854443099156e-11
other O 0 1.8582952884815818e-11
genes O 0 6.33698579721731e-11
was O 0 3.6283964721661732e-09
found O 0 5.635329008990553e-11
in O 0 1.5126027166911804e-11
families O 0 3.783131577103638e-13
with O 0 3.19839987827919e-12
four O 0 5.723668414225891e-11
or O 0 2.902700475815312e-11
five O 0 8.427099296159923e-11
cases O 0 7.242394878259617e-11
of O 0 1.0090049329392059e-07
female O 0 2.2403818888960814e-07
breast B-Disease 1 0.9007335305213928
cancer I-Disease 1 0.9741193056106567
only O 0 2.3380997049571306e-07
. O 0 1.5020904129414703e-06

These O 0 1.6438717054256813e-09
estimates O 0 2.339088256420041e-09
were O 0 5.577757700159225e-10
not O 0 2.004656857179654e-11
substantially O 0 6.143766051458499e-10
affected O 0 1.274780003779341e-10
either O 0 5.130810012965448e-11
by O 0 2.0934821584606134e-11
changing O 0 1.8772879084583138e-10
the O 0 2.9414479185696507e-10
assumed O 0 3.1805498235115692e-09
penetrance O 0 3.09411802845716e-08
model O 0 3.8558037318559e-10
for O 0 8.865278650072028e-11
BRCA1 O 0 4.189452673664107e-10
or O 0 2.4286657754335472e-12
by O 0 6.9946808761711665e-12
including O 0 1.2266200555277607e-10
or O 0 3.013626848069606e-10
excluding O 0 6.100473370906911e-08
BRCA1 O 0 2.0729396510432707e-07
mutation O 0 2.0263140498855137e-08
data O 0 3.569223494537255e-08
. O 0 4.9385057820927614e-08

Among O 0 1.3558851819084339e-08
those O 0 6.547106190524232e-10
families O 0 5.275596626219681e-11
with O 0 7.34349636655196e-10
disease O 1 0.9674472212791443
due O 0 8.357723345397972e-06
to O 0 2.845445823407289e-10
BRCA1 O 0 1.5932890562453395e-09
that O 0 4.681233265607654e-12
were O 0 2.2964047330376047e-11
tested O 0 1.1389100600112112e-11
by O 0 2.485074646063623e-12
one O 0 5.723807278840143e-12
of O 0 2.872969362410771e-10
the O 0 5.678706949119317e-10
standard O 0 1.8062631390591832e-09
screening O 0 3.2297720053975354e-10
methods O 0 5.4726889686662616e-11
, O 0 6.465481795780992e-12
mutations O 0 4.977561331859226e-12
were O 0 5.670270242924547e-12
detected O 0 4.1669296485524754e-11
in O 0 1.3901990669751285e-11
the O 0 6.96566068714155e-11
coding O 0 1.2014992334385965e-09
sequence O 0 4.942597373047697e-11
or O 0 6.8558600636869915e-12
splice O 0 2.61283161773207e-10
sites O 0 6.83979478957597e-12
in O 0 2.0969979225293756e-12
an O 0 6.346147023682247e-13
estimated O 0 1.3051791418472458e-11
63 O 0 2.0570130321306834e-10
% O 0 3.00456846902275e-11
( O 0 1.2534751882287143e-11
95 O 0 2.1588513199333192e-09
% O 0 5.227540067487269e-10
CI O 0 1.2429253501977655e-06
51 O 0 1.9482291335748414e-09
% O 0 2.0875499939787545e-10
- O 0 8.831158582189857e-10
77 O 0 2.585270442168053e-09
% O 0 6.300964194849712e-10
) O 0 2.0009102708051785e-10
. O 0 7.1263124290510405e-09

The O 0 6.419230658138986e-08
estimated O 0 2.409842991824007e-09
sensitivity O 0 3.679607285533848e-09
was O 0 1.1204059013891765e-08
identical O 0 1.9994261801770108e-10
for O 0 1.9401542872277133e-11
direct O 0 1.0229869729094787e-10
sequencing O 0 5.353039123079384e-10
and O 0 5.401816494110534e-11
other O 0 7.094231452287048e-11
techniques O 0 9.96194557956187e-08
. O 0 1.5889598614649003e-07

The O 0 2.0327598804215086e-07
penetrance O 0 9.639597919886e-06
of O 0 5.871419261893607e-07
BRCA2 O 0 1.2306993824040546e-07
was O 0 4.700082101294356e-09
estimated O 0 4.452618135308839e-11
by O 0 1.2777784906548018e-11
maximizing O 0 3.1475031470051817e-09
the O 0 3.101401802041437e-09
LOD O 0 1.8446849935571663e-05
score O 0 1.171356878160168e-08
in O 0 2.1727559751383296e-09
BRCA2 O 0 6.184203726888882e-08
- O 0 1.317200393202711e-08
mutation O 0 2.2949051547982435e-09
families O 0 5.347553563156415e-12
, O 0 2.1787212658996857e-11
over O 0 1.4397565084589559e-10
all O 0 4.10984773990819e-10
possible O 0 2.781612984392723e-08
penetrance O 0 1.5871071809669957e-05
functions O 0 6.287398264248623e-07
. O 0 1.2444181152204692e-07

The O 0 1.5575988498994775e-08
estimated O 0 2.0811503631534833e-09
cumulative O 0 1.1930667653814453e-07
risk O 0 2.0187146176908755e-08
of O 0 2.395573339697421e-08
breast B-Disease 0 0.0009552466799505055
cancer I-Disease 0 7.73346982896328e-06
reached O 0 4.702720701743601e-08
28 O 0 4.917101392720724e-09
% O 0 1.3351626228230717e-11
( O 0 1.783555833405337e-12
95 O 0 8.986241195607647e-10
% O 0 9.663855132791e-11
CI O 0 3.7507024330807326e-07
9 O 0 1.7781170980057937e-09
% O 0 8.480369184660219e-12
- O 0 1.0467546100734193e-11
44 O 0 8.512975914476417e-12
% O 0 1.6706865925419923e-12
) O 0 5.611701695776988e-14
by O 0 6.036002318625389e-13
age O 0 1.5223711180567534e-11
50 O 0 7.544280304638828e-12
years O 0 1.9854205085545473e-12
and O 0 9.413462847759901e-13
84 O 0 1.1987287551473713e-10
% O 0 6.944537826736319e-12
( O 0 1.3427622728989785e-12
95 O 0 6.371858596310176e-10
% O 0 9.229954994749434e-11
CI O 0 1.7906977234360966e-07
43 O 0 1.930535592498117e-10
% O 0 1.8253338077145465e-11
- O 0 2.5458329888650155e-11
95 O 0 2.703273993542865e-10
% O 0 5.485707808144946e-12
) O 0 2.2420598906093547e-13
by O 0 3.975017797558378e-12
age O 0 2.711386393183801e-10
70 O 0 1.7109577088447736e-09
years O 0 2.9207527507679742e-09
. O 0 1.147253492206346e-08

The O 0 1.84705436367949e-06
corresponding O 1 0.9999169111251831
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 0.20161743462085724
were O 0 8.502689041733902e-08
0 O 0 1.7624563497520285e-06
. O 0 6.828896914612415e-08

4 O 0 1.3643597185364342e-07
% O 0 1.1416582124113006e-09
( O 0 5.199208077955042e-11
95 O 0 4.082100435454095e-09
% O 0 5.704718364363259e-10
CI O 0 1.6969434000202455e-06
0 O 0 3.330759890118884e-09
% O 0 2.1980887596195764e-11
- O 0 1.8499314927145072e-11
1 O 0 7.025945797378697e-11
% O 0 1.1315109006010404e-12
) O 0 1.8108912196927555e-14
by O 0 1.2122674554731344e-13
age O 0 1.0077240257533315e-11
50 O 0 8.805516212018194e-12
years O 0 2.445782075130576e-12
and O 0 1.756644742861857e-12
27 O 0 1.2223204393091436e-10
% O 0 7.700653482933806e-12
( O 0 9.779028715267701e-13
95 O 0 3.819942417937483e-10
% O 0 7.890478548322477e-11
CI O 0 2.9462017892001313e-07
0 O 0 8.749491131609943e-10
% O 0 1.2994734628624105e-11
- O 0 1.6926071655376518e-11
47 O 0 2.7867756713373382e-11
% O 0 5.751560686051427e-12
) O 0 3.991258820841559e-13
by O 0 8.728214331843454e-12
age O 0 7.786961631062184e-10
70 O 0 5.990161699997998e-09
years O 0 5.431358918173146e-09
. O 0 1.897553758567483e-08

The O 0 1.4795459435390512e-07
lifetime O 0 6.191521038090286e-07
risk O 0 1.2752527709380956e-06
of O 0 3.5503526305546984e-06
breast B-Disease 1 0.9999988079071045
cancer I-Disease 1 0.9991304278373718
appears O 0 9.729076211328902e-09
similar O 0 8.256573202913842e-11
to O 0 2.136462881607848e-11
the O 0 8.017985386743476e-09
risk O 0 1.7658662088138044e-08
in O 0 5.393747670723315e-10
BRCA1 O 0 2.712530866588736e-09
carriers O 0 1.0454416846106263e-11
, O 0 2.629818238175652e-12
but O 0 7.85566219279471e-13
there O 0 5.25547704313678e-12
was O 0 4.0300335291121314e-10
some O 0 2.0134423642237387e-12
suggestion O 0 8.243434407306793e-11
of O 0 6.903393967583327e-10
a O 0 4.000168640772017e-09
lower O 0 1.4235435052967205e-08
risk O 0 2.866419102076634e-09
in O 0 3.9466316326119966e-10
BRCA2 O 0 4.910728268470166e-09
carriers O 0 9.641688142325577e-11
< O 0 6.721573075907372e-09
50 O 0 3.500899570241245e-10
years O 0 1.395369375600808e-10
of O 0 2.5286170934890606e-09
age O 0 8.480984803327374e-08
. O 0 7.553049385933264e-08

Eye B-Disease 1 0.5697380900382996
movement I-Disease 0 6.945564382476732e-05
abnormalities I-Disease 0 0.0006245619733817875
correlate O 0 1.1291136026159165e-08
with O 0 1.1304231994913039e-09
genotype O 0 1.5387939811262186e-06
in O 0 4.499451833339663e-08
autosomal O 1 0.9992907047271729
dominant O 1 0.9999977350234985
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999978542327881
I I-Disease 1 0.9488247632980347
. O 0 5.15350393470726e-07

We O 0 5.134136316087279e-08
compared O 0 1.1558986656723391e-08
horizontal O 0 1.858883393879296e-07
eye O 0 1.410060917805822e-06
movements O 0 7.085451869670578e-08
( O 0 2.3386286240878462e-09
visually O 0 5.934347679925622e-09
guided O 0 2.5751290877451538e-08
saccades O 0 1.8961665091410396e-06
, O 0 9.088803598622519e-10
antisaccades O 0 1.3769935947038903e-07
, O 0 1.758580919775099e-10
and O 0 2.2621177500625755e-11
smooth O 0 1.0864624755413388e-09
pursuit O 0 1.6310013339904117e-09
) O 0 2.140348662194036e-12
in O 0 4.047623781283649e-12
control O 0 1.6496691512823958e-10
subjects O 0 1.2136150591424144e-11
( O 0 9.68707969742355e-13
n O 0 2.0400323097469197e-10
= O 0 2.474548621567152e-10
14 O 0 2.511082730638492e-10
) O 0 3.21287245939883e-12
and O 0 7.689498343621537e-12
patients O 0 1.349687289015078e-12
with O 0 1.4450785403366528e-12
three O 0 1.3793015340990422e-11
forms O 0 3.362623790525987e-10
of O 0 5.5800828846486183e-08
autosomal O 0 0.04396497458219528
dominant O 1 0.9692909121513367
cerebellar B-Disease 1 0.9999998807907104
ataxias I-Disease 1 0.9993839263916016
type I-Disease 0 0.00148600316606462
I I-Disease 0 7.169387390604243e-05
spinocerebellar B-Disease 1 0.9983764886856079
ataxias I-Disease 0 3.122438101854641e-06
1 I-Disease 0 1.0980046027952994e-07
and I-Disease 0 1.6162411686782008e-10
2 I-Disease 0 4.937627195999994e-09
( O 0 2.929531617290593e-11
SCA1 B-Disease 0 6.255311291170074e-08
, O 0 3.6637696348984505e-11
n O 0 3.48546858042198e-10
= O 0 1.7303393440304404e-10
11 O 0 2.730098924708102e-10
; O 0 3.1114340704602172e-12
SCA2 B-Disease 0 1.9457903732700288e-08
, O 0 2.0235148626146504e-11
n O 0 1.8254808775708398e-10
= O 0 8.518178523653219e-11
10 O 0 5.310588427342999e-11
) O 0 4.402781091095154e-12
and O 0 1.2608179777995332e-10
SCA3 B-Disease 1 0.9999997615814209
/ O 0 2.9581267426692648e-06
Machado B-Disease 0 1.464551701246819e-06
- I-Disease 0 5.496359563039732e-07
Joseph I-Disease 0 2.255296521980199e-06
disease I-Disease 0 0.04896199703216553
( O 0 8.801260276136702e-10
MJD B-Disease 1 1.0
) O 0 7.975270444049443e-11
( O 0 1.1717282526191308e-11
n O 0 1.5664886054977956e-09
= O 0 2.4805417719875322e-09
16 O 0 3.6597223029843917e-09
) O 0 2.147121924700457e-10
. O 0 4.603954995019421e-09

In O 0 1.9564565434393444e-07
SCA1 B-Disease 0 4.761539457831532e-05
, O 0 8.061165956974037e-09
saccade O 0 2.4765725470388134e-07
amplitude O 0 2.389750264342183e-08
was O 0 3.948245286267138e-09
significantly O 0 2.6402836514338723e-11
increased O 0 3.761291625381524e-11
, O 0 4.3054223380911694e-11
resulting O 0 1.0394379801326181e-09
in O 0 2.5730069186380433e-09
hypermetria B-Disease 0 1.4888161786075216e-05
. O 0 2.320740861705417e-07

The O 0 2.767426110494853e-07
smooth O 0 8.903526804715511e-07
pursuit O 0 5.434879426502448e-07
gain O 0 8.10954716712331e-08
was O 0 4.6775207351856807e-07
decreased O 0 9.025624763125961e-07
. O 0 1.6458717766454356e-07

In O 0 3.939912289752101e-07
SCA2 B-Disease 0 0.00014044744602870196
, O 0 2.2229846408095e-08
saccade O 0 5.291951197250455e-07
velocity O 0 2.081826444566559e-08
was O 0 3.6757583643520775e-08
markedly O 0 1.7458559042893285e-08
decreased O 0 1.0904972924663525e-07
. O 0 2.782966213032978e-08

The O 0 3.5766316131002895e-08
percentage O 0 6.26738216880085e-09
of O 0 1.24713839255719e-08
errors O 0 1.4602840110455872e-06
in O 0 1.0945185202615448e-08
antisaccades O 0 8.847570825309958e-06
was O 0 1.0116507809243558e-07
greatly O 0 2.1546213424539218e-10
increased O 0 1.1002294214579322e-10
and O 0 3.684154370464654e-11
was O 0 1.3137874121937898e-09
significantly O 0 6.206481162340793e-11
correlated O 0 5.663473856554191e-11
with O 0 1.1530519594682431e-11
age O 0 2.4169883872104947e-08
at O 0 2.3789596525602974e-05
disease O 1 0.9967749714851379
onset O 1 0.999927282333374
. O 0 3.44652875128304e-07

In O 0 8.106899151982816e-09
addition O 0 1.2752233713442251e-09
, O 0 3.2248229087095126e-10
a O 0 1.4388396030184936e-10
correlation O 0 1.9905944947939958e-10
between O 0 3.097439527088852e-10
smooth O 0 2.7758096265984022e-08
pursuit O 0 1.1869810911946388e-08
gain O 0 2.63941368761067e-10
and O 0 1.5687803486819085e-11
the O 0 8.062418788146175e-11
number O 0 1.4766765588092312e-10
of O 0 5.993818774641113e-09
trinucleotide O 0 3.0917019557819003e-06
repeats O 0 6.975135846687408e-08
was O 0 2.684573985334282e-07
found O 0 2.277837829467444e-08
. O 0 7.067945517746921e-08

In O 0 1.6370411231036996e-06
SCA3 B-Disease 1 1.0
, O 0 6.026135679348954e-07
gaze B-Disease 0 1.6189775124075823e-05
- I-Disease 0 2.34949993682676e-06
evoked I-Disease 0 8.591475761932088e-07
nystagmus I-Disease 0 0.00018287803686689585
was O 0 3.5208785220675054e-08
often O 0 3.363609737960793e-11
present O 0 6.419136056035057e-11
as O 0 1.5965614941215733e-10
was O 0 1.9979070842168767e-08
saccade O 0 4.3436560304144223e-07
hypometria O 0 3.4585403341225174e-07
and O 0 6.104960981190288e-10
smooth O 0 2.9258170997081834e-08
pursuit O 0 3.9594457490466084e-08
gain O 0 8.181928912165404e-09
was O 0 2.4969102341287908e-08
markedly O 0 9.092363306706375e-09
decreased O 0 4.8602444735479366e-08
. O 0 3.331269837758555e-08

Three O 0 2.2517811615330174e-08
major O 0 1.2831735318741266e-07
criteria O 0 1.5160485133947077e-07
, O 0 2.0527575195217196e-09
saccade O 0 1.5927831498174783e-07
amplitude O 0 7.438173632579037e-09
, O 0 2.8164179322054395e-10
saccade O 0 7.931770795721604e-09
velocity O 0 3.690197591943445e-10
, O 0 2.4260001993403613e-11
and O 0 1.1615901816808272e-11
presence O 0 1.6084820975148517e-10
of O 0 5.861520158134681e-09
gaze B-Disease 0 1.154715164375375e-06
- I-Disease 0 1.2952989436598727e-07
evoked I-Disease 0 2.861498771267179e-08
nystagmus I-Disease 0 3.3348052852488763e-07
, O 0 3.3053157433293734e-11
permitted O 0 4.6209650689243986e-11
the O 0 7.117421235713906e-11
correct O 0 1.168425911579618e-10
assignment O 0 5.7514430717997556e-11
of O 0 2.606808380267722e-10
90 O 0 5.025435623196017e-10
% O 0 1.5467965450155496e-11
of O 0 2.2954117773199556e-10
the O 0 7.920639699676713e-10
SCA1 B-Disease 0 1.57729073180235e-06
, O 0 7.221552522640451e-11
90 O 0 2.180809421936658e-10
% O 0 7.630430141902789e-12
of O 0 1.4891754496204612e-10
the O 0 1.0106046000046831e-09
SCA2 B-Disease 0 4.586140676110517e-06
, O 0 1.368920810040919e-10
and O 0 2.7128747165372502e-11
93 O 0 1.6984947892595414e-09
% O 0 5.0458817679732704e-11
of O 0 1.2511260916170386e-09
the O 0 8.77104966434672e-09
patients O 0 6.081740111518741e-10
with O 0 5.257858592955245e-10
SCA3 B-Disease 1 1.0
to O 0 1.2813528016408782e-09
their O 0 1.9169421605624848e-09
genetically O 0 3.776379031705801e-08
confirmed O 0 2.0684316481833775e-09
patient O 0 2.0705352987704373e-09
group O 0 5.567076244439306e-10
and O 0 1.1798224897052734e-10
, O 0 2.708941126972064e-10
therefore O 0 5.003342185005977e-10
, O 0 1.506562791186994e-10
may O 0 4.5624470867977607e-10
help O 0 1.2701348306443094e-10
orient O 0 1.6811482339562644e-07
diagnoses O 0 1.791691417452057e-08
of O 0 3.42322437063558e-08
SCA1 B-Disease 0 0.05568018555641174
, O 0 5.038414130353885e-09
SCA2 B-Disease 0 3.83729457098525e-05
, O 0 1.10735443037413e-09
and O 0 1.449821040999666e-09
SCA3 B-Disease 1 1.0
at O 0 1.0344449918875398e-07
early O 0 1.383426972978441e-08
clinical O 0 1.3249719188479503e-07
stages O 0 1.4684576399304206e-07
of O 0 5.349326759329642e-09
the O 0 5.760641030860825e-08
diseases O 0 0.022898608818650246
. O 0 5.020638127462007e-09
. O 0 5.1361837449803716e-08

Genetic O 0 5.1217540431025554e-08
basis O 0 4.3195331755896405e-09
and O 0 2.941010213142192e-10
molecular O 0 7.444677407875133e-08
mechanism O 0 6.523329716401349e-07
for O 0 2.700627874219208e-06
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 0.0003220051876269281

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 0.9999997615814209
causes O 0 6.243593588806107e-07
more O 0 1.3401274881474912e-11
than O 0 9.354848493070556e-12
300 O 0 4.546659923554408e-11
, O 0 3.399800926895402e-11
000 O 0 5.184346840714227e-10
sudden O 0 8.028330000797723e-09
deaths O 0 5.730760865851892e-10
each O 0 2.3780868767253605e-12
year O 0 5.1645163839930674e-11
in O 0 2.8874505564324693e-10
the O 0 2.3834910933828724e-08
USA O 0 2.8581880542333238e-06
alone O 0 1.81955943645562e-08
. O 0 2.211490190973109e-08

In O 0 1.4403895853831727e-08
approximately O 0 1.5928788288377405e-09
5 O 0 1.9256978234238886e-08
- O 0 7.033475135642675e-09
12 O 0 1.5293896149515263e-09
% O 0 5.0948547464235716e-11
of O 0 2.7359320364794826e-10
these O 0 4.139913672290829e-12
cases O 0 3.726407203641369e-12
, O 0 2.5923328154237035e-12
there O 0 3.9435503473850275e-12
are O 0 1.3520010848713793e-12
no O 0 1.365129537189702e-10
demonstrable O 1 0.9936210513114929
cardiac O 1 1.0
or O 0 3.385441402770084e-07
non O 1 0.9999630451202393
- O 1 0.9297690391540527
cardiac O 1 1.0
causes O 0 4.811516305380792e-07
to O 0 5.0757953395930144e-11
account O 0 7.490383313601967e-12
for O 0 1.127147507273829e-11
the O 0 2.5879434706332916e-10
episode O 0 1.1104231978364965e-09
, O 0 9.885778827489755e-12
which O 0 1.538917864668532e-12
is O 0 2.6890776931576266e-12
therefore O 0 1.1989316657523563e-11
classified O 0 2.526783782208497e-10
as O 0 1.0944538608725907e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 4.255613748682663e-05
IVF B-Disease 1 1.0
) O 0 2.864469550445392e-08
. O 0 9.339675699493455e-08

A O 0 1.3301947774380096e-06
distinct O 0 5.3705626612554624e-08
group O 0 3.260288750084328e-08
of O 0 0.00011187805648660287
IVF B-Disease 1 1.0
patients O 0 8.36637923384842e-07
has O 0 5.912088041348795e-10
been O 0 1.6037429717563612e-10
found O 0 7.395624043726734e-12
to O 0 2.188490924939779e-12
present O 0 6.203025593176648e-11
with O 0 1.2617898392797144e-10
a O 0 1.476013533618925e-08
characteristic O 0 8.525359589839354e-06
electrocardiographic O 0 0.0003220269863959402
pattern O 0 6.24422864348162e-06
. O 0 2.503372229512024e-07

Because O 0 2.3185679154380523e-08
of O 0 1.0129193128705083e-07
the O 0 2.791440145699653e-08
small O 0 2.663298193095187e-10
size O 0 1.5452314428010538e-10
of O 0 4.519403962177648e-09
most O 0 8.925066935505654e-11
pedigrees O 0 6.93858692724092e-10
and O 0 4.8601910690448946e-11
the O 0 6.625823223416205e-10
high O 0 2.9689910974184386e-08
incidence O 0 3.916254627256421e-06
of O 0 4.319123547702475e-08
sudden B-Disease 0 4.1411326492379885e-06
death I-Disease 0 1.1125013088530977e-06
, O 0 1.3877146654017736e-10
however O 0 3.531937936562812e-11
, O 0 1.0653680194983028e-11
molecular O 0 1.3339217508345769e-09
genetic O 0 6.530331830845171e-10
studies O 0 3.359076905518066e-11
of O 0 4.605658965317616e-09
IVF B-Disease 1 1.0
have O 0 1.1581926390169528e-10
not O 0 1.929879346607155e-11
yet O 0 2.5851412677191377e-10
been O 0 6.568031674092367e-10
done O 0 3.0950493279391367e-09
. O 0 2.406348897920907e-08

Because O 0 1.2998705187783344e-06
IVF B-Disease 1 1.0
causes O 0 0.0029469765722751617
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 0.9999876022338867
, O 0 3.696474237813163e-10
we O 0 2.8033717708320083e-11
investigated O 0 3.5139449683363466e-10
whether O 0 3.6947167547651816e-11
malfunction O 0 1.2470668480091263e-06
of O 0 3.063072018250068e-09
ion O 0 1.167616137109917e-08
channels O 0 3.595123754251972e-09
could O 0 2.9397034806422084e-10
cause O 0 7.920719191645276e-09
the O 0 3.5400480324909722e-09
disorder O 0 2.219214323417873e-08
by O 0 2.4194016581824407e-11
studying O 0 1.6647655476376144e-10
mutations O 0 4.4156674844364474e-11
in O 0 3.7299576621796504e-11
the O 0 1.7665290341639661e-09
cardiac O 0 0.00229769223369658
sodium O 0 5.43770454441983e-07
channel O 0 2.3113634597393684e-06
gene O 0 3.0197813316590327e-07
SCN5A O 0 7.14310008333996e-05
. O 0 1.3261285403132206e-07

We O 0 1.981470987288958e-08
have O 0 2.7155938608913743e-10
now O 0 1.541719113484774e-10
identified O 0 2.9413749214057816e-10
a O 0 8.345622526384489e-10
missense O 0 4.117572771633604e-08
mutation O 0 1.541872851618109e-09
, O 0 2.013743893858333e-10
a O 0 1.1106372488356442e-09
splice O 0 1.3987100544454734e-07
- O 0 2.599190196406198e-08
donor O 0 8.304896326194466e-09
mutation O 0 8.99715235647136e-09
, O 0 1.9440965504102792e-10
and O 0 9.256911903676723e-11
a O 0 2.753597128091201e-09
frameshift O 0 7.83355176281475e-08
mutation O 0 5.15573972403871e-10
in O 0 5.3371421865344715e-11
the O 0 3.0629768166257065e-10
coding O 0 1.7845430022589426e-08
region O 0 2.0083710250418108e-09
of O 0 1.9109807070094575e-09
SCN5A O 0 2.562719782872591e-05
in O 0 5.7487619109508614e-09
three O 0 1.2000820781565835e-08
IVF B-Disease 1 0.9999998807907104
families O 0 2.8898101689378564e-09
. O 0 6.495493209968117e-08

We O 0 2.8319977474211555e-09
show O 0 5.42586864327177e-10
that O 0 4.399045797770507e-12
sodium O 0 3.9572050497538314e-11
channels O 0 1.8449420810529027e-11
with O 0 2.771148545008262e-12
the O 0 4.028427036395499e-10
missense O 0 2.076880534218617e-08
mutation O 0 3.328167463845233e-10
recover O 0 6.124893370262896e-10
from O 0 6.400271979067895e-11
inactivation O 0 2.8473169777498697e-07
more O 0 2.2325576717191487e-12
rapidly O 0 2.0384366070103077e-11
than O 0 4.447291601823722e-13
normal O 0 4.5268878923199196e-11
and O 0 5.623193317233488e-12
that O 0 4.440402906480401e-12
the O 0 1.3937155873833262e-09
frameshift O 0 6.742479996546535e-08
mutation O 0 5.470395803008898e-10
causes O 0 9.167126779896506e-11
the O 0 1.236636765211685e-10
sodium O 0 2.402425480774184e-10
channel O 0 4.3574302499571615e-10
to O 0 1.753612706434371e-11
be O 0 6.260290896786813e-11
non O 0 1.45014809049826e-08
- O 0 1.4442080420451475e-08
functional O 0 1.1250725862055333e-07
. O 0 2.0655230414945436e-08

Our O 0 3.98685564562129e-08
results O 0 2.4548103549904e-09
indicate O 0 3.55139445629149e-10
that O 0 2.2188596446315323e-11
mutations O 0 1.3435372259174017e-10
in O 0 1.4811447901497132e-10
cardiac O 0 1.33803732751403e-05
ion O 0 4.986636525927679e-08
- O 0 2.1564160235243435e-08
channel O 0 2.6965034649606423e-09
genes O 0 1.3011575324128888e-11
contribute O 0 1.3140459857383102e-12
to O 0 8.972080890734535e-13
the O 0 8.947259599878521e-11
risk O 0 8.353505664970839e-10
of O 0 1.1572569569295865e-09
developing O 0 3.9778324634198725e-08
IVF B-Disease 1 0.9999997615814209
. O 0 7.255841705244848e-09
. O 0 2.3032466600625412e-08

Molecular O 0 1.5758128313336783e-07
heterogeneity O 0 2.631028337418684e-07
in O 0 1.3551457733740335e-08
mucopolysaccharidosis B-Disease 0 0.00011367859406163916
IVA I-Disease 1 1.0
in O 0 6.201081959034127e-08
Australia O 0 7.908627530639478e-09
and O 0 1.506042651699957e-10
Northern O 0 1.1508213937361234e-08
Ireland O 0 4.453125868053576e-08
: O 0 1.851097192195894e-10
nine O 0 1.3227082762412579e-09
novel O 0 2.7240082411950084e-10
mutations O 0 2.0030258007786017e-10
including O 0 2.9461980077805094e-10
T312S O 0 9.028442349290344e-08
, O 0 9.866236716504773e-10
a O 0 7.644742616719213e-10
common O 0 8.149684260772005e-10
allele O 0 8.04742827931193e-10
that O 0 3.546045401758846e-11
confers O 0 5.199186148274748e-08
a O 0 1.9279838170405128e-08
mild O 0 6.4044252212625e-05
phenotype O 0 7.550109444309783e-07
. O 0 4.337293546541332e-08

Mucopolysaccharidosis B-Disease 1 0.8400011658668518
IVA I-Disease 1 1.0
( O 0 0.0011845857370644808
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 2.5723213781247978e-08
is O 0 6.015806186532302e-10
an O 0 2.0927695132400004e-09
autosomal B-Disease 1 0.999997615814209
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
caused O 0 5.073587203696661e-07
by O 0 4.1732947653194685e-10
a O 0 1.8434327841987397e-07
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 5.925774537729467e-09
N O 0 7.825843795217224e-07
- O 0 1.3087934291888814e-08
acetylgalactosamine O 0 8.67433982421062e-07
- O 0 7.610023544657452e-08
6 O 0 6.866105763947417e-07
- O 0 1.5441139566974016e-07
sulfate O 0 9.169360737359966e-08
sulfatase O 0 7.331179222092032e-05
( O 0 6.313105593847013e-09
GALNS O 0 5.880582466488704e-05
) O 0 4.5110155610927904e-09
. O 0 1.91339601940399e-08

Previous O 0 5.8712124939575006e-08
studies O 0 1.697124996091759e-09
of O 0 2.167210766401695e-08
patients O 0 1.496607282547302e-10
from O 0 3.595051339955191e-11
a O 0 4.6550430177205726e-10
British O 0 3.4614546784439426e-09
- O 0 2.3220363409848233e-09
Irish O 0 4.51107595722533e-09
population O 0 4.932386096778707e-12
showed O 0 4.2290389939969586e-11
that O 0 3.879428028819021e-12
the O 0 5.716677686784521e-10
I113F O 0 4.4957801037526224e-08
mutation O 0 2.451435443528993e-10
is O 0 4.355639113273746e-12
the O 0 1.2067204874233184e-11
most O 0 1.689126377830974e-12
common O 0 1.4457243562027156e-11
single O 0 2.2293046575416753e-10
mutation O 0 4.322780355892064e-09
among O 0 1.9504451387319932e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 2.737942850217223e-06
and O 0 1.2537562099623756e-09
produces O 0 7.568345949948707e-09
a O 0 2.6367244387870414e-08
severe O 1 0.9999758005142212
clinical O 1 0.9998651742935181
phenotype O 0 2.286813105456531e-05
. O 0 9.899666508772498e-08

We O 0 1.2851490982512814e-09
studied O 0 2.672509991086258e-09
mutations O 0 7.155547682158314e-11
in O 0 5.290812579716864e-11
the O 0 5.251865609068318e-10
GALNS O 0 7.185022923295037e-07
gene O 0 5.518203671783795e-10
from O 0 2.3677101945729362e-11
23 O 0 1.717657571731479e-09
additional O 0 5.019383575444181e-09
MPS B-Disease 1 0.9999995231628418
IVA I-Disease 1 1.0
patients O 0 1.0132844607824154e-07
( O 0 4.5498698558743556e-11
15 O 0 4.734964642594264e-10
from O 0 5.6652241925414515e-11
Australia O 0 4.03451716479708e-10
, O 0 1.4773040429849615e-11
8 O 0 4.664268415943695e-10
from O 0 1.9889728752886526e-11
Northern O 0 1.2573555530082103e-09
Ireland O 0 1.9206605195165594e-09
) O 0 4.271564872648792e-12
, O 0 2.2596458124773955e-12
with O 0 1.0800269099192628e-12
various O 0 1.0336567018986997e-10
clinical O 0 2.794439978970331e-06
phenotypes O 0 4.2622630758160085e-08
( O 0 2.0792172150674304e-10
severe O 0 0.05497531220316887
, O 0 1.4101549927758583e-09
16 O 0 5.87061643742004e-09
cases O 0 9.004680334712134e-11
; O 0 1.2028898710436664e-11
intermediate O 0 6.009478692448056e-09
, O 0 2.9231912029858975e-11
4 O 0 9.760874331021796e-10
cases O 0 1.105340124984977e-11
; O 0 6.662643960847481e-12
mild O 0 7.296758752772803e-08
, O 0 1.9991859556700575e-10
3 O 0 1.0195596367168491e-08
cases O 0 1.596393989222733e-10
) O 0 1.3626193229310246e-10
. O 0 9.492796770871337e-09

We O 0 2.1620170542746564e-08
found O 0 4.910772344324243e-10
two O 0 3.101801107630031e-11
common O 0 3.228873002303345e-10
mutations O 0 3.1358030755379573e-11
that O 0 1.466080837460304e-12
together O 0 4.8408798671017994e-12
accounted O 0 2.6694468857613174e-10
for O 0 3.1727849514329165e-11
32 O 0 5.432195249177596e-10
% O 0 5.2918423115722035e-11
of O 0 9.45839850885477e-10
the O 0 3.1672859890363725e-09
44 O 0 2.8798670115293135e-09
unrelated O 0 1.185505249523544e-09
alleles O 0 5.159445787272787e-11
in O 0 1.417756884114496e-10
these O 0 3.263060377456384e-10
patients O 0 5.7735078939913365e-09
. O 0 3.34383614131184e-08

One O 0 1.6746268372003215e-08
is O 0 8.044481747404575e-10
the O 0 3.4726037601018334e-09
T312S O 0 3.0247852578213497e-07
mutation O 0 1.6366017874247518e-08
, O 0 2.7049035233872587e-10
a O 0 2.1680024442360946e-10
novel O 0 3.2441821451456576e-10
mutation O 0 3.3245828312544745e-10
found O 0 3.205039705855839e-11
exclusively O 0 1.4135527470759968e-10
in O 0 8.082084446137117e-10
milder O 0 3.0044757295399904e-06
patients O 0 1.5468081926428567e-07
. O 0 1.0610789047404978e-07

The O 0 1.8619245167883491e-07
other O 0 5.485399912075195e-10
is O 0 1.3354790884267942e-10
the O 0 5.146906789654793e-10
previously O 0 4.561623079268884e-09
described O 0 7.742148033784702e-10
I113F O 0 9.894773000951318e-09
that O 0 4.9845846200602395e-11
produces O 0 1.3214475069744935e-09
a O 0 9.067043116317564e-09
severe O 0 0.042635075747966766
phenotype O 0 4.193945187580539e-06
. O 0 1.2799873161384312e-07

The O 0 3.139866180390527e-07
I113F O 0 4.7426340188394533e-07
and O 0 2.5963544647567005e-09
T312S O 0 3.8877839614315235e-08
mutations O 0 6.448135914105535e-10
accounted O 0 5.567659666638747e-10
for O 0 3.986500365926737e-11
8 O 0 2.4508990392746455e-09
( O 0 5.274245883785111e-12
18 O 0 1.9830910524820666e-10
% O 0 1.1080187982404066e-11
) O 0 1.2008558210319098e-12
and O 0 8.52820418451028e-12
6 O 0 2.2829429457971173e-09
( O 0 5.174354434506201e-12
14 O 0 1.4812662207930316e-10
% O 0 9.987915876308318e-12
) O 0 1.1006166681162832e-12
of O 0 7.805724122622593e-11
44 O 0 6.984795519748843e-10
unrelated O 0 9.461988970116408e-10
alleles O 0 2.502996698794391e-10
, O 0 1.2723533338032667e-10
respectively O 0 5.317354556666487e-09
. O 0 3.611647869661283e-08

The O 0 4.987816737411777e-07
relatively O 0 9.790473853854564e-08
high O 0 1.2258568915513024e-07
residual O 0 1.1931631888728589e-05
GALNS O 0 0.0012283804826438427
activity O 0 2.10279367252042e-08
seen O 0 6.15372308665485e-10
when O 0 2.732035604691152e-11
the O 0 1.6108031575257087e-10
T312S O 0 4.81398299001512e-09
mutant O 0 5.075161624290558e-09
cDNA O 0 8.15954948052422e-09
is O 0 6.298702531770672e-11
overexpressed O 0 8.299116949217478e-09
in O 0 5.055408869303335e-11
mutant O 0 2.7046573869426993e-09
cells O 0 6.907183852655763e-11
provides O 0 2.8461430261195186e-12
an O 0 9.513205110819878e-13
explanation O 0 7.458165161844388e-12
for O 0 1.1348161993440797e-11
the O 0 1.428580143070235e-09
mild O 0 1.00897468655603e-05
phenotype O 0 5.303356420682803e-09
in O 0 8.125714684448226e-11
patients O 0 1.335498812232716e-11
with O 0 5.443412214034549e-12
this O 0 4.637407402530158e-10
mutation O 0 3.032802808888846e-08
. O 0 2.3114678171509695e-08

The O 0 9.573692949516044e-09
distribution O 0 2.4306761048364933e-09
and O 0 3.336708340184735e-11
relative O 0 1.2697375095793717e-10
frequencies O 0 1.813978689479967e-10
of O 0 5.860153473591367e-10
the O 0 5.851006346091481e-10
I113F O 0 1.4383470414713884e-08
and O 0 1.7399402751916426e-10
T312S O 0 1.2715249297912123e-08
mutations O 0 1.590871046008857e-10
in O 0 3.7602372604528256e-11
Australia O 0 9.033374048783571e-11
corresponded O 0 2.663661175308918e-12
to O 0 4.612535613873758e-12
those O 0 4.820407528000059e-12
observed O 0 1.1787450182598747e-10
in O 0 4.8507163563638045e-11
Northern O 0 6.955776843398098e-09
Ireland O 0 8.928243033778926e-09
and O 0 7.193357021151314e-11
are O 0 1.2032339534451264e-11
unique O 0 3.104499990413956e-11
to O 0 4.3912078834251744e-12
these O 0 2.3614760320811445e-12
two O 0 5.1356440801397785e-12
populations O 0 1.1873279269491999e-11
, O 0 1.562520295442238e-12
suggesting O 0 7.645536981293333e-12
that O 0 5.206129039155016e-13
both O 0 9.806041395554743e-12
mutations O 0 2.9416538649407187e-11
were O 0 1.5159248856200236e-10
probably O 0 1.0139984685242354e-10
introduced O 0 1.5470391634408998e-10
to O 0 8.833878940850415e-12
Australia O 0 2.4259183550867647e-10
by O 0 5.756217030805644e-11
Irish O 0 7.567768633975902e-09
migrants O 0 7.467534229865791e-11
during O 0 3.106752355375164e-10
the O 0 1.6007792869032755e-09
19th O 0 1.1812764455498836e-07
century O 0 6.47707224743499e-07
. O 0 2.1803630545491615e-07

Haplotype O 0 1.014910708363459e-06
analysis O 0 1.188959153353153e-08
using O 0 4.190341851284529e-09
6 O 0 2.1444070341658517e-07
RFLPs O 0 5.208625566410774e-07
provides O 0 3.532330261624139e-10
additional O 0 2.3889307199098653e-11
data O 0 1.507269864475802e-10
that O 0 1.1831208755752609e-11
the O 0 8.90254481245023e-10
I113F O 0 4.290558308639447e-08
mutation O 0 8.843665799673772e-10
originated O 0 4.5436110429619703e-10
from O 0 4.4612466498783476e-11
a O 0 5.84478188070392e-10
common O 0 2.4523065800252652e-09
ancestor O 0 1.1161596091824322e-07
. O 0 1.335389185896929e-07

The O 0 1.5937889941142203e-07
other O 0 9.62399937520786e-10
9 O 0 5.2556082152932504e-08
novel O 0 1.0955476525964514e-09
mutations O 0 1.2197375054423532e-10
identified O 0 2.4842418053228066e-11
in O 0 8.943432799890516e-12
these O 0 5.8762647525689715e-12
23 O 0 1.2872054533374921e-08
patients O 0 1.3977773105633418e-10
were O 0 5.962229321365697e-11
each O 0 1.034231511196082e-12
limited O 0 2.192939024814322e-10
to O 0 7.219500691713066e-11
a O 0 9.118100940952445e-09
single O 0 4.523666419231631e-08
family O 0 1.3894164041516888e-08
. O 0 8.959601416336227e-08

These O 0 1.1223453277864337e-09
data O 0 8.691889430423316e-10
provide O 0 5.2512216797140354e-11
further O 0 8.625655745220229e-12
evidence O 0 4.2163536551065306e-11
for O 0 2.0481680587658424e-11
extensive O 0 3.2720866016688888e-09
allelic O 0 9.485288643418244e-08
heterogeneity O 0 8.774986781645566e-08
in O 0 3.3624793616127135e-08
MPS B-Disease 1 0.9994719624519348
IVA I-Disease 1 1.0
in O 0 3.882685462031077e-08
British O 0 3.151244527543895e-07
- O 0 3.7373766303971934e-07
Irish O 0 2.924936666204303e-07
patients O 0 3.483248689484242e-10
and O 0 3.3005528865537315e-11
provide O 0 2.2953755215993077e-11
evidence O 0 1.6859963425375213e-10
for O 0 1.177316022449304e-10
their O 0 8.363880421580205e-11
transmission O 0 1.9892443248181735e-09
to O 0 6.171806989085926e-12
Australia O 0 7.705652782519223e-11
by O 0 2.6039795320009773e-11
British O 0 1.9929517591776857e-08
- O 0 1.8978651539214297e-08
Irish O 0 2.8018524389494814e-08
migrants O 0 1.3925144370929843e-09
. O 0 5.857180851442934e-10
. O 0 1.566477259018484e-08

Identification O 0 2.043847899813045e-07
of O 0 1.902553776744753e-07
constitutional O 0 2.7618030799203552e-05
WT1 O 0 0.00284660910256207
mutations O 0 1.1687300904839049e-08
, O 0 1.765258356156707e-10
in O 0 1.416834982670423e-10
patients O 0 7.372853022546977e-11
with O 0 1.2669289228828262e-10
isolated O 0 0.00015988906670827419
diffuse B-Disease 1 0.9999990463256836
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 2.1920203430170204e-09
and O 0 2.0376979617542368e-11
analysis O 0 3.409769341877755e-11
of O 0 9.68399027634348e-10
genotype O 0 2.498653728366662e-08
/ O 0 5.904994182515111e-08
phenotype O 0 2.8200569657244046e-10
correlations O 0 4.253396246323149e-11
by O 0 6.673149012537127e-12
use O 0 3.091500319629681e-11
of O 0 1.6024319648977325e-09
a O 0 5.2585638066204865e-09
computerized O 0 8.311689043694059e-07
mutation O 0 2.2724481851810197e-08
database O 0 2.396574316776423e-08
. O 0 2.3491001144293477e-08

Constitutional O 0 1.416579152646591e-06
mutations O 0 5.2430202401865245e-09
of O 0 1.2426458972925047e-08
the O 0 3.268239368026116e-08
WT1 O 0 1.2119317034375854e-05
gene O 0 5.927311530484758e-09
, O 0 1.6667861535424322e-10
encoding O 0 7.388539224884028e-10
a O 0 1.1100808272601626e-08
zinc O 0 8.085589797701687e-07
- O 0 1.5666618082832429e-06
finger O 0 1.8789287423714995e-06
transcription O 0 1.986463985303999e-06
factor O 0 1.7294205179041455e-08
involved O 0 3.0959629304661007e-10
in O 0 1.5344329140631885e-09
renal O 1 1.0
and O 0 9.430032754664808e-09
gonadal O 1 1.0
development O 0 1.3070400939341198e-07
, O 0 2.4936891093729763e-11
are O 0 7.333184081671773e-13
found O 0 1.2394785718627954e-12
in O 0 3.3649812537089874e-12
most O 0 1.4611516857554463e-11
patients O 0 1.476751880502558e-11
with O 0 1.0700381553041538e-10
Denys B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.679008038190659e-06
DDS B-Disease 1 1.0
) O 0 4.203221326548601e-09
, O 0 1.4153231919777909e-09
or O 0 2.9313468985492364e-08
diffuse B-Disease 1 0.9999994039535522
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 3.7007251307841216e-07
DMS B-Disease 0 0.010033480823040009
) O 0 1.1980859013216438e-11
associated O 0 4.47468555264674e-11
with O 0 3.941769827209285e-11
pseudohermaphroditism B-Disease 1 1.0
and O 0 1.1591043680425628e-08
/ O 0 2.0247514385118848e-06
or O 0 9.283974478080381e-09
Wilms B-Disease 1 0.9999920129776001
tumor I-Disease 1 0.8073486089706421
( O 0 5.286563720119375e-08
WT B-Disease 1 1.0
) O 0 3.6926564028760822e-09
. O 0 1.142523586850075e-08

Most O 0 1.7824882903028083e-08
mutations O 0 6.535521634987163e-08
in O 0 2.349486010189139e-07
DDS B-Disease 1 1.0
patients O 0 7.31919953977922e-07
lie O 0 6.182292366929687e-08
in O 0 2.8054338852001592e-09
exon O 0 1.6380391798520577e-07
8 O 0 3.553125793587242e-08
or O 0 2.1169892228112275e-10
exon O 0 1.4744097498464726e-08
9 O 0 1.171602637128899e-08
, O 0 2.2314787517796475e-10
encoding O 0 4.200512826457725e-09
zinc O 0 1.719363496022197e-07
finger O 0 5.385918484535068e-07
2 O 0 4.268879820301663e-06
or O 0 9.596399230815678e-09
zinc O 0 2.785476169719914e-07
finger O 0 2.6848968559534114e-07
3 O 0 1.9132798456666933e-07
, O 0 1.037464766873164e-10
respectively O 0 1.372536528876367e-10
, O 0 1.0836507906286652e-11
with O 0 7.998024985356178e-12
a O 0 2.2096928731230037e-09
hot O 0 2.923667352661141e-07
spot O 0 1.0377215176049503e-07
( O 0 4.588853602660592e-11
R394W O 0 7.829963344363478e-09
) O 0 5.052767579338813e-11
in O 0 6.293049414907159e-10
exon O 0 4.013752175069385e-07
9 O 0 1.2723905911116162e-06
. O 0 1.4991923080742708e-07

We O 0 2.576405311316421e-09
analyzed O 0 4.764034722271049e-10
a O 0 1.677380873088552e-10
series O 0 3.9309150379196467e-10
of O 0 2.5550197513268813e-09
24 O 0 4.428959243796271e-08
patients O 0 5.585508167094133e-10
, O 0 1.6193792140573038e-10
10 O 0 6.021442788828324e-10
with O 0 8.456988997984638e-10
isolated B-Disease 0 2.408434374956414e-05
DMS I-Disease 1 0.9761996865272522
( O 0 8.786304128705069e-09
IDMS B-Disease 0 0.0005751412827521563
) O 0 6.375100447542081e-11
, O 0 2.8069243110384612e-11
10 O 0 1.2203449362147012e-10
with O 0 2.2958408785189732e-10
DDS B-Disease 1 1.0
, O 0 4.778258344551034e-10
and O 0 5.478600212383e-11
4 O 0 1.905514857014623e-08
with O 0 1.6314586348542548e-09
urogenital B-Disease 1 0.9999998807907104
abnormalities I-Disease 1 0.9998389482498169
and O 0 5.361269828085824e-08
/ O 0 0.011358837597072124
or O 0 2.198856918766978e-06
WT B-Disease 1 1.0
. O 0 2.262161387989181e-06

We O 0 1.4328315955935977e-07
report O 0 4.559563393513599e-08
WT1 O 0 2.4791610485408455e-05
heterozygous O 0 1.162358742590186e-08
mutations O 0 6.738398172778659e-10
in O 0 2.591475090074624e-10
16 O 0 2.5439243600544614e-08
patients O 0 6.461211010666545e-10
, O 0 1.0751444873280391e-10
4 O 0 1.6204129593688776e-08
of O 0 1.3967446754747925e-08
whom O 0 2.2286765766210692e-09
presented O 0 6.701809951437099e-08
with O 0 4.543650433674884e-08
IDMS B-Disease 1 0.9898689985275269
. O 0 1.7967893199966056e-06

One O 0 5.057625074300631e-08
male O 0 4.142882037427853e-09
and O 0 6.219376680327571e-10
two O 0 2.938628673732069e-09
female O 0 8.03653037451113e-08
IDMS B-Disease 1 0.9999974966049194
patients O 0 5.4411604111237466e-08
with O 0 1.812527905542538e-08
WT1 O 1 0.9999998807907104
mutations O 0 4.2586084418871906e-06
underwent O 0 0.08775936812162399
normal O 0 0.00010261414718115702
puberty O 0 0.0017232027603313327
. O 0 1.1918159259494132e-07

Two O 0 5.040944728307295e-08
mutations O 0 3.6936658176500714e-08
associated O 0 3.09010772525653e-08
with O 0 1.164962259991853e-08
IDMS B-Disease 1 0.9986932873725891
are O 0 5.74035194378375e-11
different O 0 4.308013364442975e-13
from O 0 1.7906844410053857e-11
those O 0 2.7386407377982813e-11
described O 0 1.1808254818390651e-08
in O 0 2.5190107066919154e-07
DDS B-Disease 1 1.0
patients O 0 4.218739377392922e-06
. O 0 2.811896706589323e-07

No O 0 2.1328726234060014e-06
WT1 O 0 0.0001974425686057657
mutations O 0 1.5977908773834315e-08
were O 0 9.672029843699192e-10
detected O 0 1.4778072099375095e-09
in O 0 2.015899946972155e-10
the O 0 4.627266569912081e-09
six O 0 1.6795498325450353e-08
other O 0 3.2497283086740936e-08
IDMS B-Disease 1 1.0
patients O 0 1.998581744544481e-08
, O 0 2.0606337469697422e-10
suggesting O 0 4.626064531443319e-10
genetic O 0 6.285650666626452e-09
heterogeneity O 0 2.946897836864082e-08
of O 0 2.9287484437645617e-08
this O 0 1.3976453772102104e-08
disease O 1 0.9472174644470215
. O 0 2.1601152866423945e-07

We O 0 2.6885908610552178e-08
analyzed O 0 1.222827616942368e-08
genotype O 0 4.494828331758072e-08
/ O 0 5.57678454526922e-08
phenotype O 0 7.130265822219428e-10
correlations O 0 6.368031657544293e-10
, O 0 2.7320198187075206e-11
on O 0 1.076634337238147e-10
the O 0 1.6570602529020206e-11
basis O 0 3.376568469271035e-11
of O 0 1.0178448361930492e-10
the O 0 3.371473100699518e-10
constitution O 0 4.3934406113166347e-10
of O 0 1.5087978644245936e-09
a O 0 4.118764440619316e-09
WT1 O 0 2.4611981643829495e-06
mutation O 0 6.378923500527378e-10
database O 0 3.21735221797681e-10
of O 0 1.1588561221742566e-09
84 O 0 5.903091349068745e-08
germ O 0 0.00013366273196879774
- O 0 4.867750362791412e-07
line O 0 2.985197156135655e-08
mutations O 0 6.432118171417756e-10
, O 0 2.348939619201129e-11
to O 0 3.7930609174396945e-12
compare O 0 2.538036968091628e-11
the O 0 2.094709405930928e-10
distribution O 0 1.966271367948025e-09
and O 0 3.649186508525304e-11
type O 0 7.701616011601686e-10
of O 0 3.277764282216822e-09
mutations O 0 1.3873044379941746e-10
, O 0 7.26045482415949e-12
according O 0 2.932890041940084e-12
to O 0 2.6627977166987504e-12
the O 0 3.390264180502811e-10
different O 0 3.0865054956308313e-10
symptoms O 0 4.093371899216436e-06
. O 0 4.11653608978213e-08

This O 0 2.056959047536111e-09
demonstrated O 0 8.697349507258423e-09
( O 0 1.5772629036181485e-10
1 O 0 1.2183482667182943e-08
) O 0 2.1858221829762492e-11
the O 0 1.3469472759375378e-10
association O 0 7.051036837735225e-11
between O 0 1.358150484437326e-11
mutations O 0 2.3071563756693614e-11
in O 0 3.7368361877065936e-11
exons O 0 1.1011270117933236e-08
8 O 0 5.087101406786587e-09
and O 0 6.370603350402959e-11
9 O 0 8.204228407748815e-09
and O 0 2.9191921102622587e-10
DMS B-Disease 0 1.0517055670788977e-07
; O 0 1.2621840204951607e-11
( O 0 3.7519249859729875e-12
2 O 0 9.670626521796066e-10
) O 0 3.839529822552423e-12
among O 0 1.3060059977920702e-11
patients O 0 3.262602644646395e-12
with O 0 1.486252093618745e-11
DMS B-Disease 0 4.3379986891523e-06
, O 0 5.385623544351681e-11
a O 0 2.7161106697093373e-11
higher O 0 2.6687631271560264e-11
frequency O 0 2.3164349605142576e-10
of O 0 1.045566411228549e-09
exon O 0 3.596565534280671e-08
8 O 0 4.7407051617653906e-09
mutations O 0 1.4749172716488346e-10
among O 0 1.125954884884095e-11
46 O 0 5.256304835832282e-10
, O 0 7.844922489397277e-10
XY O 0 3.3898522815434262e-06
patients O 0 1.0598395772110081e-10
with O 0 2.2240246103089056e-11
female O 0 5.39569985913424e-11
phenotype O 0 2.7089927523427093e-10
than O 0 2.5202160237186577e-12
among O 0 2.5331426192765072e-11
46 O 0 2.9734723572261146e-09
, O 0 3.583608298995955e-09
XY O 0 0.0007863935898058116
patients O 0 1.4343293219809539e-10
with O 0 9.800039252327863e-12
sexual O 0 4.0190870076450835e-10
ambiguity O 0 1.100041746582292e-08
or O 0 5.250242463006316e-10
male O 0 1.1857805015669243e-10
phenotype O 0 1.0001665468051257e-10
; O 0 2.3298320737941136e-12
and O 0 8.146692521970866e-12
( O 0 7.206811970111859e-12
3 O 0 1.4807726156362833e-09
) O 0 1.3152847951405922e-12
statistically O 0 2.158042147759609e-11
significant O 0 9.097449356343379e-12
evidence O 0 3.1618686835432896e-11
that O 0 1.404422043070619e-12
mutations O 0 1.0904369421305127e-11
in O 0 5.237587447082248e-11
exons O 0 5.908790967623645e-08
8 O 0 1.2356147216507907e-08
and O 0 3.302972895191658e-10
9 O 0 1.4076833920739773e-08
preferentially O 0 2.406204124838496e-10
affect O 0 1.0162076041764223e-10
amino O 0 7.802375412424567e-11
acids O 0 4.410177084634981e-12
with O 0 1.1532559846330614e-12
different O 0 1.2984124409323727e-12
functions O 0 7.185188000136122e-10
. O 0 3.458410779977328e-10
. O 0 6.028674004454615e-09

The O 0 8.863631819622242e-07
185delAG O 0 5.01101067129639e-06
BRCA1 O 0 6.489698307632352e-07
mutation O 0 3.1662170663082634e-09
originated O 0 4.5416614913307285e-10
before O 0 1.1849779490979984e-10
the O 0 7.042072480700767e-11
dispersion O 0 1.034909824504382e-09
of O 0 6.492291704240927e-10
Jews O 0 1.6900207622239094e-10
in O 0 1.2698635198926667e-10
the O 0 4.921489882292462e-10
diaspora O 0 4.772274242448304e-10
and O 0 1.621041911814558e-10
is O 0 6.991776602127686e-11
not O 0 6.00750144075235e-11
limited O 0 3.0525735272846077e-09
to O 0 1.943912364410494e-09
Ashkenazim O 0 5.776110356237041e-06
. O 0 1.5782491402660526e-07

The O 0 1.2043498998082214e-07
185delAG O 0 3.2264759397548914e-07
mutation O 0 1.8167087389997505e-08
in O 0 2.262663834073919e-09
BRCA1 O 0 9.909088660720045e-09
is O 0 3.62701604861293e-11
detected O 0 2.846971269843124e-10
in O 0 3.7144804593269853e-11
Ashkenazi O 0 2.26402363523448e-09
Jews O 0 1.2584297492956864e-10
both O 0 7.246871852606418e-11
in O 0 4.500556816111612e-09
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.4747957948202384e-06
in O 0 2.3756152600640235e-09
the O 0 5.872240027571252e-09
general O 0 4.133435993480816e-08
population O 0 7.26763871305991e-10
. O 0 7.815624591955839e-09

All O 0 9.54164960376147e-08
tested O 0 1.821810258206824e-07
Ashkenazi O 0 2.2102130969869904e-07
mutation O 0 7.105735999601848e-09
carriers O 0 2.699059586941388e-10
share O 0 2.8537875187972794e-11
the O 0 3.388932190429017e-10
same O 0 8.357999847774522e-10
allelic O 0 3.6377053902469925e-07
pattern O 0 3.442540617015766e-07
at O 0 4.3436767782623065e-07
the O 0 5.847274309189743e-08
BRCA1 O 0 2.8320758360678155e-07
locus O 0 3.944040258829773e-07
. O 0 5.268424985160891e-08

Our O 0 7.048411276855404e-08
previous O 0 1.00772172828556e-08
study O 0 1.9957951957749742e-10
showed O 0 7.875056162731653e-10
that O 0 1.4688021632291992e-11
this O 0 6.071480124214546e-11
Ashkenazi O 0 3.575880924699959e-08
mutation O 0 4.180769952455421e-09
also O 0 1.1099293012462041e-10
occurs O 0 4.14564459150224e-11
in O 0 5.295153898687843e-11
Iraqi O 0 4.184150248498497e-10
Jews O 0 1.3340255289318037e-10
with O 0 3.523258074178415e-11
a O 0 2.1986696907561054e-09
similar O 0 2.762935435995928e-09
allelic O 0 2.746209020187962e-06
pattern O 0 3.2108687264553737e-06
. O 0 4.429136879480211e-07

We O 0 2.534900822581676e-08
extended O 0 7.711614458116856e-09
our O 0 6.588031231657965e-10
analysis O 0 5.531382990531242e-11
to O 0 2.910911442444153e-11
other O 0 2.3043858488058788e-11
non O 0 1.0539663364284024e-08
- O 0 4.513451390408818e-09
Ashkenazi O 0 9.058330974198725e-09
subsets O 0 6.895241000393071e-08
354 O 0 3.4778335766816326e-09
of O 0 2.5703679185085093e-09
Moroccan O 0 1.0429043584281317e-07
origin O 0 9.610811035898337e-10
, O 0 3.232976941713872e-10
200 O 0 5.180550988193033e-10
Yemenites O 0 8.209507740275512e-08
and O 0 4.19563439546522e-10
150 O 0 1.5781603801556798e-09
Iranian O 0 4.4111096997312416e-09
Jews O 0 1.7694166132287137e-08
. O 0 1.1339507466345822e-07

Heteroduplex O 0 4.823764811590081e-06
analysis O 0 4.971714151480455e-09
complemented O 0 3.0741456047422844e-09
by O 0 1.6949405767796577e-10
direct O 0 9.240476162020173e-10
DNA O 0 6.724368617483378e-09
sequencing O 0 3.751909449789537e-09
of O 0 1.2673265104012899e-08
abnormally O 0 4.416398624584872e-08
migrating O 0 1.259217952132019e-09
bands O 0 2.352422256990394e-08
were O 0 1.2411536687295666e-08
employed O 0 5.7087294891289275e-08
. O 0 1.7342308922252414e-07

Four O 0 2.3687798389460113e-08
of O 0 2.5412521864609516e-08
Moroccan O 0 2.579677129688207e-07
origin O 0 8.378861493518741e-10
( O 0 4.916280924027738e-11
1 O 0 1.2491661038893653e-09
. O 0 9.475759586707877e-12
1 O 0 4.834942446407808e-10
% O 0 7.558467740587105e-12
) O 0 7.230062360440159e-13
and O 0 6.551059607978749e-12
none O 0 7.759707459920051e-11
of O 0 6.741676661370377e-10
the O 0 3.0530920014371077e-09
Yemenites O 0 9.826692348724464e-08
or O 0 6.858753842653442e-11
Iranians O 0 2.7333868501955294e-10
was O 0 3.427508499243004e-09
a O 0 3.9785036376471794e-10
carrier O 0 8.298432496722796e-10
of O 0 6.633881888262749e-09
the O 0 6.124104601212821e-08
185delAG O 0 3.3916146549017867e-06
mutation O 0 7.888892241680878e-07
. O 0 1.6817047310269118e-07

BRCA1 O 0 2.828587639669422e-05
allelic O 0 6.736342129443074e-06
patterns O 0 9.620814722666182e-08
were O 0 3.1505542619214566e-09
determined O 0 1.3732180947911843e-09
for O 0 1.30960353672549e-10
four O 0 4.636680275837968e-11
of O 0 5.726258911487037e-10
these O 0 9.546800849857817e-12
individuals O 0 1.2722355721001e-12
and O 0 1.3959569611365907e-11
for O 0 1.2682513372830329e-10
12 O 0 2.3241986113475832e-09
additional O 0 3.2979746711347957e-10
non O 0 1.0149847895490893e-07
- O 0 1.3156788547519227e-08
Ashkenazi O 0 8.828367370483647e-09
185delAG O 0 2.6523157004021414e-08
mutation O 0 3.816390758970556e-09
carriers O 0 2.603394722022756e-10
who O 0 3.1692967694674223e-10
had O 0 1.9457239375242352e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9862765073776245

Six O 0 9.255879831471248e-07
non O 0 1.3633361049869563e-05
- O 0 6.091289037613024e-07
Ashkenazi O 0 4.033379354950739e-07
individuals O 0 1.0565093938597059e-10
shared O 0 6.561211129962885e-09
the O 0 2.5319291552250434e-08
common O 0 3.5988367841355284e-08
Ashkenazi O 0 5.2850516851776774e-08
haplotype O 0 1.8985572580731969e-07
, O 0 4.7519486123803745e-09
four O 0 3.923142699591153e-09
had O 0 1.1147209377782019e-08
a O 0 3.125410374948956e-09
closely O 0 3.900852973970359e-10
related O 0 5.298692595800958e-10
pattern O 0 8.893032088508335e-08
, O 0 3.5583511137637913e-10
and O 0 1.4080310528630235e-10
the O 0 3.1245284137781937e-09
rest O 0 1.3153094169382484e-09
( O 0 1.390474801271635e-11
n O 0 9.360265895708153e-10
= O 0 4.1533473882360283e-10
6 O 0 2.3777868563001903e-09
) O 0 5.6966007432046606e-12
displayed O 0 4.185052304706005e-10
a O 0 8.373238213899015e-10
distinct O 0 4.234071315778465e-09
BRCA1 O 0 1.579342239210746e-07
allelic O 0 1.0407646868770826e-06
pattern O 0 1.069082486537809e-06
. O 0 2.428490688544116e-07

We O 0 2.9866438211456625e-08
conclude O 0 8.054376365862481e-08
that O 0 3.2599251076348423e-10
the O 0 8.06642663775392e-09
185delAG O 0 1.1601691767282318e-06
BRCA1 O 0 2.969632078020368e-07
mutation O 0 3.973083639863262e-09
occurs O 0 1.1991496684515823e-10
in O 0 4.4335334015155325e-11
some O 0 2.7141530342666975e-11
non O 0 5.1116774102411e-07
- O 0 1.649281387017254e-07
Ashkenazi O 0 9.008969925616839e-08
populations O 0 2.2345931771639016e-09
at O 0 1.351856848685884e-08
rates O 0 8.892531710991136e-10
comparable O 0 3.6948530346414543e-10
with O 0 1.123813628961523e-11
that O 0 1.3306557244963102e-10
of O 0 1.0857736043590194e-07
Ashkenazim O 0 1.6686601156834513e-05
. O 0 1.337566146730751e-07

The O 0 1.634470407907429e-07
majority O 0 4.6992840729842555e-09
of O 0 1.553086725891717e-08
Jewish O 0 1.775532254555401e-08
185delAG O 0 6.758264134987257e-07
mutation O 0 2.316552105696701e-08
carriers O 0 6.589174206261816e-10
have O 0 4.110190660044921e-11
a O 0 4.69683569814805e-10
common O 0 5.711577322209394e-10
allelic O 0 7.801686763286853e-08
pattern O 0 1.2352215605915262e-07
, O 0 5.389387269794099e-10
supporting O 0 3.9316874755890296e-10
the O 0 2.182054537058775e-09
founder O 0 2.0709853743028361e-07
effect O 0 1.9920282312568816e-08
notion O 0 3.3499500950995298e-09
, O 0 2.3595547390953264e-11
but O 0 2.8388725831912653e-12
dating O 0 1.9306709009292433e-11
the O 0 2.5731514141646983e-11
mutations O 0 4.9360186077374024e-12
origin O 0 1.5142790450381471e-12
to O 0 6.439792817926338e-13
an O 0 4.7793925934958015e-12
earlier O 0 3.718239049987915e-10
date O 0 9.725384941816628e-09
than O 0 3.3281846029131756e-11
currently O 0 2.757364059302603e-10
estimated O 0 1.1384529985392078e-09
. O 0 8.542103913100618e-09

However O 0 2.9116321798028366e-08
, O 0 1.0503214964430185e-09
the O 0 2.3496443679604795e-10
different O 0 9.295690953092794e-12
allelic O 0 3.051410857324299e-08
pattern O 0 5.1091870290065344e-08
at O 0 8.788654071167912e-08
the O 0 6.50717213446228e-09
BRCA1 O 0 4.599031377949814e-09
locus O 0 1.8582688721124896e-09
even O 0 1.5292773991593123e-11
in O 0 8.877931376161108e-12
some O 0 3.379807501577292e-12
Jewish O 0 3.3020911005543496e-10
mutation O 0 8.361428216474565e-10
carriers O 0 1.3647026564367337e-10
, O 0 1.1756443041299747e-10
might O 0 3.5934609454724153e-11
suggest O 0 1.2368271337659387e-11
that O 0 2.139250799074177e-12
the O 0 2.510862351368104e-10
mutation O 0 2.0969360969846917e-10
arose O 0 3.1274885459176005e-11
independently O 0 4.581516069301905e-11
. O 0 1.825909146102589e-10
. O 0 1.1767873786538985e-08

Crystal O 0 1.807347325666342e-05
structure O 0 1.096255800803192e-06
of O 0 2.212407025581342e-06
the O 0 4.133015318075195e-05
hemochromatosis B-Disease 1 1.0
protein O 0 2.0596475224010646e-05
HFE O 0 0.010039332322776318
and O 0 8.176745391885731e-10
characterization O 0 1.716684683295e-09
of O 0 1.3407042143143144e-09
its O 0 3.2217489787100817e-10
interaction O 0 4.5682113647416145e-10
with O 0 4.3631684376599367e-10
transferrin O 0 2.6303162030671956e-06
receptor O 0 3.3159167855956184e-07
. O 0 6.450184031336903e-08

HFE O 1 0.9988586902618408
is O 0 9.475271411929498e-08
an O 0 7.566628212885007e-09
MHC O 0 1.8380468418399687e-06
- O 0 2.2980717062637268e-07
related O 0 3.720903407611331e-08
protein O 0 1.5688515375700263e-08
that O 0 7.288916692438363e-11
is O 0 4.595965968912097e-11
mutated O 0 4.8556412363121026e-11
in O 0 4.187213770157072e-11
the O 0 2.7753754849868528e-08
iron B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.00010460659541422501

HFE O 0 0.00015361892292276025
binds O 0 1.1326554805179967e-08
to O 0 8.007863261383363e-10
transferrin O 0 7.847594218901577e-08
receptor O 0 3.072047283225743e-09
( O 0 1.4525632086037632e-10
TfR O 0 3.158823247417786e-08
) O 0 1.6507194916526302e-11
and O 0 1.3559400130480626e-11
reduces O 0 1.2837030050061315e-10
its O 0 6.088073795096349e-11
affinity O 0 2.2339316507746787e-10
for O 0 1.6489778431605373e-09
iron O 0 4.634278866433306e-06
- O 0 1.0087239843414864e-07
loaded O 0 5.11514208767494e-09
transferrin O 0 1.303380656736408e-07
, O 0 1.7302446142508643e-09
implicating O 0 2.964165446428524e-07
HFE O 0 0.0004966265987604856
in O 0 1.760469530154296e-07
iron O 0 0.001062861643731594
metabolism O 0 0.00011939233081648126
. O 0 2.1447384312978102e-07

The O 0 3.0155445074342424e-06
2 O 0 2.5698094759718515e-05
. O 0 1.363929413855658e-06

6 O 0 0.0001615892251720652
A O 0 8.36554590932792e-06
crystal O 0 6.286436018854147e-06
structure O 0 2.801401706165052e-07
of O 0 5.147668389327009e-07
HFE O 0 0.001327533507719636
reveals O 0 7.436471438637682e-09
the O 0 7.170894433805586e-10
locations O 0 2.6280371212550335e-09
of O 0 1.864344483237801e-07
hemochromatosis B-Disease 1 1.0
mutations O 0 1.550562558350066e-07
and O 0 4.542356712988749e-09
a O 0 5.791621049411333e-08
patch O 0 0.0003895148984156549
of O 0 2.1659689082298428e-05
histidines O 1 0.6934325098991394
that O 0 1.1628460416801545e-09
could O 0 3.3601102455982357e-10
be O 0 4.2727158616751026e-11
involved O 0 3.437751472379347e-11
in O 0 2.43318448722718e-10
pH O 0 3.0602998890572053e-07
- O 0 1.706458476746775e-07
dependent O 0 1.6894359688990335e-08
interactions O 0 1.4275839177457783e-08
. O 0 3.587706842722582e-08

We O 0 5.3793797860635095e-08
also O 0 2.661913134360816e-09
demonstrate O 0 5.880781195344298e-09
that O 0 6.665396568017457e-10
soluble O 0 2.825649403348507e-07
TfR O 0 1.818450073187705e-05
and O 0 2.7731529073093952e-08
HFE O 0 0.0006421243888325989
bind O 0 1.6374887223946644e-08
tightly O 0 4.838203793156026e-08
at O 0 2.2097191632042268e-08
the O 0 2.432081425141064e-09
basic O 0 2.8518329031612666e-08
pH O 0 6.692840504030073e-09
of O 0 5.1201394235533826e-09
the O 0 4.785000395912675e-09
cell O 0 7.784411337752317e-09
surface O 0 3.7466724167600773e-10
, O 0 3.987199459487556e-11
but O 0 1.78742888545802e-11
not O 0 4.201766712341737e-11
at O 0 1.1645912678659442e-08
the O 0 9.919451926521106e-09
acidic O 0 1.482059008850456e-08
pH O 0 5.8214126852362824e-08
of O 0 4.735438707825779e-08
intracellular O 0 1.1363338217051933e-06
vesicles O 0 1.6870497347554192e-05
. O 0 2.585267964150262e-07

TfR O 0 0.00047447896213270724
HFE O 0 0.00029459851793944836
stoichiometry O 0 3.199932621100743e-07
( O 0 2.7125257595628227e-09
2 O 0 2.2350674200311005e-08
1 O 0 1.2066971422086681e-08
) O 0 1.1050871155660058e-11
differs O 0 7.749645543342343e-12
from O 0 2.1839719269167723e-11
TfR O 0 1.9538120454853924e-08
transferrin O 0 7.486310238391525e-09
stoichiometry O 0 2.0393406963137295e-09
( O 0 3.066243092764154e-11
2 O 0 1.4424893501896463e-09
2 O 0 9.913584397835962e-10
) O 0 2.290642285227018e-12
, O 0 2.596687621869709e-12
implying O 0 2.0253680677040364e-11
a O 0 6.955302219585624e-12
different O 0 2.2707135921996163e-13
mode O 0 8.532377582248785e-10
of O 0 1.1091568635768212e-10
binding O 0 1.3739719084693292e-10
for O 0 7.223880521545212e-11
HFE O 0 1.739681920298608e-06
and O 0 1.0610490958073981e-10
transferrin O 0 1.5362200400659276e-08
to O 0 1.5247141049723467e-10
TfR O 0 2.584518483672582e-07
, O 0 9.666564770860475e-11
consistent O 0 6.736894930803317e-10
with O 0 2.3071126606377668e-11
our O 0 1.0747472911631917e-09
demonstration O 0 2.287232803155348e-08
that O 0 8.319521460631307e-11
HFE O 0 2.916935272878618e-06
, O 0 4.2391437582445235e-10
transferrin O 0 4.3349199785325254e-08
, O 0 4.979940348981415e-10
and O 0 7.232349163999174e-10
TfR O 0 5.404688749877096e-07
form O 0 4.322285640512291e-09
a O 0 2.6397337649086694e-08
ternary O 0 1.0659697181836236e-05
complex O 0 4.780971266882261e-06
. O 0 1.1163682955839249e-07

Identification O 0 9.784125865053284e-08
of O 0 2.5657845625914888e-08
three O 0 2.3337481946938965e-10
novel O 0 8.39594727075621e-10
mutations O 0 2.335912574480403e-10
and O 0 1.639774080408607e-11
a O 0 1.7033471855221194e-10
high O 0 1.0933536298551871e-09
frequency O 0 3.750578514427616e-09
of O 0 8.037646104241958e-09
the O 0 1.095590018707071e-08
Arg778Leu O 0 9.820415471040178e-06
mutation O 0 1.5811078668548362e-08
in O 0 1.3107537277790016e-09
Korean O 0 2.669363823315507e-07
patients O 0 2.786957886691255e-10
with O 0 7.100557364303484e-10
Wilson B-Disease 0 8.738042379263788e-05
disease I-Disease 1 0.9999266862869263
. O 0 5.558884481615678e-07

Four O 0 3.2338682842691924e-08
mutations O 0 7.501804510923193e-09
- O 0 4.1447254517379406e-08
- O 0 3.4304534324292035e-08
R778L O 0 2.055688099744657e-07
, O 0 9.088838015536282e-10
A874V O 0 1.6985797657298463e-08
, O 0 1.848705077911461e-10
L1083F O 0 3.991533326086483e-09
, O 0 2.4499293219126805e-11
and O 0 5.191169109158844e-12
2304delC O 0 7.737438467714242e-10
- O 0 2.1151810858377473e-10
- O 0 1.6453295670348922e-10
in O 0 8.44844055825078e-11
the O 0 2.5328552588632647e-09
copper O 0 1.552527635340084e-07
- O 0 2.5512518320169875e-08
transporting O 0 7.867913431880424e-09
enzyme O 0 5.972441430301956e-10
, O 0 1.275276884094012e-09
P O 0 9.902846613840666e-06
- O 0 4.856704194367012e-08
type O 0 8.657181638227485e-09
ATPase O 0 4.196716751891927e-09
( O 0 4.3705043056840864e-11
ATP7B O 0 5.173762929189252e-07
) O 0 4.649439253739951e-12
, O 0 2.370239204560476e-12
were O 0 4.126779213492471e-12
identified O 0 2.943376792297059e-11
in O 0 8.846764987247013e-11
Korean O 0 5.468482200399194e-08
Patients O 0 3.303879947402777e-10
with O 0 5.034463401720757e-10
Wilson B-Disease 0 5.201800013310276e-05
disease I-Disease 1 0.9955001473426819
. O 0 2.239937515469137e-07

Arg778Leu O 0 1.90331647900166e-05
, O 0 1.1964983670509355e-08
the O 0 3.3439238045218644e-09
most O 0 5.026736665803e-11
frequently O 0 1.7731604379234156e-11
reported O 0 3.7810723302333926e-11
mutation O 0 8.515465416136792e-11
of O 0 9.016130619876606e-10
this O 0 8.71250016576397e-11
enzyme O 0 6.408798491897016e-11
, O 0 1.7374454305829623e-11
was O 0 8.468320489285475e-10
found O 0 9.858626068282028e-12
in O 0 7.146528594598189e-12
six O 0 8.753442415354584e-11
of O 0 1.4596822639489915e-09
eight O 0 2.9444917615251143e-09
unrelated O 0 4.772822581600167e-09
patients O 0 3.367416415156477e-11
studied O 0 5.876764075374297e-10
, O 0 2.039961082000996e-11
an O 0 4.131977312388235e-12
allele O 0 9.185189414617767e-11
frequency O 0 4.256395236268418e-09
of O 0 1.2161589069137335e-08
37 O 0 1.7556810405494616e-07
. O 0 1.0802003913568115e-07

5 O 0 3.9636324800085276e-07
% O 0 4.8633577165446695e-09
, O 0 4.3280337647111367e-10
which O 0 6.723066547920098e-11
is O 0 4.576738640849065e-11
considerably O 0 3.8618958725367136e-11
higher O 0 9.68097546572011e-11
than O 0 3.4752686839389924e-12
those O 0 2.888334319980923e-12
in O 0 6.97571236885075e-11
other O 0 1.0732411487301974e-10
Asian O 0 1.854873588058581e-08
populations O 0 2.6438289335573018e-09
. O 0 1.0659773508336912e-08

The O 0 1.6280966974591138e-07
novel O 0 1.533760674021778e-08
single O 0 5.449903195398065e-09
nucleotide O 0 6.111371853023684e-09
deletion O 0 7.525622791604292e-09
, O 0 1.9251156224697752e-10
2304delC O 0 8.36589908459473e-09
, O 0 3.625959532627121e-10
was O 0 1.0951513473855812e-08
found O 0 3.2564945184887506e-10
in O 0 5.147809956085325e-10
one O 0 2.757423400723269e-09
patient O 0 2.4084985739136755e-07
. O 0 5.115252292853256e-07

Since O 0 6.30294110237628e-08
a O 0 5.9253224549138395e-09
mutation O 0 2.3690722716906976e-09
at O 0 1.8161614434575313e-08
cDNA O 0 6.884360459480376e-08
nucleotide O 0 6.348415126922191e-08
2302 O 0 2.8158410714240745e-06
( O 0 9.848143828206091e-11
2302insC O 0 4.58352245047422e-09
) O 0 2.2077359038141786e-11
had O 0 2.360789341793179e-10
been O 0 1.302963709148841e-10
previously O 0 1.6164886096348141e-09
described O 0 8.034055087868808e-10
, O 0 2.6474494471684373e-11
this O 0 6.668326914954781e-12
region O 0 1.8586542027687614e-10
of O 0 1.3705047097190004e-09
the O 0 1.9480332014154556e-08
ATP7B O 0 0.32685548067092896
gene O 0 4.51966464254383e-08
may O 0 1.3116241426303077e-09
be O 0 1.6364785915268243e-10
susceptible O 0 8.433764797644017e-09
to O 0 1.5534555586338428e-10
gene O 0 2.9769989851047285e-07
rearrangements O 0 0.00014721557090524584
causing O 0 0.0005616318667307496
Wilson B-Disease 0 4.6994402509881184e-05
disease I-Disease 1 0.9826142191886902
. O 0 1.942316458780624e-07

Disruption O 0 1.4655264749308117e-05
of O 0 3.306821838577889e-07
splicing O 0 3.0267585771071026e-07
regulated O 0 1.6828430204895994e-08
by O 0 4.0596739858678177e-10
a O 0 5.657757817800757e-09
CUG O 0 8.287808304885402e-05
- O 0 6.332463726721471e-07
binding O 0 2.9116387167960056e-07
protein O 0 2.324824208699283e-06
in O 0 1.2569986438393244e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 7.667693716939539e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999750852584839
DM B-Disease 1 1.0
) O 0 1.3711538571214987e-08
is O 0 3.2949373784951774e-10
caused O 0 1.24686427849241e-09
by O 0 6.588467271750886e-11
a O 0 1.6206037622978897e-09
CTG O 0 1.9754790514525666e-07
expansion O 0 9.797170852365866e-10
in O 0 4.18780531086238e-11
the O 0 1.4544289383966458e-10
3 O 0 4.625325455975826e-09
untranslated O 0 9.377536258625696e-08
region O 0 9.347634888356993e-10
of O 0 1.5769989758496195e-09
the O 0 7.12298557914437e-08
DM B-Disease 1 1.0
gene O 0 1.6590003042438184e-06
. O 0 1.32583267031805e-07

One O 0 6.2265019806773125e-09
model O 0 1.7872475055469295e-08
of O 0 2.455777575960383e-06
DM B-Disease 1 1.0
pathogenesis O 1 0.9997217059135437
suggests O 0 4.7275401371393855e-09
that O 0 9.560267508201825e-12
RNAs O 0 9.849802085071246e-10
from O 0 3.7898736232611085e-11
the O 0 2.7650587375305236e-10
expanded O 0 1.222033585435156e-10
allele O 0 6.754750231374729e-11
create O 0 1.5732901093024054e-11
a O 0 6.187227119536232e-11
gain O 0 2.4663968090088417e-10
- O 0 3.16143611289732e-10
of O 0 9.748655216412772e-09
- O 0 2.586853842245773e-09
function O 0 2.128626830355529e-09
mutation O 0 7.754913378121842e-11
by O 0 6.892637502420307e-12
the O 0 2.0403748135500166e-10
inappropriate O 0 5.213328380104798e-11
binding O 0 3.1525002053278683e-10
of O 0 5.624861687536509e-10
proteins O 0 2.2915959060898494e-11
to O 0 2.8628373976991028e-11
the O 0 7.826274739386463e-09
CUG O 0 0.00014517309318762273
repeats O 0 7.541625564044807e-07
. O 0 1.4200267628439178e-07

Data O 0 1.2415659966791281e-07
presented O 0 4.388311580783011e-08
here O 0 1.7258017237509193e-09
indicate O 0 1.4622117405771462e-10
that O 0 8.472108431467618e-12
the O 0 3.41382505597565e-10
conserved O 0 1.262397741896848e-08
heterogeneous O 0 9.07981956288495e-08
nuclear O 0 1.7419581581634702e-06
ribonucleoprotein O 0 2.1159462448849808e-07
, O 0 1.0697469576825824e-09
CUG O 0 3.744690957319108e-06
- O 0 7.722610106952743e-09
binding O 0 5.007832371006771e-09
protein O 0 1.7286381215342317e-09
( O 0 7.136806423613251e-11
CUG O 0 1.7810237977755605e-06
- O 0 8.191046951822045e-09
BP O 0 3.7044232126248744e-09
) O 0 5.168287672829841e-12
, O 0 7.977122434832395e-12
may O 0 3.3772831753431376e-11
mediate O 0 2.1008763617658133e-09
the O 0 3.849464302874139e-09
trans O 0 4.963851907291428e-08
- O 0 1.3420940803143822e-08
dominant O 0 3.435200213175449e-08
effect O 0 1.3999666315100967e-08
of O 0 5.528467017512639e-09
the O 0 7.399966861498797e-09
RNA O 0 1.460182232904117e-07
. O 0 1.5460141611356448e-08

CUG O 0 0.2547634541988373
- O 0 1.890588282549288e-05
BP O 0 1.6662528423694312e-06
was O 0 6.034220945139168e-08
found O 0 2.1949393691489405e-10
to O 0 1.209132707152838e-11
bind O 0 2.941143509294086e-11
to O 0 1.0391416893629213e-11
the O 0 2.037319202230492e-09
human O 0 4.98720282848808e-07
cardiac O 1 1.0
troponin O 1 0.9908419847488403
T O 0 2.219750422227662e-05
( O 0 3.2788868842281715e-11
cTNT O 0 4.4568966295344126e-09
) O 0 5.599945854251054e-12
pre O 0 1.3246429730884302e-08
- O 0 6.695467513750941e-10
messenger O 0 1.9745385881897448e-10
RNA O 0 2.1136767336393802e-10
and O 0 8.90377528650621e-12
regulate O 0 3.731679548701905e-11
its O 0 1.1846795766601304e-10
alternative O 0 5.904316147109512e-09
splicing O 0 1.840078027726122e-07
. O 0 1.8632917431204987e-08

Splicing O 0 2.5561820393704693e-07
of O 0 1.485447143068086e-07
cTNT O 0 5.519726073544007e-06
was O 0 1.3460544323606882e-06
disrupted O 0 6.862203008495271e-05
in O 0 5.837156322741066e-07
DM B-Disease 1 1.0
striated O 1 0.9923743605613708
muscle O 0 0.005416447296738625
and O 0 7.742243468555898e-08
in O 0 5.158988791720276e-09
normal O 0 2.367095142119524e-08
cells O 0 5.064251240582962e-10
expressing O 0 1.1967093982434562e-10
transcripts O 0 1.0751102230699416e-09
that O 0 3.2151850626327416e-11
contain O 0 2.738565152426986e-09
CUG O 0 7.420742349495413e-06
repeats O 0 2.595467947230645e-07
. O 0 5.610466757843824e-08

Altered O 0 1.516271197488095e-07
expression O 0 1.1966283963715796e-08
of O 0 8.60678550651528e-09
genes O 0 8.9387691692977e-10
regulated O 0 1.4319355701175596e-09
posttranscriptionally O 0 7.869297746765369e-08
by O 0 3.2946061434557805e-09
CUG O 1 0.7199540138244629
- O 0 2.041371317318408e-06
BP O 0 2.537262275836838e-07
therefore O 0 1.4343409793227124e-09
may O 0 1.970227175851491e-10
contribute O 0 6.069279800957617e-11
to O 0 1.0971955566319025e-09
DM B-Disease 1 1.0
pathogenesis O 1 0.9663000106811523
. O 0 2.0076788231904175e-08
. O 0 4.292637356684281e-08

Identification O 0 1.1945024880333222e-07
of O 0 1.8648917077257465e-08
a O 0 2.6046775847277104e-09
novel O 0 1.9949779606065476e-09
nonsense O 0 9.286488911186552e-09
mutation O 0 3.16239506803484e-10
and O 0 2.490110027897341e-11
a O 0 2.0882269524680197e-10
missense O 0 1.936477644903789e-09
substitution O 0 9.734788530835203e-10
in O 0 7.146668673518874e-11
the O 0 1.1813113820480226e-09
vasopressin O 0 3.032727846630223e-08
- O 0 2.0884600715476154e-08
neurophysin O 0 2.2203271328180563e-06
II O 0 0.023291900753974915
gene O 0 7.856722494814505e-10
in O 0 2.4174181753600088e-11
two O 0 8.864479462966646e-12
Spanish O 0 3.4496960843455327e-09
kindreds O 0 1.398834115207137e-07
with O 0 1.020010298447005e-09
familial B-Disease 1 0.999990701675415
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 6.694925559713738e-06

Familial B-Disease 1 0.9999998807907104
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 3.864443897327874e-06
FNDI B-Disease 1 1.0
) O 0 4.881570148107528e-10
is O 0 2.1373309372352267e-11
an O 0 5.057154348064863e-11
autosomal B-Disease 1 0.999710738658905
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 6.905526106493198e-07
by O 0 6.190535306593858e-10
deficiency O 0 0.0004563594120554626
in O 0 7.320760886386779e-09
the O 0 8.575373726671387e-07
antidiuretic O 0 4.980896846973337e-05
hormone O 0 2.666707246135047e-07
arginine O 0 1.6904488120417227e-07
vasopressin O 0 7.184070938137666e-08
( O 0 2.793898168373943e-10
AVP O 0 6.339352154327571e-08
) O 0 7.523670271861183e-13
encoded O 0 8.877587792492647e-13
by O 0 9.557021840578273e-12
the O 0 3.5969207612396303e-09
AVP O 0 6.555136224051239e-06
- O 0 1.0818727247396964e-07
neurophysin O 0 1.3431535990093835e-05
II O 1 0.9999927282333374
( O 0 9.079126073174848e-08
AVP O 0 0.00013802344619762152
- O 0 1.5078097703735693e-07
NPII O 0 9.881629921437707e-06
) O 0 5.949452042131043e-10
gene O 0 4.954088694830716e-09
on O 0 2.3179445918231067e-08
chromosome O 0 3.2705659691600886e-07
20p13 O 0 1.7473604430051637e-06
. O 0 1.4158078442960687e-07

In O 0 1.4456079888702789e-08
this O 0 4.23929780168919e-10
study O 0 4.405591724765401e-10
, O 0 9.925951727218774e-11
we O 0 2.615912174375179e-11
analyzed O 0 6.336526442440871e-11
two O 0 6.6239210297358575e-12
families O 0 1.5308611583247922e-12
with O 0 4.241746190403184e-11
FNDI B-Disease 1 0.9999996423721313
using O 0 9.442590043207133e-10
direct O 0 7.070136698317242e-10
automated O 0 2.2971660129655902e-08
fluorescent O 0 1.989509668121059e-09
, O 0 4.8252481871235986e-11
solid O 0 9.860855465504414e-10
phase O 0 5.8886491238752114e-09
, O 0 5.112952075614352e-11
single O 0 1.4352133370643116e-10
- O 0 1.7960966047780857e-10
stranded O 0 2.1335359867702408e-10
DNA O 0 4.957722773979434e-11
sequencing O 0 3.284845659368152e-11
of O 0 7.381299460540447e-10
PCR O 0 2.105808363239703e-07
- O 0 3.332660526211839e-06
amplified O 0 8.587023330619559e-06
AVP O 0 0.014081504195928574
- O 0 1.3901824786444195e-05
NPII O 0 0.0019184997072443366
DNA O 0 5.751984645030461e-06
. O 0 3.7907801697656396e-07

In O 0 2.083073624703502e-08
one O 0 1.1710390435126783e-09
of O 0 9.672938006133336e-09
the O 0 1.1003753463967314e-08
families O 0 2.357593460733387e-11
, O 0 7.42842592993398e-11
affected O 0 6.388063689133361e-11
individuals O 0 1.5113532170554778e-12
presented O 0 2.006992572134436e-09
a O 0 5.199031760660944e-10
novel O 0 7.343987085128845e-10
nonsense O 0 4.1788963400790635e-09
mutation O 0 2.0089487018370988e-10
in O 0 1.094887028263436e-10
exon O 0 1.2202903576508106e-08
3 O 0 1.478066558036062e-09
of O 0 5.928869062366005e-10
the O 0 5.056665086655698e-10
gene O 0 1.9803884920843728e-10
, O 0 1.2215668580839445e-11
consisting O 0 3.7627269355855475e-11
in O 0 7.6254287606492e-11
a O 0 6.412876896177977e-09
G O 0 5.780066203442402e-07
to O 0 6.760660475890745e-09
T O 0 5.210700237512356e-06
transition O 0 2.419853331048216e-07
at O 0 1.656146331185937e-08
nucleotide O 0 4.682642273934334e-09
2101 O 0 9.418172197683816e-08
, O 0 1.3240296012351216e-11
which O 0 7.948808169837285e-13
produces O 0 1.972827500321128e-12
a O 0 2.107761708225464e-11
stop O 0 1.2047847441909454e-10
signal O 0 2.09445882859427e-09
in O 0 2.2222956808093386e-10
codon O 0 7.111132127590736e-09
82 O 0 9.521647470478456e-09
( O 0 9.741512041472333e-10
Glu O 0 1.5527378991464502e-06
) O 0 3.1310953829688515e-10
of O 0 2.8582478606153927e-08
NPII O 0 0.00036065521999262273
. O 0 6.845569373581384e-07

The O 0 2.6540672024566447e-06
premature O 0 2.836718977050623e-06
termination O 0 4.5878806531618466e-08
eliminates O 0 1.585620452715375e-07
part O 0 1.7442240984877344e-09
of O 0 1.3040415858256438e-08
the O 0 1.9968480202692263e-08
C O 0 1.6337752413164708e-06
- O 0 1.987895004162965e-08
terminal O 0 2.35490489330914e-08
domain O 0 4.867754532789093e-10
of O 0 1.444375286041577e-09
NPII O 0 8.388946298509836e-06
, O 0 3.145688987071793e-10
including O 0 2.0655800681002034e-10
a O 0 5.911185985141287e-10
cysteine O 0 6.358855664245766e-10
residue O 0 9.161787772882235e-09
in O 0 3.288866123885015e-10
position O 0 1.31256516766598e-09
85 O 0 2.744515947838977e-09
, O 0 2.9504815257652695e-11
which O 0 7.240927475671288e-12
could O 0 6.636922348507435e-12
be O 0 1.2367422190517896e-11
involved O 0 1.9947208815263018e-11
in O 0 8.279629759577745e-11
the O 0 3.859926156479787e-09
correct O 0 1.2077010502764551e-08
folding O 0 6.437831245875714e-08
of O 0 3.1095478192355586e-08
the O 0 1.900205433003066e-07
prohormone O 0 0.0005516575183719397
. O 0 3.72565125417168e-07

In O 0 6.663162466225003e-09
the O 0 8.897711012423315e-09
second O 0 3.478916710264457e-08
family O 0 6.891487380755734e-10
, O 0 2.191296033515755e-10
a O 0 3.958996463993003e-10
G279A O 0 7.2061632216957605e-09
substitution O 0 4.240998219273706e-09
at O 0 1.0731747046577311e-08
position O 0 2.554516598252121e-10
- O 0 5.4285055617331324e-11
1 O 0 9.316805105186177e-10
of O 0 3.664603065445249e-10
the O 0 2.8562394116526946e-10
signal O 0 8.471248591490621e-09
peptide O 0 2.13807127558141e-09
was O 0 1.75696579507445e-09
observed O 0 2.25789456576031e-10
in O 0 3.2206903810561016e-11
all O 0 1.5060455660353966e-10
affected O 0 7.76510022948429e-10
individuals O 0 6.123091617071807e-11
. O 0 2.0612411333331693e-08

This O 0 8.309839927278517e-09
missense O 0 6.27723068191699e-07
mutation O 0 1.5489510118982253e-08
, O 0 1.111936542841363e-09
which O 0 4.254112340174032e-10
replaces O 0 3.7931160932203056e-06
Ala O 0 5.526410404854687e-06
with O 0 2.9951821023388447e-09
Thr O 0 0.0003187176480423659
, O 0 2.3370279045309417e-09
is O 0 1.013029937713128e-10
frequent O 0 1.0664120697612134e-09
among O 0 9.481938789690503e-09
FNDI B-Disease 1 1.0
patients O 0 2.0174738324385544e-07
and O 0 4.549655374663786e-10
is O 0 1.1561841761764668e-10
thought O 0 7.164246973445643e-11
to O 0 4.273088393541569e-12
reduce O 0 4.760691840743903e-10
the O 0 5.923533330509656e-10
efficiency O 0 3.588122465814081e-09
of O 0 1.1145758760378044e-09
cleavage O 0 8.277075691509594e-10
by O 0 7.881457708691642e-10
signal O 0 3.991939649949927e-07
peptidases O 0 1.1798133527918253e-06
. O 0 3.3030624901897454e-09
. O 0 3.121515845805334e-08

Genetic O 0 6.387396638274367e-07
heterogeneity O 0 1.677155864854285e-06
of O 0 1.7396040448147687e-06
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.6097563221583187e-08
due O 0 4.799481757800095e-06
to O 0 4.381952578569326e-09
TWIST O 0 1.5017269106465392e-05
and O 0 5.904363931108492e-08
FGFR O 1 0.9795249104499817
mutations O 0 4.29858175721165e-07
. O 0 1.3687738942280703e-07

Thirty O 0 3.096083673881367e-06
- O 0 4.5337208121054573e-07
two O 0 3.62963570310626e-09
unrelated O 0 3.0732092426433155e-08
patients O 0 1.942725286196989e-10
with O 0 1.5478529916124195e-11
features O 0 8.60115711986964e-09
of O 0 3.7106381114426767e-06
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.3996296505401915e-08
a O 0 2.0953429213932395e-08
common O 0 5.169393375581421e-07
autosomal B-Disease 1 0.9752130508422852
dominant I-Disease 1 0.9999505281448364
condition I-Disease 1 0.999906063079834
of O 0 0.18999376893043518
craniosynostosis B-Disease 1 1.0
and O 0 1.0653075150912628e-06
limb B-Disease 1 0.9999220371246338
anomalies I-Disease 1 0.7702208161354065
, O 0 2.6255722040957608e-09
were O 0 2.7509186595331414e-10
screened O 0 8.01466282229768e-10
for O 0 8.055947575691391e-11
mutations O 0 2.854300684695943e-10
in O 0 4.764988958960714e-10
TWIST O 0 1.1369766070856713e-06
, O 0 5.1652304655647185e-09
FGFR2 O 0 0.0008859015069901943
, O 0 6.555681775211042e-09
and O 0 7.62034702006531e-09
FGFR3 O 0 0.0007807271904312074
. O 0 6.845582447567722e-07

Nine O 0 8.712313359637847e-08
novel O 0 9.520920940531141e-09
and O 0 1.3449967806167251e-09
three O 0 2.1437307484717394e-09
recurrent O 0 2.538173612265382e-05
TWIST O 0 7.061954238452017e-05
mutations O 0 3.957867633630485e-08
were O 0 5.920532064607187e-09
found O 0 4.626390937012559e-10
in O 0 9.13991327067265e-10
12 O 0 1.2542714955543488e-07
families O 0 3.630612033234115e-09
. O 0 1.0912046377598017e-07

Seven O 0 1.87071350410406e-07
families O 0 4.75626260598716e-10
were O 0 1.9245842697301896e-09
found O 0 1.2943314475766243e-10
to O 0 2.088763884078304e-11
have O 0 7.969643694982764e-11
the O 0 4.962145805365026e-09
FGFR3 O 0 0.0029944381676614285
P250R O 0 6.263106797632645e-07
mutation O 0 2.473596438790082e-09
, O 0 3.5403954073975896e-11
and O 0 9.755224406049479e-12
one O 0 7.450884527415713e-12
individual O 0 6.147897729097407e-12
was O 0 1.2393888582096224e-08
found O 0 9.330226868886626e-11
to O 0 1.1075518106806737e-11
have O 0 2.20234819964249e-11
an O 0 1.5091741745187903e-10
FGFR2 O 0 7.539020589319989e-05
VV269 O 0 1.0096072173837456e-06
- O 0 4.2493283558542316e-07
270 O 0 1.5117461771296803e-07
deletion O 0 4.156970305757568e-07
. O 0 1.0946087769525548e-07

To O 0 2.690210498812462e-09
date O 0 1.8391166634046385e-07
, O 0 1.2370501289993285e-09
our O 0 5.146533754718519e-10
detection O 0 9.107758991433457e-09
rate O 0 7.876858609812132e-10
for O 0 3.3277738897830034e-10
TWIST O 0 1.8389062006463064e-07
or O 0 6.30348884200771e-10
FGFR O 0 1.1292856470390689e-05
mutations O 0 5.541470615710864e-10
is O 0 2.6575221190316967e-11
68 O 0 6.396565499500184e-10
% O 0 3.121874286859949e-11
in O 0 5.7355363514144386e-11
our O 0 5.904732702788351e-09
Saethre B-Disease 1 0.9999618530273438
- I-Disease 1 0.9999995231628418
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 1.2096767143532361e-08
, O 0 1.8134874157915704e-10
including O 0 3.221927169505534e-10
our O 0 2.7957920423204996e-09
five O 0 2.021696143827967e-09
patients O 0 4.3046691211579e-10
elsewhere O 0 4.5009579396904087e-10
reported O 0 2.716293301396888e-10
with O 0 1.094125567924209e-09
TWIST O 0 4.081669612787664e-05
mutations O 0 3.383769069387199e-07
. O 0 1.5708822331816918e-07

More O 0 2.1295283314515245e-09
than O 0 1.056316367709087e-09
35 O 0 8.2292723746491e-09
different O 0 5.956276027951901e-10
TWIST O 0 2.1821810491928773e-07
mutations O 0 5.129814351079176e-10
are O 0 5.784697807570405e-12
now O 0 8.148759444992493e-12
known O 0 2.371465870898426e-11
in O 0 1.994070533695158e-11
the O 0 6.605419544669644e-10
literature O 0 5.075616371641445e-09
. O 0 1.0246418824522152e-08

The O 0 1.575401142872579e-07
most O 0 1.194666587878146e-09
common O 0 7.265698598324377e-10
phenotypic O 0 1.5491016469582064e-08
features O 0 4.087146454612167e-10
, O 0 1.3817449788511293e-11
present O 0 1.2878640862079571e-11
in O 0 1.6443655465048224e-11
more O 0 7.161684982028016e-13
than O 0 2.6377554654399837e-12
a O 0 1.9286107433291733e-10
third O 0 4.356368599189864e-09
of O 0 2.7507955024930197e-08
our O 0 1.1840415758967993e-08
patients O 0 8.231242076828238e-11
with O 0 1.819705844341435e-11
TWIST O 0 1.4612436416427954e-07
mutations O 0 3.5211975002447105e-10
, O 0 4.722650395749817e-11
are O 0 1.254285911245212e-11
coronal B-Disease 0 2.6949012408294948e-06
synostosis I-Disease 0 1.307525690208422e-05
, O 0 1.8989612105002607e-09
brachycephaly B-Disease 0 9.037088602781296e-06
, O 0 6.713808620162354e-09
low B-Disease 0 6.068594302632846e-05
frontal I-Disease 1 0.9999860525131226
hairline I-Disease 1 0.9999990463256836
, O 0 1.9164173181707156e-07
facial B-Disease 1 0.9999998807907104
asymmetry I-Disease 1 0.9999916553497314
, O 0 4.3740138266912254e-07
ptosis B-Disease 1 0.9999797344207764
, O 0 2.5764311573084342e-08
hypertelorism B-Disease 0 0.00012149113899795339
, O 0 6.810488617503552e-09
broad B-Disease 0 7.823202849976951e-07
great I-Disease 0 5.417153715825407e-06
toes I-Disease 0 2.045703695330303e-06
, O 0 2.6891997517708432e-09
and O 0 8.54446646769702e-09
clinodactyly B-Disease 0 6.75774208502844e-05
. O 0 7.086167670422583e-07

Significant O 0 5.172677788323199e-07
intra O 0 2.446260623401031e-05
- O 0 1.1491246141304146e-06
and O 0 1.3926958253307475e-08
interfamilial O 0 4.755650934384903e-06
phenotypic O 0 1.7791072650652495e-06
variability O 0 1.4325323149932956e-07
is O 0 4.25553862981598e-11
present O 0 1.735100778332832e-11
for O 0 1.086414153084192e-10
either O 0 1.0081884216361914e-09
TWIST O 0 1.949821779589911e-07
mutations O 0 4.078473558877249e-09
or O 0 2.2618742434588057e-09
FGFR O 0 0.002075929893180728
mutations O 0 1.1646561404177191e-07
. O 0 8.536065365660761e-08

The O 0 2.9117989797100563e-08
overlap O 0 2.1001551608890168e-09
in O 0 2.2512892938753026e-10
clinical O 0 2.2648670494618273e-08
features O 0 1.6958080495399486e-09
and O 0 7.066533469490821e-11
the O 0 4.5458387054608806e-10
presence O 0 1.907334706841013e-10
, O 0 2.048187661141121e-11
in O 0 2.0294516067664858e-11
the O 0 8.491687908396273e-11
same O 0 3.3335528781819335e-11
genes O 0 1.1498191287984127e-11
, O 0 3.135693744590884e-12
of O 0 6.045652173325422e-11
mutations O 0 2.728994114020722e-11
for O 0 9.31082728278243e-12
more O 0 6.30274532651548e-13
than O 0 7.621411314551185e-12
one O 0 9.827241798099351e-11
craniosynostotic B-Disease 0 2.5355884645250626e-06
condition I-Disease 0 6.98324220138602e-06
- O 0 4.555293031671681e-09
such O 0 4.4600068083155975e-10
as O 0 4.415470211682759e-09
Saethre B-Disease 0 3.546038715285249e-05
- I-Disease 0 2.3251162417636806e-07
Chotzen I-Disease 0 3.5044820378971053e-06
, I-Disease 0 2.447876568112406e-09
Crouzon I-Disease 0 1.6152307580341585e-06
, I-Disease 0 2.003355481505764e-09
and I-Disease 0 1.5091231597708088e-09
Pfeiffer I-Disease 0 3.851798282994423e-06
syndromes I-Disease 0 6.770458185201278e-06
- O 0 2.8334480361991154e-07
support O 0 1.3263469433866248e-08
the O 0 7.05244573850905e-08
hypothesis O 0 2.624096495651429e-08
that O 0 1.0612980633206703e-10
TWIST O 0 9.704431391810431e-08
and O 0 8.00473243245392e-10
FGFRs O 0 8.018995458769496e-07
are O 0 2.7794820264825937e-11
components O 0 7.968493087595618e-10
of O 0 3.6237282063922294e-09
the O 0 1.112957170867901e-09
same O 0 2.0018341151395447e-10
molecular O 0 1.1882699268994656e-08
pathway O 0 1.7551327058384913e-10
involved O 0 3.186410553815411e-12
in O 0 3.91719989778494e-12
the O 0 5.125821642137929e-11
modulation O 0 3.259462033611271e-08
of O 0 4.828284545510542e-07
craniofacial O 1 1.0
and O 0 3.4923943985631922e-06
limb O 1 0.9998682737350464
development O 0 1.1057048965312788e-07
in O 0 1.5315352319689168e-09
humans O 0 2.3515911440341597e-09
. O 0 9.35553634562325e-10
. O 0 2.4755236083251475e-08

Mutation O 0 5.668853830798071e-08
analysis O 0 5.656754176186496e-09
of O 0 8.882334867621466e-08
UBE3A O 1 0.9999996423721313
in O 1 0.7344553470611572
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.00028957994072698057
. O 0 1.5456389519385993e-06

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.184290396049619e-05
AS B-Disease 1 1.0
) O 0 8.292783681973503e-10
is O 0 1.4850683183187385e-10
caused O 0 3.3573763769112475e-09
by O 0 6.047627398864108e-10
chromosome O 0 1.2686717809629044e-07
15q11 O 0 2.888710071147216e-07
- O 0 1.5715199808141733e-08
q13 O 0 1.6295841120950172e-08
deletions O 0 3.7174377465198916e-10
of O 0 7.307907612386089e-10
maternal O 0 7.137980762017548e-10
origin O 0 5.990178492121245e-11
, O 0 1.7246086503330815e-11
by O 0 1.5732098956888763e-10
paternal O 0 1.0298933972308078e-07
uniparental B-Disease 0 0.03340274468064308
disomy I-Disease 1 0.9186868071556091
( O 0 3.130913626137044e-07
UPD B-Disease 1 0.9999997615814209
) O 0 3.755494248913749e-10
15 O 0 1.1606700045518892e-09
, O 0 5.511331668817121e-11
by O 0 3.0168648135209253e-10
imprinting O 0 0.00036512588849291205
defects O 0 0.004037241451442242
, O 0 2.4486926375466567e-10
and O 0 3.898485700926102e-11
by O 0 1.1069947736253027e-10
mutations O 0 3.300365536418326e-10
in O 0 5.331864394442221e-10
the O 0 3.1504178821251116e-08
UBE3A O 0 0.019453028216958046
gene O 0 3.8565806903534394e-07
. O 0 5.2948490036897056e-08

UBE3A O 0 0.013161774724721909
encodes O 0 1.0696443268898292e-06
a O 0 3.7642945471816347e-07
ubiquitin O 0 5.263594289317552e-07
- O 0 3.0127569061733084e-07
protein O 0 9.860676186690398e-08
ligase O 0 1.0407259942724068e-08
and O 0 6.380310724196647e-10
shows O 0 1.95082190401763e-08
brain O 0 3.6538838230626425e-06
- O 0 3.522591640603423e-08
specific O 0 8.25201684762078e-09
imprinting O 0 7.767692295601591e-06
. O 0 1.5506898876083142e-07

Here O 0 1.9168632547916786e-07
we O 0 4.197629355218169e-09
describe O 0 7.552051428660889e-09
UBE3A O 0 3.907836799044162e-05
coding O 0 8.262239248324477e-07
- O 0 3.234954348840802e-08
region O 0 7.843251381700611e-09
mutations O 0 3.9273928553740234e-10
detected O 0 2.334865911723938e-10
by O 0 3.825671723856061e-11
SSCP O 0 2.439789341224241e-06
analysis O 0 3.955705207836502e-10
in O 0 3.766182365971815e-10
13 O 0 2.638988760850225e-08
AS B-Disease 1 0.9998912811279297
individuals O 0 8.0309404959511e-11
or O 0 6.841784916389315e-10
families O 0 4.311160040071371e-10
. O 0 6.34220640449712e-08

Two O 0 1.818525419139405e-08
identical O 0 3.305062179492779e-08
de O 0 3.5292200664116535e-06
novo O 0 7.414443530251447e-07
5 O 0 1.947907435351226e-07
- O 0 2.1797344373908345e-08
bp O 0 8.06648792206488e-09
duplications O 0 2.2518069187071887e-08
in O 0 3.2253906212531547e-09
exon O 0 2.8877627755719004e-07
16 O 0 8.125370953848687e-08
were O 0 1.4742382425936285e-08
found O 0 1.4780503043709814e-08
. O 0 6.281830167154112e-08

Among O 0 1.3276174826160059e-08
the O 0 2.067982762810061e-08
other O 0 3.5283170829458754e-10
11 O 0 1.1881656547529929e-08
unique O 0 1.0090849267285762e-09
mutations O 0 4.4281522892930525e-10
, O 0 2.4372995288679533e-10
8 O 0 2.5798684077926737e-08
were O 0 1.0406699946230447e-09
small O 0 1.1446971842632436e-10
deletions O 0 2.1887437695600198e-10
or O 0 1.1579739944700407e-10
insertions O 0 2.558365075344682e-09
predicted O 0 4.0325133454643947e-08
to O 0 1.8050773376021567e-10
cause O 0 6.00781930870653e-08
frameshifts O 0 7.877699317759834e-06
, O 0 3.2201147304178335e-10
1 O 0 7.983253169641102e-09
was O 0 1.5265161357191914e-09
a O 0 5.960205246013928e-11
mutation O 0 1.497134707872938e-11
to O 0 2.735157369690433e-12
a O 0 1.1207446776184682e-10
stop O 0 5.502081013020188e-10
codon O 0 9.52057099823378e-10
, O 0 1.996955552308055e-11
1 O 0 1.2304565144560797e-09
was O 0 9.474974138612424e-10
a O 0 1.254097520275721e-10
missense O 0 9.70642233255603e-10
mutation O 0 3.2442548647537706e-11
, O 0 5.5545654881195006e-12
and O 0 6.846686412265157e-12
1 O 0 9.588696947560038e-09
was O 0 6.4554250833737115e-09
predicted O 0 3.746831733764111e-09
to O 0 1.6030786073595316e-11
cause O 0 6.474928926358814e-10
insertion O 0 2.950443778182432e-10
of O 0 6.8395835661760884e-09
an O 0 8.392936901024939e-10
isoleucine O 0 1.7567508621141315e-06
in O 0 1.4307207640840147e-09
the O 0 8.533407758193334e-09
hect O 0 3.553519434262853e-07
domain O 0 4.558083244177169e-09
of O 0 7.29060678494875e-09
the O 0 1.7079523573215738e-08
UBE3A O 0 8.710020665603224e-06
protein O 0 1.420317974343277e-09
, O 0 3.1789276072613504e-11
which O 0 3.8983720765384255e-12
functions O 0 3.547474813903051e-10
in O 0 8.249808614024801e-10
E2 O 0 3.7999229789420497e-06
binding O 0 1.188485310166243e-08
and O 0 1.1390025589363972e-09
ubiquitin O 0 6.152308174023347e-08
transfer O 0 6.10381363230772e-08
. O 0 6.653297646153078e-08

Eight O 0 9.429334824062607e-08
of O 0 2.4381156649155855e-08
the O 0 1.0604169098371585e-08
cases O 0 3.779826729388702e-10
were O 0 5.534794844663793e-10
familial O 0 3.822511729367761e-08
, O 0 6.678809727489465e-10
and O 0 1.4719186980372e-10
five O 0 9.187839933311182e-10
were O 0 3.502718115555581e-09
sporadic O 0 2.411712330285809e-06
. O 0 2.0881101647773903e-07

In O 0 9.922176857912746e-09
two O 0 7.252684008918209e-10
familial O 0 2.81734571672132e-07
cases O 0 1.5068681857854926e-09
and O 0 2.451529257374574e-10
one O 0 8.372595672323513e-11
sporadic O 0 3.1750423090670665e-07
case O 0 2.397949394605803e-09
, O 0 2.155291362049283e-10
mosaicism O 0 3.676389894735621e-07
for O 0 1.0706430186857574e-09
UBE3A O 0 1.5467963748960756e-05
mutations O 0 2.157582307260597e-10
was O 0 3.5698399791783686e-10
detected O 0 1.0534889627322741e-10
in O 0 1.0031846880975692e-11
the O 0 2.397481657645528e-10
mother O 0 9.73277916593851e-11
of O 0 3.2397937665962218e-09
three O 0 6.590736845168976e-09
AS B-Disease 1 1.0
sons O 0 2.0221866847691672e-08
, O 0 9.627869335115946e-11
in O 0 4.9241732219540424e-11
the O 0 7.363820109240748e-10
maternal O 0 3.154462691057347e-09
grandfather O 0 2.0312429516167185e-09
of O 0 1.6366238142495604e-08
two O 0 9.52296907996697e-10
AS B-Disease 1 0.9999995231628418
first O 0 8.01095367819471e-09
cousins O 0 9.813442281014773e-10
, O 0 6.613547903766559e-11
and O 0 2.737648302497675e-11
in O 0 2.0167652270419723e-10
the O 0 3.819470961730076e-09
mother O 0 7.845701310849051e-10
of O 0 4.198120251430737e-08
an O 0 1.643439873078023e-08
AS B-Disease 1 1.0
daughter O 0 1.7991710592468735e-06
. O 0 7.635233032488031e-07

The O 0 1.4802735925911747e-08
frequencies O 0 3.766010003847242e-10
with O 0 1.7511060310115845e-11
which O 0 2.0014857826655685e-11
we O 0 1.7143108113626404e-11
detected O 0 9.763867492296185e-11
mutations O 0 5.968916333420893e-12
were O 0 1.3160407659473794e-11
5 O 0 1.5491090354924353e-10
( O 0 2.109461910704269e-12
14 O 0 8.567386383662168e-11
% O 0 4.348433939316276e-12
) O 0 2.932379816397712e-13
of O 0 2.8363629153704828e-11
35 O 0 5.870106484229254e-11
in O 0 1.1585146904302679e-11
sporadic O 0 3.435886686276035e-09
cases O 0 1.661364101845919e-11
and O 0 2.0380711007739194e-11
8 O 0 2.0161547986674577e-09
( O 0 5.388631381386677e-12
80 O 0 8.972927956207855e-11
% O 0 1.6334092065029004e-11
) O 0 2.5417172706820867e-12
of O 0 1.8277734881166907e-10
10 O 0 3.934515768744262e-10
in O 0 1.4056188157862692e-10
familial O 0 5.518261758652443e-08
cases O 0 9.919446375405983e-10
. O 0 1.7380903383212853e-09
. O 0 3.096964107385247e-08

The O 0 2.1960819140076637e-05
hemochromatosis B-Disease 1 1.0
845 O 0 4.264802555553615e-06
G O 0 4.943481599184452e-06
- O 0 1.1140433997525179e-07
- O 0 2.9074257668071368e-08
> O 0 4.3404050131812255e-08
A O 0 7.146566893823092e-09
and O 0 4.831962260865019e-11
187 O 0 2.4444693491609826e-10
C O 0 8.193797640387857e-09
- O 0 6.035139943350032e-09
- O 0 1.0810822459461633e-08
> O 0 5.600106689485074e-08
G O 0 1.7607548841169773e-07
mutations O 0 8.037396304061417e-10
: O 0 2.1024777405176387e-11
prevalence O 0 2.86363222024022e-09
in O 0 4.01312559572542e-11
non O 0 4.361034910971284e-08
- O 0 3.562259109912702e-08
Caucasian O 0 8.830105713286684e-08
populations O 0 2.919233921261366e-08
. O 0 2.6829148680462822e-08

Hemochromatosis B-Disease 1 0.9999796152114868
, O 0 3.13951574071325e-07
the O 0 2.797938577714376e-05
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999996423721313
, O 0 1.0336774103336666e-08
leads O 0 5.9892477644041264e-09
, O 0 1.6042049633124833e-10
if O 0 1.3612398708229279e-10
untreated O 0 5.9110792705041604e-08
, O 0 3.27399982125165e-11
to O 0 9.129437483768044e-11
progressive O 1 0.6746363043785095
iron B-Disease 1 0.9975842237472534
overload I-Disease 0 0.035836152732372284
and O 0 5.658515789264129e-08
premature B-Disease 0 3.7023808090452803e-06
death I-Disease 0 1.0672110875020735e-06
. O 0 9.415154522685043e-08

The O 0 2.4747461793594994e-05
hemochromatosis B-Disease 1 1.0
gene O 0 1.670615688453836e-06
, O 0 9.12566910926671e-09
HFE O 0 0.0003322670527268201
, O 0 9.339490292248342e-10
recently O 0 1.66738478579731e-09
has O 0 2.1863851007442037e-11
been O 0 1.9187179622903727e-11
identified O 0 1.4132958692236741e-11
, O 0 8.477167752485304e-12
and O 0 1.3659181424818811e-11
characterization O 0 3.3533240073602144e-10
of O 0 1.5727995572589748e-09
this O 0 3.148352412107869e-11
gene O 0 2.4603402648537553e-10
has O 0 2.8440700315657264e-12
shown O 0 2.2314422445240956e-12
that O 0 3.642305641121668e-13
it O 0 3.0183277752171556e-13
contains O 0 2.824177306945397e-12
two O 0 6.680710130067824e-13
mutations O 0 6.953719826514881e-13
that O 0 8.71832662487082e-13
result O 0 1.579599090417716e-10
in O 0 2.493623640908993e-10
amino O 0 6.262587670669006e-10
acid O 0 2.7975882721520406e-10
substitutions O 0 1.9569550424591853e-09
- O 0 4.854498136808161e-09
cDNA O 0 7.171965688002047e-09
nucleotides O 0 3.984594321160273e-10
845 O 0 1.0730411004189477e-09
G O 0 2.467039017517436e-08
- O 0 2.5762934896533807e-08
- O 0 2.0758786689611952e-08
> O 0 2.9291784997553805e-08
A O 0 8.669145401540845e-09
( O 0 4.601489762140476e-12
C282Y O 0 3.0438396247944866e-10
) O 0 8.927424229553116e-13
and O 0 2.7967853727384195e-12
187 O 0 8.698751441382768e-11
C O 0 5.931496183109175e-09
- O 0 8.421516817236352e-09
- O 0 2.103912954964926e-08
> O 0 7.853793704271084e-08
G O 0 3.742391641026188e-07
( O 0 1.1188058257616262e-09
H63D O 0 4.789888407685794e-06
) O 0 8.210564450550351e-10
. O 0 4.699293398857662e-09

Although O 0 2.2721660570823587e-05
hemochromatosis B-Disease 1 1.0
is O 0 5.230175403880821e-09
common O 0 6.559268128647489e-10
in O 0 1.566027724164698e-10
Caucasians O 0 1.1274737587996242e-08
, O 0 1.250552855713849e-10
affecting O 0 3.9842293353409275e-10
> O 0 6.478045655455844e-09
= O 0 1.2242855618183057e-09
1 O 0 1.4522045788112337e-08
/ O 0 2.1607999833861413e-09
300 O 0 9.640506275221394e-12
individuals O 0 2.0119710476655672e-13
of O 0 9.515047083574757e-11
northern O 0 8.309186672050828e-10
European O 0 4.254810392900765e-10
origin O 0 3.013895383263687e-11
, O 0 1.2492386465556837e-11
it O 0 2.0217007321715608e-12
has O 0 3.731378921123518e-12
not O 0 1.6111700732249212e-12
been O 0 2.5672687933853133e-11
recognized O 0 1.269679500426335e-10
in O 0 6.397513768741092e-11
other O 0 6.036595529002042e-11
populations O 0 3.243590063206625e-09
. O 0 1.083751755004414e-08

The O 0 3.389717662116709e-08
present O 0 9.733935879552291e-10
study O 0 1.300994312281034e-10
used O 0 4.441625192641574e-11
PCR O 0 4.166313960496382e-09
and O 0 3.841906792700911e-10
restriction O 0 1.3945565591200193e-08
- O 0 4.262049380088229e-09
enzyme O 0 5.517884413275276e-11
digestion O 0 5.276595271830331e-10
to O 0 2.8056652053715103e-12
analyze O 0 1.3714891201888069e-11
the O 0 1.91840692637113e-11
frequency O 0 7.13291439802255e-11
of O 0 1.3677906030018505e-10
the O 0 2.4391505482057596e-10
845 O 0 1.507230229513823e-09
G O 0 1.846867192512036e-08
- O 0 1.2100735524711581e-08
- O 0 8.555735675486176e-09
> O 0 9.656973887217646e-09
A O 0 2.3537856108646338e-09
and O 0 1.4882801588345096e-11
187 O 0 7.646196870103594e-11
C O 0 2.370898366521601e-09
- O 0 9.767671116378551e-10
- O 0 2.0614838724952733e-09
> O 0 1.4295703287814376e-08
G O 0 1.871151944499161e-08
mutations O 0 2.2654264575372451e-10
in O 0 9.359457653346226e-11
HLA O 0 8.717561783555539e-09
- O 0 3.751878807634057e-10
typed O 0 7.1078032348737e-11
samples O 0 6.076956212547335e-12
from O 0 1.1250060778789095e-11
non O 0 2.476458504929724e-08
- O 0 1.003438843127924e-08
Caucasian O 0 1.5564584288085825e-08
populations O 0 5.68885438756439e-10
, O 0 9.23076476366802e-11
comprising O 0 5.388513524273719e-10
Australian O 0 8.049166666523888e-09
Aboriginal O 0 8.81668871244301e-09
, O 0 2.0779920839597565e-10
Chinese O 0 7.770997179079586e-10
, O 0 5.451604723205605e-10
and O 0 3.4816964866735134e-09
Pacific O 0 3.081866680076928e-06
Islanders O 0 6.782348918932257e-06
. O 0 4.842090106649266e-07

Results O 0 6.240010463898216e-08
showed O 0 5.519553258892529e-09
that O 0 6.804781738090071e-11
the O 0 2.5572233219861573e-09
845 O 0 2.1983520781532206e-08
G O 0 4.813916802959284e-07
- O 0 1.5286154564364551e-07
- O 0 9.013181312411689e-08
> O 0 7.032404880646936e-08
A O 0 7.298745607897672e-09
mutation O 0 1.2240210234271132e-10
was O 0 1.0371561248723182e-10
present O 0 1.1126710447104116e-12
in O 0 8.203382634644485e-13
these O 0 1.8267252131515949e-13
populations O 0 2.0276942017810606e-12
( O 0 6.520151307970803e-14
allele O 0 7.013098326895395e-13
frequency O 0 4.1192948357915427e-11
0 O 0 9.345472312682901e-11
. O 0 4.918995983108077e-13
32 O 0 8.867268898316016e-12
% O 0 1.017647663185961e-12
) O 0 2.0479432494453775e-13
, O 0 7.311996060715975e-13
and O 0 1.963540007671183e-12
, O 0 3.4232436763731444e-12
furthermore O 0 1.559237287895865e-11
, O 0 2.2825738694998154e-12
it O 0 8.102631521463011e-13
was O 0 4.1096048786215533e-10
always O 0 1.984823069789421e-11
seen O 0 2.5723957686185628e-11
in O 0 3.896142089510057e-12
conjunction O 0 2.5761925925849027e-10
with O 0 7.797540391152324e-11
HLA O 0 6.862387635919731e-07
haplotypes O 0 2.5867912256671843e-08
common O 0 4.104121764658686e-10
in O 0 6.092220478093324e-11
Caucasians O 0 1.4464209829867514e-09
, O 0 1.9708387699601815e-11
suggesting O 0 5.5104594498534e-11
that O 0 1.873763297299824e-11
845 O 0 5.218308007925998e-09
G O 0 7.3436813181615435e-06
- O 0 1.8375108993495815e-05
- O 0 1.2820845768146683e-05
> O 0 5.630492978525581e-06
A O 0 2.1485953993760631e-07
may O 0 1.0198289435159325e-10
have O 0 1.898495033056391e-12
been O 0 4.661489076684955e-12
introduced O 0 1.5891203283824318e-11
into O 0 8.858187078818192e-13
these O 0 4.2314147520074175e-13
populations O 0 6.171065394799946e-12
by O 0 1.5218661400528966e-11
Caucasian O 0 8.503998394360224e-09
admixture O 0 2.355938875098218e-07
. O 0 9.540647738504049e-08

187 O 0 3.1915209319777205e-07
C O 0 6.279164495026635e-07
- O 0 1.1880369754635467e-07
- O 0 8.278883001366921e-08
> O 0 1.6792206736226944e-07
G O 0 2.2392862319975393e-07
was O 0 2.9970450565741658e-09
present O 0 3.04799796513322e-11
at O 0 1.609798683244179e-10
an O 0 1.309869638969896e-12
allele O 0 1.389403782997567e-11
frequency O 0 2.6814594988877616e-10
of O 0 2.0316111015716842e-09
2 O 0 3.3286855227743217e-07
. O 0 2.6398696562068835e-08

68 O 0 1.1421442422943073e-06
% O 0 5.005597270013595e-09
in O 0 5.614185782931713e-10
the O 0 1.2438688967719713e-09
two O 0 5.8192173302273886e-11
populations O 0 8.813014901187799e-11
analyzed O 0 1.2087206235911196e-10
( O 0 5.892508009308628e-11
Australian O 0 4.8362451821049035e-09
Aboriginal O 0 5.050825979679985e-09
and O 0 3.6309633077991066e-10
Chinese O 0 5.428945737406821e-09
) O 0 1.0210925438514096e-09
. O 0 2.6570448952156767e-08

In O 0 5.86735904306579e-09
the O 0 6.739211411144197e-09
Australian O 0 1.3886084282432876e-08
Aboriginal O 0 1.6434735794490507e-09
samples O 0 2.7196056517908573e-10
, O 0 1.995094922602192e-10
187 O 0 1.3291168166063017e-09
C O 0 3.162699968584093e-08
- O 0 3.5347870408486415e-08
- O 0 6.955699660693426e-08
> O 0 3.4371279866718396e-07
G O 0 2.679223825907684e-06
was O 0 2.7014314341045065e-08
found O 0 8.178686894400045e-12
to O 0 6.403281767666802e-13
be O 0 1.546046385532407e-12
associated O 0 3.640545157002073e-11
with O 0 6.880018776911356e-11
HLA O 0 7.41678059057449e-06
haplotypes O 0 2.295549883513104e-08
common O 0 2.599737647379641e-10
in O 0 7.8375611556325e-11
Caucasians O 0 1.8469471507742696e-09
, O 0 8.208520668739894e-12
suggesting O 0 1.2686016299945369e-11
that O 0 9.94293839970406e-13
it O 0 2.327922143247063e-12
was O 0 3.667407211249696e-10
introduced O 0 6.004637065348817e-11
by O 0 1.875096952708155e-11
recent O 0 6.229931570622682e-10
admixture O 0 8.47938324000097e-08
. O 0 6.312313161060956e-08

In O 0 1.4873942966175946e-08
the O 0 3.985211716184267e-09
Chinese O 0 8.089194314386816e-10
samples O 0 9.76021694021334e-11
analyzed O 0 2.3365631651728336e-10
, O 0 6.32713048620559e-11
187 O 0 3.187252684000441e-10
C O 0 1.0413852891133502e-08
- O 0 6.7665948400019715e-09
- O 0 9.949011392507146e-09
> O 0 3.988673569210732e-08
G O 0 2.8982691446799436e-07
was O 0 1.1327354165757697e-08
present O 0 6.925216650133237e-11
in O 0 7.600162860166293e-11
association O 0 2.3579541097440426e-10
with O 0 6.043031960251133e-12
a O 0 2.569964518972512e-10
wide O 0 4.432081368577201e-10
variety O 0 3.885311516960144e-10
of O 0 2.9435931470089827e-09
HLA O 0 1.743311202062614e-07
haplotypes O 0 4.5214556543271556e-09
, O 0 5.6950610893835574e-11
showing O 0 2.6339219694193616e-10
this O 0 5.849370900840034e-12
mutation O 0 3.985260732530804e-11
to O 0 2.105253471551549e-12
be O 0 5.69319027685089e-12
widespread O 0 3.587438346386307e-09
and O 0 4.970381745073027e-11
likely O 0 3.237455442617332e-11
to O 0 6.294927686750773e-12
predate O 0 4.531911734773075e-09
the O 0 4.3895206913724394e-10
more O 0 9.838545776685859e-12
genetically O 0 2.7589228679403277e-09
restricted O 0 8.129807244072751e-11
845 O 0 7.993701811592757e-10
G O 0 3.1815895340514544e-07
- O 0 1.316115231020376e-06
- O 0 1.3691802678295062e-06
> O 0 1.29408306293044e-06
A O 0 2.3681796790242515e-07
mutation O 0 8.075281243691279e-08
. O 0 1.4289597061178938e-08

Genotype O 0 3.538768942235038e-05
- O 0 1.2181182000858826e-06
phenotype O 0 2.1649101711318508e-07
correlations O 0 2.041954161313697e-07
in O 0 1.7292465770424315e-07
attenuated B-Disease 1 0.9999746084213257
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 0.0002391276357229799

Germ O 0 0.0004620597464963794
- O 0 9.247216326002672e-07
line O 0 7.020838665994233e-08
mutations O 0 3.968441131263489e-09
of O 0 7.114239419792057e-09
the O 0 7.812971603016194e-09
tumor B-Disease 0 2.9089515010127798e-06
suppressor O 0 1.1466962860140484e-05
APC O 0 1.8161412640438357e-07
are O 0 3.4824167854941024e-11
implicated O 0 2.37749198106485e-09
in O 0 1.1951959422162872e-08
attenuated B-Disease 1 0.9999992847442627
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 0.005120177287608385
AAPC B-Disease 1 1.0
) O 0 3.457737707268649e-10
, O 0 1.059736465247596e-10
a O 0 6.852755585207149e-10
variant O 0 3.6398705560714006e-07
of O 0 1.13208716356894e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 7.097661728039384e-05
FAP B-Disease 0 0.0002717016905080527
) O 0 1.9642781623474548e-08
. O 0 1.1614262263037745e-07

AAPC B-Disease 1 0.9999998807907104
is O 0 4.230357841805699e-09
recognized O 0 7.184996486664375e-10
by O 0 3.005611731721203e-11
the O 0 1.5784334950197376e-10
occurrence O 0 8.861603006948826e-09
of O 0 1.2913785596424532e-08
< O 0 5.344148803487769e-07
100 O 0 1.488915657432699e-08
colonic B-Disease 0 2.020348620135337e-05
adenomas I-Disease 0 6.966069122427143e-06
and O 0 3.360973999111394e-11
a O 0 7.440068006125955e-11
later O 0 9.695357849892616e-10
onset O 1 0.9999978542327881
of O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.293334189218399e-09
age O 0 9.241256648806484e-09
> O 0 5.852306728115764e-08
40 O 0 5.629111621274774e-10
years O 0 2.768679174813826e-10
) O 0 1.0892838020470919e-10
. O 0 4.24077972738246e-09

The O 0 8.151246788656863e-08
aim O 0 6.29324645728957e-08
of O 0 2.2212034433977124e-09
this O 0 2.942091709146055e-11
study O 0 3.9057125589270214e-11
was O 0 5.619156806524472e-10
to O 0 4.9334047264038006e-11
assess O 0 5.575441885952159e-09
genotype O 0 1.1376508979310529e-07
- O 0 1.1272280886487351e-07
phenotype O 0 5.1267385003939125e-08
correlations O 0 7.794339751399093e-08
in O 0 1.4158888461679453e-07
AAPC B-Disease 1 1.0
families O 0 4.079367954545887e-09
. O 0 5.058695862203422e-08

By O 0 1.4792208347103042e-08
protein O 0 2.750480732061078e-08
- O 0 2.378708607864155e-08
truncation O 0 2.0463005512283416e-06
test O 0 9.329651362577351e-08
( O 0 3.7714517620024424e-10
PTT O 0 1.2178122688055737e-07
) O 0 2.126855289108498e-11
assay O 0 4.0942155221657117e-10
, O 0 1.0655773138856794e-11
the O 0 6.652210032820349e-11
entire O 0 2.149031230747056e-10
coding O 0 7.59897811342114e-10
region O 0 2.7420288262192116e-10
of O 0 2.7958171888720074e-10
the O 0 2.386009834154379e-09
APC B-Disease 0 1.653413050917152e-08
gene O 0 2.5348112497880493e-10
was O 0 7.151662595461517e-10
screened O 0 9.728849947876483e-10
in O 0 4.356189714505021e-11
affected O 0 6.851549189113015e-11
individuals O 0 3.022362091500974e-12
from O 0 6.106241623449193e-10
11 O 0 4.9703252443578094e-05
AAPC B-Disease 1 1.0
kindreds O 0 1.8173233911511488e-05
, O 0 3.888425137432705e-10
and O 0 5.4506871238757526e-11
their O 0 6.815419756334151e-11
phenotypic O 0 6.609672453805615e-08
differences O 0 1.3754829497614196e-09
were O 0 1.6879148079240736e-09
examined O 0 3.21295239302799e-08
. O 0 4.877220050047981e-08

Five O 0 7.521722267256337e-08
novel O 0 5.264728386578099e-08
germ O 0 1.4602488590753637e-05
- O 0 6.357539064083539e-07
line O 0 2.3753271705118095e-07
APC B-Disease 0 1.6475458153308864e-07
mutations O 0 5.097744448789854e-10
were O 0 5.541766490146927e-10
identified O 0 7.423868741973649e-10
in O 0 1.6205140562775e-09
seven O 0 3.0998005939864015e-08
kindreds O 0 4.849362812819891e-05
. O 0 1.1889193274328136e-06

Mutations O 0 4.7165364946977206e-08
were O 0 4.464996372632868e-09
located O 0 1.3496405104618248e-09
in O 0 3.256207109503251e-11
three O 0 1.0936654359916531e-11
different O 0 4.151386699680071e-12
regions O 0 5.376963874148544e-10
of O 0 9.486425867066828e-09
the O 0 6.79726781527279e-08
APC B-Disease 0 1.1353704110206309e-07
gene O 0 3.4703376283751197e-10
( O 0 7.347327607432064e-12
1 O 0 1.967757068399578e-09
) O 0 2.4559633840515183e-12
at O 0 2.771669560530654e-10
the O 0 2.0680360202085524e-10
5 O 0 6.295570176284571e-10
end O 0 7.045354299961559e-10
spanning O 0 2.920563346719973e-09
exons O 0 1.6642717426407216e-08
4 O 0 2.5706423656401967e-09
and O 0 7.493902720590029e-11
5 O 0 9.951396373608645e-10
, O 0 3.3073082467138804e-11
( O 0 2.7612823052386437e-12
2 O 0 2.680257682463605e-10
) O 0 1.0758183623463258e-12
within O 0 1.8649920149882426e-11
exon O 0 5.717790130255196e-10
9 O 0 5.846543804644e-10
, O 0 4.927571805452002e-12
and O 0 1.9715108452028618e-12
( O 0 1.5710222836182175e-12
3 O 0 3.549613381004235e-10
) O 0 3.4604656379971788e-12
at O 0 6.89891810345955e-10
the O 0 6.245601258392242e-10
3 O 0 9.075711737693837e-09
distal O 0 1.6630302690501253e-09
end O 0 1.2987636521799573e-09
of O 0 9.83636061491211e-10
the O 0 2.4357487138360057e-09
gene O 0 1.3960308464788795e-08
. O 0 1.3194886960832264e-08

Variability O 0 4.994575419914327e-07
in O 0 1.0496866709175379e-09
the O 0 8.985949206952171e-10
number O 0 3.0089646330111464e-09
of O 0 0.0036872851196676493
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 0.005314442794770002
most O 0 2.9802901813091864e-10
apparent O 0 5.017220416903001e-09
in O 0 4.6164898293010737e-11
individuals O 0 2.907851097497943e-13
with O 0 4.495290858302914e-12
mutations O 0 2.3071224097837018e-10
in O 0 2.0975800263389743e-10
region O 0 6.600977098258909e-09
1 O 0 4.027886575386219e-07
, O 0 3.044298146903657e-10
and O 0 1.8042041194377134e-09
upper O 0 0.02125702053308487
- O 0 4.849182369071059e-05
gastrointestinal O 1 0.968679666519165
manifestations O 1 0.9335464239120483
were O 0 4.027791433713901e-09
more O 0 1.3873884679993509e-11
severe O 0 1.8443769249643083e-06
in O 0 2.91690005482792e-09
them O 0 1.279638173201647e-09
. O 0 5.838849403971835e-08

In O 0 3.949201410335945e-09
individuals O 0 2.939332111040471e-11
with O 0 4.5294962225383983e-11
mutations O 0 2.77660616720965e-10
in O 0 4.3119990911222317e-10
either O 0 6.576305056071874e-10
region O 0 1.4829723227194336e-08
2 O 0 5.648896816978777e-08
or O 0 7.975483468092293e-11
region O 0 8.682610741495012e-10
3 O 0 2.641434626582395e-09
, O 0 1.433688584517867e-11
the O 0 4.035330750107313e-11
average O 0 1.3198717292717266e-11
number O 0 1.097550869633146e-10
of O 0 1.4511552848262e-08
adenomas B-Disease 0 8.881425310391933e-05
tended O 0 7.440071336795029e-10
to O 0 2.183551256473848e-11
be O 0 4.9519770228823035e-11
lower O 0 3.814372706578695e-10
than O 0 1.4484119199159595e-12
those O 0 1.0328397208672624e-12
in O 0 5.7504530651120156e-12
individuals O 0 1.5015457410436084e-13
with O 0 1.2347357294592576e-12
mutations O 0 1.135210155045474e-11
in O 0 2.112498717621314e-11
region O 0 2.061459197788551e-10
1 O 0 3.3180025393875212e-09
, O 0 8.54872422850761e-12
although O 0 1.0205775460847555e-11
age O 0 3.1519412080349696e-10
at O 0 1.0242062309373523e-08
diagnosis O 0 8.751469238177378e-08
was O 0 1.3914452701158098e-08
similar O 0 7.601374640842096e-09
. O 0 3.154374184077824e-08

In O 0 3.780581039336539e-07
all O 0 5.994622256366711e-07
AAPC B-Disease 1 1.0
kindreds O 0 1.6004822100512683e-05
, O 0 2.9054063599431856e-09
a O 0 2.2902961749338147e-09
predominance O 0 3.7530853091993777e-07
of O 0 3.0245591915445402e-06
right O 1 0.992905855178833
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 0.006664844695478678
rectal B-Disease 1 1.0
polyp I-Disease 1 0.9999423027038574
sparing O 0 5.398342182161286e-07
was O 0 1.7928371676134702e-07
observed O 0 7.255111711401696e-08
. O 0 2.581413838242952e-08

No O 0 9.48224351304816e-06
desmoid B-Disease 1 0.9995009899139404
tumors I-Disease 1 1.0
were O 0 6.85082781615165e-08
found O 0 1.623598588906816e-09
in O 0 1.3815645294457113e-09
these O 0 1.7956933717755419e-09
kindreds O 0 1.9211294784327038e-05
. O 0 1.9220765068439505e-07

Our O 0 6.262330742856648e-08
data O 0 3.886795774121765e-09
suggest O 0 2.5161311922872187e-10
that O 0 1.8523890754629235e-11
, O 0 4.88665719000636e-10
in O 0 1.0861252341953787e-08
AAPC B-Disease 1 1.0
families O 0 5.287453114233287e-11
, O 0 2.657993616872467e-11
the O 0 7.76782180245128e-11
location O 0 1.3738888915426628e-09
of O 0 4.091188721133676e-09
the O 0 5.161698268807413e-08
APC B-Disease 0 1.2120275414417847e-06
mutation O 0 1.9067035950115496e-08
may O 0 5.7565956446126165e-09
partially O 0 8.034920995214634e-08
predict O 0 6.7816086080085825e-09
specific O 0 1.424482420908646e-09
phenotypic O 0 1.2364619124127785e-06
expression O 0 1.2579612018726039e-07
. O 0 4.9743729135798276e-08

This O 0 2.6780680784099786e-08
should O 0 1.4251075874938124e-09
help O 0 6.616487219224254e-11
in O 0 4.9677754965227194e-11
the O 0 1.1289967849492655e-09
design O 0 3.351338406787363e-08
of O 0 1.6238285382996764e-08
tailored O 0 1.6705211436374157e-08
clinical O 0 9.531778778182343e-05
- O 0 6.13573888585961e-07
management O 0 8.704689236083141e-08
protocols O 0 4.471390724347657e-08
in O 0 1.1650921893924249e-10
this O 0 1.26677123651886e-11
subset O 0 1.691164008832402e-08
of O 0 1.7187200995749663e-08
FAP B-Disease 0 6.768676030333154e-06
patients O 0 2.4296007428148414e-09
. O 0 1.573435715052085e-09
. O 0 5.024644877948958e-08

Wilms B-Disease 1 0.9998525381088257
' I-Disease 0 1.2353409147181083e-05
tumor I-Disease 0 7.619121333846124e-07
1 O 0 1.4596948005873855e-07
and O 0 8.68509486551261e-10
Dax O 0 3.0309431167552248e-05
- O 0 9.777522080867129e-08
1 O 0 2.2314281977742212e-07
modulate O 0 1.6844550643213552e-08
the O 0 8.271051399333373e-09
orphan O 0 3.2543105987770105e-09
nuclear O 0 2.438111046387803e-08
receptor O 0 4.990228230639104e-10
SF O 0 6.096418474044185e-06
- O 0 6.437448352158981e-09
1 O 0 7.764911380547801e-09
in O 0 7.432975762666771e-11
sex O 0 5.589938928407534e-11
- O 0 2.0106429021726768e-10
specific O 0 1.6784369727407267e-10
gene O 0 9.428593017446474e-09
expression O 0 1.9048135513344278e-08
. O 0 1.6133721914002308e-08

Products O 0 2.8660659268098243e-07
of O 0 1.0311396181350574e-07
steroidogenic O 0 3.4804479582817294e-06
factor O 0 1.794961335122025e-08
1 O 0 8.983352017821744e-08
( O 0 1.574131242021437e-10
SF O 0 1.102499390981393e-05
- O 0 3.161517625471788e-08
1 O 0 4.047292279096837e-08
) O 0 5.267653327423183e-11
and O 0 2.3818663708041754e-10
Wilms B-Disease 0 0.0002664781059138477
tumor I-Disease 0 1.8692542198550655e-06
1 O 0 5.646871272801945e-07
( O 0 3.6891206756095585e-10
WT1 O 0 6.123275966274377e-07
) O 0 1.2874121907424652e-11
genes O 0 1.1379894422625103e-11
are O 0 8.78144399644315e-13
essential O 0 8.136136903091895e-11
for O 0 4.8382887973819066e-11
mammalian O 0 3.887939570290655e-08
gonadogenesis O 0 6.214888514932682e-08
prior O 0 1.0769353409045834e-08
to O 0 1.4564083272716744e-10
sexual O 0 1.1104634989322903e-09
differentiation O 0 8.692593667092297e-08
. O 0 2.4888555216762143e-08

In O 0 8.132421847051319e-09
males O 0 2.8646959804312644e-10
, O 0 6.028337828922758e-10
SF O 0 0.0672314316034317
- O 0 6.423334184546547e-07
1 O 0 3.7755296489194734e-07
participates O 0 4.804862063778614e-10
in O 0 2.5795445640630632e-11
sexual O 0 2.3274882021695475e-11
development O 0 3.6115117840740396e-11
by O 0 4.3486412387716555e-12
regulating O 0 6.225631676848309e-10
expression O 0 4.6071677028969305e-10
of O 0 7.720632466678978e-10
the O 0 4.40131042722669e-09
polypeptide O 0 7.29978319213842e-06
hormone O 0 4.28074073965945e-08
Mullerian O 0 8.013391834538197e-07
inhibiting O 0 2.422342149088763e-08
substance O 0 3.4873739451768415e-08
( O 0 1.2719439945740874e-09
MIS O 0 3.9267059037229046e-05
) O 0 1.880768873974148e-09
. O 0 1.7122873785524462e-08

Here O 0 1.4266316838984494e-07
, O 0 2.588956826699018e-09
we O 0 1.5276717391099481e-10
show O 0 1.0112582993215824e-09
that O 0 6.323092049953516e-10
WT1 O 0 5.4268301028059795e-05
- O 0 3.753379189674888e-07
KTS O 0 1.1553293916222174e-05
isoforms O 0 1.8231826715009447e-08
associate O 0 1.4694657046732118e-08
and O 0 1.4108914037080922e-10
synergize O 0 1.1474241112807704e-08
with O 0 9.977967341257e-10
SF O 0 0.018570108339190483
- O 0 1.3860686465250183e-07
1 O 0 9.920685073439017e-08
to O 0 4.905539863209185e-10
promote O 0 2.1842668118665642e-08
MIS O 0 0.00019723447621800005
expression O 0 1.5865461477915233e-07
. O 0 3.1311163439795564e-08

In O 0 4.6497056871430686e-08
contrast O 0 1.1753700590588778e-07
, O 0 3.284857186258705e-08
WT1 O 0 0.00030419795075431466
missense O 0 6.295180128290667e-07
mutations O 0 2.5616413434903507e-09
, O 0 6.863452167715778e-11
associated O 0 1.9542573115316486e-10
with O 0 1.9876844614685751e-10
male B-Disease 0 7.061824902621083e-09
pseudohermaphroditism I-Disease 1 1.0
in O 0 2.81911411548208e-07
Denys B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.1569468227889956e-07
fail O 0 1.21598318969518e-07
to O 0 8.997710215785659e-11
synergize O 0 6.402466823374198e-08
with O 0 3.294731820702168e-09
SF O 1 0.9998899698257446
- O 0 5.881669494556263e-06
1 O 0 5.2054897423658986e-06
. O 0 8.026005815509052e-08

Additionally O 0 1.7115893058416987e-07
, O 0 1.5454916235668748e-09
the O 0 1.726947584934635e-09
X O 0 9.763124353412422e-07
- O 0 5.706138850314346e-08
linked O 0 4.154658483912499e-08
, O 0 5.187581475496472e-10
candidate O 0 1.4718267715707611e-09
dosage O 0 1.3358574690869318e-08
- O 0 6.673134045342977e-09
sensitive O 0 5.466372687834564e-09
sex O 0 1.791795600780688e-10
- O 0 5.180215145728084e-10
reversal O 0 6.697003396283208e-09
gene O 0 8.866534173535001e-10
, O 0 8.455291328202108e-11
Dax O 0 9.7941619969788e-06
- O 0 1.8097953358164887e-08
1 O 0 7.935391010960302e-08
, O 0 2.5875190878821286e-10
antagonizes O 0 1.7866740309457896e-09
synergy O 0 1.1247325293339827e-09
between O 0 5.221122978404935e-10
SF O 0 5.315419548423961e-05
- O 0 8.322101230362478e-09
1 O 0 1.1844051961418245e-08
and O 0 3.0536903561362294e-10
WT1 O 0 3.3184205676661804e-06
, O 0 9.13804379387706e-11
most O 0 8.274162605070856e-12
likely O 0 9.77754162356792e-12
through O 0 1.8190212790897275e-12
a O 0 5.194070867853284e-12
direct O 0 4.3532057299178195e-12
interaction O 0 1.3436697934854358e-11
with O 0 4.2987183257459094e-11
SF O 0 0.36717715859413147
- O 0 7.974245477271324e-07
1 O 0 1.6142453205247875e-06
. O 0 5.588444196291675e-08

We O 0 4.7191370811106026e-08
propose O 0 2.7212276876298347e-08
that O 0 6.864581680865456e-10
WT1 O 0 1.7710541214910336e-05
and O 0 1.4645326729123553e-08
Dax O 0 0.011886636726558208
- O 0 1.5769659285069793e-06
1 O 0 1.1642113122434239e-06
functionally O 0 4.7925016843919366e-08
oppose O 0 6.972230570667648e-10
each O 0 1.561111374719093e-12
other O 0 2.5742841018583373e-12
in O 0 9.141250950639446e-11
testis O 0 2.4294999789731264e-08
development O 0 2.4665192110973067e-10
by O 0 3.060370706853277e-11
modulating O 0 4.235075223846252e-08
SF O 0 0.0002788140263874084
- O 0 1.0012712436946458e-07
1 O 0 2.017595051029275e-07
- O 0 1.4732430386743545e-08
mediated O 0 1.942512710684241e-07
transactivation O 0 6.672048016298504e-07
. O 0 1.7356784898225897e-09
. O 0 8.330581557913774e-09

A O 0 1.9288759176561143e-06
mouse O 0 1.5480831905279047e-07
model O 0 1.2292091788879134e-08
for O 0 1.431164236009863e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.997701108455658
centre O 0 0.002080365549772978
mutations O 0 3.5853881286129763e-07
. O 0 1.3641918883422477e-07

Imprinting O 0 8.379104656341951e-06
in O 0 2.411757193954145e-08
the O 0 1.6541139302717056e-07
15q11 O 0 6.258518624235876e-06
- O 0 8.197300758183701e-07
q13 O 0 1.1564917485884507e-06
region O 0 1.9726471123249212e-08
involves O 0 8.816549712520327e-10
an O 0 1.1505525004951167e-10
imprinting O 0 5.63147352750093e-07
centre O 0 6.288325039349729e-06
( O 0 8.870899015356315e-10
IC O 0 1.7130506648754817e-06
) O 0 5.829526444900424e-11
, O 0 1.1473938986428234e-11
mapping O 0 1.138995425753464e-10
in O 0 2.6303913908121146e-11
part O 0 9.597012767814661e-11
to O 0 2.5412630333399022e-11
the O 0 2.1534924954380585e-09
promoter O 0 1.1206793715246022e-06
and O 0 1.651407677272232e-09
first O 0 2.3866572718134194e-08
exon O 0 1.1093303555753664e-06
of O 0 1.4754118637938518e-07
SNRPN O 0 0.0016925078816711903
. O 0 1.5182926063062041e-06

Deletion O 0 4.169890246430441e-07
of O 0 1.9267969264546991e-07
this O 0 2.3750411415335293e-08
IC O 0 0.00014839194773230702
abolishes O 0 2.3773900466039777e-06
local O 0 2.1470176747584446e-08
paternally O 0 2.993291836617118e-09
derived O 0 2.8171095664553114e-11
gene O 0 5.234801134235134e-11
expression O 0 8.498055731331888e-11
and O 0 1.0210877282590403e-11
results O 0 7.588694672655549e-10
in O 0 8.038768584128775e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9993694424629211
PWS B-Disease 1 1.0
) O 0 1.1377766639952824e-07
. O 0 2.4191842840082245e-07

We O 0 2.3313214470022103e-08
have O 0 2.874794846619011e-10
created O 0 9.662736166760055e-10
two O 0 3.220133326653496e-10
deletion O 0 8.335620194088733e-09
mutations O 0 6.291813181569239e-10
in O 0 5.844704165092196e-10
mice O 0 1.2689205242111257e-08
to O 0 2.3689805672688635e-10
understand O 0 4.2309654446626155e-08
PWS B-Disease 1 1.0
and O 0 1.7399809371099195e-09
the O 0 2.0324599780963126e-09
mechanism O 0 1.2084337086548658e-08
of O 0 3.4763745215826702e-09
this O 0 5.745166564707915e-09
IC O 0 0.0002387401182204485
. O 0 2.8476918600972567e-07

Mice O 0 4.035807796753943e-05
harbouring O 0 4.305410402594134e-05
an O 0 1.1296026336538034e-08
intragenic O 0 1.2058698303007986e-05
deletion O 0 1.0027788448496722e-06
in O 0 1.8644010779667042e-08
Snrpn O 0 0.000623419473413378
are O 0 2.8016478026415825e-09
phenotypically O 0 7.68023511454885e-08
normal O 0 1.025676255039798e-08
, O 0 9.620618190986363e-11
suggesting O 0 1.0269711470112242e-10
that O 0 6.504085030972773e-12
mutations O 0 1.1960726853388337e-10
of O 0 5.829698501713665e-09
SNRPN O 0 0.0026975932996720076
are O 0 5.277276879378512e-11
not O 0 1.7608723507089863e-11
sufficient O 0 9.951168777888597e-10
to O 0 2.204422422380503e-09
induce O 0 1.6935524399741553e-05
PWS B-Disease 1 1.0
. O 0 1.0685655524866888e-06

Mice O 0 1.2965634823558503e-06
with O 0 1.7939885132989275e-09
a O 0 1.1580458370019642e-08
larger O 0 1.929137738443387e-09
deletion O 0 1.2803885063306097e-08
involving O 0 1.0591469923326713e-09
both O 0 1.6130421442994702e-09
Snrpn O 0 4.997933501726948e-06
and O 0 6.181818612560619e-09
the O 0 2.753483840933768e-07
putative O 0 0.0005085602169856429
PWS O 1 1.0
- O 0 0.004400074947625399
IC O 1 0.9540659785270691
lack O 0 1.0565073580437456e-06
expression O 0 6.341320801794836e-09
of O 0 4.324066882333e-09
the O 0 2.1391521887181852e-09
imprinted O 0 6.2847997917003795e-09
genes O 0 1.9152636421271296e-10
Zfp127 O 0 1.9364276226951915e-07
( O 0 8.255539030166403e-10
mouse O 0 2.9262636758176086e-08
homologue O 0 1.9853889909882128e-07
of O 0 2.516445718470095e-08
ZNF127 O 0 0.00015718037320766598
) O 0 1.738919341853773e-09
, O 0 3.369642787021121e-09
Ndn O 0 1.6962194422376342e-05
and O 0 4.7594683749707656e-09
Ipw O 0 1.6297384490826516e-06
, O 0 1.361248447295793e-09
and O 0 4.413910070777405e-10
manifest O 0 1.3201305826271437e-08
several O 0 7.701292381590008e-10
phenotypes O 0 6.7877842013786e-08
common O 0 4.910168627247913e-08
to O 0 1.0744161471620828e-07
PWS B-Disease 1 1.0
infants O 0 0.002141654724255204
. O 0 3.997002409050765e-07

These O 0 2.639625462652617e-10
data O 0 3.2377409087125386e-10
demonstrate O 0 7.561427178837121e-11
that O 0 3.235947534235839e-12
both O 0 6.499124155512348e-12
the O 0 1.0536597983001883e-10
position O 0 2.1283902418289813e-10
of O 0 1.4880291443475357e-09
the O 0 3.547144800108981e-09
IC O 0 1.944722043845104e-06
and O 0 1.257230292095457e-10
its O 0 2.427880951838546e-10
role O 0 4.692626842661696e-10
in O 0 1.4854026342270288e-10
the O 0 6.813447583908783e-10
coordinate O 0 1.0362332103497351e-09
expression O 0 2.10408446221777e-09
of O 0 3.755488808820928e-09
genes O 0 4.837283004710535e-11
is O 0 4.8832791109398865e-12
conserved O 0 4.516934742904155e-11
between O 0 1.7131471588549552e-11
mouse O 0 3.712954166346094e-09
and O 0 4.306079104399174e-11
human O 0 4.4864556514312426e-10
, O 0 1.1353963776106202e-11
and O 0 7.644457983291275e-12
indicate O 0 5.2819398160819375e-11
that O 0 1.3732115271281042e-11
the O 0 2.149344036084244e-09
mouse O 0 1.2431651263966614e-08
is O 0 3.0474338330588324e-11
a O 0 5.341949105286403e-11
suitable O 0 1.0371720149393582e-10
model O 0 1.9894093317152084e-11
system O 0 3.033690798570632e-10
in O 0 2.8949264860300694e-11
which O 0 5.553410595965369e-12
to O 0 4.797751172042064e-12
investigate O 0 8.017075198152313e-11
the O 0 1.9104987036833165e-10
molecular O 0 1.7888700520884981e-09
mechanisms O 0 1.017783191059607e-09
of O 0 6.559380816284488e-10
imprinting O 0 1.3558929978785272e-08
in O 0 4.088782090683196e-11
this O 0 1.0155172709691573e-11
region O 0 1.4836244732752135e-10
of O 0 2.705378421286042e-10
the O 0 8.204662504951443e-10
genome O 0 2.038963442529962e-09
. O 0 6.731667445691869e-10
. O 0 2.0874725947805928e-08

Mutations O 0 1.089139445298315e-08
of O 0 2.980964097787364e-08
the O 0 2.8700696930172853e-08
ATM O 0 4.295927737985039e-06
gene O 0 7.006843105727967e-09
detected O 0 2.382885222473874e-09
in O 0 7.155946946113545e-10
Japanese O 1 0.9997923970222473
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 0.04899415746331215
: O 0 2.959562872550947e-10
possible O 0 8.42597880357232e-10
preponderance O 0 1.5540859976681531e-07
of O 0 4.516422347222715e-09
the O 0 2.429892731470318e-09
two O 0 2.1350420043031448e-10
founder O 0 2.593436647657654e-07
mutations O 0 7.934024992550803e-09
4612del165 O 0 1.0222179014363064e-07
and O 0 9.084181407104097e-09
7883del5 O 0 8.20542572910199e-06
. O 0 9.173731996270362e-07

The O 0 1.804936800908763e-06
ATM O 0 0.45371824502944946
( O 0 6.333300916594453e-06
A O 1 1.0
- O 1 0.9999979734420776
T O 1 1.0
, O 0 7.0422672138192866e-09
mutated O 0 1.3075326377176566e-09
) O 0 1.137891690594639e-11
gene O 0 2.720249303589384e-10
on O 0 1.6846053441099684e-09
human O 0 3.1894737961835062e-09
chromosome O 0 9.451644444880003e-08
11q22 O 0 7.326721060962882e-07
. O 0 1.3006712151764077e-07

3 O 0 8.392766517317796e-07
has O 0 1.5464438618550957e-09
recently O 0 6.403254593223551e-10
been O 0 6.342548014570681e-11
identified O 0 1.988536765806792e-11
as O 0 1.2254149951707038e-11
the O 0 1.1682876888130522e-10
gene O 0 2.749051264405722e-10
responsible O 0 1.2328943421735516e-10
for O 0 1.0175802908629628e-11
the O 0 3.28756161183108e-10
human O 0 2.2819629919013096e-07
recessive B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9997865557670593
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.348862437884236e-08
. O 0 6.084471948497594e-08

In O 0 3.215797050870606e-08
order O 0 5.188266261058061e-09
to O 0 7.475087215880194e-11
define O 0 9.046033921933372e-10
the O 0 3.482179544711528e-10
types O 0 5.161830407551804e-10
of O 0 2.4450313773627386e-08
disease O 1 0.5373185873031616
- O 0 1.7078221503652458e-08
causing O 0 1.3779309249173366e-08
ATM O 0 3.9384022443300637e-07
mutations O 0 2.6371593797591686e-10
in O 0 2.1782818604432208e-10
Japanese O 0 0.0001932393352035433
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.6916541884247636e-08
as O 0 1.3053391700879047e-10
well O 0 1.2053403414258312e-11
as O 0 1.8821342054331502e-11
to O 0 4.006179502719087e-12
look O 0 8.633654555167958e-12
for O 0 8.897154714360145e-12
possible O 0 1.3738356285930564e-10
mutational O 0 2.224142292561737e-08
hotspots O 0 2.4276333832062846e-08
, O 0 2.8225147913341075e-11
reverse O 0 7.419834746613674e-10
- O 0 1.766073259856782e-10
transcribed O 0 2.906125340373933e-10
RNA O 0 1.5260204211386963e-10
derived O 0 4.541405446145674e-12
from O 0 7.713986567570164e-12
ten O 0 4.0919670429850896e-10
patients O 0 4.315123258713527e-11
belonging O 0 1.5578498213653091e-10
to O 0 4.4712303304272893e-11
eight O 0 3.894134792403747e-09
unrelated O 0 1.5020773957985512e-07
Japanese O 1 0.7269409894943237
A B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
families O 0 9.878094175963525e-11
was O 0 1.7059101908856178e-09
analyzed O 0 8.000745205238857e-11
for O 0 1.9876872717206062e-11
mutations O 0 1.6284350604078845e-11
by O 0 1.394293795003998e-11
the O 0 1.0026616203973049e-09
restriction O 0 1.1056075166493429e-08
endonuclease O 0 4.529986696866217e-08
fingerprinting O 0 4.758862459652846e-08
method O 0 1.4553851457321798e-08
. O 0 2.3932624770850452e-08

As O 0 1.2483711842037337e-08
has O 0 1.3176262858571874e-10
been O 0 2.6394780458516287e-11
reported O 0 1.3421124454848776e-11
by O 0 1.3452058911234133e-11
others O 0 4.200420566924379e-11
, O 0 2.6875458455921653e-11
mutations O 0 3.6481984100333875e-11
that O 0 3.108339280410988e-11
lead O 0 1.1390725696003301e-08
to O 0 1.0680037965116185e-09
exon O 0 5.684808911610162e-06
skipping O 0 4.04720054802965e-07
or O 0 2.1087689372478735e-09
premature O 0 1.8828336223464248e-08
protein O 0 2.9359226161318475e-09
truncation O 0 3.1653735277359374e-07
were O 0 8.322716404940422e-10
also O 0 6.918813438838711e-11
predominant O 0 4.988840895947533e-09
in O 0 2.8614852154440484e-10
our O 0 3.3977363145254458e-09
mutants O 0 1.0479571699306689e-07
. O 0 1.6747035758157836e-08

Six O 0 1.787663528318717e-08
different O 0 7.53354323368427e-11
mutations O 0 2.902917906055791e-10
were O 0 2.895739759090077e-10
identified O 0 8.707466692126076e-11
on O 0 2.7622821807682385e-09
12 O 0 2.8327109546921747e-09
of O 0 3.957050687120045e-09
the O 0 2.740656590560775e-08
16 O 0 9.861165040092601e-08
alleles O 0 5.990801188460182e-09
examined O 0 1.2368978730137314e-07
. O 0 7.837272875121926e-08

Four O 0 4.1742858059024e-08
were O 0 4.113535734262541e-09
deletions O 0 1.0457862131829643e-08
involving O 0 2.456234104997179e-09
a O 0 1.7089137216430572e-08
loss O 0 1.9133784689984168e-07
of O 0 2.9536390684370417e-06
a O 0 3.5834776213050645e-07
single O 0 4.5120503955331515e-07
exon O 0 9.11427559913136e-06
exon O 0 2.812354978232179e-06
7 O 0 4.155670012551127e-07
, O 0 2.6254070029096965e-09
exon O 0 1.657885349004573e-07
16 O 0 2.3546130378804264e-08
, O 0 2.9114808342001197e-09
exon O 0 2.4903189910219226e-07
33 O 0 3.628038314218429e-08
or O 0 8.603946000107499e-09
exon O 0 1.2489175560403964e-06
35 O 0 1.711657944269973e-07
. O 0 1.2520331438281573e-07

The O 0 3.551093925580062e-07
others O 0 6.998308155203858e-09
were O 0 4.114744545091753e-09
minute O 0 2.3690464701076053e-08
deletions O 0 2.1687314166740634e-09
, O 0 3.337805032366248e-10
4649delA O 0 1.6924934342910092e-08
in O 0 1.8459013206850727e-09
exon O 0 1.4088227828779054e-07
33 O 0 7.030712456668198e-09
and O 0 6.152901521616627e-10
7883del5 O 0 1.7194128076880588e-07
in O 0 1.1500117302887247e-08
exon O 0 3.7987779251125176e-06
55 O 0 3.1032055858304375e-07
. O 0 1.68085804830298e-07

The O 0 1.5754912396914733e-07
mutations O 0 2.1280840201143292e-08
4612del165 O 0 6.556597753615279e-08
and O 0 3.3930586118557926e-10
7883del5 O 0 1.766267132552457e-08
were O 0 7.85877585229855e-10
found O 0 3.5228684552857104e-11
in O 0 1.497234801417502e-11
more O 0 6.840247769243635e-13
than O 0 1.3805061694488474e-12
two O 0 1.2823074199697082e-11
unrelated O 0 1.3903482531940625e-10
families O 0 3.2696528861134166e-13
; O 0 4.5286620590709314e-13
44 O 0 1.7548304823145067e-11
% O 0 1.1936608819429484e-11
( O 0 2.8742600747394542e-12
7 O 0 2.6220989823855234e-09
of O 0 2.353758521422833e-09
16 O 0 1.8166560478150018e-09
) O 0 2.3004937798470904e-12
of O 0 6.545006203673154e-11
the O 0 1.0490456420209071e-10
mutant O 0 6.448628298016956e-10
alleles O 0 9.193036956678391e-12
had O 0 1.791811837792423e-11
one O 0 2.0678760353359804e-12
of O 0 9.791618210686082e-11
the O 0 1.7823004183625812e-09
two O 0 1.0566246766430254e-09
mutations O 0 2.546055277719006e-08
. O 0 1.0730358468435952e-07

The O 0 1.971553160728945e-07
4612del165 O 0 1.9844443954752933e-07
mutations O 0 6.60291266108004e-10
in O 0 1.249222530974592e-10
three O 0 1.0098752563358904e-11
different O 0 8.300651290447936e-13
families O 0 7.022991129618239e-13
were O 0 1.688100007002369e-11
all O 0 9.483119151054709e-12
ascribed O 0 1.0187931609451084e-09
to O 0 2.3768546159042003e-11
the O 0 5.478456577279189e-10
same O 0 1.4974703699266456e-09
T O 0 9.581862769891814e-08
- O 0 4.643446516183758e-09
- O 0 4.412969545342094e-09
> O 0 1.0771447733759487e-08
A O 0 6.310986844226818e-09
substitution O 0 2.4605435466895642e-09
at O 0 3.2441840325247995e-09
the O 0 5.520782719869999e-10
splice O 0 1.4939024239879473e-08
donor O 0 1.708850949633245e-09
site O 0 6.613730452187383e-09
in O 0 2.498399931383233e-09
intron O 0 9.253565622202586e-06
33 O 0 1.3176712627682718e-06
. O 0 7.897413638602302e-07

Microsatellite O 0 1.7498752640676685e-05
genotyping O 0 2.036758587564691e-06
around O 0 1.9935895156919514e-09
the O 0 7.951871161537838e-09
ATM O 0 2.3848519958846737e-06
locus O 0 3.9381912841918165e-08
also O 0 9.709897469400985e-11
indicated O 0 8.657106975729079e-11
that O 0 9.613422904952706e-12
a O 0 3.041332463649127e-10
common O 0 2.3566099072169777e-10
haplotype O 0 5.373439471156871e-09
was O 0 4.08670430829261e-09
shared O 0 5.439180356114903e-11
by O 0 6.992453491228012e-12
the O 0 7.250065825470386e-11
mutant O 0 9.225752939379106e-10
alleles O 0 1.0304199334065789e-11
in O 0 1.2092988069256627e-11
both O 0 1.969013840863454e-10
mutations O 0 9.508126730395361e-09
. O 0 3.195211206730164e-08

This O 0 8.889127656175333e-09
suggests O 0 2.0734400862920666e-09
that O 0 3.026205327993914e-11
these O 0 2.4974114790077273e-11
two O 0 3.491377187359035e-10
founder O 0 8.042116519391129e-07
mutations O 0 1.1079375195066632e-09
may O 0 2.5368379619195025e-10
be O 0 8.681381308273117e-11
predominant O 0 1.114782666178371e-08
among O 0 1.9577006682425235e-10
Japanese O 0 4.492591187954531e-08
ATM O 0 1.6936404563239194e-06
mutant O 0 2.3966435946931597e-07
alleles O 0 7.089761222545121e-09
. O 0 8.277143415114097e-09

W474C O 0 4.318350329413079e-05
amino O 0 1.4881570677971467e-06
acid O 0 3.5600042025407674e-08
substitution O 0 1.3136451926243353e-08
affects O 0 1.2929275705619858e-10
early O 0 2.422168576821093e-10
processing O 0 2.725671355285897e-10
of O 0 2.5248664270449694e-10
the O 0 3.7851730083637847e-10
alpha O 0 1.1231933161326424e-09
- O 0 6.323125356644255e-11
subunit O 0 3.448727414756547e-10
of O 0 1.2568808216428806e-09
beta O 0 9.076321560996803e-08
- O 0 3.6927499280636766e-08
hexosaminidase O 0 7.088127631504904e-07
A O 0 3.14778709764596e-08
and O 0 5.4134197124966477e-11
is O 0 1.7016383094259346e-11
associated O 0 3.7055872259550426e-10
with O 0 2.0742312312194144e-09
subacute O 1 0.9997267127037048
G B-Disease 1 0.997525155544281
( I-Disease 0 5.060761409936276e-08
M2 I-Disease 0 3.490375092951581e-05
) I-Disease 0 1.9602501843962727e-09
gangliosidosis I-Disease 0 2.5856968477455666e-06
. O 0 1.388574588645497e-07

Mutations O 0 1.638932189962361e-08
in O 0 1.3899352779844776e-09
the O 0 7.424438841496794e-09
HEXA O 0 6.168315849208739e-06
gene O 0 9.335643369468016e-10
, O 0 3.844705456779174e-11
encoding O 0 3.379512988899158e-11
the O 0 1.693127860136201e-10
alpha O 0 4.5287293359841385e-10
- O 0 3.083714880669497e-11
subunit O 0 8.566602288651026e-11
of O 0 5.667258884400894e-10
beta O 0 2.130220089213708e-08
- O 0 2.3302366258803886e-08
hexosaminidase O 0 5.228372970123019e-07
A O 0 7.35766292336848e-08
( O 0 4.413427609484266e-11
Hex O 0 2.1443902653572877e-08
A O 0 6.820368270155086e-09
) O 0 5.237345713365871e-12
, O 0 8.609350211907785e-12
that O 0 1.7576240810002197e-11
abolish O 0 1.7619004211155698e-07
Hex O 0 5.404173748502217e-07
A O 0 5.2013088946978314e-08
enzyme O 0 5.868251440332983e-10
activity O 0 3.788128921655698e-09
cause O 0 0.0764695405960083
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 8.879438695430508e-08
TSD B-Disease 1 0.9994864463806152
) O 0 5.15232856379555e-10
, O 0 3.982519869438761e-10
the O 0 2.6010550158162005e-08
fatal O 1 0.989658772945404
infantile B-Disease 0 0.011849379166960716
form I-Disease 0 1.6297052596314643e-08
of I-Disease 0 5.729056738346117e-06
G I-Disease 0 0.003748879302293062
( I-Disease 0 1.950508421444397e-09
M2 I-Disease 0 1.501838141848566e-06
) I-Disease 0 8.73791247690825e-11
gangliosidosis I-Disease 0 1.7619458958506584e-07
, I-Disease 0 4.54435628016725e-10
Type I-Disease 0 3.2417052153732584e-08
1 I-Disease 0 3.4427023365424247e-06
. O 0 5.26141512580125e-08

Less O 0 3.3061661497413297e-07
severe O 1 0.82774418592453
, O 0 2.160434604547845e-07
subacute O 1 0.9999922513961792
( O 0 2.634998566009017e-07
juvenile O 1 0.9999997615814209
- O 0 1.032167983794352e-05
onset O 1 1.0
) O 0 3.51979578816497e-09
and O 0 7.700928783549443e-09
chronic O 1 1.0
( O 0 4.9095296716927805e-09
adult O 0 1.1613801689236425e-06
- O 0 6.68507311729627e-08
onset O 1 0.9999207258224487
) O 0 4.988893326229871e-11
variants O 0 5.769101862895809e-10
are O 0 1.2597325526469971e-12
characterized O 0 1.951377254227893e-11
by O 0 3.978841128099431e-12
a O 0 7.49104459019101e-11
broad O 0 4.538076581184214e-10
spectrum O 0 5.303212313734207e-10
of O 0 1.8959418757180657e-10
clinical O 0 3.159588857215567e-08
manifestations O 0 8.369158166487978e-08
and O 0 2.6345639211888816e-11
are O 0 3.791959422242558e-13
associated O 0 3.2082550591866488e-12
with O 0 3.0329703592374413e-12
residual O 0 9.978543857869226e-07
levels O 0 1.0867410793480303e-07
of O 0 3.30432463613306e-08
Hex O 0 1.0047556315839756e-05
A O 0 9.117441095440881e-07
enzyme O 0 4.150466637042882e-09
activity O 0 1.2019008899244454e-08
. O 0 2.5254902169535853e-08

We O 0 2.5392704827709167e-08
identified O 0 7.011762281905476e-09
a O 0 4.946714149411946e-09
1422 O 0 6.063260684641136e-07
G O 0 5.714437065762468e-07
- O 0 7.469881779798015e-08
- O 0 2.22361222768086e-08
> O 0 2.6607978043102776e-08
C O 0 7.422232783937943e-08
( O 0 5.6576004298092286e-11
amino O 0 1.7546440689297782e-10
acid O 0 4.909983530865247e-11
W474C O 0 1.7656691386758183e-10
) O 0 2.3082544989977416e-13
substitution O 0 8.746912916191008e-12
in O 0 1.361069785522917e-12
the O 0 7.035061335564086e-12
first O 0 2.6241125591908165e-11
position O 0 1.4003712078825004e-10
of O 0 5.892881738134292e-10
exon O 0 1.7923852624335268e-08
13 O 0 1.5401593334019026e-09
of O 0 3.991396102520639e-09
HEXA O 0 9.755722567206249e-05
of O 0 9.905800624210315e-09
a O 0 4.85716533660252e-09
non O 0 4.49580568329111e-08
- O 0 5.5545101851350864e-09
Jewish O 0 5.383841816808399e-09
proband O 0 0.00011471034667920321
who O 0 2.4846247725918147e-08
manifested O 0 1.4869962683405902e-07
a O 0 1.293713722816392e-07
subacute O 0 0.010436829179525375
variant O 0 6.495025445474312e-06
of O 0 4.303406967665069e-05
G B-Disease 1 0.9254662990570068
( I-Disease 0 1.7770229732150256e-08
M2 I-Disease 0 2.8645803467952646e-05
) I-Disease 0 1.394632964668574e-09
gangliosidosis I-Disease 0 3.0157343644532375e-06
. O 0 1.6219658505178813e-07

On O 0 4.930190584673255e-07
the O 0 1.2308824182127864e-07
second O 0 1.8963459069709643e-07
maternally O 0 5.2513396298081716e-08
inherited O 0 3.3228172213739526e-08
allele O 0 5.236544087239281e-09
, O 0 1.0043531284420482e-10
we O 0 1.2997263855452079e-11
identified O 0 1.140401870158847e-10
the O 0 2.922211361777727e-10
common O 0 5.791389057208107e-08
infantile O 1 0.9999992847442627
disease O 1 0.9999988079071045
- O 0 2.0830822222706047e-07
causing O 0 4.252944734162156e-07
4 O 0 2.3849293029343244e-06
- O 0 4.54533193305906e-08
bp O 0 4.7975934336363935e-09
insertion O 0 3.045467211748587e-09
, O 0 1.2481419231491486e-09
+ O 0 1.1320420156835098e-08
TATC O 0 6.547333669004729e-06
1278 O 0 1.679737692938943e-06
, O 0 4.2306708136763405e-10
in O 0 8.576873655741224e-10
exon O 0 3.5459669334159116e-07
11 O 0 1.7975486343857483e-07
. O 0 7.982266936323867e-08

Pulse O 0 0.0016193018527701497
- O 0 4.964632353221532e-06
chase O 0 1.9589060684666038e-07
analysis O 0 7.712023242234523e-10
using O 0 4.5655459968152456e-10
proband O 0 1.1057407789394347e-07
fibroblasts O 0 7.838750093469571e-09
revealed O 0 8.241677340592446e-10
that O 0 5.101221094844233e-12
the O 0 2.6148558318617177e-10
W474C O 0 2.7841222660640597e-09
- O 0 2.729094172870816e-10
containing O 0 2.0655839538807896e-10
alpha O 0 2.9684232849547243e-09
- O 0 3.9962771980484035e-10
subunit O 0 2.6178714751523557e-09
precursor O 0 1.2269418370181029e-08
was O 0 1.2418592376661763e-08
normally O 0 7.213430547325927e-11
synthesized O 0 6.858535406273347e-10
, O 0 3.165181311493015e-11
but O 0 1.3321710921887497e-11
not O 0 1.1081265245682648e-11
phosphorylated O 0 5.364936828122779e-10
or O 0 1.4283388707903022e-11
secreted O 0 1.4208990754827067e-11
, O 0 1.2443042256282677e-11
and O 0 1.5464955704924677e-11
the O 0 2.334443971463429e-09
mature O 0 5.342484676873482e-09
lysosomal O 0 2.3873636223470385e-07
alpha O 0 1.4913288381990242e-08
- O 0 1.134992655416056e-09
subunit O 0 6.476093883378553e-09
was O 0 1.0229879165990496e-08
not O 0 4.804312503381425e-10
detected O 0 7.841983773460015e-08
. O 0 3.585661190186329e-08

When O 0 1.9068455259230177e-08
the O 0 1.1506172903352763e-08
W474C O 0 6.272682639973937e-08
- O 0 2.3005499727446477e-09
containing O 0 1.3120093900198526e-09
alpha O 0 4.391599528474899e-09
- O 0 9.32695698452335e-10
subunit O 0 7.363332166221426e-09
was O 0 1.104490365833044e-08
transiently O 0 1.420372885974075e-08
co O 0 2.4799693409960355e-09
- O 0 2.0066125150375314e-10
expressed O 0 2.039377694496025e-11
with O 0 3.692326826232328e-12
the O 0 2.6778154693651857e-10
beta O 0 9.016165591901881e-10
- O 0 7.437116200659233e-11
subunit O 0 1.2380597935734983e-10
to O 0 6.1649713112288396e-12
produce O 0 9.919177285100389e-11
Hex O 0 3.7911011219193824e-08
A O 0 1.6636084509968896e-08
( O 0 1.2034795902893247e-11
alphabeta O 0 5.2151136742395465e-09
) O 0 7.807507244883549e-12
in O 0 1.046974729135286e-10
COS O 0 3.245813786634244e-07
- O 0 9.128784839163018e-09
7 O 0 9.6603081090052e-09
cells O 0 8.266091283681831e-11
, O 0 7.217073726834e-12
the O 0 6.937181384891744e-11
mature O 0 3.8813542657667455e-11
alpha O 0 1.3336412529874053e-10
- O 0 8.763845552040017e-12
subunit O 0 8.453791833229474e-11
was O 0 2.311782709707444e-10
present O 0 1.0027102412268896e-11
, O 0 5.76049754771879e-12
but O 0 7.276421761133467e-13
its O 0 8.354469026305988e-12
level O 0 1.6242986955461447e-09
was O 0 7.481424368904754e-10
much O 0 2.427166627405608e-11
lower O 0 8.321235367425572e-11
than O 0 4.979305271053669e-13
that O 0 4.070872328468256e-13
from O 0 6.7471883115344244e-12
normal O 0 4.3987233300235573e-10
alpha O 0 1.6652299539288151e-09
- O 0 1.0821166879226851e-10
subunit O 0 2.398982124063309e-10
transfections O 0 4.237723061351062e-09
, O 0 1.6197924945782205e-11
although O 0 1.4090324393367659e-11
higher O 0 3.235171505688861e-11
than O 0 1.3726713992898154e-12
in O 0 2.2779557753982438e-11
those O 0 1.238595250668828e-11
cells O 0 6.314110345684298e-11
transfected O 0 1.8068996299192008e-10
with O 0 2.9879822574518933e-12
an O 0 1.516337749807306e-11
alpha O 0 4.680320575545238e-09
- O 0 5.371755817940027e-10
subunit O 0 3.0869899969587777e-09
associated O 0 1.538609017970316e-09
with O 0 4.428103661524574e-09
infantile O 1 0.9995587468147278
TSD B-Disease 1 0.9992982149124146
. O 0 8.202931098821864e-07

Furthermore O 0 7.345226293864471e-08
, O 0 1.0002320083302152e-09
the O 0 4.922870444623584e-10
precursor O 0 5.669943181629833e-09
level O 0 8.449979382874062e-09
of O 0 1.3934178255681218e-09
the O 0 2.0983934589935416e-09
W474C O 0 2.484937411395549e-08
alpha O 0 7.610442054328814e-09
- O 0 5.436922023704938e-10
subunit O 0 1.570227836644733e-09
was O 0 4.970642564217087e-09
found O 0 6.096428917246044e-11
to O 0 3.5445624300273204e-12
accumulate O 0 1.1349503802049465e-11
in O 0 1.1572358522837778e-11
comparison O 0 2.7298842006362456e-11
to O 0 1.251594921453103e-11
the O 0 9.939464806762999e-10
normal O 0 2.434240542470434e-08
alpha O 0 6.1064916678788e-08
- O 0 3.764144995699326e-09
subunit O 0 2.6096120819829594e-08
precursor O 0 2.2677595268305595e-07
levels O 0 2.901399511756608e-07
. O 0 2.5238337642008446e-08

We O 0 2.4230304873640307e-08
conclude O 0 2.0536399247816917e-08
that O 0 7.630841097894248e-11
the O 0 7.141906621654925e-09
1422 O 0 9.282939004151558e-07
G O 0 2.746486643445678e-06
- O 0 2.9821302405252936e-07
- O 0 1.0970709496405107e-07
> O 0 9.601932049463358e-08
C O 0 1.0988467380457223e-07
mutation O 0 4.265608977149782e-10
is O 0 4.996318463124094e-12
the O 0 2.645854195459929e-11
cause O 0 5.519529833186709e-10
of O 0 3.463463826847146e-08
Hex B-Disease 1 0.9998506307601929
A I-Disease 1 0.9999977350234985
enzyme I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
in O 0 8.340681034724184e-08
the O 0 2.932399354449444e-07
proband O 0 0.00015173728752415627
. O 0 3.419231404677703e-07

The O 0 1.3307641211213195e-07
resulting O 0 2.5136730030794752e-08
W474C O 0 1.1007767142245939e-07
substitution O 0 4.6567347311565754e-08
clearly O 0 4.1326672639563355e-10
interferes O 0 5.823569404483919e-11
with O 0 1.0999477370599031e-11
alpha O 0 2.2267687693755533e-09
- O 0 1.006201511000171e-10
subunit O 0 3.261666492448967e-10
processing O 0 9.188996785702841e-10
, O 0 1.4504999631959059e-11
but O 0 3.381374390556968e-12
because O 0 6.40939471635571e-12
the O 0 7.624104819692334e-11
base O 0 2.55334253740358e-10
substitution O 0 2.468487414475362e-09
falls O 0 2.3876487453833306e-09
at O 0 6.345793890361051e-10
the O 0 1.1670894806137255e-10
first O 0 1.664098719933449e-10
position O 0 2.378942320913069e-10
of O 0 1.7129593299358703e-09
exon O 0 9.182259930184955e-08
13 O 0 5.278259163077337e-09
, O 0 4.3237430302767166e-10
aberrant O 0 1.1373010977422382e-08
splicing O 0 2.4844540646995483e-08
may O 0 1.1329573945673133e-09
also O 0 5.3766737589944213e-11
contribute O 0 2.963640097219944e-11
to O 0 1.4793800906520715e-10
Hex B-Disease 0 0.006560959853231907
A I-Disease 1 0.691827654838562
deficiency I-Disease 0 0.0006856866530142725
in O 0 3.2916915859715346e-09
this O 0 9.563577707538684e-10
proband O 0 1.467466745452839e-06
. O 0 8.251591410157744e-09
. O 0 3.835979711652726e-08

Two O 0 1.1295401947108985e-08
frequent O 0 4.6589203606117735e-08
missense O 0 2.891542862926144e-06
mutations O 0 4.7181919171634945e-07
in O 0 3.0121500458335504e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.00025698341778479517

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 5.556501037062844e-06
an O 0 0.00013997175847180188
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 4.787966827279888e-05
by O 0 1.1179904918501293e-10
early O 0 1.3330699175639893e-06
childhood O 1 0.9999996423721313
deafness B-Disease 1 1.0
and O 0 0.3264986276626587
goiter B-Disease 1 1.0
. O 0 6.907623901497573e-05

A O 0 1.2900473222998698e-07
century O 0 1.2414140826422226e-08
after O 0 6.980693245672853e-10
its O 0 7.672873447717166e-11
recognition O 0 8.927182881812712e-10
as O 0 2.031211865372029e-09
a O 0 1.391311741372192e-07
syndrome O 0 0.0001606153091415763
by O 0 1.3214423999485803e-09
Vaughan O 0 4.82332825413323e-06
Pendred O 0 0.0007987726130522788
, O 0 3.277583093819203e-09
the O 0 9.549255608476415e-09
disease O 0 2.352671253902372e-05
gene O 0 3.048221675072682e-09
( O 0 1.7609236291349362e-10
PDS O 0 1.7374154595017899e-06
) O 0 8.008607665921375e-11
was O 0 4.364627326225445e-09
mapped O 0 2.3908475199618806e-09
to O 0 7.788952260945337e-10
chromosome O 0 1.498277470091125e-06
7q22 O 0 9.82013443717733e-06
- O 0 6.521919203805737e-06
q31 O 0 9.759476597537287e-06
. O 0 1.9644922133466025e-07

1 O 0 2.465436182319536e-06
and O 0 5.365103472598776e-09
, O 0 8.23657031467917e-10
recently O 0 2.671506127427392e-09
, O 0 1.5700084288194915e-10
found O 0 2.9425236552915734e-11
to O 0 1.967589979834372e-11
encode O 0 3.062299303024929e-10
a O 0 1.100249402696818e-08
putative O 0 8.08617642178433e-07
sulfate O 0 1.0115115856024204e-06
transporter O 0 4.388812158140354e-05
. O 0 3.6821862181568576e-07

We O 0 8.210130353347722e-09
performed O 0 8.741839252479622e-09
mutation O 0 6.481341574549049e-10
analysis O 0 5.419174137211158e-11
of O 0 1.027681051368745e-09
the O 0 2.326160242205333e-08
PDS B-Disease 0 0.0002183927717851475
gene O 0 9.759594910008218e-09
in O 0 8.413870156154246e-10
patients O 0 1.4872084119765816e-10
from O 0 8.862201250625645e-11
14 O 0 3.69137680422682e-08
Pendred B-Disease 0 2.911910087277647e-06
families O 0 1.3208135973830082e-11
originating O 0 8.036901005814556e-11
from O 0 2.419558477184669e-11
seven O 0 8.486717578692904e-11
countries O 0 1.1463899274311018e-11
and O 0 1.0168164227275511e-10
identified O 0 1.1038916447603242e-09
all O 0 2.2519948128518763e-09
mutations O 0 2.591092318482424e-08
. O 0 8.135683060572774e-08

The O 0 5.7253370044918483e-08
mutations O 0 1.3745834470668683e-09
include O 0 5.245888723415248e-10
three O 0 3.4158378903192954e-10
single O 0 3.209606580512059e-09
base O 0 1.1979757630342647e-08
deletions O 0 1.2221537559753415e-08
, O 0 3.9868157664102455e-09
one O 0 1.6942658387364418e-09
splice O 0 2.291576066681955e-07
site O 0 2.2279595057739243e-08
mutation O 0 2.3396549142518097e-09
and O 0 3.898681100178436e-10
10 O 0 2.282674138598395e-08
missense O 0 8.999865599434997e-07
mutations O 0 1.567500191868021e-07
. O 0 2.4231280804087874e-07

One O 0 1.5727524171893492e-08
missense O 0 2.3677007732203492e-07
mutation O 0 2.563181000780901e-09
( O 0 7.426938924970372e-11
L236P O 0 8.885636226807492e-09
) O 0 2.2397455418099455e-11
was O 0 7.85612352949272e-10
found O 0 9.841811393629385e-12
in O 0 4.621914396346627e-12
a O 0 3.1911622649927196e-11
homozygous O 0 2.352989747489431e-10
state O 0 1.701839537349148e-11
in O 0 2.1896612995009335e-11
two O 0 3.5080698762568474e-11
consanguineous O 0 8.827866082583569e-08
families O 0 3.1048774662423284e-12
and O 0 4.807543252383084e-12
in O 0 2.9532518791564044e-11
a O 0 1.6663093127533557e-10
heterozygous O 0 3.35995467559691e-11
state O 0 3.1114340704602172e-12
in O 0 7.850753033777913e-12
five O 0 2.3588483596959087e-11
additional O 0 1.7898009463390707e-10
non O 0 8.342063324562332e-07
- O 0 1.416479108229396e-06
consanguineous O 0 1.177746344183106e-05
families O 0 4.95413576828696e-09
. O 0 9.015381863264338e-08

Another O 0 2.858237735381408e-07
missense O 0 1.147834382209112e-06
mutation O 0 1.6313721928895575e-08
( O 0 2.6902605143597214e-10
T416P O 0 1.580824360303268e-08
) O 0 5.913596695661383e-11
was O 0 1.2241641034194117e-09
found O 0 1.299431395818118e-11
in O 0 5.297262628545241e-12
a O 0 1.407369793621216e-11
homozygous O 0 1.9229798309261525e-10
state O 0 2.5319881608032446e-11
in O 0 5.4512075409185456e-11
one O 0 1.8360394801741897e-11
family O 0 6.8117256626920586e-12
and O 0 4.568485780648279e-12
in O 0 1.9624366368042878e-11
a O 0 1.4276642368304948e-10
heterozygous O 0 5.41065317549716e-11
state O 0 1.8431587853195985e-11
in O 0 5.631095936764474e-11
four O 0 2.824719069760562e-10
families O 0 1.7124228424147958e-10
. O 0 2.3749187505472946e-08

Pendred B-Disease 0 0.030396239832043648
patients O 0 6.409871389223554e-08
in O 0 2.546306721029623e-09
three O 0 2.787820641003691e-09
non O 0 3.0600947411585366e-06
- O 0 4.960615456184314e-07
consanguineous O 0 6.881051831442164e-06
families O 0 9.739835327149393e-11
were O 0 2.574090385287775e-10
shown O 0 1.6420657888982504e-10
to O 0 6.593219026296282e-11
be O 0 2.5872326503417753e-10
compound O 0 7.758353071096735e-09
heterozygotes O 0 1.163490015443358e-08
for O 0 5.715238282633095e-10
L236P O 0 1.1398869759204899e-07
and O 0 3.51268680809369e-09
T416P O 0 2.1549703888013028e-06
. O 0 1.528047022247847e-07

In O 0 1.2465010357232131e-08
total O 0 1.566767160454674e-08
, O 0 1.4882987064979147e-09
one O 0 7.98050445172116e-11
or O 0 3.7290611570872656e-11
both O 0 3.4561142142619516e-11
of O 0 1.925469117480816e-09
these O 0 1.1775983833894887e-11
mutations O 0 4.6419895705085423e-11
were O 0 2.3184317313185154e-11
found O 0 3.8813227805356565e-12
in O 0 6.3405253269976924e-12
nine O 0 1.6741207031767402e-10
of O 0 2.380432295723267e-09
the O 0 1.2125688897413056e-08
14 O 0 6.27462100055709e-08
families O 0 4.039992229643019e-10
analyzed O 0 3.62711816137562e-08
. O 0 8.58621191923703e-08

The O 0 5.6215746724319615e-08
identification O 0 3.147036409245629e-08
of O 0 3.1262349153848845e-08
two O 0 3.2894824641971354e-09
frequent O 0 4.417771748421728e-08
PDS B-Disease 0 0.00012873948435299098
mutations O 0 3.629649469871765e-09
will O 0 1.2335671373264745e-10
facilitate O 0 4.303068457112147e-10
the O 0 3.614593624412521e-10
molecular O 0 4.324927260768163e-07
diagnosis O 0 7.526220724685118e-05
of O 0 5.064394645160064e-05
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.6922125723795034e-05

Insertional O 0 1.6192352632060647e-05
mutation O 0 4.319922553008837e-08
by O 0 1.3981006352636882e-09
transposable O 0 1.1196292462045676e-06
element O 0 1.630968569088509e-07
, O 0 1.0646830084226622e-08
L1 O 0 4.459753199625993e-06
, O 0 3.8431383075909764e-10
in O 0 4.845808754261327e-10
the O 0 5.6938318948596134e-08
DMD B-Disease 1 1.0
gene O 0 2.3334566279231694e-08
results O 0 6.997276646991679e-10
in O 0 4.790276508792601e-10
X B-Disease 1 0.9999970197677612
- I-Disease 1 0.9999457597732544
linked I-Disease 1 0.9995197057723999
dilated I-Disease 1 0.5313830971717834
cardiomyopathy I-Disease 1 1.0
. O 0 3.0746497941436246e-05

X B-Disease 1 0.9999982118606567
- I-Disease 1 0.9999903440475464
linked I-Disease 1 0.9999568462371826
dilated I-Disease 1 0.9999390840530396
cardiomyopathy I-Disease 1 1.0
( O 0 1.936231456056703e-06
XLDCM B-Disease 1 0.999996542930603
) O 0 2.182640457260021e-10
is O 0 2.80696195453789e-11
a O 0 8.652534938535794e-11
clinical O 0 1.0833966257450811e-07
phenotype O 0 6.983453815223584e-09
of O 0 9.068824802227482e-09
dystrophinopathy B-Disease 0 3.483442196738906e-05
which O 0 8.4915414977349e-11
is O 0 1.0515250996323555e-11
characterized O 0 5.480836964832925e-11
by O 0 2.4285976008009413e-11
preferential O 0 4.311946000257194e-08
myocardial B-Disease 1 0.9999877214431763
involvement I-Disease 0 1.7111380756773542e-08
without O 0 1.2237713620244506e-10
any O 0 8.604478241025504e-11
overt O 0 1.0374202830121249e-08
clinical O 0 1.729024006635882e-05
signs O 0 4.676332537201233e-05
of O 0 0.000543115776963532
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.001733141834847629

To O 0 1.5095693584044056e-09
date O 0 5.796218260911701e-08
, O 0 3.35361821646174e-10
several O 0 1.494447898764406e-10
mutations O 0 3.661584646597049e-10
in O 0 1.5704733069554777e-09
the O 0 4.037401231471449e-05
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9999635219573975
, O 0 1.0990412420142093e-06
DMD O 1 1.0
, O 0 2.1298239560874066e-10
have O 0 2.3797658722096715e-12
been O 0 3.0044066193224417e-12
identified O 0 1.0258429522513879e-11
in O 0 2.3621033948262316e-11
patients O 0 1.8368626064635407e-11
with O 0 7.266109935955001e-11
XLDCM B-Disease 1 0.9999871253967285
, O 0 1.2620503531124427e-09
but O 0 2.436303762898273e-11
a O 0 5.0212268370986024e-11
pathogenic O 0 1.2242008795571024e-10
correlation O 0 8.437939930105998e-11
of O 0 3.3561392553949077e-10
these O 0 2.771403766199665e-11
cardiospecific O 0 7.917022060155432e-08
mutations O 0 1.5856430612970485e-09
in O 0 2.92294277670635e-09
DMD O 1 1.0
with O 0 1.6845088657291285e-09
the O 0 8.685335473046507e-08
XLDCM B-Disease 1 0.9924378991127014
phenotype O 0 8.432835585381326e-08
has O 0 2.2456754511512855e-10
remained O 0 5.058567786875301e-09
to O 0 4.399845418556758e-11
be O 0 1.0266661965019352e-09
elucidated O 0 2.9355376227613306e-06
. O 0 1.0349818779786801e-07

We O 0 1.1923884102316151e-08
report O 0 9.292969727070499e-10
here O 0 1.3246112540166166e-10
the O 0 8.815469187961611e-11
identification O 0 6.256021256589861e-10
of O 0 4.5947237681254194e-10
a O 0 6.803071994632148e-10
unique O 0 8.17227063798498e-10
de O 0 4.557442139230261e-07
novo O 0 3.242976447381807e-07
L1 O 0 4.396102610826347e-07
insertion O 0 1.0589974452912543e-09
in O 0 3.5135894194127104e-10
the O 0 4.380256157787699e-09
muscle O 0 4.3630898005631025e-08
exon O 0 1.4838035440334352e-06
1 O 0 3.584403600598307e-07
in O 0 4.062325142939471e-09
DMD O 1 1.0
in O 0 2.2741553085126043e-09
three O 0 8.303610021798136e-10
XLDCM B-Disease 1 0.9826395511627197
patients O 0 1.741913613351187e-09
from O 0 8.513418442435139e-11
two O 0 1.0596112182126305e-10
unrelated O 0 1.273401029067145e-08
Japanese O 0 2.6497073690734396e-07
families O 0 7.52343742860262e-10
. O 0 5.6107342771838375e-08

The O 0 4.857112045897338e-08
insertion O 0 9.240268994403777e-09
was O 0 1.1059790949730086e-07
a O 0 3.3769067542266384e-09
5 O 0 7.4056427656898904e-09
- O 0 1.0868312916301193e-09
truncated O 0 5.652545098655537e-10
form O 0 7.947238700456438e-11
of O 0 2.104642238265342e-09
human O 0 6.363736204662018e-09
L1 O 0 4.255390706475737e-08
inversely O 0 4.938472408788641e-10
integrated O 0 3.818436677960335e-09
in O 0 5.828292015674919e-11
the O 0 6.725698886711484e-10
5 O 0 8.011213026293262e-09
- O 0 2.3937178905697465e-09
untranslated O 0 2.4172425128199393e-07
region O 0 9.414625745662875e-10
in O 0 6.346372039001125e-11
the O 0 1.0025124064227953e-09
muscle O 0 2.2673480870594176e-08
exon O 0 2.1908138592152682e-07
1 O 0 6.797760221388671e-08
, O 0 9.499937295154304e-12
which O 0 6.225099645831844e-13
affected O 0 2.60412720033687e-12
the O 0 2.1311027595394272e-11
transcription O 0 1.864036425214266e-10
or O 0 8.554383763847984e-12
the O 0 5.322067092583538e-11
stability O 0 7.690785785996468e-09
of O 0 9.993699201515938e-10
the O 0 8.930112205263185e-10
muscle O 0 1.3925915975931957e-09
form O 0 3.373673007622813e-10
of O 0 1.87900930370688e-08
dystrophin O 0 9.955905255765174e-08
transcripts O 0 1.5524699303881562e-09
but O 0 4.282757742196663e-12
not O 0 5.445756692812331e-13
that O 0 5.224482413530851e-13
of O 0 5.016184689843328e-10
the O 0 2.0322206140122034e-08
brain O 0 3.08451744785998e-05
or O 0 7.6746964339236e-09
Purkinje O 1 0.8981084823608398
cell O 0 0.00048567893099971116
form O 0 1.1679746947379499e-08
, O 0 1.942096261586812e-09
probably O 0 4.659582164556753e-10
due O 0 3.4342093613304314e-09
to O 0 8.381282647074162e-12
its O 0 6.74660050048459e-11
unique O 0 7.688578246289879e-11
site O 0 8.734850620584211e-10
of O 0 2.0095705099976158e-09
integration O 0 2.712636444357486e-07
. O 0 1.1204512873064232e-07

We O 0 2.558473788383253e-08
speculate O 0 1.5674509468155406e-09
that O 0 6.884005952084715e-12
this O 0 7.148777663584793e-12
insertion O 0 1.0787185728000637e-10
of O 0 1.3314713775969267e-09
an O 0 4.3272907479519063e-10
L1 O 0 1.988143139897147e-06
sequence O 0 2.6451417056705395e-08
in O 0 5.422345950023555e-08
DMD O 1 1.0
is O 0 2.733450799041748e-09
responsible O 0 1.177554609377296e-09
for O 0 1.3600065518204474e-11
some O 0 1.5209279148609145e-12
of O 0 1.2380740876949403e-10
the O 0 2.33150582173991e-10
population O 0 5.488512422324732e-12
of O 0 2.3247385960711853e-10
Japanese O 0 9.252282495708641e-08
patients O 0 3.6060615604682766e-10
with O 0 2.9216429275891187e-10
XLDCM B-Disease 1 0.7729548215866089
. O 0 3.8313075378937356e-08
. O 0 1.0999519162169236e-07

Severe O 0 0.27669453620910645
early O 0 0.07868309319019318
- O 1 0.99998939037323
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9961974620819092
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.673287570476532
red O 1 0.998462438583374
hair O 0 0.02409892901778221
pigmentation O 1 0.9619680047035217
caused O 0 3.800789045271813e-06
by O 0 1.4273933146569107e-08
POMC O 0 0.005956013221293688
mutations O 0 1.4170844497840562e-09
in O 0 4.025715871769364e-10
humans O 0 4.58381954615561e-09
. O 0 5.609746889234657e-09

Sequential O 0 1.9568560105653887e-07
cleavage O 0 3.850721697062909e-08
of O 0 4.5870578446738364e-08
the O 0 1.5932654306993754e-08
precursor O 0 3.9363964532412865e-08
protein O 0 2.29164220932887e-09
pre O 0 1.1870102980537922e-06
- O 0 1.5647549389541382e-07
pro O 0 2.756047706498066e-06
- O 0 4.149954335730399e-08
opiomelanocortin O 0 8.318960453834734e-07
( O 0 3.2454960940953015e-09
POMC O 0 1.5007801721367287e-06
) O 0 4.0926987493472566e-11
generates O 0 1.4966386463477477e-10
the O 0 1.5713692569363502e-09
melanocortin O 0 2.9168545552238356e-06
peptides O 0 2.0309949277930173e-09
adrenocorticotrophin O 0 1.5894190141807485e-07
( O 0 8.875739587743681e-10
ACTH O 0 2.513822323635395e-07
) O 0 1.1114037468118454e-10
, O 0 4.503070138994758e-10
melanocyte O 0 4.318127082569845e-07
- O 0 6.32516119480897e-08
stimulating O 0 6.156757592634676e-08
hormones O 0 2.6773365746635136e-09
( O 0 4.3015476597352276e-11
MSH O 0 1.918307930282026e-07
) O 0 7.364556880995465e-12
alpha O 0 1.3906080453818248e-10
, O 0 1.069551456948925e-12
beta O 0 1.5482103446484707e-11
and O 0 1.4347820891449925e-12
gamma O 0 6.233624727514098e-11
as O 0 3.115531704150909e-12
well O 0 2.230676364109452e-12
as O 0 5.233440850821447e-12
the O 0 5.6914559870557824e-11
opioid O 0 4.450797064237122e-09
- O 0 1.0555953888768954e-09
receptor O 0 6.463059532002546e-10
ligand O 0 2.95207214229265e-09
beta O 0 1.1860717563649814e-07
- O 0 2.4506721274519805e-07
endorphin O 0 4.889584488410037e-06
. O 0 4.7928217838943965e-08

While O 0 4.435511158362715e-08
a O 0 3.905060719233688e-09
few O 0 2.918017216746449e-10
cases O 0 2.2142862543539366e-10
of O 0 4.679483467384671e-08
isolated O 1 0.9422921538352966
ACTH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.999974250793457
have O 0 8.681020902123748e-10
been O 0 5.056318141960503e-10
reported O 0 9.170262327273804e-10
( O 0 3.8477077080045774e-10
OMIM O 0 0.0012780786491930485
201400 O 0 9.236824780600728e-07
) O 0 7.956491021587908e-11
, O 0 8.792866434959024e-11
an O 0 3.233161793847472e-10
inherited O 0 0.2691834270954132
POMC O 1 1.0
defect O 0 0.1225099042057991
has O 0 1.0112467530021263e-09
not O 0 4.878645404327031e-11
been O 0 1.966401624864389e-10
described O 0 6.950030551067243e-10
so O 0 5.799029312303361e-11
far O 0 7.955827108219182e-10
. O 0 6.967607824037714e-09

Recent O 0 8.72747740743307e-09
studies O 0 5.510756295734609e-10
in O 0 1.989577114169805e-10
animal O 0 1.3441121549107038e-09
models O 0 8.695798248137265e-11
elucidated O 0 1.3470282667071842e-08
a O 0 2.651928399100001e-10
central O 0 1.5930793351159878e-09
role O 0 2.808183963143307e-10
of O 0 4.099734773888031e-09
alpha O 0 7.62740413051688e-08
- O 0 2.131223908463653e-08
MSH O 0 3.4145887184422463e-06
in O 0 1.2293650819561464e-10
the O 0 2.372924079452332e-10
regulation O 0 4.6824992772087626e-09
of O 0 1.284396700107493e-09
food O 0 4.4710279922810514e-10
intake O 0 3.403680809421772e-11
by O 0 3.877238374111469e-12
activation O 0 4.804184272622081e-10
of O 0 1.1578177305793247e-09
the O 0 4.1597867372900055e-09
brain O 0 8.02492010620881e-08
melanocortin O 0 1.913520463858731e-06
- O 0 4.904250783255293e-09
4 O 0 3.3821166312009154e-08
- O 0 2.680949240385644e-09
receptor O 0 1.1298498803213874e-09
( O 0 9.29915380809554e-11
MC4 O 0 1.255762890650658e-05
- O 0 1.9964140562933608e-08
R O 0 4.94441501075471e-08
; O 0 1.4277178397859025e-11
refs O 0 1.2984713304575735e-09
3 O 0 7.50980333474871e-10
- O 0 3.443979823547494e-11
5 O 0 2.6582878259739928e-11
) O 0 1.1508163671146432e-13
and O 0 4.3086300044285764e-13
the O 0 1.5727049870739584e-11
linkage O 0 3.981276197606576e-09
of O 0 4.016322829869523e-09
human O 0 1.9720118871191517e-07
obesity B-Disease 1 0.9999998807907104
to O 0 5.411406739375124e-11
chromosome O 0 3.3574150126725044e-09
2 O 0 1.0018057494676214e-08
in O 0 5.942383390911132e-11
close O 0 3.7823508214351875e-10
proximity O 0 1.9231423120658064e-09
to O 0 1.727153316199992e-11
the O 0 3.908928736251482e-09
POMC O 0 1.5198601204247097e-06
locus O 0 8.732801703992266e-10
, O 0 3.221845706891102e-11
led O 0 8.939787798922794e-11
to O 0 5.002516630103759e-12
the O 0 1.2024660434040157e-10
proposal O 0 9.581904020228293e-11
of O 0 2.3862267717333907e-10
an O 0 1.273288002812123e-10
association O 0 1.0688969709349294e-08
of O 0 6.162408539012176e-08
POMC O 1 0.9926422238349915
with O 0 1.1087709417267888e-08
human O 0 0.00047655217349529266
obesity B-Disease 1 1.0
. O 0 1.3515315231416025e-06

The O 0 4.424644473033368e-08
dual O 0 8.475196011659136e-08
role O 0 1.326281129365725e-08
of O 0 1.29968910300704e-07
alpha O 0 9.511623829894233e-06
- O 0 3.709279326358228e-06
MSH O 0 0.00023831868020351976
in O 0 2.15717599338916e-09
regulating O 0 6.960677012557426e-08
food O 0 1.8686089120478755e-08
intake O 0 4.720908108879485e-09
and O 0 6.835523813641942e-10
influencing O 0 1.1880551653575822e-07
hair O 0 2.229040546808392e-06
pigmentation O 0 4.515254659054335e-06
predicts O 0 6.410614705743001e-09
that O 0 4.115099320328719e-12
the O 0 7.817509833918379e-11
phenotype O 0 1.8299083082151668e-10
associated O 0 2.760183054340004e-11
with O 0 1.3428166564799504e-11
a O 0 1.0265491567906793e-08
defect O 0 2.752260343186208e-06
in O 0 1.3394191533677713e-08
POMC O 1 0.7800121307373047
function O 0 3.646833590664755e-08
would O 0 9.846717191619447e-11
include O 0 5.836418903726326e-09
obesity B-Disease 1 1.0
, O 0 2.46258929914589e-10
alteration O 0 6.899477966726408e-08
in O 0 3.3243752195488696e-09
pigmentation O 1 0.9904689192771912
and O 0 3.558559228622471e-06
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.593040542502422e-05

The O 0 6.390084195118106e-08
observation O 0 4.700344220509578e-07
of O 0 3.7414491060872024e-08
these O 0 9.502809650285826e-10
symptoms O 0 3.556645879143616e-06
in O 0 2.2462121052058137e-09
two O 0 5.974070682590593e-10
probands O 0 1.0328877579013351e-05
prompted O 0 6.6512524377060345e-09
us O 0 8.978937732218029e-11
to O 0 3.5054948527291074e-11
search O 0 4.5064554865525963e-10
for O 0 3.7273209518851047e-10
mutations O 0 2.663660181312366e-09
within O 0 8.60008952940916e-09
their O 0 2.183704594926894e-08
POMC O 0 0.00017278807354159653
genes O 0 2.6518856444113226e-08
. O 0 7.802133694667646e-08

Patient O 0 1.277616775041679e-06
1 O 0 3.4560580388642848e-06
was O 0 1.329272549810412e-07
found O 0 2.8505792171173994e-10
to O 0 1.2239831544136326e-11
be O 0 6.891787140972383e-11
a O 0 6.39768793497808e-10
compound O 0 2.843564717025515e-09
heterozygote O 0 2.521883590844709e-09
for O 0 6.112881034692208e-11
two O 0 2.073042605632569e-11
mutations O 0 1.0227313440580588e-10
in O 0 2.1591055332503828e-10
exon O 0 7.34624876486123e-08
3 O 0 2.759882100633604e-08
( O 0 5.278917927786786e-11
G7013T O 0 1.3473314908196699e-08
, O 0 2.0684620682942523e-10
C7133delta O 0 1.9070274248633723e-08
) O 0 7.219303713862368e-12
which O 0 2.178304628688843e-12
interfere O 0 1.0058363864029474e-11
with O 0 2.091541566676125e-12
appropriate O 0 7.272932256441322e-11
synthesis O 0 6.584253142705165e-09
of O 0 1.8877564400554547e-08
ACTH O 0 2.7482526547828456e-06
and O 0 1.653413050917152e-08
alpha O 0 6.866629973956151e-06
- O 0 3.933075277018361e-06
MSH O 0 0.0014206708874553442
. O 0 2.2439699876031227e-07

Patient O 0 2.209622920190668e-07
2 O 0 1.9472685153232305e-07
was O 0 1.2714642672051468e-08
homozygous O 0 1.5195847913318516e-09
for O 0 1.470316507434788e-10
a O 0 5.251934998007357e-10
mutation O 0 3.4123801007091004e-10
in O 0 4.120113972216899e-10
exon O 0 7.12813701397863e-08
2 O 0 3.3966948365105054e-08
( O 0 6.946501707183472e-11
C3804A O 0 9.257486333069664e-09
) O 0 8.132909623537188e-11
which O 0 5.441714856502244e-10
abolishes O 0 1.9159251678502187e-06
POMC O 0 2.7291724109090865e-05
translation O 0 1.1372950581289842e-07
. O 0 7.292083381571501e-08

These O 0 2.9542912560742707e-09
findings O 0 4.696907307533138e-10
represent O 0 6.755819514925321e-11
the O 0 2.0872355233070294e-10
first O 0 1.3024989420351574e-10
examples O 0 4.196858693905625e-10
of O 0 7.933071977106465e-09
a O 0 2.8116662065258424e-07
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 1.9356107827661617e-08
the O 0 1.9278992624549574e-08
POMC O 0 8.762140168983024e-06
gene O 0 3.3716018865703745e-10
and O 0 1.0065042549411984e-11
define O 0 1.5950578358125966e-10
a O 0 3.4053515562959547e-10
new O 0 1.3240669893832546e-08
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 0.9996234178543091
resulting O 0 5.428252070061035e-09
in O 0 1.03271072249278e-10
early O 0 2.3135966330301017e-05
- O 1 0.9997773766517639
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999721050262451
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.033171094954013824
red O 0 0.0527699813246727
hair O 0 4.4007015276292805e-06
pigmentation O 0 3.46580745826941e-05
. O 0 7.218984521273342e-09
. O 0 2.6558288013234232e-08

A O 0 1.7362608559778892e-06
European O 0 3.775637651415309e-07
multicenter O 0 5.213006261328701e-06
study O 0 1.6844680317262828e-08
of O 0 6.355788354994729e-05
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 9.211624529825713e-08
classification O 0 1.364925878988288e-07
of O 0 3.958500194300996e-09
105 O 0 4.093467786958627e-09
mutations O 0 3.253742414388583e-11
and O 0 4.770686016369874e-12
a O 0 2.516427517751385e-11
general O 0 4.1741227141400827e-10
system O 0 2.9939753454222284e-10
for O 0 3.565557571416633e-11
genotype O 0 7.261957701842903e-10
- O 0 1.1291297757898278e-10
based O 0 7.555242542700569e-11
prediction O 0 1.60791326919707e-08
of O 0 1.6042065453802934e-08
metabolic O 1 0.9992388486862183
phenotype O 0 8.900657348931418e-07
. O 0 1.744740707465553e-08

Phenylketonuria B-Disease 1 0.9997921586036682
( O 0 2.6183126919931965e-06
PKU B-Disease 1 0.9805834293365479
) O 0 5.2427804320132054e-09
and O 0 7.03035052396217e-09
mild B-Disease 1 0.9999969005584717
hyperphenylalaninemia I-Disease 1 1.0
( O 0 0.1266104280948639
MHP B-Disease 1 1.0
) O 0 3.2254152682043014e-09
are O 0 7.331880103045307e-10
allelic B-Disease 1 0.9943951368331909
disorders I-Disease 1 0.9999988079071045
caused O 0 1.275785166399146e-07
by O 0 7.479879216010232e-11
mutations O 0 1.920933204169195e-11
in O 0 4.5085941924316586e-11
the O 0 1.0618715906574039e-09
gene O 0 3.6998051289316436e-09
encoding O 0 7.2506676218608845e-09
phenylalanine O 0 2.195733515009124e-07
hydroxylase O 0 1.3665061260326183e-06
( O 0 5.120305957007076e-09
PAH O 0 0.0780763179063797
) O 0 6.047630840555485e-09
. O 0 3.631223322031474e-08

Previous O 0 1.5177758427853405e-07
studies O 0 5.672874614504053e-09
have O 0 8.641121151953257e-11
suggested O 0 1.2953167705109792e-10
that O 0 5.553686416998049e-12
the O 0 7.52929441016903e-10
highly O 0 1.6399578584014307e-08
variable O 0 2.385943389526801e-07
metabolic O 1 0.9998677968978882
phenotypes O 0 2.323186663488741e-06
of O 0 0.00042875780491158366
PAH B-Disease 1 1.0
deficiency I-Disease 1 0.9999927282333374
correlate O 0 1.7107309702169005e-07
with O 0 6.013448228259222e-08
PAH O 1 1.0
genotypes O 0 0.00014106456364970654
. O 0 2.256984572568399e-07

We O 0 3.594288955355296e-08
identified O 0 2.8159949927442085e-09
both O 0 1.6593698637379362e-10
causative O 0 2.0685822832433587e-08
mutations O 0 2.4914379448404134e-09
in O 0 1.8368749854502653e-09
686 O 0 2.96483278816595e-07
patients O 0 1.683522876660959e-09
from O 0 5.098317878982073e-10
seven O 0 5.129582536511634e-09
European O 0 3.453039596479357e-07
centers O 0 1.4904009049132583e-07
. O 0 1.4744581733339146e-07

On O 0 6.693123566492432e-08
the O 0 2.06241201894386e-09
basis O 0 5.615771181410878e-10
of O 0 7.560436166009765e-10
the O 0 8.805794426969271e-10
phenotypic O 0 5.648659850976401e-08
characteristics O 0 1.6889744047787758e-09
of O 0 2.979166469074812e-09
297 O 0 2.7240838917919064e-08
functionally O 0 6.418214866243943e-07
hemizygous O 0 7.558296601928305e-06
patients O 0 1.3192916759052764e-09
, O 0 7.210170654969872e-11
105 O 0 1.6956721582417345e-09
of O 0 1.7690005016390842e-09
the O 0 1.7117313122483324e-09
mutations O 0 1.8805562662649322e-10
were O 0 6.998207568997827e-11
assigned O 0 9.872858086623637e-11
to O 0 9.580601936787225e-12
one O 0 2.5613016915726483e-11
of O 0 1.835796181737237e-09
four O 0 1.8916912480904102e-09
arbitrary O 0 2.438325736875413e-07
phenotype O 0 3.3404964483452204e-07
categories O 0 1.5151582033468003e-07
. O 0 5.526709045966527e-08

We O 0 1.6616485964959793e-08
proposed O 0 1.0000073658034125e-08
and O 0 3.917517699125739e-10
tested O 0 1.9883832358402742e-09
a O 0 2.653329778112834e-10
simple O 0 1.1787450182598747e-10
model O 0 2.1441416350742593e-11
for O 0 2.8379037401299323e-12
correlation O 0 6.106471578393169e-11
between O 0 1.0358849888980615e-10
genotype O 0 9.11749165055653e-09
and O 0 3.861993780329698e-10
phenotypic O 0 4.80209166653367e-07
outcome O 0 1.746109887790226e-07
. O 0 6.071256564155192e-08

The O 0 2.9014316282882646e-08
observed O 0 1.4659384817150567e-08
phenotype O 0 2.991899172855028e-09
matched O 0 7.897302811699092e-10
the O 0 5.667086244720565e-10
predicted O 0 4.4746557570363166e-09
phenotype O 0 2.1447683906661297e-10
in O 0 1.1700755815635677e-11
79 O 0 2.992662229139853e-10
% O 0 1.068556961664191e-11
of O 0 1.555931494756635e-10
the O 0 2.35046898611202e-10
cases O 0 8.60930077228872e-12
, O 0 3.930356907988486e-12
and O 0 1.96367488242144e-12
in O 0 9.096372960426535e-12
only O 0 1.3611172085259415e-11
5 O 0 7.091461862174242e-10
of O 0 1.1600990168503245e-09
184 O 0 1.3836742862594065e-09
patients O 0 6.752456926939487e-11
was O 0 7.120208311839349e-10
the O 0 2.668388010551581e-10
observed O 0 5.346131315420166e-10
phenotype O 0 1.6339180008984044e-10
more O 0 2.0054385940510705e-13
than O 0 1.0166136595740616e-12
one O 0 1.1968754112801072e-11
category O 0 7.215484876255118e-10
away O 0 6.872923064005221e-11
from O 0 1.0322454696565231e-11
that O 0 2.526416228998407e-11
expected O 0 9.354167218589282e-09
. O 0 3.0009079665660465e-08

Among O 0 1.4925722879866044e-08
the O 0 9.01231800298774e-09
seven O 0 9.719538507368952e-10
contributing O 0 5.51564627304657e-10
centers O 0 2.454692005215975e-10
, O 0 3.323693403833872e-11
the O 0 2.078206218225631e-10
proportion O 0 3.9011133212696336e-10
of O 0 5.957358162334003e-09
patients O 0 1.0197569871861489e-10
for O 0 1.04134853518012e-10
whom O 0 3.9938673895845156e-11
the O 0 1.6449122619555112e-10
observed O 0 3.328929354395882e-10
phenotype O 0 1.9732811218364787e-10
did O 0 1.0641677643252745e-11
not O 0 2.716529041643656e-12
match O 0 1.7539523167187099e-09
the O 0 1.6770544675193122e-10
predicted O 0 1.495692014685801e-09
phenotype O 0 3.08681032124003e-11
was O 0 1.3355860861707924e-10
4 O 0 3.231941103631897e-10
% O 0 1.0003129401192634e-11
- O 0 8.241170246225948e-11
23 O 0 6.951065278926194e-10
% O 0 1.071835675769961e-10
( O 0 8.709277049545605e-11
P O 0 3.8379016586986836e-07
< O 0 1.7650581440875612e-08
. O 0 5.1661026151395006e-11
0001 O 0 1.2672342108999146e-06
) O 0 2.8220453317934213e-12
, O 0 8.133025503065383e-13
suggesting O 0 1.0789767516949933e-12
that O 0 4.050539336450734e-14
differences O 0 5.941413810592322e-13
in O 0 9.00693853268103e-13
methods O 0 7.473301491534023e-12
used O 0 2.7959316719478045e-12
for O 0 1.0958475446520843e-11
mutation O 0 4.404457076834234e-10
detection O 0 2.4015941235688842e-08
or O 0 1.317666392663952e-10
phenotype O 0 1.902624013894183e-08
classification O 0 4.225892524800656e-08
may O 0 1.371442681641355e-10
account O 0 2.1235426611587727e-12
for O 0 4.025727234208132e-12
a O 0 2.156490784555043e-11
considerable O 0 1.2232440060877536e-10
proportion O 0 2.6008983855518863e-10
of O 0 3.2938898275602924e-09
genotype O 0 6.207661726875813e-07
- O 0 8.244923037636909e-07
phenotype O 0 3.439456008891284e-07
inconsistencies O 0 3.7800188579240057e-07
. O 0 1.515588934353218e-07

Our O 0 9.834286629484268e-08
data O 0 8.20258616585079e-09
indicate O 0 1.742634703205681e-09
that O 0 1.1087698120748612e-10
the O 0 3.4030950502028645e-08
PAH O 1 0.9996345043182373
- O 0 3.5065809811385407e-07
mutation O 0 3.717177454731768e-09
genotype O 0 1.484383727046179e-09
is O 0 1.5467080741182748e-11
the O 0 3.665684769615929e-11
main O 0 1.439331542840705e-09
determinant O 0 2.900269890915297e-08
of O 0 6.482779646432846e-09
metabolic O 1 0.969903826713562
phenotype O 0 1.4636921008559511e-08
in O 0 1.128259985438973e-10
most O 0 4.827460098333347e-10
patients O 0 1.7536956775643375e-08
with O 0 1.737125444378762e-06
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0007556140189990401

In O 0 1.0549800144588062e-08
the O 0 4.122835850495221e-09
present O 0 3.6702693662071795e-10
study O 0 3.1196479427508805e-11
, O 0 1.2174242516871381e-11
the O 0 1.322884163323934e-10
classification O 0 8.148911767591471e-09
of O 0 1.2568670548773753e-08
105 O 0 3.42866826485988e-07
PAH O 0 0.10694100707769394
mutations O 0 3.9300004917031117e-10
may O 0 1.52510018502916e-11
allow O 0 1.6265903554635308e-12
the O 0 1.5516987000863125e-11
prediction O 0 4.886367976908446e-10
of O 0 1.1947913491905382e-10
the O 0 1.5199493053064117e-10
biochemical O 0 5.359273913541074e-09
phenotype O 0 7.434340365541914e-10
in O 0 1.165225554933258e-10
> O 0 4.5056842701285404e-09
10 O 0 4.3622197520853945e-10
, O 0 7.410806690533178e-11
000 O 0 3.1176747294914264e-10
genotypes O 0 1.1678761291378237e-09
, O 0 2.5246724849603552e-11
which O 0 4.577940890954091e-12
may O 0 1.3992597878986768e-11
be O 0 2.6689757175180073e-12
useful O 0 3.80267388758182e-12
for O 0 7.651386468854326e-12
the O 0 4.845605583447821e-10
management O 0 9.770062092684384e-09
of O 0 9.014020641018305e-09
hyperphenylalaninemia B-Disease 1 1.0
in O 0 1.8754543873455987e-07
newborns O 0 2.4035011847445276e-07
. O 0 2.5323927843601268e-08

Somatic O 0 3.701226432895055e-06
instability O 0 1.04210357676493e-06
of O 0 1.2520176539965178e-07
the O 0 1.6334341523815965e-07
CTG O 0 9.175601735478267e-05
repeat O 0 1.679502474871697e-07
in O 0 3.985888064050869e-09
mice O 0 7.024615911177534e-08
transgenic O 0 1.1318719828068424e-07
for O 0 1.1566192448242418e-09
the O 0 0.0001867617102107033
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 0.0016119404463097453
is O 0 5.319553131322152e-10
age O 0 2.7782273703813587e-10
dependent O 0 5.1908550374735185e-11
but O 0 1.2635948060460422e-12
not O 0 5.939351658060255e-13
correlated O 0 9.082729360287978e-12
to O 0 1.4108254495215355e-12
the O 0 8.168074550063409e-11
relative O 0 1.9178016952281496e-09
intertissue O 0 6.142951747278858e-08
transcription O 0 1.6435903305023203e-08
levels O 0 1.2545007699316102e-08
and O 0 3.9156647368976394e-10
proliferative O 0 6.096180732129142e-05
capacities O 0 8.132205948641058e-07
. O 0 6.256504292423415e-08

A O 0 1.2199306183902081e-05
( O 0 3.981445217959845e-08
CTG O 0 9.095372661249712e-06
) O 0 4.4951756206224047e-10
nexpansion O 0 2.0994592730971817e-08
in O 0 4.775715933824642e-10
the O 0 1.9750217017389105e-09
3 O 0 1.039476700270825e-07
- O 0 2.982670466167292e-08
untranslated O 0 1.6312530988216167e-06
region O 0 1.704548147074547e-08
( O 0 2.1387511206505394e-10
UTR O 0 2.819941755660693e-06
) O 0 1.0839428660203154e-10
of O 0 5.675710568198156e-09
the O 0 2.274656054623847e-07
DM O 1 0.9999977350234985
protein O 0 1.6552469617181487e-07
kinase O 0 6.165029731164395e-08
gene O 0 4.969467504167824e-09
( O 0 1.2986985098439874e-10
DMPK O 0 1.7137565464508953e-06
) O 0 3.2921779885564106e-11
is O 0 1.1510127920222324e-11
responsible O 0 9.997475070022688e-10
for O 0 9.19112252972809e-09
causing O 1 0.9999990463256836
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9922045469284058
DM B-Disease 1 1.0
) O 0 6.105047845039735e-08
. O 0 6.833183618937255e-08

Major O 0 9.712514838611241e-06
instability O 0 0.0002661850885488093
, O 0 1.045283681833098e-08
with O 0 3.522843128322961e-10
very O 0 2.0769062858416731e-10
large O 0 1.2347017852576414e-10
expansions O 0 1.1290226531457392e-09
between O 0 5.032101957347379e-10
generations O 0 4.01720184894927e-10
and O 0 1.0791693233480615e-10
high O 0 4.87386975223103e-09
levels O 0 2.632587481343762e-09
of O 0 3.998810615968296e-09
somatic O 0 8.816606396067073e-07
mosaicism O 0 6.182980996527476e-06
, O 0 9.582361293336561e-11
is O 0 1.280037360829045e-11
observed O 0 9.610297002637935e-10
in O 0 9.129842992727788e-10
patients O 0 2.9724007699627464e-09
. O 0 2.1486892265443203e-08

There O 0 3.3743717153811303e-08
is O 0 1.0256797633445558e-09
a O 0 4.5729889319723327e-10
good O 0 1.5333202763034848e-10
correlation O 0 1.842938301965802e-10
between O 0 1.2310474861720877e-10
repeat O 0 6.8428058774827605e-09
size O 0 1.4647406898493642e-10
( O 0 1.6792045184899074e-11
at O 0 9.510371379306548e-10
least O 0 1.2769014144653479e-11
in O 0 1.850658515323289e-11
leucocytes O 0 2.2387538933799078e-08
) O 0 7.841234606065228e-12
, O 0 4.906732572335093e-12
clinical O 0 2.3602233500952252e-09
severity O 0 3.187803088167129e-08
and O 0 1.0954008533570203e-10
age O 0 3.550583604905455e-09
of O 0 4.3841449581805136e-08
onset O 1 0.9997819066047668
. O 0 3.1673243938712403e-07

The O 0 1.3701122043130454e-05
trinucleotide O 0 0.09180217236280441
repeat O 0 1.952495404111687e-05
instability O 0 4.885670932708308e-05
mechanisms O 0 4.059305865666829e-06
involved O 0 1.7636885729643836e-08
in O 0 1.137249512339622e-07
DM B-Disease 1 1.0
and O 0 2.6203654357459527e-08
other O 0 2.657307041076251e-09
human O 0 0.013907797634601593
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 8.164433573654151e-10
unknown O 0 4.0011780555460064e-08
. O 0 1.6833757499057356e-08

We O 0 9.133313660925069e-09
studied O 0 2.2684856659793695e-08
somatic O 0 6.343113767570685e-08
instability O 0 1.5331757197145635e-08
by O 0 3.570731765822899e-10
measuring O 0 1.9754283187012334e-07
the O 0 5.341916775591926e-08
CTG O 0 1.9689650798682123e-05
repeat O 0 3.571784290556934e-08
length O 0 4.5392020697754276e-10
at O 0 4.301765610392749e-09
several O 0 3.2288467038954494e-11
ages O 0 6.217677761544138e-11
in O 0 1.0030737525312805e-11
various O 0 1.722169629125858e-11
tissues O 0 1.6088348708809264e-10
of O 0 2.8903170967709002e-09
transgenic O 0 4.1665074945740344e-07
mice O 0 1.5397275676676259e-09
carrying O 0 6.645893557699623e-11
a O 0 1.3673447096795854e-10
( O 0 1.0757147256290622e-10
CTG O 0 7.789091682752769e-07
) O 0 1.034571803226747e-10
55expansion O 0 3.862955466615858e-08
surrounded O 0 2.235927665239501e-09
by O 0 3.485354019283626e-11
45 O 0 8.295314435358137e-10
kb O 0 8.924075700633693e-08
of O 0 1.4958269289877535e-08
the O 0 6.216844639084229e-08
human O 0 2.0139129901508568e-06
DM B-Disease 1 1.0
region O 0 4.912182660632425e-08
, O 0 3.136965409655801e-10
using O 0 4.3598327725824504e-10
small O 0 3.286071192931672e-09
- O 0 3.705722235736175e-07
pool O 0 1.2700036222668132e-06
PCR O 0 4.85848340758821e-06
. O 0 3.6145496551398537e-07

These O 0 4.392755936777348e-09
mice O 0 1.3648966401547113e-08
have O 0 3.1947066519988354e-11
been O 0 2.5911871606720815e-11
shown O 0 1.4998642952623875e-11
to O 0 3.779217390420531e-12
reproduce O 0 2.4395602205018463e-10
the O 0 1.5235310235617305e-10
intergenerational O 0 3.514040614049918e-09
and O 0 6.145860903528089e-11
somatic O 0 9.467247430450243e-09
instability O 0 1.6919091905265304e-08
of O 0 1.0242882098054906e-08
the O 0 2.4310343960110004e-08
55 O 0 1.2931316462072573e-07
CTG O 0 3.3259108022321016e-05
repeat O 0 1.0310314024764011e-07
suggesting O 0 1.198000254554188e-09
that O 0 9.77961114867476e-12
surrounding O 0 2.9082880548259027e-10
sequences O 0 1.6345164111086774e-10
and O 0 5.2056480653872583e-11
the O 0 1.2949592509414742e-09
chromatin O 0 2.4296250344946202e-08
environment O 0 3.2332130306400586e-09
are O 0 4.8455822687643035e-12
involved O 0 2.108453342475336e-11
in O 0 2.575411273131323e-10
instability O 0 1.404065528731735e-06
mechanisms O 0 2.5066933631023858e-06
. O 0 2.2589441073250782e-07

As O 0 4.936195896476647e-09
observed O 0 2.4833393119649827e-09
in O 0 5.96589166956818e-11
some O 0 1.1325673905659972e-11
of O 0 1.0866199051662306e-09
the O 0 3.539210924330405e-09
tissues O 0 2.0281003543232146e-08
of O 0 3.076092980336398e-05
DM B-Disease 1 1.0
patients O 0 2.7911205791042448e-08
, O 0 7.042985639138521e-11
there O 0 4.368837583368368e-11
is O 0 3.6788738722037806e-11
a O 0 5.6808276832631677e-11
tendency O 0 4.442726742048819e-11
for O 0 4.654871627041146e-11
repeat O 0 8.97834695479105e-09
length O 0 4.0094014219782537e-10
and O 0 1.2549805639139322e-10
somatic O 0 2.9804184009663004e-08
mosaicism O 0 3.047316354809482e-08
to O 0 1.6074928931367194e-12
increase O 0 3.30303883203098e-12
with O 0 3.4015828348499255e-12
the O 0 7.079163921730469e-10
age O 0 1.7771237814656615e-09
of O 0 8.982595112172476e-09
the O 0 2.1230892599533036e-08
mouse O 0 2.0686167090389063e-07
. O 0 2.5843204909392625e-08

Furthermore O 0 1.2287034678593045e-07
, O 0 1.925388293244623e-09
we O 0 7.406723151470729e-11
observed O 0 8.975564042001949e-11
no O 0 1.1097996653608444e-11
correlation O 0 2.4903903592110588e-11
between O 0 5.0695159875546736e-11
the O 0 2.4565152134670143e-09
somatic O 0 2.483611467596347e-07
mutation O 0 4.5453991681654315e-09
rate O 0 1.7572606703097904e-09
and O 0 1.1296467927746079e-10
tissue O 0 8.799120365665658e-08
proliferation O 0 0.0004205307050142437
capacity O 0 2.2781946995564795e-07
. O 0 2.4387995622987546e-08

The O 0 5.604658213087532e-07
somatic O 0 3.881385509885149e-06
mutation O 0 2.1769052338527217e-08
rates O 0 3.1266207400904023e-09
in O 0 4.223283528448363e-11
different O 0 1.4449076700742691e-12
tissues O 0 2.920194364097739e-10
were O 0 3.350325572526458e-10
also O 0 2.3627433343165194e-11
not O 0 2.772988652935404e-12
correlated O 0 2.841577494139269e-11
to O 0 5.828133548685388e-12
the O 0 7.14729941897474e-10
relative O 0 2.4878684001805595e-08
inter O 0 2.910460807470372e-06
- O 0 1.2380131364508884e-09
tissue O 0 2.1318111165236076e-10
difference O 0 8.621580532830464e-11
in O 0 1.922303982659912e-11
transcriptional O 0 7.32159499694518e-10
levels O 0 3.052455788132846e-10
of O 0 1.0095618091510161e-10
the O 0 2.0325752192462687e-10
three O 0 2.183634523200695e-11
genes O 0 4.0793562972041286e-11
( O 0 3.412638574507021e-11
DMAHP O 0 7.415570962621132e-06
, O 0 2.2410853173226997e-09
DMPK O 0 6.348757324303733e-06
and O 0 1.50132262177749e-09
59 O 0 7.649355815431136e-09
) O 0 3.827291608637928e-11
surrounding O 0 6.42303377151876e-10
the O 0 2.612758231990142e-09
repeat O 0 1.554824393679155e-07
. O 0 8.81023343168863e-09
. O 0 5.697611982213857e-08

A O 0 2.9651607746927766e-07
novel O 0 1.7985529510156084e-08
missense O 0 1.8164634241202293e-07
mutation O 0 6.8824408394618786e-09
in O 0 9.923232235919954e-10
patients O 0 2.2565728452494938e-10
from O 0 2.5849192231142126e-10
a O 0 1.563739893128968e-08
retinoblastoma B-Disease 0 9.907560888677835e-05
pedigree O 0 9.232203979081532e-08
showing O 0 7.547098057614221e-09
only O 0 1.3216837346785582e-10
mild O 0 1.4745452858733188e-07
expression O 0 2.7049464890183117e-09
of O 0 9.495077613053127e-09
the O 0 1.3653784769473987e-08
tumor B-Disease 0 3.888087576342514e-06
phenotype O 0 4.032228773098723e-08
. O 0 8.053421041154252e-09

We O 0 1.1000941491090543e-08
have O 0 9.690101498982528e-11
used O 0 4.68809747966592e-11
single O 0 6.543910413547849e-10
strand O 0 2.120603248556563e-09
conformation O 0 4.811942511118161e-10
polymorphism O 0 8.768314546658829e-11
analysis O 0 5.675571991548001e-12
to O 0 1.129723159638829e-12
study O 0 3.873202539944609e-12
the O 0 6.307671052141473e-11
27 O 0 3.2101024061148564e-09
exons O 0 2.090169815005538e-08
of O 0 1.674753780100957e-09
the O 0 6.488618531363954e-09
RB1 O 0 7.049392252156395e-07
gene O 0 1.4096916689521066e-10
in O 0 6.885135257067576e-12
individuals O 0 5.570115766198591e-13
from O 0 9.335633828488898e-12
a O 0 6.377122718781436e-10
family O 0 1.203920990677787e-10
showing O 0 2.4870713488667207e-08
mild O 0 4.994831670046551e-06
expression O 0 3.5929659247813106e-08
of O 0 7.919061317807063e-08
the O 0 4.610196313592496e-08
retinoblastoma B-Disease 0 1.6868694729055278e-05
phenotype O 0 2.3761472789374238e-07
. O 0 5.274648628983414e-08

In O 0 4.532743957952334e-08
this O 0 1.7221088999264111e-09
family O 0 1.0540482930920803e-09
affected O 0 3.965821004925374e-10
individuals O 0 8.050598382380869e-12
developed O 0 1.6680090197951358e-08
unilateral B-Disease 1 0.9849860668182373
tumors I-Disease 1 1.0
and O 0 1.1772812058552518e-08
, O 0 7.28219484713577e-10
as O 0 2.422672340518517e-10
a O 0 2.151073486000854e-10
result O 0 2.626046602394183e-10
of O 0 1.5704733069554777e-09
linkage O 0 1.542470862148093e-08
analysis O 0 3.115594171543279e-10
, O 0 1.1509826425282199e-10
unaffected O 0 1.2786800951403166e-08
mutation O 0 7.229714604761739e-10
carriers O 0 6.927198398232193e-11
were O 0 6.290309939593897e-11
also O 0 2.150432609759889e-11
identified O 0 1.9372266291117768e-10
within O 0 6.229681770442141e-10
the O 0 6.506377658865858e-09
pedigree O 0 2.1283749163103494e-07
. O 0 9.502220166268671e-08

A O 0 4.432568232459744e-07
single O 0 1.1784584863505643e-08
band O 0 3.9507025206830804e-08
shift O 0 3.2645310898971047e-09
using O 0 2.218767669592836e-10
SSCP O 0 8.540907288079325e-07
was O 0 5.109369372036099e-09
identified O 0 1.4681866833399226e-10
in O 0 5.46682560331746e-11
exon O 0 9.121823296709408e-09
21 O 0 1.6715497874741914e-09
which O 0 1.830329637853012e-11
resulted O 0 5.257578261641527e-10
in O 0 7.737537693897067e-11
a O 0 8.023518516253603e-10
missense O 0 1.547648587063577e-08
mutation O 0 8.117571059784723e-10
converting O 0 2.560185841105067e-09
a O 0 2.7804021307531457e-09
cys O 0 1.0905844646913465e-05
- O 0 5.80536209326965e-07
- O 0 2.90980125328133e-07
> O 0 5.063469643573626e-07
arg O 0 3.7295367860679107e-07
at O 0 1.557156359410783e-08
nucleotide O 0 5.803295621831239e-09
position O 0 2.5463116060109314e-09
28 O 0 4.686680821208711e-09
in O 0 5.888567411460599e-10
the O 0 1.7663715823346138e-08
exon O 0 3.502524350551539e-06
. O 0 8.57671835774454e-08

The O 0 3.8758346931899723e-07
mutation O 0 1.1503281172053903e-07
destroyed O 0 2.336637862754287e-06
an O 0 4.227317162985855e-09
NdeI O 0 7.662093594262842e-06
restriction O 0 6.760146220585739e-07
enzyme O 0 3.103018642036659e-08
site O 0 6.556572884619527e-08
. O 0 3.868551701202705e-08

Analysis O 0 1.569767427156421e-08
of O 0 4.887202464942675e-08
all O 0 4.874297410140116e-09
family O 0 1.174979002982468e-09
members O 0 1.4024667538414803e-10
demonstrated O 0 2.674063748209221e-10
that O 0 1.1749531902971455e-11
the O 0 1.5309833401033757e-09
missense O 0 2.718229836773389e-07
mutation O 0 9.999276073813235e-08
co O 0 2.697214995350805e-06
- O 0 3.3371288736816496e-05
segregated O 0 1.2715664524876047e-05
with O 0 2.09120143424002e-09
patients O 0 2.9819819502563405e-08
with O 0 5.476393738490515e-08
tumors B-Disease 1 1.0
or O 0 2.740704303505481e-07
who O 0 1.0675970329998563e-08
, O 0 6.13324058207354e-10
as O 0 3.1752567242193663e-10
a O 0 1.9763018999086057e-10
result O 0 2.9909674736927627e-10
of O 0 8.595132938715722e-10
linkage O 0 8.635132608958429e-09
analysis O 0 5.601807559485472e-11
had O 0 9.622012908661048e-11
been O 0 4.570501269118843e-11
predicted O 0 1.2461486287307366e-09
to O 0 1.154292980642957e-11
carry O 0 2.0608774409236474e-10
the O 0 7.919390476729404e-09
predisposing O 0 1.3311288284967304e-06
mutation O 0 4.7169683625725156e-07
. O 0 8.179607391411992e-08

These O 0 1.6619490228464429e-09
observations O 0 6.073165526032653e-09
point O 0 1.4013184390648803e-08
to O 0 8.811484875081987e-11
another O 0 1.6732906726879548e-10
region O 0 1.377433611615686e-09
of O 0 8.656026118103455e-09
the O 0 7.355095732464179e-08
RB1 O 0 7.426590855175164e-06
gene O 0 1.1572480751453895e-09
where O 0 1.6956842874282785e-10
mutations O 0 1.8989521760603978e-11
only O 0 5.7218865062713675e-12
modify O 0 1.546392354445647e-11
the O 0 7.488230174823585e-11
function O 0 3.398758496864218e-10
of O 0 9.077837370696784e-10
the O 0 1.3740224513725252e-09
gene O 0 1.3512115870639718e-09
and O 0 6.711369654466282e-11
raise O 0 8.038557319789419e-11
important O 0 1.0623714408186657e-10
questions O 0 2.0939694422850152e-11
for O 0 1.1187882564822615e-10
genetic O 0 3.216895194668723e-08
counseling O 0 5.478362763433609e-10
in O 0 6.830372378807681e-11
families O 0 2.0793419069908836e-12
with O 0 5.907066936289285e-12
these O 0 1.0230571945157863e-10
distinctive O 0 2.121085707074144e-08
phenotypes O 0 1.915857517076347e-08
. O 0 3.768965584072248e-09
. O 0 6.832910059983988e-08

Maternal B-Disease 0 8.289350080303848e-05
disomy I-Disease 0 0.01336010079830885
and O 0 0.0002971029025502503
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.20022696256637573
with O 0 3.4019969064047473e-09
gamete O 0 1.0524292520130984e-05
complementation O 1 0.9999527931213379
in O 0 3.933557035651347e-09
a O 0 9.153259261651669e-10
case O 0 2.7046456740897895e-10
of O 0 1.959659545747172e-09
familial O 0 1.8394848666503094e-07
translocation O 0 3.9046091160344076e-07
( O 0 1.291034917860756e-10
3 O 0 4.99891861238666e-09
; O 0 5.672422167396496e-12
15 O 0 1.1362635138345567e-10
) O 0 1.2377705197602618e-12
( O 0 2.5928371862743438e-12
p25 O 0 1.3758345573933184e-09
; O 0 3.658411681234375e-12
q11 O 0 1.0636493907867361e-09
. O 0 2.0915425641421237e-11
2 O 0 2.096541162899257e-09
) O 0 8.072020135641012e-11
. O 0 1.5160066535457872e-09

Maternal B-Disease 0 0.00047389630344696343
uniparental I-Disease 1 0.9935075044631958
disomy I-Disease 1 0.9889513850212097
( I-Disease 0 4.0108079701894894e-06
UPD I-Disease 1 0.9999998807907104
) I-Disease 0 1.1505091324082173e-09
for I-Disease 0 6.442395505956711e-10
chromosome I-Disease 0 3.152341321310814e-08
15 I-Disease 0 8.235978121717835e-09
is O 0 7.805887880518725e-11
responsible O 0 3.2940516980772827e-10
for O 0 1.3977579510493499e-11
an O 0 3.6018718389818627e-12
estimated O 0 3.23418444803103e-11
30 O 0 5.5849831703813635e-11
% O 0 6.768753092745161e-12
of O 0 5.869132957414536e-11
cases O 0 7.192150347501425e-11
of O 0 1.4373071053341846e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9997770190238953
PWS B-Disease 1 1.0
) O 0 3.4314490449105506e-07
. O 0 3.7369065353232145e-07

We O 0 8.232742487734868e-09
report O 0 2.7035729210922455e-10
on O 0 5.909349121147045e-10
an O 0 1.846033222119292e-11
unusual O 0 4.5877357468526725e-10
case O 0 7.17201631417197e-10
of O 0 1.527451942706648e-08
maternal B-Disease 0 1.2088098344520404e-07
disomy I-Disease 0 9.166016752715223e-06
15 I-Disease 0 8.839811727057167e-08
in O 0 3.085466815377913e-08
PWS B-Disease 1 1.0
that O 0 1.3309654767201806e-10
is O 0 5.634340216609246e-11
most O 0 5.947210605927733e-12
consistent O 0 2.1207234579545542e-10
with O 0 9.147455362623624e-12
adjacent O 0 2.6728770308181993e-09
- O 0 9.43646827344935e-10
1 O 0 3.489782685051068e-08
segregation O 0 8.129491675390454e-07
of O 0 4.076848192369198e-09
a O 0 2.375515562036412e-09
paternal O 0 1.580835684578119e-09
t O 0 1.4002889958675269e-09
( O 0 4.781580947160746e-12
3 O 0 2.725853154306179e-10
; O 0 1.1567210947763251e-12
15 O 0 4.936614658723748e-11
) O 0 1.328060491440075e-12
( O 0 1.4970197390745676e-12
p25 O 0 7.813951152790821e-10
; O 0 1.6242280957701194e-12
q11 O 0 2.1806181860206664e-10
. O 0 2.359463536008577e-12
2 O 0 6.736840252319354e-11
) O 0 3.6301823634794783e-13
with O 0 2.1578518052262075e-12
simultaneous O 0 6.575267441633059e-09
maternal O 0 2.9319396688265442e-08
meiotic O 0 2.384410890954314e-06
nondisjunction O 0 1.6907920326048043e-06
for O 0 1.1751230211132224e-08
chromosome O 0 4.396823669594596e-07
15 O 0 1.8696574954901735e-07
. O 0 6.959535170381059e-08

The O 0 4.74819131568438e-07
patient O 0 1.781669851652623e-07
( O 0 1.523607240372371e-09
J O 0 1.231647274835268e-05
. O 0 2.529493836611607e-10
B O 0 8.441698895467198e-09
. O 0 2.7933785926720356e-12
) O 0 3.0720995951132035e-13
, O 0 8.33689129016435e-13
a O 0 1.2048645067763708e-11
17 O 0 2.7244342892807083e-10
- O 0 2.119510261744395e-10
year O 0 2.492858142133514e-10
- O 0 8.709517551608315e-09
old O 0 4.481739068751267e-08
white O 0 3.835802342422312e-09
male O 0 1.8166168569422325e-10
with O 0 2.638477769600911e-10
PWS B-Disease 1 1.0
, O 0 2.0092330021981297e-09
was O 0 9.378481102828573e-09
found O 0 5.35464970974342e-11
to O 0 7.88481779867567e-12
have O 0 2.4310864085719253e-11
47 O 0 5.604653408042282e-10
chromosomes O 0 1.0152776536154207e-10
with O 0 3.532699133224071e-11
a O 0 9.634014475068398e-09
supernumerary O 0 6.0403863244573586e-06
, O 0 4.1735734312986494e-10
paternal O 0 1.4003878057167185e-09
der O 0 3.818456661974778e-06
( O 0 3.002529128104392e-11
15 O 0 1.180283787372005e-10
) O 0 2.3178206316060157e-12
consisting O 0 2.3896964268521614e-11
of O 0 5.839043693001145e-10
the O 0 1.0820332185801362e-08
short O 0 1.1239310815369663e-08
arm O 0 9.324831040657955e-08
and O 0 5.451421092317332e-09
the O 0 5.107223728373356e-07
proximal O 0 6.189235136844218e-05
long O 0 4.7548343218295486e-07
arm O 0 4.3744645950027916e-07
of O 0 2.413101185538835e-07
chromosome O 0 1.430585825801245e-06
15 O 0 2.1217255152805592e-07
, O 0 1.745858457802285e-09
and O 0 2.7910926903018662e-09
distal O 0 1.3654014310304774e-06
chromosome O 0 0.00033630614052526653
arm O 0 0.0009881701553240418
3p O 0 0.062234580516815186
. O 0 4.946678927808534e-06

The O 0 1.4145514342089882e-06
t O 0 1.2032626273139613e-07
( O 0 1.451884584779961e-10
3 O 0 2.468798276922257e-09
; O 0 3.214674403409501e-12
15 O 0 1.0897367730411389e-10
) O 0 1.0024707843350744e-12
was O 0 6.807182595380823e-11
present O 0 8.305264462271644e-12
in O 0 9.991402670495031e-12
the O 0 8.062634587746587e-11
balanced O 0 2.4677801468975247e-10
state O 0 7.799008834574739e-12
in O 0 2.680890232031885e-11
the O 0 7.766788878704745e-10
patients O 0 1.532452081898228e-10
father O 0 7.523036082979218e-10
and O 0 1.178439901217132e-09
a O 0 3.00000913000531e-08
sister O 0 3.6547825743582507e-07
. O 0 4.879555604020425e-07

Fluorescent O 0 2.7123621748614823e-07
in O 0 1.6439782868360453e-09
situ O 0 2.2019694512209753e-08
hybridization O 0 3.7092076632383453e-10
analysis O 0 4.3399266819177384e-11
demonstrated O 0 1.5891545024349085e-10
that O 0 1.4229141302724013e-11
the O 0 6.9235066568751336e-09
PWS B-Disease 1 1.0
critical O 0 1.1160271817800549e-08
region O 0 4.1527453698009253e-10
resided O 0 7.010474978308423e-10
on O 0 4.162522826423043e-10
the O 0 1.601529880934649e-10
derivative O 0 3.8055869566733236e-10
chromosome O 0 5.791482293737715e-10
3 O 0 7.67191199457784e-10
and O 0 1.7472682372135506e-12
that O 0 2.722607024812501e-13
there O 0 5.699469975833926e-12
was O 0 4.066493808352334e-10
no O 0 4.5511108770490694e-11
deletion O 0 2.930851950022628e-10
of O 0 1.0891928470257994e-09
the O 0 4.996051927719236e-08
PWS B-Disease 1 1.0
region O 0 1.386652481727424e-08
on O 0 5.0222568326319106e-09
the O 0 1.1876304384372816e-09
normal O 0 4.0360355058055575e-09
pair O 0 4.5275980187220455e-10
of O 0 3.219238431384497e-09
15s O 0 4.215861082457195e-08
present O 0 6.55161591645026e-10
in O 0 1.039022290427738e-08
J O 0 0.001467670314013958
. O 0 4.04772549700283e-07

B O 0 0.003623096738010645
. O 0 7.195739271992352e-06

Methylation O 0 6.143362156763033e-07
analysis O 0 1.8891071817961347e-08
at O 0 9.969491543415643e-08
exon O 0 1.2018051620543702e-07
alpha O 0 1.035548180539081e-08
of O 0 1.1600769234121344e-09
the O 0 1.4373782164511795e-09
small O 0 7.630436837935406e-10
nuclear O 0 3.771168337607378e-07
ribonucleoprotein O 0 1.7426629028705065e-07
- O 0 1.8074461038963818e-08
associated O 0 6.363177540436027e-09
polypeptide O 0 1.9513954896410723e-07
N O 0 7.562388759652094e-07
( O 0 9.917738852394109e-11
SNRPN O 0 6.643786036875099e-07
) O 0 1.4654638613720294e-11
gene O 0 5.626682800241589e-11
showed O 0 7.67767516229867e-11
a O 0 2.2677641015045324e-11
pattern O 0 4.040786039105626e-10
characteristic O 0 4.704889366990983e-09
of O 0 3.399784898050484e-09
only O 0 1.9974100151642915e-10
the O 0 1.010645123145082e-09
maternal O 0 4.808550446711024e-09
chromosome O 0 1.964218121486283e-08
15 O 0 2.072547466980268e-08
in O 0 5.74740255387951e-09
J O 0 0.0010598551016300917
. O 0 2.218990431401835e-07

B O 0 0.004654879681766033
. O 0 8.029586751945317e-06

Maternal B-Disease 0 2.796401986415731e-06
disomy I-Disease 0 5.124596100358758e-06
was O 0 1.7992192624660674e-07
confirmed O 0 6.3373426506529995e-09
by O 0 2.6434845978862143e-10
polymerase O 0 6.74494726737862e-09
chain O 0 7.004036461921714e-09
reaction O 0 1.4616846621962054e-10
analysis O 0 5.010865333776593e-11
of O 0 6.637384530883139e-10
microsatellite O 0 3.4870744514137186e-08
repeats O 0 4.338300829687114e-09
at O 0 1.7475716873605052e-08
the O 0 9.119839994298218e-09
gamma O 0 2.9451345540110196e-07
- O 0 1.7816461195252487e-07
aminobutyric O 0 1.948284307218273e-06
acid O 0 9.296665126612425e-08
receptor O 0 2.4925181918433736e-08
beta3 O 0 3.242336390485434e-07
subunit O 0 2.1530459193286333e-08
( O 0 5.750184217667709e-10
GABRB3 O 0 2.1849600670975633e-06
) O 0 1.4766350364681102e-09
locus O 0 1.7336917323973466e-07
. O 0 6.778959971143195e-08

A O 0 5.5361702834488824e-05
niece O 0 2.0560089524224168e-06
( O 0 4.969221034656357e-09
B O 0 4.2129514099542575e-07
. O 0 1.7514141525953875e-10
B O 0 5.7754685478528245e-09
. O 0 4.869420405090308e-12
) O 0 1.706850399950735e-13
with O 0 7.203001758417094e-13
45 O 0 1.0109337672536967e-10
chromosomes O 0 1.8124212200487655e-11
and O 0 9.165129592758614e-12
the O 0 1.187387410617191e-10
derivative O 0 5.071366104836272e-10
3 O 0 9.094526243202949e-10
but O 0 4.242892929356978e-12
without O 0 4.618627095359651e-12
the O 0 4.949559512246182e-11
der O 0 2.7005967240256723e-08
( O 0 2.165425607922322e-12
15 O 0 4.2120612553375736e-11
) O 0 2.300976466654281e-12
demonstrated O 0 6.65611871175642e-11
a O 0 7.27092136498797e-11
phenotype O 0 3.29016480726807e-10
consistent O 0 2.033932466893873e-10
with O 0 2.384277454289818e-12
that O 0 1.513017467390243e-12
reported O 0 1.6992577483998517e-11
for O 0 8.312447258296274e-11
haploinsufficiency O 0 7.91685351941851e-07
of O 0 2.994927115196333e-07
distal O 0 1.0704106898629107e-06
3 O 0 1.4316230590338819e-05
p O 0 3.963549170293845e-05
. O 0 4.813085752175539e-07

Uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999983310699463
associated O 0 6.48570107841806e-07
with O 0 4.7650545731414695e-09
unbalanced O 0 2.091124315484194e-06
segregation O 0 5.6789729569572955e-05
of O 0 1.1859948045866986e-07
non O 0 2.3761003831168637e-06
- O 0 5.47739666956204e-08
Robertsonian O 0 1.7256912769880728e-06
translocations O 0 1.2263245707799797e-07
has O 0 3.292160988266346e-10
been O 0 5.552269755071393e-11
reported O 0 1.179844832943644e-10
previously O 0 1.631972113003144e-09
but O 0 2.1489728399548547e-11
has O 0 1.925180848072472e-11
not O 0 6.83452600069856e-12
, O 0 1.0277113361711887e-11
to O 0 3.479526779551212e-12
our O 0 4.2672917283104184e-11
knowledge O 0 7.794447032249963e-11
, O 0 8.695330046271099e-12
been O 0 4.9775990620948285e-12
observed O 0 3.4451885788655545e-11
in O 0 2.8759229372954387e-11
a O 0 4.956317023463441e-10
case O 0 3.4339278087713865e-09
of O 0 1.7476759239798412e-07
PWS B-Disease 1 1.0
. O 0 4.238479505147552e-06

Furthermore O 0 5.245844363344077e-07
, O 0 8.839858622877728e-09
our O 0 2.1754014145614065e-09
findings O 0 1.8717745409180253e-10
are O 0 3.381206772901102e-12
best O 0 2.6304066563787032e-11
interpreted O 0 6.388527207246142e-11
as O 0 6.752302883494821e-11
true O 0 1.1283488587920942e-09
gamete O 0 1.306344756812905e-07
complementation O 0 0.0003017660928890109
resulting O 0 2.5350507470989214e-08
in O 0 1.62337965292636e-08
maternal B-Disease 0 8.369161150767468e-06
UPD I-Disease 1 1.0
15 I-Disease 0 2.774926724669058e-05
and O 0 1.1151525541208684e-05
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9993403553962708
- I-Disease 1 0.9999954700469971
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 2.7277934350422584e-05
2 I-Disease 0 0.0010596314677968621
and O 0 6.118080619899047e-08
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 3.332107256781569e-09
a O 0 1.4874842468870497e-09
case O 0 2.2045137937354298e-10
for O 0 7.864454920625263e-11
" O 0 4.865157610112192e-09
lumping O 0 4.568704170537785e-08
" O 0 8.752019198254857e-08
. O 0 1.9639561088524715e-08

Recent O 0 1.5290462229700097e-08
studies O 0 2.0183208437885014e-09
demonstrated O 0 2.255313047427876e-09
the O 0 3.7689779075478214e-10
existence O 0 2.1086001833481305e-09
of O 0 3.7293141907923655e-09
a O 0 8.396655815090526e-09
genetically O 0 1.1569882829576272e-08
distinct O 0 4.997533498141138e-10
, O 0 1.5844452139202048e-10
usually O 0 5.755141155305843e-11
lethal O 0 2.3049286923537693e-09
form O 0 4.7668681502077703e-11
of O 0 1.4000299808358818e-09
the O 0 1.3110894592216482e-08
Schwartz B-Disease 0 0.35053741931915283
- I-Disease 1 0.9986086487770081
Jampel I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
( O 0 7.935584633855797e-09
SJS B-Disease 1 0.9937440752983093
) O 0 1.1409724276489897e-09
of O 0 1.2661699884120026e-06
myotonia B-Disease 1 1.0
and O 0 0.4289628863334656
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 3.604742175866704e-07
which O 0 2.131283816098062e-09
we O 0 1.886085509994473e-09
called O 0 3.016436664893263e-07
SJS B-Disease 0 0.018341800197958946
type I-Disease 0 4.0548613355895213e-07
2 I-Disease 0 3.930757884518243e-06
. O 0 5.952341197712485e-08

This O 0 8.1952549635389e-08
disorder O 0 0.23435336351394653
is O 0 1.5036353273600866e-09
reminiscent O 0 1.87104532756166e-07
of O 0 1.6409622105584276e-08
another O 0 5.536317626564369e-09
rare O 0 5.396171331994992e-08
condition O 0 7.529609433731821e-07
, O 0 5.228028565618104e-10
the O 0 1.9652750538057262e-08
Stuve B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.926058659928458e-08
SWS B-Disease 1 0.9999998807907104
) O 0 1.722032655360195e-10
, O 0 3.9535985596472756e-11
which O 0 3.6058604019340024e-11
comprises O 0 1.3843843849059567e-09
campomelia B-Disease 0 1.5371366316685453e-05
at O 0 3.78714457838214e-06
birth O 0 1.90134539934661e-06
with O 0 7.582335825873088e-08
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 2.7637651101031224e-07
contractures B-Disease 0 0.023417752236127853
, O 0 1.3476545435153753e-09
and O 0 3.7716457734759956e-10
early B-Disease 0 4.7148995463430765e-07
death I-Disease 0 5.659730959450826e-06
. O 0 1.2068494470440783e-07

To O 0 9.492868713323332e-09
test O 0 1.5065642955391922e-08
for O 0 5.195710528482778e-10
possible O 0 2.6390074570059596e-09
nosologic O 0 5.202181796448713e-07
identity O 0 4.1964987040898905e-10
between O 0 2.942513732673291e-10
these O 0 2.5817312176990015e-10
disorders O 0 0.009707711637020111
, O 0 3.4724809833130976e-11
we O 0 4.874736465182439e-12
reviewed O 0 9.381616143666616e-12
the O 0 4.454867030823095e-12
literature O 0 1.2021231449513281e-12
and O 0 5.385895722465062e-13
obtained O 0 3.826465186373973e-12
a O 0 1.632353453795421e-11
follow O 0 1.5318286569754314e-11
- O 0 2.9101289086841398e-11
up O 0 7.615192330889808e-12
of O 0 1.0752368440059001e-10
the O 0 3.475829069010672e-10
only O 0 5.458448623651968e-11
two O 0 7.222778625193271e-11
surviving O 0 6.32323065019591e-08
patients O 0 2.203038446113581e-10
, O 0 3.570110179706987e-11
one O 0 3.4560482947698645e-11
with O 0 3.5836475453798755e-10
SJS B-Disease 1 0.9538366794586182
type I-Disease 0 5.444938437904057e-07
2 I-Disease 0 3.5944578939961502e-06
at O 0 1.9885282753762112e-08
age O 0 2.3862814502173535e-10
10 O 0 5.825958465655035e-11
years O 0 1.3544563040590596e-11
and O 0 6.628092172333844e-12
another O 0 2.711658848852938e-11
with O 0 9.757798041798438e-11
SWS B-Disease 1 0.9897072315216064
at O 0 2.1190400900650275e-07
age O 0 1.3854628555520776e-08
7 O 0 2.1820230244884442e-07
years O 0 2.3589597830664388e-08
. O 0 5.566965199932383e-08

Patients O 0 2.723044900676541e-08
reported O 0 1.6250734091727281e-09
as O 0 1.1035590219421465e-09
having O 0 1.003471350458085e-08
either O 0 6.113787520689584e-08
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 1.5739834680061904e-07
SWS B-Disease 1 0.9999681711196899
presented O 0 1.3815731669808429e-08
a O 0 1.9855737887208846e-10
combination O 0 3.9835226783857536e-10
of O 0 8.141543550443942e-10
a O 0 1.1883849460048168e-09
severe O 0 0.00017426445265300572
, O 0 2.2701767132815576e-09
prenatal O 1 0.999929666519165
- O 1 0.9999849796295166
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 3.1255835697407974e-09
with O 0 1.793904402802582e-07
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9344536066055298
respiratory O 1 1.0
and O 0 3.546203686255467e-07
feeding O 0 2.54084085327122e-07
difficulties O 0 8.151135375555896e-07
, O 0 5.218096510439807e-10
tendency O 0 3.937218329141956e-10
to O 0 3.828569752895028e-11
hyperthermia B-Disease 1 0.9078505635261536
, O 0 1.1117175235941801e-10
and O 0 1.4003491075054164e-11
frequent O 0 1.524592119217516e-10
death O 0 7.225265719057461e-09
in O 0 2.731896098229214e-10
infancy O 0 5.302193351042206e-09
) O 0 1.911597399470444e-12
with O 0 4.346013132705551e-12
a O 0 9.424434566085438e-10
distinct O 0 3.231297540651212e-08
campomelic B-Disease 1 0.9999510049819946
- I-Disease 1 0.9999979734420776
metaphyseal I-Disease 1 1.0
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.00027579820016399026

The O 0 3.864443698375908e-08
similarity O 0 2.5109081036589487e-08
of O 0 1.0166180430815075e-07
the O 0 4.8528434604122594e-08
clinical O 0 1.2562708434415981e-05
and O 0 4.534185471527508e-09
radiographic O 0 5.125354800838977e-05
findings O 0 1.4822342464526628e-08
is O 0 2.8774224669625426e-10
so O 0 1.0663071987881967e-11
extensive O 0 5.648365775101638e-09
that O 0 1.9250789851099626e-10
these O 0 1.7201819968448717e-09
disorders O 1 0.9977707862854004
appear O 0 1.6709472694387273e-09
to O 0 2.433331661166882e-11
be O 0 4.449128565564564e-11
a O 0 3.585117480664479e-10
single O 0 1.931081516914901e-09
entity O 0 6.434124344423253e-08
. O 0 1.7305234223385924e-07

The O 0 1.2609110910943855e-07
follow O 0 7.142151758898763e-09
- O 0 3.413338722779713e-09
up O 0 1.681776107265165e-10
observation O 0 6.720445089314353e-09
of O 0 1.6712787820338804e-09
an O 0 4.57518502250398e-11
identical O 0 2.0456353277964467e-10
and O 0 1.6728271545751738e-11
unique O 0 2.928739750718279e-10
pattern O 0 1.6361624943783681e-07
of O 0 0.11512676626443863
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 1.37382059506308e-07
the O 0 3.8053880757615843e-07
two O 0 2.249770814088947e-09
patients O 0 4.1532999262017256e-10
( O 0 2.3188033090870697e-11
one O 0 1.9412287055597943e-10
with O 0 5.1288386870851355e-09
SJS B-Disease 1 0.9999889135360718
type I-Disease 0 4.4768744373868685e-06
2 I-Disease 0 4.047766651638085e-06
, O 0 8.289047920273518e-11
one O 0 7.808281798915573e-12
with O 0 6.543619812671153e-11
SWS B-Disease 1 0.5832661986351013
) O 0 2.0235543796154332e-10
surviving O 0 3.453424213262224e-08
beyond O 0 3.144540627886272e-08
infancy O 0 1.8129496126562117e-08
adds O 0 9.908190240492942e-11
to O 0 5.127168221236156e-12
the O 0 1.280267419856429e-10
evidence O 0 2.562436651754041e-10
in O 0 6.074004493816787e-11
favor O 0 1.0120146942682595e-09
of O 0 2.639636731416317e-09
identity O 0 1.9551242402826574e-08
. O 0 5.539753544780979e-08

The O 0 3.122248699582997e-07
hypothesis O 0 2.154808953491738e-07
that O 0 2.956343170268383e-09
SWS B-Disease 1 0.9996111989021301
and O 0 1.6972883543076023e-07
SJS B-Disease 1 0.9999574422836304
type I-Disease 0 2.508398210920859e-05
2 I-Disease 0 4.9931615649256855e-05
are O 0 6.030254767752652e-11
the O 0 5.701552563408541e-10
same O 0 1.3272294374644389e-09
disorder O 0 3.0557973218492407e-07
should O 0 1.264776998410877e-11
be O 0 1.9272079591903246e-12
testable O 0 6.824551340711693e-11
by O 0 1.0120112213518606e-12
molecular O 0 1.5965492816683025e-10
methods O 0 1.0304224140611495e-10
. O 0 1.6462523011462338e-10
. O 0 5.5132400866853e-09

A O 0 2.2159017589729046e-06
mouse O 0 3.990477281945459e-08
model O 0 1.29854060837431e-09
of O 0 9.870965378411256e-09
severe O 1 0.9999992847442627
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9899967908859253
defects O 1 0.9999839067459106
in O 0 2.513193564368521e-08
hemostasis O 1 0.9997037053108215
and O 0 8.234330266532197e-07
thrombosis B-Disease 1 0.998999297618866
. O 0 2.1214586013229564e-05

von B-Disease 0 0.021674424409866333
Willebrand I-Disease 1 0.9997145533561707
factor I-Disease 0 4.727307896246202e-05
( I-Disease 0 5.708140520255256e-07
vWf I-Disease 0 0.0023971605114638805
) I-Disease 0 1.1006525710399728e-05
deficiency I-Disease 1 1.0
causes O 1 0.9999840259552002
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 4.9546006266609766e-06
humans O 0 3.366502809853955e-08
. O 0 7.208554642090803e-09

We O 0 1.9909078829982718e-08
generated O 0 1.2184383502145124e-09
a O 0 2.2177617520213744e-09
mouse O 0 4.740976056183399e-09
model O 0 6.360866000587606e-11
for O 0 2.2632874741024267e-11
this O 0 3.546397203679774e-11
disease O 0 5.117288814915355e-09
by O 0 1.1376746766877943e-11
using O 0 8.927604489006313e-11
gene O 0 3.6007234971435764e-09
targeting O 0 1.8902028386946768e-08
. O 0 1.4761064370816257e-08

vWf B-Disease 0 0.001643835799768567
- I-Disease 1 0.8654990196228027
deficient I-Disease 0 0.16058512032032013
mice O 0 1.062634964910103e-06
appeared O 0 1.8493487630166783e-08
normal O 0 6.001929619969815e-09
at O 0 4.358446048513542e-09
birth O 0 6.017986664552666e-10
; O 0 2.4638928050602082e-12
they O 0 3.0897597848300595e-12
were O 0 4.642609213734161e-11
viable O 0 6.12127593058176e-09
and O 0 7.773917620745863e-10
fertile O 0 7.131550461281222e-08
. O 0 3.329237330262913e-08

Neither O 0 3.4424596378812566e-05
vWf O 0 7.634794019395486e-05
nor O 0 4.403976163303014e-06
vWf O 0 9.034883078129496e-06
propolypeptide O 0 1.3760941328655463e-05
( O 0 4.351828053472673e-08
von B-Disease 0 0.0003703086986206472
Willebrand I-Disease 1 0.655407726764679
antigen O 0 7.4462855081947055e-06
II O 1 0.9998403787612915
) O 0 2.38518482742478e-10
were O 0 1.0992729643222177e-10
detectable O 0 8.282749597299244e-09
in O 0 1.2599477017261052e-10
plasma O 0 9.421618152316569e-09
, O 0 1.0460166066650345e-10
platelets O 0 2.0577517467756934e-09
, O 0 1.3211494398479573e-10
or O 0 5.606831665616596e-11
endothelial O 0 2.5499371503201473e-09
cells O 0 8.021877606623207e-11
of O 0 1.5624354587906453e-10
the O 0 5.144532022605119e-10
homozygous O 0 1.1964777613115984e-08
mutant O 0 2.482633476574847e-07
mice O 0 7.077132124777563e-08
. O 0 4.379387075204022e-09

The O 0 2.8203729129927524e-07
mutant O 0 3.083530828007497e-06
mice O 0 3.6462009234128345e-07
exhibited O 0 2.5578790996405587e-07
defects O 0 0.00014377236948348582
in O 0 1.5007071141326378e-09
hemostasis O 0 2.1555790226557292e-05
with O 0 7.361081744150511e-10
a O 0 1.599258183659913e-07
highly O 0 7.15994701749878e-07
prolonged O 1 0.9945107698440552
bleeding O 0 0.018613647669553757
time O 0 4.157502342394537e-09
and O 0 4.837792944023533e-10
spontaneous O 0 2.8921780881319137e-07
bleeding O 0 7.635087513335748e-07
events O 0 1.7906920390942105e-10
in O 0 2.5431056566160848e-11
approximately O 0 5.9263076217230815e-12
10 O 0 8.871672840804479e-11
% O 0 1.3204717874693017e-10
of O 0 9.977439319186487e-09
neonates O 0 5.042113002673432e-07
. O 0 1.5054935431635386e-07

As O 0 9.558348779137305e-09
in O 0 3.6247566059799396e-10
the O 0 1.2521454983982494e-09
human O 0 6.462720136823918e-08
disease O 0 2.7315661554894177e-06
, O 0 3.2784927550544296e-11
the O 0 1.6339585240388033e-10
factor O 0 3.9617609193243197e-10
VIII O 0 4.9728452466979434e-08
level O 0 7.409867386343194e-09
in O 0 1.3515763161442429e-11
these O 0 3.0214051746635384e-12
mice O 0 8.772785276001116e-10
was O 0 8.737416901105632e-10
reduced O 0 1.4173627826963298e-09
strongly O 0 2.6940075170678313e-11
as O 0 2.5539110756755967e-11
a O 0 8.918839278226898e-11
result O 0 1.4239874557286925e-10
of O 0 7.107033850317634e-10
the O 0 5.590687912615522e-10
lack O 0 5.992401241883272e-09
of O 0 1.1869374372253105e-09
protection O 0 8.343556956447173e-09
provided O 0 4.2535605593307935e-10
by O 0 1.2125566106746533e-09
vWf O 0 1.6000344658095855e-06
. O 0 1.2382031400193227e-07

Defective O 0 0.18324033915996552
thrombosis B-Disease 0 9.628985026211012e-06
in O 0 1.1641247965599177e-08
mutant O 0 3.3845179814306903e-07
mice O 0 1.9490590474902092e-08
was O 0 1.7318425582502073e-09
also O 0 1.340337129479563e-11
evident O 0 5.975663019963662e-11
in O 0 3.547917602070294e-12
an O 0 7.461875084838199e-13
in O 0 9.130774261678631e-12
vivo O 0 2.7064430696555064e-09
model O 0 6.592116297277073e-10
of O 0 9.606017670193978e-08
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 4.5512974793382455e-06

In O 0 4.662509489605782e-09
this O 0 1.2869415255689631e-10
model O 0 5.679660075585957e-10
, O 0 2.1094719027114905e-10
the O 0 1.523072667986014e-09
exteriorized O 0 5.715478437195998e-07
mesentery O 0 5.60810178740212e-07
was O 0 3.1832886548954775e-08
superfused O 0 1.096004211831314e-07
with O 0 8.974251342053208e-10
ferric O 0 6.496957666968228e-06
chloride O 0 5.4128808102404946e-08
and O 0 5.514165568598628e-09
the O 0 1.8123550660220644e-08
accumulation O 0 1.821813810920503e-07
of O 0 6.630418170061603e-07
fluorescently O 0 5.704784143745201e-06
labeled O 0 3.133308723590744e-08
platelets O 0 1.9232229142573942e-09
was O 0 1.3574551482875563e-09
observed O 0 1.193386084397119e-10
by O 0 1.1817029299532322e-10
intravital O 0 2.1586345155810704e-07
microscopy O 0 6.617089809424215e-08
. O 0 6.450749623354568e-08

We O 0 4.831905187074881e-08
conclude O 0 7.882036356932076e-08
that O 0 2.7219149156820777e-10
these O 0 2.8733640466960253e-10
mice O 0 6.213667802512646e-08
very O 0 2.3897339662681816e-10
closely O 0 3.5659692976253154e-09
mimic O 0 3.1167380711849546e-06
severe O 1 0.9999594688415527
human O 1 0.9359127283096313
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 1.1642629971220231e-07
will O 0 2.010213384640025e-10
be O 0 2.847122017313186e-11
very O 0 3.758851736812563e-12
useful O 0 5.6378205055829245e-12
for O 0 6.969590703176376e-12
investigating O 0 1.2587227093963094e-10
the O 0 1.0188645760411674e-10
role O 0 2.582415947749439e-10
of O 0 9.024405667190649e-10
vWf O 0 7.480800867654125e-09
in O 0 1.3990522629292457e-10
normal O 0 1.5763411909119895e-08
physiology O 0 6.663686491492626e-08
and O 0 6.036261768205264e-11
in O 0 5.252987489434702e-10
disease O 0 3.1324716474046e-06
models O 0 2.68719513307758e-09
. O 0 1.270576421852354e-09
. O 0 2.3412408012291053e-08

Oral O 0 0.00012217331095598638
contraceptives O 0 5.801283350592712e-06
and O 0 1.5697695365801678e-09
the O 0 8.899339931645045e-09
risk O 0 9.079608389583882e-07
of O 0 0.011872298084199429
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.6458030343055725

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999942779541016
Study O 0 1.641330641177774e-06
Group O 0 4.961519266544201e-07
. O 0 4.488792910706252e-07

BACKGROUND O 0 4.185250872978941e-06
Women O 0 7.681693059424788e-10
with O 0 5.2115887994030885e-11
mutations O 0 3.160308681415813e-10
in O 0 4.874462500303878e-10
either O 0 1.001721150473145e-09
the O 0 9.999997274690031e-09
BRCA1 O 0 1.3188194536439823e-08
or O 0 1.1176962133596646e-10
the O 0 4.837703126980841e-09
BRCA2 O 0 9.589684601962745e-09
gene O 0 3.038926055243252e-10
have O 0 2.475881912683553e-12
a O 0 2.5404390396888132e-11
high O 0 3.7647551742736596e-09
lifetime O 0 3.926745151261457e-08
risk O 0 1.3542715350922663e-05
of O 1 0.9478781819343567
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0020758172031491995

Oral O 0 0.18321073055267334
contraceptives O 0 0.29710790514945984
protect O 0 3.871947683364851e-06
against O 1 0.999998927116394
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.4571828899079264e-07
general O 0 9.161168463833747e-07
, O 0 1.7709239630292473e-10
but O 0 5.306565950546904e-12
it O 0 3.789807009879631e-12
is O 0 3.99069015680209e-12
not O 0 5.392967973236185e-13
known O 0 1.5987914117610025e-11
whether O 0 3.21868703564987e-12
they O 0 4.855046486368364e-12
also O 0 1.059750117521352e-11
protect O 0 4.6161196393113e-11
against O 0 2.9272890778031524e-09
hereditary B-Disease 0 0.007060167379677296
forms I-Disease 0 5.983392838970758e-07
of I-Disease 1 0.9019857048988342
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.404482372890925e-05

METHODS O 0 9.483658232056769e-07
We O 0 7.272440427641413e-09
enrolled O 0 9.965457792304733e-09
207 O 0 1.6884534659311612e-08
women O 0 2.18640702764894e-10
with O 0 7.1809997947980264e-09
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 4.793817964809932e-08
161 O 0 3.5662619524146066e-09
of O 0 2.0253247967616517e-08
their O 0 1.9289465580385468e-09
sisters O 0 1.1318197046250589e-08
as O 0 5.247599577096196e-10
controls O 0 5.370634781343142e-08
in O 0 1.0448446552402402e-09
a O 0 3.4710276874960755e-09
case O 0 5.420957460700038e-09
- O 0 1.739533850297903e-08
control O 0 1.2369875435069844e-07
study O 0 2.6183257784140324e-09
. O 0 1.4783660517991848e-08

All O 0 1.4994489205832906e-08
the O 0 2.2807419952641794e-08
patients O 0 5.501011313135962e-10
carried O 0 3.1568145320015617e-10
a O 0 3.779920543234283e-10
pathogenic O 0 2.842311941364528e-09
mutation O 0 3.5861227876132773e-10
in O 0 1.7380628880570015e-10
either O 0 6.860811918585341e-10
BRCA1 O 0 5.888177501134351e-09
( O 0 5.646906206524527e-11
179 O 0 1.2405849680874326e-09
women O 0 5.5207269311630114e-11
) O 0 2.3803662166366202e-11
or O 0 3.1463132099673885e-10
BRCA2 O 0 1.28779236163723e-08
( O 0 1.971768581743305e-10
28 O 0 1.4475676834990736e-07
women O 0 4.0761774511288706e-10
) O 0 6.218855430617509e-10
. O 0 1.850625963584207e-08

The O 0 6.536749879160197e-07
control O 0 3.8989710446912795e-06
women O 0 1.2264474991141583e-09
were O 0 7.0969558008116e-10
enrolled O 0 1.1695681090273524e-09
regardless O 0 9.460653371817784e-10
of O 0 2.689635847374916e-09
whether O 0 1.883686678860741e-10
or O 0 5.798852370508811e-11
not O 0 4.5162196898873574e-11
they O 0 9.62320501063374e-11
had O 0 8.399182460649968e-10
either O 0 4.759813432286819e-09
mutation O 0 3.5228804762255095e-08
. O 0 4.905235684304898e-08

Lifetime O 0 2.990058476370905e-07
histories O 0 5.7041471990260106e-08
of O 0 9.13131330548822e-08
oral O 0 3.706724601215683e-05
- O 0 3.311328384825174e-07
contraceptive O 0 9.249689014723117e-08
use O 0 1.726880721752977e-10
were O 0 4.613197671088365e-11
obtained O 0 9.227680251855386e-12
by O 0 5.109742056558231e-12
interview O 0 7.925834294431056e-11
or O 0 8.427814652753329e-13
by O 0 4.120131156821333e-13
written O 0 6.044158771568997e-13
questionnaire O 0 1.3587035955966303e-13
and O 0 5.181551260106942e-13
were O 0 6.3495654047118766e-12
compared O 0 8.499364406722165e-12
between O 0 5.5455383340952125e-11
patients O 0 8.792128136647648e-11
and O 0 5.407135503232574e-11
control O 0 1.2429360367605113e-06
women O 0 5.513989004973796e-12
, O 0 1.2063706804343877e-11
after O 0 2.3922558378686176e-10
adjustment O 0 8.50246983929992e-10
for O 0 2.621371349154078e-11
year O 0 6.717427308844393e-11
of O 0 1.5169437928008733e-09
birth O 0 1.7671128560436955e-08
and O 0 2.839797730302962e-09
parity O 0 5.038444669480668e-06
. O 0 1.307840591380227e-07

RESULTS O 0 2.3206214905258093e-07
The O 0 8.40096525678291e-09
adjusted O 0 2.604525128901969e-08
odds O 0 4.2141050471400376e-07
ratio O 0 1.08264428533289e-08
for O 0 1.8307378013560083e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 1.4214379895349794e-08
with O 0 9.700600565876183e-12
any O 0 7.324384848628185e-11
past O 0 3.003699233783408e-10
use O 0 5.04874059226168e-11
of O 0 2.0861221639023597e-09
oral O 0 2.2550191260961583e-06
contraceptives O 0 3.4215605637655244e-07
was O 0 1.3894725725549506e-07
0 O 0 4.2329918414907297e-07
. O 0 3.0563036546027433e-08

5 O 0 1.3435622747692832e-07
( O 0 9.816942814211416e-10
95 O 0 1.054201614891781e-08
percent O 0 1.994574505559399e-09
confidence O 0 5.9722053968869204e-09
interval O 0 1.680924732738731e-08
, O 0 1.55789742217749e-10
0 O 0 6.262133589451935e-10
. O 0 5.407174274302262e-12
3 O 0 6.492932580481892e-11
to O 0 2.204599783978134e-12
0 O 0 3.782863189361052e-10
. O 0 1.632814369822988e-11
8 O 0 2.299926915583228e-09
) O 0 9.352319613187277e-11
. O 0 2.4881090521233773e-09

The O 0 2.1892914503496286e-07
risk O 0 3.0147337071184666e-08
decreased O 0 8.25494061995613e-10
with O 0 6.959349329455078e-12
increasing O 0 5.980497347346514e-11
duration O 0 1.2067032928442245e-09
of O 0 4.163467903772755e-10
use O 0 2.6231666144793664e-11
( O 0 1.2230659193757099e-11
P O 0 1.943082850175415e-08
for O 0 4.112904114506044e-11
trend O 0 3.2733786792249475e-09
, O 0 1.220716756844542e-11
< O 0 2.004443694358926e-10
0 O 0 1.4918563606691748e-10
. O 0 1.1219626573286123e-12
001 O 0 4.690673544027746e-11
) O 0 2.9528754387411066e-14
; O 0 1.3598488010819771e-14
use O 0 1.4586384400674945e-13
for O 0 7.124218749654521e-13
six O 0 2.660741635698849e-12
or O 0 5.041682132542191e-13
more O 0 5.364690286511868e-14
years O 0 6.705351985464292e-12
was O 0 2.4252197472485193e-10
associated O 0 8.76814332945175e-12
with O 0 1.779481618481571e-12
a O 0 5.163393670959415e-11
60 O 0 6.042343708712039e-11
percent O 0 1.2933196180675566e-10
reduction O 0 2.44113564917825e-08
in O 0 3.017401439819878e-09
risk O 0 4.5676105742131767e-07
. O 0 5.2250832993649965e-08

Oral O 0 0.0004306870396248996
- O 0 4.672136128647253e-06
contraceptive O 0 6.716341431456385e-06
use O 0 9.889980390198616e-09
protected O 0 4.6114590077195317e-05
against O 1 0.934719443321228
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 2.948390420698388e-10
for O 0 4.2469028294078726e-11
carriers O 0 8.71070143099173e-12
of O 0 8.310117177723342e-11
the O 0 8.853826005683629e-10
BRCA1 O 0 3.9120235939549275e-09
mutation O 0 2.3050243658229164e-10
( O 0 5.682818365188025e-12
odds O 0 1.384901970880037e-09
ratio O 0 9.665509712042386e-12
, O 0 1.3758430159049873e-12
0 O 0 2.068457037596172e-11
. O 0 2.356062664844033e-13
5 O 0 3.2244382944940364e-12
; O 0 3.495561316530643e-14
95 O 0 1.6421966217428086e-11
percent O 0 3.196899776153339e-12
confidence O 0 6.027610355285873e-11
interval O 0 3.835902706583738e-10
, O 0 1.1016084745796295e-11
0 O 0 4.429417249651735e-11
. O 0 7.603592235005951e-13
3 O 0 1.2491218996657505e-11
to O 0 5.629940957874169e-13
0 O 0 2.512643565433237e-11
. O 0 6.264166702713014e-13
9 O 0 4.097627445687202e-11
) O 0 6.776083329423227e-14
and O 0 7.656488697172989e-14
for O 0 7.754520224730055e-13
carriers O 0 1.6385852093583897e-12
of O 0 5.4529332438324474e-11
the O 0 7.300732796089449e-10
BRCA2 O 0 1.6798470392487275e-09
mutation O 0 4.065739064862406e-11
( O 0 4.072326243581559e-12
odds O 0 9.034498149596004e-10
ratio O 0 1.1298358082445503e-11
, O 0 6.554496528865528e-12
0 O 0 8.514831895123365e-11
. O 0 1.0181020523164497e-12
4 O 0 3.394876046947104e-11
; O 0 2.099590033083354e-13
95 O 0 4.614500101474128e-11
percent O 0 1.9540253096139715e-11
confidence O 0 2.3733223719624164e-10
interval O 0 1.5325755109429906e-09
, O 0 2.825892471414182e-11
0 O 0 2.3047475039561505e-10
. O 0 3.4659482315430035e-12
2 O 0 6.550476133737604e-11
to O 0 2.400709839256443e-12
1 O 0 2.958993050583558e-10
. O 0 9.244415129228134e-12
1 O 0 1.801037430304575e-09
) O 0 7.506262972301059e-11
. O 0 1.8057015882533278e-09

CONCLUSIONS O 0 3.7417134990391787e-06
Oral O 0 0.00020257532014511526
- O 0 5.584476184594678e-06
contraceptive O 0 5.800934559374582e-06
use O 0 1.3550028876707643e-09
may O 0 2.3278488858746726e-10
reduce O 0 5.945821612840518e-10
the O 0 7.953854241904423e-10
risk O 0 1.8268696067025303e-07
of O 1 0.7888177037239075
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.5917428299871972e-06
women O 0 5.519702750422795e-12
with O 0 6.995081163613248e-12
pathogenic O 0 3.670117099119352e-09
mutations O 0 2.6049795653904084e-10
in O 0 4.908515816026693e-10
the O 0 4.535165132324437e-08
BRCA1 O 0 1.42237036016013e-06
or O 0 7.901257959019858e-08
BRCA2 O 0 1.3378064068092499e-05
gene O 0 3.269200533395633e-05

A O 0 1.5164350770646706e-05
Japanese O 0 3.127170430161641e-06
family O 0 1.3817735400323272e-08
with O 0 2.056316894538668e-08
adrenoleukodystrophy B-Disease 1 1.0
with O 0 6.940949504041782e-08
a O 0 1.6860597895629326e-07
codon O 0 1.1822096013247574e-07
291 O 0 1.0224261437485893e-08
deletion O 0 9.525370714413839e-09
: O 0 5.759467902599624e-11
a O 0 1.1227451607309646e-10
clinical O 0 1.9410233420558143e-08
, O 0 1.1286108853036936e-10
biochemical O 0 2.8769315818522045e-08
, O 0 5.750206422128201e-10
pathological O 0 0.002195037668570876
, O 0 4.656783847423185e-10
and O 0 5.795394164564982e-10
genetic O 0 1.6832481719575298e-07
report O 0 7.457408024436063e-09
. O 0 2.5103958023464656e-08

We O 0 2.561530365596809e-08
report O 0 2.2992119319553694e-09
a O 0 2.1029129548821857e-09
Japanese O 0 6.950288877760613e-08
family O 0 1.749024813868516e-09
with O 0 8.249769933854623e-08
adrenoleukodystrophy B-Disease 1 1.0
( O 0 0.23662441968917847
ALD B-Disease 1 1.0
) O 0 3.719281826963794e-10
with O 0 8.648739363570357e-11
a O 0 2.8812352503848615e-09
three O 0 8.382090577185863e-10
base O 0 1.864297693998651e-08
pair O 0 1.3353276706595807e-08
deletion O 0 5.0050751099206536e-08
( O 0 1.1238018293724394e-09
delGAG O 0 1.8966696302413766e-07
291 O 0 8.135307538736924e-09
) O 0 9.47907238812995e-11
in O 0 5.576428208087236e-10
the O 0 2.927132527474896e-07
ALD B-Disease 1 1.0
gene O 0 9.723810762807261e-06
. O 0 4.337902055340237e-07

A O 0 4.829463478017715e-07
variety O 0 1.520681536248958e-08
of O 0 1.3164921597308421e-08
phenotypes O 0 8.568735054836907e-09
were O 0 2.2782177533375858e-10
observed O 0 4.70151417797382e-10
within O 0 8.832675146841495e-10
this O 0 4.031455724806676e-10
family O 0 3.4133904591726605e-09
. O 0 8.065768497544923e-08

While O 0 5.3771433528027046e-08
the O 0 6.246631301110028e-08
proband O 0 1.3064313861832488e-05
( O 0 2.9502988940777186e-09
patient O 0 3.7325302848501e-09
1 O 0 4.567833045143743e-08
) O 0 1.6082265727468403e-11
was O 0 4.925387320220409e-10
classified O 0 4.5265857034904045e-11
as O 0 2.3783603558813482e-11
having O 0 9.771673747938081e-11
a O 0 2.745336458165326e-10
rare O 0 4.965942768109244e-09
intermediate O 0 6.19135276380689e-09
type O 0 1.3369860774048448e-09
of O 0 6.891846204837293e-09
adult O 0 2.286124889394614e-08
cerebral O 0 5.697584128938615e-07
and O 0 1.606609512094792e-09
cerebello O 1 0.9998107552528381
- O 0 0.0046454668045043945
brain O 0 0.030528532341122627
stem O 0 6.398667817819614e-09
forms O 0 4.456197078006596e-10
, O 0 1.1176599923334862e-10
his O 0 1.6071274311357797e-09
younger O 0 1.4897529876378712e-09
brother O 0 2.1557909235525585e-08
( O 0 1.2183959396949717e-10
patient O 0 9.637151077157569e-10
2 O 0 4.024882827025067e-08
) O 0 1.4110091567376415e-11
and O 0 1.4886614163600598e-10
nephew O 0 8.622086511422822e-08
( O 0 1.829091739180555e-10
patient O 0 4.8587405210298584e-09
3 O 0 9.21768830153269e-08
) O 0 1.6667543734083523e-10
had O 0 4.957311894315808e-09
a O 0 3.4508505564190273e-07
childhood O 1 0.9999574422836304
ALD B-Disease 1 1.0
type O 0 0.12507948279380798
. O 0 3.3676769817247987e-06

Another O 0 4.555531631922349e-06
nephew O 0 4.893789082416333e-05
( O 0 6.166464316947895e-08
patient O 0 1.607110533541345e-07
4 O 0 5.680602725988138e-07
) O 0 2.2748308792230887e-10
of O 0 1.3091953299237957e-08
patient O 0 6.096239246744517e-08
1 O 0 2.3586551378684817e-06
was O 0 6.690456189062388e-08
classified O 0 6.160957299883307e-10
as O 0 1.3502422790967472e-10
having O 0 4.69002336966895e-10
an O 0 2.5868529540673535e-10
adolescent O 0 2.1076969858313532e-07
form O 0 2.2755232365057054e-08
. O 0 1.9998979894353397e-07

The O 0 1.6811931402571645e-07
tau O 0 1.7813945873967896e-07
level O 0 2.911743379740983e-08
in O 0 4.3529693738442177e-10
the O 0 2.1864581256636484e-09
cerebrospinal O 0 7.729775575171516e-08
fluid O 0 9.443994475333284e-10
( O 0 4.5819639749034025e-10
CSF O 0 2.512197454507259e-07
) O 0 5.081791931704771e-11
in O 0 1.054445905590562e-10
patient O 0 2.2023043388941232e-09
1 O 0 2.0509902753929055e-07
was O 0 2.3390089864960828e-08
as O 0 1.1614490619260565e-10
high O 0 5.869728592067247e-10
as O 0 5.617661717749467e-12
that O 0 7.538019687614028e-13
of O 0 3.4477670718402464e-10
patients O 0 1.5856242707723567e-10
with O 0 2.1977724085076034e-09
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.9999808073043823
( O 0 1.225331502929805e-10
AD B-Disease 0 3.977541851440947e-09
) O 0 4.3024034335203964e-10
. O 0 8.543179497166875e-09

His O 0 6.702302357552981e-07
brain O 0 7.239062256303441e-07
magnetic O 0 4.0855606897594043e-08
resonance O 0 1.5188554414180544e-08
image O 0 8.142463592264448e-09
( O 0 1.0248187715111712e-10
MRI O 0 2.686519984251845e-08
) O 0 3.2431290292178616e-11
showed O 0 4.940886366711084e-09
abnormalities B-Disease 0 4.531837930699112e-06
in I-Disease 0 1.0871542555079827e-10
the I-Disease 0 9.155564084650791e-10
bilateral I-Disease 0 2.3087190470505448e-07
cerebellar I-Disease 1 0.9999474287033081
hemispheres I-Disease 0 2.298709489423345e-07
and O 0 1.0063421207462397e-09
brain O 0 4.766493475472089e-07
stem O 0 5.671930702888517e-10
, O 0 6.0070854540628105e-12
but O 0 1.822727082115283e-12
not O 0 2.604817837120743e-12
in O 0 2.2241940927925086e-11
the O 0 2.5391191371682e-09
cerebral O 0 5.694998321814637e-07
white O 0 2.1716238529645437e-10
matter O 0 8.129121507882697e-12
, O 0 7.733752874217181e-13
where O 0 1.9805791121735306e-12
marked O 0 1.3312471958126793e-10
reductions O 0 1.0576288733687988e-09
of O 0 8.164340870031594e-10
the O 0 3.0931195382777332e-09
cerebral O 0 2.5524981239755107e-08
blood O 0 1.3859477454580826e-10
flow O 0 1.0509441927819552e-10
and O 0 1.1203129396397671e-10
oxygen O 0 2.741000315609199e-09
metabolism O 0 2.8337066027006586e-08
were O 0 2.2999169235760064e-10
clearly O 0 5.726158089358613e-11
demonstrated O 0 5.2958203794473135e-11
by O 0 9.511703924491854e-12
positron O 0 9.687740609720663e-10
emission O 0 1.2034929497417579e-08
tomography O 0 1.297098251029638e-08
( O 0 6.348930270405617e-10
PET O 0 2.539537717893836e-07
) O 0 1.543983052521014e-09
. O 0 2.071496219002711e-08

In O 0 9.350387841777774e-08
patients O 0 5.8640807765186764e-09
2 O 0 1.9618594748749274e-08
and O 0 2.2298746182869422e-10
3 O 0 1.0031843800106799e-08
, O 0 5.891148679992853e-11
the O 0 3.1026545221912727e-10
autopsy O 0 3.750637489474684e-08
findings O 0 3.5434780110144004e-10
showed O 0 3.647868229705864e-09
massive O 0 8.803365290077636e-07
demyelination B-Disease 1 1.0
of I-Disease 0 3.162731445627287e-05
the I-Disease 0 6.448587555496488e-06
cerebral I-Disease 0 0.022621501237154007
white I-Disease 0 5.234307209889266e-09
matter I-Disease 0 3.52699675021384e-11
with O 0 4.7338400560592575e-12
sparing O 0 1.6014419790266743e-09
of O 0 2.2782765896067758e-08
the O 0 2.2695637369452015e-07
U O 1 0.9947846531867981
- O 0 3.4257595871167723e-07
fibers O 0 1.2505779523053207e-08
, O 0 1.3396427023248947e-10
compatible O 0 5.00745001019709e-09
with O 0 3.017214256217926e-11
the O 0 1.2708163410479756e-09
findings O 0 5.127320235054356e-10
of O 0 3.153808592060159e-08
childhood O 1 0.984505832195282
ALD B-Disease 1 1.0
. O 0 6.7662103901966475e-06

Oleic O 0 0.00019578069623094052
and O 0 1.9447334409505856e-07
erucic O 0 8.657771104481071e-05
acids O 0 3.965272554751209e-08
( O 0 2.563728562776646e-09
Lorenzos O 0 1.7921925064001698e-06
Oil O 0 1.3945378185553636e-08
) O 0 5.4340164312716155e-11
were O 0 2.93937263418087e-10
administered O 0 4.670696052144763e-10
to O 0 4.600228531437267e-11
patients O 0 1.139908237246523e-10
1 O 0 6.546011288577347e-09
and O 0 4.670675651796685e-11
4 O 0 2.8930418061179353e-09
, O 0 7.943234611729189e-12
but O 0 1.9989207771659023e-12
sufficient O 0 7.618610603499221e-11
effectiveness O 0 8.748173296879713e-10
was O 0 1.1956535761470377e-09
not O 0 2.326773496097445e-11
obtained O 0 1.268803728748935e-09
. O 0 9.45997236101448e-09

The O 0 1.5718698875843984e-07
findings O 0 3.966035055924522e-09
in O 0 3.926883818117233e-10
this O 0 1.5427104038678863e-10
family O 0 5.213408177384693e-11
suggest O 0 4.7489265991851326e-11
that O 0 1.1725375878568478e-11
delGAG291 O 0 9.915876120203393e-09
is O 0 5.025289212534645e-11
part O 0 8.646908883358506e-11
of O 0 1.4822137961445492e-09
the O 0 2.25250174068492e-09
cause O 0 2.2294644352882642e-08
of O 0 5.362537791597788e-08
Japanese O 0 6.461789598688483e-05
ALD B-Disease 1 1.0
with O 0 1.1352227602401399e-08
phenotypic O 0 1.2137846169935074e-05
variations O 0 2.460350970068248e-06
. O 0 5.234215336713532e-07

Moreover O 0 1.0283054763249311e-07
, O 0 1.1045362402484216e-09
although O 0 2.3282219208109467e-10
the O 0 2.0266753553155326e-10
scale O 0 5.4553006556545824e-09
of O 0 1.5837510192184823e-09
the O 0 8.734934442422571e-10
study O 0 5.329391095099112e-11
is O 0 4.620424702561632e-12
limited O 0 3.291832778584691e-11
, O 0 8.898733312723284e-12
there O 0 1.7260401441454576e-11
is O 0 2.1866520746871565e-11
a O 0 1.1712507352878987e-10
possibility O 0 2.073859306506165e-09
that O 0 1.7193675649895823e-10
PET O 0 2.725908814227296e-07
can O 0 4.177346663025716e-11
detect O 0 3.986785568343976e-09
an O 0 3.745586618641994e-10
insidious B-Disease 0 1.0147858802156406e-06
lesion I-Disease 0 9.682346899353433e-06
which O 0 1.3529800890754728e-10
is O 0 3.553154298563399e-11
undetectable O 0 2.278427668755967e-09
by O 0 2.728197702472901e-11
computed O 0 4.320577229321998e-10
tomogram O 0 7.020999248652515e-08
( O 0 4.271900888586089e-11
CT O 0 1.201495649638673e-07
) O 0 9.039918986986084e-12
or O 0 6.923271851644319e-12
MRI O 0 8.57574455892518e-10
analysis O 0 2.8727378115211977e-11
, O 0 6.3862942711878645e-12
and O 0 2.4686719682365244e-12
that O 0 1.783858542651895e-12
the O 0 2.368501783589494e-10
higher O 0 4.0108164012231384e-10
level O 0 6.790552120605753e-09
of O 0 1.8163268666882004e-09
tau O 0 3.4409823879144597e-09
reflects O 0 8.330410146417666e-12
the O 0 1.4408353850303701e-11
process O 0 3.76958672609895e-11
of O 0 1.2266977433839088e-09
neuronal B-Disease 0 1.3767529708275106e-05
degeneration I-Disease 1 0.9999997615814209
in O 0 1.540851258141629e-06
ALD B-Disease 1 1.0
. O 0 3.883651515934616e-06

Lorenzos O 0 0.00011605204781517386
Oil O 0 2.1538474470617075e-07
should O 0 4.965239330800841e-10
be O 0 1.5951026957616854e-11
given O 0 1.0995869145769e-11
in O 0 1.4053365242350235e-11
the O 0 2.491531703174843e-10
early O 0 1.0715138998307339e-08
stage O 0 8.384417071738426e-08
. O 0 2.5601321063106752e-09
. O 0 3.063862408225759e-08

Nonsense O 0 6.006959665683098e-06
mutation O 0 9.060650540959614e-08
in O 0 3.654191171875709e-09
exon O 0 1.915912832828326e-07
4 O 0 7.463316364919592e-08
of O 0 1.8614800367799944e-08
human O 0 9.402803868852061e-09
complement O 0 8.887364622012228e-09
C9 O 0 1.0931489669019356e-05
gene O 0 1.7917486383467462e-09
is O 0 2.8519700490114985e-11
the O 0 1.1578547842727716e-10
major O 0 9.296307723616337e-09
cause O 0 2.7574669658747553e-08
of O 0 4.4906379059739265e-08
Japanese O 0 8.043673915381078e-06
complement B-Disease 0 8.235481072915718e-05
C9 I-Disease 1 1.0
deficiency I-Disease 1 0.9999983310699463
. O 0 2.8204581212776247e-06

Deficiency B-Disease 1 0.9052854776382446
of I-Disease 0 2.6450656150700524e-05
the I-Disease 0 3.1378594940179028e-06
ninth I-Disease 0 2.458158996887505e-05
component I-Disease 0 2.86298444507338e-07
of I-Disease 0 8.181324062661588e-08
human I-Disease 0 4.0737873518992274e-08
complement I-Disease 0 4.7832848792950244e-09
( O 0 6.938825625191214e-10
C9 O 0 1.9666660591610707e-05
) O 0 3.67540928247756e-11
is O 0 1.1226674104247714e-11
the O 0 1.7500784155188853e-10
most O 0 3.6342681641876595e-10
common O 0 3.576717972464394e-06
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.2492791629247222e-07
Japan O 0 3.2110187930811662e-06
but O 0 2.674803711855134e-10
is O 0 5.3120573911824565e-11
rare O 0 4.2310741021900355e-10
in O 0 9.198618949879389e-11
other O 0 5.281436052384514e-11
countries O 0 2.780204677588216e-10
. O 0 1.8048554650818005e-08

We O 0 8.57853077462778e-09
studied O 0 5.1648663124126415e-09
the O 0 4.901443140248318e-10
molecular O 0 3.1929983101974813e-09
basis O 0 1.997304321932347e-09
of O 0 8.240475324328145e-08
C9 B-Disease 1 0.9999569654464722
deficiency I-Disease 0 6.628523988183588e-05
in O 0 3.15270631823239e-09
four O 0 1.13713571892049e-09
Japanese O 0 1.7963609479920706e-06
C9 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9995718598365784
deficient I-Disease 0 0.17838521301746368
patients O 0 4.7062624908278394e-09
who O 0 6.4359839679895e-10
had O 0 5.2041169595895553e-08
suffered O 1 0.999980092048645
from O 0 0.00010216084774583578
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 7.191699751274427e-07

Direct O 0 3.404328907663512e-08
sequencing O 0 2.908257812350712e-08
of O 0 5.025431093486077e-08
amplified O 0 1.7160152765427483e-07
C9 O 0 4.178315521130571e-06
cDNA O 0 8.096533576917864e-08
and O 0 6.231250515575937e-10
DNA O 0 3.290511640940963e-09
revealed O 0 1.1757839146753213e-09
a O 0 4.6003362230706557e-10
nonsense O 0 2.796608056243599e-09
substitution O 0 3.758226174710444e-09
( O 0 2.1501751767960542e-10
CGA O 0 1.1250747178337406e-07
- O 0 8.223577374621982e-09
- O 0 1.111930725272714e-08
> O 0 3.461462938503246e-08
TGA O 0 3.101510230862914e-07
) O 0 1.1133764049597872e-11
at O 0 3.4835015427781e-10
codon O 0 4.0755165908734625e-10
95 O 0 8.757288227911886e-10
in O 0 1.445446679015916e-10
exon O 0 1.2594755460781926e-08
4 O 0 2.5447528528843577e-09
in O 0 1.4681922344550458e-10
the O 0 3.4421114847305034e-09
four O 0 1.3649409602578544e-08
C9 B-Disease 0 0.05703819915652275
- I-Disease 0 2.3635599063709378e-05
deficient I-Disease 0 4.964594609191408e-06
individuals O 0 8.54842308051218e-10
. O 0 1.40175998808445e-07

An O 0 1.2581718777937567e-08
allele O 0 2.0218280383232923e-08
- O 0 6.187953260905488e-09
specific O 0 1.3048544467153533e-09
polymerase O 0 4.0246295185397685e-08
chain O 0 2.8111352889936825e-07
reaction O 0 1.715470321350665e-09
system O 0 1.0760913049523424e-08
designed O 0 6.49317100087643e-10
to O 0 7.62385380520536e-12
detect O 0 1.5443180068075435e-10
exclusively O 0 2.559406853119839e-11
only O 0 1.9050676834664326e-12
one O 0 8.066594809653937e-13
of O 0 4.1114448651180524e-11
the O 0 5.129352151356237e-11
normal O 0 4.965785768695774e-11
and O 0 4.102066776534574e-12
mutant O 0 4.4868322945923467e-10
alleles O 0 2.4996831861356927e-12
indicated O 0 3.5568410196307187e-12
that O 0 1.4382391761921798e-13
all O 0 1.91104705844769e-12
the O 0 7.844410537805047e-11
four O 0 3.133519138609486e-11
patients O 0 2.6829300499991993e-12
were O 0 4.2238131395255785e-12
homozygous O 0 7.057455314596339e-11
for O 0 1.7348228756319806e-11
the O 0 2.0743924633581656e-10
mutation O 0 1.282237094279992e-10
in O 0 9.681068446898422e-11
exon O 0 1.2658794901199144e-08
4 O 0 8.367000425835158e-09
and O 0 2.8226117623764146e-11
that O 0 6.054996781745814e-12
the O 0 8.106245119599009e-10
parents O 0 2.7708857777697382e-11
of O 0 1.3378916863260315e-09
patient O 0 4.599978620234424e-09
2 O 0 1.3859126113402453e-07
were O 0 6.798392515605656e-09
heterozygous O 0 3.195339459693969e-08
. O 0 3.119605196388875e-08

The O 0 1.4228436384655652e-07
common O 0 4.052421331834921e-08
mutation O 0 5.210877951355997e-09
at O 0 4.117823948490695e-08
codon O 0 4.061041281033795e-08
95 O 0 1.7902499038768838e-08
in O 0 2.7415438808020554e-09
exon O 0 2.759587971468136e-07
4 O 0 4.764366678955412e-08
might O 0 1.5664100572188033e-10
be O 0 1.6617507717087143e-11
responsible O 0 2.781785357619526e-10
for O 0 2.29731275669387e-10
most O 0 9.243666387881433e-10
Japanese O 0 6.292854322964558e-06
C9 B-Disease 1 0.9999961853027344
deficiency I-Disease 1 0.7596682906150818
. O 0 3.120801395084527e-08
. O 0 1.0253559423745173e-07

BRCA1 O 0 5.84989606977615e-07
required O 0 2.5558484217924615e-09
for O 0 1.3526608722003175e-09
transcription O 0 9.195796337735374e-07
- O 0 9.499589737060887e-07
coupled O 0 9.749511491463636e-07
repair O 0 1.528466668787587e-06
of O 0 7.207938779174583e-07
oxidative O 0 0.055177826434373856
DNA O 0 1.4402063243323937e-05
damage O 0 8.843538671499118e-05
. O 0 1.2473743993268727e-07

The O 0 1.1035385796276387e-05
breast B-Disease 1 0.9999995231628418
and I-Disease 1 0.996343195438385
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999985694885254
gene O 0 5.959366262686672e-06
BRCA1 O 0 2.666493799097225e-07
encodes O 0 3.057281983132043e-09
a O 0 1.6710373529349454e-08
zinc O 0 3.686508023292845e-07
finger O 0 3.5965834399576124e-07
protein O 0 1.2953015016137215e-07
of O 0 9.87804810392845e-07
unknown O 0 2.4696344098629197e-06
function O 0 2.721809835293243e-07
. O 0 3.8443516814368195e-08

Association O 0 1.7981641349251731e-06
of O 0 1.799579649741645e-07
the O 0 8.941572815501786e-08
BRCA1 O 0 1.510892211342707e-08
protein O 0 4.090663918709936e-10
with O 0 4.950230156341995e-11
the O 0 1.2368597701595263e-08
DNA O 0 1.3268864051951823e-07
repair O 0 2.6233965400024317e-07
protein O 0 2.5336634124073498e-08
Rad51 O 0 8.63536797623965e-08
and O 0 4.594230898491425e-11
changes O 0 9.3508881193749e-12
in O 0 5.936002557549447e-12
the O 0 1.515854802791594e-11
phosphorylation O 0 4.727724461917049e-11
and O 0 2.973480836554465e-11
cellular O 0 7.292164205807694e-09
localization O 0 8.479658930582445e-08
of O 0 5.771853550662343e-10
the O 0 5.594037455480816e-10
protein O 0 7.224352782664312e-10
after O 0 2.2705319846494376e-09
exposure O 0 6.658614104537719e-09
to O 0 1.382112202463759e-10
DNA O 0 7.896316134292647e-08
- O 0 4.947141363231822e-08
damaging O 0 9.796339384138264e-08
agents O 0 1.952562139750924e-10
are O 0 4.574327461953631e-12
consistent O 0 1.8263375534122162e-10
with O 0 2.054475166379799e-11
a O 0 9.290436198128305e-10
role O 0 1.490756296185225e-09
for O 0 2.2891082362974657e-09
BRCA1 O 0 6.975535882247641e-08
in O 0 8.517650584849434e-09
DNA O 0 1.9247524960519513e-06
repair O 0 2.4383482013945468e-05
. O 0 1.3256737929623341e-06

Here O 0 5.841299710596104e-08
, O 0 7.025185988496219e-10
it O 0 1.56070711909706e-11
is O 0 1.1324723277195137e-11
shown O 0 6.564083304683166e-11
that O 0 3.004963985975273e-11
mouse O 0 1.1692050883027605e-08
embryonic O 0 1.1940725741510505e-08
stem O 0 1.1915398667738941e-09
cells O 0 4.1808953521460523e-10
deficient B-Disease 0 9.039846204927926e-09
in I-Disease 0 2.792449049771051e-10
BRCA1 I-Disease 0 5.997089491671659e-09
are O 0 1.0121390704720401e-11
defective O 0 1.0191701926842711e-09
in O 0 2.968284645854524e-11
the O 0 1.939319121957439e-10
ability O 0 5.97440629954149e-12
to O 0 3.868138014756495e-12
carry O 0 2.3757851588812606e-11
out O 0 2.3718098665637122e-11
transcription O 0 1.1787147258246478e-08
- O 0 4.750673454623211e-08
coupled O 0 2.7728567886242672e-08
repair O 0 8.756143898835944e-08
of O 0 4.535519693149581e-08
oxidative O 0 7.76601882535033e-06
DNA O 0 1.627963257533338e-07
damage O 0 5.468559152177477e-07
, O 0 1.8297058312910508e-10
and O 0 7.341784125092232e-11
are O 0 5.7980231726872944e-11
hypersensitive O 0 1.8284133318502427e-08
to O 0 7.379441502308737e-10
ionizing O 0 2.6356672151450766e-06
radiation O 0 4.4382754822436254e-06
and O 0 3.1497611185926644e-09
hydrogen O 0 2.6782316808748874e-08
peroxide O 0 1.895586478894984e-07
. O 0 2.2485070871880453e-07

These O 0 6.8520527030102585e-09
results O 0 1.0333166322595844e-08
suggest O 0 1.824924766857805e-09
that O 0 2.667456810989677e-10
BRCA1 O 0 4.3806679173030716e-08
participates O 0 1.1973126934350375e-09
, O 0 7.461355838733752e-11
directly O 0 4.0864876586776955e-12
or O 0 5.008779415532905e-12
indirectly O 0 1.1212828408824205e-11
, O 0 1.351687078238184e-11
in O 0 1.076804756472427e-10
transcription O 0 8.932539685702068e-08
- O 0 3.815374043369957e-07
coupled O 0 1.6403340907800157e-07
repair O 0 3.1052098847794696e-07
of O 0 1.7717171374442842e-07
oxidative O 0 0.00010124302934855223
DNA O 0 5.599839028036513e-07
damage O 0 1.6554757849007729e-06
. O 0 2.430587953128338e-09
. O 0 1.665929616478934e-08

Truncation O 0 1.3990202205604874e-05
mutations O 0 4.743710135812762e-08
in O 0 2.0004076173307794e-09
the O 0 4.751441462502726e-09
transactivation O 0 8.002143090379832e-07
region O 0 1.3287473343837064e-08
of O 0 1.875149813201915e-08
PAX6 O 0 0.00360800395719707
result O 0 2.2714774061682874e-08
in O 0 1.5534710184894607e-09
dominant O 0 2.4007474053178157e-07
- O 0 3.7804291252996336e-08
negative O 0 1.1348828543589207e-08
mutants O 0 6.25637881057628e-07
. O 0 5.2716313092560085e-08

PAX6 O 1 0.9551721215248108
is O 0 4.5180790664289816e-08
a O 0 5.8547597880931335e-09
transcription O 0 1.5784021201170617e-08
factor O 0 1.2503245105932592e-09
with O 0 3.908887449832754e-11
two O 0 9.27699167485585e-11
DNA O 0 3.32686167503482e-09
- O 0 5.576480943680906e-10
binding O 0 3.8560316051317045e-10
domains O 0 2.5761778821298265e-10
( O 0 1.2546496827581244e-11
paired O 0 1.8917879762714307e-10
box O 0 9.002353529297125e-09
and O 0 1.1363220087101666e-10
homeobox O 0 9.169864867430988e-09
) O 0 1.491847097245813e-11
and O 0 3.596080030976445e-11
a O 0 2.9292051006990505e-09
proline O 0 1.3991450487083057e-07
- O 0 1.0463214294986756e-07
serine O 0 6.352364039230451e-07
- O 0 1.1100299843747052e-06
threonine O 0 1.073687872121809e-05
( O 0 7.080855901619998e-09
PST O 0 0.018729643896222115
) O 0 2.027720436004188e-09
- O 0 1.9995120226212748e-08
rich O 0 7.475208896323693e-09
transactivation O 0 3.798118541453732e-06
domain O 0 2.044561284719748e-07
. O 0 4.046042079153267e-08

PAX6 O 1 0.9997228980064392
regulates O 0 2.300536652910523e-05
eye O 0 0.00019715438247658312
development O 0 6.857664658355134e-08
in O 0 1.6033309124807715e-09
animals O 0 7.310891336764769e-10
ranging O 0 3.7073493164285765e-09
from O 0 1.339290067736698e-10
jellyfish O 0 2.5754409715972315e-10
to O 0 3.59367362257057e-11
Drosophila O 0 1.6242932332488635e-08
to O 0 1.3099434037489033e-10
humans O 0 3.3383285025223586e-09
. O 0 1.0089679314262412e-08

Heterozygous O 0 1.6182144690901623e-07
mutations O 0 2.8321436307265913e-09
in O 0 4.3818085271318807e-10
the O 0 3.332247144882672e-09
human O 0 6.534462215768144e-08
PAX6 O 0 0.0004733766836579889
gene O 0 4.117084007049243e-09
result O 0 2.424299372361105e-10
in O 0 1.4691300259661588e-11
various O 0 1.5498028207994174e-11
phenotypes O 0 2.6660884611118263e-10
, O 0 1.955371281558982e-11
including O 0 6.309274214189031e-10
aniridia B-Disease 1 1.0
, O 0 3.7769123650832626e-07
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 4.961760424748718e-08
autosomal B-Disease 0 0.0005861345562152565
dominant I-Disease 0 0.0007110086735337973
keratitis I-Disease 1 0.999994158744812
, O 0 1.2689713280167325e-08
and O 0 1.5379379547653116e-08
familial B-Disease 1 0.9999874830245972
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.0009171806741505861

It O 0 5.953360027177723e-09
is O 0 4.2556705381890936e-10
believed O 0 6.891908710393579e-10
that O 0 7.310257434112177e-12
the O 0 3.2560037999118663e-10
mutated O 0 5.383110068812869e-10
allele O 0 5.664362867641159e-10
of O 0 2.709335200634655e-09
PAX6 O 0 3.619090421125293e-05
produces O 0 2.1922909321236972e-10
an O 0 2.711539846822486e-11
inactive O 0 1.0217729773387418e-08
protein O 0 2.249587538472042e-08
and O 0 5.352429166549655e-09
aniridia B-Disease 1 1.0
is O 0 5.726327856336866e-09
caused O 0 2.9327116735089476e-08
due O 0 1.1509513342389255e-07
to O 0 9.747497253798088e-10
genetic O 0 1.1122584737677244e-06
haploinsufficiency O 0 4.6127526729833335e-05
. O 0 1.325983163269484e-07

However O 0 1.3765859563363847e-08
, O 0 8.357505798528564e-10
several O 0 9.921050092565054e-11
truncation O 0 4.074890824767863e-08
mutations O 0 1.148714942611484e-10
have O 0 8.172558116359419e-12
been O 0 1.6643042846653522e-11
found O 0 2.3628412594567383e-12
to O 0 4.013748968606512e-13
occur O 0 7.38141839318196e-12
in O 0 2.906523285939322e-11
the O 0 7.780266431112182e-10
C O 0 4.795615495822858e-07
- O 0 7.3105468345602276e-09
terminal O 0 1.344253774959725e-08
half O 0 5.816321035911898e-11
of O 0 5.961890980898943e-10
PAX6 O 0 1.863211946329102e-05
in O 0 7.422806813650595e-10
patients O 0 1.1578569353298818e-10
with O 0 1.0103863579136174e-10
Aniridia B-Disease 1 1.0
resulting O 0 2.0445686033099264e-08
in O 0 1.6072859709836962e-10
mutant O 0 2.182458214150529e-09
proteins O 0 1.2556982363631786e-11
that O 0 5.168386552067972e-12
retain O 0 3.533051073922877e-10
the O 0 1.608535082908702e-09
DNA O 0 5.065654562486088e-09
- O 0 4.946447695886036e-10
binding O 0 3.084422162125122e-10
domains O 0 8.284068570008074e-11
but O 0 9.668238432070098e-12
have O 0 1.056680090649742e-11
lost O 0 2.109951990902914e-09
most O 0 1.8625498712787625e-11
of O 0 1.2406512484020027e-09
the O 0 1.1682621092745649e-08
transactivation O 0 2.8180572826386197e-06
domain O 0 1.2147718564392562e-07
. O 0 4.297913491768668e-08

It O 0 2.204796567539802e-09
is O 0 2.2340934657805178e-10
not O 0 3.9832470655198904e-11
clear O 0 3.762477551738641e-10
whether O 0 1.8903441312279057e-11
such O 0 1.8250005673348113e-10
mutants O 0 2.009713711004224e-07
really O 0 1.270096583461111e-09
behave O 0 2.6902487182400847e-11
as O 0 4.4751036210044504e-11
loss O 0 1.3531330500526906e-09
- O 0 7.099690280121251e-10
of O 0 7.814461078226032e-09
- O 0 5.6674562820546726e-09
function O 0 6.826875953436229e-09
mutants O 0 5.975213213105235e-09
as O 0 1.6730800078690322e-10
predicted O 0 2.912519558861959e-09
by O 0 3.971316053785756e-10
haploinsufficiency O 0 1.7735998198986636e-06
. O 0 1.566746874459568e-07

Contrary O 0 1.1122662613161083e-07
to O 0 3.180960772564134e-10
this O 0 1.9011274499103337e-10
theory O 0 1.0130444927369808e-08
, O 0 9.39942360056456e-11
our O 0 3.604430295900407e-11
data O 0 1.1761981666413845e-10
showed O 0 2.5576904483237684e-10
that O 0 3.1378356944028463e-12
these O 0 5.989695284897012e-12
mutants O 0 2.36026820310542e-09
are O 0 4.433928918468055e-12
dominant O 0 9.76934866336876e-10
- O 0 1.1372825597932845e-10
negative O 0 1.676621862178873e-11
in O 0 3.394164116432563e-11
transient O 0 4.911009376940001e-09
transfection O 0 2.274781074618204e-08
assays O 0 6.391467355371105e-10
when O 0 5.5655549613398136e-11
they O 0 1.5571509359713076e-11
are O 0 2.232038338878528e-12
coexpressed O 0 1.5345623438633993e-08
with O 0 9.89144766094796e-10
wild O 0 1.4408560673473403e-05
- O 0 1.4167940207698848e-06
type O 0 4.430832632351667e-06
PAX6 O 1 0.9758903384208679
. O 0 9.0043812406293e-07

We O 0 1.63304090250449e-08
found O 0 4.660213326346252e-10
that O 0 6.003763892287184e-12
the O 0 3.007528670551096e-10
dominant O 0 2.4084565453108553e-08
- O 0 1.040274977270883e-09
negative O 0 1.7058181256413008e-10
effects O 0 5.4629772705538926e-08
result O 0 7.123944212317213e-10
from O 0 3.618744540134777e-11
the O 0 1.5868405200958335e-10
enhanced O 0 2.6470934333389096e-09
DNA O 0 2.3142456839764236e-09
binding O 0 3.7270578290282685e-10
ability O 0 4.9101989835209636e-11
of O 0 3.4184577391016546e-10
these O 0 2.4133006704119e-10
mutants O 0 1.0420692575507928e-07
. O 0 2.3324911779809554e-08

Kinetic O 0 1.0794301630312475e-07
studies O 0 6.043779254838455e-09
of O 0 4.9571413640592255e-09
binding O 0 6.399387686428781e-09
and O 0 2.0342001694206857e-10
dissociation O 0 1.4805607850831848e-09
revealed O 0 2.295622025805244e-10
that O 0 2.2503169033044612e-12
various O 0 2.5611063617092533e-11
truncation O 0 4.415766596821413e-08
mutants O 0 3.59560381468782e-09
have O 0 1.3783440534764768e-11
3 O 0 1.0025755781128964e-09
- O 0 5.031621785889229e-10
5 O 0 2.5042348195114528e-09
- O 0 1.1214593698127828e-09
fold O 0 3.729475617220146e-10
higher O 0 1.3959655653650316e-10
affinity O 0 2.0545339735056345e-11
to O 0 9.62889230154973e-12
various O 0 3.696782463480375e-11
DNA O 0 3.9328201806299035e-10
- O 0 4.77844708246522e-11
binding O 0 2.9707146464996725e-11
sites O 0 7.51248889485634e-12
when O 0 1.3866233465262279e-12
compared O 0 5.459622337555814e-12
with O 0 3.863795134534387e-12
the O 0 2.214756156249109e-09
wild O 0 1.017436147776607e-06
- O 0 2.2063001381411596e-07
type O 0 5.116681904837606e-07
PAX6 O 0 0.00944061391055584
. O 0 3.0241849913181795e-07

These O 0 4.889838756128029e-09
results O 0 6.829284693310456e-09
provide O 0 3.229014555738985e-10
a O 0 4.579727430620295e-10
new O 0 2.9166039028361013e-10
insight O 0 5.731263241770534e-10
into O 0 2.7618313885868773e-11
the O 0 1.1301769242688664e-10
role O 0 4.173620893332952e-10
of O 0 2.9549902524905747e-09
mutant O 0 6.319806402643735e-07
PAX6 O 0 0.0005435703787952662
in O 0 1.6386071166607508e-08
causing O 0 6.344880034703237e-07
aniridia B-Disease 1 0.9999955892562866
. O 0 1.0980338771560127e-07
. O 0 2.39097715848402e-07

Reversal O 0 3.457422735664295e-06
of O 0 8.295491170429159e-06
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 2.603663915579091e-06
excellent O 0 9.606750239754547e-08
neuropsychologic O 0 9.172882755592582e-07
outcome O 0 1.556066564489811e-08
in O 0 1.3118260644429114e-10
very B-Disease 0 5.852777984483026e-11
- I-Disease 0 6.159104337655208e-09
long I-Disease 0 3.099286516317079e-08
- I-Disease 0 1.906852048705332e-05
chain I-Disease 1 0.9999654293060303
acyl I-Disease 1 0.999998927116394
- I-Disease 1 1.0
coenzyme I-Disease 1 0.9999998807907104
A I-Disease 1 0.9999997615814209
dehydrogenase I-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
. O 0 3.5666319035954075e-06

Very B-Disease 0 5.515725476357147e-08
- I-Disease 0 2.246513730597144e-07
long I-Disease 0 1.4983774576649012e-07
- I-Disease 0 1.7536674477014458e-06
chain I-Disease 0 0.01619347743690014
acyl I-Disease 0 0.004835686180740595
- I-Disease 1 0.9958873391151428
coenzyme I-Disease 0 0.09347467124462128
A I-Disease 0 0.0001146181530202739
dehydrogenase I-Disease 0 2.565875831805897e-07
( I-Disease 0 5.06931552290979e-10
VLCAD I-Disease 1 0.9999614953994751
) I-Disease 0 3.9310146249249556e-09
deficiency I-Disease 0 0.00024150320678018034
is O 0 1.820033013189004e-10
a O 0 2.085839723164895e-09
disorder O 0 0.008531542494893074
of O 0 3.390191750440863e-06
fatty O 0 3.5538650422495266e-07
acid O 0 3.939624182436319e-09
beta O 0 1.6153643755956182e-08
oxidation O 0 1.9605238321673824e-08
that O 0 3.784102545201229e-11
reportedly O 0 2.787617081612126e-10
has O 0 2.421366926408375e-12
high O 0 1.3218047489882423e-10
rates O 0 1.146313946542854e-10
of O 0 1.8071340257552748e-10
morbidity O 0 3.0459154913842212e-06
and O 0 1.017189332763735e-09
mortality O 0 7.3263063313788734e-06
. O 0 5.590160867541272e-08

We O 0 8.95980356574455e-09
describe O 0 1.1078444828171996e-09
the O 0 6.720775047597272e-10
outcome O 0 2.215618133405428e-09
of O 0 1.2648578850971148e-09
a O 0 6.859006140835788e-10
5 O 0 2.2797490561998757e-09
- O 0 6.202058311366443e-10
year O 0 6.238100036526362e-10
- O 0 2.607601956583494e-08
old O 0 1.3693562550542993e-07
girl O 0 1.547554084879721e-08
with O 0 3.0045388399457806e-08
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 6.113799599916092e-08
was O 0 2.4065920811722208e-08
first O 0 5.69098101976806e-10
seen O 0 4.141410547831015e-10
at O 0 7.775489696548732e-10
5 O 0 2.536527932139876e-10
months O 0 4.246376514305261e-11
of O 0 3.2522179393978945e-10
age O 0 2.068036852875821e-09
with O 0 2.9967994752411187e-09
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9951232075691223
hepatomegaly B-Disease 1 1.0
, O 0 0.2809627056121826
encephalopathy B-Disease 1 1.0
, O 0 1.8991347872088227e-07
and O 0 8.284994805762835e-07
hypotonia B-Disease 1 0.9999911785125732
. O 0 1.4517398085445166e-05

Biochemical O 0 9.214484634867404e-06
studies O 0 4.999770339964016e-07
indicated O 1 0.9498559236526489
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.8974677920341492
by O 0 4.667652486745055e-09
a O 0 2.0004467415901672e-08
stable O 0 9.639768450142583e-07
yet O 0 2.5834088646092823e-08
inactive O 0 3.617184063386958e-07
enzyme O 0 3.649206092859458e-08
. O 0 3.584683483381923e-08

Molecular O 0 1.0154083156521665e-06
genetic O 0 6.956337017527403e-08
analysis O 0 8.591035660643342e-10
of O 0 2.6140506648175688e-08
her O 0 1.1630772789317234e-08
VLCAD O 1 0.9992479681968689
gene O 0 2.618118060127017e-07
revealed O 0 4.247257834322227e-08
a O 0 2.767487128352286e-09
T1372C O 0 4.2838692593250016e-08
( O 0 1.7910131711040833e-10
F458L O 0 2.803456133904092e-08
) O 0 2.3822979700049984e-10
missense O 0 2.895284367809836e-08
mutation O 0 7.945807567466545e-09
and O 0 2.2002719646252444e-09
a O 0 8.326868083941008e-08
1668 O 0 0.00018655435997061431
ACAG O 0 0.1290292590856552
1669 O 0 2.862223846022971e-05
splice O 0 5.503280135599198e-06
site O 0 2.375537917487236e-07
mutation O 0 2.9128386813681573e-07
. O 0 1.0118572646433677e-07

After O 0 5.3811959332961123e-08
initial O 0 2.205323390569447e-08
treatment O 0 6.473191316302973e-09
with O 0 5.63148472298991e-10
intravenous O 0 4.9086796849451275e-08
glucose O 0 3.4616591619851533e-06
and O 0 3.38375882869002e-10
carnitine O 0 1.729902265878991e-08
, O 0 3.8831906440384145e-11
the O 0 2.1990544107897136e-10
patient O 0 2.4380295005066444e-10
has O 0 1.1059769419730081e-11
thrived O 0 4.2542017131275145e-10
on O 0 3.2805333449736906e-10
a O 0 2.935383602853392e-10
low O 0 2.9593740791256096e-08
- O 0 9.467481909553044e-09
fat O 0 1.766270507630452e-08
diet O 0 4.447809676122461e-09
supplemented O 0 5.90625812146861e-11
with O 0 1.0320643645256311e-11
medium O 0 1.0178575315933358e-08
- O 0 6.722060241770578e-09
chain O 0 2.95620914414485e-08
triglyceride O 0 4.009520182535198e-08
oil O 0 3.69689878709778e-09
and O 0 3.3946123689787555e-10
carnitine O 0 1.0610889944473456e-07
and O 0 1.1400458355126375e-09
avoidance O 0 1.2934599453728879e-06
of O 0 1.423321265292543e-07
fasting O 0 1.6205710835492937e-06
. O 0 1.7573495370015735e-07

Her O 0 1.051557410391979e-05
ventricular O 1 0.9999958276748657
hypertrophy O 1 0.9957677125930786
resolved O 0 8.827644819575653e-07
significantly O 0 7.29753091288643e-10
over O 0 2.0267565403742083e-10
1 O 0 5.277725811936307e-09
year O 0 5.7057487207190505e-11
, O 0 4.7049208279359434e-11
and O 0 2.1121575322080588e-10
cognitively O 0 3.752190878003603e-07
, O 0 1.4396631109470093e-10
she O 0 4.738458236897003e-11
is O 0 6.823793266552691e-12
in O 0 2.1801678518063028e-11
the O 0 8.596920397785368e-10
superior O 0 9.470353390383934e-09
range O 0 1.1220242512877121e-09
for O 0 2.9973351578505003e-10
age O 0 5.964045612927293e-08
. O 0 8.339313239957846e-08

Clinical O 0 7.420636393362656e-06
recognition O 0 3.1925087569106836e-06
of O 1 0.9999830722808838
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 1.819993826757127e-07
important O 0 2.561870937611843e-09
because O 0 2.162046583431554e-11
it O 0 3.685368416689316e-12
is O 0 2.3428262368313524e-12
one O 0 1.3275237029444775e-12
of O 0 2.4133053888597544e-10
the O 0 1.4477623544451035e-09
few O 0 3.466930353912545e-10
directly O 0 5.122393620382582e-10
treatable O 1 0.9999918937683105
causes O 0 1.294827143283328e-07
of O 0 0.00014790389104746282
cardiomyopathy B-Disease 1 1.0
in O 0 4.5228986778056424e-07
children O 0 1.0331525635010053e-09
. O 0 2.757496897487499e-09
. O 0 7.015832181878068e-08

Cloning O 0 6.019903935339244e-07
of O 0 2.2115955289336853e-08
a O 0 2.5211090992627305e-09
novel O 0 1.0545025963537569e-09
member O 0 1.5560065458330996e-09
of O 0 4.026162958581381e-09
the O 0 2.7635113752921825e-08
low O 0 8.9313954276804e-07
- O 0 4.907603567971819e-08
density O 0 1.3472543969328399e-08
lipoprotein O 0 2.012940421991516e-05
receptor O 0 1.6419600115114008e-06
family O 0 3.0902313596925524e-08
. O 0 1.104697346931971e-07

A O 0 4.0268801626552886e-07
gene O 0 2.9287692271395827e-09
encoding O 0 1.1318688208916683e-09
a O 0 6.544609854053363e-10
novel O 0 4.087239990901992e-10
transmembrane O 0 2.520527342397827e-09
protein O 0 4.474474679661e-10
was O 0 1.1369362118429649e-09
identified O 0 2.079025666901213e-11
by O 0 4.72580178115245e-12
DNA O 0 5.870733760238167e-11
sequence O 0 8.526756557769577e-12
analysis O 0 3.0893709899310062e-12
within O 0 1.320068186705381e-11
the O 0 6.816268105502843e-10
insulin B-Disease 1 0.999995231628418
- I-Disease 1 1.0
dependent I-Disease 1 0.9999994039535522
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 1.5844740630654996e-08
IDDM B-Disease 0 0.0001010111955110915
) O 0 9.793560407089785e-11
locus O 0 9.784402621448862e-09
IDDM4 O 0 1.0631437135089072e-06
on O 0 4.735339942385508e-08
chromosome O 0 3.7117882811799063e-07
11q13 O 0 9.808039749259478e-07
. O 0 1.029420104714518e-07

Based O 0 1.0758470558869249e-08
on O 0 3.777949686423199e-08
its O 0 2.708994362166095e-09
chromosomal O 0 6.72809164825594e-07
position O 0 2.0190610072745585e-08
, O 0 2.4639471019050063e-10
this O 0 3.044442128952163e-11
gene O 0 6.812421182722517e-10
is O 0 1.0548556819700572e-11
a O 0 1.6348398329535385e-11
candidate O 0 3.670939247024663e-11
for O 0 3.080023389112618e-11
conferring O 0 3.682480809175104e-08
susceptibility O 0 2.83840768133814e-06
to O 0 1.2369894442088025e-08
diabetes B-Disease 1 0.9999998807907104
. O 0 8.680066230226657e-07

The O 0 2.4302607926074415e-07
gene O 0 7.604364782309858e-08
, O 0 1.7562186149788772e-09
termed O 0 7.153087722144846e-08
low O 0 7.683868830099527e-08
- O 0 4.016483146074279e-09
density O 0 9.763033714804692e-10
lipoprotein O 0 4.2779248587976326e-08
receptor O 0 1.22442100902731e-09
related O 0 6.971644928022158e-10
protein O 0 8.701311338121798e-10
5 O 0 6.424593301801451e-09
( O 0 1.8912241564472687e-11
LRP5 O 0 9.629039254832605e-08
) O 0 4.521156019010597e-12
, O 0 5.381020715816698e-12
encodes O 0 1.4853451801855044e-11
a O 0 9.823231117422893e-11
protein O 0 2.6628055316280097e-10
of O 0 3.952351335101412e-09
1615 O 0 4.28996088430722e-07
amino O 0 1.9096071390833913e-09
acids O 0 9.662449659830763e-12
that O 0 4.5287314480099705e-13
contains O 0 5.758421083718046e-12
conserved O 0 4.732786038075254e-11
modules O 0 5.910100880912594e-11
which O 0 7.97527733957526e-13
are O 0 2.2023585754572805e-13
characteristic O 0 1.5630703675828528e-10
of O 0 7.420372094557592e-10
the O 0 1.8241244070793527e-09
low O 0 5.963329385849647e-08
- O 0 2.9758722153161443e-09
density O 0 7.560984061072418e-10
lipoprotein O 0 8.289792390314688e-07
( O 0 3.894513600499749e-09
LDL O 0 2.2629968952969648e-05
) O 0 2.1118522486318625e-09
receptor O 0 4.0990485672409704e-08
family O 0 3.5257357033913195e-09
. O 0 2.9333214968119137e-08

These O 0 1.2581040653714126e-09
modules O 0 1.461571930150285e-08
include O 0 3.871790443810141e-09
a O 0 4.128690722637884e-09
putative O 0 2.076631133718365e-08
signal O 0 3.754517052811934e-08
peptide O 0 6.919506301272804e-09
for O 0 2.0998056071697135e-10
protein O 0 1.052320675043461e-09
export O 0 1.1689352596988556e-08
, O 0 7.376271121684042e-11
four O 0 4.603423545135321e-11
epidermal O 0 1.1299107427475974e-08
growth O 0 7.306555915853608e-10
factor O 0 3.088248545779493e-10
( O 0 2.4988502586587025e-11
EGF O 0 9.462264749515725e-09
) O 0 4.132308210891278e-12
repeats O 0 8.322045830233549e-11
with O 0 1.0250195657535155e-11
associated O 0 3.052432473449329e-10
spacer O 0 3.2218492318492054e-09
domains O 0 4.3211623168559754e-10
, O 0 1.3511697316559435e-10
three O 0 1.7064105684028164e-10
LDL O 0 2.173640467617588e-07
- O 0 6.101799954194576e-08
receptor O 0 5.676846992486162e-09
( O 0 1.7853411804491515e-10
LDLR O 0 5.137387233844493e-06
) O 0 3.2098480123865514e-11
repeats O 0 9.343980034159927e-10
, O 0 7.92832882678951e-11
a O 0 2.367237239564446e-10
single O 0 8.096835424353799e-10
transmembrane O 0 8.904111226115674e-09
spanning O 0 7.736099760791149e-09
domain O 0 3.0371603010337367e-09
, O 0 2.2418537859447696e-10
and O 0 1.0908368652806644e-10
a O 0 5.0818549368614185e-09
cytoplasmic O 0 7.074230268244719e-08
domain O 0 5.077662024177698e-08
. O 0 3.8029568827369076e-08

The O 0 1.6999548790863628e-07
encoded O 0 8.777007565186068e-09
protein O 0 4.945016396362689e-09
has O 0 1.3656321906641011e-10
a O 0 1.5828442723186953e-10
unique O 0 2.2091521667544356e-10
organization O 0 1.904155055854062e-09
of O 0 2.7778961353419618e-08
EGF O 0 1.4570660823665094e-05
and O 0 3.1962641422467186e-09
LDLR O 0 0.00023228273494169116
repeats O 0 3.24889768421599e-08
; O 0 1.2623194156624606e-10
therefore O 0 8.422347264058772e-10
, O 0 4.5776840651434725e-10
LRP5 O 0 5.622236858471297e-05
likely O 0 1.7899792759124011e-09
represents O 0 9.640584858194856e-11
a O 0 1.046477557387071e-10
new O 0 1.433317492471886e-10
category O 0 4.116486707061995e-09
of O 0 6.152987008789523e-09
the O 0 1.0019225982205171e-07
LDLR O 1 0.7786584496498108
family O 0 7.310535465876455e-08
. O 0 2.294127909863164e-07

Both O 0 1.3093331574509648e-07
human O 0 1.3858519309906114e-07
and O 0 2.0730929861656477e-08
mouse O 0 2.4894193302316125e-06
LRP5 O 0 0.00252562016248703
cDNAs O 0 1.1402515156078152e-05
have O 0 8.81908990280067e-10
been O 0 2.244814750751445e-10
isolated O 0 2.123144771104535e-09
and O 0 9.653336463522066e-11
the O 0 1.6357617482753994e-09
encoded O 0 8.050222155553399e-10
mature O 0 1.6845884409644185e-10
proteins O 0 4.104422531014951e-12
are O 0 8.962143635722619e-13
95 O 0 4.664534869469605e-10
% O 0 2.817749159000904e-11
identical O 0 1.175938096897866e-10
, O 0 1.2483811727415084e-11
indicating O 0 1.610446775934804e-10
a O 0 1.4858814179063984e-10
high O 0 7.681751346133581e-10
degree O 0 4.970746925181402e-09
of O 0 1.2973152552220313e-09
evolutionary O 0 7.598808693387582e-09
conservation O 0 5.74352254645305e-09
. O 0 2.5309029871856126e-10
. O 0 1.155475448655352e-08

The O 0 1.679841830082296e-06
APC B-Disease 0 3.066890485570184e-06
variants O 0 7.158233472637221e-08
I1307K O 0 2.701496555346239e-07
and O 0 7.858730888266052e-10
E1317Q O 0 8.267175388709802e-08
are O 0 3.7560871080088987e-11
associated O 0 7.199568941018697e-09
with O 0 0.0004159078816883266
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.6802202651433618e-07
but O 0 1.726492143694358e-10
not O 0 4.5197873221880513e-11
always O 0 4.413596224606131e-11
with O 0 1.4435558651215707e-11
a O 0 1.3183810709804789e-09
family O 0 1.62192634323155e-10
history O 0 6.578001698898106e-09
. O 0 2.2224588391850375e-08

Classical O 1 0.9941630959510803
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 0.0019903546199202538
FAP B-Disease 0 0.000524817151017487
) O 0 6.486796100269032e-10
is O 0 1.5761231209054927e-10
a O 0 2.832354351056665e-09
high O 0 0.06133202463388443
- O 1 0.9999105930328369
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
that O 0 1.2725499820565034e-10
predisposes O 0 4.1693007379883795e-10
to O 0 4.4076630366374214e-12
hundreds O 0 1.8490072320465067e-11
or O 0 9.258408276147101e-12
thousands O 0 1.0376488557284347e-10
of O 0 3.9046790334396064e-06
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.7857023477554321
carcinoma I-Disease 1 1.0
and O 0 7.943367741347629e-09
that O 0 1.0660352461888678e-10
results O 0 8.263036921363209e-10
from O 0 1.853436015775145e-10
truncating O 0 1.9148124863477278e-08
mutations O 0 8.973492782171633e-11
in O 0 1.4191718633593808e-10
the O 0 8.707757181980469e-09
APC B-Disease 0 4.7621864496250055e-07
gene O 0 9.637840747700466e-08
. O 0 7.167674453967265e-08

A O 0 7.608962846461509e-07
variant O 0 6.161891974443279e-07
of O 0 1.7649544759024138e-07
FAP B-Disease 0 3.418568303459324e-05
is O 0 6.6323792680123e-08
attenuated B-Disease 1 0.995210587978363
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 1.2456430553697828e-08
which O 0 4.298037967198631e-11
results O 0 3.021177752415838e-10
from O 0 1.8809580282219684e-10
germ O 0 0.00013272755313664675
- O 0 2.279698030349664e-08
line O 0 3.864707220913033e-09
mutations O 0 4.3874428395929144e-11
in O 0 2.341808864880779e-11
the O 0 1.6797628565878853e-10
5 O 0 7.395447587654758e-10
and O 0 1.75666581975209e-11
3 O 0 1.434543484002404e-09
regions O 0 3.168589557400736e-10
of O 0 1.5302592526467151e-09
the O 0 2.6127297658717907e-08
APC B-Disease 0 1.1774371841966058e-06
gene O 0 2.2919280695532507e-07
. O 0 8.682056318320974e-08

Attenuated B-Disease 1 0.9999994039535522
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 2.9522759632527595e-06
have O 0 1.9567823750232805e-10
" O 0 7.111661481928877e-09
multiple O 0 3.2846946851350367e-07
" O 1 0.9999998807907104
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 1.6032420946388015e-09
typically O 0 6.240263167311966e-11
fewer O 0 6.41841050794123e-12
than O 0 2.52984330532946e-12
100 O 0 1.329316379194978e-10
) O 0 2.4319012515566785e-12
without O 0 3.270984871850402e-11
the O 0 2.3106808133555035e-10
florid O 0 1.6348671749710775e-08
phenotype O 0 1.1707979030717297e-09
of O 0 2.105533525309511e-09
classical O 0 2.1209375518083107e-06
FAP B-Disease 0 1.866959428298287e-05
. O 0 2.0841055459186464e-07

Another O 0 2.3274346006019186e-07
group O 0 6.044219702516784e-08
of O 0 2.3037353003019234e-07
patients O 0 4.829525224181452e-09
with O 0 6.15903050782407e-10
multiple O 0 1.3498067801265279e-06
adenomas B-Disease 1 0.9999092817306519
has O 0 4.995351354786237e-10
no O 0 1.44621037367898e-10
mutations O 0 1.3083446652462083e-11
in O 0 4.891111821114791e-11
the O 0 1.7097865345760965e-09
APC B-Disease 0 2.199073279030017e-08
gene O 0 3.544106397246338e-10
, O 0 2.7148261069753765e-11
and O 0 2.6272877970412445e-11
their O 0 3.8046635286725916e-11
phenotype O 0 9.76443037536967e-10
probably O 0 3.838608944595201e-11
results O 0 2.8340213856226093e-11
from O 0 1.1652361367464614e-11
variation O 0 5.117230639228865e-09
at O 0 6.8036980493957344e-09
a O 0 3.087223809927764e-10
locus O 0 1.3657058817173606e-09
, O 0 1.8825399572541812e-11
or O 0 8.338135737417929e-12
loci O 0 3.069187681781216e-10
, O 0 5.830860794198145e-11
elsewhere O 0 1.4674755854926502e-10
in O 0 1.0959316787406692e-10
the O 0 3.151275462798253e-09
genome O 0 5.099772337757713e-08
. O 0 3.989883623489732e-08

Recently O 0 1.0293965146956907e-07
, O 0 1.396115445473356e-09
however O 0 6.743708924616953e-10
, O 0 1.7626508586054968e-10
a O 0 6.115974948706082e-10
missense O 0 2.3768629731080182e-08
variant O 0 2.773988860838017e-08
of O 0 6.938037699910637e-08
APC B-Disease 0 2.428863581371843e-07
( O 0 1.6478325648439096e-10
I1307K O 0 1.5060184210824445e-08
) O 0 2.763153941764962e-11
was O 0 6.450497913590425e-10
described O 0 1.2693282536169193e-10
that O 0 2.382318300964137e-12
confers O 0 2.5569732442498605e-10
an O 0 3.5157781633904372e-12
increased O 0 4.6240175577416665e-10
risk O 0 1.0867120892044113e-07
of O 1 0.9991492033004761
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 8.35104358998251e-08
including O 0 7.0774124338868205e-09
multiple O 0 5.376230092224432e-07
adenomas B-Disease 1 0.9999161958694458
, O 0 6.283193521028352e-09
in O 0 2.833874290786298e-08
Ashkenazim O 0 7.306758925551549e-05
. O 0 4.805774551641662e-07

We O 0 8.887364622012228e-09
have O 0 1.1088924917190823e-10
studied O 0 1.8868482332123904e-09
a O 0 3.477951260322243e-10
set O 0 1.7730202861443445e-09
of O 0 1.3309763291502463e-09
164 O 0 1.0658817828357314e-08
patients O 0 4.4125883502665886e-10
with O 0 8.001512230570995e-10
multiple O 1 0.9999998807907104
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 8.188352694560308e-06
/ I-Disease 1 0.9997746348381042
or I-Disease 0 1.821698788262438e-06
carcinoma I-Disease 1 1.0
and O 0 2.8696481635392956e-08
analyzed O 0 1.0517232418294498e-08
codons O 0 8.053973488131305e-09
1263 O 0 1.4774111889437336e-07
- O 0 1.1578868530648379e-08
1377 O 0 6.672881625036098e-08
( O 0 1.6136197933391827e-10
exon O 0 1.9574077469997064e-08
15G O 0 2.411448818406825e-08
) O 0 6.192040370028851e-12
of O 0 2.0352480811780538e-10
the O 0 2.838000057181489e-09
APC B-Disease 0 1.7679692376759704e-08
gene O 0 4.5995027231349184e-10
for O 0 3.6020955662685594e-10
germ O 0 5.924510332988575e-06
- O 0 1.234690500950819e-07
line O 0 8.636175152787473e-08
variants O 0 2.8267007223803375e-07
. O 0 7.279520986003263e-08

Three O 0 6.039759625764418e-08
patients O 0 2.0412476153808257e-09
with O 0 2.1640653158350176e-10
the O 0 1.547536498947011e-08
I1307K O 0 1.86747811881105e-07
allele O 0 4.9441859495402696e-09
were O 0 3.7724587342857774e-10
detected O 0 9.34688548781537e-10
, O 0 3.890774855075385e-11
each O 0 8.349626545722799e-12
of O 0 8.04222999306603e-09
Ashkenazi O 0 7.83370694534824e-07
descent O 0 8.783105158727267e-07
. O 0 4.7316922291429364e-07

Four O 0 5.320735567693191e-07
patients O 0 2.8135270113693878e-08
had O 0 1.2506519375676817e-08
a O 0 1.1307257352655142e-08
germ O 0 3.600309355533682e-05
- O 0 1.6681815395713784e-07
line O 0 4.170601286546116e-08
E1317Q O 0 1.4781625168325263e-07
missense O 0 2.5473134712683532e-08
variant O 0 6.9175003503119115e-09
of O 0 4.519972840455466e-09
APC O 0 1.2106969649039456e-08
that O 0 1.941924052117905e-11
was O 0 3.164363659990954e-09
not O 0 8.830341839682898e-12
present O 0 1.1397423803349849e-11
in O 0 1.8910366328395156e-11
controls O 0 4.0967171877070996e-09
; O 0 6.635479058575422e-12
one O 0 6.398328047940716e-12
of O 0 1.5383354312614728e-10
these O 0 3.2399926925413824e-12
individuals O 0 1.0985088706727542e-12
had O 0 2.2951752998157104e-10
an O 0 2.4318375438370232e-11
unusually O 0 6.361924875797342e-10
large O 0 6.826790521774484e-11
number O 0 4.5528675274297825e-10
of O 0 3.769449108403933e-08
metaplastic B-Disease 0 7.81221388024278e-05
polyps I-Disease 0 3.8770422179368325e-06
of I-Disease 0 4.5050764896359397e-08
the I-Disease 0 1.4797603853367036e-07
colorectum I-Disease 0 0.00011774750601034611
. O 0 1.0152456297873869e-06

There O 0 3.439737383814645e-08
is O 0 2.9970495529774155e-10
increasing O 0 3.2572522457030573e-10
evidence O 0 1.5631448913033807e-10
that O 0 2.09452745945915e-12
there O 0 7.465195128730784e-12
exist O 0 6.11080630541494e-11
germ O 0 2.3837774421053837e-08
- O 0 2.054060810330327e-10
line O 0 1.0086013968457763e-10
variants O 0 7.418472086628825e-11
of O 0 5.039132444650818e-10
the O 0 4.551463206325934e-09
APC B-Disease 0 4.2907384312229624e-08
gene O 0 2.620652583829042e-10
that O 0 4.235656530376941e-12
predispose O 0 1.695376131150006e-11
to O 0 1.9508329413692183e-12
the O 0 6.139136421445812e-11
development O 0 3.8972311489082756e-10
of O 0 4.316238921830973e-09
multiple O 1 0.9999983310699463
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999849796295166
carcinoma I-Disease 1 1.0
, O 0 1.8836201931549112e-08
but O 0 7.881317820590539e-11
without O 0 1.4525299019130244e-10
the O 0 3.1831759450540176e-10
florid O 0 1.4680622051344017e-08
phenotype O 0 1.8415045877073766e-10
of O 0 9.022509128708833e-11
classical O 0 1.2872256149876193e-07
FAP B-Disease 0 1.3141118415660458e-07
, O 0 2.3179276206763966e-11
and O 0 4.5680672786097e-12
possibly O 0 9.780115085844532e-12
with O 0 8.820455216912437e-13
importance O 0 3.977301332724892e-08
for O 1 0.5272997617721558
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 9.492534900346072e-07
in O 0 3.252954502985794e-11
the O 0 9.62860347009098e-11
general O 0 1.1039044123251074e-09
population O 0 1.9041204377123755e-11
. O 0 2.31698285557691e-10
. O 0 1.7198154012021405e-08

Genomic O 0 5.077541231912619e-07
structure O 0 8.054131228618644e-08
of O 0 3.2483217893286565e-08
the O 0 5.287749331728264e-07
human O 1 0.9999985694885254
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9929432272911072
CLD B-Disease 1 0.9999998807907104
) O 0 8.445467436501986e-09
gene O 0 2.4787749453025754e-07
. O 0 5.400588065640477e-08

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999792575836182
CLD B-Disease 1 1.0
) O 0 1.2738036181403345e-09
is O 0 5.7178088652687364e-11
caused O 0 4.838032752196852e-10
by O 0 3.096150419379384e-11
mutations O 0 5.1927462330070284e-11
in O 0 4.014978280397763e-11
a O 0 2.0290270852374448e-10
gene O 0 2.2356962114944423e-10
which O 0 1.925702132477003e-11
encodes O 0 1.728337195583407e-10
an O 0 8.018068847759352e-11
intestinal O 0 0.0006122411577962339
anion O 0 2.011264086831943e-06
transporter O 0 6.452135130530223e-05
. O 0 2.0284183221974672e-07

We O 0 2.320372871622567e-08
report O 0 1.1177052616773153e-09
here O 0 3.3006047894801327e-10
the O 0 2.669029164348302e-10
complete O 0 4.746676829370244e-09
genomic O 0 2.0017138169237114e-08
organization O 0 2.0205010997642603e-09
of O 0 4.769364903012274e-09
the O 0 1.8769783949323937e-08
human O 0 1.1264533128496623e-07
CLD B-Disease 0 1.4939905668143183e-05
gene O 0 2.773511420528507e-09
which O 0 9.849158988384232e-11
spans O 0 1.4747774113033074e-09
approximately O 0 1.964171186807917e-10
39kb O 0 1.6032697658374673e-07
, O 0 8.251099248290927e-10
and O 0 6.839175337169934e-10
comprises O 0 3.31044986978668e-08
21 O 0 1.2921025245304918e-06
exons O 0 3.339854447403923e-05
. O 0 5.779481853096513e-07

All O 0 2.670820435923815e-07
exon O 0 6.350585863401648e-06
/ O 0 1.3520136690203799e-06
intron O 0 4.6053716573624115e-07
boundaries O 0 6.231681837221004e-09
conform O 0 2.2343629169085943e-09
to O 0 1.670369675910166e-10
the O 0 1.9763868763789105e-08
GT O 0 8.369564602617174e-05
/ O 0 8.414666808675975e-06
AG O 0 0.00015362522390205413
rule O 0 9.048403057931864e-07
. O 0 2.6358000582149543e-07

An O 0 1.3803187481897794e-09
analysis O 0 8.371353610314713e-10
of O 0 7.934403356557596e-09
the O 0 2.4654115193811776e-08
putative O 0 8.660884986966266e-08
promoter O 0 2.471670086379163e-06
region O 0 1.722582965157926e-08
sequence O 0 4.268288833486622e-09
shows O 0 9.59224522034674e-09
a O 0 5.449822992886766e-08
putative O 0 1.9205353964935057e-06
TATA O 0 0.00028988270787522197
box O 0 3.201544416242541e-07
and O 0 3.926456659808508e-10
predicts O 0 8.275311991212675e-09
multiple O 0 7.262594969859038e-10
transcription O 0 2.4851649627066763e-08
factor O 0 4.666388164764612e-09
binding O 0 6.005422381605285e-09
sites O 0 7.249257194530401e-09
. O 0 1.3951178878812698e-08

The O 0 7.829085291177762e-08
genomic O 0 1.6663149438045366e-07
structure O 0 7.930245971010663e-08
was O 0 6.656788542613867e-08
determined O 0 3.163440176479071e-09
using O 0 1.7943331542813468e-10
DNA O 0 4.533024511310657e-10
from O 0 1.6528525076386913e-11
several O 0 6.4517466889790764e-12
sources O 0 2.0450958634898875e-11
including O 0 3.6123729008075145e-11
multiple O 0 1.0176104403569752e-09
large O 0 1.9208997059649846e-08
- O 0 1.1483594875016934e-07
insert O 0 7.164489801425589e-08
libaries O 0 1.4184623751134495e-06
and O 0 2.049694192152174e-09
genomic O 0 5.813911840846231e-08
DNA O 0 5.98685119257425e-08
from O 0 1.8097116027959714e-09
Finnish O 0 0.0026191680226475
CLD B-Disease 1 0.9999896287918091
patients O 0 4.257972818777489e-08
and O 0 4.885224225148477e-09
controls O 0 8.16267856862396e-06
. O 0 4.841157874579949e-07

Exon O 0 8.03562143119052e-05
- O 0 2.6058921775984345e-07
specific O 0 1.0705129227517318e-08
primers O 0 3.329713393895872e-08
developed O 0 2.63714050596775e-09
in O 0 1.094269050372354e-10
this O 0 2.2450277747942948e-11
study O 0 4.663527550241575e-11
will O 0 1.1580065031879805e-11
facilitate O 0 2.1008031425573392e-10
mutation O 0 1.7368036175913204e-10
screening O 0 4.724770019670643e-10
studies O 0 2.2208877098472968e-11
of O 0 1.8009059521428838e-10
patients O 0 5.329563526612624e-11
with O 0 8.040212939874891e-11
the O 0 6.28630061783042e-07
disease O 1 0.9998716115951538
. O 0 1.8496773179776937e-07

Genomic O 0 3.946997821913101e-07
sequencing O 0 6.840564026333595e-08
of O 0 2.6875508751800226e-07
a O 0 1.2161784752606764e-06
BAC O 0 0.0806565135717392
clone O 0 0.00018200492195319384
H O 1 0.9999998807907104
_ O 0 6.649425898785921e-09
RG364P16 O 0 1.9220649960516312e-08
revealed O 0 1.6943725311691082e-09
the O 0 1.394541843113828e-10
presence O 0 4.369804171289182e-11
of O 0 1.6907438782354234e-09
another O 0 9.629911312813988e-10
, O 0 1.7053432277425173e-10
highly O 0 3.8275710378954386e-10
homologous O 0 2.505628760030021e-10
gene O 0 5.473683728496326e-10
3 O 0 1.4006984905279296e-08
of O 0 1.3252544839303937e-08
the O 0 8.406114204717596e-08
CLD B-Disease 0 0.00041753798723220825
gene O 0 3.133606041316739e-09
, O 0 6.200801677680445e-11
with O 0 7.905629276216963e-12
a O 0 2.507369034621121e-10
similar O 0 1.3346998506413854e-10
genomic O 0 5.8638791600174045e-09
structure O 0 1.3117723796085556e-08
, O 0 1.9390750116698996e-10
recently O 0 5.790819490592014e-10
identified O 0 1.3390806519186782e-10
as O 0 4.888857096929655e-10
the O 0 6.165407171465631e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 8.583040767007333e-07
( O 0 2.128253351330045e-09
PDS B-Disease 0 8.993980372906663e-06
) O 0 2.416856714759774e-10
. O 0 1.5299849165373303e-09
. O 0 4.065900682803658e-08

The O 0 9.141819532487716e-07
APCI1307K O 0 0.14241883158683777
allele O 0 3.6094625102123246e-06
and O 0 4.3886295486572635e-08
cancer B-Disease 1 0.8719821572303772
risk O 0 6.22688460794052e-08
in O 0 2.448356239970195e-10
a O 0 1.98876626278377e-09
community O 0 1.7867209101130044e-10
- O 0 3.3332686610876294e-10
based O 0 1.2709466812310666e-10
study O 0 7.013788161369661e-11
of O 0 3.0583318100241286e-09
Ashkenazi O 0 1.7007948827085784e-07
Jews O 0 2.7153895132414618e-08
. O 0 2.098048668131014e-07

Mutations O 0 1.7080655823065172e-07
in O 0 1.8552416491957047e-08
APC O 0 1.61097887030337e-06
are O 0 3.4061309328592415e-10
classically O 0 1.2856281728090835e-07
associated O 0 2.8871449231360202e-08
with O 0 1.9752832258745912e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 6.059237784938887e-05
FAP B-Disease 0 7.14353664079681e-05
) O 0 1.0367763592089574e-10
, O 0 5.7873057041080145e-11
a O 0 1.477226674317933e-09
highly O 0 4.315230034990236e-05
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 0.00038605218287557364
by O 0 1.391173148901359e-10
multiple O 0 5.510790934692977e-09
intestinal O 1 0.9999908208847046
polyps B-Disease 0 0.0020214077085256577
and O 0 5.748057030352527e-10
, O 0 1.2203495158846778e-10
without O 0 4.0349171226417013e-10
surgical O 0 0.0054446323774755
intervention O 0 1.656026995533466e-07
, O 0 1.8592703765474283e-11
the O 0 7.707945393065074e-11
development O 0 7.691813408428061e-09
of O 0 0.0004637888341676444
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 7.007640192568942e-07
CRC B-Disease 1 0.999951958656311
) O 0 4.847123591389391e-09
. O 0 4.420157395657043e-08

APC B-Disease 0 8.530548075214028e-05
is O 0 4.179607770993243e-08
a O 0 5.786100132354477e-08
tumour O 1 1.0
- O 0 5.938669573879451e-07
suppressor O 0 9.346970841761504e-07
gene O 0 4.4620001027340095e-09
, O 0 9.430904668317197e-11
and O 0 1.6642955069645637e-10
somatic O 0 3.1040897283673985e-06
loss O 0 6.155249252515205e-07
occurs O 0 6.279493902638933e-08
in O 0 6.956508968869457e-08
tumours B-Disease 1 1.0
. O 0 1.81400491783279e-06

The O 0 2.2963877199799754e-06
germline O 0 1.6996991689666174e-05
T O 0 7.62575098178786e-07
- O 0 2.694025669214284e-09
to O 0 1.9643472959351982e-10
- O 0 5.094636712499323e-09
A O 0 1.1634766927670626e-08
transversion O 0 9.200824990784895e-08
responsible O 0 2.2458392923141446e-09
for O 0 9.687218388565455e-11
the O 0 3.081130905968621e-09
APC O 0 7.425504122693383e-08
I1307K O 0 1.9681408502947306e-08
allele O 0 8.346164315220506e-10
converts O 0 2.166150731008898e-10
the O 0 4.467038683397817e-10
wild O 0 8.224785297272774e-09
- O 0 2.328403858609107e-10
type O 0 2.2158493095947307e-10
sequence O 0 5.243327994008951e-10
to O 0 7.160667198080617e-11
a O 0 1.2374614222210312e-08
homopolymer O 0 0.0005645783967338502
tract O 0 7.628648290847195e-06
( O 0 1.1117434750573807e-09
A8 O 0 1.1144243217131589e-06
) O 0 1.1005835132138486e-11
that O 0 5.3546368727896976e-12
is O 0 3.0760971547749705e-10
genetically O 0 1.3373787055570574e-07
unstable O 0 2.3539399762739777e-07
and O 0 4.330232172833348e-09
prone O 0 2.633589133438363e-07
to O 0 1.7321498679834235e-09
somatic O 0 4.178598464932293e-05
mutation O 0 4.5993189701221127e-07
. O 0 9.056297045617612e-08

The O 0 4.147003664911608e-07
I1307K O 0 1.2722110795948538e-06
allele O 0 9.058404515371876e-08
was O 0 4.0159338965395364e-08
found O 0 8.177056809444139e-10
in O 0 7.26240123594124e-10
6 O 0 1.175747229353874e-06
. O 0 1.444960844310117e-07

1 O 0 8.706023777449445e-07
% O 0 7.2987740296071024e-09
of O 0 1.6295778948460793e-08
unselected O 0 1.0548397767706774e-05
Ashkenazi O 0 3.7260383578541223e-07
Jews O 0 1.077751132783078e-08
and O 0 1.2962888540357653e-09
higher O 0 8.687219832381743e-09
proportions O 0 1.1478186223712328e-07
of O 0 2.996875082317274e-06
Ashkenazim O 0 0.0021128524094820023
with O 0 4.68854954860376e-09
family O 0 2.401162380039068e-09
or O 0 2.475988580830091e-10
personal O 0 6.5732113085914534e-09
histories O 0 2.5743926101995385e-08
of O 0 0.0001236999232787639
CRC B-Disease 1 0.9999997615814209
( O 0 1.048323983177113e-09
ref O 0 8.917609761738277e-08
. O 0 4.592498326072558e-10
2 O 0 2.580675584340497e-08
) O 0 3.784227098346804e-10
. O 0 7.825931902516459e-09

To O 0 2.103225815730525e-09
evaluate O 0 2.5813435833299536e-09
the O 0 1.225823109685109e-09
role O 0 2.2023924906022785e-09
of O 0 6.59004495418003e-09
I1307K O 0 2.6999947522199363e-07
in O 0 6.218312975647677e-09
cancer B-Disease 0 2.5504625682515325e-06
, O 0 1.0248075721364103e-09
we O 0 1.1725879156543328e-09
genotyped O 0 1.7292147731495788e-06
5 O 0 2.8680020136562234e-07
, O 0 1.4283084048827277e-08
081 O 0 1.388783311995212e-05
Ashkenazi O 0 6.936171104143796e-08
volunteers O 0 1.0835112806972802e-09
in O 0 3.862907216323208e-10
a O 0 2.286202338552812e-09
community O 0 4.013787524570489e-09
survey O 0 1.1788136689006024e-08
. O 0 1.1225046847584963e-07

Risk O 0 1.1222902003282798e-06
of O 0 2.658561299995199e-07
developing O 0 0.08975813537836075
colorectal B-Disease 1 1.0
, I-Disease 0 2.453640991006978e-05
breast I-Disease 1 0.5880725979804993
and I-Disease 0 6.457951684524232e-08
other I-Disease 0 2.2835408231003385e-08
cancers I-Disease 1 0.9996711015701294
were O 0 1.6464268171034746e-08
compared O 0 1.3960728129092104e-09
between O 0 3.0105489212672865e-09
genotyped O 0 0.000302462576655671
I1307K O 0 1.6416517212292092e-07
carriers O 0 4.8574845534776756e-11
and O 0 1.214914367025921e-11
non O 0 2.251797193153493e-09
- O 0 1.418608980285896e-10
carriers O 0 1.0839856789957025e-11
and O 0 1.850036400116717e-12
their O 0 1.3037336835108881e-11
first O 0 5.408190006939151e-10
- O 0 5.379346301737087e-09
degree O 0 2.2545364686266112e-07
relatives O 0 4.239220885438044e-08
. O 0 4.173291046072336e-08

Sperm O 0 6.843082900331865e-08
DNA O 0 1.4424735184093151e-08
analysis O 0 9.378333665210903e-10
in O 0 2.4280812915833394e-09
a O 0 2.350642347437315e-07
Friedreich B-Disease 1 0.9999994039535522
ataxia I-Disease 1 1.0
premutation O 1 0.9999806880950928
carrier O 0 5.606445938610705e-06
suggests O 0 1.7599214530150675e-08
both O 0 1.2739446164644619e-09
meiotic O 0 3.6189446745993337e-06
and O 0 2.199613380327037e-09
mitotic O 0 1.8082776875871787e-07
expansion O 0 4.3402891947152966e-08
in O 0 2.249487485173063e-09
the O 0 2.4080890170807834e-08
FRDA B-Disease 0 0.00019081079517491162
gene O 0 8.799084412203229e-07
. O 0 1.365221322657817e-07

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 6.854252660559723e-06
usually O 0 3.4741143295491383e-09
caused O 0 2.6499376026833943e-09
by O 0 2.3522078382298695e-11
an O 0 6.088639575158039e-12
expansion O 0 4.719602930691735e-09
of O 0 3.2686635620393645e-08
a O 0 2.1216970935711288e-07
GAA O 0 6.751849014108302e-06
trinucleotide O 0 1.172871907328954e-05
repeat O 0 7.546611868747277e-08
in O 0 3.105154577909275e-09
intron O 0 4.267656663614616e-07
1 O 0 2.8402197926880035e-07
of O 0 2.270892629496757e-08
the O 0 7.621382991374048e-08
FRDA B-Disease 0 0.0007980353548191488
gene O 0 9.13300084448565e-07
. O 0 9.30707955149046e-08

Occasionally O 0 6.943862729258399e-08
, O 0 1.7762257220610422e-09
a O 0 7.725405315461842e-10
fully O 0 4.816533838436499e-10
expanded O 0 1.1717668502164713e-10
allele O 0 3.923671665351236e-10
has O 0 1.815119755887995e-11
been O 0 2.07011872921381e-11
found O 0 5.134850444149519e-12
to O 0 1.83080005149161e-12
arise O 0 2.000386488398842e-11
from O 0 1.1553194165236924e-11
a O 0 2.6196331215366797e-10
premutation O 0 4.2789533694076454e-08
of O 0 1.486486755908345e-08
100 O 0 1.0555496032793599e-08
or O 0 6.363247706531183e-10
less O 0 5.6946758419940124e-09
triplet O 0 2.3685597625444643e-06
repeats O 0 2.317329290235648e-06
. O 0 4.950237553202896e-07

We O 0 4.590120994407698e-08
have O 0 3.8444139538462707e-10
examined O 0 2.344600069648095e-09
the O 0 1.6787546908147988e-09
sperm O 0 2.5210467047287466e-09
DNA O 0 4.523112107079896e-09
of O 0 8.524703609680273e-09
a O 0 6.662123297473954e-08
premutation O 0 1.5405046724481508e-05
carrier O 0 2.002200517381425e-06
. O 0 6.41984968297038e-07

This O 0 2.4462254444301834e-08
mans O 0 4.484117198444437e-06
leucocyte O 0 1.891632905426377e-06
DNA O 0 2.6430335253735393e-08
showed O 0 4.339020698296281e-09
one O 0 6.434851262948627e-11
normal O 0 7.22489013060823e-10
allele O 0 2.2027779600364283e-10
and O 0 2.1269892097608434e-11
one O 0 9.782484718112716e-12
allele O 0 1.349948763884612e-10
of O 0 5.586754947550787e-10
approximately O 0 5.398966274050565e-10
100 O 0 7.99809818374797e-09
repeats O 0 1.4713621965256607e-07
. O 0 6.811141162188505e-08

His O 0 1.1190373783165342e-07
sperm O 0 2.6442827927297685e-09
showed O 0 1.1910853414676126e-09
an O 0 3.869689638169582e-11
expanded O 0 2.61771521126164e-10
allele O 0 4.810474241168095e-10
in O 0 1.9673132567454843e-10
a O 0 6.021882104079168e-09
tight O 0 6.30384278110796e-08
range O 0 3.818094285179541e-09
centering O 0 2.15493889399454e-09
on O 0 1.4528244163258819e-09
a O 0 1.608770477945498e-10
size O 0 7.494488363235519e-11
of O 0 1.5664706198847966e-09
approximately O 0 3.5914295981598343e-09
320 O 0 9.303242620717356e-09
trinucleotide O 0 1.331273506366415e-05
repeats O 0 1.6689596122887451e-06
. O 0 5.64216065868095e-07

His O 0 9.792543096409645e-07
affected O 0 2.1686173568014055e-07
son O 0 2.5459490871071466e-07
has O 0 3.313752383604651e-09
repeat O 0 7.654131195522496e-08
sizes O 0 6.912567851458107e-09
of O 0 9.804563205761951e-08
1040 O 0 7.222119506877789e-07
and O 0 1.6341502373506955e-08
540 O 0 3.074669621128123e-07
. O 0 9.95753808297195e-08

These O 0 1.707759267333131e-09
data O 0 2.1490240698085472e-09
suggest O 0 2.690332401300566e-10
that O 0 4.110172705656945e-12
expansion O 0 1.1849309311529055e-09
occurs O 0 9.773774671539837e-12
in O 0 9.886684353144215e-12
two O 0 4.123474565270735e-12
stages O 0 2.259382014813127e-09
, O 0 1.5446619677783602e-11
the O 0 5.53862511409875e-11
first O 0 1.11418423098808e-10
during O 0 4.5015244309887237e-10
meiosis O 0 3.969309325668746e-10
followed O 0 1.6008457059957237e-10
by O 0 9.29778753988586e-11
a O 0 1.2618457390090043e-09
second O 0 5.784994261404108e-09
mitotic O 0 2.2313750491775863e-07
expansion O 0 6.904505767124647e-07
. O 0 1.807839566936309e-07

We O 0 5.1037787329732964e-09
also O 0 8.804647289029077e-11
show O 0 1.1158068913275088e-10
that O 0 3.2358055037512434e-12
in O 0 1.847061566195851e-11
all O 0 2.7740320457381173e-11
informative O 0 2.8608956870179725e-10
carrier O 0 2.509273067108353e-10
father O 0 2.582982439047754e-10
to O 0 4.940844261502875e-11
affected O 0 2.645350882790609e-10
child O 0 2.4580748547720077e-10
transmissions O 0 2.344582306079701e-09
, O 0 7.483614422598706e-12
with O 0 5.800715810466706e-13
the O 0 4.229152097967592e-11
notable O 0 1.6174468708829437e-10
exception O 0 1.8751514230253008e-10
of O 0 1.0435221575733067e-09
the O 0 4.4005212807007865e-09
premutation O 0 2.3562084550121654e-07
carrier O 0 4.548251997249508e-09
, O 0 1.0229361108171631e-10
the O 0 3.131453707450049e-10
expansion O 0 2.3582522601373057e-09
size O 0 5.060032393089386e-10
decreases O 0 1.947519701062106e-09
. O 0 2.388500508487823e-09
. O 0 4.681929866023893e-08

The O 0 2.7334945684742706e-07
R496H O 0 2.186852952945628e-06
mutation O 0 8.189192612917395e-08
of O 0 1.5890628901615855e-07
arylsulfatase O 0 0.001436169957742095
A O 0 6.653323907812592e-06
does O 0 2.8424800291304564e-09
not O 0 4.92466645241052e-09
cause O 0 4.7367757360916585e-05
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 3.721496796060819e-06

Deficiency B-Disease 1 0.9987039566040039
of I-Disease 0 9.84174112090841e-05
arylsulfatase I-Disease 1 0.9999511241912842
A I-Disease 1 0.7254837155342102
( O 0 6.003352126526806e-08
ARSA O 1 0.7703220844268799
) O 0 3.093815648114173e-09
enzyme O 0 1.1844187852716459e-08
activity O 0 5.917859269288783e-08
causes O 0 1.8143777197110467e-05
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.794768536456104e-06
MLD B-Disease 1 1.0
) O 0 1.5259347563301162e-08
. O 0 2.102577134621697e-08

A O 0 5.034411287851981e-07
number O 0 1.5111284668023472e-08
of O 0 1.5409365516916296e-07
ARSA O 0 0.0008712498820386827
gene O 0 6.299071486637331e-08
mutations O 0 4.189758762151996e-09
responsible O 0 1.5434684641491003e-08
for O 0 7.571811622142377e-09
MLD B-Disease 1 1.0
have O 0 2.965605094829016e-09
been O 0 2.0845829507010194e-09
identified O 0 6.963582155350423e-09
. O 0 3.743097920505534e-08

Recently O 0 2.804660255151248e-07
, O 0 4.549067789128003e-09
the O 0 5.0734287881937234e-09
R496H O 0 1.7580737221578602e-07
mutation O 0 1.8550080582713235e-08
of O 0 7.394100975943729e-08
ARSA O 0 0.0054921540431678295
was O 0 1.0897654334485196e-07
proposed O 0 6.607296931804285e-10
to O 0 1.475439909137677e-11
be O 0 2.6447391152095712e-11
a O 0 2.2169611979538928e-10
cause O 0 4.6699768496694105e-09
of O 0 4.7104722966651025e-07
MLD B-Disease 1 1.0
( O 0 1.1594442073104005e-09
Draghia O 0 4.561159983040852e-07
et O 0 2.358177795258598e-07
al O 0 7.760395881462046e-09
. O 0 3.806848239418237e-11
, O 0 4.8578273348365286e-11
1997 O 0 4.178482004846273e-09
) O 0 4.072812365141232e-10
. O 0 1.0552879459169162e-08

We O 0 1.6801170232838558e-08
have O 0 3.0781396875845246e-10
investigated O 0 4.606467207679543e-09
the O 0 1.6409363867708748e-09
R496H O 0 5.483302700781678e-08
mutation O 0 9.982440429823214e-10
and O 0 3.3853773950820454e-11
found O 0 1.4683596352704775e-11
this O 0 1.9017855866498845e-12
mutation O 0 1.1044808123639172e-10
at O 0 1.3813564736508965e-09
a O 0 2.541170919523328e-11
relatively O 0 4.934042324017396e-12
high O 0 1.9107673776552758e-11
frequency O 0 3.342256332805604e-11
in O 0 4.953825977899173e-12
an O 0 1.4751859673048373e-12
African O 0 2.3697748624540438e-11
American O 0 6.304408384227855e-12
population O 0 7.812940290390091e-13
( O 0 5.113327296302206e-13
f O 0 9.285918145529592e-10
= O 0 3.894541078519609e-10
0 O 0 4.4007375521459835e-10
. O 0 6.581480586215216e-12
09 O 0 3.8470401864110215e-10
, O 0 4.683608535727135e-12
n O 0 9.991311944457237e-11
= O 0 2.735379145413219e-10
61 O 0 1.0775964565112872e-09
subjects O 0 9.94081150729187e-10
) O 0 3.635952927627528e-10
. O 0 6.5862253428861095e-09

The O 0 1.181218794954475e-05
ARSA O 0 0.19424130022525787
enzyme O 0 1.767517510131711e-08
activity O 0 1.1615048922664073e-09
in O 0 4.7136513442458394e-11
subjects O 0 9.930307270922256e-11
with O 0 8.288331826422635e-12
and O 0 6.956817760750411e-11
without O 0 3.963075978496988e-10
the O 0 8.486705227461755e-10
R496H O 0 4.821235322083339e-08
mutation O 0 1.9399861717062095e-09
was O 0 2.9601912032717337e-09
determined O 0 5.046779105732924e-10
and O 0 3.431161604838806e-11
found O 0 3.9004119378738267e-11
to O 0 1.6850213932495528e-11
be O 0 7.261320433826768e-10
normal O 0 1.2701728735464712e-07
. O 0 3.6508492229359035e-08

It O 0 4.42885594864606e-09
is O 0 5.22774934452741e-10
therefore O 0 3.901009237861075e-10
concluded O 0 2.0086352581216715e-09
that O 0 6.830199600349474e-12
the O 0 3.0001379158761665e-10
R496H O 0 2.852219260773836e-08
mutation O 0 1.2999160636795182e-09
of O 0 1.7960093856572712e-08
ARSA O 0 7.06346909282729e-05
does O 0 2.5209865445185997e-11
not O 0 7.42483852178566e-12
negatively O 0 1.4624473507196534e-12
influence O 0 1.307396638866587e-11
the O 0 7.885859326650646e-11
activity O 0 2.6526111862601454e-10
of O 0 2.4736106496447974e-09
ARSA O 0 0.000968899461440742
and O 0 5.910171796408292e-10
is O 0 8.506650245321268e-11
not O 0 6.322908169265062e-11
a O 0 4.1738701384019805e-09
cause O 0 1.224830157298129e-06
of O 0 6.569534161826596e-05
MLD B-Disease 1 1.0

Down O 0 6.04315209784545e-06
- O 0 2.7947172043241153e-07
regulation O 0 2.8194531864755845e-07
of O 0 1.9171555720731703e-07
transmembrane O 0 2.9649236239492893e-05
carbonic O 0 0.00013169946032576263
anhydrases O 0 0.009050960652530193
in O 0 1.0076390935864765e-05
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 0.014096994884312153
lines O 0 3.933197323391369e-09
by O 0 4.6032150313735087e-10
wild O 0 7.763906069158111e-07
- O 0 4.084711235918803e-08
type O 0 2.659585618403071e-07
von B-Disease 1 0.9991868138313293
Hippel I-Disease 1 0.9999973773956299
- I-Disease 0 0.20590724050998688
Lindau I-Disease 0 0.011604798026382923
transgenes O 0 2.3840721041779034e-05
. O 0 1.6387923551519634e-07

To O 0 4.296683897564435e-08
discover O 0 3.9596645962092225e-08
genes O 0 1.6745430597708832e-09
involved O 0 8.974079812595903e-10
in O 0 3.5437703882479354e-09
von B-Disease 1 0.9995430707931519
Hippel I-Disease 1 0.9999998807907104
- I-Disease 1 0.9999808073043823
Lindau I-Disease 1 0.9999921321868896
( O 0 3.966029566981888e-07
VHL B-Disease 1 0.6768224239349365
) O 0 1.4797986169767796e-09
- O 0 3.2528351567862046e-08
mediated O 0 1.0970213679684093e-06
carcinogenesis O 0 0.001294121379032731
, O 0 2.2447814718162817e-09
we O 0 6.914924743917084e-10
used O 0 1.0596667543438798e-08
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 0.001036331057548523
lines O 0 9.092363306706375e-09
stably O 0 1.0553326035278587e-07
transfected O 0 2.7107929234659878e-09
with O 0 4.97101700080993e-11
wild O 0 2.59350571241157e-07
- O 0 7.2793270078364e-08
type O 0 9.681835990704712e-07
VHL O 1 0.8821297883987427
- O 0 7.462070357178163e-07
expressing O 0 4.1644725001788174e-08
transgenes O 0 1.8510056634113425e-06
. O 0 5.283882131834616e-08

Large O 0 4.0012392332755553e-07
- O 0 9.09913211444291e-08
scale O 0 5.975535373181629e-07
RNA O 0 7.164912574353366e-08
differential O 0 2.237677954042283e-08
display O 0 2.456989989241265e-08
technology O 0 3.81498566071059e-09
applied O 0 3.9126335504846566e-10
to O 0 8.468473318423708e-12
these O 0 7.564121204395313e-12
cell O 0 1.2003767979607005e-09
lines O 0 5.0177514920868305e-11
identified O 0 1.726596643436551e-11
several O 0 3.6976194675575336e-12
differentially O 0 1.9183016286561383e-10
expressed O 0 1.2164052751173493e-11
genes O 0 3.946748310112991e-12
, O 0 2.759023695272922e-12
including O 0 2.8786285855009197e-11
an O 0 2.2093124552036159e-10
alpha O 0 4.817742365048616e-07
carbonic O 0 7.448958854183729e-07
anhydrase O 0 2.3098737074178644e-06
gene O 0 3.9272173069093697e-08
, O 0 4.279685938968214e-09
termed O 0 6.739136324540596e-07
CA12 O 0 0.0009811206255108118
. O 0 1.2625971521629253e-06

The O 0 1.667437175001396e-07
deduced O 0 1.2079612865534273e-08
protein O 0 7.977876137488238e-10
sequence O 0 1.1554022183446477e-09
was O 0 1.1410687505986061e-08
classified O 0 4.964443856003697e-10
as O 0 1.8069133689291306e-10
a O 0 1.3503691498328863e-09
one O 0 1.4156688044053567e-09
- O 0 2.3049217645620956e-07
pass O 0 9.365041364617355e-08
transmembrane O 0 1.108571177610429e-05
CA O 0 2.6335139864386292e-06
possessing O 0 3.2128358640193255e-08
an O 0 5.853607043526665e-10
apparently O 0 5.2817936690985334e-09
intact O 0 6.4900667062772754e-09
catalytic O 0 1.9522652383585637e-09
domain O 0 2.127279241648239e-09
in O 0 3.5866562497766097e-10
the O 0 3.7001226527166864e-09
extracellular O 0 3.264078713982599e-07
CA O 0 5.020754997531185e-06
module O 0 3.1117456273932476e-06
. O 0 6.524947337993581e-08

Reintroduced O 0 3.541111800586805e-05
wild O 0 3.3417723898310214e-05
- O 0 3.1526474231213797e-06
type O 0 4.260785772203235e-06
VHL B-Disease 0 0.009004917927086353
strongly O 0 7.306894200809211e-09
inhibited O 0 3.826960082164987e-09
the O 0 1.058355292293811e-09
overexpression O 0 2.5320257890371067e-08
of O 0 8.687667474305272e-09
the O 0 1.13175708804647e-08
CA12 O 0 2.481732371961698e-05
gene O 0 1.2319101294622214e-09
in O 0 1.5921339246993682e-10
the O 0 1.4436461803768452e-08
parental O 0 0.00015960786549840122
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9979396462440491
lines O 0 5.066797825747926e-07
. O 0 7.446750771578081e-08

Similar O 0 1.4686194482749215e-08
results O 0 4.2472230177281745e-09
were O 0 3.712322116378175e-10
obtained O 0 1.1889919604435306e-10
with O 0 2.527482945158255e-10
CA9 O 0 0.00010527616541367024
, O 0 1.1605216787557993e-09
encoding O 0 2.6351696380544354e-09
another O 0 4.012723930912898e-09
transmembrane O 0 2.632348525821726e-07
CA O 0 1.0942434158778269e-07
with O 0 6.310185707292248e-11
an O 0 7.925687328658171e-10
intact O 0 3.133587256343162e-07
catalytic O 0 1.3764815776085015e-07
domain O 0 5.997109155941871e-07
. O 0 5.962430549288911e-08

Although O 0 5.0875502921599036e-08
both O 0 1.5464438618550957e-09
domains O 0 8.669078788159368e-09
of O 0 9.925000199473288e-08
the O 0 6.849637657069252e-07
VHL B-Disease 0 0.0001481946965213865
protein O 0 1.4210639776024436e-08
contribute O 0 1.329085591583734e-10
to O 0 3.068612378087643e-11
regulation O 0 1.4303203954568744e-08
of O 0 9.390133115516619e-09
CA12 O 0 0.0001325406483374536
expression O 0 1.0289172180932837e-08
, O 0 1.5072640358049227e-10
the O 0 4.53833609581622e-10
elongin O 0 2.9071154372672936e-08
binding O 0 2.267338095052196e-09
domain O 0 1.3353855798925451e-09
alone O 0 9.018086971623873e-11
could O 0 1.3947785981738292e-10
effectively O 0 4.660997809935452e-09
regulate O 0 1.8872633233968372e-08
CA9 O 0 8.804319077171385e-05
expression O 0 8.80197390529247e-08
. O 0 4.082335891553157e-08

We O 0 2.3563478634969215e-07
mapped O 0 1.1249636600041413e-06
CA12 O 0 0.00014763053331989795
and O 0 1.1401707666891525e-07
CA9 O 0 0.00026711865211836994
loci O 0 4.136472497862087e-08
to O 0 2.0271944123351204e-09
chromosome O 0 2.0281204626826366e-07
bands O 0 9.897596555674681e-07
15q22 O 0 2.236203044958529e-06
and O 0 2.5564055761151394e-08
17q21 O 0 5.858197710040258e-06
. O 0 3.171746811858611e-07

2 O 0 2.2061810796003556e-06
respectively O 0 1.5266108732703287e-07
, O 0 4.619823634754994e-09
regions O 0 3.3385596509560855e-08
prone O 0 4.1146130058677954e-08
to O 0 1.32435104549522e-10
amplification O 0 3.5625514982484674e-08
in O 0 7.206131802384164e-10
some O 0 4.2401629429811294e-10
human O 0 2.479862644122477e-07
cancers B-Disease 0 0.00013515942555386573
. O 0 1.0371912395612526e-07

Additional O 0 1.1970644031578104e-08
experiments O 0 1.7936779173055584e-08
are O 0 1.6123584412053305e-10
needed O 0 2.951969224618267e-10
to O 0 1.4562438060972127e-11
define O 0 1.975691277245062e-10
the O 0 4.77198280890434e-10
role O 0 1.183049880282283e-09
of O 0 2.8617936465025196e-08
CA O 0 8.257292734015209e-07
IX O 0 3.152006911477656e-06
and O 0 2.154433520473731e-09
CA O 0 1.1799365751130608e-07
XII O 0 4.041469026105915e-07
enzymes O 0 9.382854909700811e-11
in O 0 4.292868144295525e-11
the O 0 2.846113622556601e-10
regulation O 0 4.908237372092117e-09
of O 0 6.181732903343118e-10
pH O 0 4.418410082251967e-09
in O 0 1.6313021766745095e-10
the O 0 7.860155304406646e-10
extracellular O 0 2.3819857197793226e-09
microenvironment O 0 8.583702637565693e-09
and O 0 4.329302888406161e-11
its O 0 1.1869979998913038e-10
potential O 0 8.321017763712746e-10
impact O 0 1.0809482198226306e-08
on O 0 8.199429402111491e-08
cancer B-Disease 0 2.2744421585230157e-05
cell O 0 2.4775604288151953e-06
growth O 0 4.0626454733683204e-07
. O 0 6.46111786295478e-08

A O 0 1.6392673387599643e-06
gene O 0 5.3208065509124935e-08
encoding O 0 1.795687332162288e-08
a O 0 1.3550889299551727e-08
transmembrane O 0 1.5279681520041777e-07
protein O 0 1.6228655752570376e-08
is O 0 6.291354243126435e-11
mutated O 0 1.3635603757222725e-10
in O 0 2.0334038272618038e-11
patients O 0 6.335006963453793e-10
with O 0 4.6271104281458975e-08
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9992708563804626
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 0.023097146302461624
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 8.583096899883458e-09
. O 0 1.5598821789808426e-08

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.00030180325848050416
WFS B-Disease 1 0.9999775886535645
; O 0 1.163326217579197e-07
OMIM O 1 0.9909517765045166
222300 O 0 5.285784936859272e-06
) O 0 2.797748421823343e-10
is O 0 7.649202105053376e-11
an O 0 1.6940040481472352e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 5.928442181613036e-09
by O 0 2.4180822275066127e-11
young O 0 4.0024233927127284e-11
- O 0 2.443398372520278e-09
onset O 1 0.9999905824661255
non O 1 0.9998254179954529
- O 0 0.014591798186302185
immune O 1 0.9925352334976196
insulin B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
dependent I-Disease 1 0.9999995231628418
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 1.3962026059743948e-05
progressive O 1 0.9999982118606567
optic B-Disease 1 1.0
atrophy I-Disease 1 0.9999804496765137
. O 0 3.2309942525898805e-06

Linkage O 0 1.5208345303108217e-06
to O 0 2.7936863933319955e-09
markers O 0 1.3378897101290477e-08
on O 0 2.299677959172186e-08
chromosome O 0 3.106604822278314e-07
4p O 0 2.274216603836976e-05
was O 0 7.890787578901381e-09
confirmed O 0 9.92493531803973e-10
in O 0 2.201740317842038e-10
five O 0 1.0808776096382644e-09
families O 0 2.683987199159077e-10
. O 0 5.792946922156261e-08

On O 0 3.174581664211473e-08
the O 0 2.138050625433152e-09
basis O 0 3.3221567719010636e-09
of O 0 2.1755438339710054e-08
meiotic O 0 0.0050361258909106255
recombinants O 0 0.12121883034706116
and O 0 1.1210926231797202e-07
disease O 0 0.4611329138278961
- O 0 3.6304594885905317e-09
associated O 0 1.495529478034996e-09
haplotypes O 0 9.371542653013876e-09
, O 0 4.715793866516549e-10
the O 0 2.2200991267595782e-08
WFS B-Disease 0 0.0006984466454014182
gene O 0 5.3286139944930255e-09
was O 0 4.4234105267548784e-09
localized O 0 1.774678892729753e-08
to O 0 2.9509841792396685e-10
a O 0 2.4911352980439005e-08
BAC O 0 3.322572592878714e-05
/ O 0 3.7740716152256937e-07
P1 O 0 8.711430155017297e-07
contig O 0 5.088880357106973e-07
of O 0 1.641867086732418e-08
less O 0 1.0175444931093125e-09
than O 0 1.140749925077067e-10
250 O 0 6.300474808540457e-09
kb O 0 3.860790002363501e-06
. O 0 2.2094080520673742e-07

Mutations O 0 5.031780503372829e-08
in O 0 3.453027197508618e-09
a O 0 2.2579733638394828e-09
novel O 0 2.8606734758795938e-09
gene O 0 2.762340134410124e-09
( O 0 1.4712872586919445e-10
WFS1 O 0 1.4356097608470009e-06
) O 0 1.4308919327188363e-10
encoding O 0 1.0665544003529703e-09
a O 0 2.3475490440461044e-09
putative O 0 2.789502850930603e-08
transmembrane O 0 2.1143440775972522e-08
protein O 0 2.5690347627005394e-09
were O 0 3.7602321256713367e-10
found O 0 1.755319327390037e-11
in O 0 1.2109144416350137e-11
all O 0 5.09584631436244e-11
affected O 0 8.720779653970112e-11
individuals O 0 1.381870854723355e-12
in O 0 1.290023976530108e-09
six O 0 9.81092327378974e-08
WFS B-Disease 1 0.9956270456314087
families O 0 2.8576710442429487e-11
, O 0 4.713849102722101e-11
and O 0 2.566421727911994e-11
these O 0 2.903918945584838e-11
mutations O 0 2.2082129180756027e-10
were O 0 7.069580337804027e-11
associated O 0 1.2876288923990842e-10
with O 0 6.721464357317686e-11
the O 0 1.7579731093064765e-07
disease O 1 0.9992309808731079
phenotype O 0 1.2350784572845441e-06
. O 0 6.270266794672352e-08

WFS1 O 0 0.0143375089392066
appears O 0 3.588322883274486e-08
to O 0 1.4629761291296006e-10
function O 0 6.1539373596986024e-09
in O 0 7.913814048521317e-10
survival O 0 5.791714556835359e-07
of O 0 1.9936742035042698e-08
islet O 0 4.2212204220959393e-07
beta O 0 1.1201841232377774e-07
- O 0 2.318382286148335e-08
cells O 0 2.556735712033742e-09
and O 0 1.0101748326718507e-09
neurons O 0 6.5397216530982405e-09
. O 0 7.786649658392264e-10
. O 0 2.4756369398915012e-08

Stable O 0 1.440685878151271e-06
interaction O 0 3.354969635438465e-09
between O 0 5.705610428563546e-10
the O 0 4.873377257297307e-09
products O 0 2.506064911145245e-09
of O 0 7.7618320659667e-09
the O 0 2.656842212900301e-08
BRCA1 O 0 8.575540988431385e-08
and O 0 9.895411157145872e-10
BRCA2 O 0 2.847104596526151e-08
tumor B-Disease 0 8.889385583188414e-08
suppressor O 0 1.332186343461217e-07
genes O 0 3.777679280503321e-10
in O 0 2.0468413075569458e-10
mitotic O 0 2.99064851105868e-07
and O 0 2.8839362897770116e-08
meiotic O 0 0.008279123343527317
cells O 0 1.531097041151952e-06
. O 0 2.4016313204811013e-07

BRCA1 O 0 2.5773812012630515e-05
and O 0 5.4456453568718644e-08
BRCA2 O 0 1.3322549818894913e-07
account O 0 1.443793418154371e-10
for O 0 1.2878106914193665e-10
most O 0 4.703018530172187e-11
cases O 0 2.178588386081426e-11
of O 0 6.73585409671773e-10
familial O 0 2.966540932902717e-07
, O 0 1.0464362709683428e-09
early O 0 5.738307322644687e-07
onset O 1 1.0
breast B-Disease 1 0.9999250173568726
and I-Disease 0 2.287855932081584e-05
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 9.678858077677432e-06
encode O 0 1.5750390991442487e-09
products O 0 2.4821604771574357e-09
that O 0 1.191945413897555e-11
each O 0 3.2526550897138407e-12
interact O 0 1.216820654653672e-11
with O 0 8.32396651606615e-11
hRAD51 O 0 4.0619016772325267e-07
. O 0 3.842226092842793e-08

Results O 0 1.0514187209764714e-07
presented O 0 5.370706190888086e-08
here O 0 2.7561875004522562e-09
show O 0 2.773870910743881e-09
that O 0 6.999982538058447e-11
BRCA1 O 0 1.1960442414249428e-08
and O 0 2.9651739397174026e-10
BRCA2 O 0 6.4648881803464064e-09
coexist O 0 1.034055507886933e-09
in O 0 7.282426744970039e-11
a O 0 3.786949087647429e-10
biochemical O 0 6.28224938736821e-08
complex O 0 6.327284296503422e-08
and O 0 1.2396151882754225e-09
colocalize O 0 8.776524737186264e-06
in O 0 2.3269233651035393e-08
subnuclear O 0 1.6284771845676005e-05
foci O 0 3.0132791835058015e-06
in O 0 1.5069198111561377e-09
somatic O 0 2.0810878353927365e-08
cells O 0 1.9685819641068747e-10
and O 0 1.4119783467436697e-11
on O 0 5.867176744445146e-10
the O 0 1.9245723070770993e-10
axial O 0 4.1583092524888343e-10
elements O 0 3.14349546393089e-09
of O 0 2.7767203647499628e-08
developing O 0 6.492594906148952e-08
synaptonemal O 0 5.562385922530666e-06
complexes O 0 1.3414143040790805e-06
. O 0 4.3995041210109775e-07

Like O 0 1.349331796518527e-06
BRCA1 O 0 5.877044259250397e-06
and O 0 9.584933735595769e-08
RAD51 O 0 0.0013135867193341255
, O 0 1.3035545975981222e-07
BRCA2 O 0 2.0675851430951298e-07
relocates O 0 2.017629086026318e-08
to O 0 5.288242621581674e-10
PCNA O 0 3.587484798117657e-07
+ O 0 7.886871711271226e-10
replication O 0 1.2482299638350014e-09
sites O 0 6.49756567994153e-11
following O 0 3.637160017611052e-10
exposure O 0 9.112328669402814e-09
of O 0 1.3130314613363225e-08
S O 0 3.5619069649328594e-07
phase O 0 1.9944506846059085e-07
cells O 0 2.687989608674002e-09
to O 0 1.492212048370689e-10
hydroxyurea O 0 2.6992171342499205e-07
or O 0 2.5125022062866265e-09
UV O 0 1.2284740478207823e-05
irradiation O 0 4.362466086149652e-07
. O 0 3.24698383735722e-08

Thus O 0 2.591295640286262e-07
, O 0 2.603248638877176e-08
BRCA1 O 0 1.0335023148400069e-07
and O 0 1.8354950892529587e-09
BRCA2 O 0 9.899681074898581e-09
participate O 0 1.1656656195846438e-10
, O 0 4.512680853996365e-11
together O 0 1.475541216988674e-11
, O 0 4.3420132073146434e-11
in O 0 1.1651389575373372e-10
a O 0 1.5900952776704003e-09
pathway O 0 6.854389278387885e-10
( O 0 7.803160027852751e-12
s O 0 1.7711501709705146e-10
) O 0 7.206327006480107e-13
associated O 0 1.1458171217393343e-11
with O 0 2.581241427199177e-12
the O 0 1.0399849037501241e-10
activation O 0 5.275659353820572e-10
of O 0 4.681097287573266e-09
double O 0 5.267138902809165e-08
- O 0 9.248982735243771e-08
strand O 0 1.570325167676856e-07
break O 0 2.3219939748742036e-07
repair O 0 4.1154180507874116e-07
and O 0 4.839179279514383e-09
/ O 0 2.4045189661592303e-07
or O 0 1.6458387985807121e-09
homologous O 0 2.1683190354337967e-08
recombination O 0 1.0206728973116697e-07
. O 0 1.435940930605284e-07

Dysfunction O 0 0.20812824368476868
of O 0 1.7089289485738846e-06
this O 0 7.711909333352196e-09
pathway O 0 4.579295520557025e-08
may O 0 2.1208124145744023e-10
be O 0 1.1153615357695212e-11
a O 0 1.9975155210461004e-11
general O 0 1.4349560428783548e-10
phenomenon O 0 7.34555583026264e-10
in O 0 7.25652263972032e-12
the O 0 1.5685737431159197e-11
majority O 0 2.394992841200927e-12
of O 0 2.0182648954869542e-11
cases O 0 1.0284367975288422e-11
of O 0 2.1950326001274334e-09
hereditary B-Disease 1 0.9999990463256836
breast I-Disease 1 0.9975517392158508
and I-Disease 0 6.046368980605621e-06
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0029057094361633062
. O 0 2.854891590686748e-06

A O 0 7.31245279439463e-07
novel O 0 1.9435573150872187e-08
Arg362Ser O 0 3.266152361902641e-07
mutation O 0 2.776009200289309e-09
in O 0 6.39900576970831e-10
the O 0 3.4671767679128607e-09
sterol O 0 2.1948414996586507e-07
27 O 0 4.2253608967257605e-07
- O 0 5.143261816442646e-08
hydroxylase O 0 3.21070473319196e-07
gene O 0 7.633192744549433e-09
( O 0 6.396257135055095e-11
CYP27 O 0 3.3354251627315534e-07
) O 0 4.0731654160630626e-12
: O 0 1.7085744711403672e-12
its O 0 1.1801886724838173e-11
effects O 0 6.162132470954873e-10
on O 0 2.004723720361312e-09
pre O 0 5.3599713112362224e-08
- O 0 1.1389242882131612e-09
mRNA O 0 2.604856330634675e-09
splicing O 0 1.2231985202504347e-08
and O 0 4.203331849250702e-10
enzyme O 0 1.2641897528808954e-09
activity O 0 1.7702907584293825e-08
. O 0 2.3033258855775784e-08

A O 0 4.6322273306032e-07
novel O 0 5.61332180737395e-09
C O 0 3.256031888554389e-08
to O 0 7.144924235591432e-11
A O 0 4.033203548914344e-09
mutation O 0 2.0662065114418482e-10
in O 0 8.691387887171942e-11
the O 0 1.517149184060429e-09
sterol O 0 1.6551523174257454e-07
27 O 0 3.012716547345917e-07
- O 0 4.346585313896867e-08
hydroxylase O 0 1.4891108435222122e-07
gene O 0 1.8539850765719734e-09
( O 0 3.0755148427985546e-11
CYP27 O 0 9.055933958279638e-08
) O 0 1.0738774453011857e-11
was O 0 2.0097917774464236e-10
identified O 0 6.991372758502479e-12
by O 0 1.2411990706062692e-11
sequencing O 0 1.3240460949859312e-09
amplified O 0 1.3801667364532477e-08
CYP27 O 0 1.2792695088137407e-05
gene O 0 9.78630598780228e-09
products O 0 1.8604925378085113e-09
from O 0 9.556334196192395e-11
a O 0 1.390858095362546e-09
patient O 0 3.683090055162097e-09
with O 0 4.055651370293845e-09
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 1.5646311624095688e-07
CTX B-Disease 0 0.0008454282651655376
) O 0 6.715345612917645e-09
. O 0 4.52297612696384e-08

The O 0 4.869560825682129e-07
mutation O 0 8.737525547530822e-08
changed O 0 9.778562848339334e-09
the O 0 1.0461134181127818e-08
adrenodoxin O 0 1.1522070053615607e-06
cofactor O 0 2.2857919645957736e-07
binding O 0 1.0061065758293353e-08
residue O 0 9.62571533591472e-08
362Arg O 0 1.2479522304431612e-08
to O 0 2.173144303396768e-10
362Ser O 0 6.084773929160292e-08
( O 0 1.3193269809974595e-09
CGT O 0 7.870543413446285e-06
362Arg O 0 1.1994761450750957e-07
to O 0 5.510882861159416e-10
AGT O 0 5.927596248511691e-06
362Ser O 0 2.0915695841949855e-08
) O 0 2.366667278819179e-11
, O 0 8.017605676591266e-12
and O 0 7.520302089392139e-12
was O 0 1.0701816099967232e-09
responsible O 0 4.021688759792141e-09
for O 0 2.895349293652316e-09
deficiency O 0 2.2568758595298277e-06
in O 0 5.428345328795103e-09
the O 0 5.421312110343024e-08
sterol O 0 2.8561471481225453e-06
27 O 0 6.417566282834741e-07
- O 0 1.1503320074268686e-08
hydroxylase O 0 1.9504945214521285e-08
activity O 0 2.469597859544592e-10
, O 0 9.324688590717223e-12
as O 0 3.6208278129251648e-12
confirmed O 0 1.4421467492420348e-11
by O 0 1.4541141728219298e-12
expression O 0 4.086801383418326e-11
of O 0 1.7403053997888662e-10
mutant O 0 4.337821213340476e-09
cDNA O 0 9.766913500186547e-09
into O 0 5.224231047762373e-10
COS O 0 2.0278046122257365e-06
- O 0 1.2748694189212983e-07
1 O 0 4.1048582488656393e-07
cells O 0 2.5133902070706426e-08
. O 0 1.8448780281232757e-08

Quantitative O 0 5.7686676768753387e-08
analysis O 0 2.1458006482788505e-09
showed O 0 1.3714303026546304e-09
that O 0 1.6104551719964277e-11
the O 0 2.6293844879177186e-10
expression O 0 6.732964186184631e-10
of O 0 1.9519039717863507e-09
CYP27 O 0 7.955816840876651e-07
gene O 0 3.3722449832573886e-10
mRNA O 0 1.7181678302335968e-10
in O 0 2.7103094074609757e-11
the O 0 1.8714498006833225e-10
patient O 0 1.169849106474885e-09
represented O 0 8.714765020734205e-10
52 O 0 1.6015872006391874e-07
. O 0 2.1410558304069127e-07

5 O 0 3.24140899010672e-07
% O 0 3.52517082191639e-09
of O 0 1.0837847952416269e-08
the O 0 2.806998189441856e-08
normal O 0 3.5072798709734343e-07
level O 0 7.009918590483721e-06
. O 0 1.9364793502063549e-07

As O 0 3.1554918678011745e-09
the O 0 9.968018632733333e-10
mutation O 0 6.312066425095963e-10
occurred O 0 3.7307654743301555e-09
at O 0 1.516107905885633e-09
the O 0 4.808364262309794e-10
penultimate O 0 4.7029448779767336e-08
nucleotide O 0 3.3306966074064803e-09
of O 0 8.49456327500775e-09
exon O 0 1.2532719040336815e-07
6 O 0 3.061111186752896e-08
( O 0 3.590679142906339e-11
- O 0 6.358346071877463e-10
2 O 0 6.2792402388822666e-09
position O 0 2.16960049925774e-09
of O 0 1.3439615642596436e-08
exon O 0 2.5754221155693813e-07
6 O 0 1.8939745416446385e-07
- O 0 1.3599463777325127e-08
intron O 0 1.0268981753824846e-07
6 O 0 4.790856422687284e-08
splice O 0 1.5115839246959695e-08
site O 0 5.152878679304251e-10
) O 0 1.0534959406574562e-12
of O 0 4.594476188390928e-11
the O 0 1.4899340095020364e-10
gene O 0 5.165967098541557e-10
, O 0 3.185707253550163e-11
we O 0 1.2620732584012195e-11
hypothesized O 0 8.639934601095689e-11
that O 0 1.6712507029323365e-12
the O 0 2.2015471390357533e-10
mutation O 0 8.893804026577357e-10
may O 0 5.836371386180872e-10
partially O 0 3.348398003311104e-09
affect O 0 3.632602899039661e-11
the O 0 7.025986042963339e-11
normal O 0 5.801411018246938e-10
splicing O 0 7.16065762240703e-10
efficiency O 0 4.199028624807255e-10
in O 0 4.776351189561545e-11
exon O 0 8.694115649632295e-09
6 O 0 1.5448167189902051e-09
and O 0 2.810385084373035e-11
cause O 0 3.659853253790146e-10
alternative O 0 3.254147229458937e-10
splicing O 0 7.770700749532011e-10
elsewhere O 0 3.249866001309165e-11
, O 0 4.863997117403318e-13
which O 0 3.482479604167976e-13
resulted O 0 3.426185030130924e-11
in O 0 5.7588387183948875e-12
decreased O 0 2.5067328768280106e-10
transcript O 0 1.946086403137315e-09
in O 0 1.574191332842645e-10
the O 0 2.72994959971129e-09
patient O 0 4.4725503300924174e-08
. O 0 5.922229107113708e-08

Transfection O 0 8.4173470895621e-06
of O 0 8.277673941847752e-07
constructed O 0 8.41789642436197e-07
minigenes O 0 1.7977046127271024e-06
, O 0 1.0003903261335267e-09
with O 0 2.406762809881169e-11
or O 0 3.243673038499928e-11
without O 0 1.2631093393444814e-10
the O 0 9.801787159702258e-10
mutation O 0 6.247280470716987e-10
, O 0 4.686157364930388e-11
into O 0 1.344844929862532e-10
COS O 0 1.2665745998674538e-06
- O 0 1.1155163903708853e-08
1 O 0 8.5214857392657e-09
cells O 0 2.142342900302019e-11
confirmed O 0 1.0544413432678201e-11
that O 0 4.297918629065506e-13
the O 0 3.0185898919343757e-11
mutant O 0 1.8598325102203717e-09
minigene O 0 1.6247579281980506e-08
was O 0 2.1128392369007543e-09
responsible O 0 1.2206778643442107e-10
for O 0 3.219191926917553e-11
a O 0 1.8743254170949797e-10
mRNA O 0 4.837174549798817e-10
species O 0 5.096552953970379e-12
alternatively O 0 3.450068009058782e-11
spliced O 0 2.059385328934127e-09
at O 0 8.38420533000317e-09
an O 0 1.9447271570882663e-10
activated O 0 5.920535173231656e-08
cryptic O 0 1.067132870957721e-08
5 O 0 1.503917168577118e-08
splice O 0 4.6297675027062724e-08
site O 0 6.950830133689578e-09
88 O 0 5.977037087490089e-09
bp O 0 1.530019888562606e-09
upstream O 0 7.48047873644353e-11
from O 0 1.9636759232555256e-11
the O 0 5.467975516815216e-10
3 O 0 2.008831856414872e-08
end O 0 1.879557665063203e-08
of O 0 5.364226041137954e-08
exon O 0 2.9204147722339258e-06
6 O 0 1.5324380910897162e-06
. O 0 1.057742764487557e-07

Our O 0 2.2209420080798736e-08
data O 0 1.5733996328037847e-09
suggest O 0 7.581645034004936e-11
that O 0 2.563431454952192e-12
the O 0 2.5989593810393785e-10
C O 0 1.4801718961621191e-08
to O 0 5.529431773565463e-11
A O 0 5.665695024248407e-09
mutation O 0 1.4546926163649943e-10
at O 0 9.20455600628145e-10
the O 0 2.520209041456667e-10
penultimate O 0 4.052931501519197e-08
nucleotide O 0 1.7922578976481418e-09
of O 0 2.5649025126028846e-09
exon O 0 2.2240193686684506e-08
6 O 0 8.16073253417926e-09
of O 0 2.6211037784662494e-09
the O 0 5.243830702994501e-09
CYP27 O 0 9.562631021253765e-06
gene O 0 1.3426464384735937e-09
not O 0 7.908676318002517e-12
only O 0 8.376631853435068e-12
causes O 0 9.400648037782844e-10
the O 0 1.1987665970991657e-08
deficiency B-Disease 0 1.584968231327366e-05
in I-Disease 0 7.1778778476527805e-09
the I-Disease 0 9.439069259542521e-08
sterol I-Disease 0 4.8557594709564e-06
27 I-Disease 0 2.4812375158944633e-06
- I-Disease 0 4.64890774765081e-08
hydroxylase I-Disease 0 3.614749388702876e-08
activity I-Disease 0 7.81114950498818e-10
, O 0 4.282506640973516e-11
but O 0 1.4758591918018205e-11
also O 0 6.526307272380905e-11
partially O 0 2.1029289420937403e-09
leads O 0 5.61115390262934e-11
to O 0 5.033113682773038e-12
alternative O 0 6.394332840997663e-10
pre O 0 1.2181322617266233e-08
- O 0 1.646035807656432e-10
mRNA O 0 3.072116172564421e-10
splicing O 0 7.275405833340187e-10
of O 0 2.900709394904055e-10
the O 0 3.1121392130017966e-09
gene O 0 3.2895030699364725e-08
. O 0 2.715166935729485e-08

To O 0 1.1959689238949522e-08
our O 0 4.592605851172493e-09
knowledge O 0 2.078674787853174e-09
, O 0 1.4959794514268765e-10
this O 0 4.875591683856095e-12
is O 0 3.929179898110036e-12
the O 0 2.006022084555248e-11
first O 0 3.894212383115381e-11
report O 0 3.0536638755823686e-12
regarding O 0 3.454807186858977e-12
effects O 0 1.303622487736078e-10
on O 0 3.925408331717506e-10
pre O 0 6.656963424944706e-09
- O 0 1.8309485871892406e-10
mRNA O 0 3.402832182697324e-10
splicing O 0 8.496731096485632e-10
of O 0 9.23085718973482e-10
a O 0 3.4483460531475885e-10
mutation O 0 2.9396754475108366e-10
at O 0 3.0126630079507777e-09
the O 0 1.3916435781524683e-09
- O 0 3.811138515885659e-09
2 O 0 2.958149458720527e-08
position O 0 5.218616649926844e-09
of O 0 1.2862924059220404e-08
a O 0 2.3927514192223498e-08
5 O 0 1.7102057370266266e-07
splice O 0 2.1299676973285386e-06
site O 0 4.3587607478912105e-07
. O 0 7.373314048209068e-08

ATM O 0 4.7464025556109846e-05
germline O 0 2.731295353441965e-06
mutations O 0 5.5119366848543905e-09
in O 0 1.8368224719012005e-09
classical O 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 0.0014774207957088947
in O 0 4.097920669465793e-09
the O 0 1.1255657739184244e-08
Dutch O 0 3.3197245556948474e-06
population O 0 1.7916392813788207e-09
. O 0 1.8091050435486977e-08

Germline O 0 8.632091521576513e-06
mutations O 0 6.459353496524045e-09
in O 0 1.3023232492415104e-09
the O 0 5.842188066651488e-09
ATM O 0 3.1748834317113506e-06
gene O 0 2.730814019358263e-09
are O 0 2.9805938533272736e-12
responsible O 0 1.0691120211347993e-10
for O 0 7.751984471005002e-11
the O 0 4.812585757463239e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0019135260954499245
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.0326408173000345e-08
. O 0 3.56203493367957e-08

In O 0 1.3377391638869085e-08
our O 0 1.8777939203573624e-09
study O 0 1.1246011760723817e-10
, O 0 3.0966108149899085e-11
we O 0 1.9972525369671423e-11
have O 0 1.99644033943569e-12
determined O 0 4.6272798093216494e-11
the O 0 1.611015071345534e-10
ATM O 0 2.5447203455541967e-08
mutation O 0 6.772643557084734e-11
spectrum O 0 8.032549625447416e-11
in O 0 1.3821456132379062e-11
19 O 0 2.498562023944828e-09
classical O 1 0.9108858108520508
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.777440221204188e-09
, O 0 1.7644731162280713e-11
including O 0 2.263015642933741e-11
some O 0 3.2621483639361237e-12
immigrant O 0 2.0444172396660854e-11
populations O 0 1.1203914532242898e-11
, O 0 1.6781279057326293e-12
as O 0 5.901874475244817e-12
well O 0 5.217524329248491e-12
as O 0 4.0877915635784134e-11
12 O 0 8.159857234346646e-10
of O 0 1.6217169829246814e-09
Dutch O 0 1.2259188508778607e-07
ethnic O 0 2.3672384052986217e-09
origin O 0 2.502983820207305e-09
. O 0 1.898447976600437e-08

Both O 0 8.170201404311683e-09
the O 0 1.0810635941993496e-08
protein O 0 6.316008160922593e-09
truncation O 0 4.25114023983042e-07
test O 0 2.6496357108385382e-08
( O 0 2.0069072792505693e-10
PTT O 0 5.907461542165038e-08
) O 0 9.245932144907876e-12
and O 0 1.2692041861939174e-11
the O 0 2.6402194319707917e-10
restriction O 0 1.7427310705642185e-09
endonuclease O 0 9.789759225498074e-09
fingerprinting O 0 6.053435974706645e-09
( O 0 5.6342326637537354e-11
REF O 0 6.72631861320383e-09
) O 0 1.9605460917920814e-12
method O 0 7.633500602455268e-12
were O 0 5.083369055552955e-12
used O 0 1.0886990094161053e-12
and O 0 3.80155715934416e-12
compared O 0 9.86897369381623e-12
for O 0 2.81882971825409e-11
their O 0 3.500450276860967e-11
detection O 0 2.789905639843937e-09
efficiency O 0 3.699796302658598e-10
, O 0 4.898877310755001e-12
identifying O 0 3.2655676773796216e-11
76 O 0 2.5457566610320725e-10
% O 0 1.0006812219132133e-11
and O 0 5.7658725884091044e-12
60 O 0 5.0197616896507924e-11
% O 0 1.0392011036419735e-11
of O 0 2.1016367812709547e-10
the O 0 1.5407910503029143e-09
mutations O 0 7.002990964899425e-10
, O 0 2.002246562993193e-10
respectively O 0 1.6383509660045092e-08
. O 0 4.881808379764152e-08

Most O 0 1.2916352432057465e-07
patients O 0 6.722240097900567e-09
were O 0 3.0070654855052226e-09
found O 0 4.6311848800328903e-10
to O 0 2.5664867453478735e-10
be O 0 4.968330191701398e-09
compound O 0 9.397255098519963e-07
heterozygote O 0 4.455727321328595e-06
. O 0 1.2807076643639448e-07

Seventeen O 0 6.609243428101763e-07
mutations O 0 1.539006078132843e-08
were O 0 1.0930700788946979e-09
distinct O 0 3.829002670485693e-10
, O 0 7.669333224047392e-11
of O 0 8.914932125847486e-10
which O 0 7.06475503098325e-11
10 O 0 4.2463380034440945e-10
were O 0 1.4586797048021793e-10
not O 0 2.3524054232337832e-11
reported O 0 1.2981741237538813e-09
previously O 0 1.9090252934006458e-08
. O 0 4.443673873311127e-08

Mutations O 0 5.168742518435465e-07
are O 0 1.6825180138013707e-09
small O 0 1.3358262274110189e-09
deletions O 0 1.4816576410225935e-08
or O 0 7.716485228570491e-09
point O 0 1.131586486735614e-06
mutations O 0 5.84185677610094e-08
frequently O 0 5.063828911744395e-09
affecting O 0 3.4503955248510465e-08
splice O 0 7.927325214041048e-07
sites O 0 1.3311601776422322e-07
. O 0 9.792359634275272e-08

Moreover O 0 1.4149818525766023e-06
, O 0 3.024530670359127e-08
a O 0 6.381740291772076e-08
16 O 0 1.2570609442263958e-06
. O 0 6.82457994116703e-07

7 O 0 4.911676569463452e-06
- O 0 1.5103195494248212e-07
kb O 0 5.22221398568945e-07
genomic O 0 6.808880925746053e-08
deletion O 0 1.140559646728434e-08
of O 0 1.1368499919228725e-08
the O 0 6.1261817840829735e-09
3 O 0 2.1366250990695335e-08
end O 0 2.652627895116666e-09
of O 0 1.2507658242455477e-09
the O 0 7.142393343428921e-10
gene O 0 1.1635293839518113e-09
, O 0 5.330377111922857e-11
most O 0 2.241254057344655e-11
likely O 0 1.879963719420008e-11
a O 0 5.936107855264439e-11
result O 0 1.6313488060415438e-10
of O 0 3.161345629720813e-10
recombination O 0 9.495720182384204e-11
between O 0 3.8438769528470473e-11
two O 0 4.255530650087991e-11
LINE O 0 9.897378028256298e-09
elements O 0 1.0836352926091308e-09
, O 0 3.782502366878049e-10
was O 0 2.525268705255712e-08
identified O 0 1.8729513939774733e-08
. O 0 4.634671313397121e-08

The O 0 1.1777151343039804e-07
most O 0 6.167565347325876e-10
frequently O 0 1.3195376735719577e-10
found O 0 5.087853402474529e-11
mutation O 0 1.5345900938878998e-10
, O 0 1.1289160578575874e-11
identified O 0 1.8326456671657887e-11
in O 0 2.662631400085491e-11
three O 0 6.011972170094637e-11
unrelated O 0 1.1718864989518352e-08
Turkish O 0 6.888602683829959e-07
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
individuals O 0 2.6573044112354616e-11
, O 0 1.1860067095081916e-10
was O 0 6.37199537578681e-09
previously O 0 1.5812700038253524e-09
described O 0 1.3832962553195216e-10
to O 0 5.851557953462372e-12
be O 0 3.202552459335983e-11
a O 0 4.5250422853193584e-10
Turkish O 0 4.6725716629225644e-08
A B-Disease 1 1.0
- I-Disease 1 0.999996542930603
T I-Disease 1 1.0
founder O 0 0.0010529266437515616
mutation O 0 2.7216744911129354e-06
. O 0 1.7202295055085415e-07

The O 0 2.796081588485322e-08
presence O 0 4.117869156772258e-09
of O 0 3.017897753920806e-08
a O 0 1.0401152650274526e-07
founder O 0 8.762140350881964e-05
mutation O 0 8.914022231465424e-08
among O 0 1.3377275676074163e-10
relatively O 0 1.3206404025911667e-10
small O 0 1.409043194622317e-11
ethnic O 0 1.1050581977256613e-10
population O 0 4.684448575570377e-12
groups O 0 3.652011852650627e-12
in O 0 5.977828648751071e-11
Western O 0 1.7268892094080002e-08
Europe O 0 5.3391666199331667e-08
could O 0 1.7756862646933769e-10
indicate O 0 2.650896724354368e-10
a O 0 7.469475593602226e-10
high O 0 3.864729425373525e-09
carrier O 0 1.2561660045484757e-10
frequency O 0 1.3850051105990246e-09
in O 0 1.8222247322174923e-10
such O 0 4.236363482235106e-10
communities O 0 8.312642241214974e-10
. O 0 6.913859706969561e-09

In O 0 2.411973696325731e-07
patients O 0 9.593435379429138e-09
of O 0 8.570958165421416e-09
Dutch O 0 2.7819344268209534e-06
ethnic O 0 4.1718322130179786e-09
origin O 0 2.8217034264699237e-10
, O 0 3.6690282756435266e-11
however O 0 4.122989102905983e-11
, O 0 2.6831975877272818e-11
no O 0 1.198168786409326e-10
significant O 0 1.1317004000588327e-09
founder O 0 3.184418915225251e-07
effect O 0 4.651914409237179e-08
could O 0 6.347162240238902e-10
be O 0 2.468853732562337e-10
identified O 0 4.311491164088466e-09
. O 0 1.64402944591302e-08

The O 0 6.799549367997315e-08
observed O 0 8.68604388415406e-09
genetic O 0 5.2480224610462756e-09
heterogeneity O 0 1.1724923254519126e-08
including O 0 4.671907305464629e-10
the O 0 1.1871614802316799e-09
relative O 0 1.275408845202719e-08
high O 0 4.792126873098823e-08
percentage O 0 9.302866255112008e-10
of O 0 1.413489503221399e-08
splice O 0 4.5810162419002154e-07
- O 0 4.568808620319942e-08
site O 0 6.921064166220958e-09
mutations O 0 1.179937120232566e-10
had O 0 1.9911944315609276e-10
no O 0 1.1053659376702996e-10
reflection O 0 1.255524684218301e-09
on O 0 3.1847459780465215e-08
the O 0 1.4316031915484473e-08
phenotype O 0 1.6451436124498287e-07
. O 0 3.548093729932589e-08

All O 0 2.2313360048542563e-08
patients O 0 2.2346315908805536e-09
manifested O 0 5.5839448620531584e-09
classical O 0 0.07508882880210876
A B-Disease 1 1.0
- I-Disease 1 0.9999510049819946
T I-Disease 1 0.9999996423721313
and O 0 1.5159951072263311e-09
increased O 0 8.68660698927215e-09
cellular O 0 1.2652707255256246e-06
radioresistant O 0 2.6552393137535546e-06
DNA O 0 2.3746885347009083e-07
synthesis O 0 4.019390758003283e-07
. O 0 3.038703155766598e-08

Determination O 0 2.805666383665084e-07
of O 0 5.852798068417542e-08
the O 0 4.540607445591149e-09
genomic O 0 2.26837748584785e-08
structure O 0 2.184125236226464e-08
of O 0 4.4601129900456726e-08
the O 0 2.9833415737812174e-08
COL4A4 O 0 8.123012230498716e-05
gene O 0 2.6255471130554042e-09
and O 0 2.5381046223071912e-11
of O 0 6.432437360537335e-10
novel O 0 5.938673552918772e-09
mutations O 0 2.440312414364598e-07
causing O 0 4.0846323827281594e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.6957148545770906e-05

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.3366530993152992e-07
a O 0 2.885912522287981e-07
progressive O 1 0.999995231628418
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 9.034360118675977e-05
by O 0 8.69688587812334e-09
glomerular B-Disease 1 0.9997684359550476
basement I-Disease 1 0.9999737739562988
membrane I-Disease 0 1.6683167132214294e-06
abnormalities I-Disease 0 0.0038946194108575583
and O 0 2.6157173649288268e-11
associated O 0 2.2915971897852216e-10
with O 0 3.4945733806690527e-11
mutations O 0 2.427195666676596e-10
in O 0 8.622604297237046e-10
either O 0 1.3708236767939752e-09
the O 0 1.2073432742454315e-07
COL4A3 O 1 0.9997628331184387
or O 0 1.5498041738837287e-09
the O 0 1.1028483903885444e-08
COL4A4 O 0 2.474989196343813e-05
gene O 0 7.39948324834927e-10
, O 0 1.1923797019197657e-11
which O 0 1.4495865445496303e-12
encode O 0 7.502751891985682e-12
the O 0 7.466698370706126e-10
alpha3 O 0 3.093711313795211e-07
and O 0 1.9062480483000854e-09
alpha4 O 0 1.5282907043001615e-05
type O 0 2.616061465232633e-05
IV O 1 0.9999243021011353
collagen O 0 0.003964971750974655
chains O 0 1.519638863101136e-05
, O 0 1.797156423677393e-09
respectively O 0 1.8250371880412786e-08
. O 0 2.1516092019169264e-08

To O 0 2.9398004031122582e-09
date O 0 9.104756770739186e-08
, O 0 7.803941937112313e-10
mutation O 0 2.941773213915866e-10
screening O 0 5.659222535037145e-10
in O 0 4.760662003500116e-11
the O 0 2.4268714815534054e-10
two O 0 2.5661427843770568e-11
genes O 0 3.6337884090631434e-11
has O 0 2.2950603223437227e-11
been O 0 9.334250039572112e-11
hampered O 0 7.487409803275114e-09
by O 0 6.118072021221721e-11
the O 0 1.8580383898125774e-09
lack O 0 2.1504561686924717e-08
of O 0 2.7192079699034366e-09
genomic O 0 3.575539864186794e-08
structure O 0 5.370798561443735e-08
information O 0 4.411185194896916e-09
. O 0 6.095076798828813e-08

We O 0 1.2036536212178817e-08
report O 0 5.649645196115216e-10
here O 0 1.1587605874829876e-10
the O 0 1.5276978293510268e-10
complete O 0 5.159057181458593e-09
characterization O 0 9.61976054369984e-10
of O 0 1.36714450871267e-09
the O 0 1.8422572356513456e-09
48 O 0 7.741944862971195e-09
exons O 0 5.903282840336033e-08
of O 0 6.158763277142043e-09
the O 0 2.3036157870137686e-08
COL4A4 O 0 0.00014032643230166286
gene O 0 6.505347815988216e-09
, O 0 8.111329663496036e-11
a O 0 4.1472974360301507e-11
comprehensive O 0 8.289589015220145e-10
gene O 0 5.855346069116862e-11
screen O 0 6.155433801557919e-11
, O 0 4.480678848783892e-12
and O 0 1.5378703085294765e-12
the O 0 3.3702114016209705e-11
subsequent O 0 1.7876174152053892e-10
detection O 0 1.9846586596372617e-09
of O 0 2.217096645162897e-10
10 O 0 1.0555948476431709e-10
novel O 0 4.5243499918745655e-11
mutations O 0 1.4922453897558974e-11
in O 0 1.686561480751525e-11
eight O 0 3.5277265553190773e-09
patients O 0 2.9870882656268805e-08
diagnosed O 0 0.14885006844997406
with O 0 9.516664363218297e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 8.659051673021168e-06

Furthermore O 0 1.032007261869694e-07
, O 0 3.976730056365341e-09
we O 0 4.035279055347729e-10
identified O 0 1.312735364855655e-09
a O 0 1.8488822695061913e-09
glycine O 0 1.4560015415554517e-08
to O 0 1.7861347123560023e-10
alanine O 0 5.610110598297524e-09
substitution O 0 1.8109037824842744e-08
in O 0 1.2865224441327427e-09
the O 0 2.5132451675347056e-09
collagenous O 0 1.0584329857010744e-07
domain O 0 4.882892978841369e-10
that O 0 6.931146195182647e-12
is O 0 1.6482403983331118e-11
apparently O 0 1.0555606388962246e-10
silent O 0 2.6391382412782605e-09
in O 0 2.6575934161665593e-11
the O 0 1.3530575271314405e-10
heterozygous O 0 2.695124123874848e-10
carriers O 0 4.079262969081121e-11
, O 0 1.4524101539514778e-11
in O 0 2.1098542357655958e-10
11 O 0 1.2421936901318986e-07
. O 0 1.003110128294793e-07

5 O 0 1.1434745061933427e-07
% O 0 1.3664354092668418e-09
of O 0 2.494034090361197e-09
all O 0 1.9408474827287137e-10
control O 0 9.467590267320247e-09
individuals O 0 2.0714211595995735e-12
, O 0 9.524375212122127e-12
and O 0 5.926251243210112e-12
in O 0 3.9352569813910776e-11
one O 0 2.2108582325985893e-11
control O 0 2.326687065234978e-09
individual O 0 1.2629112165762901e-11
homozygous O 0 1.0757953416984378e-09
for O 0 1.9370123560680241e-10
this O 0 5.689017035237498e-10
glycine O 0 3.0614444312959677e-07
substitution O 0 7.68578729548608e-07
. O 0 1.199144463726043e-07

There O 0 8.009577889822594e-09
has O 0 1.4184574348430345e-10
been O 0 4.7666589425565675e-11
no O 0 1.3046795588333993e-10
previous O 0 2.2913753117137503e-09
finding O 0 8.352262770294772e-10
of O 0 3.066596754308648e-09
a O 0 4.078255955164423e-09
glycine O 0 1.6222498899765014e-08
substitution O 0 8.027472020444293e-09
that O 0 1.2154706928446668e-11
is O 0 5.149160178102852e-12
not O 0 1.0746841784536887e-12
associated O 0 1.3666633796871608e-11
with O 0 3.2732113460637313e-12
any O 0 1.4635845313470952e-10
obvious O 0 3.187187402886593e-09
phenotype O 0 1.3395794473680667e-09
in O 0 5.0425042613655435e-11
homozygous O 0 6.991597079064604e-09
individuals O 0 1.3554855848862957e-10
. O 0 2.084432715321327e-08

Founder O 0 0.0008067129529081285
BRCA1 O 0 3.824601662927307e-06
and O 0 1.6539965841388948e-08
BRCA2 O 0 5.580157846907241e-08
mutations O 0 3.730542541546811e-10
in O 0 1.0672945166545489e-10
French O 0 1.1911118917851127e-06
Canadian O 0 0.0004522533854469657
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.0817050224432023e-06
. O 0 2.3833058548916597e-06

We O 0 1.0047910059540754e-08
have O 0 8.928693895349227e-11
identified O 0 1.680618422206237e-10
four O 0 3.6296667060842225e-11
mutations O 0 3.082203589577226e-11
in O 0 1.6288886905968525e-11
each O 0 3.4014141329918868e-12
of O 0 2.62607802170578e-09
the O 0 1.5496683545279666e-06
breast B-Disease 1 0.999981164932251
cancer I-Disease 1 0.9999902248382568
- O 0 3.525934516801499e-05
susceptibility O 0 0.00015488725330214947
genes O 0 2.500860185605802e-09
, O 0 5.770796618342899e-10
BRCA1 O 0 4.553859955791495e-09
and O 0 1.7897974768921188e-10
BRCA2 O 0 1.0850852438792913e-09
, O 0 5.538231765550572e-12
in O 0 1.561243148651137e-11
French O 0 8.82325394968575e-08
Canadian O 0 1.2836279665862094e-06
breast B-Disease 1 0.9999828338623047
cancer I-Disease 1 0.9999995231628418
and O 1 0.9121343493461609
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.61521658270658e-08
from O 0 1.4562903771775382e-08
Quebec O 0 2.050481634796597e-05
. O 0 6.383590402947448e-07

To O 0 2.1185424969871747e-08
identify O 0 6.634833482621616e-08
founder O 0 1.0516837392060552e-05
effects O 0 1.5670917491661385e-05
, O 0 2.282185329605113e-09
we O 0 2.3046682617877678e-10
examined O 0 3.3683750233493015e-10
independently O 0 8.461809725135438e-11
ascertained O 0 5.597679653135401e-09
French O 0 2.808390675568262e-08
Canadian O 0 4.968891786916174e-08
cancer B-Disease 0 3.16760832674845e-07
families O 0 1.0467984985773615e-11
for O 0 2.968279094739401e-11
the O 0 6.240016836578377e-10
distribution O 0 3.3638249963274802e-09
of O 0 5.187019702646012e-09
these O 0 2.862347581178426e-10
eight O 0 1.94954239418621e-08
mutations O 0 3.8383806355568595e-08
. O 0 6.249586448348055e-08

Mutations O 0 6.796386031737711e-08
were O 0 4.66121141684539e-09
found O 0 4.3424791540402907e-10
in O 0 1.984839237412217e-10
41 O 0 8.328659539813543e-09
of O 0 2.5796076386086497e-08
97 O 0 1.4699837720399955e-06
families O 0 3.681783766751323e-09
. O 0 5.280245218841628e-08

Six O 0 2.6960369936546158e-08
of O 0 2.546594579655448e-08
eight O 0 7.871335583331529e-09
mutations O 0 1.315121123113272e-09
were O 0 8.389111627593593e-10
observed O 0 6.955843012690366e-09
at O 0 3.238226042867609e-08
least O 0 3.725453723291139e-09
twice O 0 7.619014041893024e-08
. O 0 8.163709708242095e-08

The O 0 1.3488069043887663e-06
BRCA1 O 0 1.6758336869315826e-06
C4446T O 0 6.036455033608945e-07
mutation O 0 2.131748289002644e-08
was O 0 1.6388478130124895e-08
the O 0 8.429322795322491e-10
most O 0 6.395866475328305e-11
common O 0 1.5989812252037439e-10
mutation O 0 1.243967984176919e-10
found O 0 1.599474545865842e-11
, O 0 3.2074108993751516e-12
followed O 0 9.220822716482502e-11
by O 0 2.0796377120380072e-10
the O 0 3.0886699420307195e-08
BRCA2 O 0 2.885769561089546e-07
8765delAG O 0 1.0988777603415656e-06
mutation O 0 5.420618549578649e-07
. O 0 2.0116083021548548e-07

Together O 0 8.515165461631113e-09
, O 0 1.3078020888457331e-09
these O 0 1.792762119312563e-11
mutations O 0 6.904680993624623e-11
were O 0 1.361863261051255e-10
found O 0 4.371171133388252e-11
in O 0 7.369282267744026e-11
28 O 0 1.0114169057828803e-08
of O 0 1.1475116856729528e-08
41 O 0 1.3269846554919695e-08
families O 0 1.1899646198965108e-11
identified O 0 1.9142630536261862e-10
to O 0 2.0311944834427997e-11
have O 0 1.339831717794837e-10
a O 0 3.782872237678703e-09
mutation O 0 7.171981764031443e-08
. O 0 5.759059007459655e-08

The O 0 1.9365974424090382e-07
odds O 0 3.39707781904508e-07
of O 0 1.9463248790430043e-08
detection O 0 5.047910534017319e-08
of O 0 4.361498273652842e-09
any O 0 3.814685511915883e-10
of O 0 5.052155582774276e-09
the O 0 9.00049901275679e-09
four O 0 5.023463867104283e-09
BRCA1 O 0 6.855834300267816e-08
mutations O 0 6.401304375458494e-09
was O 0 3.6300465922067815e-07
18 O 0 9.09550351479993e-07
. O 0 4.488934166602121e-07

7x O 0 0.00024461824796162546
greater O 0 1.6616715470263443e-07
if O 0 5.850214201963411e-10
one O 0 9.361314501354911e-11
or O 0 1.6060042185017664e-11
more O 0 1.019382495082155e-12
cases O 0 7.971650423099774e-11
of O 0 0.0014242531033232808
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 3.3538904631313926e-07
also O 0 7.342960267608944e-11
present O 0 4.319891319659597e-11
in O 0 3.3383906750117376e-10
the O 0 2.134502885553502e-08
family O 0 9.727796346226114e-09
. O 0 7.019620085202405e-08

The O 0 3.217893151941098e-07
odds O 0 2.0352855756300414e-07
of O 0 9.228485531309616e-09
detection O 0 8.119157968167201e-08
of O 0 3.740091347737007e-09
any O 0 4.392988472989856e-10
of O 0 9.657766142368018e-09
the O 0 1.1000144795048072e-08
four O 0 3.904122358733275e-09
BRCA2 O 0 2.535771237432982e-08
mutations O 0 4.702081390917101e-09
was O 0 1.1795158627592173e-07
5 O 0 1.2459327081160154e-06
. O 0 1.8683955715914635e-07

3x O 0 2.6541938495938666e-06
greater O 0 1.9001106466021156e-08
if O 0 6.152182235874548e-11
there O 0 8.230158915489838e-11
were O 0 1.0353733148615873e-10
at O 0 7.07174208081085e-10
least O 0 1.3013660461747012e-11
five O 0 1.5222696367334088e-11
cases O 0 1.7094815146778686e-11
of O 0 1.8358566222786976e-08
breast B-Disease 1 0.9770384430885315
cancer I-Disease 0 0.26038670539855957
in O 0 6.84599470446301e-08
the O 0 2.0526958905975334e-06
family O 0 3.253976998962571e-08
. O 0 2.3845512941989e-07

Interestingly O 0 5.081983189825223e-08
, O 0 6.391113749337762e-10
the O 0 2.5107427248372005e-10
presence O 0 2.256719117132988e-10
of O 0 2.606656934744933e-08
a O 0 4.506538971327245e-06
breast B-Disease 1 0.999890923500061
cancer I-Disease 1 0.6231933236122131
case O 0 2.3485579703219628e-08
< O 0 1.2456102638225275e-07
36 O 0 3.8183398110014366e-10
years O 0 4.5389053626720965e-11
of O 0 4.458883817726189e-10
age O 0 8.55181481185241e-10
was O 0 4.593175173539521e-09
strongly O 0 1.2888568684532586e-11
predictive O 0 8.731398243311261e-11
of O 0 6.948492892178137e-10
the O 0 1.28744723215668e-10
presence O 0 2.661275887161363e-11
of O 0 1.4240687795652462e-10
any O 0 8.625362923897484e-11
of O 0 1.954977735252328e-09
the O 0 3.292306871571782e-09
eight O 0 5.980401063254703e-09
mutations O 0 5.4427453655137015e-09
screened O 0 2.575345945388108e-07
. O 0 8.5339003419449e-08

Carriers O 0 1.1442376823822542e-08
of O 0 1.9318118660294203e-08
the O 0 3.106534807173489e-09
same O 0 5.013611192872247e-10
mutation O 0 9.740156459159266e-10
, O 0 1.8411805066675946e-11
from O 0 5.430418267837744e-12
different O 0 1.0178263397039866e-12
families O 0 9.808842106606708e-13
, O 0 7.713663041641894e-12
shared O 0 4.494204314253736e-11
similar O 0 8.346828089811353e-11
haplotypes O 0 1.720565911966787e-09
, O 0 2.547902513971856e-11
indicating O 0 1.3436576851155735e-10
that O 0 1.7356528540790617e-12
the O 0 8.353103625458047e-11
mutant O 0 1.6275548686550678e-09
alleles O 0 1.0131839811577947e-11
were O 0 9.083820501354367e-12
likely O 0 2.7478692064819565e-12
to O 0 4.4307561634406023e-13
be O 0 2.6772865608509777e-12
identical O 0 2.5864765190730665e-11
by O 0 7.32618393034512e-12
descent O 0 3.6064057296059104e-10
for O 0 3.969352971311402e-11
a O 0 2.071553484306321e-10
mutation O 0 1.3528252129635376e-10
in O 0 4.858605531787852e-11
the O 0 1.9818633401058605e-09
founder O 0 2.549559781073185e-07
population O 0 6.413130582139104e-10
. O 0 2.6984395162799046e-08

The O 0 4.9307125493669446e-08
identification O 0 3.312926111220804e-08
of O 0 6.600035362680501e-08
common O 0 9.880594831201961e-08
BRCA1 O 0 1.2466394139210024e-07
and O 0 2.4532142983701988e-09
BRCA2 O 0 1.3937455634049911e-08
mutations O 0 1.481153255600276e-10
will O 0 1.2592623992169205e-11
facilitate O 0 6.609222197306863e-11
carrier O 0 1.3026803247218055e-10
detection O 0 2.7225550702780765e-09
in O 0 4.0438753040605846e-11
French O 0 9.842711534702175e-08
Canadian O 0 9.89605723589193e-07
breast B-Disease 1 0.9998395442962646
cancer I-Disease 1 0.9999983310699463
and O 0 0.3545015752315521
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 6.72465318984905e-07
. O 0 8.507229267706862e-07

Are O 0 3.880205312611906e-08
Dp71 O 0 1.161144973593764e-05
and O 0 5.211089870726937e-08
Dp140 O 0 1.4256024769565556e-05
brain O 0 1.395616891386453e-05
dystrophin O 0 1.9008593881153502e-06
isoforms O 0 1.4762190581052437e-08
related O 0 1.3765537598686706e-09
to O 0 3.571815065939177e-10
cognitive B-Disease 1 0.9997709393501282
impairment I-Disease 1 1.0
in O 1 0.5165282487869263
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9998500347137451

Molecular O 0 5.145568025000102e-07
study O 0 1.7452758127589618e-09
and O 0 1.0710958509019264e-10
neuropsychological O 0 3.4024463246851155e-08
analysis O 0 8.280293811724349e-11
were O 0 3.0772693421221575e-11
performed O 0 9.777546133848958e-11
concurrently O 0 7.678993552140412e-11
on O 0 1.2347776134902233e-09
49 O 0 1.0207347855839544e-08
patients O 0 1.2695443585286625e-09
with O 0 8.441848109441707e-08
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999839067459106
DMD B-Disease 1 1.0
) O 0 1.298331997467983e-10
in O 0 7.88749534436084e-12
order O 0 3.82151463251823e-11
to O 0 3.785891305313482e-12
find O 0 6.1170300595658755e-12
a O 0 7.64665934738229e-12
molecular O 0 8.27429375016564e-11
explanation O 0 2.202149703908751e-12
for O 0 2.1937065879107376e-12
the O 0 2.7619490028385485e-10
cognitive B-Disease 0 6.153826689114794e-06
impairment I-Disease 0 2.010268872254528e-06
observed O 0 1.6745430597708832e-09
in O 0 8.711058541166494e-10
most O 0 7.26960038832658e-08
DMD B-Disease 1 1.0
patients O 0 1.3628568922285922e-06
. O 0 2.3228267309605144e-07

Complete O 0 1.1698077884148006e-07
analysis O 0 1.2553139638882271e-09
of O 0 1.214575640062776e-08
the O 0 1.7584584455221375e-08
dystrophin O 0 5.021938704885542e-07
gene O 0 7.929168432951883e-09
was O 0 1.2053076758888892e-08
performed O 0 2.8706319543658765e-09
to O 0 3.693399405757525e-11
define O 0 7.731700280011466e-10
the O 0 1.0697388530545027e-09
localization O 0 7.566501381006674e-08
of O 0 4.896695826595021e-10
deletions O 0 2.483172556466684e-10
and O 0 3.9977847421379664e-11
duplications O 0 6.627318249741165e-09
in O 0 2.2627574813860463e-10
relation O 0 2.353426342693865e-09
to O 0 2.561014733615252e-10
the O 0 2.4524716479845665e-08
different O 0 3.4816913796476e-08
DMD B-Disease 1 1.0
promoters O 0 0.01416461169719696
. O 0 1.1309283536320436e-06

Qualitative O 0 6.875974634112936e-08
analysis O 0 4.752800819574077e-09
of O 0 2.233235107951259e-08
the O 0 2.426735257188284e-08
Dp71 O 0 2.1973246475681663e-06
transcript O 0 8.648735416727504e-08
and O 0 1.8052495609488517e-10
testing O 0 1.0117829907230202e-09
for O 0 3.041980903284447e-11
the O 0 1.0756962681712778e-10
specific O 0 2.8474909929965264e-11
first O 0 6.117958362139575e-10
exon O 0 1.8790235145615952e-08
of O 0 2.0977131143240513e-09
Dp140 O 0 4.8901210192298095e-08
were O 0 1.2545289251875147e-09
also O 0 1.442686803354576e-10
carried O 0 5.826950033593903e-10
out O 0 2.3401860449467904e-09
. O 0 6.162948551491354e-08

Neuropsychological O 0 5.729419717681594e-05
analysis O 0 3.6953569093611804e-08
assessed O 0 7.650380240420418e-08
verbal O 0 4.453032431683823e-08
and O 0 3.960372918498933e-09
visuospatial O 0 6.389300779119367e-06
intelligence O 0 2.1469318767231016e-08
, O 0 1.3723645553298525e-09
verbal O 0 4.364563110925701e-08
memory O 0 0.008486879989504814
, O 0 6.127105045550252e-09
and O 0 3.0269935447080343e-09
reading O 0 5.302762815517781e-07
skills O 0 2.4652757701915107e-07
. O 0 1.1238629582521753e-07

Comparison O 0 6.833405308270812e-08
of O 0 4.590331315057483e-08
molecular O 0 2.704004486986378e-07
and O 0 2.9761788589155458e-09
psychometric O 0 1.0565426009634393e-06
findings O 0 1.276564187691065e-09
demonstrated O 0 7.602936613615441e-10
that O 0 1.3707673017504529e-11
deletions O 0 2.1244156434008232e-10
and O 0 6.874797953138057e-11
duplications O 0 9.158678260234865e-09
that O 0 3.5643134277396626e-11
were O 0 2.157141965053455e-10
localized O 0 4.846895151899844e-08
in O 0 1.2458634124357104e-09
the O 0 5.117015700051297e-09
distal O 0 8.19248491268354e-09
part O 0 1.6218065779227686e-09
of O 0 2.1320410326097772e-08
the O 0 1.4566015060779591e-08
gene O 0 1.2992946274437145e-08
seemed O 0 4.220740978944093e-10
to O 0 2.3847822588213274e-12
be O 0 8.501341991484779e-12
preferentially O 0 3.3020072787159904e-11
associated O 0 7.19688406092267e-11
with O 0 8.029397702280505e-10
cognitive B-Disease 1 0.9999662637710571
impairment I-Disease 1 0.999997615814209
. O 0 1.0168871540372493e-06

Two O 0 3.16379811238221e-08
altered O 0 6.723730194835298e-08
Dp71 O 0 7.108218937901256e-07
transcripts O 0 2.4516250363149084e-08
and O 0 3.6879738152251207e-10
two O 0 1.6516840672942124e-10
deleted O 0 9.080399765437619e-10
Dp140 O 0 7.005239499591198e-09
DNA O 0 6.471644886651973e-10
sequences O 0 3.79173220599327e-11
were O 0 3.6918149093345676e-11
found O 0 9.342865023298508e-12
in O 0 1.8694617034964445e-11
four O 0 2.812536870067106e-10
patients O 0 7.576820837407183e-10
with O 0 1.1186890525038962e-08
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 6.28031239102711e-06

These O 0 2.7514865941213884e-09
findings O 0 8.169964149651321e-10
suggest O 0 7.569348620117822e-11
that O 0 2.015113553452408e-12
some O 0 1.4522764501395669e-12
sequences O 0 3.3638855589934735e-11
located O 0 5.469790176348965e-10
in O 0 4.640413747702965e-11
the O 0 1.121679749083171e-09
distal O 0 1.6252934553762088e-09
part O 0 1.9890156188751007e-10
of O 0 1.2959970874248938e-09
the O 0 1.3681723531888679e-09
gene O 0 1.8507795296329732e-10
and O 0 1.0951078585619278e-11
, O 0 8.148448062128555e-12
in O 0 4.1659896019008436e-12
particular O 0 3.981864837854232e-11
, O 0 4.14557312089503e-11
some O 0 4.137594780684317e-11
DMD B-Disease 1 1.0
isoforms O 0 4.621833138429565e-09
expressed O 0 1.908531943595193e-10
in O 0 1.1093240909199054e-10
the O 0 4.675582587765348e-09
brain O 0 1.1062339808631805e-06
may O 0 1.312001340902924e-10
be O 0 5.048920916767008e-12
related O 0 4.678001909452778e-12
to O 0 1.2110293236972103e-12
the O 0 7.911112875902404e-10
cognitive B-Disease 1 0.8963695168495178
impairment I-Disease 0 0.1285340040922165
associated O 0 2.8963877962695506e-09
with O 0 1.694524409678877e-09
DMD B-Disease 1 1.0
. O 0 2.976566548795745e-08
. O 0 5.851692463920699e-08

I1307K O 0 5.843363396706991e-05
APC O 0 8.850549420458265e-06
and O 0 5.265800240294993e-09
hMLH1 O 0 1.7323728229712287e-07
mutations O 0 2.9101983045620727e-09
in O 0 8.685426267085461e-10
a O 0 2.365108331403576e-09
non O 0 4.408243725606553e-08
- O 0 2.7799196278266436e-09
Jewish O 0 2.087682471341168e-09
family O 0 7.04868385881241e-11
with O 0 5.369072408889508e-10
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0002354530297452584

We O 0 1.5541683495712277e-08
describe O 0 2.3352544342714054e-09
a O 0 1.0035972053401565e-09
French O 0 7.054234885117694e-08
Canadian O 0 4.0114025523507735e-07
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.1809732061228715e-05
HNPCC B-Disease 1 0.9999614953994751
) O 0 3.1143879142270237e-10
kindred O 0 1.7979047584049113e-08
which O 0 1.2281370365130329e-10
carries O 0 2.4701066192456267e-10
a O 0 1.7387559447801237e-10
novel O 0 2.6352287019193454e-10
truncating O 0 2.338179427852083e-08
mutation O 0 2.6731066249396918e-09
in O 0 1.3937129228480671e-09
hMLH1 O 0 7.591494295411394e-07
. O 0 1.638807844983603e-07

Interestingly O 0 9.850637638919579e-08
, O 0 2.3749402444650514e-09
the O 0 6.198064284035354e-09
I1307K O 0 6.495703814834997e-07
APC O 0 2.1288030893629184e-07
polymorphism O 0 4.517930030090156e-09
, O 0 3.41317876739744e-11
associated O 0 3.0985429499974515e-11
with O 0 2.678757606358606e-12
an O 0 4.795408861668626e-12
increased O 0 1.2786915970508517e-09
risk O 0 1.0701983228500467e-06
of O 1 0.9999964237213135
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 3.6665403513325145e-07
is O 0 1.7832754717339583e-10
also O 0 1.2188508882737814e-11
present O 0 1.7392360121548656e-11
in O 0 6.609941066715308e-11
this O 0 3.560055028550835e-10
family O 0 1.2416548900162638e-09
. O 0 2.726662096108612e-08

The O 0 1.68779237696981e-07
I1307K O 0 5.055971428191697e-07
polymorphism O 0 9.575578019394015e-08
has O 0 1.01470132296555e-09
previously O 0 9.867986427991582e-10
only O 0 1.5346333578913907e-11
been O 0 3.656906721882791e-11
identified O 0 2.4182574345776864e-11
in O 0 8.771186901790351e-12
individuals O 0 7.378725993927027e-13
of O 0 1.5467596092832991e-09
self O 0 1.412137180523132e-07
- O 0 9.34623400894452e-08
reported O 0 9.401011524801106e-09
Ashkenazi O 0 5.4380063119197075e-08
Jewish O 0 2.0635148700876016e-08
origins O 0 7.084336743901076e-07
. O 0 7.95973335243616e-07

In O 0 4.8151034270915716e-09
addition O 0 9.243507625988912e-10
, O 0 2.2373727870395044e-10
in O 0 1.4985725160787666e-10
this O 0 6.175283895348826e-11
family O 0 1.2170604801742257e-10
, O 0 5.603592242997557e-11
there O 0 7.25843621318667e-11
appears O 0 7.397560342070619e-11
to O 0 2.37839544066365e-12
be O 0 8.994548161833649e-12
no O 0 1.1445132168386163e-11
relationship O 0 7.831127239732449e-13
between O 0 9.538955562937712e-12
the O 0 1.6985360340449063e-10
I1307K O 0 1.2996607123838544e-09
polymorphism O 0 1.807178851009894e-10
and O 0 6.7388030919324216e-12
the O 0 9.008717383185427e-11
presence O 0 5.4615520439504905e-11
or O 0 7.03463537421456e-11
absence O 0 2.278024702206949e-08
of O 0 8.369988080403346e-08
cancer B-Disease 0 1.6470776245114394e-05
. O 0 4.092406413747085e-09
. O 0 3.4390225778224703e-08

Identification O 0 1.1285349188483451e-07
of O 0 3.2605004918195846e-08
a O 0 1.8924672939846232e-09
novel O 0 5.71689584560886e-10
mutation O 0 2.4638246998165414e-10
of O 0 1.491660794883387e-09
the O 0 2.3092820100600875e-08
CPO O 0 0.03525494784116745
gene O 0 1.5063660541159152e-08
in O 0 1.2625801515397939e-09
a O 0 1.2200366050763023e-08
Japanese O 0 2.6673330921767047e-06
hereditary B-Disease 1 0.9999732971191406
coproporphyria I-Disease 1 0.999880313873291
family O 0 4.3620832457236247e-07
. O 0 5.182899371902749e-07

Hereditary B-Disease 1 0.9999954700469971
coproporphyria I-Disease 1 0.9999597072601318
( O 0 4.716181592812063e-06
HCP B-Disease 1 0.9999991655349731
) O 0 1.2752087164003e-09
is O 0 1.8748402830226496e-10
an O 0 7.876828633790467e-10
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 9.120017097075106e-08
by O 0 1.4127871095226396e-10
a O 0 1.133762062011101e-08
deficiency B-Disease 0 2.1915086108492687e-05
of I-Disease 0 0.00021753738110419363
coproporphyrinogen I-Disease 1 0.9999493360519409
oxidase I-Disease 0 1.2909816859973944e-06
( O 0 4.139475429099093e-10
CPO O 0 0.0002182869939133525
) O 0 9.321506240500543e-12
caused O 0 1.6403378655382994e-10
by O 0 9.175589107957016e-12
a O 0 1.0510945586128528e-10
mutation O 0 1.0826555624232626e-10
in O 0 1.0333589539612831e-10
the O 0 1.1412168099411701e-08
CPO O 0 0.0005441491957753897
gene O 0 1.190418643659541e-07
. O 0 2.2526274179313077e-08

Only O 0 1.6361962451583167e-08
11 O 0 4.145697829471828e-08
mutations O 0 2.476466809397948e-09
of O 0 9.67603774881809e-09
the O 0 5.021059568122155e-09
gene O 0 5.2529598448813886e-09
have O 0 4.341110457217745e-11
been O 0 1.1363675278541763e-10
reported O 0 1.189450760108457e-09
in O 0 1.682631101118659e-08
HCP B-Disease 1 0.9999997615814209
patients O 0 1.4022295999893686e-06
. O 0 4.6793678620815626e-07

We O 0 4.363514349847719e-08
report O 0 3.6294625083144183e-09
another O 0 1.6614324360730848e-09
mutation O 0 7.467712670461424e-09
in O 0 1.4196110953434982e-09
a O 0 2.0684167267859266e-08
Japanese O 0 1.3847859463567147e-06
family O 0 4.4395822129672524e-08
. O 0 2.770430853615835e-07

Polymerase O 0 6.150690410322568e-07
chain O 0 5.523099275706045e-07
reaction O 0 8.053850919509387e-09
- O 0 1.6934913915633842e-08
single O 0 4.014783172578973e-09
strand O 0 4.7771213651515154e-09
conformational O 0 9.667583400485569e-10
polymorphism O 0 2.1485312140523405e-10
and O 0 4.2111674390665765e-12
direct O 0 8.057280537210332e-12
sequence O 0 1.8888880043421707e-11
analyses O 0 2.0372975875759813e-11
demonstrated O 0 1.3854377367561455e-10
a O 0 2.341417060236495e-10
C O 0 6.648106509743457e-09
to O 0 7.03117425393529e-11
T O 0 7.197509699352622e-09
substitution O 0 6.8054728519229e-10
in O 0 5.529389099367954e-11
exon O 0 1.4566952089012375e-09
1 O 0 3.172526408246057e-10
of O 0 1.135704516541658e-10
the O 0 4.593085356496829e-10
CPO O 0 6.862007921881741e-07
gene O 0 2.776044949470702e-10
at O 0 5.257919100110087e-10
nucleotide O 0 4.230339967215002e-10
position O 0 3.827045624849035e-10
85 O 0 1.0077808587638515e-09
, O 0 4.259192651345778e-11
which O 0 8.474419950499357e-12
lies O 0 1.9681165031038006e-10
in O 0 3.4820247379885316e-11
the O 0 9.390737076842015e-10
putative O 0 1.5170835254707526e-08
presequence O 0 4.9194401441354785e-08
for O 0 7.561777315423512e-10
targeting O 0 6.159150967022242e-09
to O 0 9.9507135864485e-10
mitochondria O 0 1.773011746308839e-07
. O 0 1.0206806422274894e-07

This O 0 1.686724093730163e-09
mutation O 0 1.645954927909088e-09
changes O 0 4.1126863026264004e-10
the O 0 1.901353297029118e-09
codon O 0 4.812789722308253e-09
for O 0 2.2359948614880665e-10
glutamine O 0 1.5199906888696546e-09
to O 0 1.1149197537418942e-10
a O 0 2.4173327783927334e-09
termination O 0 3.849649488074647e-08
codon O 0 4.104603235077775e-08
at O 0 1.349253011539986e-07
amino O 0 3.176138108074156e-08
acid O 0 1.1559846413433661e-08
position O 0 2.1187364751540372e-08
29 O 0 7.441113325512561e-07
. O 0 1.6941866931574623e-07

MaeI O 0 3.223977182642557e-05
restriction O 0 1.035129884030539e-07
analysis O 0 2.3008965843729356e-09
showed O 0 1.4063623599014363e-09
two O 0 7.376313448936855e-11
other O 0 3.386371738578475e-11
carriers O 0 1.2634467083660894e-10
in O 0 3.656531744056224e-10
the O 0 2.3988290465126738e-08
family O 0 8.094383829870822e-09
. O 0 6.67433255330252e-08

The O 0 2.774833319563186e-06
C O 1 0.9956108927726746
- O 0 0.14536051452159882
T O 0 2.9341212211875245e-05
mutation O 0 1.9408483709071334e-09
is O 0 2.8570661461668756e-11
located O 0 3.3874961863356035e-11
within O 0 2.4189124661622152e-11
a O 0 4.1878927409255695e-11
recently O 0 1.4066996179007418e-10
proposed O 0 5.387822132885134e-11
putative O 0 3.6734484898381936e-10
alternative O 0 2.932943610201022e-10
translation O 0 5.988559093061951e-10
initiation O 0 9.671365930330467e-10
codon O 0 1.639369195949314e-09
( O 0 2.3901932516556812e-11
TIC O 0 2.32355601426093e-09
- O 0 2.6711086675845763e-09
1 O 0 1.2060987764073161e-08
) O 0 9.773998450868238e-12
, O 0 8.060569572920784e-12
supporting O 0 3.9752930114378415e-11
that O 0 2.6496116065088948e-11
TIC O 0 9.195070305167974e-08
- O 0 4.403789688467441e-08
1 O 0 1.7907456140164868e-07
is O 0 1.207600686115029e-10
the O 0 5.830630422920535e-10
real O 0 3.9711533617037276e-08
TIC O 0 1.0656566473699058e-07
rather O 0 2.9733290829447867e-10
than O 0 1.9867170408804924e-11
TIC O 0 4.38693916748889e-08
- O 0 1.958117223921363e-08
2 O 0 5.857521756524875e-08
. O 0 1.5328094349342791e-09
. O 0 1.0716692422363394e-08

Human B-Disease 0 2.589744099168456e-07
complement I-Disease 0 4.1031478303921176e-07
factor I-Disease 0 3.514031050144695e-05
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
associated O 0 1.3988521459395997e-05
with O 0 0.0009371386258862913
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.003772787284106016

This O 0 2.0560215752141175e-09
study O 0 2.434242807325404e-10
reports O 0 1.039491062670983e-10
on O 0 9.952441093474818e-10
six O 0 2.2212445771607747e-10
cases O 0 9.998538108568766e-11
of O 0 3.721911312482007e-08
deficiency B-Disease 0 0.00016443706408608705
in I-Disease 0 3.8456993145530305e-09
the I-Disease 0 6.7649690294047105e-09
human I-Disease 0 2.1100041713850715e-09
complement I-Disease 0 9.551782698125066e-10
regulatory I-Disease 0 1.7984019606842594e-08
protein I-Disease 0 1.1903523500222946e-08
Factor I-Disease 0 3.942151849400943e-08
H I-Disease 1 0.9999997615814209
( O 0 1.521068826448868e-10
FH O 0 4.044575874218026e-08
) O 0 2.934282049109338e-13
in O 0 2.801107869959685e-13
the O 0 1.1658601601488572e-12
context O 0 8.305406709596674e-12
of O 0 1.3503659301861148e-10
an O 0 4.454134394649145e-09
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 8.280324436782394e-06

Five O 0 2.8841617094599314e-08
of O 0 1.4459195618599097e-08
the O 0 2.142108268543552e-09
cases O 0 2.9836841330954655e-11
were O 0 2.788413423771008e-11
observed O 0 6.938107033338525e-11
in O 0 1.1392815510435916e-11
children O 0 1.0482230534958337e-11
presenting O 0 2.744201754723008e-09
with O 0 1.689728321707662e-07
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9883559942245483
HUS B-Disease 1 1.0
) O 0 2.0404893348313635e-06
. O 0 1.955406105480506e-06

Two O 0 1.598247201251013e-09
of O 0 7.561102854936053e-09
the O 0 4.374411943786072e-09
children O 0 9.290997832200887e-11
exhibited O 0 9.039260895349344e-09
a O 0 4.669685083058539e-08
homozygous O 0 0.014633542858064175
deficiency O 1 0.9986650943756104
characterized O 0 1.0940494377109644e-07
by O 0 1.8069307161638903e-10
the O 0 2.25282814625416e-09
absence O 0 1.3577925450647399e-08
of O 0 9.357824737321607e-09
the O 0 2.530257336985642e-09
150 O 0 9.641541037774815e-11
- O 0 1.0433425651212858e-10
kD O 0 9.124672128990596e-10
form O 0 1.1508267949711382e-10
of O 0 7.659926026803987e-09
Factor O 0 2.9162231740542666e-08
H O 1 0.9999946355819702
and O 0 1.0115278753497492e-10
the O 0 1.6059316376715316e-10
presence O 0 3.434061715545944e-11
, O 0 5.418241376398125e-12
upon O 0 2.2669727206547918e-11
immunoblotting O 0 2.9449747085408262e-09
, O 0 1.914933836499877e-11
of O 0 9.682545043521174e-11
the O 0 7.805058266363574e-10
42 O 0 1.2368425172937236e-09
- O 0 1.308942509936628e-09
kD O 0 1.0845043973972679e-08
Factor O 0 1.024704499030804e-08
H O 1 0.8110224604606628
- O 0 2.1444476416832003e-08
like O 0 6.291525078694349e-10
protein O 0 3.647909752046985e-09
1 O 0 1.0548536977239564e-07
( O 0 9.541580719973908e-11
FHL O 0 1.0312221832009527e-07
- O 0 5.940573588603115e-10
1 O 0 1.7573646982071978e-09
) O 0 2.37364598462686e-12
and O 0 4.4712024881155e-12
other O 0 2.6673181025005377e-11
FH O 0 5.936149705121352e-07
- O 0 4.7704746819476895e-09
related O 0 9.644488541127316e-10
protein O 0 3.0911497805874433e-09
( O 0 2.628813000615793e-10
FHR O 0 5.8719911066873465e-06
) O 0 5.335506481074503e-10
bands O 0 1.5305876388538309e-07
. O 0 5.108290324074005e-08

Southern O 0 5.115954877510376e-07
blot O 0 2.519063571071456e-07
and O 0 1.1099362540178959e-09
PCR O 0 5.4582147690496186e-09
analysis O 0 9.818285767737578e-11
of O 0 5.391155299960815e-10
DNA O 0 1.2121773584894413e-09
of O 0 1.6791484869216333e-09
one O 0 1.7222460957366792e-10
patient O 0 5.154500715143229e-10
with O 0 2.7676019809241836e-10
homozygous O 0 0.00013443066563922912
deficiency O 1 0.9748329520225525
ruled O 0 7.59563704377797e-07
out O 0 6.810066399687287e-11
the O 0 1.0294578384195674e-10
presence O 0 4.218034602154752e-11
of O 0 7.047665784298829e-10
a O 0 1.8235250809350845e-10
large O 0 4.64764164653797e-11
deletion O 0 2.9689653513464975e-10
of O 0 3.229983169816819e-09
the O 0 2.221136696789472e-08
FH O 0 2.6094507120433263e-05
gene O 0 1.082565259657997e-09
as O 0 4.256334174002063e-11
the O 0 4.797462982431e-10
underlying O 0 6.8277518039394636e-06
defect O 0 3.3023168271029135e-06
for O 0 4.505839257262778e-09
the O 0 4.423645441420376e-05
deficiency O 1 0.9999997615814209
. O 0 1.7329395632259548e-05

The O 0 8.988357080852438e-08
other O 0 4.038536172146223e-10
four O 0 3.23897630938319e-10
children O 0 4.1847549731022227e-11
presented O 0 1.2867237275671073e-09
with O 0 9.266738487667681e-10
heterozygous O 0 2.3531461010861676e-06
deficiency O 0 0.15458573400974274
and O 0 2.0724753024836673e-09
exhibited O 0 3.9172007859633595e-07
a O 0 1.5078521542477574e-08
normal O 0 6.599796620321285e-08
immunoblotting O 0 5.005247203371255e-07
pattern O 0 9.212253182511176e-09
of O 0 2.1244817016707884e-09
proteins O 0 6.92664328671988e-11
of O 0 6.060032031740548e-09
the O 0 2.0539067691061064e-07
FH O 0 0.0195732694119215
family O 0 2.4813758159325516e-08
. O 0 1.3438928192499588e-07

Factor B-Disease 1 0.9847329258918762
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999980926513672
is O 0 4.553060595213765e-09
the O 0 2.7083588705067996e-09
only O 0 3.857048458399959e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 2.440117668811581e-06
with O 0 4.4664638210178964e-08
HUS B-Disease 1 1.0
. O 0 1.961580892384518e-06

These O 0 1.0294819441369896e-09
observations O 0 8.129936723832998e-10
suggest O 0 3.995850317295435e-10
a O 0 2.5168320205715133e-10
role O 0 4.097199524100148e-10
for O 0 5.752707754602682e-10
FH O 0 1.0028381439042278e-05
and O 0 1.3042796842555049e-09
/ O 0 7.533387815783499e-07
or O 0 3.6300165096037063e-09
FH O 0 4.0505015931557864e-05
receptors O 0 4.447578416666431e-10
in O 0 3.1475721334883744e-11
the O 0 7.670477586430025e-10
pathogenesis O 0 0.00153304822742939
of O 0 3.434647624089848e-07
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 1.3357917794110108e-07
. O 0 2.1848464371032605e-07

Further O 0 6.518377393405217e-09
evidence O 0 4.609930215337954e-09
for O 0 3.4776329038699316e-10
a O 0 4.79873529801722e-10
major O 0 7.948277591651731e-09
ancient O 0 8.868149592444752e-08
mutation O 0 0.0036006916780024767
underlying O 1 1.0
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 1.3035943879913248e-07
linkage O 0 1.7288767821810325e-06
disequilibrium O 0 9.974653494282393e-07
studies O 0 2.2349969097668065e-10
in O 0 3.1447757592451e-11
the O 0 5.318548379484866e-10
Japanese O 0 4.5381071345218515e-08
population O 0 7.294858606066157e-10
. O 0 2.029671541947664e-08

The O 1 0.9988070726394653
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9832895994186401
DM B-Disease 1 1.0
) O 0 3.1750402307295644e-09
mutation O 0 1.6807315539324463e-09
is O 0 4.732271519092279e-11
an O 0 2.0518904284005934e-11
unstable O 0 1.2501558011024372e-08
( O 0 2.4573340584588266e-10
CTG O 0 3.3963012811000226e-06
) O 0 2.2172224126149054e-11
n O 0 1.0558107721436727e-09
repeat O 0 2.1974873032348796e-09
, O 0 1.4604829498554572e-11
present O 0 1.112433929695289e-11
at O 0 1.693092332999413e-10
a O 0 8.885283134252298e-12
copy O 0 2.0623705868083597e-11
number O 0 3.2163304138077553e-12
of O 0 5.315087953094988e-11
5 O 0 9.95403537373818e-10
- O 0 3.6868064157147273e-10
37 O 0 4.437114009547827e-10
repeats O 0 4.677310760925479e-10
on O 0 1.8221214537206265e-09
normal O 0 4.864840197349452e-10
chromosomes O 0 2.3863121548228783e-11
but O 0 3.6080463703541676e-12
amplified O 0 1.402549743012571e-10
to O 0 1.3088087905122059e-11
50 O 0 3.8975059291068703e-10
- O 0 7.979961136328484e-10
3000 O 0 8.313340016385951e-10
copies O 0 2.7996127638374446e-09
on O 0 1.2436518659342255e-07
DM B-Disease 1 0.9951116442680359
chromosomes O 0 1.3963776268610673e-07
. O 0 1.1570284641493345e-07

Previous O 0 3.699070134643989e-07
findings O 0 1.3566922696384154e-08
in O 0 2.334524129565807e-09
Caucasian O 0 5.585705764588056e-08
populations O 0 2.6655406770714762e-09
of O 0 6.22822682316837e-08
a O 0 4.1383435018360615e-05
DM B-Disease 1 1.0
founder O 1 0.9999969005584717
chromosome O 0 7.726214244030416e-05
raise O 0 6.573424027322972e-09
a O 0 1.1288331380754357e-09
question O 0 1.1272748706714353e-10
about O 0 2.0576151459755776e-12
the O 0 3.308728291351315e-11
molecular O 0 1.9550523422395827e-09
events O 0 2.2765671292557244e-10
involved O 0 8.762262443395841e-11
in O 0 8.224541186985235e-11
the O 0 1.2654032266468107e-09
expansion O 0 1.4032367801064538e-07
mutation O 0 1.0877572265144408e-07
. O 0 4.824500976496893e-08

To O 0 4.9165671534012745e-09
investigate O 0 8.943378482229036e-09
whether O 0 1.7804859808734363e-09
a O 0 9.745141582584438e-09
founder O 0 7.559792720712721e-07
chromosome O 0 8.650550142874636e-08
for O 0 3.1516360632366514e-09
the O 0 1.0416642908239737e-06
DM B-Disease 1 1.0
mutation O 0 3.363826195368347e-08
exists O 0 5.812164638463457e-10
in O 0 1.7996552165167046e-11
the O 0 1.1059395066403965e-10
Japanese O 0 2.3685753358648753e-09
population O 0 2.5487676205693255e-11
, O 0 3.7946402964283976e-11
we O 0 2.588333158914935e-10
genotyped O 0 6.372095384676868e-08
families O 0 1.4547834291389616e-11
using O 0 1.0068273992303034e-10
polymorphic O 0 5.484115384035704e-09
markers O 0 4.640736683825253e-09
near O 0 1.1083442075232597e-07
the O 0 5.5374056451285014e-09
( O 0 8.110406235495304e-10
CTG O 0 1.0760461464087712e-06
) O 0 1.29793578662607e-10
n O 0 8.21075651913361e-09
repeat O 0 3.489270383738585e-08
region O 0 6.660202167552143e-09
and O 0 6.578024236425506e-10
constructed O 0 1.419054740381398e-07
haplotypes O 0 9.641202041166252e-07
. O 0 1.3508135054962622e-07

Six O 0 2.750181593569323e-08
different O 0 1.8871894325034333e-10
haplotypes O 0 5.658818125198195e-08
were O 0 2.631533213559578e-09
found O 0 1.1717785630693811e-09
and O 0 2.379928476514692e-09
DM B-Disease 1 1.0
alleles O 0 2.2710356262223286e-08
were O 0 9.785726895472635e-09
always O 0 5.9084843684331645e-09
haplotype O 0 7.858564003981883e-07
A O 0 1.6075075564003782e-06
. O 0 9.571414238962461e-08

To O 0 2.117466868511997e-09
find O 0 1.0195313343563939e-10
an O 0 4.982053831981137e-12
origin O 0 3.0741777179432717e-11
of O 0 7.09265202125664e-10
the O 0 3.829778716379906e-09
( O 0 3.90330157085117e-10
CTG O 0 7.755618298688205e-07
) O 0 4.621053192876978e-11
n O 0 4.307652456958522e-09
repeat O 0 1.3458623548956439e-08
mutation O 0 4.2403974775950815e-10
and O 0 1.4475564844018685e-11
to O 0 5.254535521970194e-12
investigate O 0 4.79735973168971e-11
the O 0 1.2858078490829428e-10
mechanism O 0 5.086729926162548e-10
of O 0 4.0335709772243433e-10
the O 0 2.6301319455690475e-10
expansion O 0 1.0224626700860995e-09
mutation O 0 3.68135869011077e-11
in O 0 8.328869711970999e-12
the O 0 8.658626593494034e-11
Japanese O 0 1.4863753561300541e-09
population O 0 1.81739139796383e-12
we O 0 7.29476808819518e-12
have O 0 3.6044698042275725e-12
studied O 0 1.0425116325762929e-09
90 O 0 1.1433650470848988e-08
Japanese O 0 7.102730705810245e-07
DM B-Disease 1 0.9999996423721313
families O 0 2.7258323376244675e-10
comprising O 0 1.290095252848289e-09
190 O 0 2.7133018054570357e-09
affected O 0 6.925484630215806e-10
and O 0 8.401121465162475e-10
130 O 0 3.942362170050728e-08
unaffected O 0 2.8548590762511594e-06
members O 0 2.8400211959933586e-08
. O 0 1.351589276055165e-07

The O 0 3.4363119993940927e-07
results O 0 4.561598743180184e-08
suggest O 0 2.199542104008856e-09
that O 0 7.694945375336104e-11
a O 0 1.1555366663529298e-09
few O 0 1.0393978733258535e-10
common O 0 1.6689907789135816e-10
ancestral O 0 7.062037066241089e-10
mutations O 0 3.7010013109739504e-11
in O 0 2.0065081540732166e-11
both O 0 8.614955276931013e-11
Caucasian O 0 3.187096142553969e-09
and O 0 1.4035130002643115e-10
Japanese O 0 2.1876523703667772e-08
populations O 0 1.0560984031737775e-10
have O 0 7.848024530590636e-13
originated O 0 4.061156792800613e-12
by O 0 2.0050417489508865e-12
expansion O 0 2.5901752964685443e-10
of O 0 2.598949666587913e-10
an O 0 1.6784041170780917e-11
ancestral O 0 3.5582695123714814e-10
n O 0 1.456086806683743e-09
= O 0 1.2693143203179602e-09
5 O 0 1.1081022766035176e-09
repeat O 0 1.8938322021710974e-09
to O 0 5.2134182387808536e-11
n O 0 2.3492867651242477e-09
= O 0 3.50806694804362e-09
19 O 0 1.0626137303404448e-08
- O 0 5.032737782073582e-09
37 O 0 4.144423026986033e-09
copies O 0 8.914494031841969e-09
. O 0 1.8936633594535124e-08

These O 0 1.183413256278243e-09
data O 0 2.7534292623698775e-09
support O 0 7.747554264803114e-10
multistep O 0 4.6369791562028695e-08
models O 0 3.886558630483705e-09
of O 0 1.416714834334698e-08
triplet O 0 3.8367377896975086e-07
repeat O 0 2.822319977724419e-08
expansion O 0 3.09035974588312e-09
that O 0 7.851831164418233e-12
have O 0 3.572805896620568e-12
been O 0 8.2695560468804e-12
proposed O 0 3.837598988587487e-11
for O 0 3.276542231978041e-11
both O 0 5.458870688812567e-09
DM B-Disease 1 1.0
and O 0 2.829416700933507e-07
Friedreichs B-Disease 1 0.9643625617027283
ataxia I-Disease 1 0.9999998807907104
. O 0 4.983651251677657e-07
. O 0 3.8050907846809423e-07

The O 0 1.0695536900584557e-08
molecular O 0 4.408008180689649e-08
basis O 0 7.372273103101179e-08
of O 0 0.21808961033821106
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.2597956811077893e-07
the O 0 1.871205412840027e-08
western O 0 1.933957705091416e-08
Cape O 0 1.5738153535949095e-07
, O 0 5.11189146568114e-10
South O 0 1.6774080791037704e-08
Africa O 0 2.03065511072964e-08
. O 0 1.7059695878174352e-08

Deficiency B-Disease 0 0.051259640604257584
of I-Disease 0 5.621227501251269e-06
the I-Disease 0 3.846706988497317e-07
sixth I-Disease 0 3.2832083434186643e-06
component I-Disease 0 6.91976040911868e-08
of I-Disease 0 2.500203244437671e-08
human I-Disease 0 1.197290533383466e-08
complement I-Disease 0 4.306937917419873e-09
( O 0 5.634128164011543e-10
C6 O 0 6.33938325336203e-05
) O 0 2.3860937531372528e-11
has O 0 1.1297927871023461e-11
been O 0 1.3177714128231877e-11
reported O 0 8.582706594040257e-12
in O 0 6.864508961257343e-12
a O 0 2.658541269073833e-11
number O 0 5.29378069158426e-11
of O 0 4.823612620441509e-10
families O 0 9.905743759974772e-13
from O 0 4.0388478152186824e-12
the O 0 4.5546044713518086e-10
western O 0 9.581036408690125e-09
Cape O 0 2.0257813559965143e-07
, O 0 5.845551265259985e-10
South O 0 1.3631302309136117e-08
Africa O 0 3.85790421830734e-08
. O 0 3.988514052366554e-08

Meningococcal B-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
is O 0 3.913665835852953e-09
endemic O 0 1.4054406527463925e-08
in O 0 2.1770482638849842e-10
the O 0 3.0907723047590707e-09
Cape O 0 1.5427481514507235e-07
and O 0 2.2950780165231777e-11
almost O 0 1.7457301229595323e-11
all O 0 6.2370828987634575e-12
pedigrees O 0 6.395577401008268e-10
of O 0 6.71790756356927e-09
total O 0 0.00017829441640060395
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 1.640877833608556e-08
C6Q0 O 0 0.001221667742356658
) O 0 4.8438381777815565e-11
have O 0 4.947697199858547e-12
been O 0 1.4799297204382e-11
ascertained O 0 1.0849072751284439e-09
because O 0 3.11389351803637e-11
of O 0 6.436822186373092e-09
recurrent O 1 0.9999909400939941
disease O 1 0.9999997615814209
. O 0 1.0137199524251628e-06

We O 0 8.121663341853491e-09
have O 0 6.937816293683952e-11
sequenced O 0 1.0127174654428472e-09
the O 0 1.4503347134375844e-10
expressed O 0 1.3526833819721418e-10
exons O 0 2.7099259725105185e-08
of O 0 9.56235979288067e-09
the O 0 5.7749975468368575e-08
C6 O 0 0.00013241848500911146
gene O 0 1.39324507486549e-09
from O 0 1.6389360354973626e-11
selected O 0 3.3728096704432886e-11
cases O 0 8.052271523173449e-12
and O 0 1.0498057284591411e-11
have O 0 7.896979077604005e-12
found O 0 1.1929165988355805e-11
three O 0 3.271509105284842e-11
molecular O 0 1.646794771659188e-05
defects O 0 0.0043563079088926315
leading O 0 5.140809733461538e-08
to O 0 1.88982607340904e-10
total O 0 1.082512085304188e-06
deficiency O 1 0.9999253749847412
879delG O 0 0.00016718833649065346
, O 0 9.838856396271467e-10
which O 0 1.4700915831888928e-11
is O 0 1.1312935831175874e-11
the O 0 2.1307379471924293e-10
common O 0 4.5998911346600835e-09
defect O 0 3.566474404692599e-08
in O 0 2.7123639445569836e-10
the O 0 4.662047192738328e-09
Cape O 0 1.4615028476328007e-07
and O 0 3.443716839468536e-11
hitherto O 0 2.4994248892795667e-09
unreported O 0 4.746448234449474e-10
, O 0 2.170827580194601e-11
and O 0 3.3366448493055145e-11
1195delC O 0 5.095763366824713e-09
and O 0 1.180425618363401e-10
1936delG O 0 1.2962376061409486e-08
, O 0 8.754710845160218e-11
which O 0 4.891743694140915e-12
have O 0 1.4438883031916983e-12
been O 0 7.366073896675207e-12
previously O 0 6.237585448154448e-11
reported O 0 4.758810012717163e-11
in O 0 1.7312670741453928e-10
African O 0 1.7463987589394492e-08
- O 0 4.185982405147115e-08
Americans O 0 3.4088167844004147e-09
. O 0 4.254108532109058e-08

We O 0 1.9182085253532932e-08
also O 0 2.9386326705349575e-10
show O 0 2.793972830872349e-10
that O 0 1.619749126491321e-11
the O 0 6.512507200184814e-10
879delG O 0 3.755999600230098e-08
and O 0 7.23440529704078e-10
1195delC O 0 1.846999680310546e-06
defects O 0 2.7194588255952112e-05
are O 0 1.637967365908377e-11
associated O 0 5.963790017382564e-10
with O 0 1.04534103595455e-09
characteristic O 1 0.9999939203262329
C6 O 1 1.0
/ O 1 0.9999995231628418
C7 O 1 0.9999312162399292
region O 0 2.7068580266131903e-07
DNA O 0 4.871213832302601e-08
marker O 0 2.374402541249765e-08
haplotypes O 0 3.7839185118571095e-09
, O 0 5.4383920977674194e-11
although O 0 5.836435501560544e-11
small O 0 3.0914944215698625e-11
variations O 0 3.2539009264809238e-09
were O 0 4.560100297368308e-09
observed O 0 6.282321152184522e-08
. O 0 3.903044998310179e-08

The O 0 4.65418196426981e-07
1936delG O 0 7.008849479461787e-06
defect O 0 9.021743608172983e-06
was O 0 1.0229746294498909e-07
observed O 0 4.044620638410379e-09
only O 0 1.043971645242614e-10
once O 0 4.801216091365745e-10
in O 0 5.216869644608657e-11
the O 0 9.388463340087583e-10
Cape O 0 8.719828059611245e-08
, O 0 2.029347176413232e-11
but O 0 5.951170979623388e-12
its O 0 3.6076561876763336e-11
associated O 0 3.8526060119892236e-10
haplotype O 0 1.483883416142362e-08
could O 0 4.292976529818304e-10
be O 0 5.378276157763651e-10
deduced O 0 1.5119299590082846e-08
. O 0 2.1401408645260744e-08

The O 0 5.895462606986257e-08
data O 0 2.4224746653089824e-09
from O 0 2.0593055038986563e-10
the O 0 7.886149511193707e-10
haplotypes O 0 1.6117597256837257e-09
indicate O 0 7.884490976772796e-11
that O 0 2.34769322038364e-12
these O 0 3.544589751922067e-12
three O 0 6.685191289435011e-11
molecular O 0 6.20583659838303e-06
defects O 0 3.8945449887251016e-06
account O 0 1.8371850915577248e-11
for O 0 2.8790969608394335e-10
the O 0 1.4699203632062563e-07
defects O 0 0.00033115610131062567
in O 0 3.011506599648328e-10
all O 0 8.221518466022815e-10
the O 0 1.6144095837944406e-08
38 O 0 4.310021850528756e-08
unrelated O 0 1.5474331149789577e-08
C6Q0 O 0 6.466501872637309e-06
individuals O 0 1.5744279144302986e-11
we O 0 8.346286856086849e-11
have O 0 8.331649606341252e-12
studied O 0 8.626124259336621e-10
from O 0 2.5799148928307147e-10
the O 0 6.3598291077937574e-09
Cape O 0 2.7203511763218557e-06
. O 0 6.228036397715186e-08

We O 0 1.1120834031430604e-08
have O 0 1.0013844614631395e-10
also O 0 3.447489169139395e-11
observed O 0 3.118233726784325e-10
the O 0 7.728397366513207e-10
879delG O 0 1.0865876731713797e-07
defect O 0 2.591819452391064e-07
in O 0 1.273451344374621e-09
two O 0 7.934736423464983e-09
Dutch O 1 0.9999904632568359
C6 B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
deficient I-Disease 1 1.0
kindreds O 0 2.3566142772324383e-05
, O 0 4.899704530991755e-10
but O 0 4.57570856204903e-11
the O 0 7.10053016383938e-10
879delG O 0 2.2205780680906173e-07
defect O 0 1.9333737100168946e-07
in O 0 7.612629415731931e-10
the O 0 2.3046617059208074e-08
Cape O 0 2.440611069687293e-06
probably O 0 4.596827640757084e-10
did O 0 2.8158633411101697e-11
not O 0 5.942074089715366e-12
come O 0 5.634412641314368e-12
from O 0 1.1786635036037385e-11
The O 0 3.987840613284277e-10
Netherlands O 0 1.593469960425864e-07
. O 0 3.5970304512744633e-09
. O 0 2.626880757361505e-08

Complement B-Disease 1 0.9999996423721313
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.338080295454347e-07
seven O 0 2.9847062599230867e-09
further O 0 6.299318289215705e-10
molecular O 0 1.5726145647931844e-05
defects O 0 0.007447804789990187
and O 0 8.237324156112891e-10
their O 0 1.9310741894429384e-09
associated O 0 1.2553282147109712e-07
marker O 0 3.4469635465939064e-06
haplotypes O 0 1.2061640290994546e-06
. O 0 1.2959081630015135e-07

Seven O 0 3.781280000225706e-08
further O 0 2.1440824671259406e-09
molecular O 0 7.844286642466614e-08
bases O 0 1.2646613356537273e-07
of O 1 0.996001660823822
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.3711543545014138e-07
described O 0 3.509404393753357e-07
. O 0 7.971221549496477e-08

All O 0 9.577930448756433e-09
these O 0 3.9279773877964885e-10
new O 0 3.41651706925461e-09
molecular O 0 6.843253231636481e-06
defects O 0 8.501733645971399e-06
involve O 0 8.391368711002656e-10
single O 0 1.1081894513154111e-08
- O 0 7.987518202412502e-09
nucleotide O 0 1.8301822279909175e-08
events O 0 6.393897411527405e-09
, O 0 2.867620585433883e-10
deletions O 0 4.364017480718019e-10
and O 0 8.693559760963865e-11
substitutions O 0 2.0337316275487183e-09
, O 0 2.4250532137948255e-10
some O 0 2.025657939996872e-11
of O 0 1.636229707280279e-09
which O 0 1.6166017136054478e-10
alter O 0 1.94390858965221e-09
splice O 0 1.878120592380128e-08
sites O 0 5.435739636183712e-10
, O 0 1.1945587574668792e-10
and O 0 2.524972175788065e-10
others O 0 3.822393512820099e-09
codons O 0 4.2017609303002246e-07
. O 0 1.3778002028175251e-07

They O 0 4.766581795934144e-09
are O 0 1.8044741048606205e-11
distributed O 0 3.7590399543097064e-11
along O 0 1.540008814915339e-10
the O 0 4.144327991895125e-09
C7 O 0 2.509367186576128e-05
gene O 0 3.5869660575116313e-09
, O 0 6.427503668193779e-11
but O 0 4.8572595598428414e-12
predominantly O 0 5.664832752189097e-12
towards O 0 2.0970510050677404e-11
the O 0 3.473946963428176e-10
3 O 0 4.2385984500015184e-08
end O 0 2.0799497235657327e-07
. O 0 6.315841716286741e-08

All O 0 3.2741546363013185e-08
were O 0 1.2933678128490556e-08
found O 0 1.885527955991506e-09
in O 0 9.470547679413244e-10
compound O 0 1.0164765740228177e-07
heterozygous O 0 2.314366120970135e-08
individuals O 0 7.350376973747075e-10
. O 0 5.072822162333068e-08

The O 0 9.660279465606436e-05
C6 O 1 0.9999809265136719
/ O 1 0.9991171956062317
C7 O 1 0.9461612701416016
marker O 0 3.865096459776396e-06
haplotypes O 0 1.3687778732673905e-07
associated O 0 5.6842472950791034e-09
with O 0 4.076303738997922e-09
most O 0 1.0868463959923247e-06
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999995231628418
are O 0 4.087787885964644e-09
tabulated O 0 1.1272463495970442e-07
. O 0 4.852081847417367e-09
. O 0 4.5081279154146614e-08

A O 0 9.70227233665355e-07
genome O 0 2.73116960158859e-08
- O 0 6.248773942729713e-09
wide O 0 1.5002663555918616e-09
search O 0 2.773784812948321e-10
for O 0 1.7733373103290262e-10
chromosomal O 0 2.0756035610247636e-06
loci O 0 9.947116552666557e-08
linked O 0 3.1823665835872816e-07
to O 0 1.7249492945126121e-09
mental O 1 0.9999998807907104
health O 0 0.12860926985740662
wellness O 0 6.82132231304422e-05
in O 0 3.237561885249818e-10
relatives O 0 2.340515281584743e-10
at O 0 6.314574640953197e-09
high O 0 2.443383948502742e-07
risk O 0 1.6879131692348892e-07
for O 0 2.2047352388199215e-07
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 1.3245039731657471e-08
the O 0 9.718119287072113e-08
Old O 0 1.4708726894241408e-06
Order O 0 1.0547933015914168e-07
Amish O 0 7.159721349125903e-07
. O 0 8.336132850672584e-08

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 0.0003098949964623898
BPAD B-Disease 1 1.0
; O 1 0.891169011592865
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 2.997982750940764e-09
is O 0 4.5334375142758176e-11
characterized O 0 1.4495879496756459e-10
by O 0 5.2432723961215455e-12
episodes O 0 1.0964507080046815e-09
of O 0 2.382404673539895e-08
mania B-Disease 0 1.2825478734157514e-05
and O 0 3.6616984999682245e-09
/ O 0 3.7368888570199488e-06
or O 0 7.035071636352086e-09
hypomania B-Disease 0 0.027093471959233284
interspersed O 0 4.422484778388025e-08
with O 0 1.8264666168388288e-10
periods O 0 4.4931573484063847e-07
of O 0 3.258969854869065e-06
depression B-Disease 1 0.9999439716339111
. O 0 6.746956273673277e-07

Compelling O 0 3.132798269689374e-07
evidence O 0 3.190357844573555e-08
supports O 0 8.357972092198906e-09
a O 0 6.600281432511679e-10
significant O 0 1.1975342939507527e-09
genetic O 0 8.553124430932257e-09
component O 0 1.544858641011615e-08
in O 0 6.780182526533451e-10
the O 0 6.310505007434131e-09
susceptibility O 0 2.614106051623821e-07
to O 0 2.2080666184365327e-09
develop O 0 5.747262434852018e-07
BPAD B-Disease 1 1.0
. O 0 5.5108794185798615e-06

To O 0 1.2248414504867355e-09
date O 0 4.27394510893464e-08
, O 0 2.979284319248876e-10
however O 0 6.008853831174221e-11
, O 0 2.6108476491870647e-11
linkage O 0 3.2020670559518294e-09
studies O 0 8.615973906556107e-11
have O 0 8.363557242596631e-12
attempted O 0 4.564875422108372e-10
only O 0 9.189810371013074e-12
to O 0 1.5852060983312377e-11
identify O 0 2.9183125360709994e-10
chromosomal O 0 3.9521202666037425e-07
loci O 0 2.499319862181437e-09
that O 0 3.7512614542434264e-11
cause O 0 2.6063275981869083e-09
or O 0 2.182181345344869e-11
increase O 0 5.104688546864189e-11
the O 0 3.393565206621929e-09
risk O 0 6.024227872103438e-08
of O 0 5.0193097678175036e-08
developing O 0 2.1282803572830744e-06
BPAD B-Disease 1 1.0
. O 0 2.728379513428081e-06

To O 0 2.440101010137141e-09
determine O 0 8.156496034139593e-10
whether O 0 3.0012367591147893e-10
there O 0 3.064087317206088e-10
could O 0 1.4888006105717722e-10
be O 0 1.1205031347216732e-10
protective O 0 3.960584749052032e-09
alleles O 0 2.060381032453762e-11
that O 0 2.020413133671517e-12
prevent O 0 2.2478653660673587e-10
or O 0 8.957294975187047e-12
reduce O 0 3.798871217597366e-10
the O 0 9.485299212741438e-10
risk O 0 2.105172258737298e-09
of O 0 1.7001930974203106e-09
developing O 0 2.7081483722213306e-08
BPAD B-Disease 1 1.0
, O 0 2.8335256363476446e-10
similar O 0 1.589556958281335e-11
to O 0 2.2037211465375517e-12
what O 0 3.040929270545223e-12
is O 0 1.812856071856106e-12
observed O 0 3.256020800201931e-11
in O 0 1.6315815018486113e-11
other O 0 2.7247773481953175e-10
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 3.183412977669775e-10
we O 0 6.463229257347436e-11
used O 0 5.198516062066005e-10
mental O 1 0.9999719858169556
health O 0 5.4248688684310764e-05
wellness O 0 4.4493540372059215e-06
( O 0 6.900912133400716e-12
absence O 0 1.936252491674395e-09
of O 0 6.443541256118124e-09
any O 0 6.724839067828725e-07
psychiatric B-Disease 1 1.0
disorder I-Disease 1 0.9998314380645752
) O 0 6.5580513242125e-11
as O 0 1.479713018781581e-10
the O 0 1.0677226880417834e-09
phenotype O 0 5.013458537206361e-10
in O 0 8.77316552738705e-11
our O 0 2.3190963038821621e-10
genome O 0 5.68416869128896e-10
- O 0 1.0821606943878237e-09
wide O 0 4.212691973037863e-09
linkage O 0 1.1864536020311789e-08
scan O 0 5.205444075784271e-09
of O 0 5.3353668150180056e-09
several O 0 5.828406646202211e-10
large O 0 2.350375893911405e-09
multigeneration O 0 7.966134944581427e-06
Old O 0 1.6593800182818086e-06
Order O 0 4.538410180998653e-08
Amish O 0 8.654511418626498e-08
pedigrees O 0 9.904516318215428e-09
exhibiting O 0 5.322864371493097e-09
an O 0 3.827206052076093e-10
extremely O 0 2.7986745365637944e-08
high O 0 7.491889846278355e-07
incidence O 0 0.14074453711509705
of O 0 0.00010717322584241629
BPAD B-Disease 1 1.0
. O 0 2.818215943989344e-05

We O 0 2.224210327028686e-08
have O 0 3.127931524904426e-10
found O 0 6.5843719365688e-11
strong O 0 2.8434476995187197e-11
evidence O 0 9.377325999038177e-11
for O 0 4.0023241665299025e-11
a O 0 3.2306404773585484e-10
locus O 0 2.7125823809370786e-09
on O 0 5.721698670413389e-09
chromosome O 0 3.52031470640668e-08
4p O 0 6.121855676610721e-06
at O 0 3.479500776393252e-08
D4S2949 O 0 2.2690956669180196e-08
( O 0 4.9166185012161634e-11
maximum O 0 8.894962100214343e-09
GENEHUNTER O 0 1.122417529586528e-06
- O 0 4.523957652935451e-09
PLUS O 0 4.345505733027721e-09
nonparametric O 0 4.2317056525575936e-09
linkage O 0 2.287039668757984e-09
score O 0 8.685774322003681e-10
= O 0 1.4673076642601757e-10
4 O 0 2.1278950823599985e-10
. O 0 3.004595704181323e-12
05 O 0 3.898764866505644e-09
, O 0 2.3439717181106268e-11
P O 0 1.9126031869376448e-09
= O 0 2.337346462211176e-11
5 O 0 2.4666400866291127e-11
. O 0 9.156913508695519e-13
22 O 0 1.560805477918148e-11
x O 0 6.488252990433097e-11
10 O 0 5.291821841835187e-11
( O 0 1.5702553190014013e-12
- O 0 2.7620105855219457e-11
4 O 0 2.8902055748680766e-10
) O 0 2.037813494337737e-12
; O 0 3.676423748766311e-12
SIBPAL O 0 5.771693878386941e-08
Pempirical O 0 2.0015917812088446e-08
value O 0 3.5392494490693593e-10
< O 0 9.819415280887256e-10
3 O 0 3.2501898394876605e-10
x O 0 1.6703952110397324e-10
10 O 0 9.79300043835174e-11
( O 0 1.918863505590007e-12
- O 0 3.3495570900266e-11
5 O 0 7.936468843228184e-11
) O 0 8.031759393851978e-13
) O 0 2.4111715770692987e-13
and O 0 1.8031485592845398e-12
suggestive O 0 2.5093579991697368e-11
evidence O 0 7.705898419363422e-12
for O 0 6.678700561341122e-12
a O 0 8.990762301319677e-11
locus O 0 1.8093767595317445e-09
on O 0 7.601562934667072e-09
chromosome O 0 9.267153444625365e-08
4q O 0 6.699114152297625e-08
at O 0 6.094318827365441e-09
D4S397 O 0 6.227986570905841e-09
( O 0 2.56820415628356e-11
maximum O 0 5.082630316621817e-09
GENEHUNTER O 0 1.0092318234455888e-06
- O 0 1.8273212942787609e-09
PLUS O 0 3.3948082123202994e-09
nonparametric O 0 3.869560671887484e-09
linkage O 0 1.5949613851873323e-09
score O 0 4.602846159773577e-10
= O 0 1.1428274993008358e-10
3 O 0 1.1574153441218371e-10
. O 0 3.5806648444880462e-12
29 O 0 2.9362012821110284e-10
, O 0 2.0941930481410687e-11
P O 0 3.3481295513837495e-09
= O 0 6.953487785565926e-11
2 O 0 1.0859231569515515e-10
. O 0 1.5897472140785629e-12
57 O 0 2.005666292770325e-11
x O 0 1.494074586272376e-10
10 O 0 7.221429010328961e-11
( O 0 3.5900817908773863e-12
- O 0 6.999648777261669e-11
3 O 0 2.7207783248606177e-10
) O 0 3.02278861663563e-12
; O 0 2.704725549432241e-12
SIBPAL O 0 2.6872580605186158e-08
Pempirical O 0 7.362348952710818e-09
value O 0 2.401903120841098e-10
< O 0 1.286046491522086e-09
1 O 0 5.514751988400235e-10
x O 0 3.930173131383441e-10
10 O 0 1.3280845867491564e-10
( O 0 3.904571110879829e-12
- O 0 4.855215188226403e-11
3 O 0 1.9236474912975865e-10
) O 0 6.64014741628971e-13
) O 0 1.5980885234925801e-13
that O 0 2.4491698816589413e-13
are O 0 3.198393806747024e-12
linked O 0 1.4274416093584819e-09
to O 0 6.818101638828011e-10
mental O 1 0.9999974966049194
health O 0 0.1031821146607399
wellness O 0 0.006846645846962929
. O 0 1.6124684520946175e-07

These O 0 6.960753751172888e-09
findings O 0 1.5631517191749822e-09
are O 0 2.209952013054739e-11
consistent O 0 7.50887185763105e-10
with O 0 4.347582016617224e-11
the O 0 1.3035285073570435e-09
hypothesis O 0 5.998642138571597e-10
that O 0 3.542467534589644e-12
certain O 0 8.646793003830311e-11
alleles O 0 1.5443975265316823e-10
could O 0 2.8191412745903754e-11
prevent O 0 2.1833981844743278e-10
or O 0 1.2199486212893795e-11
modify O 0 9.296280412129931e-11
the O 0 1.3561424205832395e-10
clinical O 0 3.013802185591885e-08
manifestations O 0 1.153189828073664e-06
of O 0 1.3864202230706724e-07
BPAD B-Disease 1 1.0
and O 0 6.287158571538498e-10
perhaps O 0 1.897150075924614e-10
other O 0 1.0905228109425735e-10
related O 0 7.299904041246918e-07
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 0 6.365055742207915e-05

Segregation O 1 0.9736980199813843
distortion O 1 0.999983549118042
in O 0 0.0013091947184875607
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0015645689563825727

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999995231628418
DM B-Disease 1 1.0
) O 0 6.13031048146695e-08
is O 0 1.2235642499192068e-09
an O 0 6.160416621270315e-10
autosomal B-Disease 1 0.9999971389770508
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
which O 0 2.6910956102410566e-11
, O 0 6.0201045537500164e-12
in O 0 8.34916510927819e-12
the O 0 1.648785136199038e-10
typical O 0 5.010543091543695e-10
pedigree O 0 4.70355920878518e-10
, O 0 4.30919926477924e-12
shows O 0 4.308971235378323e-11
a O 0 8.788340194465505e-11
three O 0 1.197976856603944e-10
generation O 0 9.258616096019523e-09
anticipation O 0 2.992163317117047e-08
cascade O 0 2.003484041779302e-06
. O 0 2.0314305970714486e-07

This O 0 6.30400509571416e-10
results O 0 2.919382513510982e-09
in O 0 3.806554627061587e-09
infertility B-Disease 1 0.9999986886978149
and O 1 0.9999983310699463
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.24454975128173828
CDM B-Disease 0 0.014855308458209038
) O 0 1.7760501186056543e-12
with O 0 1.029013137719692e-12
the O 0 1.5465552449800413e-10
disappearance O 0 1.0912188486145169e-08
of O 0 2.0698532665619496e-08
DM B-Disease 1 1.0
in O 0 1.0094241886804411e-08
that O 0 1.4355425737022642e-09
pedigree O 0 5.94317441482417e-07
. O 0 1.2584675346261065e-07

The O 0 8.961135833374101e-09
concept O 0 4.551272247965699e-09
of O 0 7.305361648946018e-09
segregation O 0 1.4256528629630338e-05
distortion O 0 4.209660801279824e-06
, O 0 5.153977244987118e-11
where O 0 4.031397611570231e-12
there O 0 2.9605651697545143e-12
is O 0 1.2108977015534705e-12
preferential O 0 4.1529887168101354e-11
transmission O 0 4.4013753752736307e-10
of O 0 1.9101452364278515e-10
the O 0 2.8436608623394477e-10
larger O 0 2.3450092562216085e-11
allele O 0 1.377443437089454e-10
at O 0 2.120061237675941e-09
the O 0 3.577066198801049e-09
DM B-Disease 1 0.9999991655349731
locus O 0 1.1704256230871124e-08
, O 0 4.94678464857401e-11
has O 0 1.0987985694932423e-11
been O 0 2.30601267248165e-11
put O 0 1.8909437904390813e-10
forward O 0 4.668573860833192e-11
to O 0 5.979136890460479e-12
explain O 0 2.3125149017921842e-10
partially O 0 5.033937711118597e-09
the O 0 5.528295599077637e-10
maintenance O 0 6.612856395804556e-07
of O 0 8.360318020095292e-07
DM B-Disease 1 1.0
in O 0 8.082859714875212e-09
the O 0 9.64129309721784e-09
population O 0 1.2281259342827866e-09
. O 0 1.5084447468893813e-08

In O 0 1.6701930505291784e-08
a O 0 3.4453431219105823e-09
survey O 0 1.8351520303383495e-09
of O 0 5.944773207033904e-08
DM B-Disease 1 1.0
in O 0 6.089673121323358e-08
Northern O 0 5.111014615977183e-07
Ireland O 0 1.6043999551129673e-07
, O 0 3.187679897820317e-09
59 O 0 5.491811805313773e-08
pedigrees O 0 8.42855811811205e-08
were O 0 2.2387196096929074e-08
ascertained O 0 8.69385189616878e-07
. O 0 1.3654543806751462e-07

Sibships O 0 1.0671188647393137e-05
where O 0 9.708241321959576e-09
the O 0 1.0950839124390654e-09
status O 0 9.841577552904823e-10
of O 0 1.005020511257726e-09
all O 0 5.3754840856345965e-11
the O 0 3.748023558181046e-10
members O 0 1.1863635941689044e-11
had O 0 5.823558302253673e-11
been O 0 8.087214925511788e-11
identified O 0 6.046101813650395e-11
were O 0 6.182579448399395e-11
examined O 0 9.298798536727659e-11
to O 0 5.6346706814314196e-12
determine O 0 8.431182835222373e-11
the O 0 5.725298013459224e-10
transmission O 0 1.658314729979793e-08
of O 0 1.1531152921406829e-08
the O 0 3.4964494943778845e-07
DM B-Disease 1 1.0
expansion O 0 3.8835489135635726e-07
from O 0 1.3213213856388961e-09
affected O 0 1.203542820960024e-09
parents O 0 3.001968118532261e-11
to O 0 7.261815454517873e-11
their O 0 3.1615341455903945e-09
offspring O 0 4.74063526212376e-08
. O 0 6.411558928220984e-08

Where O 0 3.492306532848488e-08
the O 0 1.9524931005321378e-08
transmitting O 0 8.230655339502846e-07
parent O 0 1.5016585308558206e-08
was O 0 2.7560847115637443e-07
male O 0 1.0967232455527665e-08
, O 0 5.121448154454811e-09
58 O 0 6.710591264891264e-07
. O 0 4.252308087870915e-07

3 O 0 1.8378997879153758e-07
% O 0 1.5452173984797923e-09
of O 0 6.388643392085669e-09
the O 0 6.107794270349132e-09
offspring O 0 7.836966631202813e-10
were O 0 3.7150987841627625e-10
affected O 0 6.287371318025592e-11
, O 0 1.7945820177112104e-11
and O 0 8.146194656333261e-12
in O 0 5.6364683753695743e-11
the O 0 1.1378972208930804e-09
case O 0 2.3661178571998676e-10
of O 0 1.7416046382834338e-09
a O 0 2.1345343270695594e-09
female O 0 2.6551172371824805e-10
transmitting O 0 5.951353188038411e-08
parent O 0 1.6817031101012958e-09
, O 0 6.257599327597063e-09
68 O 0 1.8368815517533221e-06
. O 0 7.600405069752014e-07

7 O 0 3.381654096301645e-06
% O 0 3.564726469562629e-08
were O 0 4.1758070778996625e-08
affected O 0 2.2134740618184878e-07
. O 0 2.431533516755735e-07

Studies O 0 2.1097436686545734e-08
on O 0 6.857337808696684e-08
meiotic O 0 1.3935487913840916e-05
drive O 0 4.934852171345483e-08
in O 0 2.4436128676086355e-09
DM B-Disease 1 0.9999438524246216
have O 0 2.2622041392916792e-11
shown O 0 7.893245085321965e-12
increased O 0 1.3532530131199483e-11
transmission O 0 1.9349814806002286e-10
of O 0 7.654689382352586e-11
the O 0 9.951354323911588e-11
larger O 0 3.8237312621758335e-11
allele O 0 8.401357387555208e-11
at O 0 1.021166595727152e-09
the O 0 3.515213453653132e-09
DM B-Disease 1 0.9999527931213379
locus O 0 2.189518433226567e-08
in O 0 1.9494410530285222e-09
non O 0 3.2677962735760957e-06
- O 0 1.860447446233593e-05
DM O 1 1.0
heterozygotes O 0 5.878624506294727e-06
for O 0 2.5695653604884683e-08
CTGn O 0 4.12593872169964e-05
. O 0 3.0082034641054634e-07

This O 0 4.614663318136536e-09
study O 0 9.956617752493457e-10
provides O 0 5.852834189523648e-11
further O 0 1.8960423509017943e-11
evidence O 0 1.0450155324415178e-10
that O 0 3.757792688130479e-11
the O 0 8.747813495801893e-08
DM B-Disease 1 1.0
expansion O 0 5.739243533753324e-07
tends O 0 4.899648464729012e-10
to O 0 4.122053393063041e-11
be O 0 2.237411089733854e-10
transmitted O 0 4.1147520946083205e-09
preferentially O 0 3.0515026061550543e-09
. O 0 8.603946000107499e-09

Diagnosis O 1 0.9577810168266296
of O 0 0.0031775757670402527
hemochromatosis B-Disease 1 1.0
. O 0 0.00028793036472052336

If O 0 2.3750553168611077e-07
untreated O 1 0.6495308876037598
, O 0 1.022846390696941e-06
hemochromatosis B-Disease 1 1.0
can O 0 8.374504645303205e-09
cause O 0 1.0327025847800542e-05
serious O 0 0.05613566190004349
illness O 0 0.06476453691720963
and O 0 1.636338009536331e-10
early B-Disease 0 1.7752409320337392e-08
death I-Disease 0 2.0436093706166503e-08
, O 0 1.9817932017662798e-11
but O 0 4.606855695532541e-12
the O 0 9.783072130176151e-10
disease O 0 0.00023566304298583418
is O 0 3.22693816112718e-11
still O 0 1.9909998996703315e-11
substantially O 0 3.9378192373540344e-10
under O 0 1.0028460906141845e-07
- O 0 0.0010313763050362468
diagnosed O 0 0.0004209638573229313
. O 0 2.310168127905854e-07

The O 0 2.371230465314511e-07
cornerstone O 0 4.833481216337532e-05
of O 0 1.1264296517765615e-07
screening O 0 7.052257444684074e-08
and O 0 4.428135358391927e-10
case O 0 4.785928875428169e-10
detection O 0 1.2814170169406225e-08
is O 0 1.1558219659146829e-11
the O 0 4.969291644840723e-11
measurement O 0 2.2175925540324215e-09
of O 0 4.415815268998813e-09
serum O 0 3.6355181087799338e-09
transferrin O 0 1.9526421368709634e-08
saturation O 0 8.845137955404425e-09
and O 0 1.057212858923684e-10
the O 0 1.1043276293420945e-09
serum O 0 3.291573946739845e-08
ferritin O 0 2.4229764221672667e-06
level O 0 2.617004838612047e-06
. O 0 5.5731906201117454e-08

Once O 0 8.706812195669045e-07
the O 0 7.772204924094694e-08
diagnosis O 0 1.0045256203738973e-05
is O 0 1.4255479019453787e-09
suspected O 0 1.3476712013016368e-07
, O 0 1.9971289066944564e-09
physicians O 0 4.781424145505753e-09
must O 0 9.67138369389886e-10
use O 0 7.378990751760739e-10
serum O 0 1.6351478393517027e-08
ferritin O 0 3.138808096991852e-06
levels O 0 9.941199152763147e-08
and O 0 1.0033656128172197e-09
hepatic O 1 0.9999998807907104
iron O 1 0.9933381080627441
stores O 0 1.265741389033792e-06
on O 0 4.989833541912958e-07
liver O 0 0.0004843624192290008
biopsy O 0 2.2835979507362936e-07
specimens O 0 2.3107071811523383e-10
to O 0 2.073801894098004e-11
assess O 0 2.7963307225320477e-09
patients O 0 3.0086745594903874e-11
for O 0 5.465481192623578e-11
the O 0 7.664949785990416e-10
presence O 0 1.4560340710900732e-09
of O 0 1.666556528334695e-07
iron B-Disease 0 0.14212851226329803
overload I-Disease 0 0.00018403673311695457
. O 0 5.819686634822574e-07

Liver O 1 0.999997615814209
biopsy O 1 0.8941156268119812
is O 0 3.97967632181917e-08
also O 0 4.003738729441153e-10
used O 0 3.311891386137411e-11
to O 0 1.0432425756601305e-11
establish O 0 4.40539826840336e-10
the O 0 7.581186234340009e-10
presence O 0 2.7121205281588345e-10
or O 0 4.689456808981696e-11
absence O 0 1.799016224879324e-08
of O 0 8.119529582018004e-08
cirrhosis B-Disease 1 1.0
, O 0 5.068445663169996e-10
which O 0 1.405529512221726e-11
can O 0 9.068655548727378e-12
affect O 0 5.358126164978216e-10
prognosis O 0 6.38034691746725e-07
and O 0 1.1985076264764416e-09
management O 0 1.0491766033737804e-06
. O 0 1.261839770450024e-07

A O 0 9.901834800984943e-07
DNA O 0 2.7955643133736885e-08
- O 0 2.195522430525898e-09
based O 0 4.666029784772263e-10
test O 0 9.705070080912037e-10
for O 0 2.397527454345294e-10
the O 0 4.397987307669382e-09
HFE O 0 2.1133229893166572e-05
gene O 0 4.6402123810018736e-10
is O 0 5.551303340622926e-12
commercially O 0 5.514149900576193e-11
available O 0 3.8789991184395856e-12
, O 0 1.7457692192898722e-12
but O 0 8.654737625353459e-13
its O 0 5.631672645584063e-12
place O 0 1.6132566116322522e-10
in O 0 2.3708146557055443e-11
the O 0 6.706050159621668e-10
diagnosis O 0 9.245478622688097e-07
of O 0 4.263897608325351e-07
hemochromatosis B-Disease 1 1.0
is O 0 6.344853531459194e-09
still O 0 6.321994594493674e-10
being O 0 1.7327413948109438e-09
evaluated O 0 3.3980036562297755e-08
. O 0 3.9993238942770404e-08

Currently O 0 3.242441337647506e-08
, O 0 9.775312781457046e-10
the O 0 8.951958063718735e-10
most O 0 2.8047142733300667e-11
useful O 0 4.2831439783785896e-11
role O 0 6.13677164640336e-11
for O 0 3.019666808268262e-11
this O 0 1.2601272456058688e-11
test O 0 2.7625599030578485e-10
is O 0 3.5334586818980274e-12
in O 0 3.670265480426593e-12
the O 0 7.65975755046e-11
detection O 0 8.403468854112361e-08
of O 0 7.495356868503222e-08
hemochromatosis B-Disease 1 1.0
in O 0 2.574412150124772e-08
the O 0 1.5975622602582007e-08
family O 0 1.7254782325171192e-10
members O 0 2.2554486056591827e-11
of O 0 4.44502790131196e-09
patients O 0 9.540639389626904e-10
with O 0 2.1042760589562448e-10
a O 0 2.945262700393414e-08
proven O 0 1.4011425264470745e-07
case O 0 1.873182942091489e-09
of O 0 3.117963487397901e-08
the O 0 3.8194113471945457e-07
disease O 1 0.9898251891136169
. O 0 1.0598976274422967e-07

It O 0 4.2578971459761306e-09
is O 0 6.670433094768669e-10
crucial O 0 6.780305028541989e-08
to O 0 6.35250607672333e-09
diagnose O 1 0.9999996423721313
hemochromatosis B-Disease 1 1.0
before O 1 0.9096400737762451
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 1.6509180511548038e-07
because O 0 8.279243068898268e-09
phlebotomy O 1 0.9999998807907104
therapy O 0 0.014096763916313648
can O 0 5.453487106343857e-10
avert O 0 0.11120877414941788
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 0 3.186960972900721e-10
can O 0 4.363238936822e-12
even O 0 1.558386926447941e-11
lead O 0 4.21113144355445e-10
to O 0 1.009045364624983e-11
normal O 0 6.9765442312075265e-09
life O 0 1.5643737694137627e-10
expectancy O 0 2.2750576977870196e-09
. O 0 1.3047816993516648e-10
. O 0 2.4957949040782523e-09

Prevalence O 0 4.5396541281661484e-06
of O 0 9.551663282536538e-08
the O 0 6.853925071936828e-08
I1307K O 0 2.440208390908083e-06
APC B-Disease 0 5.727466145799553e-07
gene O 0 1.6804430069683463e-09
variant O 0 3.980372920153741e-09
in O 0 3.5998405645276677e-11
Israeli O 0 3.847531460099418e-10
Jews O 0 8.662624090272075e-11
of O 0 1.306794117361676e-10
differing O 0 1.3875763385517992e-11
ethnic O 0 6.651207362651235e-11
origin O 0 3.890641281367735e-11
and O 0 1.3624737449369206e-10
risk O 0 3.929626757326332e-07
for O 0 3.657949127955362e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.004402396734803915

BACKGROUND O 0 2.9193701266194694e-05
& O 0 7.028027175692841e-05
AIMS O 0 3.1701952707408054e-07
Israeli O 0 4.9093609177930375e-09
Jews O 0 1.881698130645759e-09
of O 0 1.3395980325014989e-08
European O 0 3.5456594105198747e-07
birth O 0 4.811690814676695e-07
, O 0 2.9025373216029493e-09
i O 0 1.114359049481095e-09
. O 0 6.271836522353524e-11
e O 0 5.1692174846129646e-11
. O 0 1.6940865377179648e-11
, O 0 1.5089747160135225e-11
Ashkenazim O 0 2.609177762735726e-09
, O 0 1.0382877717318717e-11
have O 0 5.3853124216962645e-12
the O 0 5.261781566012758e-10
highest O 1 0.9999997615814209
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9839756488800049
of O 0 6.2206848561174866e-09
any O 0 3.4315231212111996e-10
Israeli O 0 7.587540373776847e-09
ethnic O 0 2.0735281935913008e-08
group O 0 1.3283614919146203e-07
. O 0 4.638181962945964e-07

The O 0 1.8339793541599647e-06
I1307K O 0 2.0239027435309254e-05
APC B-Disease 0 3.5795501389657147e-06
gene O 0 4.0308908211272865e-08
variant O 0 2.192523567146054e-07
was O 0 4.8831491739065314e-08
found O 0 8.787321426062533e-10
in O 0 1.1630412188878836e-09
6 O 0 2.144937980119721e-06
. O 0 2.3847059082982014e-07

1 O 0 1.037968928585542e-07
% O 0 2.819153521738116e-10
of O 0 3.8926548096007707e-10
American O 0 5.265325397907361e-10
Jews O 0 1.9655353733494252e-10
, O 0 4.705943620897379e-11
28 O 0 1.1689703649508942e-09
% O 0 6.063205493234136e-11
of O 0 1.5075207748793673e-09
their O 0 1.0673429784446853e-07
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 4.6595471303589875e-07
, O 0 9.712454451804575e-11
but O 0 7.808788338170558e-12
not O 0 4.6018319363461124e-12
in O 0 1.2856191111687565e-10
non O 0 8.93598155471409e-08
- O 0 1.4003244785953939e-08
Jews O 0 9.674948842075537e-09
. O 0 6.870652669022093e-08

We O 0 2.4566009670934363e-08
assessed O 0 4.6192973002234794e-08
the O 0 5.8628395471771455e-09
I1307K O 0 1.494651087341481e-07
prevalence O 0 3.166973527868322e-08
in O 0 3.839048176579318e-11
Israeli O 0 2.137368754207003e-10
Jews O 0 5.36646907467464e-11
of O 0 5.2708490350106274e-11
differing O 0 7.528137835333126e-12
ethnic O 0 8.554633390556177e-11
origin O 0 9.994838984228593e-11
and O 0 1.47897943891806e-10
risk O 0 7.011410048107791e-07
for O 0 4.419192919158377e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.017342424020171165

METHODS O 0 4.039286977786105e-06
DNA O 0 1.3562205936068494e-07
samples O 0 1.7881980340916925e-09
from O 0 6.988606915392381e-10
500 O 0 8.951531182965766e-10
unrelated O 0 2.12330686366613e-09
Jews O 0 8.875739587743681e-10
of O 0 3.6368930977914715e-08
European O 0 3.588685899558186e-07
or O 0 1.2237229007894257e-09
non O 0 2.5470689024587045e-07
- O 0 5.540659486769073e-09
European O 0 6.304922806066315e-09
origin O 0 1.83779921836269e-10
, O 0 1.3618910686685748e-11
with O 0 2.993024664915689e-12
or O 0 3.436296039383002e-11
without O 0 3.1071437089913445e-10
a O 0 2.8455870992871724e-10
personal O 0 6.315823974922807e-10
and O 0 6.208508707139515e-10
/ O 0 2.0641532216814085e-07
or O 0 1.4607984266667984e-10
family O 0 4.7455310514532556e-11
history O 0 4.977043777110168e-10
of O 0 1.2722673581322397e-08
neoplasia B-Disease 0 3.67800603271462e-05
, O 0 7.408930691177318e-10
were O 0 1.3369140516861222e-10
examined O 0 2.6377680595324193e-10
for O 0 1.295517026989046e-10
the O 0 2.577673186010543e-09
I1307K O 0 3.149366278876187e-08
variant O 0 1.5577288348112006e-09
by O 0 1.0338124106779034e-10
the O 0 9.708402970431962e-10
allele O 0 1.2166038176886218e-09
- O 0 1.6058526730589051e-09
specific O 0 4.368006512045497e-10
oligonucleotide O 0 8.239453563874122e-08
( O 0 2.8731790280289715e-09
ASO O 0 0.004781934432685375
) O 0 8.939178286482274e-10
method O 0 1.678460925802483e-08
. O 0 3.3738889015921814e-08

RESULTS O 0 3.462166944245837e-07
In O 0 1.6901861021878517e-09
persons O 0 2.771944340729249e-10
at O 0 1.3152967603957677e-09
average O 0 4.3692896523062075e-10
risk O 0 6.102440153199495e-08
for O 0 1.258673137272126e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 4.199193170961735e-08
I1307K O 0 2.493408146619913e-07
was O 0 1.8447336103122325e-08
found O 0 1.5254617014015537e-10
in O 0 1.0311893006154094e-10
5 O 0 8.977939103260724e-08
. O 0 4.650681262319267e-08

0 O 0 4.1858467625388585e-07
% O 0 2.3063229104280936e-09
of O 0 2.360840190007707e-09
120 O 0 3.6134653047525944e-09
European O 0 4.440445877662569e-08
and O 0 4.748125448372775e-09
1 O 0 4.9163299991050735e-06
. O 0 2.7589987894316437e-07

6 O 0 1.037329184327973e-06
% O 0 3.2977938158040843e-09
of O 0 9.160250336037734e-09
188 O 0 6.179531997219101e-09
non O 0 6.537241858950438e-08
- O 0 4.251178076231099e-09
European O 0 6.5564322859756885e-09
Jews O 0 1.454085851726461e-09
( O 0 1.741892602380446e-10
P O 0 3.766815268591017e-07
= O 0 3.078992616423193e-09
0 O 0 4.249054441629596e-09
. O 0 6.632686067042926e-11
08 O 0 1.3372615237372543e-09
) O 0 3.9080898239785e-11
. O 0 1.3682689425920103e-09

It O 0 5.117386514541522e-09
occurred O 0 1.347506781712582e-07
in O 0 7.4225843249564605e-09
15 O 0 3.238807266825461e-07
. O 0 2.0603847872280312e-07

4 O 0 2.623064006002096e-07
% O 0 2.216746786132262e-09
of O 0 7.227898279893452e-09
52 O 0 1.7152160580735654e-08
Ashkenazi O 0 3.137219550808368e-08
Israelis O 0 2.117062969375638e-09
with O 0 5.753376663975018e-10
familial O 1 0.6580555438995361
cancer B-Disease 1 0.9999611377716064
( O 0 4.206790471528166e-09
P O 0 0.001940495683811605
= O 0 8.04939670473459e-09
0 O 0 1.2081541322928047e-09
. O 0 3.5449887383215417e-12
02 O 0 3.538527526547597e-10
) O 0 1.6109174812237864e-13
and O 0 1.9090606103323166e-13
was O 0 3.346051213881651e-11
not O 0 1.2428923992433005e-12
detected O 0 4.682146337309234e-11
in O 0 1.667542146033263e-11
51 O 0 8.308996268802105e-10
non O 0 1.4100965728403025e-08
- O 0 4.82850981420313e-10
European O 0 3.078110544230128e-10
Jews O 0 7.825744913203536e-11
at O 0 2.3227673118242365e-09
increased O 0 1.2337166843678915e-08
cancer B-Disease 0 0.0002327225374756381
risk O 0 1.46258366839902e-06
. O 0 6.926772044835161e-08

Colorectal B-Disease 1 0.9999998807907104
neoplasia I-Disease 1 0.999990701675415
occurred O 0 0.0007983277318999171
personally O 0 6.061964796799657e-08
or O 0 3.1913524600746257e-10
in O 0 2.0072556117245455e-10
the O 0 1.0698673058584518e-09
families O 0 3.0418922589148245e-12
of O 0 7.905516796746781e-10
13 O 0 1.443167096937259e-08
of O 0 2.8100837212718943e-08
20 O 0 5.929677726612681e-08
Ashkenazi O 0 1.3932836395724735e-07
I1307K O 0 7.04111542404462e-08
carriers O 0 3.2569041907848373e-10
, O 0 8.688254976574328e-11
8 O 0 3.123342473543289e-09
of O 0 3.552852678723184e-09
whom O 0 1.3507168716841988e-09
also O 0 1.4800102254852732e-09
had O 0 3.538481951892436e-09
a O 0 2.513134811366058e-09
personal O 0 7.148897918085595e-09
or O 0 1.5126648822416655e-09
family O 0 6.343833791611075e-10
history O 0 1.0799713123788024e-08
of O 0 3.7776939620925987e-07
noncolonic O 0 0.06005366891622543
neoplasia B-Disease 1 0.9996395111083984
. O 0 4.94383994009695e-06

CONCLUSIONS O 0 2.26327915697766e-06
The O 0 3.3788870723583386e-07
I1307K O 0 1.6125810361700132e-05
APC O 0 1.3283998669066932e-05
variant O 0 5.585102940131037e-07
may O 0 2.8273507979292845e-09
represent O 0 3.527496073019165e-10
a O 0 2.045769109670914e-09
susceptibility O 0 1.7417457343071874e-07
gene O 0 1.9335887557758724e-08
for O 0 1.2173912544710674e-08
colorectal B-Disease 1 1.0
, I-Disease 0 3.718185936918417e-08
or I-Disease 0 3.381784297040724e-10
other I-Disease 0 2.3511415037091865e-10
, I-Disease 0 7.528953460678167e-09
cancers I-Disease 0 0.007069131825119257
in O 0 6.213404013521995e-09
Ashkenazi O 0 8.588504130102592e-08
Jews O 0 4.690461352652164e-10
, O 0 2.56275445309484e-10
and O 0 3.446366803050438e-10
partially O 0 5.615659048885391e-08
explains O 0 1.3879369875624548e-10
the O 0 3.2066677091435736e-10
higher O 0 4.643304407636606e-09
incidence O 1 0.8660265803337097
of O 1 0.9999867677688599
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.5469350955754635e-07
European O 0 8.105417492743072e-08
Israelis O 0 4.980315893021725e-08
. O 0 9.916201548776371e-08

Systematic O 0 1.375452711727121e-07
analysis O 0 6.444733635646571e-09
of O 0 3.709430629328381e-08
coproporphyrinogen O 0 0.0002646195935085416
oxidase O 0 0.0012314862105995417
gene O 0 0.00024973825202323496
defects O 1 0.641323983669281
in O 0 2.283296751670605e-08
hereditary B-Disease 1 0.9999836683273315
coproporphyria I-Disease 1 0.99986732006073
and O 0 1.0952352624826744e-07
mutation O 0 1.6437196848073654e-07
update O 0 7.096081731106096e-07
. O 0 1.9743264090266166e-07

Hereditary B-Disease 1 0.9999912977218628
coproporphyria I-Disease 1 0.9998534917831421
( O 0 2.4144119379343465e-06
HC B-Disease 1 1.0
) O 0 1.604420774015125e-08
is O 0 7.57435003606588e-10
an O 0 7.367191856566535e-10
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 2.0258123186067678e-05
autosomal O 1 0.9999994039535522
dominant O 1 0.9988705515861511
inheritance O 0 7.805929413962076e-08
caused O 0 1.9071148216198708e-08
by O 0 7.908559224167888e-11
deficient B-Disease 0 2.7465423269035227e-09
activity I-Disease 0 1.343544997478574e-10
of I-Disease 0 1.1886456263709988e-09
coproporphyrinogen I-Disease 0 5.1826796152454335e-06
III I-Disease 0 0.12752558290958405
oxidase I-Disease 0 1.1622505979858033e-07
( O 0 5.280673120999779e-10
CPO O 0 1.0004930118157063e-05
) O 0 7.610989061213047e-10
. O 0 6.289140319637454e-09

Clinical O 0 5.272613634588197e-05
manifestations O 0 0.009104568511247635
of O 0 7.05879028828349e-06
the O 0 5.9552016864472535e-06
disease O 1 0.9999599456787109
are O 0 6.24847786359628e-12
characterized O 0 2.3635465806748357e-10
by O 0 2.057153232482012e-11
acute O 0 0.05465058982372284
attacks O 0 5.332388397505383e-08
of O 1 0.8112717270851135
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 1.3999852832569104e-08
precipitated O 0 4.3251660031273786e-08
by O 0 1.8221343878188634e-10
drugs O 0 4.81217465875261e-09
, O 0 6.278323694264287e-11
fasting O 0 1.8491794762098834e-08
, O 0 1.4613620313852493e-09
cyclical O 0 0.00020719623717013747
hormonal O 0 1.8517634089221247e-05
changes O 0 2.696000933610776e-08
, O 0 1.4855052743456554e-09
or O 0 1.2304055552192494e-08
infectious B-Disease 1 0.9999998807907104
diseases I-Disease 1 0.9999980926513672
. O 0 3.148525991036877e-07

Skin O 1 0.9999988079071045
photosensitivity O 1 0.9999569654464722
may O 0 1.057453800967778e-06
also O 0 3.246016122560036e-09
be O 0 4.836566147581323e-10
present O 0 6.252374173953967e-09
. O 0 3.01331368746105e-08

The O 0 1.4869863207422895e-07
seven O 0 3.227484413059756e-08
exons O 0 3.759616049592296e-07
, O 0 1.4761788458272918e-09
the O 0 7.89304532844426e-09
exon O 0 1.595988265989945e-07
/ O 0 3.0340064682832235e-08
intron O 0 2.6185468016137747e-08
boundaries O 0 4.978961687385208e-10
and O 0 1.4624452690514822e-11
part O 0 4.91867241381172e-11
of O 0 6.90961177163274e-10
3 O 0 9.408742229766176e-09
noncoding O 0 1.3502506890361587e-09
sequence O 0 6.533231594607614e-11
of O 0 1.307058905553049e-09
the O 0 5.7130180586284496e-09
CPO O 0 5.4706742957932875e-06
gene O 0 2.729651227273422e-10
were O 0 3.437063134104079e-11
systematically O 0 5.1229478992276256e-11
analyzed O 0 7.606105849322642e-12
by O 0 5.447358709942396e-12
an O 0 2.4065884701718332e-11
exon O 0 6.825951359701321e-09
- O 0 2.6937636565804723e-09
by O 0 3.779835999750958e-09
- O 0 6.365450531120587e-07
exon O 0 2.1609055238513974e-06
denaturing O 0 1.3964357094664592e-05
gradient O 0 1.3518470609596989e-07
gel O 0 4.533453079602623e-08
electrophoresis O 0 7.568417892400703e-09
( O 0 3.720509178517517e-10
DGGE O 0 8.465896144116414e-07
) O 0 1.610501142168541e-11
strategy O 0 2.8250785391592537e-11
followed O 0 2.560611878782426e-12
by O 0 1.7311025117712486e-13
direct O 0 1.2087839409979928e-12
sequencing O 0 1.6363622262760558e-11
in O 0 9.513789929471717e-12
seven O 0 2.0701512726262195e-10
unrelated O 0 9.458529071082467e-09
heterozygous O 0 1.4931737268852885e-07
HC B-Disease 1 1.0
patients O 0 3.22758153536995e-09
from O 0 1.235262447885077e-10
France O 0 5.7213526361010736e-08
, O 0 4.118118346330135e-10
Holland O 0 1.4788851032676575e-08
, O 0 1.446693320694692e-10
and O 0 1.4266679504437718e-10
Czech O 0 3.1933402624417795e-06
Republic O 0 4.886335318587953e-06
. O 0 1.0270230177411577e-06

Seven O 0 8.39979890088216e-08
novel O 0 1.578555597347986e-08
mutations O 0 1.6791166235208266e-09
and O 0 1.3526600672886246e-10
two O 0 8.546690438704374e-11
new O 0 9.82981473995892e-10
polymorphisms O 0 1.7451776557209087e-07
were O 0 5.154821280939359e-08
detected O 0 1.1995737168035703e-06
. O 0 2.1525538329569827e-07

Among O 0 2.4233957063302114e-08
these O 0 4.188430158258427e-10
mutations O 0 2.2568107382880953e-09
two O 0 1.9169374421146301e-10
are O 0 7.797331530445817e-11
missense O 0 1.641159563803285e-08
( O 0 3.6809885695099354e-10
G197W O 0 1.427791431751757e-07
, O 0 2.0756796281773404e-09
W427R O 0 3.529922665279628e-08
) O 0 4.115399340753889e-11
, O 0 3.25968696479606e-11
two O 0 2.1863476307171226e-11
are O 0 2.1772507408091002e-11
nonsense O 0 1.0081561363506353e-08
( O 0 7.869271900773356e-11
Q306X O 0 1.327235210624167e-08
, O 0 1.3080259098074976e-10
Q385X O 0 4.262943775756867e-09
) O 0 9.381616143666616e-12
, O 0 1.2081760938920105e-11
two O 0 4.069965718611623e-12
are O 0 1.0003735036526185e-12
small O 0 1.0567003001782371e-11
deletions O 0 2.081598088343739e-10
( O 0 7.704756277426839e-11
662de14bp O 0 1.4109762247471735e-08
; O 0 4.151692045706312e-10
1168del3bp O 0 3.8750326325498463e-07
removing O 0 2.2059971627186314e-07
a O 0 4.005910270166169e-09
glycine O 0 1.4588369623425024e-08
at O 0 3.193060749140386e-08
position O 0 7.381017463892192e-10
390 O 0 1.585479109111887e-10
) O 0 4.389298820239862e-12
, O 0 5.360349317196089e-12
and O 0 5.896024120322085e-12
one O 0 9.92742433397753e-12
is O 0 1.5794839394733806e-11
a O 0 1.4576644058461596e-10
splicing O 0 3.3233353846640057e-09
mutation O 0 3.7400896268913186e-10
( O 0 2.0791804042352702e-11
IVS1 O 0 2.517958819225896e-07
- O 0 3.0681179818969895e-09
15c O 0 8.262789563673323e-09
- O 0 6.004929886671562e-09
- O 0 3.994450548105988e-09
> O 0 5.517985179892548e-09
g O 0 2.8405020557897842e-09
) O 0 1.0839650357863384e-11
which O 0 5.017796941841901e-12
creates O 0 8.561570896681303e-11
a O 0 3.259464920191135e-10
new O 0 1.1363942009623429e-09
acceptor O 0 2.1681774153847755e-09
splice O 0 3.6947125181541196e-07
site O 0 1.8719376271292276e-07
. O 0 4.4782783703567475e-08

The O 0 7.228770471101598e-08
pathological O 0 1.6383905858674552e-06
significance O 0 4.35020126587915e-08
of O 0 2.2312169889460165e-08
the O 0 6.84831613639858e-09
point O 0 9.904176145880683e-09
mutations O 0 3.121470859568376e-10
G197W O 0 1.3133195864156733e-08
, O 0 1.6234615041188505e-10
W427R O 0 6.851909262195477e-09
, O 0 9.777546133848958e-11
and O 0 5.0773739379561533e-11
the O 0 1.0797525096251093e-09
in O 0 1.632093571402038e-09
- O 0 6.726626367026256e-09
frame O 0 1.1968977808862746e-08
deletion O 0 4.454210777993239e-09
390delGly O 0 2.448643598995659e-08
were O 0 4.0811795609663193e-10
assessed O 0 6.555853637735254e-10
by O 0 3.574136819839424e-11
their O 0 4.4398040799364935e-11
respective O 0 5.631173860543015e-10
expression O 0 1.6531788160634164e-09
in O 0 1.765224633132334e-10
a O 0 1.3776378648966414e-10
prokaryotic O 0 1.2693621154191703e-10
system O 0 5.588321472238533e-10
using O 0 3.491162567370587e-11
site O 0 1.0802057026637613e-09
- O 0 6.337690372504312e-10
directed O 0 5.908469824511542e-10
mutagenesis O 0 1.7320854794888874e-07
. O 0 3.608645471331329e-08

These O 0 1.7962209497568438e-09
mutations O 0 2.0652619614480727e-09
resulted O 0 2.9473461449214255e-09
in O 0 2.0781862342111879e-10
the O 0 2.32376429210035e-09
absence O 0 1.544947103582217e-08
or O 0 1.5130940944629856e-10
a O 0 8.655031136228786e-10
dramatic O 0 3.5950844079479793e-08
decrease O 0 6.155888598868842e-08
of O 0 5.49192122889508e-07
CPO O 1 0.9988296627998352
activity O 0 1.7067072803911287e-06
. O 0 1.5303628231322364e-07

The O 0 5.2569617992048734e-08
two O 0 5.790510848591168e-10
polymorphisms O 0 3.9295549925100204e-08
were O 0 8.512822669004549e-10
localized O 0 1.866507304271181e-08
in O 0 4.705434375473772e-10
noncoding O 0 7.156674808328489e-09
part O 0 3.73464342784402e-10
of O 0 1.411333494516498e-09
the O 0 1.3051705272104641e-09
gene O 0 1.8040001437125142e-10
1 O 0 1.3911048979409202e-09
) O 0 9.237430698832982e-13
a O 0 2.625704688397068e-11
C O 0 1.0102023217939404e-08
/ O 0 1.1985516579215982e-08
G O 0 1.477100575186796e-08
polymorphism O 0 2.4451980440431953e-09
in O 0 1.4215884025503556e-10
the O 0 1.3116041586158644e-09
promotor O 0 5.982879542898445e-07
region O 0 2.859882330952246e-09
, O 0 1.346038142058248e-10
142 O 0 7.271604429703871e-10
bp O 0 6.205678748649746e-10
upstream O 0 1.285268558248731e-10
from O 0 2.164109690061533e-11
the O 0 1.9112531002285493e-10
transcriptional O 0 4.325593216947254e-09
initiation O 0 1.4669446768422745e-09
site O 0 5.287001947351655e-10
( O 0 7.023075263706824e-12
- O 0 2.7165783511584607e-10
142C O 0 8.969822218318768e-09
/ O 0 2.595345982570052e-08
G O 0 1.5671705710929018e-08
) O 0 6.6649828017739665e-12
, O 0 2.6062639459784043e-12
and O 0 3.477589527109415e-12
2 O 0 5.014654247403882e-10
) O 0 2.593232920067301e-12
a O 0 5.1124254135670455e-11
6 O 0 1.1520946419096845e-09
bp O 0 1.278910449764581e-10
deletion O 0 4.56384582903091e-11
polymorphism O 0 5.339199221632285e-11
in O 0 2.250811516335549e-11
the O 0 2.762465256544999e-10
3 O 0 3.52001761072529e-09
noncoding O 0 2.8826754316924053e-09
part O 0 1.920476416783501e-10
of O 0 2.0658135202467065e-09
the O 0 6.550470388333451e-09
CPO O 0 1.0187382940785028e-05
gene O 0 2.317916747429649e-09
, O 0 1.4532477998763227e-10
574 O 0 1.2887745315381949e-09
bp O 0 5.829184912542473e-10
downstream O 0 1.2566285512161102e-10
of O 0 2.3094647028099047e-10
the O 0 5.579279260814474e-10
last O 0 6.40572206389578e-10
base O 0 8.503167614470897e-10
of O 0 1.455223386237492e-09
the O 0 2.9670479406718187e-09
normal O 0 3.6856359741932465e-08
termination O 0 1.4369760492627393e-08
codon O 0 7.752317898734873e-09
( O 0 1.3947014376736178e-10
+ O 0 2.683486988175332e-09
574 O 0 1.491468104575233e-08
delATTCTT O 0 1.3124785880336276e-07
) O 0 2.049580949403662e-09
. O 0 2.2001474420108025e-08

Five O 0 1.1008518185917637e-06
intragenic O 0 0.00014728127280250192
dimorphisms O 0 0.00011136302055092528
are O 0 1.358740009393955e-09
now O 0 1.4259796121685042e-10
well O 0 1.8285956082664256e-11
characterized O 0 3.860307351555292e-10
and O 0 7.925346143244916e-12
the O 0 1.3012325938976943e-10
high O 0 4.002043973994063e-10
degree O 0 2.952522448751438e-09
of O 0 1.4746367460460874e-09
allelic O 0 2.1287137030867598e-07
heterogeneity O 0 7.204901919521944e-08
in O 0 1.7739877344880028e-09
HC B-Disease 1 0.9999979734420776
is O 0 1.8866934681227576e-09
demonstrated O 0 5.912551004350064e-10
with O 0 3.956878661531826e-12
seven O 0 4.6728142188978694e-11
new O 0 1.482217994175361e-11
different O 0 1.0574053568510045e-12
mutations O 0 1.6898588431346617e-11
making O 0 7.2010683006829e-12
a O 0 2.267828980162534e-11
total O 0 7.404957202972184e-11
of O 0 2.2570301183577612e-09
nineteen O 0 2.603232132969424e-06
CPO O 1 0.9997232556343079
gene B-Disease 0 3.8437838156824e-06
defects I-Disease 0 1.2775492905348074e-05
reported O 0 2.5117163904297968e-09
so O 0 9.741545070607316e-11
far O 0 4.892877769613335e-10
. O 0 9.575771287018142e-10
. O 0 3.129545689262159e-08

Coincidence O 0 1.0291844887433399e-07
of O 0 5.4110124381168134e-08
two O 0 6.446512768043533e-10
novel O 0 4.415806831303826e-09
arylsulfatase O 0 6.484513619398058e-07
A O 0 3.0856902810683096e-08
alleles O 0 2.966372980583998e-10
and O 0 1.4675706483391338e-10
mutation O 0 2.7476061426057186e-09
459 O 0 1.878414401801365e-08
+ O 0 1.542077399108166e-07
1G O 0 0.1740678995847702
> O 0 3.643986929091625e-06
A O 0 6.331642765644574e-08
within O 0 1.0496725710851251e-09
a O 0 5.781924383718717e-10
family O 0 8.711170673691981e-11
with O 0 1.3186803871079178e-09
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 5.712481043751438e-10
molecular O 0 1.4487401278628909e-09
basis O 0 2.765185302955331e-10
of O 0 8.866314349376125e-10
phenotypic O 0 6.497153890450136e-07
heterogeneity O 0 6.781668275834818e-07
. O 0 9.790996102765348e-08

In O 0 4.86187623494061e-08
a O 0 1.566065144231743e-08
family O 0 2.4729018832658767e-10
with O 0 7.487702124997497e-11
three O 0 1.7025783005664152e-09
siblings O 0 1.1970888724732731e-09
, O 0 6.556475501406922e-11
one O 0 1.49250733300077e-11
developed O 0 6.753091974509573e-10
classical O 0 2.6493710265640402e-06
late O 1 0.990662157535553
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 3.3917938679906e-08
MLD B-Disease 1 1.0
) O 0 2.5565199957000573e-10
, O 0 2.1119560267290893e-10
fatal O 0 3.707698397192871e-07
at O 0 2.0658617927438172e-08
age O 0 2.0243622333993017e-09
5 O 0 6.178872080653264e-09
years O 0 1.1006786454492712e-10
, O 0 4.619695945229374e-11
with O 0 1.8951068492256695e-10
deficient O 0 1.9916253677365603e-06
arylsulfatase O 0 5.539042831514962e-05
A O 0 3.2350151286664186e-06
( O 0 2.1543665462697703e-10
ARSA O 0 8.386558079109818e-07
) O 0 5.373246552559108e-12
activity O 0 2.0643382836471602e-11
and O 0 3.4888240300207096e-12
increased O 0 3.27620652829097e-10
galactosylsulfatide O 0 3.106050883161515e-07
( O 0 8.635578474525119e-09
GS O 1 0.9999966621398926
) O 0 4.102026274210857e-09
excretion O 0 8.102126258791031e-08
. O 0 2.7764924581674677e-08

The O 0 7.217651898372424e-08
two O 0 1.1669164523553377e-09
other O 0 3.141803484041361e-10
siblings O 0 1.0953372431288244e-08
, O 0 4.65437066665686e-09
apparently O 0 3.307256690732174e-08
healthy O 0 5.671793257278068e-09
at O 0 4.7465160690762787e-08
12 O 0 7.070558361021995e-09
( O 0 3.6584065638001206e-11
1 O 0 2.067115367765382e-08
/ O 0 5.5212692195993895e-09
2 O 0 1.2284749884017288e-09
) O 0 1.1547283311832968e-12
and O 0 2.2646376961199532e-12
15 O 0 3.3303120677841136e-11
years O 0 1.1705934832573206e-11
, O 0 5.562750780840897e-12
respectively O 0 3.7712194478345396e-11
, O 0 8.669710782616136e-12
and O 0 1.262607726704168e-11
their O 0 1.2507293811747644e-10
father O 0 8.770593695750506e-10
, O 0 4.38583863671127e-10
apparently O 0 1.123201864849932e-09
healthy O 0 1.0622195484311092e-10
as O 0 2.6101355452001762e-11
well O 0 2.8300131335590173e-11
, O 0 8.529623535258324e-11
presented O 0 1.1353244566691956e-08
ARSA O 0 0.00014610144717153162
and O 0 1.267145322003671e-08
GS O 1 0.9991482496261597
values O 0 3.1245821485725855e-09
within O 0 4.657831897958431e-10
the O 0 3.487051203343583e-10
range O 0 1.0861501031911303e-08
of O 0 2.0266162437110324e-07
MLD B-Disease 1 1.0
patients O 0 2.2520059701491846e-06
. O 0 2.062555211068684e-07

Mutation O 0 7.17588193310803e-08
screening O 0 1.4514486501582269e-08
and O 0 1.7324826295794793e-10
sequence O 0 2.8113031347309914e-10
analysis O 0 1.8161837311847506e-10
disclosed O 0 3.2335689681417534e-10
the O 0 4.400292352713109e-10
involvement O 0 2.3661008707875908e-09
of O 0 5.237432709748191e-09
three O 0 8.127036821292677e-10
different O 0 4.0910541621030916e-10
ARSA O 0 0.00033861640258692205
mutations O 0 1.2324717912903793e-09
being O 0 4.1343151124806354e-10
the O 0 1.8107913779541462e-10
molecular O 0 1.5827877897223175e-09
basis O 0 1.2943320859548635e-09
of O 0 9.016067004097295e-09
intrafamilial O 0 7.871759407862555e-06
phenotypic O 0 1.5335494026658125e-05
heterogeneity O 0 1.10077426143107e-05
. O 0 5.775636395810579e-07

The O 0 3.2192650678553036e-07
late O 0 1.7141885109595023e-05
infantile O 1 0.9990512728691101
patient O 0 2.5804104097915115e-07
inherited O 0 1.9513508675572666e-07
from O 0 8.702024656415119e-10
his O 0 4.5028230033494765e-09
mother O 0 1.1962603130299954e-09
the O 0 3.966904582597408e-09
frequent O 0 1.0470037281606892e-08
0 O 0 1.3063397830137546e-07
- O 0 2.0128974043132075e-08
type O 0 2.2215562722749382e-08
mutation O 0 1.5665818864363246e-08
459 O 0 8.150932373496289e-09
+ O 0 6.077835124074227e-09
1G O 0 5.880435764993308e-06
> O 0 2.6552616105846027e-08
A O 0 2.484884298326051e-09
, O 0 6.539711480679777e-12
and O 0 1.5189566184709014e-12
from O 0 7.670060767073217e-12
his O 0 1.9937405892900273e-10
father O 0 7.573656701787002e-10
a O 0 2.667187026794693e-10
novel O 0 9.75595507157756e-11
, O 0 2.0222492083665777e-11
single O 0 2.420404432434964e-10
basepair O 0 6.315203648910028e-08
microdeletion O 0 6.883953318492786e-08
of O 0 2.1983353803989303e-08
guanine O 0 3.880930776745117e-08
at O 0 1.35726992311902e-07
nucleotide O 0 3.1807029898800465e-08
7 O 0 1.3515943919628626e-07
in O 0 5.281965531622745e-09
exon O 0 3.8126461276988266e-07
1 O 0 9.705541970106424e-08
( O 0 5.09537190218623e-10
7delG O 0 7.701270732241028e-08
) O 0 3.329483577729775e-09
. O 0 3.1919281440195846e-08

The O 0 2.7836705385198e-07
two O 0 2.6816769249649042e-08
clinically O 0 2.2536029064212926e-05
unaffected O 0 1.362159082418657e-06
siblings O 0 4.673104125885175e-09
carried O 0 3.192880682068022e-10
the O 0 1.548456918243346e-09
maternal O 0 1.6641893196833735e-08
mutation O 0 6.0399187873372284e-09
459 O 0 1.572998442611606e-08
+ O 0 1.5327751512472787e-08
1G O 0 1.4914225175743923e-05
> O 0 5.220879017997504e-08
A O 0 2.6670052832855617e-09
and O 0 6.756266986845949e-12
, O 0 2.621429982807566e-12
on O 0 6.954296860595122e-11
their O 0 1.582620146045599e-11
paternal O 0 3.474289606009151e-11
allele O 0 6.536148705604816e-11
, O 0 1.0371220375560153e-11
a O 0 2.869277038186624e-11
novel O 0 5.88849732863217e-11
cytosine O 0 5.565260474682532e-10
to O 0 2.431011988934806e-11
thymidine O 0 1.4475973308947232e-08
transition O 0 6.534287422255147e-08
at O 0 4.048218826824268e-08
nucleotide O 0 4.265320896479352e-08
2435 O 0 6.553946718668158e-07
in O 0 8.526635508765423e-10
exon O 0 3.962180628036549e-08
8 O 0 7.106061516992668e-09
, O 0 8.325347355953028e-11
resulting O 0 1.7215431857842134e-10
in O 0 6.09944109108973e-11
substitution O 0 1.5991772350787414e-09
of O 0 6.093946680607587e-09
alanine O 0 6.019160281311997e-09
464 O 0 4.798746733314374e-09
by O 0 1.6945632674847388e-09
valine O 0 2.8601157282537315e-06
( O 0 1.9640598036829715e-09
A464V O 0 3.7415139786389773e-07
) O 0 4.66236738105863e-09
. O 0 5.453482998518666e-08

The O 0 1.8341543182032183e-06
fathers O 0 3.4337008969487215e-07
genotype O 0 1.1742788075252975e-07
thus O 0 5.692080584651649e-09
was O 0 4.4429025791714594e-08
7delG O 0 9.651321306591853e-07
/ O 0 3.3496246487629833e-06
A464V O 0 3.925876626453828e-06
. O 0 2.7206678510083293e-07

Mutation O 0 3.9489214032073505e-07
A464V O 0 5.980791684123687e-07
was O 0 7.588094064203688e-08
not O 0 5.1009124008016826e-11
found O 0 3.5943793080805975e-11
in O 0 9.178132559517493e-11
18 O 0 2.9740240492515113e-08
unrelated O 0 4.442286353878444e-06
MLD B-Disease 1 1.0
patients O 0 2.4209839466493577e-08
and O 0 9.477449935957338e-10
50 O 0 2.6494639371321682e-08
controls O 0 1.977976125999703e-06
. O 0 2.5347324594804377e-07

A464V O 0 5.041655185777927e-06
, O 0 1.4327641295608373e-08
although O 0 2.8429625320569585e-09
clearly O 0 2.9345454954921024e-09
modifying O 0 3.271120618819623e-08
ARSA O 0 0.00026369374245405197
and O 0 6.067748614668744e-08
GS O 1 1.0
levels O 0 1.6335741293005412e-06
, O 0 1.8417900538025833e-09
apparently O 0 3.981071472480835e-09
bears O 0 1.283280037789325e-09
little O 0 3.61227645018225e-11
significance O 0 4.5186773767191823e-10
for O 0 3.3284704853420166e-11
clinical O 0 1.8476635332831393e-08
manifestation O 0 1.1568921536309063e-06
of O 0 9.252597124032036e-07
MLD B-Disease 1 1.0
, O 0 2.4329919412480194e-08
mimicking O 0 2.0131091105213272e-07
the O 0 4.414882681658128e-08
frequent O 0 4.377819777801051e-07
ARSA O 0 0.09940111637115479
pseudodeficiency O 0 0.00012948889343533665
allele O 0 2.818489974742988e-06
. O 0 3.7316323187042144e-07

Our O 0 5.526287694124221e-08
results O 0 3.0511884130390854e-09
demonstrate O 0 3.8064146279381816e-10
that O 0 2.529539295040295e-12
in O 0 2.697030619669416e-11
certain O 0 2.596373116503514e-10
genetic O 0 1.4563562444891431e-07
conditions O 0 6.985377694945782e-05
MLD B-Disease 1 1.0
- O 0 4.534405434242217e-06
like O 0 2.1783215231607755e-08
ARSA O 1 0.8810924291610718
and O 0 5.2873907918638e-08
GS O 1 0.999998927116394
values O 0 4.019702348756482e-09
need O 0 1.0736608824224447e-10
not O 0 2.126501232047051e-12
be O 0 7.79418684541261e-13
paralleled O 0 1.8799493212151575e-11
by O 0 6.467553922973046e-12
clinical O 0 3.7649584555765614e-05
disease O 0 0.001581528689712286
, O 0 4.14542289384201e-11
a O 0 4.7208136705334525e-11
finding O 0 5.4727829906786596e-11
with O 0 1.2467868751309119e-11
serious O 0 2.444290601033572e-07
diagnostic O 0 1.6385811250074767e-06
and O 0 6.295513887977222e-09
prognostic O 0 0.05274784192442894
implications O 0 2.858122570614796e-06
. O 0 1.3234438256404246e-07

Moreover O 0 3.386254832093982e-07
, O 0 5.056532526026558e-09
further O 0 8.731589673516282e-09
ARSA O 0 7.57806483306922e-05
alleles O 0 6.504492056080835e-09
functionally O 0 1.8047728644887684e-08
similar O 0 2.521949593603523e-10
to O 0 5.650289264247377e-11
A464V O 0 2.7613195285880465e-08
might O 0 4.613021770127901e-11
exist O 0 2.13656887321223e-11
which O 0 2.0075599169167013e-12
, O 0 3.0823371199167893e-12
together O 0 1.6840726946645845e-12
with O 0 1.2139415341005932e-11
0 O 0 2.7705095106966837e-08
- O 0 9.36717814425947e-10
type O 0 5.667140090537259e-10
mutations O 0 2.586374170387984e-10
, O 0 3.6055717439476e-11
may O 0 1.8094034603954867e-10
cause O 0 1.3861394698722052e-08
pathological O 1 0.9997782111167908
ARSA O 1 0.9995624423027039
and O 0 1.1578978664772421e-08
GS O 1 1.0
levels O 0 5.4192547338516306e-08
, O 0 1.3396188672243348e-11
but O 0 1.1114217185470565e-12
not O 0 1.0629296921804698e-12
clinical O 0 1.2159635520703205e-09
outbreak O 0 3.1322793248023117e-09
of O 0 4.6068512893349123e-10
the O 0 4.732763514425642e-09
disease O 0 2.3815291569917463e-06
. O 0 7.584513017633299e-10
. O 0 1.933323190428382e-08

Human O 1 0.9924095869064331
MLH1 O 1 1.0
deficiency O 1 0.9999998807907104
predisposes O 0 9.941586540662684e-06
to O 0 7.153047221208908e-08
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 1.7351138694721158e-06
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.7331607937812805
1 I-Disease 1 0.999569833278656
. O 0 4.641766508939327e-07

Heterozygous O 0 5.349997991288546e-07
germ O 0 1.6736690668039955e-05
- O 0 1.173624966099851e-07
line O 0 1.889734235760443e-08
mutations O 0 4.788704988101244e-10
in O 0 1.1737957827939738e-10
the O 0 3.236520385030417e-09
DNA O 0 1.4343997634114203e-07
mismatch O 0 0.00016196809883695096
repair O 0 1.8844954183805385e-06
genes O 0 3.6495522159896154e-09
lead O 0 3.1274932865699157e-08
to O 0 6.873257962780599e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.5818407923216e-05

The O 0 2.9252757940412266e-06
disease O 0 0.17128536105155945
susceptibility O 0 1.9788164706824318e-07
of O 0 1.9394912342818316e-08
individuals O 0 4.116074495130739e-11
who O 0 2.4995774339231502e-09
constitutionally O 0 3.613035369198769e-05
lack O 0 9.026149996316235e-07
both O 0 1.042521513561212e-09
wild O 0 4.2437801539563225e-07
- O 0 4.292766142555138e-09
type O 0 3.266393377998611e-09
alleles O 0 8.650146710031947e-10
is O 0 1.3259003617260845e-10
unknown O 0 2.7022300841395008e-08
. O 0 1.0562787089440917e-08

We O 0 5.059021201958558e-09
have O 0 1.2720427489121278e-10
identified O 0 2.791352149422721e-10
three O 0 4.131498962389735e-11
offspring O 0 1.2949907812753736e-10
in O 0 6.442379962834366e-11
a O 0 2.2259715848349515e-08
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 2.2549384937065042e-07
who O 0 3.441520624036798e-09
developed O 0 1.8837137076843646e-06
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
at O 0 3.8138623494887725e-05
a O 0 1.695546036906137e-09
very O 0 1.3277572617764744e-11
early O 0 1.8672292600996343e-09
age O 0 6.025796528419392e-10
, O 0 2.2621049131088533e-11
and O 0 1.3154258932113194e-11
at O 0 2.47726039681595e-09
least O 0 6.650087598647492e-12
two O 0 1.5283608796948234e-12
of O 0 1.18655418823721e-10
them O 0 5.123512291510535e-12
displayed O 0 3.5176617174670355e-09
signs O 0 9.578555903999586e-08
of O 0 5.081062326439678e-08
neurofibromatosis B-Disease 1 0.9987732768058777
type I-Disease 0 4.808828180102864e-07
1 I-Disease 0 1.355230142507935e-05
( O 0 4.062557845685433e-09
NF1 B-Disease 0 1.085192707250826e-05
) O 0 3.6154850224789925e-09
. O 0 3.130984893573441e-08

DNA O 0 4.4231175166942194e-08
sequence O 0 9.490691565972043e-10
analysis O 0 1.3023425393665633e-10
and O 0 2.218829980860093e-11
allele O 0 1.61966037803829e-10
- O 0 1.1260413435021377e-10
specific O 0 3.153936140032343e-11
amplification O 0 1.0117676696452804e-09
in O 0 1.4954373850351033e-10
two O 0 8.610766266681225e-11
siblings O 0 6.015541953452441e-10
revealed O 0 4.108886120235411e-09
a O 0 2.7327939911003796e-09
homozygous O 0 7.79707534093177e-08
MLH1 O 0 7.880030170781538e-05
mutation O 0 4.20432000325377e-09
( O 0 6.030761307007637e-11
C676T O 0 5.89113504645411e-08
- O 0 4.219626248413988e-07
- O 0 4.753347582209244e-07
> O 0 8.504309221279982e-07
Arg226Stop O 0 8.741450074012391e-06
) O 0 3.352928823474599e-09
. O 0 1.9530332906469994e-08

Thus O 0 8.019947017601226e-08
, O 0 1.9426966701985293e-09
a O 0 2.608197213760377e-09
homozygous O 0 9.562491953829522e-08
germ O 0 0.00013193601625971496
- O 0 1.0483624919288559e-06
line O 0 2.3465882748041622e-07
MLH1 O 0 8.074565266724676e-05
mutation O 0 5.625561794175837e-09
and O 0 2.97315339015114e-10
consequent O 0 8.750516826694366e-06
mismatch O 1 0.9999997615814209
repair O 1 0.9999998807907104
deficiency O 1 1.0
results O 0 4.8752717702882364e-06
in O 0 1.494024814974182e-08
a O 0 4.586769364323118e-08
mutator O 0 0.04306904971599579
phenotype O 0 3.896305855732862e-08
characterized O 0 2.4666049203148077e-09
by O 0 1.7123705231547603e-10
leukemia B-Disease 1 0.9999114274978638
and O 0 5.426960925092317e-08
/ O 1 0.9999984502792358
or O 0 0.020227806642651558
lymphoma B-Disease 1 1.0
associated O 1 0.996044397354126
with O 0 3.2666352467458637e-07
neurofibromatosis B-Disease 1 1.0
type I-Disease 0 0.00014749349793419242
1 I-Disease 0 0.001530334004200995
. O 0 2.5090398647620304e-09
. O 0 6.013606501653612e-09

Missense O 0 8.252857696788851e-06
mutations O 0 1.6107431832779184e-08
in O 0 1.120672554755231e-09
the O 0 5.2948965212351595e-09
most O 0 2.0307693027188378e-10
ancient O 0 2.0811385947894223e-09
residues O 0 1.6630277599460896e-08
of O 0 1.1243256103909971e-08
the O 0 6.932270224524473e-08
PAX6 O 0 0.14282387495040894
paired O 0 2.7702663274453698e-08
domain O 0 9.978010417910355e-09
underlie O 0 2.2761440732210758e-08
a O 0 7.740199037264972e-10
spectrum O 0 5.726134233441371e-08
of O 0 2.7756885856433655e-07
human O 1 0.999964714050293
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 9.849711932474747e-05

Mutations O 0 2.2013981748614242e-08
of O 0 2.522914321900771e-08
the O 0 1.682669648062074e-08
human O 0 1.0613440792894835e-07
PAX6 O 0 0.04043623059988022
gene O 0 4.04388083552476e-06
underlie O 0 0.05284842848777771
aniridia B-Disease 1 1.0
( O 1 0.8179814219474792
congenital B-Disease 1 1.0
absence I-Disease 1 0.9987857937812805
of I-Disease 0 0.019163720309734344
the I-Disease 0 1.2404019571476965e-06
iris I-Disease 0 2.5211334104824346e-06
) O 0 2.542553945161785e-10
, O 0 2.4991708702515325e-10
a O 0 3.840443518754455e-09
rare O 0 0.0001296449190704152
dominant O 1 0.9999966621398926
malformation B-Disease 1 1.0
of I-Disease 1 0.9999444484710693
the I-Disease 1 0.9990164041519165
eye I-Disease 1 0.9999862909317017
. O 0 2.055969616776565e-06

The O 0 7.285855474492564e-08
spectrum O 0 2.1623145585181192e-07
of O 0 1.414196617588459e-07
PAX6 O 0 0.4254445433616638
mutations O 0 9.947989809688806e-08
in O 0 4.2398276889343833e-08
aniridia B-Disease 1 1.0
patients O 0 1.215939136045563e-07
is O 0 2.3904087043113975e-10
highly O 0 4.5591502795261363e-10
biased O 0 6.596665574898353e-11
, O 0 1.6862935743947038e-12
with O 0 5.936667715582267e-13
92 O 0 8.726707689810098e-10
% O 0 7.55048454315066e-12
of O 0 7.867306112130379e-11
all O 0 4.213861204416247e-11
reported O 0 2.956657141339747e-10
mutations O 0 1.4361059563761103e-10
leading O 0 4.694670430183123e-09
to O 0 9.653244176233144e-11
premature O 0 8.755622005196528e-09
truncation O 0 2.7729711860047246e-07
of O 0 8.797508854740954e-08
the O 0 1.2588150966053036e-08
protein O 0 1.9024088970809316e-09
( O 0 5.035257974461693e-11
nonsense O 0 2.4941007037426743e-09
, O 0 4.0197904033201226e-11
splicing O 0 7.627730669312882e-10
, O 0 1.3877219685876074e-11
insertions O 0 2.5336064843339834e-11
and O 0 4.991527156883446e-12
deletions O 0 5.103209174683876e-11
) O 0 3.1682963544388265e-12
and O 0 2.352656437720757e-11
just O 0 1.1650877485003264e-10
2 O 0 2.500416540485162e-09
% O 0 3.358680000786762e-11
leading O 0 1.6882552300589992e-10
to O 0 8.662272288351147e-12
substitution O 0 1.1777971931081765e-09
of O 0 7.103947208264572e-09
one O 0 7.419310166234538e-10
amino O 0 1.532198479203828e-09
acid O 0 1.4337057929747488e-10
by O 0 5.553509041522631e-11
another O 0 7.75051078871769e-10
( O 0 1.4730168473864325e-10
missense O 0 1.1645450825881198e-07
) O 0 1.3293752765264344e-09
. O 0 3.8848039451977456e-08

The O 0 5.354596765982933e-08
extraordinary O 0 1.1822046452891755e-08
conservation O 0 1.6496519705810897e-08
of O 0 3.1330442684662785e-09
the O 0 2.5106926315743294e-08
PAX6 O 0 2.4030634449445643e-05
protein O 0 2.3022979078746175e-08
at O 0 1.339263775435029e-07
the O 0 3.395386372062603e-08
amino O 0 1.6160646509888466e-07
acid O 0 3.5315323998474923e-08
level O 0 1.5421641137436382e-06
amongst O 0 5.734415609026655e-09
vertebrates O 0 1.1852639758558325e-08
predicts O 0 2.7417950132502256e-09
that O 0 3.0614743379286935e-11
pathological O 0 0.00022247275046538562
missense O 0 2.316473342034442e-07
mutations O 0 4.2085782081535683e-10
should O 0 1.7120497727840522e-11
in O 0 1.2842141412783281e-11
fact O 0 3.61006537163977e-11
be O 0 3.3146214939439034e-11
common O 0 1.7711501709705146e-10
even O 0 1.4182185807676273e-11
though O 0 1.852745908081932e-11
they O 0 7.579444016858616e-12
are O 0 5.304066647698891e-12
hardly O 0 3.073194476677088e-10
ever O 0 4.447137380569899e-10
seen O 0 9.87549930719922e-10
in O 0 1.926460990731016e-09
aniridia B-Disease 1 1.0
patients O 0 1.7091686288495112e-07
. O 0 7.326533335572094e-08

This O 0 1.0025124064227953e-09
indicates O 0 2.690465628063521e-10
that O 0 4.542228572435025e-12
there O 0 3.71028832657494e-11
is O 0 2.7243497388584892e-11
a O 0 2.232074525210237e-10
heavy O 0 7.706810123409014e-08
ascertainment O 0 3.7560678265435854e-06
bias O 0 2.1994077670228762e-09
in O 0 3.487861041651108e-11
the O 0 1.9987665689225054e-10
selection O 0 5.155592064376435e-10
of O 0 2.5369311096312686e-09
patients O 0 1.598688542658877e-10
for O 0 2.4773394446953034e-10
PAX6 O 0 2.2924643417354673e-05
mutation O 0 7.719057060207035e-10
analysis O 0 4.931175259792475e-11
and O 0 1.1356128711004221e-11
that O 0 8.493805485343398e-12
the O 0 5.632766253427235e-09
missing O 0 6.921673900706082e-08
PAX6 O 0 0.0023788295220583677
missense O 0 9.928718327500974e-07
mutations O 0 6.25793417086129e-09
frequently O 0 2.842673874070556e-10
may O 0 4.756362526059377e-10
underlie O 0 4.6038866940989465e-08
phenotypes O 0 1.1985425985017173e-08
distinct O 0 1.880309685731163e-09
from O 0 4.746785631226658e-09
textbook O 0 0.00023037006030790508
aniridia B-Disease 1 1.0
. O 0 6.21014078205917e-06

Here O 0 1.8422657888095273e-07
we O 0 8.702539799898545e-10
present O 0 6.271289598736018e-10
four O 0 2.997380954550266e-10
novel O 0 4.124550478934452e-09
PAX6 O 0 9.26101620279951e-06
missense O 0 5.967675065221556e-08
mutations O 0 4.5197290354792585e-10
, O 0 6.22801601957157e-11
two O 0 3.0287692492914076e-11
in O 0 6.366440707950005e-10
association O 0 1.7043305433617206e-08
with O 0 1.0837676311936661e-09
atypical O 0 8.398352292715572e-06
phenotypes O 0 6.63897878894204e-07
ectopia B-Disease 0 3.229654612368904e-05
pupillae I-Disease 0 7.271178219525609e-06
( O 0 2.733261672549503e-10
displaced B-Disease 0 6.115508099924227e-10
pupils I-Disease 0 6.013534670223919e-10
) O 0 5.89335413803127e-10
and O 0 5.541570544664864e-07
congenital B-Disease 1 1.0
nystagmus I-Disease 1 1.0
( O 0 1.704954755155086e-08
searching B-Disease 0 2.1131025818021953e-08
gaze I-Disease 0 1.4280741034156108e-08
) O 0 1.381940048506003e-11
, O 0 1.2237847020479808e-11
and O 0 8.957669675457858e-12
two O 0 1.4229169058299629e-11
in O 0 4.526181929254136e-10
association O 0 5.3992983417572304e-09
with O 0 2.6325810975613706e-10
more O 0 8.355433567253101e-10
recognizable O 0 1.187113593914546e-05
aniridia B-Disease 1 1.0
phenotypes O 0 2.3996767595235724e-06
. O 0 7.701902404733119e-08

Strikingly O 0 1.1089971394540044e-06
, O 0 8.880180146775274e-09
all O 0 1.4011305449201927e-09
four O 0 1.965889007138344e-09
mutations O 0 6.074957759061306e-10
are O 0 4.29046971561764e-11
located O 0 2.0906751885263475e-09
within O 0 2.9112476873649484e-09
the O 0 3.216011990048173e-08
PAX6 O 0 0.00644478015601635
paired O 0 2.4759581052080648e-08
domain O 0 7.763386378201176e-09
and O 0 3.891185151871923e-10
affect O 0 2.5254118796169678e-09
amino O 0 5.365921929012529e-09
acids O 0 1.0440592140836813e-10
which O 0 1.0987316091670696e-11
are O 0 2.946639026529807e-12
highly O 0 5.0603288920259004e-11
conserved O 0 2.6344246228937607e-10
in O 0 5.045718010077138e-11
all O 0 9.693206654004527e-11
known O 0 1.6270087499492547e-09
paired O 0 5.43836620181537e-09
domain O 0 1.4104784895607736e-08
proteins O 0 6.091855020429193e-09
. O 0 2.582334879264181e-08

Our O 0 3.9521648176332747e-08
results O 0 4.0022292147057215e-09
support O 0 5.236900912919396e-10
the O 0 7.140050772846962e-10
hypothesis O 0 3.495508327233665e-10
that O 0 1.0619935920247459e-12
the O 0 1.9677775034421252e-11
under O 0 1.3675402477097975e-10
- O 0 1.0599446320647132e-10
representation O 0 7.902964394013168e-11
of O 0 8.166287090993762e-10
missense O 0 6.809685970665669e-08
mutations O 0 1.4770097367389212e-09
is O 0 5.454556251116571e-11
caused O 0 5.979063355532332e-10
by O 0 1.2259160353522702e-10
ascertainment O 0 8.786420949036255e-05
bias O 0 4.3962952389620114e-08
and O 0 2.0690381352661547e-10
suggest O 0 1.0772546743531564e-10
that O 0 5.957451545968162e-12
a O 0 2.1309901065968972e-10
substantial O 0 5.845866457576676e-09
burden O 0 4.688104837669016e-08
of O 0 2.867863076971844e-05
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9998418092727661
related I-Disease 0 6.368414324242622e-05
disease I-Disease 1 0.9999332427978516
remains O 0 5.1905953313280406e-08
to O 0 3.123518110825785e-11
be O 0 1.8422774417103938e-10
uncovered O 0 6.41142392510119e-08
. O 0 3.1790092780425994e-09
. O 0 4.656788377133125e-08

The O 0 3.168529758568184e-07
chromosomal O 0 4.164205620327266e-06
order O 0 1.4578245277618862e-08
of O 0 3.959302219413985e-08
genes O 0 2.068246240938265e-09
controlling O 0 1.185114761881323e-08
the O 0 2.144934363457196e-08
major O 0 4.329876901465468e-06
histocompatibility O 1 0.6342310905456543
complex O 0 2.8252040920051513e-06
, O 0 7.591169914888951e-10
properdin O 0 1.6977239170046232e-07
factor O 0 1.7779687055963223e-08
B O 0 1.0346360568291857e-06
, O 0 1.5364469418965854e-10
and O 0 2.1251776727293503e-10
deficiency B-Disease 0 2.7056034923589323e-07
of I-Disease 0 4.891305707133142e-07
the I-Disease 0 9.883195417614843e-08
second I-Disease 0 5.3419981327351707e-08
component I-Disease 0 6.154691334359086e-08
of I-Disease 0 3.887316779582761e-08
complement I-Disease 0 1.8535516232986993e-07
. O 0 2.0248950249879272e-07

The O 0 5.3068298200287245e-08
relationship O 0 6.403889640793636e-10
of O 0 7.307019878055598e-09
the O 0 3.3389206954836936e-09
genes O 0 1.0632228431006752e-10
coding O 0 2.606645566061161e-09
for O 0 1.5965187505351253e-10
HLA O 0 3.785853408544426e-09
to O 0 8.53730194178004e-12
those O 0 1.1542885570980932e-11
coding O 0 3.2504892111262507e-09
for O 0 1.61963872868931e-10
properdin O 0 1.5468819469788286e-07
Factor O 0 4.00860056259944e-09
B O 0 6.573063160431047e-08
allotypes O 0 9.03788155426355e-09
and O 0 2.9277164026453306e-11
for O 0 2.627173756319934e-10
deficiency B-Disease 0 4.4315111580317534e-08
of I-Disease 0 2.0592763050331087e-08
the I-Disease 0 9.115040278118158e-09
second I-Disease 0 5.836708449891148e-09
component I-Disease 0 8.696421360809836e-09
of I-Disease 0 2.8924750594683246e-08
complement I-Disease 0 5.0535462037260004e-08
( O 0 4.782044094042703e-09
C2 O 0 1.8893743458647805e-07
) O 0 1.4182483312752403e-11
was O 0 6.476930103360701e-10
studied O 0 9.962582980804768e-10
in O 0 5.808327777079292e-11
families O 0 5.262770254310656e-12
of O 0 2.0368295938766323e-09
patients O 0 8.667838891085466e-09
with O 0 7.306145022312194e-08
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.8631293177604675

Patients O 0 3.12649710565438e-08
were O 0 8.691226627277615e-10
selected O 0 1.9481129209797388e-10
because O 0 2.083578969080957e-11
they O 0 7.662252776707845e-12
were O 0 2.6212013462534323e-11
heterozygous O 0 1.5008666531812764e-10
or O 0 6.241965971875985e-11
homozygous O 0 3.39576899932581e-07
for O 0 1.2551152394735254e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 3.98689780922723e-06

12 O 0 3.7962030319249607e-07
families O 0 2.2254939557875275e-10
with O 0 1.8685143710062135e-10
15 O 0 4.129669406438552e-08
matings O 0 3.494849352136953e-07
informative O 0 2.0161505176474748e-07
for O 0 8.980002348835114e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 3.384795377314731e-07
found O 0 4.0759168484783004e-08
. O 0 3.246785595933943e-08

Of O 0 2.5773952074814588e-06
57 O 0 5.205189381740638e-07
informative O 0 2.389800357605054e-08
meioses O 0 3.813657087903266e-07
, O 0 4.4490461315049856e-10
two O 0 3.414741753249295e-11
crossovers O 0 2.473703741845412e-10
were O 0 1.2416638550671877e-10
noted O 0 2.704676760334479e-10
between O 0 2.8852167321957722e-09
the O 0 0.04119166359305382
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 5.0413073715560586e-09
and O 0 4.9007204544482263e-11
the O 0 7.151826353357649e-10
HLA O 0 1.4175074625200068e-07
- O 0 3.695399186653958e-08
B O 0 1.6717649486963637e-07
gene O 0 2.41784342547291e-10
, O 0 3.931563841846897e-12
with O 0 8.998850926575375e-13
a O 0 4.734375391723944e-11
recombinant O 0 3.291351080569882e-10
fraction O 0 2.6336657854564294e-10
of O 0 1.3560015332814146e-08
0 O 0 1.2488447964642546e-06
. O 0 5.31630242051051e-08

035 O 0 0.01387475524097681
. O 0 3.703749462147243e-05

A O 0 8.344888442479714e-07
lod O 0 2.7794178549811477e-06
score O 0 1.6188188567412e-08
of O 0 5.589197993316475e-09
13 O 0 5.0011599306287735e-09
was O 0 1.1133010069386273e-09
calculated O 0 1.0535894379160027e-10
for O 0 7.714299338212882e-11
linkage O 0 9.508962079962657e-07
between O 0 0.000579990039113909
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.4079868826399888e-08
HLA O 0 3.5655232295539463e-06
- O 0 4.9190457929171316e-08
B O 0 2.8726827849823167e-07
at O 0 1.6387656787131277e-09
a O 0 2.3004686697247756e-11
maximum O 0 6.645437672370136e-11
likelihood O 0 2.4271803317210683e-11
value O 0 9.512048267101836e-12
of O 0 3.471309004132728e-11
the O 0 6.068655300506265e-11
recombinant O 0 2.7244756450883756e-10
fraction O 0 8.672940837728405e-11
of O 0 1.8461618900289523e-09
0 O 0 3.4961959727297653e-07
. O 0 3.1572451320016626e-08

04 O 0 0.0054779499769210815
. O 0 2.9410151910269633e-05

18 O 0 5.922251489209884e-07
families O 0 3.85315723772095e-10
with O 0 2.276845101345515e-10
21 O 0 4.5710578433499904e-08
informative O 0 6.21800111400006e-10
matings O 0 1.2312664221525438e-09
for O 0 9.903882575157397e-11
both O 0 2.361627005065259e-10
properdin O 0 1.9193326750155393e-07
Factor O 0 2.113376496026831e-08
B O 0 3.554488898771524e-07
allotype O 0 5.879931563868013e-08
and O 0 4.849747825552697e-10
HLA O 0 1.1989607173745753e-06
- O 0 2.550206659179821e-07
B O 0 2.2950346192374127e-06
were O 0 4.610343662392324e-09
found O 0 2.5218642729640806e-09
. O 0 1.272891125836395e-08

Of O 0 2.374079940636875e-06
72 O 0 3.692173095259932e-06
informative O 0 1.0773116798645788e-07
meioses O 0 1.512148514848377e-06
, O 0 2.1731205723796165e-09
three O 0 3.5661509856232954e-10
recombinants O 0 3.558419905402843e-07
were O 0 4.145751297812694e-09
found O 0 2.7752933284830306e-10
, O 0 6.574420174931817e-11
giving O 0 1.0928214583261209e-10
a O 0 3.2635019686644284e-10
recombinant O 0 2.2501143170927662e-09
fraction O 0 6.364898053057289e-10
of O 0 2.8039641719601605e-08
0 O 0 2.047343059530249e-06
. O 0 8.344818525074515e-08

042 O 0 0.0051107509061694145
. O 0 3.796849705395289e-05

A O 0 1.2225499403939466e-06
lod O 0 4.748558239953127e-06
score O 0 1.9017315722180683e-08
of O 0 1.1464222460233486e-08
16 O 0 9.226742925250164e-09
between O 0 3.1186460081045198e-09
HLA O 0 2.016149664996192e-06
- O 0 5.939729774695479e-08
B O 0 1.4116834279320756e-07
and O 0 1.0787042092896826e-10
Factor O 0 1.9284975838473883e-09
B O 0 6.215777403895117e-08
allotypes O 0 1.9810666884723105e-08
was O 0 9.501559539160098e-10
calculated O 0 5.7658097046831e-11
at O 0 2.513162178363615e-10
a O 0 2.0315740409393435e-11
maximum O 0 6.383752554350863e-11
likelihood O 0 7.337206536783825e-11
value O 0 2.0026960992347576e-11
of O 0 1.267409788230367e-10
the O 0 1.085604314776667e-10
recombinant O 0 4.691445565363495e-10
fraction O 0 1.625348328149201e-10
of O 0 2.8785984707013768e-09
0 O 0 7.269565571732528e-07
. O 0 5.0299284737320704e-08

04 O 0 0.004083041101694107
. O 0 1.8533217371441424e-05

A O 0 1.1983007652816013e-07
crossover O 0 2.0656884203162917e-08
was O 0 5.659246848921384e-09
shown O 0 8.606464152460802e-11
to O 0 6.50976928612268e-12
have O 0 2.730856773353052e-12
occurred O 0 8.097247178318057e-11
between O 0 5.27183201606829e-12
genes O 0 2.778807565995134e-12
for O 0 8.043951789382664e-12
Factor O 0 2.7255570023143605e-10
B O 0 1.0199135758170996e-08
and O 0 5.85878706660381e-11
HLA O 0 4.706381773189605e-08
- O 0 2.616958916235035e-08
D O 0 6.253044659842999e-08
, O 0 2.675822584341514e-11
in O 0 3.1355459895188176e-11
which O 0 5.132728270185183e-11
HLA O 0 2.7367551069801266e-07
- O 0 1.6380579381802818e-07
D O 0 9.438211350243364e-07
segregared O 0 1.9804438977644168e-07
with O 0 6.719621525874686e-10
HLA O 0 3.53009545506211e-06
- O 0 4.0383781652053585e-08
A O 0 4.2953072210139e-08
and O 0 1.452383990852013e-09
B O 0 4.472363798413426e-06
. O 0 5.088025645250127e-08

These O 0 8.03206334776263e-10
studies O 0 6.64019561558149e-10
suggest O 0 5.964742588737693e-11
that O 0 3.0268385454307323e-12
the O 0 6.484429659892044e-11
genes O 0 1.1556103296506137e-11
for O 0 1.524472041658509e-11
Factor O 0 2.3226933265618754e-08
B O 1 0.9999618530273438
and O 0 0.008581306785345078
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 3.750395827228914e-11
located O 0 1.5296135191800175e-10
outside O 0 2.3187590736384323e-11
those O 0 5.660055757417126e-13
for O 0 2.8568479179535977e-11
HLA O 0 1.6633133981258652e-08
, O 0 1.9128022082925966e-11
that O 0 1.47614852199357e-12
the O 0 2.012940335249791e-11
order O 0 5.0694677622420414e-11
of O 0 2.7844604399973605e-10
genese O 0 4.804335773656021e-08
is O 0 7.995908102298444e-11
HLA O 0 2.5379909285305757e-09
- O 0 6.516632788944321e-10
A O 0 6.264023966195964e-09
, O 0 3.9647299332479236e-11
- O 0 5.135257774568913e-10
B O 0 3.694081485150491e-08
, O 0 3.110701418673756e-10
- O 0 6.396397633778861e-09
D O 0 3.529222425413536e-08
, O 0 1.1113698850095943e-10
Factor O 0 5.878829423267007e-09
B O 0 9.836020581133198e-06
allotype O 0 0.001989860087633133
, O 0 9.171701094601303e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
, O 0 4.8880337277790176e-11
that O 0 6.39265279166884e-13
the O 0 2.7794131579605974e-11
genes O 0 1.2024660434040157e-10
coding O 0 7.807237807355705e-07
for O 0 9.951622814696748e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 3.1464106875489506e-09
Factor O 0 8.857005795448458e-09
B O 0 1.8865978290705243e-07
allotypes O 0 9.530477740327115e-09
are O 0 5.039038305544585e-13
approximately O 0 5.901140036693175e-13
3 O 0 5.318718035440817e-11
- O 0 4.261679550920938e-11
- O 0 6.633293220259517e-11
5 O 0 3.286445560135576e-10
centimorgans O 0 3.03602520901336e-09
from O 0 2.549759535452889e-11
the O 0 2.9416499791601325e-10
HLA O 0 8.740505208493232e-09
- O 0 1.2868733856308268e-09
A O 0 3.0955511487462672e-09
and O 0 4.5323824554577286e-11
HLA O 0 3.7395796681494176e-08
- O 0 8.223012493147053e-09
B O 0 2.3323666553665134e-08
loci O 0 7.6431347362238e-11
, O 0 4.5666738619776215e-12
and O 0 4.3046130353795176e-13
that O 0 2.342315794448546e-13
the O 0 2.4119052241533545e-11
apparent O 0 1.3457948089268257e-09
lack O 0 3.019364758216625e-09
of O 0 9.305758386091156e-10
recombinants O 0 1.0753260504259288e-08
between O 0 3.7185921009097456e-11
the O 0 5.854656759396448e-10
Factor O 0 1.3920584684967707e-08
B O 0 0.0005263910279609263
gene O 0 1.4663219189969823e-05
and O 0 0.00052220857469365
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 5.845780037816439e-07
suggests O 0 3.1003652423144956e-10
that O 0 1.6976144882191457e-12
these O 0 2.2132918327949502e-12
two O 0 1.3307235521842209e-11
genes O 0 1.0624808671755304e-10
lie O 0 3.587162511475839e-10
in O 0 4.2129612298769104e-11
close O 0 8.274771423621985e-10
proximity O 0 8.922335759109501e-09
to O 0 1.5440440592762172e-10
one O 0 1.5784675788665936e-09
another O 0 1.6254153578643127e-08
. O 0 1.2112656122553744e-07

Distribution O 0 6.157684850904843e-08
of O 0 1.2321120834712929e-07
emerin O 0 1.2129306924180128e-05
and O 0 1.4976654583165327e-08
lamins O 0 8.690174581715837e-06
in O 0 2.4119306551995123e-09
the O 0 1.2514059122281651e-08
heart O 0 5.973169663775479e-06
and O 0 8.802888973313827e-10
implications O 0 4.649927376476626e-08
for O 0 1.3707929014117326e-08
Emery B-Disease 1 0.9999755620956421
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.01678065024316311

Emerin O 0 0.00033690978307276964
is O 0 9.498813824393437e-08
a O 0 1.997465304270918e-08
nuclear O 0 3.10931397962122e-07
membrane O 0 2.137793941869859e-09
protein O 0 4.541713671812886e-10
which O 0 1.3682544680593267e-11
is O 0 4.327527919345542e-11
missing O 0 3.0924335314708173e-10
or O 0 2.5213534038392993e-10
defective O 0 1.7769457372196484e-07
in O 0 2.598535964182247e-08
Emery B-Disease 1 0.9999996423721313
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.023466335609555244
EDMD B-Disease 1 1.0
) O 0 7.079481179061986e-08
. O 0 4.7743547781919915e-08

It O 0 6.484300651976582e-09
is O 0 6.077078840149852e-10
one O 0 2.988110869850402e-10
member O 0 3.3066933635694795e-09
of O 0 2.315633906846415e-07
a O 0 1.7146477659935044e-07
family O 0 1.6153358650683458e-09
of O 0 2.0640783304770594e-07
lamina O 1 0.9998894929885864
- O 0 1.942282779054949e-06
associated O 0 2.4542169185792773e-08
proteins O 0 2.7933386159695317e-10
which O 0 4.4420737921324616e-11
includes O 0 2.4799445830225864e-10
LAP1 O 0 3.369022306287661e-05
, O 0 3.798453107606292e-09
LAP2 O 0 4.0483697375748307e-05
and O 0 9.256338806551412e-09
lamin O 0 1.322317712038057e-05
B O 0 1.4525364804285346e-06
receptor O 0 1.5184788537681015e-08
( O 0 1.4845309426192443e-09
LBR O 0 3.0074286314629717e-06
) O 0 5.851220841179838e-09
. O 0 7.00663136399271e-08

A O 0 1.1024572813767008e-05
panel O 0 2.7516463774190925e-07
of O 0 4.8202423386101145e-08
16 O 0 5.925460655475945e-08
monoclonal O 0 3.3419917944144117e-09
antibodies O 0 2.9729718686866136e-10
( O 0 9.785419002872331e-11
mAbs O 0 4.690015931174685e-09
) O 0 2.2946314987004612e-11
has O 0 1.5684630677581524e-11
been O 0 1.871552218757344e-11
mapped O 0 4.350277776898892e-11
to O 0 1.1599872104528508e-11
six O 0 6.471296415400118e-11
specific O 0 2.8512520469647917e-11
sites O 0 1.0901442942801154e-10
throughout O 0 1.8476968566272234e-10
the O 0 1.415161210438498e-09
emerin O 0 1.0082411705525374e-07
molecule O 0 5.993632812284488e-10
using O 0 2.526167053318318e-10
phage O 0 3.505632006906012e-09
- O 0 5.126312707659508e-10
displayed O 0 5.017954940456093e-10
peptide O 0 5.928473267857726e-10
libraries O 0 2.124367071143496e-10
and O 0 1.212134559391842e-11
has O 0 1.5888325377577672e-11
been O 0 9.89024834252561e-12
used O 0 8.4806450056929e-12
to O 0 1.4246223124791957e-11
localize O 0 2.1823137075216437e-08
emerin O 0 2.3020660933070758e-07
in O 0 1.1395587806717344e-09
human O 0 4.650944962492076e-09
and O 0 2.2253932030480428e-09
rabbit O 0 4.268847078492399e-06
heart O 0 0.0004024574300274253
. O 0 8.392526638090203e-07

Several O 0 8.974806320338757e-08
mAbs O 0 6.191604029481823e-07
against O 0 2.2491542850389123e-08
different O 0 3.75861147761114e-10
emerin O 0 5.715990596399934e-07
epitopes O 0 2.941766013009328e-07
did O 0 4.63270422024209e-10
not O 0 2.1751793075064363e-11
recognize O 0 3.8222891518557844e-10
intercalated O 0 9.346301510504418e-09
discs O 0 1.0140768225141983e-08
in O 0 1.5850588896970663e-10
the O 0 1.2587713094092123e-09
heart O 0 5.347941964828351e-07
, O 0 9.078507390292145e-11
though O 0 2.154669498377615e-11
they O 0 1.6012266165765787e-11
recognized O 0 6.436978727819564e-10
cardiomyocyte O 0 5.805999592212174e-08
nuclei O 0 1.8434418436186206e-09
strongly O 0 1.4235201906132033e-10
, O 0 3.924358407680906e-11
both O 0 6.930819806960642e-11
at O 0 1.0113595294569677e-07
the O 0 4.982472745496125e-08
rim O 0 9.799030209478587e-08
and O 0 1.0342660061724018e-10
in O 0 5.544430470294515e-10
intranuclear O 0 3.074364656185935e-07
spots O 0 2.1294807694971496e-08
or O 0 5.953549875314934e-10
channels O 0 2.7332333729646052e-08
. O 0 7.834433546349828e-08

A O 0 1.8442275177221745e-05
polyclonal O 0 1.007347964332439e-05
rabbit O 0 1.3076451068627648e-06
antiserum O 0 1.306027456848824e-06
against O 0 1.2066607268934604e-07
emerin O 0 1.37418385293131e-06
did O 0 1.1550363998580337e-09
recognize O 0 8.955099994878424e-10
both O 0 1.2144957262094636e-10
nuclear O 0 1.7495260351552133e-08
membrane O 0 1.4650061719301277e-10
and O 0 1.6337613553685237e-11
intercalated O 0 2.211063110379996e-09
discs O 0 4.789300955820863e-09
but O 0 1.659255198516174e-11
, O 0 6.072483661745398e-12
after O 0 5.5521108544009934e-11
affinity O 0 4.974365017118565e-11
purification O 0 2.160762679892514e-09
against O 0 2.1638475455887374e-09
a O 0 1.4826492256148072e-09
pure O 0 8.948637031380713e-08
- O 0 9.302692838275561e-09
emerin O 0 2.20063469669185e-07
band O 0 7.884352015707918e-08
on O 0 8.33832292101988e-09
a O 0 2.3411536598239024e-10
western O 0 4.5104286972019736e-10
blot O 0 1.4035627771136205e-08
, O 0 1.8214324493115441e-10
it O 0 2.350624729585693e-11
stained O 0 3.527836156536068e-08
only O 0 2.6387897422708306e-10
the O 0 6.7109660051301034e-09
nuclear O 0 8.940785960476205e-07
membrane O 0 6.149129205823556e-08
. O 0 1.8353558672856707e-08

These O 0 1.7937148433233574e-09
results O 0 3.1841858039172166e-09
would O 0 5.6648352675381375e-11
not O 0 1.6426131288493906e-11
be O 0 4.880988408589859e-12
expected O 0 5.6765276507109164e-11
if O 0 2.2310348013476755e-11
immunostaining O 0 8.00991450944366e-09
at O 0 3.1365479102873906e-09
intercalated O 0 4.360765970545799e-09
discs O 0 9.146318369346318e-09
were O 0 1.6403473024340087e-10
due O 0 5.133181657512864e-10
to O 0 3.9723502265331945e-12
a O 0 3.1283354379185724e-11
product O 0 5.6222738270550465e-11
of O 0 3.711139728856949e-10
the O 0 7.020617975861398e-10
emerin O 0 4.512592965966178e-08
gene O 0 2.5696803018782077e-10
and O 0 2.1100182365230147e-11
, O 0 7.372821103635019e-12
therefore O 0 1.0037856830458214e-11
, O 0 2.9442737310703126e-12
cast O 0 1.0174036092769345e-11
some O 0 1.7526888143951092e-12
doubt O 0 6.71316127687227e-11
upon O 0 1.4863143701915327e-11
the O 0 3.1097149161274373e-11
hypothesis O 0 1.7109862138209309e-10
that O 0 1.1975513462825216e-11
cardiac B-Disease 1 1.0
defects I-Disease 1 0.999990701675415
in O 0 2.8666372031693754e-07
EDMD B-Disease 1 1.0
are O 0 4.254875340947706e-10
caused O 0 1.742568200846506e-09
by O 0 8.588164207568028e-11
absence O 0 5.6177480445285255e-08
of O 0 6.773221628009196e-08
emerin O 0 1.6266505554085597e-05
from O 0 1.1992469239885395e-08
intercalated O 0 1.5968332718330203e-06
discs O 0 2.043457789113745e-05
. O 0 4.86432497837086e-07

Although O 0 7.585489214534391e-08
emerin O 0 2.0872669210802997e-06
was O 0 3.5513846086132617e-08
abundant O 0 2.302859014591263e-09
in O 0 1.2637600688147899e-10
the O 0 5.889949639126257e-10
membranes O 0 7.863618645131965e-10
of O 0 4.650217544366342e-09
cardiomyocyte O 0 3.995721726823831e-07
nuclei O 0 3.573111140298124e-09
, O 0 2.8233401727639773e-10
it O 0 3.6212578075067725e-11
was O 0 3.377494550704796e-08
absent O 0 9.945368084629536e-09
from O 0 5.397037677878913e-11
many O 0 8.038465032500497e-11
non O 0 2.611783713746263e-07
- O 0 9.906220554967149e-08
myocyte O 0 5.415650775830727e-06
cells O 0 2.914041896673325e-09
in O 0 3.9006817220688106e-10
the O 0 2.749767347154375e-08
heart O 0 0.0006515987333841622
. O 0 3.283723799540894e-07

This O 0 6.035067445786524e-10
distribution O 0 4.2568575331358716e-09
of O 0 1.0669089611781146e-08
emerin O 0 1.5530282553299912e-06
was O 0 3.8415080894083076e-08
similar O 0 7.518126399208569e-11
to O 0 8.106732299340003e-12
that O 0 1.3666607776019468e-11
of O 0 1.5752801729718158e-08
lamin O 0 2.7685196982929483e-05
A O 0 9.625568253568417e-08
, O 0 2.1069467004419806e-10
a O 0 7.320896666662691e-10
candidate O 0 1.4019539973375572e-09
gene O 0 5.36560185171453e-10
for O 0 1.1408979316840373e-10
an O 0 1.6911558264887105e-10
autosomal O 0 2.6434580036038824e-07
form O 0 1.1612291217488746e-07
of O 0 0.0017746352823451161
EDMD B-Disease 1 1.0
. O 0 1.3566113011620473e-05

In O 0 3.505647327983752e-08
contrast O 0 7.693621029147835e-08
, O 0 1.0202992228869334e-07
lamin O 0 0.011724301613867283
B1 O 0 0.004444400779902935
was O 0 1.2268199043319328e-06
absent O 0 1.4775183387882862e-07
from O 0 6.352721682034712e-10
cardiomyocyte O 0 2.5718216534187377e-07
nuclei O 0 4.879953330316766e-09
, O 0 2.9859231753803783e-10
showing O 0 2.1537770678037305e-08
that O 0 4.187505897590427e-09
lamin O 0 0.039829254150390625
B1 O 0 7.222021395136835e-06
is O 0 4.274020026784342e-11
not O 0 1.6517547963071366e-12
essential O 0 1.998160525928938e-10
for O 0 3.014154204006303e-11
localization O 0 7.211610864032991e-08
of O 0 1.2824921125087485e-09
emerin O 0 7.266356760737835e-08
to O 0 4.96593044463367e-10
the O 0 4.192806457581355e-08
nuclear O 0 3.944093259633519e-05
lamina O 0 0.0002330885035917163
. O 0 7.803843686815526e-07

Lamin O 1 0.999947190284729
B1 O 1 0.5969371795654297
is O 0 1.3004449961329101e-08
also O 0 9.858730498635282e-10
almost O 0 2.165903900674948e-09
completely O 0 2.2790857201471226e-07
absent O 0 1.1983441083884827e-07
from O 0 4.328679636955712e-09
skeletal O 0 0.0681140348315239
muscle O 0 0.002088426146656275
nuclei O 0 4.101377635379322e-05
. O 0 1.26138888845162e-06

In O 0 3.9580532984473393e-07
EDMD B-Disease 1 1.0
, O 0 4.8531365592907605e-09
the O 0 1.1558011214773956e-09
additional O 0 3.8286665504649875e-10
absence O 0 8.852669708403482e-08
of O 0 2.2402205104299355e-06
lamin O 1 0.9998094439506531
B1 O 1 0.9907956719398499
from O 0 5.304856642851519e-08
heart O 1 0.9997286200523376
and O 0 6.915220751579909e-07
skeletal O 1 0.9999996423721313
muscle O 1 0.9646883606910706
nuclei O 0 2.378528552071657e-05
which O 0 1.101736213371396e-08
already O 0 1.0654244597674278e-08
lack O 0 6.746814733560313e-07
emerin O 0 1.7483474948676303e-05
may O 0 4.733600733608512e-10
offer O 0 5.514767462133641e-12
an O 0 1.439581960582803e-12
alternative O 0 4.116123830666396e-10
explanation O 0 6.495830956465554e-11
of O 0 2.3417520700341754e-10
why O 0 4.586132515416175e-11
these O 0 9.355098293251096e-12
tissues O 0 8.758507252792924e-10
are O 0 2.1338522962488504e-11
particularly O 0 2.2622353990087163e-10
affected O 0 1.8535102619399169e-10
. O 0 8.060024314637815e-10
. O 0 3.0263770156579994e-08

Genetic O 0 9.977291171026081e-08
mapping O 0 3.349101973526558e-08
of O 0 9.280756785301492e-08
the O 0 2.580794387085916e-07
copper B-Disease 0 1.9053723008255474e-05
toxicosis I-Disease 0 0.022649889811873436
locus O 0 5.090079184810747e-07
in O 0 2.593737669087659e-08
Bedlington O 0 1.3387596482061781e-05
terriers O 0 1.0878708280870342e-06
to O 0 6.605658797731451e-10
dog O 0 2.377429630939787e-08
chromosome O 0 8.127893913467688e-09
10 O 0 1.3095218243108775e-09
, O 0 5.392757421174288e-11
in O 0 4.339620329751881e-11
a O 0 5.247519641038423e-10
region O 0 3.6933609504075093e-09
syntenic O 0 8.102543347376923e-08
to O 0 1.407204075487556e-10
human O 0 3.8666096990880305e-09
chromosome O 0 4.1674603323826886e-08
region O 0 2.2738918303844002e-08
2p13 O 0 7.295553814401501e-07
- O 0 4.835869162889139e-07
p16 O 0 4.7341836761916056e-07
. O 0 1.0267336136848826e-07

Abnormal O 1 0.9999997615814209
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9858928322792053
accumulation I-Disease 0 6.383989784808364e-06
is O 0 1.9066264123068777e-09
recognized O 0 2.2923676290531603e-09
as O 0 3.707644469219673e-10
an O 0 2.9669742218629835e-09
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 1.0125983180842013e-06
man O 0 4.560476796200419e-08
, O 0 6.553553255628231e-10
mouse O 0 1.1980287695223524e-07
, O 0 3.848817708984598e-09
rat O 0 8.331775234182714e-07
and O 0 6.871160529442477e-09
dog O 0 2.912851869041333e-06
. O 0 2.2651914832749753e-07

The O 0 2.437823525269778e-07
major O 0 1.2379263125694706e-06
cause O 0 2.9608531804115046e-06
of O 0 0.0001806912914616987
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999275207519531
accumulation I-Disease 0 0.21656207740306854
in O 0 5.821234935865505e-06
man O 0 8.982055987871718e-07
is O 0 8.889632363562328e-10
a O 0 3.135112613961155e-09
dysfunctional O 0 6.19955642378045e-08
ATP7B O 0 0.006026437506079674
gene O 0 3.927411995618968e-08
, O 0 7.786961631062184e-10
causing O 0 8.395506512215434e-08
Wilson B-Disease 0 3.9305149357460323e-07
disease I-Disease 0 0.0001573420304339379
( O 0 3.2214495515603403e-09
WD B-Disease 1 0.9998886585235596
) O 0 1.692822770849034e-08
. O 0 1.2940198246269574e-07

Mutations O 0 1.607450883511774e-07
in O 0 1.138021499258457e-08
the O 0 4.487384686058249e-08
ATP7B O 0 5.847113789059222e-05
genes O 0 6.424271670191217e-10
have O 0 2.2073358765806184e-11
also O 0 8.287050733135626e-12
been O 0 4.543894774333701e-11
demonstrated O 0 7.212044850213317e-10
in O 0 6.54266252286817e-10
mouse O 0 2.9498681897166534e-07
and O 0 1.700265350734753e-08
rat O 0 7.999023182492238e-06
. O 0 1.886659219962894e-07

The O 0 5.116799002280459e-07
ATP7B O 0 0.0003052351239603013
gene O 0 3.0403207063045556e-08
has O 0 1.409191652257391e-10
been O 0 6.571650168485377e-11
excluded O 0 2.492886452820642e-10
in O 0 1.091192240731953e-11
the O 0 1.0837546832176415e-10
much O 0 2.1420742957189987e-10
rarer O 0 1.344587587936985e-07
human O 0 2.168118044210132e-06
copper B-Disease 1 0.7742475867271423
overload I-Disease 1 0.9999961853027344
disease O 1 1.0
non B-Disease 0 0.037686847150325775
- I-Disease 0 1.5596894797909044e-07
Indian I-Disease 0 4.4364987239475795e-09
childhood I-Disease 0 2.1842101887159515e-06
cirrhosis I-Disease 1 0.9999991655349731
, O 0 2.086213646279589e-09
indicating O 0 1.8321312467151074e-08
genetic O 0 2.146911697309406e-07
heterogeneity O 0 4.939739483234007e-06
. O 0 2.9036638693469285e-07

By O 0 1.4278835003267432e-08
investigating O 0 8.42172909187866e-08
the O 0 1.1729133575499873e-07
common O 0 8.474728929286357e-06
autosomal O 1 0.9998067021369934
recessive O 1 0.999983549118042
copper B-Disease 1 0.9999630451202393
toxicosis I-Disease 1 0.9999996423721313
( O 0 6.837822752459033e-09
CT B-Disease 0 0.00024261005455628037
) O 0 1.4849690921359127e-10
in O 0 5.785266710134351e-10
Bedlington O 0 1.2733593166558421e-06
terriers O 0 2.649166503942979e-07
, O 0 1.8798640422090784e-10
we O 0 3.111376434272728e-11
have O 0 2.9710242512720475e-12
identified O 0 7.550974602532623e-12
a O 0 4.3448361228271004e-12
new O 0 6.035107309732002e-12
locus O 0 1.0759738655607975e-09
involved O 0 1.2035031304868937e-10
in O 0 1.327812526596972e-08
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 9.68171934800921e-06

We O 0 1.6583715733986537e-08
examined O 0 6.8600822800135575e-09
whether O 0 2.508818430779769e-10
the O 0 1.4678829707293062e-08
WD B-Disease 1 0.9135604500770569
gene O 0 6.729163146701467e-07
ATP7B O 0 0.0012316281208768487
was O 0 1.2401105209391972e-07
also O 0 1.717168490733556e-10
causative O 0 1.3158086842324224e-09
for O 0 1.8623341757617595e-10
CT B-Disease 0 1.7786072703529499e-07
by O 0 1.9252333061103855e-10
investigating O 0 1.4808008153011087e-09
the O 0 2.0800630107231655e-09
chromosomal O 0 5.698383029084653e-05
co O 0 7.878766155045014e-06
- O 0 3.2121565141096653e-07
localization O 0 4.6713361371075734e-05
of O 0 3.3955620892811567e-07
ATP7B O 0 0.0002424384729238227
and O 0 7.535185253537691e-10
C04107 O 0 1.7920605444032844e-08
, O 0 4.295767908057968e-11
using O 0 1.0553950074987384e-11
fluorescence O 0 4.845023271471405e-10
in O 0 9.01172469980338e-11
situ O 0 1.6303147276630625e-08
hybridization O 0 1.8312255045671577e-09
( O 0 4.151018972997633e-10
FISH O 0 8.786843608277195e-08
) O 0 4.81929940399084e-10
. O 0 1.0550243345619492e-08

C04107 O 0 1.681036883383058e-05
is O 0 1.0378972348235038e-08
an O 0 6.501796878666255e-10
anonymous O 0 1.0140787765067216e-08
microsatellite O 0 1.8187322439189302e-06
marker O 0 2.661519147295621e-07
closely O 0 6.123401785629312e-09
linked O 0 3.9132647344786164e-08
to O 0 3.841205575838558e-09
CT B-Disease 1 0.6082169413566589
. O 0 6.843030178060872e-07

However O 0 6.330338351290266e-07
, O 0 1.964593536740722e-07
BAC O 0 2.500807386240922e-05
clones O 0 3.015136655903916e-07
containing O 0 7.683514269274383e-09
ATP7B O 0 6.563098850165261e-06
and O 0 2.15476214648902e-09
C04107 O 0 5.42927978131047e-08
mapped O 0 3.372651935507065e-09
to O 0 2.7977001271217716e-10
the O 0 1.1865101789965138e-08
canine O 0 2.4165265131159686e-06
chromosome O 0 4.1508059211992077e-07
regions O 0 3.782794877338347e-08
CFA22q11 O 0 2.6686027467803797e-06
and O 0 1.4083622046356936e-09
CFA10q26 O 0 5.665059461534838e-07
, O 0 6.439606625718852e-10
respectively O 0 1.0234714187262739e-09
, O 0 6.294798710060334e-11
demonstrating O 0 1.2373474467253232e-09
that O 0 9.965827468816357e-11
WD B-Disease 0 0.0027225720696151257
cannot O 0 5.447107209732849e-09
be O 0 2.7608215713570416e-10
homologous O 0 1.24705679116488e-09
to O 0 1.2002440152869553e-09
CT B-Disease 0 0.00015941607125569135
. O 0 2.9112834454281256e-07

The O 0 1.7603749711270211e-06
copper O 0 2.0731247332150815e-06
transport O 0 8.619882407856494e-08
genes O 0 8.414258623190563e-09
CTR1 O 0 9.377888090966735e-06
and O 0 2.363656159687366e-09
CTR2 O 0 2.8185866540297866e-05
were O 0 1.5011079046445275e-09
also O 0 8.194602635347437e-11
excluded O 0 2.1687054929664384e-10
as O 0 2.5041368284517418e-11
candidate O 0 7.316007522017998e-11
genes O 0 3.83702618289572e-12
for O 0 1.4132930936661126e-11
CT B-Disease 0 2.1044593268015888e-07
since O 0 1.191651222143264e-09
they O 0 1.3719862919370218e-11
both O 0 1.5831665839405318e-11
mapped O 0 5.539663727738287e-10
to O 0 5.225705979050588e-10
canine O 0 1.448122930014506e-06
chromosome O 0 1.318092245128355e-06
region O 0 5.518692205441766e-07
CFA11q22 O 0 8.085352601483464e-05
. O 0 7.010053195699584e-07

2 O 0 4.6175409806892276e-05
- O 0 6.867239335406339e-06
22 O 0 3.142081595797208e-06
. O 0 9.052304221768281e-07

5 O 0 0.00010099993232870474
. O 0 8.598200111009646e-06

A O 0 2.661001303749799e-07
transcribed O 0 4.692405575212888e-09
sequence O 0 5.529993685193801e-10
identified O 0 2.471025328798504e-10
from O 0 2.0347267273845837e-11
the O 0 6.444386135839864e-10
C04107 O 0 3.180096541655075e-08
- O 0 8.265121920203455e-09
containing O 0 8.912675042438423e-09
BAC O 0 2.2340375380736077e-06
was O 0 6.2425313807068505e-09
found O 0 1.9501938258725815e-11
to O 0 2.849358552922676e-12
be O 0 5.944942454982893e-12
homologous O 0 2.9880296154027874e-11
to O 0 1.1484887693646861e-11
a O 0 2.793983377991083e-10
gene O 0 3.222191402585395e-10
expressed O 0 3.0536479594944765e-11
from O 0 3.2886825207523174e-11
human O 0 1.3337487780873403e-09
chromosome O 0 1.605262589521317e-08
2p13 O 0 8.208818513821825e-08
- O 0 1.2773613278227458e-08
p16 O 0 5.614692266675547e-09
, O 0 1.1669737398634084e-10
a O 0 1.7371415417244407e-10
region O 0 1.0817396978168858e-09
devoid O 0 5.074467068766353e-08
of O 0 8.286111241595506e-10
any O 0 9.023149449838286e-10
positional O 0 9.775197895578458e-07
candidate O 0 1.7267318241920293e-07
genes O 0 3.836404260937343e-08
. O 0 4.3541778182998314e-08

Molecular O 0 3.427006944889399e-08
analysis O 0 6.445123879039727e-10
of O 0 7.158749593116909e-09
the O 0 2.0777086717771454e-08
APC B-Disease 0 9.479158080694106e-08
gene O 0 1.0569775055202513e-09
in O 0 1.6225948362702525e-10
205 O 0 5.047953721692977e-10
families O 0 6.184804838410551e-12
: O 0 1.5773734748925072e-11
extended O 0 2.710611957112974e-09
genotype O 0 2.0120030086445695e-08
- O 0 8.132515105785387e-09
phenotype O 0 1.6986503315052914e-09
correlations O 0 8.337810442071714e-10
in O 0 2.4396065723131244e-10
FAP B-Disease 0 1.0869230848697953e-08
and O 0 3.118142896663123e-11
evidence O 0 4.025621502812271e-11
for O 0 1.3017782164725933e-11
the O 0 2.013532812705776e-10
role O 0 1.0648165682525246e-09
of O 0 2.7670557400938378e-08
APC B-Disease 0 4.363965672382619e-06
amino O 0 1.506924149907718e-07
acid O 0 4.451936774785281e-08
changes O 0 3.1160073632463536e-08
in O 0 3.150305201415904e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9998108744621277
. O 0 2.636152203194797e-06

BACKGROUND O 0 5.825183052365901e-06
/ O 0 3.142920832033269e-06
AIMS O 0 8.518060923279336e-08
The O 0 1.0076789402901909e-09
development O 0 9.080213914103297e-09
of O 0 6.964426574995741e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.828842322026958e-08
a O 0 1.199147892094743e-09
variable O 0 1.109629277351587e-09
range O 0 6.475250335924443e-10
of O 0 6.0819366209941e-10
extracolonic O 0 2.3701866211922606e-06
manifestations O 0 0.13718639314174652
in O 0 7.485954824915098e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.3256440019613365e-06
FAP B-Disease 0 2.0956556909368373e-05
) O 0 8.616237584524455e-11
is O 0 1.1883746590946043e-11
the O 0 9.663966155093462e-11
result O 0 7.94204590981451e-10
of O 0 6.425671550402967e-09
the O 0 1.8362419140771635e-08
dominant O 0 1.967564458027482e-06
inheritance O 0 1.2017019912491378e-07
of O 0 1.216494001710089e-05
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 1.3365665552100836e-07
APC B-Disease 0 1.202236489916686e-06
) O 0 2.8583009292759698e-09
gene O 0 2.468588320425624e-07
mutations O 0 1.6570633931678458e-07
. O 0 3.061152256123023e-07

In O 0 3.829990546933004e-09
this O 0 6.912639904932405e-11
study O 0 2.0154797969462734e-11
, O 0 5.430014510948711e-12
direct O 0 2.6467526087481374e-11
mutation O 0 2.7560587492758692e-11
analysis O 0 4.534195935379515e-12
of O 0 7.021284248454052e-11
the O 0 1.2619035816285873e-09
APC B-Disease 0 1.302468088937303e-08
gene O 0 4.231017758371536e-10
was O 0 1.6534500435483324e-09
performed O 0 9.626551777941472e-10
to O 0 3.0220811964021266e-11
determine O 0 3.404773130100125e-10
genotype O 0 6.4635434782189805e-09
- O 0 1.6034042982226993e-09
phenotype O 0 2.3140503402352408e-10
correlations O 0 1.5948296849810362e-10
for O 0 8.688006564172568e-11
nine O 0 1.1859643267442266e-09
extracolonic O 0 1.410019052627831e-07
manifestations O 0 9.119406172430899e-07
and O 0 2.2461767168469038e-10
to O 0 1.3559192831025246e-11
investigate O 0 1.6531338797864947e-10
the O 0 3.8105696376078413e-10
incidence O 0 1.4798676772898034e-07
of O 0 1.6670199443069578e-08
APC B-Disease 0 1.784764975809594e-07
mutations O 0 5.924234436349707e-10
in O 0 2.294935796953723e-09
non O 1 0.9999736547470093
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00017664134793449193

METHODS O 0 9.916312819768791e-07
The O 0 1.8688571401526133e-07
APC B-Disease 0 5.828834446219844e-07
gene O 0 5.311373563188226e-09
was O 0 3.475015608600529e-09
analysed O 0 9.26624388331021e-10
in O 0 1.7937275276214137e-10
190 O 0 1.755468437281138e-09
unrelated O 0 2.1776307423948538e-09
FAP B-Disease 0 6.469763036420773e-08
and O 0 4.6498074834921965e-10
15 O 0 6.123298845750469e-08
non O 1 0.977135419845581
- O 1 0.9999994039535522
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 9.710781512239919e-08
using O 0 1.8176263827385242e-09
denaturing O 0 2.3322079414356267e-06
gradient O 0 2.2568892532603968e-08
gel O 0 2.376952190630277e-09
electrophoresis O 0 5.115549095435767e-10
, O 0 7.28356611134906e-11
the O 0 2.813593802386549e-10
protein O 0 3.910783641369875e-10
truncation O 0 1.948768968418335e-08
test O 0 1.0954473994573277e-09
, O 0 1.2346963729203964e-11
and O 0 5.8825444515520076e-12
direct O 0 2.652024710947387e-10
sequencing O 0 7.433153648150892e-09
. O 0 1.812323802141691e-08

RESULTS O 0 1.4494820788968354e-05
Chain O 0 1.577772195560101e-06
terminating O 0 1.5983401624453109e-07
signals O 0 2.1337701383572494e-08
were O 0 6.990126810713093e-10
only O 0 4.72429942388608e-11
identified O 0 6.09653605376792e-10
in O 0 6.438574673417463e-10
patients O 0 2.067334081701233e-10
belonging O 0 1.772181734693845e-09
to O 0 6.367384397520937e-11
the O 0 3.0352566682267934e-08
FAP B-Disease 0 4.340415671322262e-06
group O 0 9.345000329119557e-09
( O 0 3.501033074559956e-10
105 O 0 1.0862478916351392e-07
patients O 0 6.8003123132598375e-09
) O 0 5.446055273417016e-10
. O 0 1.4984683716079417e-08

Amino O 0 7.674874495933182e-07
acid O 0 6.827032272838096e-09
changes O 0 3.245810009655514e-10
were O 0 1.4971211770298254e-10
identified O 0 4.859699448411803e-11
in O 0 4.181834392658068e-11
four O 0 1.7344332914337457e-10
patients O 0 2.8273156385538734e-11
, O 0 1.862059811896799e-11
three O 0 2.1409868669608478e-11
of O 0 1.3387192687730476e-08
whom O 0 3.29186766734324e-09
belonged O 0 3.8702118843048083e-08
to O 0 1.2533514504031729e-10
the O 0 1.245645453451516e-08
non O 0 5.701194368157303e-06
- O 0 1.4626311894971877e-06
FAP O 0 1.5340319805545732e-05
group O 0 2.3372258795006928e-07
of O 1 0.9997301697731018
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.07139626145362854
. O 0 7.476651262550149e-07

Genotype O 0 2.5028713935171254e-05
- O 0 1.476915485909558e-06
phenotype O 0 6.418202502800341e-08
correlations O 0 9.5487635576319e-09
identified O 0 3.383313351701389e-10
significant O 0 1.4905879308635406e-10
differences O 0 1.644498148767326e-10
in O 0 1.1729139881566653e-10
the O 0 4.1641270986936263e-10
nature O 0 1.1562685253707627e-09
of O 0 8.674334028846431e-10
certain O 0 1.0452633203428263e-09
extracolonic O 0 1.7013380784192123e-06
manifestations O 0 1.6519101336598396e-05
in O 0 2.650889463495787e-08
FAP B-Disease 0 8.41592645883793e-06
patients O 0 1.2823503370285039e-09
belonging O 0 2.497309026239236e-09
to O 0 3.4187577768740596e-10
three O 0 8.13229750207256e-09
mutation O 0 7.087951985340624e-07
subgroups O 0 1.1571664799703285e-05
. O 0 8.766301107243635e-07

CONCLUSIONS O 0 1.1765627050408511e-06
Extended O 0 1.481354559018655e-07
genotype O 0 2.5644152401582687e-07
- O 0 2.594247305864883e-08
phenotype O 0 4.220469307369967e-09
correlations O 0 7.484507458244138e-10
made O 0 8.050601851827821e-11
in O 0 3.8743942082364313e-11
this O 0 7.195384479213862e-12
study O 0 1.572000168925669e-11
may O 0 1.796832474476595e-11
have O 0 1.54450790264965e-12
the O 0 2.498712001197667e-11
potential O 0 2.5444398324414585e-11
to O 0 1.5599951885825192e-12
determine O 0 4.3097931473612405e-11
the O 0 8.435462051092912e-11
most O 0 6.8369385673727745e-12
appropriate O 0 4.434006981024474e-11
surveillance O 0 5.706875860767013e-09
and O 0 2.4662932807117954e-10
prophylactic O 0 1.4406199397853925e-06
treatment O 0 9.860750793677653e-08
regimens O 0 4.094399130849524e-08
for O 0 3.555040428704359e-10
those O 0 5.6158432071296005e-11
patients O 0 1.1530695669115243e-11
with O 0 2.540990204705218e-12
mutations O 0 1.4396274450323432e-10
associated O 0 3.5416669597054806e-10
with O 0 1.239094660210327e-10
life O 0 1.5766870475886208e-08
threatening O 0 6.031356747371319e-07
conditions O 0 9.282025530410465e-06
. O 0 2.736953774729045e-07

This O 0 1.5023109423140113e-09
study O 0 5.089554333537194e-10
also O 0 2.4039827420385684e-11
provided O 0 9.75195098285031e-12
evidence O 0 7.82262657428312e-11
for O 0 1.7220251266603093e-11
the O 0 2.4146176724748614e-10
pathological O 0 1.1553903505046037e-06
nature O 0 1.964179929814236e-09
of O 0 3.2133307126258615e-09
amino O 0 3.0387594662784068e-09
acid O 0 2.454912106930607e-10
changes O 0 7.846056443439053e-11
in O 0 1.3498019368896053e-10
APC O 0 5.361850075047414e-09
associated O 0 4.243073253862306e-11
with O 0 1.2788122991103101e-11
both O 0 5.005003078650816e-10
FAP B-Disease 0 3.781980240091798e-07
and O 0 3.6696130578661723e-09
non O 1 0.9999980926513672
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 4.320769221521914e-06
. O 0 4.058576585919127e-09
. O 0 2.4259669828552433e-08

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 0.021859483793377876
cancer B-Disease 1 0.9999992847442627
risk O 0 9.368037353851832e-06
of O 0 1.7778097571863327e-06
the O 0 9.127618795901071e-06
APC O 0 5.49374999536667e-05
I1307K O 0 2.053718526440207e-05
polymorphism O 0 4.932640877086669e-06
. O 0 4.345789932358457e-07

Germ O 0 0.0008509029285050929
- O 0 1.8437104927215842e-06
line O 0 1.484206677559996e-07
and O 0 1.5943408815388693e-09
somatic O 0 9.135163736573304e-08
truncating O 0 9.018133795279937e-08
mutations O 0 1.2183988262748358e-09
of O 0 5.545205628010308e-09
the O 0 2.5278854565158326e-08
APC B-Disease 0 3.62561820566043e-07
gene O 0 3.3770612972716663e-09
are O 0 2.2954280837206298e-11
thought O 0 9.434826531151685e-11
to O 0 5.268125519153344e-11
initiate O 0 6.309857667474716e-07
colorectal B-Disease 1 1.0
tumor I-Disease 0 0.14474573731422424
formation O 0 4.849086394642654e-07
in O 0 4.3451930764604185e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 1.572304768160393e-06
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 2.389887043818817e-08
respectively O 0 5.430274185869166e-08
. O 0 6.082801462525822e-08

Recently O 0 2.3174366958755854e-07
, O 0 2.5456363683673544e-09
an O 0 1.4218602961690863e-09
isoleucine O 0 2.8494598609540844e-06
- O 0 4.5479160348804726e-07
- O 0 8.093296628430835e-07
> O 0 1.3743948557021213e-06
lysine O 0 7.997458624231513e-07
polymorphism O 0 1.3917478725034016e-08
at O 0 1.620957057468786e-08
codon O 0 2.163476064964698e-09
1307 O 0 2.5151296600967044e-09
( O 0 9.118695382115405e-12
I1307K O 0 4.239548156981243e-10
) O 0 1.3339934625683503e-12
of O 0 7.67018185077184e-11
the O 0 1.51843460027834e-09
APC B-Disease 0 1.677747185624412e-08
gene O 0 2.224203876632913e-10
has O 0 6.3935462826791856e-12
been O 0 7.034054328586281e-12
identified O 0 6.280728107738165e-12
in O 0 9.31024094624755e-12
6 O 0 2.9143698565547993e-09
% O 0 8.631337311548748e-11
- O 0 5.854377538305755e-10
7 O 0 1.2884361133558286e-08
% O 0 2.198408538545138e-10
of O 0 1.4873368092693795e-09
the O 0 7.563555115552845e-09
Ashkenazi O 0 1.5225507965510587e-08
Jewish O 0 1.9265269379786787e-09
population O 0 5.107808065396569e-10
. O 0 3.220241140411417e-08

To O 0 4.772394923691081e-09
assess O 0 1.2767280566094996e-08
the O 0 4.374011375318787e-09
risk O 0 1.8236061549714577e-09
of O 0 6.668346430593886e-10
this O 0 1.3298945278350516e-10
common O 0 1.216228451283996e-08
APC B-Disease 0 4.167008000877104e-07
allelic O 0 1.7508633618490421e-06
variant O 0 1.6848149243742228e-05
in O 0 3.222972964067594e-07
colorectal O 1 1.0
carcinogenesis O 1 0.9999903440475464
, O 0 2.1467219113446845e-09
we O 0 1.4500774192516275e-10
have O 0 1.0378997140902957e-11
analyzed O 0 1.7210147196244918e-10
a O 0 6.784021261418971e-11
large O 0 2.00258254423602e-10
cohort O 0 6.530322949060974e-09
of O 0 7.800255552581348e-09
unselected O 0 2.5375878976774402e-05
Ashkenazi O 0 1.1923002318781073e-07
Jewish O 0 4.318322144314379e-09
subjects O 0 1.883271671943021e-08
with O 0 3.862150155242716e-09
adenomatous B-Disease 1 0.9756338596343994
polyps I-Disease 0 0.01392296701669693
and O 0 1.3374279461686456e-08
. O 0 1.2446389519027434e-07
or O 1 0.9999873638153076
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 9.854696259026241e-08
for O 0 6.586162282218311e-09
the O 0 2.2040792657662678e-07
APC O 0 4.4750518100045156e-06
I1307K O 0 1.4171562270348659e-06
polymorphism O 0 9.478251286054729e-07
. O 0 1.3879549953799142e-07

The O 0 2.2526160137203988e-06
APC O 0 3.181624379067216e-06
I1307K O 0 4.2877195483015385e-07
allele O 0 1.8333093265709977e-08
was O 0 8.824225794512586e-09
identified O 0 3.281541149924294e-10
in O 0 8.194352141277506e-11
48 O 0 1.0769758418405218e-09
( O 0 1.2131290763606195e-11
10 O 0 6.43166075953161e-11
. O 0 8.252381417106491e-12
1 O 0 7.622378284111164e-10
% O 0 1.9068243511943805e-11
) O 0 5.81310173608518e-12
of O 0 7.921667211086003e-10
476 O 0 4.3936378091302686e-08
patients O 0 5.1886555496594156e-08
. O 0 6.231946514390074e-08

Compared O 0 1.0409418882417754e-09
with O 0 1.5039722939258482e-11
the O 0 9.075893508958544e-11
frequency O 0 4.590379187874305e-10
in O 0 1.8289651043668087e-11
two O 0 1.0038885955160337e-12
separate O 0 3.5347258973972284e-12
population O 0 1.3682302903508803e-12
control O 0 5.053425455869842e-10
groups O 0 1.573242057462121e-11
, O 0 3.177139107357618e-11
the O 0 2.118153430430425e-09
APC O 0 1.4112514179487334e-07
I1307K O 0 2.816603483779545e-08
allele O 0 6.026187882035572e-10
is O 0 1.96043029900006e-12
associated O 0 2.289275106287514e-12
with O 0 4.4578563388429637e-13
an O 0 1.8284132888291005e-12
estimated O 0 6.418671150143496e-11
relative O 0 2.0970809533338297e-09
risk O 0 4.456615965153787e-09
of O 0 7.658172762603499e-09
1 O 0 2.529933408368379e-05
. O 0 9.421766122841291e-08

5 O 0 1.8498025383451022e-05
- O 0 8.343945410160813e-06
1 O 0 1.199584312416846e-05
. O 0 9.090152275348373e-07

7 O 0 1.1853240721393377e-05
for O 0 9.291184710491507e-07
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.998704195022583
( O 0 1.5037910472415206e-08
both O 0 7.263706969240502e-09
P O 0 1.9549903299775906e-05
= O 0 2.0002406841967968e-08
. O 0 5.47429934716348e-10
01 O 0 1.6711082650999742e-07
) O 0 5.904008948398598e-10
. O 0 5.050440510245835e-09

Furthermore O 0 4.271825915225236e-08
, O 0 1.0615739398645019e-09
compared O 0 3.027095518692846e-10
with O 0 1.6597244412164258e-10
noncarriers O 0 2.622068450364168e-06
, O 0 1.2215245703828259e-08
APC O 0 1.7622936354655394e-07
I1307K O 0 3.1217062712585175e-08
carriers O 0 8.882068691651313e-11
had O 0 2.0777215017919737e-11
increased O 0 1.5068205364010545e-11
numbers O 0 1.376292396021439e-11
of O 0 1.3000449605726772e-09
adenomas B-Disease 1 0.9998918771743774
and O 0 5.334816705726553e-06
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999994039535522
per O 0 1.7105074023859856e-09
patient O 0 1.934887450261158e-08
( O 0 2.3653731751061e-10
P O 0 9.84608141152421e-06
= O 0 2.40149655716948e-09
. O 0 4.163950434454833e-11
03 O 0 2.4583575175540773e-09
) O 0 7.021745381322053e-13
, O 0 4.262057015907289e-13
as O 0 6.865199598041216e-13
well O 0 1.6576126322248586e-12
as O 0 1.4297507622273997e-11
a O 0 2.7785715395189925e-10
younger O 0 1.6705226091318082e-10
age O 0 4.452435753421469e-09
at O 0 2.2040666181055713e-07
diagnosis O 0 4.719398475572234e-06
. O 0 4.5798454806345035e-08

We O 0 1.0022987773083969e-08
conclude O 0 1.05279491791066e-08
that O 0 6.12629252882968e-11
the O 0 3.8107170752255115e-09
APC O 0 2.1755899126674194e-07
I1307K O 0 1.4389814850801486e-07
variant O 0 4.0859509908841574e-07
leads O 0 7.31521954122627e-09
to O 0 9.012102869521144e-11
increased O 0 1.545672745351112e-07
adenoma B-Disease 1 1.0
formation O 0 1.1896310780912245e-07
and O 0 7.574595395354322e-10
directly O 0 2.776313554053722e-11
contributes O 0 2.541096673358556e-12
to O 0 9.781564664149145e-13
3 O 0 2.878833282871085e-10
% O 0 8.004479891410288e-12
- O 0 3.052093300315306e-11
4 O 0 2.190848752414709e-10
% O 0 5.7363215739958395e-12
of O 0 9.34459939982979e-11
all O 0 2.6938032360313e-10
Ashkenazi O 0 4.783689178111672e-07
Jewish O 0 3.187503170920536e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 7.799462764523923e-05

The O 0 4.612658699443273e-08
estimated O 0 1.0915581327708423e-08
relative O 0 3.738624343441188e-08
risk O 0 1.0960080842892239e-08
for O 0 3.9955913577749413e-10
carriers O 0 6.860314538670309e-10
may O 0 2.504544072134962e-10
justify O 0 2.7106675237753564e-10
specific O 0 6.89037672405024e-12
clinical O 0 8.999070377768703e-10
screening O 0 1.3712857238612486e-10
for O 0 6.9454654701150975e-12
the O 0 5.900864519237103e-11
360 O 0 1.2808169802536185e-10
, O 0 6.9248296333257464e-12
000 O 0 4.560565466937838e-11
Americans O 0 2.642171420888517e-12
expected O 0 1.3932941606009663e-11
to O 0 4.077098467863971e-12
harbor O 0 5.3707549518833275e-09
this O 0 5.547704656772012e-12
allele O 0 5.4274595234771184e-11
, O 0 1.9749056990453484e-12
and O 0 1.2892126602381815e-12
genetic O 0 9.91484533363618e-11
testing O 0 1.2017781214623824e-10
in O 0 3.8791465699350436e-12
the O 0 5.042812348254877e-11
setting O 0 9.533455136434554e-10
of O 0 4.847611756453318e-10
long O 0 8.117891775460961e-11
- O 0 3.1371208408792484e-10
term O 0 5.860890661679719e-10
- O 0 2.9605848328451145e-10
outcome O 0 7.389849843164598e-10
studies O 0 2.6103794473208985e-11
may O 0 2.004958699064474e-11
impact O 0 3.4041564012099457e-10
significantly O 0 6.282327991158354e-10
on O 0 0.04183587804436684
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 0.014899839647114277
in O 0 8.022092018444837e-11
this O 0 1.6025802213048834e-11
population O 0 5.142723746853761e-11
. O 0 5.154198845502833e-09

Localization O 0 2.0975934603484347e-05
of O 0 1.659581130297738e-07
human O 0 7.534818280419131e-08
BRCA1 O 0 1.759055656691544e-08
and O 0 2.9663049794237395e-10
its O 0 8.284594121832356e-10
loss O 0 2.4098719464404894e-08
in O 0 4.330149572240316e-09
high O 0 9.907966159516945e-06
- O 0 6.735917850164697e-07
grade O 0 1.3850560208084062e-05
, O 0 1.707779695436784e-08
non B-Disease 1 0.7987714409828186
- I-Disease 1 0.9357892870903015
inherited I-Disease 1 0.9999904632568359
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.0002549366618040949

Although O 0 1.0711747044922504e-08
the O 0 2.629039874690875e-09
link O 0 4.505469330950973e-09
between O 0 1.691840778583753e-09
the O 0 5.989193141431315e-08
BRCA1 O 0 8.819835670692555e-07
tumour B-Disease 1 1.0
- O 0 1.7970823762425425e-07
suppressor O 0 2.66021487504986e-07
gene O 0 5.060063479334076e-09
and O 0 7.85221332399999e-10
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 5.958951874163176e-07
established O 0 1.5069895553665447e-08
, O 0 1.640080606046812e-11
the O 0 6.679391761910125e-11
role O 0 1.1760703522156746e-10
, O 0 5.025497379351762e-12
if O 0 9.241801117790271e-13
any O 0 9.159117908552616e-12
, O 0 1.2019288342379753e-11
of O 0 7.174000282716975e-10
BRCA1 O 0 1.4751861066031324e-08
in O 0 1.3723645553298525e-09
non B-Disease 0 0.00018859990814235061
- I-Disease 0 6.240958464331925e-05
familial I-Disease 1 0.999881386756897
cancers I-Disease 1 1.0
is O 0 8.737741552522493e-08
unclear O 0 1.935644746708931e-07
. O 0 1.093538202212585e-07

BRCA1 O 0 5.7463043958705384e-06
mutations O 0 2.138720844868658e-08
are O 0 3.296375325478884e-11
rare O 0 1.008134575819497e-09
in O 0 1.810435690252632e-10
sporadic B-Disease 0 8.009030352695845e-06
cancers I-Disease 0 0.006157510448247194
, O 0 7.801039814125943e-10
but O 0 2.902076357003125e-10
loss O 0 1.3405851007064484e-07
of O 0 1.2805151072825538e-06
BRCA1 O 0 1.1528760524015524e-07
resulting O 0 7.41389283298588e-10
from O 0 3.0687997282230484e-11
reduced O 0 2.1079809009449946e-09
expression O 0 8.889903257980336e-10
or O 0 5.15649432875076e-11
incorrect O 0 9.050797333820526e-10
subcellular O 0 2.565601846526988e-07
localization O 0 3.820143774646567e-07
is O 0 4.442952949990087e-12
postulated O 0 2.2266475122045826e-11
to O 0 7.921443449104837e-13
be O 0 1.170746984600901e-12
important O 0 6.7240761569831164e-12
in O 0 6.322570939021332e-11
non B-Disease 0 1.3617576541946619e-06
- I-Disease 0 5.6850149121601135e-06
familial I-Disease 1 0.9999877214431763
breast I-Disease 1 1.0
and I-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9993150234222412

Epigenetic O 0 3.182245563948527e-05
loss O 0 5.131716534378938e-06
, O 0 1.7947792141370655e-09
however O 0 2.863450587753391e-10
, O 0 1.8714167368538703e-11
has O 0 3.232986144421912e-12
not O 0 8.847819395543799e-13
received O 0 9.872738911120837e-12
general O 0 5.61238722163182e-10
acceptance O 0 9.213724783130317e-10
due O 0 2.1115622583778304e-09
to O 0 8.435296731945652e-12
controversy O 0 1.0936347660805978e-10
regarding O 0 4.688490914950272e-11
the O 0 2.9712654558977647e-10
subcellular O 0 1.3477342974965723e-07
localization O 0 1.0298737151970272e-07
of O 0 7.177740624086937e-09
BRCA1 O 0 2.7412825343020586e-09
proteins O 0 1.0638389474904031e-11
, O 0 6.704354085784736e-12
reports O 0 1.0320918598927253e-11
of O 0 1.7106599470295691e-10
which O 0 3.1682011181199954e-11
have O 0 2.0506346620763338e-11
ranged O 0 2.8185084821608086e-10
from O 0 1.5232337960413567e-11
exclusively O 0 1.7857465506310177e-10
nuclear O 0 1.5019908872204724e-08
, O 0 2.080846606133946e-11
to O 0 8.585932312343836e-12
conditionally O 0 2.047792158066386e-08
nuclear O 0 3.15731760736071e-08
, O 0 3.132216708223723e-11
to O 0 2.327079674790955e-11
the O 0 5.79648062881688e-09
ER O 0 3.787512923736358e-06
/ O 0 1.2727483067465073e-07
golgi O 0 2.748268457253289e-07
, O 0 7.93364207662961e-10
to O 0 2.452347769299479e-10
cytoplasmic O 0 4.671199249628444e-08
invaginations O 0 1.2156422712905623e-07
into O 0 6.192259482951101e-10
the O 0 4.708471390557634e-09
nucleus O 0 3.218926636350261e-08
. O 0 2.9362936970755982e-08

In O 0 3.647361879188793e-08
an O 0 1.6208232533898581e-09
attempt O 0 1.3823560074399666e-08
to O 0 2.080212807564763e-10
resolve O 0 3.6556271343357594e-09
this O 0 9.92843238178942e-11
issue O 0 4.0380201959955286e-10
, O 0 5.3250015508155e-11
we O 0 2.2299884161469663e-11
have O 0 5.330435745576345e-12
comprehensively O 0 1.3490748962396992e-08
characterized O 0 5.169892958178934e-09
19 O 0 8.202589185657416e-08
anti O 0 2.4791747819108423e-06
- O 0 1.2941669638166786e-06
BRCA1 O 0 8.462207006232347e-07
antibodies O 0 4.8275847319700915e-08
. O 0 1.3031606727054168e-07

These O 0 1.9682723007008462e-08
reagents O 0 1.66065134976634e-07
detect O 0 6.283759290681701e-08
a O 0 1.2488761136353332e-08
220 O 0 2.9668951739836302e-09
- O 0 9.4913659154372e-09
kD O 0 3.241847679191778e-08
protein O 0 1.5385650531385409e-09
localized O 0 1.593074117067772e-08
in O 0 2.6927041152369213e-10
discrete O 0 1.295913776289126e-08
nuclear O 0 3.216270272332622e-07
foci O 0 7.839260973696582e-08
in O 0 2.5183349849910996e-10
all O 0 1.2367429302884148e-10
epithelial O 0 3.602057674356729e-08
cell O 0 8.68559979494421e-08
lines O 0 2.9156083103387687e-10
, O 0 8.206813700839533e-12
including O 0 1.071181164602475e-11
those O 0 8.86241687675371e-12
derived O 0 8.864720763002154e-11
from O 0 6.653240736120836e-10
breast B-Disease 0 1.3326859516382683e-05
malignancies I-Disease 0 0.0007006399682722986
. O 0 2.0866179966105847e-06

Immunohistochemical O 0 0.00010311548976460472
staining O 0 4.012070803582901e-06
of O 0 2.7665180368785514e-06
human O 0 9.524640518066008e-06
breast O 0 4.277690550225088e-06
specimens O 0 1.4607553389112127e-08
also O 0 5.047147588754797e-09
revealed O 0 1.5022807531295257e-07
BRCA1 O 0 9.440803978577605e-07
nuclear O 0 1.8665963580133393e-05
foci O 0 2.359742393309716e-05
in O 0 1.993871912020495e-08
benign O 1 0.9999998807907104
breast O 1 0.9999973773956299
, O 0 5.899641109863296e-06
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 0.00012207665713503957
low B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
grade I-Disease 1 1.0
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 8.373029413633049e-05

Conversely O 0 3.7213084169707145e-07
, O 0 8.788516581148542e-09
BRCA1 O 0 3.887324240281487e-08
expression O 0 3.516024804639528e-09
was O 0 3.2523994608624207e-09
reduced O 0 8.228342451843673e-10
or O 0 6.910474362881169e-12
undetectable O 0 3.669983872356397e-09
in O 0 6.802934951477546e-12
the O 0 4.1814676721152466e-11
majority O 0 5.0914420249292824e-12
of O 0 2.6014737586343983e-10
high O 0 4.77664116260712e-07
- O 0 9.749755491839096e-08
grade O 0 1.1346531891831546e-06
, O 0 8.022221997805445e-09
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 1.7082577574711877e-09
suggesting O 0 3.3662173049009425e-10
that O 0 7.938706116095151e-12
absence O 0 1.3007079857629833e-08
of O 0 9.037280790380464e-08
BRCA1 O 0 3.271800963489113e-08
may O 0 4.217528062899767e-11
contribute O 0 3.817462405214522e-12
to O 0 2.5358192108637656e-12
the O 0 3.6716205076281483e-10
pathogenesis O 0 1.070816097126226e-06
of O 0 3.844032592237312e-10
a O 0 7.67708951965318e-11
significant O 0 1.8762605358269013e-10
percentage O 0 3.926411973331767e-10
of O 0 8.527680783743108e-09
sporadic B-Disease 1 0.9999866485595703
breast I-Disease 1 0.9999994039535522
cancers I-Disease 1 0.9999884366989136
. O 0 4.5076035348756704e-07
. O 0 1.9915039501938736e-06

